data_2n5f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n5f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.217 -0.657 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.28 0.7 OUTLIER -171.27 -148.49 0.05 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.372 1.442 . . . . 0.0 109.937 160.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.33 143.96 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -133.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -126.15 110.98 14.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.845 -3.391 . . . . 0.0 101.845 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.3 167.24 26.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.76 139.56 44.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.81 156.34 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.03 127.17 30.25 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 164.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.03 119.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.22 75.39 Favored Glycine 0 C--O 1.25 1.102 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.01 76.79 8.63 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.745 -0.727 . . . . 0.0 111.605 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.9 53.7 2.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.623 2.882 . . . . 0.0 116.52 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -128.51 -37.59 1.79 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.483 -0.76 . . . . 0.0 112.13 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.2 mt -95.92 142.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.38 152.39 17.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.25 176.16 48.38 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.44 31.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.551 -1.825 . . . . 0.0 115.573 -172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.7 t -96.01 145.75 30.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.632 -0.667 . . . . 0.0 112.38 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -68.33 -47.96 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 117.028 -1.514 . . . . 0.0 115.191 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -19.93 60.49 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.824 -0.547 . . . . 0.0 110.208 -172.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.4 t -55.7 -55.59 30.45 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.656 0.597 . . . . 0.0 109.708 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.56 -15.14 59.93 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -61.43 -52.74 63.29 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.283 1.401 . . . . 0.0 109.782 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -79.2 -31.84 14.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.691 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -62.13 -44.83 95.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.932 0.787 . . . . 0.0 110.444 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.041 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -61.33 -36.33 79.84 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.396 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.2 -40.09 31.66 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.69 -0.631 . . . . 0.0 111.799 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -70.12 -31.25 68.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.32 0.509 . . . . 0.0 111.642 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.34 -34.6 77.66 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.917 -1.114 . . . . 0.0 110.761 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -82.29 -14.32 55.58 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.101 -0.999 . . . . 0.0 112.647 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 56.49 57.87 4.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.647 . . . . 0.0 112.918 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 pt -94.71 161.83 27.47 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.82 151.24 68.67 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 115.858 -2.295 . . . . 0.0 110.942 164.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -147.36 154.84 41.39 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -100.07 -92.77 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -165.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 178.37 7.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -153.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -134.13 174.75 10.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.095 0.958 . . . . 0.0 113.524 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.54 152.32 0.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -94.98 117.92 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 166.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.04 72.28 10.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.5 67.17 1.0 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 167.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.82 -2.41 84.29 Favored Glycine 0 C--O 1.228 -0.279 0 O-C-N 121.186 -0.946 . . . . 0.0 113.411 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -87.19 92.2 8.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -122.08 83.96 45.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 122.132 0.967 . . . . 0.0 113.078 -170.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.69 172.74 13.8 Favored 'Trans proline' 0 C--O 1.238 0.488 0 N-CA-C 110.33 -0.681 . . . . 0.0 110.33 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -55.69 -34.07 64.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -54.63 -53.04 59.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 118.716 0.689 . . . . 0.0 111.884 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -73.33 -29.14 62.47 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.644 -1.285 . . . . 0.0 112.671 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.45 -25.84 64.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.581 1.082 . . . . 0.0 111.855 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -74.34 -41.36 61.2 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.761 -0.587 . . . . 0.0 109.525 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -74.01 -54.64 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -100.86 136.18 19.86 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.871 0.868 . . . . 0.0 111.971 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.59 -24.6 15.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 116.256 -2.029 . . . . 0.0 116.304 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -104.97 -5.37 21.06 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.13 -5.21 51.12 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 122.798 1.221 . . . . 0.0 113.284 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -148.85 37.31 0.8 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.786 1.234 . . . . 0.0 111.629 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.85 136.21 28.47 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -58.26 149.38 73.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 114.354 0.867 . . . . 0.0 114.354 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 m -136.14 169.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.92 141.81 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 156.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -103.27 93.65 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.25 96.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.078 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.07 37.36 24.61 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.545 1.164 . . . . 0.0 112.125 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t0 67.94 41.25 2.13 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 126.156 1.782 . . . . 0.0 115.661 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -131.16 153.02 49.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 167.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.63 126.46 20.77 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.37 149.58 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.12 81.77 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -151.28 152.59 33.43 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 168.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.2 p -55.3 -29.99 59.29 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -165.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.18 -35.52 10.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.286 0.565 . . . . 0.0 112.165 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.53 -37.48 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.604 0.716 . . . . 0.0 110.528 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.17 -29.99 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.8 t -88.45 -49.57 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.493 0.717 . . . . 0.0 111.77 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.83 -34.12 71.48 Favored Glycine 0 C--O 1.235 0.213 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.936 -168.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.26 -30.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.52 -44.25 97.41 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 121.895 -0.503 . . . . 0.0 109.851 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -62.87 -46.3 88.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.349 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.85 -37.17 85.79 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.479 -0.763 . . . . 0.0 112.33 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.59 7.32 46.67 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -81.61 129.23 66.44 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.14 -17.08 22.21 Favored 'Trans proline' 0 C--O 1.244 0.8 0 N-CA-C 116.023 1.509 . . . . 0.0 116.023 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.41 148.87 67.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -60.22 116.78 3.56 Favored 'Trans proline' 0 C--O 1.243 0.753 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.58 170.36 11.66 Favored 'Trans proline' 0 C--O 1.249 1.033 0 N-CA-C 115.114 1.159 . . . . 0.0 115.114 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.5 tp -141.54 69.91 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 122.598 1.19 . . . . 0.0 110.005 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.47 65.06 6.45 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.277 -1.328 . . . . 0.0 112.46 -175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 m -120.12 100.54 47.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.21 86.18 0.06 OUTLIER 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.512 3.475 . . . . 0.0 117.989 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -88.55 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.004 1 C-N-CA 127.23 5.286 . . . . 0.0 111.739 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -45.36 -34.8 3.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.52 -30.17 71.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 120.559 -1.338 . . . . 0.0 112.366 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.35 -28.64 34.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.053 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -72.06 -32.38 67.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.125 0.875 . . . . 0.0 109.638 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.44 -40.62 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.318 -0.864 . . . . 0.0 109.684 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.02 -30.84 70.99 Favored Glycine 0 CA--C 1.521 0.425 0 O-C-N 121.793 -0.567 . . . . 0.0 114.313 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -73.12 -9.49 58.77 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -80.76 -46.62 15.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt -75.63 -42.12 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.925 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.13 -53.26 67.2 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.78 -18.99 21.55 Favored 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 112.637 -4.442 . . . . 0.0 113.636 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.0 t -66.96 -56.55 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.015 0.526 . . . . 0.0 111.804 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -72.92 -23.97 60.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.79 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -68.23 -47.25 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -63.26 -44.39 95.28 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -69.79 -34.89 74.35 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.06 -34.45 76.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.195 0.907 . . . . 0.0 110.286 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.78 -24.89 61.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.631 0.772 . . . . 0.0 111.762 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -87.77 127.54 35.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -116.71 39.13 3.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.51 -175.31 0.18 Allowed Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 127.053 2.141 . . . . 0.0 109.68 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.08 41.26 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 114.675 0.99 . . . . 0.0 114.675 146.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -71.79 105.75 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.653 -1.279 . . . . 0.0 112.595 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.98 -54.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.4 -36.33 93.06 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.654 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.3 p -77.85 -21.92 50.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.383 0.592 . . . . 0.0 112.204 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.63 -35.75 75.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.659 1.695 . . . . 0.0 107.02 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -79.77 -3.69 48.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.72 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.48 -31.33 24.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.882 -1.136 . . . . 0.0 108.081 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.55 -41.24 88.95 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.335 -0.853 . . . . 0.0 110.065 165.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.82 -36.53 72.37 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.91 -0.493 . . . . 0.0 110.925 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -64.0 -36.24 83.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -78.02 -33.71 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.3 -24.59 61.35 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.63 -0.668 . . . . 0.0 111.001 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.09 -33.06 71.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.579 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.28 80.45 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.108 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.94 -34.55 78.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.397 1.094 . . . . 0.0 111.744 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.76 -38.66 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.26 -36.49 93.28 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.803 -1.09 . . . . 0.0 114.665 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -69.15 -46.22 68.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.864 1.332 . . . . 0.0 110.643 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 178' ' ' HIS . 5.8 tt -68.41 -38.39 81.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.558 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -68.74 -20.07 64.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.798 1.181 . . . . 0.0 112.851 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -81.73 -52.26 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.91 -31.84 40.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.17 -81.95 0.3 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-O 117.881 -1.511 . . . . 0.0 114.319 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -77.47 -174.25 2.13 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.214 3.276 . . . . 0.0 114.18 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -33.12 165.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 119.463 3.134 . . . . 0.0 119.463 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.02 -41.37 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 121.232 -0.918 . . . . 0.0 111.113 -152.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.75 -0.27 2.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.94 47.92 Favored Glycine 0 N--CA 1.453 -0.17 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.15 -39.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.692 0.746 . . . . 0.0 112.559 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -160.95 176.84 10.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 114.11 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.2 p -123.12 -168.51 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.82 -24.94 10.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.19 -55.04 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.171 0.896 . . . . 0.0 109.614 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.46 -38.22 84.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.68 -18.93 65.63 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.799 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 97.0 p -86.24 -39.58 16.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.252 0.933 . . . . 0.0 111.957 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.83 -45.45 8.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -168.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.45 91.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.67 -35.51 98.54 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 115.988 -2.208 . . . . 0.0 116.548 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -84.98 -22.78 29.0 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.754 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.97 -28.61 68.41 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.145 -0.972 . . . . 0.0 112.697 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.55 -40.02 93.18 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -67.81 -34.56 76.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.731 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.25 -53.06 62.22 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.169 0.44 . . . . 0.0 109.967 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -68.5 -21.67 64.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.97 -41.19 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.965 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.62 -57.0 4.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.274 -0.891 . . . . 0.0 111.628 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 43.3 tp -64.73 -36.69 85.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.64 -33.29 76.66 Favored Glycine 0 C--O 1.237 0.322 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.372 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -100.39 -42.74 6.49 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -47.43 24.36 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.198 0.908 . . . . 0.0 113.214 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -136.43 64.17 1.56 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.95 114.61 0.95 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -163.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -144.33 93.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.34 158.96 47.7 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.724 -1.718 . . . . 0.0 111.127 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.21 124.41 88.88 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.26 151.22 60.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 117.023 -1.518 . . . . 0.0 112.139 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -77.69 -0.88 28.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -72.64 -24.13 61.01 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.4 62.86 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -58.95 -35.99 74.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.153 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.431 ' CD2' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -60.72 -55.88 27.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.88 -41.64 91.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -165.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 tp -67.33 -44.73 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.2 -45.1 89.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -25.31 43.19 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 118.944 -1.103 . . . . 0.0 112.041 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 13.9 mt -64.71 -32.69 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -62.35 -39.17 92.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.327 0.584 . . . . 0.0 110.613 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.22 -43.68 85.99 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.926 -0.484 . . . . 0.0 110.405 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.73 -31.69 71.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 118.486 0.585 . . . . 0.0 111.788 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.25 -23.84 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.814 -1.179 . . . . 0.0 112.243 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t -147.29 66.33 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -105.41 149.58 26.01 Favored 'General case' 0 CA--C 1.498 -1.034 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 161.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.54 -41.31 89.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.811 0.815 . . . . 0.0 110.4 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -63.8 -46.67 84.1 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.429 -0.794 . . . . 0.0 111.038 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.36 -34.75 74.32 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.891 -0.506 . . . . 0.0 110.203 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -73.55 -38.74 65.13 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.123 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.0 p -90.49 2.17 55.97 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -63.18 145.19 56.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.205 -0.934 . . . . 0.0 111.619 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 166.46 23.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.51 43.86 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -65.34 -50.75 64.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.332 1.063 . . . . 0.0 108.264 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.36 -29.16 68.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.285 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.85 1.93 55.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.2 t -96.53 -45.0 12.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.29 -53.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.917 -1.115 . . . . 0.0 112.15 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.14 23.31 11.8 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.46 -34.9 0.59 Allowed Glycine 0 C--O 1.226 -0.38 0 CA-C-N 114.612 -1.177 . . . . 0.0 114.272 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -97.05 -41.78 8.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.159 0.979 . . . . 0.0 112.785 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.35 -15.22 0.26 Allowed Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 119.412 3.116 . . . . 0.0 119.412 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 C--N 1.359 1.129 1 C-N-CA 109.882 -6.279 . . . . 0.0 113.833 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -136.0 158.39 44.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 160.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.36 126.39 75.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.1 t -128.99 109.09 10.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -128.17 156.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.204 -167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.05 129.95 43.24 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.35 167.65 20.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.38 140.21 58.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.851 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.23 127.33 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.14 86.35 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 117.131 1.612 . . . . 0.0 117.131 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.91 100.14 2.54 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 119.323 1.562 . . . . 0.0 113.699 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.38 0.69 6.43 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 N-CA-C 116.578 1.722 . . . . 0.0 116.578 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 -12.14 45.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.12 166.66 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.055 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -82.03 143.41 31.57 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.077 0.951 . . . . 0.0 111.483 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.26 -166.15 12.16 Favored Glycine 0 N--CA 1.46 0.282 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.17 127.15 30.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.473 1.137 . . . . 0.0 109.976 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.9 t -157.67 134.07 6.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.64 -43.09 41.27 Favored 'Trans proline' 0 C--N 1.345 0.35 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -119.93 2.87 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.03 -44.19 96.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.051 0.929 . . . . 0.0 112.016 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -72.89 -12.14 60.85 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.28 -39.13 85.98 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.773 -1.205 . . . . 0.0 109.544 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.71 -45.91 76.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -39.83 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.763 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.6 -49.35 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 p -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.51 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.22 -25.98 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -69.24 -38.56 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.216 0.916 . . . . 0.0 109.595 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -65.7 -41.77 91.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -75.77 -8.14 56.13 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 53.71 39.02 29.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.565 1.146 . . . . 0.0 113.93 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.57 157.07 39.05 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.66 137.17 22.18 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 114.987 -2.875 . . . . 0.0 113.399 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -150.98 161.26 43.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -105.68 132.95 51.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -84.27 123.83 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -118.85 145.08 45.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.94 135.49 55.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.95 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -76.88 61.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 52.48 52.48 14.06 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.703 1.201 . . . . 0.0 113.717 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 64.95 1.16 Allowed Glycine 0 C--O 1.228 -0.225 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -87.31 -77.51 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -165.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.02 162.5 22.66 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.15 174.11 2.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 118.002 -0.865 . . . . 0.0 114.0 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 5.59 -55.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 1 N-CA-C 122.441 4.238 . . . . 0.0 122.441 171.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -50.57 -38.42 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.433 1.469 . . . . 0.0 112.312 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.82 -20.1 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.92 -25.73 23.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.779 . . . . 0.0 109.242 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -74.33 -31.66 62.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.384 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 mt -63.76 -52.87 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -118.64 129.36 25.43 Favored Pre-proline 0 N--CA 1.469 0.494 0 O-C-N 121.986 -0.446 . . . . 0.0 110.957 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.49 -22.74 44.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 N-CA-C 116.609 1.734 . . . . 0.0 116.609 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.76 0.15 35.36 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.418 0.554 . . . . 0.0 111.135 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.75 69.48 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.073 -1.017 . . . . 0.0 114.292 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -158.25 -29.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.7 m -69.89 152.77 95.89 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 118.77 0.713 . . . . 0.0 111.575 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.74 154.41 59.14 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 117.302 -1.332 . . . . 0.0 113.147 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.7 161.8 23.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.511 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.67 137.61 33.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -106.75 93.61 4.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 55.0 mt -97.19 108.68 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t0 49.01 46.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 123.493 1.616 . . . . 0.0 111.419 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 73.27 4.89 4.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.648 -2.523 . . . . 0.0 117.322 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -112.5 139.31 48.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -98.28 141.29 31.36 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 -168.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.8 t -123.87 123.71 67.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.5 -37.75 1.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -165.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.61 149.87 49.37 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.05 -1.032 . . . . 0.0 110.309 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.3 p -60.08 -34.23 73.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -170.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -88.85 -13.33 39.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.25 -19.57 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 108.854 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.4 mt -66.33 -26.77 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 165.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -84.43 -40.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 120.504 -1.372 . . . . 0.0 111.462 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.45 -64.02 0.83 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 118.883 2.313 . . . . 0.0 118.883 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.78 -34.39 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.328 1.064 . . . . 0.0 111.103 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.31 -46.32 79.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.948 -0.47 . . . . 0.0 110.691 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.23 -40.76 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.507 . . . . 0.0 110.369 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.69 -35.72 81.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -95.34 -12.31 26.3 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.29 127.81 93.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.38 -12.92 37.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.67 162.06 71.9 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.553 -1.342 . . . . 0.0 108.096 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.9 137.52 82.03 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 116.386 -1.943 . . . . 0.0 114.836 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.14 150.94 29.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 116.342 -1.972 . . . . 0.0 113.062 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.5 mt -132.83 66.61 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.944 0.878 . . . . 0.0 110.395 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.64 84.87 2.0 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.1 m -113.78 97.89 45.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -112.93 78.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.513 2.142 . . . . 0.0 114.913 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -91.16 -131.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.657 2.905 . . . . 0.0 113.319 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -54.34 -40.47 68.07 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.178 -0.951 . . . . 0.0 112.254 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.49 -26.46 68.73 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.453 -0.779 . . . . 0.0 111.447 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.68 -28.52 45.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.9 p -81.95 -27.89 33.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.974 0.806 . . . . 0.0 109.153 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.7 -43.79 82.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.83 -30.38 76.95 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 120.829 -1.17 . . . . 0.0 114.181 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.7 p -77.5 -7.06 55.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.378 1.089 . . . . 0.0 113.139 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -93.97 -36.32 12.22 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.783 0.72 . . . . 0.0 110.974 166.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.93 -48.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.619 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -54.57 -54.49 48.26 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.06 -24.88 19.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 113.436 -3.91 . . . . 0.0 113.784 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 t -65.8 -45.25 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -76.36 -29.62 57.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.793 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.9 m -75.57 -26.23 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 118.48 -1.288 . . . . 0.0 110.038 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.61 -43.63 80.0 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.78 -39.45 84.93 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.757 -0.589 . . . . 0.0 111.195 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.2 mt -62.97 -36.51 83.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -92.36 -24.48 18.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.1 t -68.64 142.46 55.09 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -127.02 40.71 3.67 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.924 1.345 . . . . 0.0 107.669 159.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -77.78 173.39 7.67 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -61.73 102.15 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 114.948 -2.901 . . . . 0.0 109.199 146.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -122.92 24.78 8.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.849 -159.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.53 -22.89 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.238 1.018 . . . . 0.0 110.69 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.14 -33.26 54.74 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 m -68.09 -28.02 66.99 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.027 -0.69 . . . . 0.0 111.535 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -65.46 -36.15 83.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.639 -1.288 . . . . 0.0 110.013 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.07 -33.39 61.67 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.8 -0.563 . . . . 0.0 110.677 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.69 88.47 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 110.558 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.25 -46.78 88.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.74 -42.95 99.63 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.721 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.81 -41.88 86.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -69.39 -35.77 76.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.707 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.51 -35.66 77.8 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.502 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.3 -29.68 70.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.691 0.678 . . . . 0.0 111.647 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.26 -51.57 65.65 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.327 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.26 -26.11 63.68 Favored 'General case' 0 C--O 1.221 -0.43 0 O-C-N 121.878 -0.514 . . . . 0.0 111.725 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.01 -39.87 93.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.683 0.393 . . . . 0.0 110.509 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.86 -54.72 26.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.52 -39.96 89.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.89 -45.36 78.27 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.76 -23.01 62.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.404 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.61 -49.39 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.674 -0.641 . . . . 0.0 111.139 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -82.64 -37.93 24.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -77.28 0.26 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-O 116.828 -2.095 . . . . 0.0 116.931 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -60.57 -131.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 1 C-N-CA 127.989 5.793 . . . . 0.0 120.728 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.43 171.68 7.06 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.937 -1.102 . . . . 0.0 111.293 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.72 -17.42 21.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.32 5.25 35.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.27 -24.77 17.46 Favored Glycine 0 C--O 1.227 -0.334 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.44 -54.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.307 1.553 . . . . 0.0 114.535 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -156.81 176.87 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.05 120.55 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.6 p -140.75 -168.57 2.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -40.44 -38.55 0.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 118.279 2.696 . . . . 0.0 118.279 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.88 -43.54 96.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.131 0.967 . . . . 0.0 108.705 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.91 -39.33 79.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.9 mt -61.54 -37.46 83.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.475 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.4 p -77.69 -43.55 30.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.5 tp -95.12 -46.72 6.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -167.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.8 92.92 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.55 -19.41 19.06 Favored 'Trans proline' 0 C--N 1.346 0.446 1 C-N-CA 113.006 -4.196 . . . . 0.0 113.753 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.81 -23.15 20.68 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.983 -1.073 . . . . 0.0 109.587 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.6 mt -63.28 -31.35 72.47 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 165.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.45 -51.08 71.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -63.57 -34.34 77.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.0 -56.0 27.9 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.395 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.94 -51.54 43.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.692 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.69 -42.07 64.64 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.388 -0.82 . . . . 0.0 111.564 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.54 -46.9 86.27 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.26 93.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.033 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.71 -47.18 14.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.629 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -93.76 -34.39 13.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -167.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -137.44 50.47 1.96 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.959 -0.463 . . . . 0.0 110.836 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -53.02 121.71 7.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -156.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -148.15 89.2 5.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.38 153.3 74.42 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 114.639 -3.107 . . . . 0.0 109.87 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.92 126.03 91.79 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.84 155.54 57.93 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 117.142 -1.438 . . . . 0.0 112.31 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.42 -10.03 52.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -67.73 -25.24 65.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.048 -0.408 . . . . 0.0 110.488 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.99 61.54 1.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -31.52 68.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.712 -1.586 . . . . 0.0 113.137 -171.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -43.04 99.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.102 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -38.06 33.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.18 -40.12 88.86 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.631 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.08 -45.7 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.496 -0.753 . . . . 0.0 111.932 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.94 -39.85 95.87 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.64 -32.34 57.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.68 -35.58 78.38 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.167 -0.958 . . . . 0.0 111.057 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.08 -21.05 60.84 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.943 -0.473 . . . . 0.0 111.568 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.13 -8.85 58.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.232 1.015 . . . . 0.0 110.434 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -103.53 23.73 12.18 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.23 -0.919 . . . . 0.0 110.154 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.7 p -124.84 164.43 20.04 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 49.05 150.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 121.225 3.787 . . . . 0.0 121.225 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -56.93 -34.86 68.39 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 120.555 -1.341 . . . . 0.0 114.381 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -18.95 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.09 -44.86 2.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.485 0.66 . . . . 0.0 110.856 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.53 -42.65 99.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.84 -30.91 24.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.201 1.0 . . . . 0.0 109.722 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.7 p -79.01 -12.54 60.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -40.63 119.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 113.078 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.12 138.92 50.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 165.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.43 138.58 58.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.806 0.276 . . . . 0.0 111.233 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.55 -43.78 89.43 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.56 -31.19 67.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.194 0.997 . . . . 0.0 111.141 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -102.68 0.97 33.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.2 -50.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 161.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.4 pt -69.41 -50.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 121.618 -0.676 . . . . 0.0 111.875 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.11 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.336 -0.852 . . . . 0.0 110.291 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.8 -16.17 58.58 Favored Glycine 0 CA--C 1.517 0.173 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -113.15 -54.22 2.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.58 -31.04 8.55 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--N 1.357 1.006 1 C-N-CA 111.733 -5.045 . . . . 0.0 114.475 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -124.88 156.32 38.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mt -130.65 113.96 26.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.7 127.3 39.33 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.03 163.06 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 119.655 1.116 . . . . 0.0 112.926 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.49 126.42 29.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.92 172.69 12.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.248 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.04 142.83 58.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.45 134.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.67 -21.61 17.74 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.3 100.8 1.73 Allowed Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.0 96.39 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 116.917 -1.589 . . . . 0.0 114.383 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -159.36 -39.97 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -104.45 158.22 5.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.12 160.09 16.08 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 110.295 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 -179.44 18.37 Favored Glycine 0 CA--C 1.507 -0.436 0 CA-C-N 116.458 -0.337 . . . . 0.0 112.992 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.87 92.89 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.335 1.065 . . . . 0.0 111.165 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.67 132.86 24.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 103.345 -2.835 . . . . 0.0 103.345 165.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.76 -38.03 32.8 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 116.693 -1.738 . . . . 0.0 111.992 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.26 -21.44 36.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.746 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.303 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -74.14 -26.65 60.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.882 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.81 -39.62 89.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.58 1.536 . . . . 0.0 111.151 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.63 -44.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.836 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.28 -38.21 85.96 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.397 -0.814 . . . . 0.0 110.541 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.92 -48.24 79.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 p -72.32 -31.47 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.727 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.4 -46.24 70.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.206 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -65.02 -33.11 75.26 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.793 -0.567 . . . . 0.0 110.579 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.06 -41.92 99.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.373 0.606 . . . . 0.0 112.343 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.82 -16.51 57.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.29 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 59.64 40.5 19.97 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.305 1.442 . . . . 0.0 112.931 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 pt -101.49 154.61 37.14 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.62 118.96 5.98 Favored 'Trans proline' 0 C--N 1.347 0.459 0 N-CA-C 117.375 2.029 . . . . 0.0 117.375 -171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -126.32 156.17 40.86 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.816 0.817 . . . . 0.0 113.072 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.24 110.43 20.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.007 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -84.2 125.51 32.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 118.754 0.706 . . . . 0.0 111.526 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -121.95 139.29 53.84 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.539 0.736 . . . . 0.0 112.194 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.0 120.03 39.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.733 -169.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.05 120.88 45.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -77.65 76.78 4.18 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.822 0.82 . . . . 0.0 112.215 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.1 mt 55.67 27.88 11.25 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 162.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.92 2.35 11.29 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 114.245 0.458 . . . . 0.0 114.245 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -78.21 109.41 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.754 -0.851 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -116.53 87.9 22.41 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.61 169.45 12.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 N-CA-C 109.916 -0.84 . . . . 0.0 109.916 169.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -54.86 -40.19 69.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.196 0.453 . . . . 0.0 111.303 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -62.15 -39.04 91.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.53 -22.25 35.07 Favored 'General case' 0 C--O 1.212 -0.888 0 O-C-N 120.604 -1.31 . . . . 0.0 112.777 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.9 tp -68.22 -40.16 82.15 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 120.009 -1.682 . . . . 0.0 111.216 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.05 -35.2 71.86 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.346 -0.846 . . . . 0.0 112.846 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mt -117.62 22.59 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 121.478 0.656 . . . . 0.0 111.485 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -147.45 119.86 4.72 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.047 -1.658 . . . . 0.0 108.483 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.34 -13.66 37.36 Favored 'Trans proline' 0 C--N 1.352 0.731 0 N-CA-C 118.689 2.534 . . . . 0.0 118.689 -173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -120.83 7.34 10.43 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.92 -0.488 . . . . 0.0 110.117 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.16 2.07 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-O 122.641 1.134 . . . . 0.0 113.143 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -134.07 99.31 4.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.57 146.18 16.17 Favored Pre-proline 0 C--N 1.318 -0.778 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 170.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.9 142.09 38.26 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 116.868 -1.621 . . . . 0.0 111.982 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.81 131.63 50.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.152 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.91 129.9 36.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.41 71.91 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.175 0.988 . . . . 0.0 108.658 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.2 mt -87.66 126.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 54.97 35.58 24.91 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.478 1.111 . . . . 0.0 112.984 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t0 61.62 25.07 15.05 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -115.46 150.59 36.24 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.08 135.98 53.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -172.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.65 123.17 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -174.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.33 8.76 1.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -165.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -99.41 147.67 25.01 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.025 -1.672 . . . . 0.0 109.946 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.2 p -58.72 -33.52 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -83.23 -13.22 55.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.045 1.402 . . . . 0.0 111.615 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.7 -32.23 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.842 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -66.96 -15.61 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 121.759 -0.588 . . . . 0.0 111.177 161.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.0 t -83.2 -46.24 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 120.333 -1.479 . . . . 0.0 110.418 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.74 2.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 121.164 3.225 . . . . 0.0 121.164 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.4 mt -80.95 -26.89 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.78 -1.424 . . . . 0.0 110.558 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.91 -48.3 75.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.71 -39.99 95.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.315 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.68 -34.48 77.2 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.846 -0.534 . . . . 0.0 111.64 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -97.0 -1.33 45.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -82.68 132.37 52.02 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.57 -9.92 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 115.517 -2.522 . . . . 0.0 114.833 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -74.24 158.1 85.86 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.62 124.58 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 116.138 -2.108 . . . . 0.0 115.658 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.37 144.29 28.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 120.641 0.894 . . . . 0.0 112.856 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -138.94 45.1 2.01 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.022 0.915 . . . . 0.0 109.367 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.06 90.44 2.49 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m -125.63 90.74 49.99 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.212 1.005 . . . . 0.0 110.282 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -100.63 63.56 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 1 C-N-CA 125.687 4.258 . . . . 0.0 119.351 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -87.05 -128.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 CA-C-N 119.918 1.006 . . . . 0.0 114.637 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.54 -38.52 74.87 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.921 1.691 . . . . 0.0 113.745 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -64.68 -25.13 67.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.117 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.92 -32.98 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.4 -0.813 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.8 p -75.0 -33.89 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.38 -45.44 82.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.07 83.97 Favored Glycine 0 C--O 1.229 -0.21 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.61 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.3 p -63.28 -17.0 62.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.0 -27.53 13.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.6 mt -79.36 -44.78 23.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -53.36 -48.79 91.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.35 -27.9 10.91 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 111.645 -5.103 . . . . 0.0 113.507 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -67.15 -44.62 79.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -70.85 -20.65 62.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.058 -1.057 . . . . 0.0 112.703 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.2 t -85.35 -41.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -59.27 -46.97 87.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.046 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.68 -24.21 53.18 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -27.27 61.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.268 0.94 . . . . 0.0 110.994 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.98 -3.45 58.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.348 0.659 . . . . 0.0 111.641 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.3 t -121.25 121.96 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -167.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.03 41.79 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.93 -177.54 0.33 Allowed Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.504 1.121 . . . . 0.0 108.848 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.27 61.03 0.5 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 156.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -86.29 80.01 8.87 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.153 -1.592 . . . . 0.0 107.4 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -118.78 -65.35 1.18 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.45 -44.27 96.98 Favored Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.335 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -77.7 -8.79 58.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.28 -32.62 55.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.954 -1.716 . . . . 0.0 106.432 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -79.28 -9.81 59.67 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 120.956 -1.09 . . . . 0.0 111.237 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.84 74.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 165.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.74 -42.51 90.9 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.829 -1.169 . . . . 0.0 109.956 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 tp -56.46 -44.28 80.38 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.59 -27.86 68.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -81.45 -34.21 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.111 -0.993 . . . . 0.0 110.581 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -73.15 -23.58 60.47 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.0 110.481 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -68.31 -29.75 68.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.857 -0.527 . . . . 0.0 110.308 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.66 85.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.63 -39.01 80.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.99 -41.11 91.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.57 0.748 . . . . 0.0 110.027 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.65 -41.76 56.2 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.013 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -62.21 -32.62 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.65 -55.08 11.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.086 0.946 . . . . 0.0 112.624 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -76.67 -10.4 59.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.73 -0.606 . . . . 0.0 112.423 -159.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -79.81 -8.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.67 -40.75 2.86 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.33 -66.53 0.25 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.65 -169.74 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 125.174 3.916 . . . . 0.0 115.689 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -57.82 165.45 1.74 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.086 0.955 . . . . 0.0 111.841 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 pt -65.81 -21.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -146.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.92 -13.29 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.31 -11.42 61.73 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.86 -45.21 0.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -164.17 -179.32 6.08 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.89 121.46 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.4 m -138.95 179.39 6.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -38.75 -38.76 0.44 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -69.13 -39.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 120.741 -1.224 . . . . 0.0 111.792 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.84 -39.5 72.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.26 -7.21 28.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.4 p -104.55 -45.36 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.212 -0.423 . . . . 0.0 112.017 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.48 -50.94 12.76 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.16 81.17 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.02 -18.75 52.01 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 113.605 -3.797 . . . . 0.0 117.317 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -94.74 -24.41 17.12 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.346 -1.471 . . . . 0.0 109.401 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.72 -25.93 67.52 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.396 -0.815 . . . . 0.0 111.902 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -49.0 59.02 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.186 0.903 . . . . 0.0 110.318 166.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -72.98 -21.14 60.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.59 -50.11 70.74 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 122.228 0.211 . . . . 0.0 111.177 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -72.04 -20.66 61.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.806 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.6 t -78.83 -57.35 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.48 -52.26 28.31 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.69 -42.2 91.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.663 0.744 . . . . 0.0 110.642 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.29 -32.35 82.43 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -90.88 -38.33 12.99 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.205 -1.173 . . . . 0.0 114.101 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -81.82 -46.44 14.15 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -145.4 70.49 1.26 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -165.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -53.71 117.77 3.41 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -143.53 89.06 7.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.65 161.94 40.84 Favored 'Trans proline' 0 C--O 1.235 0.34 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.19 127.23 92.42 Favored Pre-proline 0 C--O 1.245 0.852 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.47 154.89 45.49 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.695 -1.736 . . . . 0.0 112.092 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.8 -2.72 31.24 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.563 -0.711 . . . . 0.0 110.731 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -69.5 -21.49 63.67 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.69 -0.631 . . . . 0.0 111.586 166.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.51 65.21 0.71 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.4 m -57.39 -34.95 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.992 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -53.86 53.5 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.569 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.2 t -68.43 -34.86 68.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -168.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.97 -52.0 65.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.351 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.35 -41.55 96.7 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.278 -0.264 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -60.63 -52.01 66.98 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.39 -37.48 79.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 121.859 -0.526 . . . . 0.0 111.312 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.93 -41.78 99.59 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.445 0.64 . . . . 0.0 112.433 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.0 mt -71.52 -40.36 70.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.01 -20.0 63.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.124 0.488 . . . . 0.0 111.429 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.72 -27.91 69.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.419 -0.801 . . . . 0.0 112.373 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 t -136.99 69.93 1.41 Allowed 'General case' 0 C--O 1.243 0.758 0 O-C-N 121.43 -0.794 . . . . 0.0 112.771 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -125.9 138.79 53.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 162.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -59.43 -37.99 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.81 1.641 . . . . 0.0 113.188 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -37.31 78.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -85.16 -34.87 22.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.093 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -70.56 -42.34 71.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.33 -35.2 73.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.688 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.4 p -77.2 -19.29 56.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.896 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -51.96 122.77 8.96 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.248 0.619 . . . . 0.0 111.626 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.15 173.07 9.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.547 0.739 . . . . 0.0 110.308 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.71 126.96 31.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.9 -29.64 69.71 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.587 -0.695 . . . . 0.0 112.242 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.12 -35.68 79.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.145 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -85.77 -6.78 59.06 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.83 -54.3 7.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.0 mt -68.7 -61.39 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.932 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.32 -3.26 39.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.843 -0.536 . . . . 0.0 110.852 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.82 -13.3 61.11 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -99.17 -21.18 16.25 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.911 1.356 . . . . 0.0 111.803 166.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.4 -8.18 0.13 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.362 1.268 1 C-N-CA 110.851 -5.633 . . . . 0.0 112.852 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.221 -0.406 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.88 159.65 40.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.5 mt -129.98 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.57 157.49 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -167.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.21 128.85 34.01 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.175 -0.953 . . . . 0.0 108.622 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.17 158.42 16.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 140.18 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.362 170.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.57 126.85 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.11 0.2 60.4 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 78.15 4.01 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.75 1.775 . . . . 0.0 114.917 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.82 90.79 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 N-CA-C 116.925 1.856 . . . . 0.0 116.925 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -157.25 -49.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.82 157.25 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 103.323 -2.843 . . . . 0.0 103.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.46 166.91 15.14 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.486 1.114 . . . . 0.0 111.739 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.11 -173.82 16.22 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -76.66 99.05 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 122.471 1.129 . . . . 0.0 110.833 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.17 136.07 17.82 Favored Pre-proline 0 C--N 1.319 -0.74 1 N-CA-C 100.134 -4.025 . . . . 0.0 100.134 162.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.29 -36.65 34.89 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 116.22 -2.053 . . . . 0.0 112.047 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -72.57 -26.0 61.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.112 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.54 -41.71 92.75 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.432 1.111 . . . . 0.0 109.863 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.98 -33.77 63.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.518 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.57 -45.99 84.52 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.148 1.34 . . . . 0.0 111.779 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.67 -35.34 65.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.479 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.55 -46.7 25.32 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.316 -0.865 . . . . 0.0 112.941 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -39.6 94.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -64.3 -43.59 94.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 112.084 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -27.14 28.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -75.45 -31.63 60.36 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 118.486 0.584 . . . . 0.0 111.041 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.52 -37.98 89.42 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.388 -1.445 . . . . 0.0 109.515 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.65 -20.4 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 51.56 40.13 26.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 112.346 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.18 135.38 73.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.64 140.95 89.35 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 115.733 -2.378 . . . . 0.0 114.215 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -148.53 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -114.53 124.51 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 167.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -90.82 149.6 21.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -135.28 133.33 38.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.38 110.79 21.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.16 109.2 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.27 78.23 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.709 0.766 . . . . 0.0 112.957 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt 55.27 54.39 8.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.7 160.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.88 15.22 58.26 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.207 -0.906 . . . . 0.0 114.39 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -74.41 114.91 13.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.342 1.071 . . . . 0.0 108.482 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 89.04 11.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -67.45 176.3 5.04 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 115.989 -2.208 . . . . 0.0 109.164 166.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -54.95 -31.45 60.51 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.553 -0.717 . . . . 0.0 112.56 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -56.98 -51.45 69.16 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.964 0.802 . . . . 0.0 112.608 172.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.25 -24.38 61.36 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 120.285 -1.509 . . . . 0.0 111.513 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.24 -35.24 77.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.603 -0.686 . . . . 0.0 112.093 170.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -67.4 -42.74 82.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.458 -0.776 . . . . 0.0 110.134 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.12 -51.79 16.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -104.63 126.41 31.39 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -65.11 -31.91 53.75 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -90.39 -4.41 57.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 120.63 -1.294 . . . . 0.0 110.244 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.93 -34.78 2.34 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-O 121.418 0.454 . . . . 0.0 112.478 -166.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -112.03 0.87 16.13 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 118.993 2.96 . . . . 0.0 118.993 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.0 147.05 72.92 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 120.145 1.338 . . . . 0.0 108.145 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.54 151.15 58.56 Favored 'Trans proline' 0 C--N 1.345 0.394 0 O-C-N 122.721 0.853 . . . . 0.0 111.495 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.87 162.6 20.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.769 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.65 128.44 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -85.49 96.33 9.57 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.73 97.76 7.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 121.014 1.734 . . . . 0.0 106.816 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.36 46.39 25.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.108 0.563 . . . . 0.0 112.507 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 71.86 4.6 5.09 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.67 2.388 . . . . 0.0 115.842 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.21 108.4 19.89 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -94.54 134.46 37.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.148 -166.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.21 134.3 65.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.0 -28.31 2.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -75.97 131.18 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.4 p -67.54 -23.12 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -95.67 -21.32 18.27 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.748 -0.595 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.08 -34.55 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.99 -24.85 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.16 -32.68 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 120.446 -1.408 . . . . 0.0 110.166 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.9 -54.81 0.42 Allowed Glycine 0 C--O 1.226 -0.386 0 N-CA-C 119.609 2.604 . . . . 0.0 119.609 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.82 -31.02 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.211 1.505 . . . . 0.0 110.885 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.88 -34.7 76.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.846 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -73.36 -38.63 65.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.884 -0.51 . . . . 0.0 111.446 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.63 -31.91 73.22 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.411 -0.805 . . . . 0.0 113.127 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 5.4 43.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -98.31 135.45 21.25 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.28 -8.87 24.64 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 116.485 -1.877 . . . . 0.0 116.67 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.05 160.15 76.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.365 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.86 137.14 65.9 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 114.86 -2.96 . . . . 0.0 114.191 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.57 88.59 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 115.967 1.487 . . . . 0.0 115.967 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.59 63.67 7.7 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 120.483 -1.386 . . . . 0.0 112.471 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.73 86.06 2.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 m -125.76 87.74 55.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.575 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -98.61 48.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 122.185 3.879 . . . . 0.0 122.185 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -80.35 -117.93 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.677 1.278 . . . . 0.0 112.289 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -53.42 -35.43 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.11 -37.56 87.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.78 0.8 . . . . 0.0 109.925 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.88 42.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.818 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -67.95 -32.29 72.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.76 -50.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.8 96.39 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.467 -0.873 . . . . 0.0 115.083 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.0 p -73.52 -8.33 55.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -80.01 -35.42 37.37 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.02 -1.05 . . . . 0.0 110.568 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.98 -37.32 9.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.633 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.65 -54.22 38.18 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.93 -24.39 13.01 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 113.423 -3.918 . . . . 0.0 113.036 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -71.73 -39.53 70.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -75.53 -26.15 57.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.787 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.71 -28.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 120.898 -1.126 . . . . 0.0 109.245 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.53 -42.77 99.74 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.768 -1.207 . . . . 0.0 109.444 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -65.21 -40.22 93.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.814 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.92 -39.1 90.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -76.16 -11.04 59.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -87.09 141.99 28.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -127.91 27.79 5.66 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -72.4 170.78 11.62 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.2 52.21 1.85 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-O 122.926 1.136 . . . . 0.0 114.378 167.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -83.67 38.55 0.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -140.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -67.25 -24.71 65.83 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.52 90.73 Favored Glycine 0 N--CA 1.454 -0.123 0 O-C-N 120.835 -1.165 . . . . 0.0 111.325 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 m -74.34 -30.57 62.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.862 -0.787 . . . . 0.0 110.16 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -66.45 -34.51 78.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.862 0.839 . . . . 0.0 111.02 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -76.31 -30.35 57.7 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.64 96.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.296 -0.878 . . . . 0.0 109.523 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -63.73 -47.3 81.61 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.98 -43.58 98.6 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.481 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.46 -44.25 83.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.893 0.77 . . . . 0.0 112.11 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.98 -27.72 54.84 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.116 -0.99 . . . . 0.0 112.347 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.01 -22.95 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.634 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -71.7 -31.13 66.42 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.101 -0.999 . . . . 0.0 109.998 168.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.68 90.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 122.0 -0.437 . . . . 0.0 112.11 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.07 -36.81 80.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.632 0.73 . . . . 0.0 110.73 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.26 -52.63 38.87 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.514 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -56.76 -42.29 79.09 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.051 -0.676 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.54 -45.14 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.13 -27.08 62.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.146 1.339 . . . . 0.0 112.677 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.08 -33.84 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 122.808 0.443 . . . . 0.0 110.318 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.56 -35.12 8.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.76 -75.02 0.24 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-O 117.381 -1.788 . . . . 0.0 116.553 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -61.55 -159.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 126.428 4.752 . . . . 0.0 118.994 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.59 167.43 1.47 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.519 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -45.5 -32.74 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.57 -7.55 39.51 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.779 -1.2 . . . . 0.0 114.236 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.05 3.71 90.64 Favored Glycine 0 CA--C 1.511 -0.203 0 O-C-N 121.672 -0.643 . . . . 0.0 113.327 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -142.39 -61.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -158.28 176.01 13.01 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.2 mm -63.12 127.98 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.0 m -142.71 161.98 36.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -171.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.27 -22.97 45.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.61 -23.61 29.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.66 -40.96 22.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.1 mt -70.79 -12.22 61.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.217 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.9 p -96.13 -23.73 16.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.2 tp -100.41 -49.17 4.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.31 -40.7 70.18 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.59 -38.63 93.01 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 114.637 -3.109 . . . . 0.0 118.259 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -87.93 -22.05 24.57 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.366 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.62 -37.74 85.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.095 1.316 . . . . 0.0 111.579 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.6 -50.27 71.93 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.801 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -63.83 -33.37 75.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.446 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.3 tp -63.47 -52.47 61.22 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.728 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.08 -34.59 78.37 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.714 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.83 -54.05 21.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.997 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.22 -44.18 63.31 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.283 -0.885 . . . . 0.0 111.693 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.15 -37.4 75.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.64 -36.57 93.44 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -75.98 -51.64 11.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.206 -1.173 . . . . 0.0 113.028 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -80.54 -36.99 32.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -146.89 53.07 1.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -171.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -34.38 102.79 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -157.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -142.7 85.41 10.22 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 169.74 21.86 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 116.296 -2.002 . . . . 0.0 109.019 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.4 mm -73.25 124.19 90.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.47 163.6 31.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 116.06 -2.16 . . . . 0.0 113.634 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.85 -4.65 36.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.491 -0.756 . . . . 0.0 112.112 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.25 -21.2 66.5 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.09 -1.006 . . . . 0.0 110.123 165.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.53 57.04 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.7 m -57.37 -34.64 69.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.088 -0.383 . . . . 0.0 111.289 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -68.79 -40.66 79.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.88 -43.03 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.137 0.494 . . . . 0.0 110.256 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.93 -43.5 92.58 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.768 -0.583 . . . . 0.0 111.788 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -69.36 -34.33 74.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.609 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -59.07 -49.31 78.36 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.84 -36.64 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.272 -0.893 . . . . 0.0 111.809 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.28 -37.81 88.81 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.523 -1.361 . . . . 0.0 112.592 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.84 -43.98 97.35 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.0 mt -65.77 -41.9 91.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.881 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.35 -33.48 65.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.1 m -115.98 18.49 15.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -66.66 139.61 57.87 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.89 -43.68 81.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.995 0.816 . . . . 0.0 112.545 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 p -67.13 -41.23 86.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -42.75 49.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.661 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -52.83 -44.92 67.07 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.544 -0.723 . . . . 0.0 112.003 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.17 -43.11 99.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.471 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 50.8 p -96.5 -4.04 42.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -56.14 133.61 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.31 148.48 50.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.83 134.7 56.64 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.443 0.464 . . . . 0.0 109.829 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.53 -34.3 72.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.74 -32.45 70.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.139 0.971 . . . . 0.0 111.423 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -94.78 -21.36 18.78 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.415 -0.803 . . . . 0.0 111.941 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.33 -42.41 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.7 -74.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.35 63.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.67 -25.27 33.13 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.06 -0.59 . . . . 0.0 114.143 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 -22.16 12.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.912 0.856 . . . . 0.0 113.177 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.59 -17.37 0.37 Allowed Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--N 1.36 1.132 1 C-N-CA 111.043 -5.504 . . . . 0.0 115.402 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.238 0.495 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.75 146.82 44.47 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 121.922 -0.486 . . . . 0.0 110.518 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.8 mt -111.23 98.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.8 t -101.82 108.71 20.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.7 m -132.58 162.49 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.33 142.64 56.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.41 167.8 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.174 0.443 . . . . 0.0 110.741 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.97 58.37 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.86 112.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.27 85.46 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 114.634 -1.166 . . . . 0.0 115.461 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.7 82.36 7.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.008 0.904 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.25 43.24 0.71 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 124.666 3.577 . . . . 0.0 115.938 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.78 -8.1 2.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.86 156.57 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.68 154.0 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.26 174.32 45.23 Favored Glycine 0 C--O 1.238 0.345 0 N-CA-C 120.787 3.075 . . . . 0.0 120.787 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.37 75.68 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.755 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.95 133.68 21.18 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.41 -40.56 56.65 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-O 123.092 1.205 . . . . 0.0 111.445 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -77.79 -17.84 57.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -60.8 -48.83 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 111.292 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.17 -12.48 60.9 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.273 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -59.18 -48.92 79.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.958 1.708 . . . . 0.0 109.029 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.74 -50.44 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.206 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.66 -41.84 91.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.053 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.95 -45.87 83.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.1 p -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.509 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 -32.49 33.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.246 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -68.66 -38.14 80.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 118.741 0.7 . . . . 0.0 112.454 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.15 -28.78 69.05 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 120.916 -1.115 . . . . 0.0 111.134 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -91.58 -12.91 32.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 53.17 33.8 16.04 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -81.61 151.97 69.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.87 143.11 44.62 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 115.419 -2.587 . . . . 0.0 112.874 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -150.97 162.5 40.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -124.53 112.35 16.75 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.1 t -80.52 133.06 35.76 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -114.68 130.7 56.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.69 121.04 44.33 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.67 104.18 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.37 90.09 0.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.189 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt 49.25 49.99 18.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.724 1.209 . . . . 0.0 113.784 174.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.33 43.47 38.21 Favored Glycine 0 C--O 1.229 -0.217 0 C-N-CA 119.845 -1.169 . . . . 0.0 112.966 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -75.81 84.25 2.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 161.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -115.47 95.69 43.83 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.383 0.673 . . . . 0.0 111.598 -160.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 169.98 18.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 N-CA-C 109.902 -0.845 . . . . 0.0 109.902 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -55.84 -32.65 63.78 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 0.506 . . . . 0.0 111.768 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -55.07 -52.54 62.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.46 -24.44 59.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 120.882 -1.136 . . . . 0.0 111.478 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.29 -32.17 73.42 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.239 0.543 . . . . 0.0 111.405 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -74.43 -39.23 62.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.663 0.744 . . . . 0.0 111.468 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.41 -37.01 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 t -121.54 143.0 36.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.91 -37.35 86.3 Favored 'Trans proline' 0 C--N 1.355 0.917 0 N-CA-C 116.207 1.579 . . . . 0.0 116.207 170.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -93.96 -21.13 19.39 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.109 -0.994 . . . . 0.0 111.941 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 4.63 90.37 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-O 122.189 0.883 . . . . 0.0 111.513 -167.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -160.68 75.19 0.54 Allowed 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.859 1.264 . . . . 0.0 109.808 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.5 160.52 63.99 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 135.48 32.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 113.473 -3.884 . . . . 0.0 112.382 165.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.35 141.69 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.58 126.34 54.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -92.7 91.06 7.34 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.61 85.09 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.5 t0 53.62 60.07 3.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.294 1.045 . . . . 0.0 112.041 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 67.49 3.69 3.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.751 1.62 . . . . 0.0 115.265 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -103.34 99.77 9.62 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.159 -0.963 . . . . 0.0 109.034 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -80.57 134.71 35.96 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.475 0.71 . . . . 0.0 111.776 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.12 126.15 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.736 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.76 80.91 1.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -148.54 145.33 27.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 162.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -58.37 -34.26 70.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -81.24 -18.17 46.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.57 -20.33 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.14 -9.91 12.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.45 -60.45 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 162.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.89 -36.35 90.94 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.6 mt -86.17 -27.7 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 120.869 -1.371 . . . . 0.0 107.94 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.41 -39.28 94.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.89 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.72 -37.61 87.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.974 0.806 . . . . 0.0 110.788 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.06 -28.42 68.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.771 1.272 . . . . 0.0 112.006 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -102.77 1.64 34.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.505 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -75.56 143.04 74.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.184 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 -16.78 12.87 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 115.59 1.342 . . . . 0.0 115.59 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -90.67 161.79 35.36 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 103.544 -2.762 . . . . 0.0 103.544 174.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.06 142.44 97.21 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 N-CA-C 119.135 2.706 . . . . 0.0 119.135 -163.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.48 106.76 2.32 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 121.585 1.523 . . . . 0.0 115.907 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.04 40.72 2.57 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 122.068 0.937 . . . . 0.0 112.745 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 79.77 5.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.308 -1.495 . . . . 0.0 112.34 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -118.93 94.54 48.25 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.08 82.18 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 124.33 3.353 . . . . 0.0 119.974 165.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.56 -146.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.392 1.395 . . . . 0.0 111.635 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -46.25 -40.32 11.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -62.79 -27.97 69.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.11 -29.04 61.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 76.8 p -76.19 -31.4 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.485 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.06 -40.63 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.546 -1.206 . . . . 0.0 114.131 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.1 p -66.98 -11.16 55.98 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -98.13 -34.01 10.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.2 pt -75.27 -30.85 23.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.042 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.73 -56.15 10.06 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -167.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.91 -20.62 16.9 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 114.618 -3.122 . . . . 0.0 113.661 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.9 t -64.29 -43.29 95.2 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.16 0.984 . . . . 0.0 111.647 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -37.83 84.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.042 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -38.58 81.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.207 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.2 -44.93 95.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.315 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.63 -27.69 61.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.8 -46.03 91.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.232 0.923 . . . . 0.0 112.166 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -72.5 -22.41 61.05 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.066 0.936 . . . . 0.0 112.234 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 t -86.3 143.06 28.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -127.9 32.99 4.85 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 123.44 1.59 . . . . 0.0 109.333 164.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.21 170.8 7.95 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.0 47.02 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.12 101.47 13.83 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.1 -45.01 1.14 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.257 0.623 . . . . 0.0 111.795 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.8 -21.03 79.03 Favored Glycine 0 C--O 1.236 0.248 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.5 p -93.72 -11.97 30.28 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 168.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -67.04 -34.97 78.85 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 119.528 -1.983 . . . . 0.0 105.799 162.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -79.34 3.28 18.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.332 -0.855 . . . . 0.0 113.167 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.45 -28.56 61.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.33 -37.47 85.75 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.959 -1.088 . . . . 0.0 109.925 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.5 tp -61.91 -36.14 80.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.459 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -78.52 -34.88 46.95 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -72.8 -39.26 66.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.711 -1.868 . . . . 0.0 110.266 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 110.444 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -64.06 -35.52 81.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.924 0.783 . . . . 0.0 109.372 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.43 81.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.73 -42.73 97.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.579 -0.701 . . . . 0.0 110.737 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.366 1.066 . . . . 0.0 112.455 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.91 -36.52 41.43 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.578 -0.701 . . . . 0.0 114.01 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.63 -28.13 66.63 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.65 -52.8 27.23 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.392 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.35 -19.44 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.05 -9.14 12.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -113.51 -53.4 2.7 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.69 -59.04 0.47 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -71.39 -164.77 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.959 3.106 . . . . 0.0 115.062 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -54.9 160.07 2.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.7 tp -61.53 -22.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -163.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.23 -11.46 60.91 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.295 -1.503 . . . . 0.0 114.076 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.82 -26.76 8.69 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.12 -44.27 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -161.88 -177.03 5.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.396 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.44 109.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -128.79 -174.37 3.23 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.14 -38.26 11.32 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.31 -46.75 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 118.868 0.758 . . . . 0.0 110.158 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.92 -39.76 75.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.462 0.649 . . . . 0.0 110.349 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.69 -24.39 66.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.686 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.5 m -82.03 -36.6 27.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 83.6 mt -97.87 -46.25 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.55 36.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.56 -33.96 43.95 Favored 'Trans proline' 0 C--N 1.353 0.8 1 C-N-CA 112.067 -4.822 . . . . 0.0 115.629 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -80.87 -28.32 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.41 -1.432 . . . . 0.0 109.358 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.8 mt -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.244 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.03 -49.92 75.75 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.053 0.842 . . . . 0.0 111.68 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -64.2 -31.77 73.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -54.03 16.53 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 121.598 -0.688 . . . . 0.0 109.713 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -30.8 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.02 -35.4 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.076 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.56 -43.54 15.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.46 -36.6 84.39 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.408 0.683 . . . . 0.0 109.624 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.72 -35.17 91.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.539 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -74.47 -51.19 15.54 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.778 -0.837 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -77.67 -47.4 19.31 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -149.42 74.94 1.26 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -168.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.69 115.97 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -161.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -131.83 97.12 19.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 148.5 46.44 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 115.644 -2.437 . . . . 0.0 113.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.32 120.75 72.65 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -71.23 167.44 26.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 N-CA-C 116.776 1.798 . . . . 0.0 116.776 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.98 -16.34 63.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.958 0.903 . . . . 0.0 111.169 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -72.64 -13.52 61.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.516 0.726 . . . . 0.0 111.963 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.53 52.06 1.0 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -25.8 68.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -54.41 43.55 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.73 -36.08 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.62 -49.25 78.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -69.23 -37.27 77.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.821 0.343 . . . . 0.0 111.772 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -62.17 -49.2 76.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.81 0.844 . . . . 0.0 110.136 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 80.4 mt -71.95 -29.55 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.268 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.47 -46.21 87.24 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.966 -1.084 . . . . 0.0 111.277 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.59 -35.28 78.68 Favored 'General case' 0 C--O 1.216 -0.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.543 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.97 -37.07 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.029 0.918 . . . . 0.0 110.417 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -67.32 -27.56 67.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.64 -0.663 . . . . 0.0 111.338 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 t -145.35 72.81 1.33 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.989 0.899 . . . . 0.0 112.712 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -127.15 139.84 52.68 Favored 'General case' 0 N--CA 1.468 0.452 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 168.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -60.57 -39.68 88.89 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.7 p -61.57 -33.45 73.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.883 0.849 . . . . 0.0 112.681 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.4 -36.12 20.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.255 0.55 . . . . 0.0 110.892 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -62.47 -38.94 91.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.47 -28.6 46.54 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.236 1.017 . . . . 0.0 112.567 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 p -95.4 -0.48 52.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -61.44 144.98 53.2 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.37 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.56 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 134.31 48.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.14 -42.39 89.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 111.747 -167.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -62.14 -22.92 66.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.72 -9.42 46.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.56 -0.712 . . . . 0.0 110.762 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.46 -43.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 168.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -60.58 -66.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.25 0.548 . . . . 0.0 109.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.99 60.64 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.932 -1.105 . . . . 0.0 111.643 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.71 -26.6 45.44 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.285 -0.959 . . . . 0.0 114.113 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -88.23 -38.89 14.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.461 1.124 . . . . 0.0 109.42 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.91 -18.05 0.43 Allowed Pre-proline 0 C--N 1.321 -0.636 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 C--N 1.355 0.87 1 C-N-CA 110.516 -5.856 . . . . 0.0 114.403 171.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.878 0.371 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -108.24 137.84 45.54 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.27 117.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 m -110.71 129.66 55.77 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.77 159.99 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.16 130.02 41.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.94 0.496 . . . . 0.0 110.005 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.88 170.97 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 111.84 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 132.11 49.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.165 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.65 112.85 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.79 -28.8 6.04 Favored Glycine 0 C--O 1.242 0.652 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.417 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.24 93.39 2.7 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.278 1.031 . . . . 0.0 112.594 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.27 72.87 5.24 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 121.181 1.254 . . . . 0.0 114.873 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -142.98 13.44 1.86 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.384 -1.448 . . . . 0.0 111.77 166.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.69 152.93 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 1 N-CA-C 99.409 -4.293 . . . . 0.0 99.409 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.37 158.43 26.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.938 1.295 . . . . 0.0 112.404 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.1 175.78 15.85 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -79.11 90.92 4.86 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.555 1.169 . . . . 0.0 109.958 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 124.94 29.15 Favored Pre-proline 0 C--N 1.319 -0.739 1 N-CA-C 97.161 -5.125 . . . . 0.0 97.161 161.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -66.42 -30.04 44.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 115.63 -2.446 . . . . 0.0 116.121 -168.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.73 -24.72 53.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.779 -0.575 . . . . 0.0 111.445 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.56 -40.72 97.74 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 123.121 1.439 . . . . 0.0 110.217 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -72.47 -16.01 61.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.587 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.15 -34.97 75.83 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.283 -0.885 . . . . 0.0 110.442 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.19 -41.36 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 122.554 1.169 . . . . 0.0 107.957 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.46 -44.93 85.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.816 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.17 -43.53 91.42 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.485 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -67.43 -39.2 85.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.428 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.95 -38.19 69.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.31 -26.58 62.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.111 0.414 . . . . 0.0 110.892 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -39.0 73.53 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.217 -0.927 . . . . 0.0 112.706 169.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -79.93 -10.03 59.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.509 -0.744 . . . . 0.0 112.66 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 55.44 35.51 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.749 1.219 . . . . 0.0 111.946 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 pt -89.05 154.78 49.73 Favored Pre-proline 0 C--O 1.242 0.701 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.93 153.21 58.18 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 114.215 -3.39 . . . . 0.0 112.666 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.04 157.26 41.42 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.68 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.88 118.16 33.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 171.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.9 t -91.02 120.46 32.03 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -114.2 112.45 23.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.426 1.108 . . . . 0.0 110.913 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.1 mt -96.57 109.93 22.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.407 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -83.36 116.41 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -72.33 54.07 0.3 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.658 1.983 . . . . 0.0 114.821 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt 54.4 54.46 9.38 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.856 1.663 . . . . 0.0 109.183 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.29 70.41 1.22 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.5 116.36 28.95 Favored 'General case' 0 C--N 1.32 -0.686 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 163.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -123.78 60.08 19.1 Favored Pre-proline 0 C--O 1.248 0.983 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.87 174.68 11.93 Favored 'Trans proline' 0 C--O 1.239 0.555 1 C-N-CA 113.118 -4.121 . . . . 0.0 110.41 161.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -55.0 -36.46 65.46 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.774 0.43 . . . . 0.0 110.572 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -55.8 -52.58 63.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -74.99 -27.2 60.06 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.213 -0.929 . . . . 0.0 111.817 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.03 -32.04 72.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.594 1.088 . . . . 0.0 111.624 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.91 -39.42 83.57 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.734 -0.604 . . . . 0.0 109.864 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.95 -37.23 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.85 0.86 . . . . 0.0 112.408 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -128.46 128.15 23.61 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.3 -14.3 31.21 Favored 'Trans proline' 0 C--O 1.242 0.714 0 N-CA-C 118.148 2.326 . . . . 0.0 118.148 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -102.97 -7.65 21.28 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.088 0.858 . . . . 0.0 110.767 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.8 8.23 72.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -159.86 55.64 0.37 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.382 1.073 . . . . 0.0 111.851 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.45 155.66 81.17 Favored Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 120.736 -1.228 . . . . 0.0 109.635 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.19 148.14 30.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 114.387 -3.275 . . . . 0.0 113.83 168.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.17 166.0 30.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.96 123.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 154.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -114.4 95.02 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mt -101.23 122.92 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 50.64 43.58 27.67 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.004 0.522 . . . . 0.0 111.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 68.39 12.87 8.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.13 2.641 . . . . 0.0 118.13 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -115.76 122.86 46.73 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.695 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -104.65 147.12 28.01 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -124.58 152.09 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.42 38.9 0.64 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 119.29 3.07 . . . . 0.0 119.29 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.19 153.72 31.34 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.882 1.673 . . . . 0.0 107.867 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -58.43 -32.65 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.54 -40.72 41.59 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.82 -0.55 . . . . 0.0 111.651 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -82.03 -20.31 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.2 pt -71.46 -3.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.854 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.55 -48.34 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 159.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.24 -36.31 91.57 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.0 mt -87.01 -30.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 120.227 2.013 . . . . 0.0 106.065 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.53 -49.42 74.81 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.656 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -60.5 -37.25 80.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.441 1.473 . . . . 0.0 112.255 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.5 -21.12 64.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -112.46 -6.34 14.0 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -76.79 135.55 67.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.55 -19.85 27.77 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 116.545 1.71 . . . . 0.0 116.545 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -75.7 160.89 78.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.029 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.44 129.19 33.84 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.78 130.32 3.67 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 N-CA-C 116.683 1.763 . . . . 0.0 116.683 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.92 48.5 2.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.72 1.208 . . . . 0.0 112.617 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.53 75.18 10.3 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.081 -1.637 . . . . 0.0 108.58 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -116.29 102.42 53.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.15 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -108.32 72.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.208 3.272 . . . . 0.0 118.21 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -82.36 -148.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 1 C-N-CA 125.681 4.254 . . . . 0.0 111.177 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.54 -29.95 28.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.71 -25.23 65.56 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 120.334 -1.479 . . . . 0.0 113.275 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.97 -34.04 59.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.8 p -72.29 -35.69 68.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -45.09 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.1 82.91 Favored Glycine 0 C--O 1.229 -0.162 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.793 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 p -70.18 -13.95 62.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -82.3 -40.6 21.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.481 -0.762 . . . . 0.0 109.671 170.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.36 -33.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -54.65 -51.87 74.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.98 -25.42 16.34 Favored 'Trans proline' 0 C--N 1.351 0.669 1 C-N-CA 112.615 -4.457 . . . . 0.0 114.042 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -69.0 -38.55 79.34 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . 0.262 0.4 OUTLIER -77.7 -27.23 50.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 118.511 -1.276 . . . . 0.0 113.703 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.74 -28.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.576 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -61.19 -44.77 96.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.492 -0.755 . . . . 0.0 110.944 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -65.7 -41.26 92.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.84 -38.91 83.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.993 -0.442 . . . . 0.0 111.615 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.4 27.35 1.47 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 t -121.13 122.0 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -113.75 26.5 10.3 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.34 168.2 30.0 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.06 94.28 0.73 Allowed 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 117.198 -1.402 . . . . 0.0 108.84 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.49 26.39 9.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 123.413 1.578 . . . . 0.0 110.993 -150.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.92 -28.49 69.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.957 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.24 -24.55 76.22 Favored Glycine 0 CA--C 1.519 0.326 0 O-C-N 121.165 -0.96 . . . . 0.0 114.156 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -91.35 -24.08 19.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.08 0.94 . . . . 0.0 111.098 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.21 -44.52 95.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 163.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -76.75 -12.73 60.03 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.752 -1.218 . . . . 0.0 114.252 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.56 -31.13 61.99 Favored 'General case' 0 C--O 1.217 -0.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.699 168.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.01 -42.36 99.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.77 -45.65 91.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.401 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -75.47 -36.78 60.6 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -76.82 -35.13 57.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.626 -1.296 . . . . 0.0 108.656 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.65 -19.03 58.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.346 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.58 -35.89 82.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.537 1.062 . . . . 0.0 110.412 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.3 mt -63.6 -37.96 89.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.937 -1.102 . . . . 0.0 113.564 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.14 -43.12 92.91 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.759 -0.588 . . . . 0.0 110.89 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.58 40.7 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.557 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -62.54 -38.06 88.53 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.432 -0.452 . . . . 0.0 111.61 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.7 -40.75 69.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.257 -0.902 . . . . 0.0 112.971 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.04 -16.65 64.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.977 1.262 . . . . 0.0 112.265 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.63 -53.84 37.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 O-C-N 121.437 -0.789 . . . . 0.0 109.363 165.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.45 -51.12 9.77 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.57 -72.23 0.29 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.554 -1.692 . . . . 0.0 115.48 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -69.35 176.86 5.91 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.012 2.475 . . . . 0.0 116.236 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -42.17 154.54 0.05 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.71 1.604 . . . . 0.0 114.411 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.65 -37.03 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.379 1.071 . . . . 0.0 112.672 -142.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.64 -22.22 65.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 117.465 2.395 . . . . 0.0 117.465 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.97 3.49 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 117.364 1.705 . . . . 0.0 117.364 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -129.6 -41.56 1.34 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.793 1.796 . . . . 0.0 114.015 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -159.87 -179.89 8.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.17 131.78 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.614 0.643 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.3 m -145.88 171.89 14.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -35.64 -39.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.51 -40.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.38 -38.92 74.79 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.04 -15.54 63.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 98.3 p -96.35 -34.41 11.58 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.63 -48.99 9.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.2 92.98 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.46 -36.2 56.14 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 112.85 -4.3 . . . . 0.0 116.762 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -78.76 -30.76 45.86 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.982 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.85 -29.33 70.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -63.47 -50.62 69.0 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 123.248 1.499 . . . . 0.0 109.11 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -77.1 -20.18 56.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.618 -170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 tp -64.14 -51.45 63.81 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.099 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.04 -34.0 77.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.381 1.446 . . . . 0.0 112.213 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.4 -52.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.78 41.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.546 -0.722 . . . . 0.0 111.549 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 tp -66.1 -42.69 88.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.704 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.83 -35.47 92.06 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.022 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -74.24 -47.35 35.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.746 -0.855 . . . . 0.0 111.528 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -87.0 -52.28 5.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -129.96 76.12 1.7 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.265 1.426 . . . . 0.0 108.089 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -56.14 121.36 9.24 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -168.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -151.0 92.76 3.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.7 163.59 36.89 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 114.994 -2.871 . . . . 0.0 109.963 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.57 118.99 65.55 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.24 166.22 26.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.714 -1.057 . . . . 0.0 111.996 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.68 3.0 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -68.12 -21.61 64.93 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.606 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -112.28 68.42 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.8 m -55.37 -38.17 68.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -55.17 -59.42 4.8 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.27 -34.51 70.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -166.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.5 tp -62.82 -44.34 96.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.28 -0.888 . . . . 0.0 113.323 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -78.78 -30.3 45.46 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.884 -1.135 . . . . 0.0 111.173 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.45 -49.2 77.78 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.666 0.787 . . . . 0.0 110.434 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.7 mm -69.88 -32.3 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.479 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.22 -38.54 91.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.047 -1.033 . . . . 0.0 112.738 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.56 -31.81 65.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 110.954 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.01 -11.43 59.55 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.637 -0.665 . . . . 0.0 111.952 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -92.73 27.38 2.37 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 122.716 1.246 . . . . 0.0 111.597 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.3 5.24 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 176.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 60.7 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.87 -32.67 67.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.924 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 m -50.8 -30.26 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -115.17 -42.68 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.494 1.14 . . . . 0.0 111.006 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.47 -31.47 62.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -94.19 -24.61 17.43 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.3 p -90.79 -21.94 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.3 126.58 27.91 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.291 0.567 . . . . 0.0 110.332 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.35 167.02 21.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.3 49.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -69.08 -37.4 78.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -162.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.45 -40.51 91.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.263 1.03 . . . . 0.0 109.748 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -78.09 -13.55 59.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.11 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.17 -50.32 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.09 -55.08 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.044 0.926 . . . . 0.0 111.494 -172.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.75 -3.09 36.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.404 1.081 . . . . 0.0 111.18 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.33 -29.9 26.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.34 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -102.96 -39.95 6.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.606 . . . . 0.0 113.22 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -59.72 -29.67 6.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--N 1.357 0.989 1 C-N-CA 111.81 -4.994 . . . . 0.0 114.238 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--O 1.232 0.156 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.33 138.33 44.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 168.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.43 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -125.82 111.3 14.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.28 155.96 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.67 125.64 24.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.64 164.24 23.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.59 127.09 30.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.351 0.596 . . . . 0.0 110.802 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.39 94.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.994 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.12 -19.45 7.28 Favored Glycine 0 C--O 1.235 0.163 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.795 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.1 69.56 23.05 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.47 74.14 5.26 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 N-CA-C 116.664 1.756 . . . . 0.0 116.664 -169.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -146.22 10.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.212 1.006 . . . . 0.0 109.442 167.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -135.03 155.78 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.33 143.48 57.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.707 0.685 . . . . 0.0 109.952 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 167.67 12.44 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 118.702 2.241 . . . . 0.0 118.702 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -65.39 103.97 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.929 -1.636 . . . . 0.0 113.781 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.2 t -166.36 141.37 3.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -62.98 -40.65 33.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 116.706 -1.729 . . . . 0.0 112.674 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.54 -27.14 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.743 -1.571 . . . . 0.0 111.471 -171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.88 -62.42 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.653 0.74 . . . . 0.0 109.644 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -70.4 -27.49 64.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.029 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -57.33 -46.16 83.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.598 1.09 . . . . 0.0 111.693 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -76.99 -35.92 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.222 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.36 -44.46 87.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.09 -39.17 93.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.466 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -39.54 93.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.685 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -33.5 54.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.958 -172.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -77.52 -33.58 54.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -67.05 -39.24 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.694 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.42 -6.46 58.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.716 -0.615 . . . . 0.0 112.402 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.26 41.63 31.9 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 113.213 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -97.6 146.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.33 152.63 34.94 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 114.738 -3.041 . . . . 0.0 113.829 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -150.58 156.6 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.937 0.875 . . . . 0.0 112.582 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.5 t -139.57 124.65 18.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.938 1.245 . . . . 0.0 112.95 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -114.18 124.85 53.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.85 108.04 20.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -83.77 95.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -67.64 97.31 0.6 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.92 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.9 mt 31.91 48.81 0.11 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.24 47.09 3.65 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.811 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -68.91 101.79 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 160.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -137.43 75.51 45.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -165.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -66.24 171.44 10.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 116.798 -1.668 . . . . 0.0 109.885 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -56.08 -36.61 68.31 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.691 -0.631 . . . . 0.0 112.313 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.95 -42.37 79.97 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -79.96 -31.44 39.94 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.086 -1.009 . . . . 0.0 111.418 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 mt -67.1 -24.67 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.296 -0.252 . . . . 0.0 111.67 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -66.75 -37.49 84.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.163 0.506 . . . . 0.0 110.962 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -88.91 -52.08 11.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-O 121.193 0.521 . . . . 0.0 111.806 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -87.35 117.06 68.07 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 120.886 -1.134 . . . . 0.0 111.302 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.33 -23.87 65.21 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 118.505 2.463 . . . . 0.0 118.505 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.4 -10.8 18.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.883 -1.136 . . . . 0.0 112.538 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -0.39 37.9 Favored Glycine 0 C--O 1.224 -0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 113.414 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -146.25 34.82 0.98 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.87 0.843 . . . . 0.0 110.708 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.8 141.2 37.48 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.68 147.85 90.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 116.131 -2.113 . . . . 0.0 113.063 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.93 162.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 132.78 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -105.81 136.53 45.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.88 91.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.1 t0 50.55 52.96 13.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.124 0.964 . . . . 0.0 111.391 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 t70 62.15 24.27 14.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -110.91 163.94 13.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -146.76 159.64 43.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.848 2.113 . . . . 0.0 115.447 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.42 162.27 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.66 -116.13 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.6 173.37 1.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 p -58.3 -30.05 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -158.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -77.92 -26.17 48.82 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.851 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -83.3 -34.85 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.87 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.306 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.81 -45.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.875 0.761 . . . . 0.0 111.646 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.43 -33.92 51.72 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -118.39 -51.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.5 -40.36 85.2 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.998 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.02 -38.36 85.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.238 0.926 . . . . 0.0 109.367 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.21 -31.82 71.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.01 1.26 49.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.54 135.87 83.73 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 -21.68 72.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 116.607 -1.795 . . . . 0.0 116.589 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -93.37 161.02 32.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.19 144.44 90.52 Favored 'Trans proline' 0 C--N 1.354 0.847 0 N-CA-C 116.705 1.771 . . . . 0.0 116.705 -156.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -84.95 29.16 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.029 1.819 . . . . 0.0 115.317 -163.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.33 111.58 3.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.81 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.15 26.55 2.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.244 1.021 . . . . 0.0 110.461 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.67 123.68 58.92 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -170.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -114.74 62.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.605 0 N-CA-C 116.452 1.674 . . . . 0.0 116.452 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -83.38 -132.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 121.192 1.261 . . . . 0.0 113.845 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.91 -32.98 70.03 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.442 -1.411 . . . . 0.0 110.638 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -62.55 -31.81 72.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.321 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.6 20.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.166 -0.334 . . . . 0.0 110.746 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.4 p -68.3 -39.26 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.537 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.76 -46.5 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.598 -0.689 . . . . 0.0 109.431 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.28 74.55 Favored Glycine 0 CA--C 1.516 0.097 0 N-CA-C 115.549 0.98 . . . . 0.0 115.549 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -66.77 -17.93 65.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -81.91 -33.65 30.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 110.757 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.97 -43.67 81.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -50.52 -59.79 6.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.59 -16.13 15.09 Favored 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 112.195 -4.737 . . . . 0.0 114.578 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -61.98 -37.4 84.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.531 1.06 . . . . 0.0 111.182 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -84.63 -24.9 28.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.985 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.72 -42.3 80.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -55.89 -47.69 76.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.514 0.725 . . . . 0.0 109.601 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.87 -41.51 97.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.58 -40.21 92.5 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -84.94 -8.31 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 t -87.91 144.07 26.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.17 39.45 2.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 123.144 1.449 . . . . 0.0 108.192 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.67 -179.36 0.51 Allowed Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 112.559 -2.11 . . . . 0.0 108.994 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -63.42 89.24 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 115.654 -2.431 . . . . 0.0 112.404 151.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -88.85 98.16 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.23 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.02 -49.08 0.46 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.025 -0.422 . . . . 0.0 110.681 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.2 -35.67 92.38 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -82.82 -36.71 25.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.44 1.114 . . . . 0.0 108.221 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.31 -31.85 73.2 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.161 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.09 73.54 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.692 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.11 -47.47 84.48 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.05 -47.8 83.08 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.88 -37.33 73.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -69.12 -44.12 73.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.24 -22.87 62.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.079 -1.013 . . . . 0.0 111.372 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.74 -33.56 75.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.473 0.579 . . . . 0.0 110.368 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.92 -46.11 79.47 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.511 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.2 mt -67.1 -38.58 85.93 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.552 -0.717 . . . . 0.0 111.239 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.002 0.521 . . . . 0.0 110.343 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.96 -51.81 50.24 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -60.94 -38.32 85.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.47 -51.39 67.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.382 0.611 . . . . 0.0 111.828 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.68 -16.1 61.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -165.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.02 -27.75 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.51 0.724 . . . . 0.0 110.778 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -106.42 -45.11 4.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 -59.71 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 119.013 2.365 . . . . 0.0 119.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -67.97 -154.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 122.019 2.909 . . . . 0.0 115.897 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -58.91 168.98 1.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.909 0.884 . . . . 0.0 112.939 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.77 -36.36 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -163.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.27 -3.58 4.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.95 -30.62 9.87 Favored Glycine 0 CA--C 1.51 -0.279 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -124.6 -43.96 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -159.17 172.22 18.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.68 118.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 m -139.84 -175.9 4.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -45.26 -41.06 8.16 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 118.736 2.865 . . . . 0.0 118.736 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.11 -39.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 119.391 0.996 . . . . 0.0 110.314 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -71.13 -35.69 71.83 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.26 -24.63 67.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.983 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.4 p -97.83 -41.68 7.93 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.13 -47.46 43.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.43 97.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.79 -25.32 20.38 Favored 'Trans proline' 0 C--N 1.347 0.493 1 C-N-CA 111.202 -5.398 . . . . 0.0 114.924 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -72.89 -31.82 64.94 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 119.916 -1.74 . . . . 0.0 109.22 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.79 -29.52 68.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -63.86 -47.65 79.89 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.886 -1.134 . . . . 0.0 110.589 168.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -62.24 -31.81 72.41 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.86 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.73 -59.15 3.82 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.279 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.02 -35.15 79.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.256 0.934 . . . . 0.0 111.743 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -57.21 -41.12 77.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.163 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.48 -35.08 14.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.66 -41.44 92.5 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.275 -0.891 . . . . 0.0 112.148 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.82 69.5 Favored Glycine 0 C--O 1.228 -0.239 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -73.27 -49.01 29.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -100.99 -29.11 12.37 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.697 2.481 . . . . 0.0 117.697 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -124.51 20.14 8.73 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.228 0.467 . . . . 0.0 110.831 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -13.25 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 -153.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -115.06 92.63 31.84 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.46 155.96 62.53 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 113.819 -3.654 . . . . 0.0 108.951 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.9 mt -65.92 125.77 90.57 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.79 153.62 58.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 117.418 -1.254 . . . . 0.0 111.317 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.69 0.98 11.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.82 -27.73 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 165.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.99 67.45 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -33.06 69.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.508 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -62.73 1.5 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.16 -35.23 67.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -160.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.45 -41.81 84.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.625 -0.672 . . . . 0.0 111.886 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -67.4 -37.04 82.5 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.469 -0.769 . . . . 0.0 110.46 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.2 -41.19 97.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.941 0.896 . . . . 0.0 112.88 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.38 -31.44 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.668 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.28 -41.5 98.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.408 -1.432 . . . . 0.0 111.159 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.36 -34.92 78.3 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.539 -0.726 . . . . 0.0 111.784 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.11 -49.78 76.28 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -70.14 -15.7 63.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.6 t -75.68 -49.32 18.71 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -85.03 144.34 28.34 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.65 -24.1 67.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.179 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.7 m -51.99 -36.58 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.82 -40.64 6.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.952 0.882 . . . . 0.0 109.2 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.29 -33.93 73.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.23 -33.56 32.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -93.77 -10.33 34.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -54.99 135.79 48.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.414 1.102 . . . . 0.0 111.778 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.08 150.92 47.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.408 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.32 121.79 13.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -40.26 93.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -169.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.47 -30.52 71.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 122.684 1.231 . . . . 0.0 108.979 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.75 9.37 39.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.627 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.66 -44.01 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.1 pt -66.04 -37.66 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.216 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.93 -3.54 45.38 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.19 -32.05 13.05 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -101.52 -55.96 2.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.87 -30.59 4.54 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 -172.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--N 1.351 0.71 1 C-N-CA 111.539 -5.174 . . . . 0.0 114.381 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.235 0.313 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -132.47 169.68 16.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -133.78 142.17 42.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -124.64 133.84 53.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.374 -2.824 . . . . 0.0 103.374 162.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.48 160.05 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.803 1.183 . . . . 0.0 109.586 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.69 133.98 51.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.928 0.331 . . . . 0.0 110.715 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.06 165.36 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.018 0.437 . . . . 0.0 110.028 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.25 127.99 33.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.31 129.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.61 -19.78 51.94 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-O 118.776 -1.013 . . . . 0.0 114.675 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.06 81.92 7.31 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 118.385 1.093 . . . . 0.0 113.327 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.06 71.0 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 N-CA-C 115.849 1.442 . . . . 0.0 115.849 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -142.58 -11.08 0.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.057 164.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -131.4 168.95 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.2 1.0 . . . . 0.0 109.231 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 mt -75.26 147.68 40.06 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.35 171.61 15.39 Favored Glycine 0 C--O 1.237 0.285 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.17 97.19 8.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.915 0.864 . . . . 0.0 109.252 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 132.31 20.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 166.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -67.77 -43.37 5.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 115.331 -2.646 . . . . 0.0 115.211 -168.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -26.1 64.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.848 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -64.34 -44.5 91.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.985 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.48 -41.97 88.16 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.5 -0.75 . . . . 0.0 110.491 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 tpt85 -58.62 -41.13 85.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.54 -41.78 80.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.253 0.933 . . . . 0.0 112.459 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.59 -39.42 84.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.389 0.614 . . . . 0.0 111.179 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.45 -41.84 99.03 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.39 95.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.751 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.7 -40.72 72.72 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.219 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -70.87 -36.97 73.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.507 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -68.91 -39.54 79.63 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.057 -1.027 . . . . 0.0 110.475 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -79.16 -4.52 50.85 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 56.1 34.87 24.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.821 1.248 . . . . 0.0 114.152 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.18 135.74 23.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.9 148.62 25.3 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 116.023 -2.184 . . . . 0.0 114.979 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -144.91 153.81 41.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.034 0.921 . . . . 0.0 112.418 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.34 117.16 32.35 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.9 123.18 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 123.995 0.809 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -111.12 94.22 4.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.33 135.65 52.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.764 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -85.25 110.82 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -78.73 53.4 1.34 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.852 1.261 . . . . 0.0 112.661 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 mt 51.05 38.97 22.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 112.843 177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.85 72.96 0.2 Allowed Glycine 0 CA--C 1.512 -0.141 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.75 -178.45 6.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 111.648 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.79 150.13 91.65 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 124.337 1.055 . . . . 0.0 113.395 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -20.03 -137.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.258 2 C-N-CA 128.975 6.45 . . . . 0.0 125.304 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -66.61 -26.9 67.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.963 -1.71 . . . . 0.0 113.975 -161.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -61.24 -44.27 97.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 110.553 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.27 -33.92 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.156 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.29 -29.35 67.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -70.15 -30.77 68.0 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.243 -0.911 . . . . 0.0 110.703 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.36 -58.94 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.041 0.448 . . . . 0.0 111.73 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 121.31 76.15 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 120.845 -1.159 . . . . 0.0 108.56 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.07 -21.79 31.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 N-CA-C 117.098 1.922 . . . . 0.0 117.098 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.1 -9.41 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.823 -1.173 . . . . 0.0 110.221 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -31.15 2.38 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.362 -162.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -118.59 31.37 6.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.81 155.1 60.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.2 171.0 17.73 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 117.247 -1.369 . . . . 0.0 113.262 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.61 159.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 163.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.25 130.45 48.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 146.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -105.32 90.81 3.54 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 mt -100.36 113.25 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 52.68 41.9 31.5 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.787 0.803 . . . . 0.0 111.596 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.29 37.76 20.18 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -136.72 148.36 47.26 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -133.95 140.72 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 119.554 3.168 . . . . 0.0 119.554 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.33 139.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.76 1.224 . . . . 0.0 108.337 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.19 15.91 0.47 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 155.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -63.57 139.14 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.734 -1.228 . . . . 0.0 108.169 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -154.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.97 -37.98 17.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.782 0.801 . . . . 0.0 109.641 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.94 -36.41 75.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.887 0.851 . . . . 0.0 111.115 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -25.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.997 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.87 -40.37 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.87 -59.08 1.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.77 . . . . 0.0 114.572 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -66.95 -39.5 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.423 -0.799 . . . . 0.0 112.806 -169.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -61.47 -44.31 97.33 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 120.109 1.322 . . . . 0.0 108.77 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -67.75 -35.07 78.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.218 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.23 -17.7 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.169 -0.957 . . . . 0.0 113.056 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -109.04 3.24 21.86 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.738 -0.601 . . . . 0.0 111.434 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -76.96 126.71 85.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.75 -8.99 22.14 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 116.62 -1.787 . . . . 0.0 114.199 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.1 162.99 17.99 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.8 138.51 85.84 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 N-CA-C 118.003 2.27 . . . . 0.0 118.003 -158.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.79 87.29 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.674 1.582 . . . . 0.0 115.709 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.31 53.4 0.96 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 123.103 1.43 . . . . 0.0 111.638 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.26 77.92 8.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.856 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.1 m -122.51 95.32 46.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 O-C-N 121.762 -0.586 . . . . 0.0 110.43 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.29 73.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 123.722 2.948 . . . . 0.0 116.458 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -84.41 -138.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 119.081 0.707 . . . . 0.0 113.221 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.95 -35.75 59.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -66.26 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.548 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.18 -32.19 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.2 p -71.94 -38.08 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.077 0.853 . . . . 0.0 109.129 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.07 -39.62 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.98 -33.05 67.68 Favored Glycine 0 C--O 1.224 -0.485 0 O-C-N 121.477 -0.764 . . . . 0.0 113.702 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.8 p -71.06 -11.81 61.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.432 1.116 . . . . 0.0 113.607 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -96.77 -26.42 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 109.516 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.25 -56.26 7.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.261 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -59.39 -55.14 49.11 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -165.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.03 -20.46 19.29 Favored 'Trans proline' 0 C--N 1.351 0.667 1 C-N-CA 113.006 -4.196 . . . . 0.0 112.716 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -69.46 -36.1 76.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.819 -0.551 . . . . 0.0 110.119 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.88 -35.97 77.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.085 -1.009 . . . . 0.0 112.018 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.0 -42.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -57.11 -49.12 76.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.304 0.642 . . . . 0.0 111.786 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -81.62 -11.16 59.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 tp -77.99 -36.95 48.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.557 0.694 . . . . 0.0 111.333 165.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -70.2 -25.45 63.42 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.304 -0.873 . . . . 0.0 111.453 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 t -88.93 149.12 23.47 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -132.05 40.58 3.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 123.105 1.431 . . . . 0.0 109.085 161.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.42 171.82 3.09 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.57 72.5 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 CA-C-O 123.158 1.233 . . . . 0.0 114.161 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -85.33 101.79 12.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.933 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.61 -52.58 0.35 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.66 -30.75 78.55 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.8 p -77.36 -24.22 50.69 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 118.452 1.126 . . . . 0.0 112.867 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -73.22 -35.91 66.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -67.42 -31.47 71.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.29 -35.85 80.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 120.506 -1.371 . . . . 0.0 111.093 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.82 -37.99 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.163 -0.335 . . . . 0.0 110.178 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.69 -41.1 89.94 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -67.88 -33.3 74.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.869 -1.144 . . . . 0.0 112.604 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -64.96 -40.65 95.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.58 -23.99 61.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.551 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.09 -26.48 66.74 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 118.626 0.648 . . . . 0.0 110.668 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.15 -46.64 70.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.35 -40.67 85.87 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 121.414 -0.803 . . . . 0.0 111.169 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.23 -39.63 87.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.33 -47.31 85.87 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-O 119.489 -0.617 . . . . 0.0 112.734 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -64.0 -41.56 97.45 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.029 0.914 . . . . 0.0 108.991 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -44.51 82.53 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.25 -0.906 . . . . 0.0 112.333 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.31 -12.62 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.0 m -96.57 -8.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.582 0.628 . . . . 0.0 112.254 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.72 -43.59 4.01 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.61 -76.19 0.24 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -69.37 -176.09 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 CA-C-N 120.909 2.354 . . . . 0.0 118.047 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -54.89 161.45 1.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.32 -30.04 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.972 -116.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.27 18.8 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.86 85.79 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -144.56 -48.6 0.26 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -172.95 175.02 3.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -166.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.3 mm -61.14 121.41 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -135.98 178.59 6.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.48 -27.37 24.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.0 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.422 0.629 . . . . 0.0 110.517 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.56 -39.8 94.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.96 -21.6 61.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.06 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.2 p -87.5 -36.56 17.57 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.674 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.18 -47.25 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.52 94.62 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.8 -29.33 12.65 Favored 'Trans proline' 0 C--N 1.352 0.73 1 C-N-CA 111.849 -4.967 . . . . 0.0 113.696 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.23 -25.87 42.56 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.135 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.07 -35.57 80.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.095 0.861 . . . . 0.0 111.494 167.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.86 -47.46 80.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -63.09 -35.09 79.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.35 -51.4 57.57 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.388 -0.82 . . . . 0.0 111.0 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -65.01 -30.88 71.89 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.751 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.17 -58.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 117.902 0.319 . . . . 0.0 110.489 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.74 67.22 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.134 -0.979 . . . . 0.0 113.127 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.03 -35.14 74.08 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.39 -37.5 94.56 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.907 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -66.07 -42.07 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.269 -0.548 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -100.74 -42.95 6.29 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 118.504 2.779 . . . . 0.0 118.504 -164.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -140.89 57.52 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -47.35 122.08 4.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -152.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -155.0 93.22 2.77 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.44 165.56 32.16 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 115.848 -2.301 . . . . 0.0 109.64 166.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.82 121.12 71.79 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.41 161.68 41.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 116.5 -1.867 . . . . 0.0 113.345 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -73.35 1.37 9.73 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.5 -21.65 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.667 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.43 78.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -40.35 82.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -54.52 39.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -66.0 -43.79 92.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.69 -47.03 85.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -75.35 -33.97 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.653 -0.654 . . . . 0.0 112.6 -174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.36 -20.67 50.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.02 -42.03 94.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -63.45 -33.5 75.7 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.496 -1.378 . . . . 0.0 111.261 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.0 -42.87 75.89 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.932 -0.48 . . . . 0.0 111.511 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.16 -18.91 22.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.38 -35.72 70.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.7 t -128.11 68.2 1.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.597 165.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -103.84 140.39 37.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.083 -3.673 . . . . 0.0 101.083 154.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.05 -45.87 68.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.8 t -61.64 -45.48 93.89 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.303 1.049 . . . . 0.0 112.518 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.73 -41.07 68.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.764 -174.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.78 -40.11 82.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.782 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -78.44 -35.3 47.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 36.4 p -88.55 -15.97 33.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -65.36 150.12 48.83 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.614 -0.678 . . . . 0.0 112.604 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.84 160.19 30.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.19 143.55 50.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -56.84 -42.95 80.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -59.71 -40.45 88.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 0.0 110.964 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.05 -12.5 60.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.58 -48.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -68.11 -51.45 48.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.323 1.059 . . . . 0.0 108.578 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.5 -5.75 44.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.18 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.77 -29.54 15.59 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 119.517 -0.602 . . . . 0.0 114.313 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -106.82 -26.07 11.42 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -64.87 -18.8 0.47 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 119.522 3.156 . . . . 0.0 119.522 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.358 1.034 1 C-N-CA 112.905 -4.263 . . . . 0.0 116.282 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.23 0.052 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -114.65 141.55 47.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.848 1.204 . . . . 0.0 112.323 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.51 96.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 t -96.16 118.62 33.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.22 163.7 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -166.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -67.88 130.88 44.34 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.634 -0.666 . . . . 0.0 112.553 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.3 166.53 22.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.479 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.88 139.72 56.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.65 126.83 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.885 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.04 -16.17 17.57 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.21 76.45 13.4 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.33 42.24 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 118.391 2.42 . . . . 0.0 118.391 -170.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -112.12 -12.56 13.65 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -125.84 159.33 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.63 135.44 57.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.839 1.255 . . . . 0.0 111.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.32 -163.7 36.99 Favored Glycine 0 CA--C 1.511 -0.198 0 N-CA-C 119.307 2.483 . . . . 0.0 119.307 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -76.35 76.38 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.157 1.383 . . . . 0.0 109.774 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -141.35 82.98 13.93 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 121.221 -0.925 . . . . 0.0 113.147 -171.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.27 -22.71 75.4 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 116.079 -2.147 . . . . 0.0 115.571 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -68.85 -38.43 79.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -69.55 -40.45 76.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.69 -35.32 79.3 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 118.381 -0.818 . . . . 0.0 112.275 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -57.59 -39.81 77.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.725 1.602 . . . . 0.0 110.767 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.42 -52.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.42 0.629 . . . . 0.0 110.293 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.09 -37.78 88.7 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.81 -41.78 97.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -66.89 -32.49 73.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.308 0.575 . . . . 0.0 111.29 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.43 -46.38 48.82 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.146 -0.346 . . . . 0.0 111.112 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -72.52 -34.37 67.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -36.31 83.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.021 -1.05 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -86.22 -7.08 58.81 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 59.55 29.33 18.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.487 1.515 . . . . 0.0 114.121 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -80.84 136.18 51.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.82 153.18 53.31 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.178 -1.415 . . . . 0.0 114.214 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -156.57 171.69 19.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.37 124.9 48.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 t -83.5 145.81 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -139.66 146.43 39.69 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 102.799 -3.037 . . . . 0.0 102.799 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.73 132.34 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.73 119.89 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.32 72.79 7.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.55 1.167 . . . . 0.0 109.937 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 mt 57.22 27.16 13.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.6 33.64 Favored Glycine 0 C--O 1.226 -0.351 0 O-C-N 121.871 -0.518 . . . . 0.0 113.537 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -68.33 117.41 10.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 154.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -140.1 101.16 7.01 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.3 175.68 7.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.972 -0.885 . . . . 0.0 111.133 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -56.49 -36.48 69.17 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 122.146 -0.346 . . . . 0.0 111.017 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -56.6 -40.58 75.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -71.52 -31.81 67.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.142 -0.974 . . . . 0.0 108.959 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.29 -23.62 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.34 -35.29 79.1 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.303 -0.873 . . . . 0.0 110.241 172.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.05 -53.03 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -90.59 139.05 26.42 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 121.661 -0.649 . . . . 0.0 111.004 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.12 -22.91 46.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 116.974 -1.551 . . . . 0.0 115.858 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -108.11 -6.24 16.57 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 0.0 111.992 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.54 4.35 38.22 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.373 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.65 58.44 1.12 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.968 0.907 . . . . 0.0 110.819 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.82 159.17 69.83 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 100.343 -3.947 . . . . 0.0 100.343 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -69.16 147.98 67.95 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 114.081 -3.479 . . . . 0.0 111.47 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.1 155.54 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.164 0.507 . . . . 0.0 109.966 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -123.33 109.18 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.67 84.98 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.8 95.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.153 0.981 . . . . 0.0 108.361 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.3 t0 51.94 46.85 25.89 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.434 1.111 . . . . 0.0 111.779 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t0 58.99 30.55 20.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -114.85 165.85 12.4 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 166.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -150.58 149.79 30.37 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.06 157.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -115.52 -121.65 0.3 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.66 -176.91 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -166.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -54.41 -36.44 63.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.67 -20.43 53.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.943 0.878 . . . . 0.0 110.006 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.6 t -91.87 -43.89 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -42.04 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.71 -0.619 . . . . 0.0 111.14 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.32 -13.85 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.66 0.743 . . . . 0.0 112.299 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.04 -64.04 0.71 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.42 -47.39 45.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.631 -168.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.08 -40.45 94.67 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.606 1.548 . . . . 0.0 108.702 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -63.42 -42.66 98.72 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.704 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.95 -40.19 94.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -87.12 4.96 40.15 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.933 -0.48 . . . . 0.0 111.968 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.45 135.91 93.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.987 -0.445 . . . . 0.0 111.516 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.44 -6.07 16.05 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.891 1.073 . . . . 0.0 114.891 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -112.11 162.32 21.87 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.38 130.89 39.75 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 116.381 -1.946 . . . . 0.0 116.791 -161.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.8 146.02 32.99 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 116.763 -1.691 . . . . 0.0 111.914 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.26 45.74 2.73 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.24 80.26 7.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.3 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.2 p -114.31 106.02 53.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -98.51 59.16 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.357 2.705 . . . . 0.0 118.71 163.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.18 -146.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 120.112 1.076 . . . . 0.0 113.107 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -51.43 -32.27 26.0 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -68.6 -30.57 69.33 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.417 -0.802 . . . . 0.0 111.599 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.46 47.48 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.247 -0.283 . . . . 0.0 110.642 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.5 p -74.85 -30.52 61.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.731 -0.605 . . . . 0.0 112.531 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.1 t -75.12 -40.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.08 91.25 Favored Glycine 0 C--O 1.222 -0.605 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.252 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.3 p -71.47 -11.66 60.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -81.21 -32.39 33.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.628 1.204 . . . . 0.0 110.004 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.3 -43.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.179 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.66 -56.83 19.18 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.3 -13.21 13.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 113.973 -3.551 . . . . 0.0 113.464 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 t -69.55 -49.51 53.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.992 -0.443 . . . . 0.0 109.808 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -70.72 -26.99 63.63 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.608 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.33 -44.51 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.2 -44.82 87.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.74 -25.96 59.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.0 -37.33 55.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.092 0.86 . . . . 0.0 110.667 174.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -87.94 40.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t -152.02 144.81 24.34 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -131.16 34.41 4.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.34 168.63 7.51 Favored Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 163.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.61 44.3 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 N-CA-C 115.959 1.484 . . . . 0.0 115.959 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.71 116.69 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.765 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -150.88 -55.49 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.74 -40.6 97.54 Favored Glycine 0 C--O 1.217 -0.906 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.1 p -69.42 -27.55 65.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.86 1.33 . . . . 0.0 112.56 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -73.73 -29.35 62.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.778 1.275 . . . . 0.0 108.372 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -83.98 -24.55 30.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.715 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.46 86.27 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.755 -1.216 . . . . 0.0 108.632 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.985 -0.447 . . . . 0.0 111.455 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.59 -40.23 86.78 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -67.33 -34.46 77.38 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.975 -1.078 . . . . 0.0 113.496 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -65.58 -42.36 91.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.718 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.8 mt -65.9 -35.52 80.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.927 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -64.98 -28.96 69.87 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.607 0.363 . . . . 0.0 111.932 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 -44.74 93.33 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.821 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 -38.35 80.41 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.908 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.12 -42.92 95.79 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.653 1.115 . . . . 0.0 111.732 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -34.14 89.11 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.952 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -77.16 -43.49 33.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.655 -0.909 . . . . 0.0 110.363 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -41.35 74.08 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -70.58 -20.76 62.75 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.896 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.94 -47.03 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 167.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -73.96 -46.18 45.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.22 -73.95 0.22 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 116.784 -2.12 . . . . 0.0 117.407 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -61.46 -164.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 126.268 4.645 . . . . 0.0 118.932 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -58.3 172.98 0.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.776 0.83 . . . . 0.0 113.123 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.29 -39.26 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.302 0.641 . . . . 0.0 112.283 -160.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.08 4.88 1.87 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.17 -14.02 66.27 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -134.58 -49.42 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -166.17 179.01 5.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 120.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -129.87 -164.09 1.37 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 171.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.75 -38.55 15.73 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.84 -40.19 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 123.033 1.397 . . . . 0.0 111.303 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -73.28 -32.31 64.58 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 120.992 -1.067 . . . . 0.0 109.915 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.9 -33.18 71.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.803 -0.561 . . . . 0.0 110.361 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.0 p -80.08 -45.96 17.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -81.18 -42.87 20.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.68 -37.83 60.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.9 -22.48 23.28 Favored 'Trans proline' 0 C--N 1.35 0.628 1 C-N-CA 111.893 -4.938 . . . . 0.0 114.731 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -74.72 -31.8 61.96 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 108.796 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.65 -31.71 71.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.502 0.592 . . . . 0.0 112.217 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -62.65 -51.38 67.5 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.418 -0.801 . . . . 0.0 109.753 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -65.58 -28.64 69.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.531 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.61 -52.36 65.5 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.602 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.36 -38.34 84.65 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.902 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.63 -49.47 84.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.31 11.43 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 120.571 -1.331 . . . . 0.0 114.191 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.07 -37.56 87.94 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.274 -0.891 . . . . 0.0 110.016 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.18 79.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -86.68 -36.02 18.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.074 0.937 . . . . 0.0 110.846 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.68 -37.29 13.11 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 -173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -150.31 62.04 0.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -52.81 128.56 27.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.261 -159.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -138.61 97.98 9.03 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.96 151.22 82.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 114.164 -3.424 . . . . 0.0 110.791 167.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.8 mt -71.6 126.84 91.56 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.68 160.7 47.41 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 117.092 -1.472 . . . . 0.0 112.781 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -74.05 -1.57 20.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.09 -1.18 57.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.515 0.674 . . . . 0.0 109.71 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.6 mt -121.71 55.56 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.0 m -58.39 -33.43 69.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -59.87 4.06 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.39 -38.61 81.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.9 tp -63.32 -45.52 90.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.585 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -83.32 -24.34 32.17 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.008 -0.433 . . . . 0.0 110.208 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.22 -47.82 82.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.58 -48.34 87.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -61.82 -35.45 78.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.17 -45.61 66.37 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.791 -0.568 . . . . 0.0 111.171 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.3 -20.83 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.35 -22.75 54.56 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.051 0.54 . . . . 0.0 112.12 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 t -128.02 67.42 1.35 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.394 1.093 . . . . 0.0 109.635 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.12 142.37 47.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 155.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -59.94 -38.78 83.41 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.671 0.607 . . . . 0.0 111.203 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.7 p -57.5 -46.13 84.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.523 0.601 . . . . 0.0 111.521 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -49.57 55.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.866 0.365 . . . . 0.0 111.698 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.33 -47.13 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -71.94 -24.24 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 112.824 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 70.4 p -120.36 27.32 8.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.914 0.864 . . . . 0.0 111.328 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -63.19 157.4 22.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.351 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 160.97 30.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.41 109.68 5.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -60.4 -36.45 78.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.16 -36.16 76.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.977 0.894 . . . . 0.0 109.69 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -90.8 -8.0 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.879 -0.513 . . . . 0.0 111.086 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.33 -50.71 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 163.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.265 19.7 pt -69.5 -50.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.734 -172.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.26 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.302 -0.874 . . . . 0.0 111.464 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.93 -31.95 13.84 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -95.61 -42.64 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -20.63 0.6 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 120.566 3.543 . . . . 0.0 120.566 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.353 0.769 1 C-N-CA 111.337 -5.308 . . . . 0.0 113.779 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--O 1.234 0.264 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -143.85 155.43 44.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.506 1.048 . . . . 0.0 109.487 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.98 106.07 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.33 1.062 . . . . 0.0 113.062 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.2 m -87.44 64.54 8.23 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.375 -0.828 . . . . 0.0 112.993 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 m -71.47 152.22 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.61 134.75 38.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.56 171.5 12.29 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.94 137.36 58.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.803 0.811 . . . . 0.0 112.502 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.16 118.4 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.95 82.97 Favored Glycine 0 C--O 1.246 0.864 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.54 100.01 4.43 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.81 80.11 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 CA-C-O 122.701 1.042 . . . . 0.0 113.926 169.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -148.51 -31.19 0.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.482 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.38 162.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.7 158.13 35.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.24 -178.78 15.46 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.76 105.84 10.34 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.8 m -128.68 153.03 79.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 149.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.18 -39.78 65.77 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.475 -1.884 . . . . 0.0 109.755 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -14.91 63.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.77 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.7 -58.02 3.46 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.69 -26.22 66.07 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.59 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -47.36 -45.95 25.32 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 120.996 1.725 . . . . 0.0 113.161 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.36 -34.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.05 -39.88 96.06 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.538 -1.351 . . . . 0.0 110.13 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.6 -33.55 72.85 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -74.71 -46.74 35.54 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.727 -0.608 . . . . 0.0 109.592 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -40.81 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.808 0.731 . . . . 0.0 111.054 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -69.03 -43.24 75.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.872 -1.142 . . . . 0.0 108.271 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.59 -12.18 60.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.066 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtmm 54.67 42.94 30.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.073 1.349 . . . . 0.0 111.874 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -95.09 157.95 35.66 Favored Pre-proline 0 C--O 1.242 0.682 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.795 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.5 119.74 6.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 117.05 -1.5 . . . . 0.0 113.909 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -136.45 154.59 50.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.566 0.698 . . . . 0.0 109.128 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.36 150.62 37.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 t -119.44 139.74 51.55 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 122.267 1.032 . . . . 0.0 113.234 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.06 97.71 5.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.385 1.474 . . . . 0.0 111.278 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.3 mt -70.67 127.96 34.45 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.563 0.697 . . . . 0.0 112.619 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.15 108.0 22.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -78.29 69.32 4.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.583 1.182 . . . . 0.0 110.45 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 58.4 41.58 22.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.791 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.69 85.02 1.4 Allowed Glycine 0 C--O 1.24 0.491 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -129.24 -76.75 0.55 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -155.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -71.7 152.08 93.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.22 -160.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 2 C-N-CA 127.266 5.31 . . . . 0.0 123.527 -170.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.27 -13.87 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -52.22 -47.17 65.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.822 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -81.6 -38.17 26.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 112.215 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.57 -27.37 67.68 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.4 -0.813 . . . . 0.0 112.027 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.75 -34.29 75.34 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.6 mt -97.41 -46.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.965 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -76.04 127.82 84.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.42 -31.75 13.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 115.672 -2.419 . . . . 0.0 116.506 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -86.9 -21.37 26.36 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.578 -1.326 . . . . 0.0 110.277 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.23 85.08 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.288 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -147.15 27.23 1.05 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.973 0.909 . . . . 0.0 111.837 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.24 143.68 27.09 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.333 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.38 159.19 53.52 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 117.353 -1.298 . . . . 0.0 113.542 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t 77.72 153.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 128.428 2.691 . . . . 0.0 109.714 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.6 33.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.769 1.628 . . . . 0.0 113.547 149.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -153.24 125.67 8.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.537 3.162 . . . . 0.0 119.537 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -147.1 134.65 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 109.506 166.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.55 39.3 24.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.031 0.933 . . . . 0.0 113.191 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.37 20.38 10.97 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.734 1.614 . . . . 0.0 114.031 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -125.33 165.79 17.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.733 1.613 . . . . 0.0 106.914 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -112.09 118.45 35.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.21 129.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 112.123 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.26 112.71 2.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.399 1.08 . . . . 0.0 111.94 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -164.11 151.46 12.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 162.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.3 p -54.56 -37.86 65.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.6 -33.09 28.08 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.015 0.912 . . . . 0.0 109.954 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -72.31 -40.7 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -73.03 -11.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -103.19 -5.46 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.627 0.649 . . . . 0.0 111.435 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.36 -66.91 0.13 Allowed Glycine 0 CA--C 1.519 0.32 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.9 -35.12 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.8 -1.412 . . . . 0.0 110.084 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.6 -38.26 86.92 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.738 -1.226 . . . . 0.0 111.726 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.77 -31.79 68.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.254 0.549 . . . . 0.0 110.528 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -65.41 -27.74 68.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.019 0.914 . . . . 0.0 111.471 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.24 6.41 40.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.867 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.44 144.04 91.23 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.05 -28.89 18.57 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 115.24 -2.706 . . . . 0.0 115.087 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.4 165.71 48.58 Favored Pre-proline 0 N--CA 1.473 0.681 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.11 142.88 76.48 Favored 'Trans proline' 0 C--N 1.354 0.868 0 N-CA-C 117.688 2.149 . . . . 0.0 117.688 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.9 90.91 0.88 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.003 1.136 . . . . 0.0 114.955 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -108.94 79.07 1.18 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.843 1.306 . . . . 0.0 111.758 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.26 73.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.841 -173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -115.63 116.15 41.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.001 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -98.35 74.67 0.07 OUTLIER 'Trans proline' 0 CA--C 1.558 1.723 1 C-N-CA 127.194 5.263 . . . . 0.0 119.032 164.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -85.13 -149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 121.304 1.336 . . . . 0.0 113.504 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.24 -38.6 12.57 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.22 -26.1 67.22 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.44 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.31 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.756 -0.59 . . . . 0.0 111.328 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.3 p -75.1 -34.39 61.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.91 -39.25 83.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -32.52 80.72 Favored Glycine 0 C--O 1.226 -0.387 0 O-C-N 121.435 -0.791 . . . . 0.0 114.202 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -70.43 -6.64 37.23 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -104.11 -35.07 8.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.502 0.667 . . . . 0.0 110.988 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.57 -51.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.432 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.04 -52.1 75.33 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -69.04 -26.4 31.01 Favored 'Trans proline' 0 C--N 1.35 0.606 1 C-N-CA 112.118 -4.788 . . . . 0.0 113.178 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -65.48 -42.57 92.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . 0.287 10.7 p90 -78.98 -18.12 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.441 -177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -79.33 -37.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.953 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.25 -40.45 90.35 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.773 -0.579 . . . . 0.0 111.607 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -64.71 -40.21 94.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.094 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.23 -35.75 82.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.142 0.496 . . . . 0.0 112.167 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.67 -0.31 26.21 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.3 t -107.0 127.82 53.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -166.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -116.64 34.37 5.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 123.272 1.51 . . . . 0.0 109.05 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.44 168.56 13.6 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 166.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.91 63.74 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-O 123.172 1.238 . . . . 0.0 113.516 159.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -80.38 69.52 6.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -167.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.92 -40.33 20.28 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.554 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 -38.84 91.81 Favored Glycine 0 C--O 1.228 -0.241 0 O-C-N 121.837 -0.539 . . . . 0.0 112.93 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 -28.48 64.01 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.288 -0.536 . . . . 0.0 110.41 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.22 -38.8 82.27 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.41 -1.431 . . . . 0.0 109.996 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -78.95 -12.48 60.03 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.114 -0.991 . . . . 0.0 113.113 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.31 76.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.9 mt -60.34 -44.27 95.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.513 0.673 . . . . 0.0 109.325 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.87 -51.64 68.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.04 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.26 -29.26 47.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -70.51 -40.49 73.49 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 mt -68.63 -24.43 64.55 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.122 -0.986 . . . . 0.0 112.354 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -61.6 -32.97 73.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.429 0.558 . . . . 0.0 112.261 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -43.07 89.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.93 -27.74 63.99 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.844 -0.535 . . . . 0.0 111.569 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.98 -48.91 72.31 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.696 -0.627 . . . . 0.0 111.838 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.12 -36.42 91.85 Favored Glycine 0 C--O 1.235 0.2 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.592 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -35.53 80.81 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 122.369 -0.489 . . . . 0.0 111.237 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -73.26 -10.21 59.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -162.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.9 m -82.03 -12.36 12.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -112.71 -49.09 2.96 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.28 -60.65 0.35 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -79.22 -177.82 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.771 2.314 . . . . 0.0 116.728 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -40.64 151.86 0.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 pt -74.45 3.24 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -141.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.05 -8.9 57.82 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.632 1.206 . . . . 0.0 109.258 162.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.88 6.22 65.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.622 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -143.26 -49.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -165.97 -174.69 3.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.479 1.112 . . . . 0.0 108.163 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.89 123.07 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.3 m -139.36 172.24 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.29 5.07 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.29 -37.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -78.45 -40.56 35.27 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.098 -1.001 . . . . 0.0 108.41 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.91 -16.26 61.02 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.831 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.8 m -77.3 -35.04 55.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.82 -38.68 6.01 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -47.96 -42.41 48.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -57.35 -37.66 96.94 Favored 'Trans proline' 0 C--N 1.354 0.864 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -99.32 -17.33 18.1 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.615 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.51 -32.69 72.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 118.506 0.594 . . . . 0.0 110.926 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.28 -52.87 63.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -68.99 -19.33 64.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.51 -47.49 72.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -36.28 80.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.276 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 -50.07 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.4 -51.67 34.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.39 -0.819 . . . . 0.0 110.34 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.82 -41.39 83.12 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.233 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.09 71.14 Favored Glycine 0 C--O 1.234 0.127 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.682 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -90.41 -40.53 12.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -96.53 -41.01 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -137.53 71.95 1.41 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.966 1.306 . . . . 0.0 108.847 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -67.84 86.32 0.23 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -154.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -121.65 99.14 45.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 110.931 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.78 168.26 23.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 118.374 -0.617 . . . . 0.0 112.676 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.54 122.02 86.01 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.6 161.88 43.94 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 116.716 -1.723 . . . . 0.0 111.319 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -69.18 -15.05 63.31 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.286 -0.884 . . . . 0.0 111.712 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.63 -25.17 68.1 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.364 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.25 61.87 0.6 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.78 1.276 . . . . 0.0 109.289 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -22.78 66.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -171.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -50.19 74.82 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -25.3 16.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.688 -168.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -61.28 -48.41 81.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.443 170.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.78 -40.45 88.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.004 0.907 . . . . 0.0 112.39 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -66.85 -49.27 66.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.053 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.4 mm -66.76 -33.89 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.52 -46.83 88.71 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.329 -0.857 . . . . 0.0 111.846 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.6 mt -66.96 -43.14 83.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.903 0.383 . . . . 0.0 111.14 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.54 -32.36 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.484 1.114 . . . . 0.0 111.849 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -62.7 -29.3 70.56 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.372 -0.83 . . . . 0.0 113.144 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -144.0 57.46 1.34 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -90.28 144.5 25.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 150.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.72 -39.65 85.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.908 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -59.02 -44.05 91.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.095 0.95 . . . . 0.0 111.297 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.24 -41.94 60.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.056 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.1 -39.83 93.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.237 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -74.32 -32.27 62.78 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.2 p -101.23 0.56 37.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 117.724 2.491 . . . . 0.0 117.724 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -58.02 150.29 21.21 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.59 167.45 20.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.742 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.77 127.19 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.99 -38.59 91.63 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 117.846 0.294 . . . . 0.0 111.081 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.29 -40.41 74.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 109.028 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -94.41 -1.78 53.07 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.5 t -77.66 -53.41 14.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 163.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.4 mt -67.74 -56.88 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.597 0.713 . . . . 0.0 110.344 -171.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.4 -4.85 44.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.02 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.03 -23.8 36.99 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.374 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -102.27 -35.99 8.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.69 -23.66 1.13 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.356 0.96 1 C-N-CA 112.852 -4.299 . . . . 0.0 114.746 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -123.53 136.5 54.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.16 125.62 57.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 175.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.4 m -129.63 105.59 8.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.19 160.77 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -169.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 130.7 45.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.07 172.03 14.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.937 0.398 . . . . 0.0 111.271 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 137.94 58.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.72 141.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.354 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.32 -38.2 3.01 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.12 81.45 6.19 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 123.107 0.563 . . . . 0.0 110.49 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.49 89.47 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 N-CA-C 117.956 2.252 . . . . 0.0 117.956 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -144.74 -33.43 0.38 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -88.98 164.29 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.34 146.17 49.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.458 1.503 . . . . 0.0 111.253 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.33 173.04 22.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 122.579 3.792 . . . . 0.0 122.579 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -81.13 78.58 7.92 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 t -128.61 135.66 27.92 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.57 -42.59 52.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 119.074 0.705 . . . . 0.0 113.703 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -12.61 60.02 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.9 t -60.47 -45.47 93.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.541 0.686 . . . . 0.0 111.247 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.96 -7.45 59.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -63.18 -43.95 96.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -42.55 67.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.734 -1.576 . . . . 0.0 111.169 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.75 -43.71 79.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.131 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.06 -40.18 87.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.255 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.2 m -62.86 -34.42 77.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.348 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -46.7 32.61 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 112.526 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.8 -24.91 61.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.735 0.303 . . . . 0.0 111.401 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.65 -31.8 71.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.28 -0.887 . . . . 0.0 111.584 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -95.81 -16.15 22.05 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 50.1 46.13 24.9 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -76.55 137.15 67.33 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 163.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.91 148.42 70.46 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 115.834 -2.311 . . . . 0.0 113.425 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -141.95 151.63 42.74 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 122.775 1.274 . . . . 0.0 113.481 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -91.97 117.61 29.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.305 -1.77 . . . . 0.0 107.494 169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 t -99.16 121.2 40.7 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -114.96 140.0 49.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.46 126.62 53.69 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -90.4 104.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -73.06 71.64 1.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.763 0.825 . . . . 0.0 113.153 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.0 mt 56.08 52.84 9.83 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.88 1.272 . . . . 0.0 113.082 169.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.21 80.19 1.01 Allowed Glycine 0 CA--C 1.51 -0.229 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.695 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -116.01 -88.86 0.58 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -148.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -74.73 159.13 83.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 119.209 -0.425 . . . . 0.0 111.729 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -60.01 -165.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.199 2.599 . . . . 0.0 118.021 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -42.21 -37.57 1.51 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -50.11 -45.99 53.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.406 0.548 . . . . 0.0 111.439 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.34 -22.37 41.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.82 -23.31 60.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.393 0.616 . . . . 0.0 110.314 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.41 -41.04 49.1 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.854 -0.529 . . . . 0.0 110.853 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.25 -40.98 86.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -116.43 128.17 26.2 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.462 1.483 . . . . 0.0 111.758 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.34 -16.51 31.19 Favored 'Trans proline' 0 C--N 1.35 0.628 0 N-CA-C 117.003 1.886 . . . . 0.0 117.003 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -100.39 -4.88 28.15 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.842 0.746 . . . . 0.0 112.147 166.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.27 -28.2 3.84 Favored Glycine 0 CA--C 1.52 0.353 0 O-C-N 122.048 -0.407 . . . . 0.0 114.081 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 33.17 2.62 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.28 148.89 35.26 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 151.13 73.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 117.222 -1.385 . . . . 0.0 113.794 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.86 169.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.336 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.8 t -124.25 138.04 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 153.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -104.68 96.37 6.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.14 129.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t0 60.26 34.18 20.92 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.78 1.276 . . . . 0.0 111.018 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.27 21.38 12.03 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.782 2.433 . . . . 0.0 114.299 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -127.56 127.88 44.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.681 0.792 . . . . 0.0 110.047 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -108.02 144.0 35.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.6 t -131.46 140.09 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.79 -0.43 2.34 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.06 139.73 30.23 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.08 -1.013 . . . . 0.0 111.143 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.5 p -75.03 -26.17 59.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 -152.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -80.65 -35.18 34.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -91.47 -10.48 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.777 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -76.53 2.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.468 -0.77 . . . . 0.0 110.389 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.1 -56.66 5.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 O-C-N 121.688 -0.633 . . . . 0.0 110.229 152.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.11 -42.79 99.43 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 120.111 2.804 . . . . 0.0 120.111 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.58 -37.4 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 118.937 1.368 . . . . 0.0 107.466 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -40.93 97.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.02 -42.2 98.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.745 0.702 . . . . 0.0 111.222 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -61.49 -34.09 74.9 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 111.462 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.03 16.4 19.69 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.09 116.95 52.74 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.49 -13.76 38.25 Favored 'Trans proline' 0 C--O 1.245 0.86 1 N-CA-C 123.16 4.254 . . . . 0.0 123.16 -167.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.43 155.37 74.09 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-N 121.357 1.89 . . . . 0.0 107.126 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.77 125.53 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 116.635 -1.777 . . . . 0.0 116.306 -168.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.19 152.84 18.53 Favored 'Trans proline' 0 C--O 1.243 0.768 0 N-CA-C 116.569 1.719 . . . . 0.0 116.569 -175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -130.76 56.87 1.76 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 69.96 8.85 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.458 -1.401 . . . . 0.0 114.251 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 m -122.31 98.43 44.11 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 123.499 0.72 . . . . 0.0 110.962 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.01 80.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.509 2.806 . . . . 0.0 116.188 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -82.76 -138.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.561 1.508 . . . . 0.0 113.487 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.65 -34.84 69.78 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 125.022 1.329 . . . . 0.0 111.931 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -65.17 -28.46 69.42 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.431 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.34 -19.25 30.08 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.912 -0.492 . . . . 0.0 110.94 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.7 p -71.56 -38.96 70.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.41 -41.67 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.12 -37.46 80.1 Favored Glycine 0 C--O 1.226 -0.406 0 CA-C-N 116.49 -0.323 . . . . 0.0 113.129 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.3 p -73.03 -9.89 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.24 -39.77 14.19 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.111 0.414 . . . . 0.0 111.633 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.6 -32.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -56.06 -51.96 76.51 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.48 -11.54 15.72 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 113.612 -3.792 . . . . 0.0 113.837 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -75.09 -44.05 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.233 -0.917 . . . . 0.0 110.97 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -20.86 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.199 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.37 -42.22 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.78 -44.34 90.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.29 -32.24 73.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.44 -41.99 92.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -97.91 -16.42 19.75 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -167.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -106.95 30.06 6.5 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.176 0.989 . . . . 0.0 111.254 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.55 165.59 18.32 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.458 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.68 70.95 4.91 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.387 1.391 . . . . 0.0 113.884 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.9 81.2 8.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -163.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -99.73 -37.71 8.99 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.04 -40.41 97.03 Favored Glycine 0 N--CA 1.453 -0.228 0 O-C-N 121.733 -0.604 . . . . 0.0 111.673 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.6 m -71.31 -32.58 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.027 0.414 . . . . 0.0 110.741 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.77 -41.38 97.98 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.918 -1.114 . . . . 0.0 109.713 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -76.18 -15.26 60.09 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.456 -0.777 . . . . 0.0 110.941 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.71 -41.83 71.41 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.41 -41.04 96.85 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.342 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 tp -58.19 -36.15 72.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -81.3 -38.07 27.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.62 -38.16 80.32 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.716 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.9 mt -74.04 -19.63 60.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.829 -1.169 . . . . 0.0 110.659 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -66.25 -32.28 73.6 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.95 -42.43 80.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -41.17 98.97 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.17 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.09 -38.67 83.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.526 0.603 . . . . 0.0 110.42 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -55.54 24.69 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -61.07 -40.45 93.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.877 -0.778 . . . . 0.0 110.555 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.716 -0.615 . . . . 0.0 111.45 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.3 -27.19 62.3 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.9 -49.85 65.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.68 -44.19 19.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.54 -69.29 0.24 Allowed Glycine 0 C--O 1.25 1.139 0 CA-C-O 116.797 -2.113 . . . . 0.0 116.06 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -72.43 -159.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 125.212 3.941 . . . . 0.0 114.499 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -54.33 163.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.82 -21.95 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -161.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.22 -19.32 63.04 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.791 -1.193 . . . . 0.0 113.255 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.41 -13.45 33.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.356 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -143.39 -47.44 0.3 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -162.54 179.62 7.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mm -71.36 114.43 9.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -129.91 -169.35 2.11 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.83 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.65 -49.96 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.335 1.064 . . . . 0.0 110.746 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.99 -36.93 67.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.819 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.97 -20.55 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.167 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.2 m -83.61 -48.62 10.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.19 -48.73 15.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.91 93.57 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.29 -36.07 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 1 C-N-CA 112.599 -4.467 . . . . 0.0 114.852 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -79.22 -26.94 42.46 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.526 -1.359 . . . . 0.0 110.483 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.32 -33.76 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.973 0.806 . . . . 0.0 111.333 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -66.15 -38.19 87.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.288 -1.507 . . . . 0.0 113.767 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -67.53 -35.95 80.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.1 tp -62.41 -51.89 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.636 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -65.95 -26.12 67.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -170.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.67 -50.44 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 118.499 0.591 . . . . 0.0 111.614 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.95 -43.07 75.78 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.681 -0.637 . . . . 0.0 111.139 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.86 -42.09 67.29 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.35 93.27 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 119.92 -1.134 . . . . 0.0 114.538 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.58 -49.61 14.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.349 1.075 . . . . 0.0 112.878 173.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -87.53 -37.24 17.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -136.71 62.47 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.152 -0.967 . . . . 0.0 110.509 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -53.55 110.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -161.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -146.5 94.48 4.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.36 168.14 25.5 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 114.9 -2.933 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.55 119.55 57.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.41 162.38 30.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 115.632 -2.445 . . . . 0.0 113.396 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.9 6.3 3.44 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.363 -0.836 . . . . 0.0 112.847 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -70.51 -22.83 62.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.423 0.63 . . . . 0.0 109.357 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.88 60.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.1 m -54.27 -38.0 65.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.015 -0.428 . . . . 0.0 111.779 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -71.85 -26.93 62.56 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 120.809 -1.182 . . . . 0.0 111.938 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.6 -34.09 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.413 1.006 . . . . 0.0 110.625 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.67 -44.37 93.96 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 120.831 -1.168 . . . . 0.0 109.641 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -70.0 -31.7 69.52 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.714 -0.616 . . . . 0.0 112.464 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 121.953 -0.467 . . . . 0.0 111.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -30.9 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 118.57 0.623 . . . . 0.0 111.121 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -68.41 -37.85 80.7 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.186 -0.946 . . . . 0.0 112.453 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.57 -34.2 73.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.45 -39.79 94.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.74 13.89 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.1 t -96.63 -52.7 3.83 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -94.03 157.05 16.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.185 -1.572 . . . . 0.0 112.594 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.38 -21.34 49.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -53.27 -30.89 40.92 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.719 0.771 . . . . 0.0 111.47 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -103.58 -44.32 5.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.697 0.761 . . . . 0.0 112.235 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -61.13 -29.69 69.93 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -85.8 -29.98 23.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 48.4 p -86.02 -18.01 33.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -60.79 140.31 57.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.691 0.758 . . . . 0.0 111.574 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.49 170.59 15.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.28 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.81 117.73 7.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.4 pm0 -60.82 -35.58 76.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -63.91 -40.03 95.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.573 -0.704 . . . . 0.0 109.216 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -78.88 -13.54 59.75 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.29 -50.37 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -45.89 47.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.782 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.6 -23.48 65.39 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.84 -16.53 57.99 Favored Glycine 0 C--O 1.24 0.469 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -89.01 -35.21 16.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 117.607 0.703 . . . . 0.0 111.614 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.95 -23.91 1.35 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 120.307 3.447 . . . . 0.0 120.307 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.353 0.797 1 C-N-CA 111.105 -5.463 . . . . 0.0 115.874 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.8 144.14 47.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.85 116.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.0 m -116.3 114.39 24.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.87 160.76 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.99 124.36 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 164.62 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.898 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 142.21 58.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.73 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 127.22 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.48 -25.1 29.57 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.401 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.53 99.43 2.27 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 117.742 0.771 . . . . 0.0 111.338 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.98 55.51 5.33 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 114.546 0.941 . . . . 0.0 114.546 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -120.12 1.31 10.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.591 -0.693 . . . . 0.0 112.292 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.5 tt -148.79 160.85 5.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.47 145.5 51.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.338 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.67 -176.69 44.24 Favored Glycine 0 C--O 1.237 0.307 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.39 64.92 2.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 111.549 -2.325 . . . . 0.0 108.205 170.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.9 t -132.1 101.84 14.84 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 112.38 -2.191 . . . . 0.0 107.812 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.42 -38.31 64.98 Favored 'Trans proline' 0 C--N 1.346 0.422 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -72.2 -32.56 66.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.2 m -63.29 -43.07 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.989 0.9 . . . . 0.0 111.887 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.38 -20.99 62.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.855 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -61.4 -33.52 73.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.675 -0.64 . . . . 0.0 110.212 174.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.47 -49.07 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.412 0.625 . . . . 0.0 111.131 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.45 -37.58 88.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.2 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.45 -41.79 90.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 p -73.29 -40.75 64.29 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -27.33 48.85 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.522 -0.736 . . . . 0.0 111.679 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -71.03 -35.24 71.91 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 118.8 0.727 . . . . 0.0 112.439 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -68.11 -35.66 78.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 119.112 0.869 . . . . 0.0 110.203 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -71.85 -20.77 61.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 56.09 37.12 28.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.596 1.159 . . . . 0.0 109.715 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -86.72 148.67 46.63 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.22 146.73 32.23 Favored 'Trans proline' 0 C--N 1.35 0.608 1 C-N-CA 113.225 -4.05 . . . . 0.0 113.733 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.89 161.23 41.5 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.73 113.83 27.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.27 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -83.91 124.31 30.86 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 122.697 0.399 . . . . 0.0 110.97 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -116.02 124.35 50.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.42 119.91 37.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.3 mt -88.09 107.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.01 80.48 2.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.08 0.943 . . . . 0.0 110.577 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.5 mt 56.09 53.15 9.41 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.535 167.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.75 35.5 10.12 Favored Glycine 0 C--O 1.236 0.274 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.171 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.87 113.59 10.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -146.55 84.68 7.6 Favored Pre-proline 0 C--O 1.254 1.296 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -161.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.92 166.96 20.97 Favored 'Trans proline' 0 C--O 1.235 0.356 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 158.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -57.83 -33.34 68.51 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.552 0.341 . . . . 0.0 111.227 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -54.66 -45.52 73.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.361 0.6 . . . . 0.0 112.468 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -77.79 -27.27 50.16 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -65.97 -34.77 78.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.007 0.432 . . . . 0.0 111.547 171.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -67.97 -43.87 77.98 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.101 -0.999 . . . . 0.0 110.273 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -70.1 -51.89 35.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -104.2 121.14 48.58 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-N 120.611 1.55 . . . . 0.0 114.743 -167.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.52 -24.61 30.58 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 118.932 2.628 . . . . 0.0 118.932 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -101.47 -5.37 25.34 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.3 1.409 . . . . 0.0 110.68 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.5 -47.5 3.85 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.255 -164.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -119.94 64.75 0.82 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.599 1.19 . . . . 0.0 113.604 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.52 155.86 73.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 165.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.92 154.3 58.23 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 113.564 -3.824 . . . . 0.0 111.476 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.16 142.57 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.93 125.61 67.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 165.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -98.85 89.09 4.2 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.2 101.46 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.61 47.54 22.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.748 0.819 . . . . 0.0 112.944 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t0 65.04 22.18 12.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 -173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -109.85 127.73 54.88 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.068 -1.02 . . . . 0.0 108.55 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -105.24 117.34 33.77 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.841 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.0 138.7 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.617 0.644 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.24 19.54 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 118.816 2.895 . . . . 0.0 118.816 -164.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.64 148.36 29.44 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.754 -1.216 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.1 p -63.78 -25.25 68.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -165.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -82.57 -35.06 27.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.304 -0.247 . . . . 0.0 111.539 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.63 -19.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.63 -0.669 . . . . 0.0 112.392 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 pt -77.37 4.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.11 0.481 . . . . 0.0 111.175 172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.94 -51.0 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.31 -55.19 7.09 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 120.249 2.86 . . . . 0.0 120.249 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.55 -29.57 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.35 1.575 . . . . 0.0 107.198 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -58.82 -43.84 90.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.76 -40.18 76.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.882 0.849 . . . . 0.0 110.664 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -63.03 -34.96 78.69 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.37 3.66 52.76 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -70.45 128.7 90.97 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.759 -0.588 . . . . 0.0 110.84 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.46 -4.99 15.69 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 N-CA-C 115.709 1.388 . . . . 0.0 115.709 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.12 155.7 37.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -59.72 122.02 10.79 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 116.603 -1.798 . . . . 0.0 116.497 -163.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.76 151.83 25.07 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 116.802 -1.665 . . . . 0.0 115.518 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.2 mt -136.87 49.9 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.942 1.697 . . . . 0.0 109.509 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.9 77.94 4.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 m -114.37 101.57 54.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -96.59 67.13 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.754 1 C-N-CA 126.045 4.497 . . . . 0.0 118.613 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.66 -113.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 116.914 -1.591 . . . . 0.0 114.134 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -63.91 -31.28 72.41 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 119.425 -2.047 . . . . 0.0 115.173 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.45 -11.77 60.57 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.358 -1.463 . . . . 0.0 111.825 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.36 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 119.762 -1.837 . . . . 0.0 110.132 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -48.25 45.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.54 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.137 0.494 . . . . 0.0 110.374 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.33 91.22 Favored Glycine 0 C--O 1.224 -0.506 0 O-C-N 120.944 -1.098 . . . . 0.0 111.764 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.1 p -70.59 -2.69 15.05 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -99.03 -36.52 9.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.722 0.772 . . . . 0.0 110.471 171.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.89 -50.16 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.685 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.78 -53.9 59.76 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.03 -17.42 31.85 Favored 'Trans proline' 0 C--N 1.349 0.579 1 C-N-CA 112.751 -4.366 . . . . 0.0 113.702 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -68.38 -56.12 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.815 0.734 . . . . 0.0 111.04 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -76.96 -25.23 52.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.428 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.27 -38.94 82.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -72.77 -44.36 61.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -68.95 -30.87 69.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.298 0.954 . . . . 0.0 112.696 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.9 tp -67.46 -38.41 84.42 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.207 -0.933 . . . . 0.0 110.762 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.9 -25.33 61.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.219 0.533 . . . . 0.0 111.98 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -90.65 109.93 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -93.59 67.87 3.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.26 176.7 1.73 Allowed Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.41 61.06 2.68 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 CA-C-N 120.195 1.105 . . . . 0.0 113.29 161.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.26 116.71 17.21 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -153.2 -57.04 0.12 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.38 -33.01 84.92 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 170.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -74.32 -30.58 62.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.047 1.424 . . . . 0.0 114.831 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.51 -32.07 70.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.251 -1.53 . . . . 0.0 107.316 174.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -77.95 -12.64 60.0 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.979 -1.075 . . . . 0.0 112.707 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.27 -34.67 31.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.224 -1.547 . . . . 0.0 107.673 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.1 tp -64.1 -35.66 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.79 -39.91 78.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.33 173.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -68.9 -35.03 76.37 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.997 0.817 . . . . 0.0 111.959 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.07 -38.56 88.62 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.416 -1.428 . . . . 0.0 110.757 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.05 -20.35 49.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.04 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.22 -36.6 82.03 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.267 0.94 . . . . 0.0 110.571 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.45 -39.18 93.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.18 -50.42 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.025 0.53 . . . . 0.0 111.873 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.98 -34.99 64.88 Favored Glycine 0 C--O 1.234 0.141 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.573 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -57.51 -42.5 82.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 122.026 0.917 . . . . 0.0 110.577 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -35.11 65.22 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -73.21 -18.48 61.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 m -89.7 4.3 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -121.44 -45.77 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.29 -70.96 0.23 Allowed Glycine 0 CA--C 1.531 1.076 0 N-CA-C 120.941 3.136 . . . . 0.0 120.941 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.22 -164.95 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.723 1 C-N-CA 127.896 5.731 . . . . 0.0 118.822 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.09 166.8 7.21 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 169.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.8 mt -78.53 -24.63 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -128.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.7 -6.44 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.39 -17.22 37.25 Favored Glycine 0 C--O 1.23 -0.146 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.05 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -130.44 -44.8 1.11 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -166.45 178.1 6.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.25 126.23 16.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.7 p -131.63 -170.18 2.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.88 -36.04 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -35.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.946 -1.096 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.27 -42.91 96.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.46 -32.91 74.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 81.5 p -72.9 -37.64 67.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -97.73 -42.88 7.4 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -166.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.45 57.4 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.12 -29.87 14.05 Favored 'Trans proline' 0 C--N 1.35 0.618 1 C-N-CA 111.781 -5.013 . . . . 0.0 115.701 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -76.59 -28.72 56.3 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 119.979 -1.701 . . . . 0.0 108.366 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.6 tp -66.44 -34.32 77.69 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.45 0.568 . . . . 0.0 111.783 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.35 -46.8 81.88 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.629 -0.67 . . . . 0.0 109.73 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -60.87 -33.58 73.31 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.16 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.92 -50.58 61.95 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.618 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -30.35 71.37 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.71 1.141 . . . . 0.0 111.607 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 94.5 t -73.06 -57.46 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.352 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -44.67 65.46 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.745 -1.222 . . . . 0.0 111.418 -166.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.41 -34.41 70.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.8 93.68 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.911 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -76.87 -46.87 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.622 -0.928 . . . . 0.0 112.37 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.96 -47.53 12.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -171.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.55 63.06 1.45 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -40.68 112.41 0.29 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -161.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -144.99 81.01 10.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.803 0.841 . . . . 0.0 111.959 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.47 154.78 40.56 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 113.303 -3.998 . . . . 0.0 110.118 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.23 129.9 91.55 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.41 163.65 31.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.711 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -76.82 6.51 6.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.257 1.503 . . . . 0.0 113.048 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.82 -15.99 42.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.372 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.2 mt -120.21 47.56 1.74 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 108.398 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.3 t -62.91 -18.82 63.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -160.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -48.66 80.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.264 1.847 . . . . 0.0 108.405 174.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.94 -33.03 50.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 118.042 -1.463 . . . . 0.0 107.883 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.2 -52.25 59.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.95 -39.53 94.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.577 0.703 . . . . 0.0 109.784 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.28 -22.78 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.752 -0.592 . . . . 0.0 111.948 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.6 mm -65.66 -34.59 71.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.456 1.025 . . . . 0.0 108.982 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.3 -33.48 75.37 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 111.159 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.06 -45.18 74.57 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.65 -30.17 70.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -67.92 -23.18 65.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.215 -0.928 . . . . 0.0 110.841 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -144.99 69.77 1.26 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.802 0.81 . . . . 0.0 111.071 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -131.99 144.54 50.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.55 -37.38 78.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -166.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.7 t -72.51 -50.48 25.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.94 1.352 . . . . 0.0 110.43 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.9 -28.98 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.698 -165.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.5 -43.39 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.302 1.041 . . . . 0.0 111.509 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.97 -37.17 78.62 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.47 -0.769 . . . . 0.0 112.17 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 32.1 p -81.72 -0.72 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -55.0 119.79 5.96 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.828 -0.545 . . . . 0.0 110.927 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.78 153.96 42.57 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.24 130.46 46.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -61.01 -36.12 78.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.065 0.46 . . . . 0.0 111.021 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -83.61 -25.51 30.78 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.857 -0.527 . . . . 0.0 109.649 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.39 -58.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -43.21 64.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 120.945 -1.097 . . . . 0.0 111.664 -168.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.79 0.09 48.84 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.605 -0.684 . . . . 0.0 111.591 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.09 -34.98 7.29 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -77.73 -41.73 36.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.676 -0.896 . . . . 0.0 112.376 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.44 -36.82 50.73 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo . . . . . 0 C--N 1.349 0.578 0 C-N-CA 114.956 -2.896 . . . . 0.0 114.545 176.283 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.685 0.279 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -121.32 142.66 49.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.56 149.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -140.46 130.27 24.47 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.7 165.7 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -58.71 118.33 5.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.54 173.12 12.91 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.24 0.543 . . . . 0.0 111.189 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.03 124.64 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.09 55.93 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 64.26 12.99 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 119.163 1.482 . . . . 0.0 112.452 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.38 108.03 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 115.617 -2.456 . . . . 0.0 115.864 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -172.71 -53.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.4 mt -99.65 144.32 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 108.573 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.67 150.51 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.184 1.394 . . . . 0.0 114.599 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -156.09 11.79 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.71 116.82 23.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.18 -1.188 . . . . 0.0 110.394 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -165.38 140.4 4.17 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 173.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.81 -55.29 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.827 -2.982 . . . . 0.0 112.514 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -66.26 -29.31 69.52 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.29 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -44.13 -59.0 2.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -86.17 -11.65 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.924 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.39 -48.8 79.57 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 m -68.82 -43.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.457 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.99 -41.52 90.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.551 -173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.19 -46.8 76.07 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.185 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.1 p -65.3 -42.44 93.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 119.593 1.088 . . . . 0.0 112.533 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.72 -36.17 73.08 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.056 -1.027 . . . . 0.0 111.775 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -76.81 -29.91 56.18 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.654 -0.654 . . . . 0.0 111.816 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.67 -29.64 70.23 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.643 -1.286 . . . . 0.0 111.265 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.18 -8.45 57.81 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.14 37.48 26.35 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.61 1.564 . . . . 0.0 113.63 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.47 157.58 67.38 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.353 0.524 . . . . 0.0 111.076 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.57 127.18 10.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -147.26 167.65 23.71 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.211 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.69 148.77 28.98 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t 72.44 143.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.852 2.061 . . . . 0.0 114.235 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.98 71.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 110.894 170.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.24 143.15 18.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.97 146.58 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.055 1.742 . . . . 0.0 108.399 158.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -88.75 80.24 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt 53.77 35.44 21.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.848 0.832 . . . . 0.0 113.209 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 1.37 83.72 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -82.87 78.82 9.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.343 1.571 . . . . 0.0 113.174 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -134.41 159.85 70.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.05 -176.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 114.662 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.29 -28.36 27.68 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -45.88 -40.71 10.38 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -85.96 -28.93 23.94 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 112.329 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.22 -22.55 63.86 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.847 0.832 . . . . 0.0 111.098 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -76.07 -3.67 37.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 112.097 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.16 -67.91 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 t -73.45 126.03 90.25 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -158.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.23 -24.26 27.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 N-CA-C 117.538 2.091 . . . . 0.0 117.538 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -100.76 -5.16 26.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.903 0.859 . . . . 0.0 111.089 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 -29.32 2.17 Favored Glycine 0 C--O 1.225 -0.427 0 O-C-N 121.806 -0.559 . . . . 0.0 113.813 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -130.81 45.61 2.79 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.149 0.974 . . . . 0.0 112.862 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.93 155.86 60.17 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.448 -0.783 . . . . 0.0 110.057 170.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.64 153.21 78.78 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 123.323 1.17 . . . . 0.0 113.706 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.21 159.34 36.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.71 124.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -92.88 80.91 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.065 0.848 . . . . 0.0 109.325 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mt -83.42 105.58 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t0 53.33 45.81 27.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.288 1.042 . . . . 0.0 109.679 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 68.7 9.87 7.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -121.84 128.15 51.33 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -94.71 144.1 25.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.09 132.55 55.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 176.77 132.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.257 1.823 . . . . 0.0 115.249 148.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -175.7 177.31 1.74 Allowed 'General case' 0 N--CA 1.48 1.034 1 N-CA-C 97.404 -5.036 . . . . 0.0 97.404 170.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.34 58.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -84.38 -24.28 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 120.695 -1.253 . . . . 0.0 110.702 -163.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.01 -24.1 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 tp -80.63 -13.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 120.791 -1.193 . . . . 0.0 109.329 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.4 t -82.72 -39.22 15.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.963 171.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.73 -55.2 0.62 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -69.08 -39.66 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.357 1.079 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.66 -37.55 81.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.657 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -68.88 -45.72 70.27 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.031 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -61.96 -37.12 83.55 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -85.86 10.17 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -100.63 133.55 21.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.063 -0.398 . . . . 0.0 111.51 175.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -66.43 -24.82 49.19 Favored 'Trans proline' 0 C--O 1.24 0.614 0 N-CA-C 116.781 1.8 . . . . 0.0 116.781 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -75.41 157.45 84.62 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.45 126.64 23.16 Favored 'Trans proline' 0 C--O 1.243 0.746 0 N-CA-C 114.741 1.016 . . . . 0.0 114.741 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.9 150.43 26.88 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 117.904 -0.931 . . . . 0.0 112.318 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 tp -142.04 64.7 1.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.841 1.305 . . . . 0.0 112.495 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.21 70.75 9.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.41 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -117.56 106.27 46.7 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.599 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -95.32 74.67 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 125.913 4.408 . . . . 0.0 119.001 164.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -87.1 -113.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 CA-C-N 119.198 0.749 . . . . 0.0 112.089 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -61.8 -43.07 99.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.998 -1.064 . . . . 0.0 112.658 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.33 -11.13 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.96 -48.75 13.95 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.617 -1.302 . . . . 0.0 111.919 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.8 p -77.89 -30.84 50.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.7 t -85.25 -36.12 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.39 -33.1 83.38 Favored Glycine 0 C--O 1.228 -0.24 0 O-C-N 121.077 -1.014 . . . . 0.0 114.078 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.4 p -75.65 -3.45 34.61 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -83.53 -34.84 25.17 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.824 -1.172 . . . . 0.0 110.777 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -38.8 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.266 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -52.72 -52.88 60.16 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 C--N 1.35 0.617 1 C-N-CA 113.186 -4.076 . . . . 0.0 114.294 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -67.41 -40.1 85.55 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.091 -1.006 . . . . 0.0 111.273 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.03 -33.32 61.76 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.901 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.38 -29.83 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -67.34 -42.99 82.62 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.737 -0.602 . . . . 0.0 109.995 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.52 -37.56 85.28 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.379 -0.826 . . . . 0.0 112.838 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.1 tp -63.99 -36.56 84.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.59 -30.98 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.4 t -89.43 110.57 21.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -98.09 44.15 1.05 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.782 1.277 . . . . 0.0 108.435 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -72.59 174.32 4.54 Favored Pre-proline 0 C--O 1.255 1.376 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 172.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.8 60.48 2.91 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 117.845 -0.97 . . . . 0.0 113.157 159.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -77.35 92.76 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -92.45 -38.3 12.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 162.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.02 -43.62 90.52 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.733 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 m -72.28 -26.28 61.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.369 1.085 . . . . 0.0 110.623 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.32 -41.39 85.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -76.78 -12.46 59.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.475 -0.766 . . . . 0.0 112.831 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.21 61.5 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.67 -42.11 95.6 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.32 -41.85 97.69 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -65.95 -46.47 78.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.926 0.869 . . . . 0.0 113.096 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -74.16 -35.05 64.01 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.97 -20.15 56.45 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.717 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -67.68 -33.34 74.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.076 1.307 . . . . 0.0 109.384 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.23 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.0 -34.8 79.3 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -38.9 90.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.845 0.858 . . . . 0.0 108.986 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -53.51 38.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.325 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -59.94 -29.65 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.021 -0.694 . . . . 0.0 112.016 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.6 -57.82 6.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -73.96 -12.33 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -166.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.9 t -61.71 -49.0 86.08 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 121.043 -1.035 . . . . 0.0 110.429 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -100.39 -39.65 7.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.41 -45.69 1.28 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.09 -163.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.112 2.956 . . . . 0.0 114.557 170.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.27 164.35 1.82 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.351 0.66 . . . . 0.0 109.885 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 mt -71.17 -22.87 22.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 121.48 -0.762 . . . . 0.0 110.389 -165.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.3 -35.19 59.85 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 167.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.21 -30.86 4.64 Favored Glycine 0 CA--C 1.518 0.259 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -129.76 -43.8 1.22 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -160.71 177.95 9.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.41 101.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 119.688 1.131 . . . . 0.0 109.471 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 175.78 5.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.89 60.77 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.59 -31.14 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.38 -0.825 . . . . 0.0 112.485 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.21 -37.53 28.48 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.598 -1.314 . . . . 0.0 108.11 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.96 -16.9 64.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.161 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.6 m -79.97 -36.4 36.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.92 -36.39 11.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.19 76.43 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -68.81 -19.91 40.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 113.809 -3.661 . . . . 0.0 116.807 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -94.26 -22.83 18.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.078 -1.014 . . . . 0.0 111.532 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.19 -36.64 84.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.72 -43.25 94.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.371 -0.83 . . . . 0.0 112.887 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -71.65 -29.22 64.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.301 -0.874 . . . . 0.0 112.443 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.3 -49.5 73.76 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.31 -37.58 83.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.6 m -80.07 -27.04 12.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.424 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.22 -44.11 7.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.09 -41.31 97.35 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.92 -38.68 95.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.748 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -73.98 -41.19 62.3 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.145 -1.209 . . . . 0.0 113.368 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -107.17 -46.55 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.25 61.05 0.75 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -165.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.14 104.09 0.22 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -142.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -150.02 100.73 3.22 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 123.465 0.706 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.5 160.42 41.59 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 115.647 -2.435 . . . . 0.0 110.087 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.3 130.59 90.87 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.63 158.32 39.78 Favored 'Trans proline' 0 C--N 1.346 0.409 0 N-CA-C 114.878 1.069 . . . . 0.0 114.878 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.66 2.85 49.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -68.21 -23.11 64.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 159.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.5 mt -114.65 42.23 2.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.333 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 51.9 m -53.41 -31.72 46.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.974 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -61.19 -36.04 78.79 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.292 -1.505 . . . . 0.0 113.234 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 -40.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.7 tp -60.05 -39.47 86.07 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.52 -0.737 . . . . 0.0 111.773 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -72.75 -23.8 60.88 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.616 -0.678 . . . . 0.0 112.164 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -38.85 61.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.5 mm -65.87 -39.61 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.11 -37.56 87.87 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.543 -1.348 . . . . 0.0 112.787 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.81 -44.85 88.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.7 -44.6 86.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.875 0.735 . . . . 0.0 110.798 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.85 -21.45 29.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.49 39.98 3.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.874 0.369 . . . . 0.0 111.465 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -72.18 143.09 49.02 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 100.445 -3.909 . . . . 0.0 100.445 155.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.03 -34.11 77.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 119.785 1.175 . . . . 0.0 110.213 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -61.65 -43.36 99.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.719 0.771 . . . . 0.0 111.006 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -70.87 -37.45 73.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.902 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.01 -44.45 82.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.0 -30.39 31.59 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.8 p -104.72 11.28 34.15 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -76.59 153.4 35.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.606 -0.684 . . . . 0.0 111.562 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.72 152.06 33.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.91 133.13 47.8 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.39 -34.29 76.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -160.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -56.81 -20.03 20.42 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -175.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -116.9 15.82 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 110.949 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.96 -46.74 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 101.794 -3.409 . . . . 0.0 101.794 156.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.23 -60.79 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.501 0.32 . . . . 0.0 110.76 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.07 60.42 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.118 -1.614 . . . . 0.0 114.173 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.96 -28.56 11.76 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 118.127 2.011 . . . . 0.0 118.127 -171.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -101.15 -24.33 14.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 111.581 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -71.56 -6.58 0.1 Allowed Pre-proline 0 C--O 1.242 0.679 0 N-CA-C 121.737 3.977 . . . . 0.0 121.737 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--N 1.357 1.011 1 C-N-CA 109.944 -6.237 . . . . 0.0 114.474 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.63 164.5 19.14 Favored 'General case' 0 C--O 1.245 0.854 1 N-CA-C 96.289 -5.449 . . . . 0.0 96.289 178.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -151.34 -10.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.0 122.54 7.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.369 2.35 . . . . 0.0 117.341 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.56 158.52 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.606 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.75 134.13 44.85 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.12 165.66 20.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 138.48 58.35 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.64 132.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.22 -50.97 4.33 Favored Glycine 0 CA--C 1.516 0.122 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.62 76.64 69.82 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 122.588 0.355 . . . . 0.0 111.418 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.25 114.11 2.71 Favored 'Trans proline' 0 C--O 1.234 0.278 0 CA-C-O 122.352 0.897 . . . . 0.0 111.62 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -166.96 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.69 159.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.2 tp -44.91 142.53 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.847 1.259 . . . . 0.0 112.084 160.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.96 -169.68 30.93 Favored Glycine 0 C--O 1.23 -0.111 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -72.85 98.2 2.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.447 1.117 . . . . 0.0 108.602 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -142.04 105.0 5.67 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.045 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.62 -44.44 48.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 115.346 1.248 . . . . 0.0 115.346 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -78.18 -29.78 48.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.9 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.1 m -65.77 -46.12 79.96 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.694 -0.629 . . . . 0.0 112.405 -169.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.27 -12.47 60.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.359 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.33 -44.81 95.62 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.86 -46.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.37 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.87 -39.91 87.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.2 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.8 -40.49 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.787 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.6 p -68.86 -34.25 75.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.646 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -40.35 42.93 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.07 -0.394 . . . . 0.0 110.869 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -73.08 -29.74 63.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.714 -0.616 . . . . 0.0 112.309 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.1 -33.47 75.87 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.295 -1.503 . . . . 0.0 110.587 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -87.27 0.07 55.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 53.21 32.38 13.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.439 1.896 . . . . 0.0 114.618 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.7 121.23 66.5 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.05 142.14 34.01 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 115.703 -2.398 . . . . 0.0 112.475 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -140.45 176.39 8.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.823 0.849 . . . . 0.0 109.064 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.77 155.12 28.39 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 t -154.29 138.43 16.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 119.678 1.126 . . . . 0.0 110.823 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -96.64 136.38 37.25 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.26 105.67 16.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.6 mm -79.25 95.03 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -78.55 80.83 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.239 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 52.62 51.8 15.34 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 155.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.47 34.02 6.87 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.696 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.86 -58.54 5.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -106.28 142.73 25.5 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.356 -160.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.75 -166.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.241 0.654 0 N-CA-C 116.166 1.564 . . . . 0.0 116.166 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -41.74 -31.73 0.33 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 118.833 2.901 . . . . 0.0 118.833 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -51.81 -42.03 62.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.472 1.033 . . . . 0.0 113.184 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -24.56 22.43 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.971 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.56 -26.01 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.608 0.718 . . . . 0.0 110.783 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.32 -30.3 70.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.75 -44.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.805 -170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -88.33 118.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 121.641 -0.662 . . . . 0.0 110.815 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -34.36 97.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 116.377 1.645 . . . . 0.0 116.377 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.2 4.15 39.09 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.282 -0.886 . . . . 0.0 110.611 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.23 -15.51 8.8 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -142.69 24.2 1.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.31 156.13 47.57 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 156.2 51.45 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 117.198 -1.401 . . . . 0.0 113.358 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -145.48 123.18 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.784 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.7 t -88.82 119.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.99 130.44 34.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 161.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.94 103.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t0 61.69 39.12 14.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.457 1.123 . . . . 0.0 112.813 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 t0 58.87 36.58 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.777 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.23 144.94 50.59 Favored 'General case' 0 C--N 1.323 -0.568 1 N-CA-C 98.684 -4.561 . . . . 0.0 98.684 164.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -128.84 156.31 43.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.02 123.97 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.32 81.53 0.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.79 148.58 26.49 Favored 'General case' 0 N--CA 1.471 0.581 1 N-CA-C 98.649 -4.574 . . . . 0.0 98.649 162.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -60.26 -28.85 68.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -166.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.2 -28.96 17.5 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.629 -0.67 . . . . 0.0 112.446 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.49 -22.99 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.156 -0.965 . . . . 0.0 110.483 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.93 -0.88 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.752 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.34 -60.16 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.376 165.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -50.0 36.4 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.37 -26.55 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.5 tp -63.5 -39.44 94.45 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.432 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.9 -34.41 77.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.363 1.438 . . . . 0.0 111.033 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.82 -36.95 85.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.969 0.89 . . . . 0.0 111.36 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -91.09 -3.86 56.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -70.31 133.17 87.49 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.8 -15.65 26.64 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 115.254 -2.698 . . . . 0.0 114.864 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -87.89 170.64 11.15 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.48 139.08 86.57 Favored 'Trans proline' 0 C--N 1.353 0.768 0 N-CA-C 117.128 1.934 . . . . 0.0 117.128 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.63 110.47 2.41 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 114.014 0.736 . . . . 0.0 114.014 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.8 mt -118.58 56.88 0.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.73 88.0 2.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -116.42 123.75 30.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 166.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -94.49 67.07 0.32 Allowed 'Trans proline' 0 CA--C 1.556 1.593 0 N-CA-C 119.253 2.751 . . . . 0.0 119.253 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.35 -167.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.764 -1.024 . . . . 0.0 111.028 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 14.71 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 1 N-CA-C 122.286 4.18 . . . . 0.0 122.286 167.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.33 -22.16 62.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.639 -0.663 . . . . 0.0 111.697 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.49 75.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.377 0.535 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -44.98 89.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.235 0.54 . . . . 0.0 109.755 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.56 -41.03 85.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.831 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.31 90.42 Favored Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.602 -0.686 . . . . 0.0 112.245 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -70.63 -8.79 54.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -101.55 -33.89 9.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 111.133 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.13 -42.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 122.891 0.477 . . . . 0.0 110.27 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -54.56 55.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.48 -30.36 79.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 114.961 -2.892 . . . . 0.0 114.52 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -61.59 -54.3 44.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.922 0.328 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -70.98 -27.72 63.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 117.916 -1.513 . . . . 0.0 113.906 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 m -74.03 -36.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.962 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -62.47 -51.32 67.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.93 -42.19 85.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.761 1.619 . . . . 0.0 112.302 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -71.52 -30.77 66.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.439 0.638 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -81.57 138.16 35.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.172 0.987 . . . . 0.0 113.641 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -124.84 30.75 5.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.29 173.42 7.02 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.44 51.76 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 CA-C-N 121.492 1.569 . . . . 0.0 116.126 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -75.45 106.41 6.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.39 -51.49 1.01 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 -40.14 94.85 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -18.02 59.48 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 120.607 -1.525 . . . . 0.0 114.237 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.76 -33.05 71.89 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.74 3.79 15.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.056 -1.028 . . . . 0.0 113.222 173.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.77 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 119.836 -1.79 . . . . 0.0 107.417 165.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.06 -37.88 81.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.496 -0.753 . . . . 0.0 109.705 171.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.28 -43.54 83.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -69.82 -34.65 73.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.72 -37.06 79.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.374 -1.454 . . . . 0.0 110.696 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.16 -20.88 59.13 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.267 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -71.27 -32.68 68.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.722 -1.237 . . . . 0.0 110.579 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.37 93.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.8 -41.38 97.91 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.557 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.9 -37.66 80.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.161 0.985 . . . . 0.0 110.838 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.29 -51.7 47.06 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.94 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -64.97 -32.73 74.59 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.604 -0.939 . . . . 0.0 111.062 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.3 -46.98 78.23 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.253 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.13 -24.59 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.885 1.221 . . . . 0.0 112.677 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -76.02 -49.25 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 122.128 -0.357 . . . . 0.0 111.501 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -83.7 -26.11 30.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.78 -93.6 1.12 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -71.57 -177.73 2.63 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 118.496 2.46 . . . . 0.0 118.496 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -36.65 148.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.081 2.153 . . . . 0.0 114.001 170.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 pt -77.37 23.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -149.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.44 -20.37 60.05 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.302 -1.499 . . . . 0.0 109.405 149.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.39 67.86 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -145.57 -54.93 0.29 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -163.21 -173.71 3.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.9 mt -77.1 114.94 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -138.93 -170.23 2.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -39.66 -45.36 1.66 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 119.62 3.193 . . . . 0.0 119.62 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.55 -39.27 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.239 . . . . 0.0 110.365 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.81 -44.64 66.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.336 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.43 -19.03 65.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.445 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -81.24 -44.65 17.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 27.6 tp -87.91 -45.79 9.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.2 -37.59 55.05 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.26 -36.9 26.35 Favored 'Trans proline' 0 C--N 1.354 0.842 1 C-N-CA 111.519 -5.187 . . . . 0.0 113.47 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -77.77 -24.26 49.01 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.63 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.74 -34.84 76.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.597 1.09 . . . . 0.0 112.434 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -66.17 -44.67 83.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.258 -0.901 . . . . 0.0 110.521 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -66.42 -31.62 72.5 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.0 -54.04 47.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -71.11 -34.32 70.97 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.96 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.11 -36.37 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.02 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.55 12.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.532 1.06 . . . . 0.0 110.232 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.34 -35.84 81.38 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.17 92.89 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.629 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -85.57 -24.94 27.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.363 -1.081 . . . . 0.0 113.439 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -101.55 -40.48 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -139.43 47.75 1.87 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 109.987 -172.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -34.31 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 -149.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -146.36 107.23 4.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.61 169.07 15.64 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 118.378 0.456 . . . . 0.0 111.935 162.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 93.8 mt -67.3 124.51 89.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -73.02 164.65 34.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.52 -8.35 57.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.505 0.669 . . . . 0.0 110.493 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.29 -24.12 67.11 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.669 166.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -118.5 44.47 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.8 t -63.12 -18.33 63.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -165.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.41 -33.93 65.23 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.915 -1.741 . . . . 0.0 109.371 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.88 -46.49 79.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.3 -41.79 98.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.286 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -65.06 -48.27 74.38 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 120.862 -1.149 . . . . 0.0 111.436 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -31.77 70.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.24 -175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.01 -31.13 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 119.575 1.079 . . . . 0.0 111.716 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -71.09 -34.66 71.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.104 -1.622 . . . . 0.0 111.16 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.71 -41.39 92.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.33 -38.74 91.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -54.57 -41.08 69.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.579 0.627 . . . . 0.0 111.201 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 t -91.25 -0.11 57.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -64.99 144.2 57.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -58.4 -43.25 88.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.322 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.6 t -60.36 -46.87 88.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -42.78 79.93 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.531 -0.73 . . . . 0.0 111.803 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.64 -42.05 82.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.919 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -77.12 -31.69 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.6 p -99.92 -9.05 23.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -64.88 142.74 58.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.123 0.874 . . . . 0.0 112.409 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.75 161.44 30.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.79 133.97 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.72 -35.29 79.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -52.5 -39.56 61.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.621 0.768 . . . . 0.0 112.661 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.72 -14.84 29.31 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.712 -0.618 . . . . 0.0 111.893 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 43.3 t -74.5 -37.59 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.4 mt -66.32 -37.74 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.295 -0.878 . . . . 0.0 108.703 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.45 -5.97 12.98 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.477 -0.764 . . . . 0.0 112.622 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.91 73.49 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.777 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -93.09 -23.24 18.69 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 118.619 1.209 . . . . 0.0 109.927 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.37 128.88 94.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.719 0.408 . . . . 0.0 111.424 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 CA--C 1.533 0.446 0 CA-C-N 119.674 0.919 . . . . 0.0 112.446 -65.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -87.67 -4.82 58.91 Favored 'General case' 0 C--N 1.322 -0.595 1 N-CA-C 124.968 5.173 . . . . 0.0 124.968 -146.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mm -87.93 126.89 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 122.647 2.476 . . . . 0.0 112.38 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.64 121.11 26.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 152.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 m -137.2 156.14 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.685 1.129 . . . . 0.0 113.812 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.96 133.29 55.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.3 165.48 13.41 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 144.4 57.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.69 131.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -44.84 3.41 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 118.851 -0.971 . . . . 0.0 114.925 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.32 85.04 52.03 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -72.85 62.24 3.87 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 121.397 1.398 . . . . 0.0 115.291 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -141.57 -10.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.047 1.339 . . . . 0.0 111.002 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.3 tt -135.42 156.23 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.83 156.6 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.01 0.924 . . . . 0.0 112.39 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.81 156.06 17.94 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.42 95.12 5.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.792 0.806 . . . . 0.0 112.685 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 75.0 m -100.16 150.23 36.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 139.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.16 -34.69 98.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.034 -1.511 . . . . 0.0 114.053 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.24 -31.04 70.83 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.96 -51.91 67.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -30.04 63.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.297 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -59.8 -40.1 87.21 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.01 -1.056 . . . . 0.0 111.494 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.46 -50.6 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -60.87 -39.13 88.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 tp -58.07 -45.18 87.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.798 0.726 . . . . 0.0 110.988 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.0 p -66.13 -36.7 83.84 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.16 -0.963 . . . . 0.0 111.5 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.08 -41.68 70.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.907 -0.496 . . . . 0.0 111.465 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -32.13 58.78 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.927 -0.483 . . . . 0.0 112.251 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.7 -37.22 81.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.173 -0.954 . . . . 0.0 111.6 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -91.92 1.97 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.507 0.67 . . . . 0.0 111.349 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 57.62 26.3 12.72 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.136 1.774 . . . . 0.0 114.71 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.56 141.71 48.97 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -68.01 164.81 30.43 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 116.377 -1.948 . . . . 0.0 110.78 175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -154.28 151.31 28.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -79.91 148.48 31.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -128.38 125.75 39.28 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.107 0.88 . . . . 0.0 110.591 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -111.9 112.22 23.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -80.84 134.23 35.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.64 116.93 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -79.32 79.18 5.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 112.658 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt 57.3 39.43 28.5 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.26 69.63 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.24 -0.981 . . . . 0.0 114.215 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.85 118.17 14.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 149.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.26 122.72 7.58 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.616 0.246 . . . . 0.0 111.619 -172.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.1 176.32 10.09 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.378 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -55.66 -37.27 68.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.863 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -53.62 -45.72 70.21 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -80.11 -22.73 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.676 -1.265 . . . . 0.0 112.488 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.241 -0.912 . . . . 0.0 111.049 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.05 -11.56 60.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.439 -0.788 . . . . 0.0 112.13 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.94 -61.06 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.654 0.74 . . . . 0.0 112.358 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -86.86 129.97 50.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 -166.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.02 -28.65 41.39 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 116.082 -2.146 . . . . 0.0 114.03 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -89.28 -10.49 46.67 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.042 -1.036 . . . . 0.0 111.077 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.01 -7.2 36.97 Favored Glycine 0 C--O 1.22 -0.726 0 O-C-N 121.709 -0.619 . . . . 0.0 113.003 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -144.85 16.27 1.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.47 143.13 28.76 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -59.18 156.48 34.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 N-CA-C 114.676 0.991 . . . . 0.0 114.676 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 m -134.98 169.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.5 m -106.76 142.7 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 160.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -126.67 53.48 1.67 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 123.033 1.397 . . . . 0.0 111.112 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -68.35 126.8 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 57.17 30.77 18.89 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.193 0.997 . . . . 0.0 111.864 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.13 18.13 11.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.082 1.753 . . . . 0.0 113.482 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -106.25 112.2 25.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.19 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -74.9 140.29 43.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.45 130.02 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.16 41.52 1.51 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -157.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.78 144.63 39.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.557 -1.34 . . . . 0.0 108.331 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -58.83 -32.35 69.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -75.97 -31.75 59.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.241 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.75 -11.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.635 -1.291 . . . . 0.0 110.342 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.12 -26.51 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 t -73.79 -44.01 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.388 -1.445 . . . . 0.0 110.447 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.54 -64.77 0.83 Allowed Glycine 0 CA--C 1.519 0.341 0 N-CA-C 119.986 2.754 . . . . 0.0 119.986 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.53 -38.06 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.969 0.884 . . . . 0.0 111.748 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.14 -45.76 83.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.888 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.87 -28.05 60.5 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.641 -1.224 . . . . 0.0 113.316 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -63.14 -40.99 99.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.56 -7.91 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -68.15 119.11 65.16 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 160.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.15 0.65 9.51 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 116.064 1.524 . . . . 0.0 116.064 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.92 162.55 67.63 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.66 132.48 49.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 115.956 1.483 . . . . 0.0 115.956 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.16 140.28 19.7 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 116.878 -1.615 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.7 mt -137.25 43.23 2.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.308 0.575 . . . . 0.0 111.501 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 80.14 4.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.968 0.89 . . . . 0.0 110.437 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.8 m -116.59 93.54 40.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -90.73 81.18 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.08 3.187 . . . . 0.0 117.543 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -87.97 -137.37 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.528 0.867 . . . . 0.0 112.704 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.45 -30.95 68.87 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.941 -1.1 . . . . 0.0 112.874 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -63.26 -29.75 71.02 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.553 -0.717 . . . . 0.0 110.597 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.91 -28.73 25.72 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.095 -0.378 . . . . 0.0 111.995 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.2 p -73.53 -33.08 64.57 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.69 -49.17 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.65 62.24 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -60.39 -26.5 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -81.44 -42.62 20.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.049 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.98 -41.06 79.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.022 -166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.48 -56.29 33.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.08 -20.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 113.827 -3.648 . . . . 0.0 113.856 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -64.76 -49.88 69.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.583 1.083 . . . . 0.0 109.943 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -72.14 -31.19 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.68 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.81 -40.01 80.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.32 -40.53 81.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.425 -1.422 . . . . 0.0 111.959 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.91 -26.71 67.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.206 0.912 . . . . 0.0 111.944 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.83 -50.67 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -70.1 -24.88 63.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.5 t -75.84 141.35 42.47 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.707 -0.62 . . . . 0.0 110.795 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -130.0 32.66 4.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.58 167.99 2.12 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 162.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -65.89 92.11 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 116.953 -1.565 . . . . 0.0 112.222 165.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.42 106.84 18.77 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.561 -169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -148.0 -48.87 0.16 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.788 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.44 -33.29 86.09 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.4 p -76.77 -20.31 56.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.594 -0.945 . . . . 0.0 113.381 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -75.3 -31.08 60.56 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.38 -28.38 59.48 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 172.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.27 95.19 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.906 -1.121 . . . . 0.0 110.09 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.53 -38.98 93.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.739 -0.601 . . . . 0.0 110.815 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -43.68 94.04 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.525 173.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -67.4 -36.97 82.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.406 1.003 . . . . 0.0 112.977 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.67 -45.7 81.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.89 -20.32 61.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 120.823 -1.173 . . . . 0.0 110.597 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.56 -28.77 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.753 -1.217 . . . . 0.0 111.557 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 -42.31 89.83 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.1 -38.39 85.59 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.01 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.96 -38.65 89.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.3 0.64 . . . . 0.0 109.808 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.59 -54.87 23.39 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.151 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -62.27 -28.18 69.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.822 -0.81 . . . . 0.0 112.577 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.27 -54.66 13.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.823 -0.548 . . . . 0.0 110.103 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.85 -22.29 65.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.21 -9.76 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.119 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -119.65 -44.53 2.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.53 -46.38 1.18 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 119.639 2.616 . . . . 0.0 119.639 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -68.79 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.695 3.248 . . . . 0.0 116.744 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -58.0 175.1 0.22 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.326 1.05 . . . . 0.0 112.444 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.63 -32.26 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.431 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.57 -3.81 5.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.28 -5.29 60.2 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -137.24 -53.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.692 1.246 . . . . 0.0 113.171 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.49 177.6 5.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 100.984 -3.71 . . . . 0.0 100.984 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.92 126.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.18 1.354 . . . . 0.0 109.181 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 m -143.29 174.39 10.76 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -41.59 -40.26 1.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.66 -32.01 56.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 120.495 1.498 . . . . 0.0 110.942 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.92 -39.23 79.76 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.27 -34.85 78.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.2 p -74.07 -37.24 64.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.74 -46.94 3.7 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -167.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.59 92.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.31 -13.73 18.65 Favored 'Trans proline' 0 C--N 1.349 0.591 1 C-N-CA 111.987 -4.876 . . . . 0.0 113.327 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -91.87 -26.67 18.37 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.909 -0.494 . . . . 0.0 110.477 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.7 -34.18 76.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.947 -0.47 . . . . 0.0 110.635 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.58 -50.14 63.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.468 1.128 . . . . 0.0 108.988 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -73.52 -14.89 61.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.718 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.3 tp -65.76 -54.27 29.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.216 0.916 . . . . 0.0 109.674 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.98 -26.85 63.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.437 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.9 -58.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 121.67 -0.644 . . . . 0.0 110.233 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.75 54.48 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.015 -1.053 . . . . 0.0 111.581 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.4 -37.92 83.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.51 95.66 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.993 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -72.31 -34.18 67.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.011 1.405 . . . . 0.0 113.418 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.03 -33.95 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 118.818 2.896 . . . . 0.0 118.818 -172.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.02 61.97 1.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -53.86 114.54 1.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -158.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -133.61 97.35 15.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 160.25 40.86 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.034 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 84.2 mt -73.11 122.4 87.56 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.59 165.36 25.08 Favored 'Trans proline' 0 C--N 1.346 0.438 0 N-CA-C 114.526 0.933 . . . . 0.0 114.526 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.22 -5.71 45.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.801 -0.562 . . . . 0.0 112.007 175.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.11 -21.87 64.92 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.985 -0.447 . . . . 0.0 110.801 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.65 58.68 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.48 72.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.451 -167.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -78.02 -35.62 49.61 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.989 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.8 -39.2 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.57 -42.38 91.84 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.592 -0.693 . . . . 0.0 111.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.99 -36.02 81.25 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 120.997 -1.065 . . . . 0.0 110.083 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -64.75 -43.32 93.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.0 -25.72 30.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 O-C-N 120.404 -1.435 . . . . 0.0 110.514 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.93 -25.94 66.61 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.065 -1.647 . . . . 0.0 112.091 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -71.67 -30.51 65.79 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.696 0.68 . . . . 0.0 109.176 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.26 -28.45 42.39 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.824 0.345 . . . . 0.0 110.263 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -79.48 13.2 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 120.835 -1.166 . . . . 0.0 111.124 170.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.4 t -134.67 171.09 14.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 60.16 136.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.04 -32.35 67.89 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.376 -0.828 . . . . 0.0 112.772 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.5 m -55.76 -32.59 63.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -102.23 -46.16 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.391 1.091 . . . . 0.0 110.49 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.15 -33.29 75.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -79.61 -32.25 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.497 -0.752 . . . . 0.0 110.898 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 41.0 p -91.67 -16.89 26.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.36 148.57 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.863 . . . . 0.0 111.967 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.93 152.81 37.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.596 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.32 51.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.33 -33.91 76.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.43 -35.34 80.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.511 1.148 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -80.76 -22.54 40.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.219 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.67 -51.79 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.4 pt -73.47 -36.02 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.71 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -20.07 65.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.51 13.11 Favored Glycine 0 CA--C 1.517 0.18 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -95.81 -25.77 15.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.369 1.585 . . . . 0.0 115.069 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -94.32 -10.27 0.15 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 121.507 3.892 . . . . 0.0 121.507 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 C--N 1.356 0.938 0 C-N-CA 113.674 -3.75 . . . . 0.0 117.077 -172.56 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.233 0.187 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -138.14 126.24 22.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.75 103.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -166.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -98.43 71.42 2.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.042 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -93.01 157.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.298 -170.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -62.87 142.91 58.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.21 161.88 22.58 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.31 143.85 54.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.868 1.318 . . . . 0.0 113.849 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.44 130.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -4.78 48.84 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.978 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.39 78.59 4.6 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.305 1.053 . . . . 0.0 112.369 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.51 45.47 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 119.043 2.67 . . . . 0.0 119.043 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -131.01 -7.16 3.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 114.187 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.28 159.18 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.7 mt -61.18 142.55 56.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.24 153.43 22.22 Favored Glycine 0 CA--C 1.508 -0.383 0 O-C-N 121.514 -0.741 . . . . 0.0 114.9 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.93 103.13 10.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.655 1.217 . . . . 0.0 108.814 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 t -132.69 137.63 30.2 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.36 -29.13 72.08 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 115.32 -2.653 . . . . 0.0 112.304 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -80.9 -16.87 52.41 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.452 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -70.23 -52.01 26.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.84 -20.08 65.12 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.943 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -61.02 -43.75 98.43 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.668 2.031 . . . . 0.0 111.554 167.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.01 -54.61 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.03 -37.82 86.84 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.6 -39.5 88.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.3 p -70.59 -40.2 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 112.416 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -48.14 76.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.539 -177.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -74.57 -28.94 61.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.515 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -71.19 -36.39 71.93 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.59 -0.694 . . . . 0.0 111.191 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.17 -5.53 59.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 53.64 36.81 24.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 113.724 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.7 pt -84.25 153.44 62.6 Favored Pre-proline 0 C--O 1.246 0.879 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.795 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.4 137.61 25.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.068 -1.488 . . . . 0.0 114.689 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -151.77 161.58 42.43 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.3 126.41 52.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.2 t -88.62 135.08 33.68 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -137.2 129.56 29.72 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.07 132.08 53.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.7 mm -105.48 101.32 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.789 1.236 . . . . 0.0 111.018 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -69.59 83.21 0.42 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.421 1.088 . . . . 0.0 113.486 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 51.12 48.26 23.37 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 122.921 1.343 . . . . 0.0 113.61 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 57.72 1.93 Allowed Glycine 0 CA--C 1.518 0.261 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.266 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.35 85.55 7.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.9 86.44 57.41 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-O 122.021 0.915 . . . . 0.0 112.219 -157.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.93 -176.51 3.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.073 -1.484 . . . . 0.0 108.31 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -47.55 -40.73 19.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.551 0.74 . . . . 0.0 112.602 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -55.87 -47.06 78.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -89.68 -21.75 22.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.11 -43.6 94.82 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -70.79 -38.8 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.502 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.3 mt -110.77 87.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.523 0.678 . . . . 0.0 112.381 -172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t 174.26 145.92 0.21 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.1 -25.12 77.09 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 116.876 1.837 . . . . 0.0 116.876 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -125.96 -14.09 6.17 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.07 -9.42 67.82 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-O 122.335 0.964 . . . . 0.0 111.642 -168.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -155.47 88.75 1.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.12 0.968 . . . . 0.0 110.534 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -143.37 150.35 51.25 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -67.09 98.51 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 115.913 -2.258 . . . . 0.0 113.145 162.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.6 t -91.55 137.72 21.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.455 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.58 113.47 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.77 126.32 33.92 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 t0 50.42 56.46 7.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.781 0.801 . . . . 0.0 112.821 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 65.5 24.31 11.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -124.97 144.13 50.53 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -123.71 132.38 53.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 118.817 0.735 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.07 134.03 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -170.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.52 -22.16 0.33 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.2 138.97 58.72 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -62.98 -29.16 70.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -165.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -85.9 -7.3 58.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.61 -10.6 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.2 -0.938 . . . . 0.0 110.16 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.07 -36.28 76.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.58 -39.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.37 -73.51 1.16 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 120.371 2.909 . . . . 0.0 120.371 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.57 -38.14 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.687 -0.89 . . . . 0.0 111.986 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.57 -41.84 95.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.795 0.725 . . . . 0.0 109.638 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.58 -34.33 73.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.39 -35.39 75.74 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.006 -1.059 . . . . 0.0 111.108 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.01 7.51 45.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.38 137.19 97.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.73 -29.11 82.92 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 117.134 -1.444 . . . . 0.0 115.299 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -81.09 169.26 19.94 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 109.811 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -57.42 134.33 62.9 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 116.811 -1.659 . . . . 0.0 116.021 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.6 135.45 3.0 Favored 'Trans proline' 0 C--O 1.247 0.962 0 N-CA-C 118.3 2.385 . . . . 0.0 118.3 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.3 mt -135.37 43.5 2.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.81 82.01 2.74 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.484 -1.385 . . . . 0.0 111.611 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -118.65 94.83 48.22 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.569 1.148 . . . . 0.0 113.775 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -106.15 59.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.905 0 N-CA-C 122.248 3.903 . . . . 0.0 122.248 -174.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -82.25 -126.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.691 0.928 . . . . 0.0 114.049 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -57.29 -32.23 66.43 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 120.982 -1.074 . . . . 0.0 112.677 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.16 -32.79 74.44 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.146 -0.972 . . . . 0.0 111.847 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.52 -33.19 60.71 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.612 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.1 p -71.27 -34.6 70.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.96 -45.42 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 123.024 0.202 . . . . 0.0 110.516 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.94 87.38 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.377 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -73.51 -0.4 14.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -94.14 -33.93 13.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 167.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.7 mt -82.26 -39.52 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.68 0.753 . . . . 0.0 110.416 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.64 -50.41 77.38 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.69 -33.75 12.56 Favored 'Trans proline' 0 C--N 1.347 0.478 1 C-N-CA 111.648 -5.101 . . . . 0.0 114.543 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -72.5 -39.77 67.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.253 0.479 . . . . 0.0 111.104 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -68.8 -30.0 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.908 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.54 -47.81 62.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -61.98 -44.12 97.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -75.28 -37.14 61.04 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.428 -174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -34.3 78.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.85 0.833 . . . . 0.0 110.579 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -76.65 0.05 21.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.124 0.97 . . . . 0.0 112.108 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -121.05 114.31 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -87.39 49.55 1.83 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.566 1.651 . . . . 0.0 110.309 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -88.51 170.47 11.18 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.62 50.31 2.67 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 CA-C-N 120.174 1.098 . . . . 0.0 114.938 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.04 100.39 4.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.897 1.279 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.9 -45.96 0.86 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 -38.09 93.67 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 166.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.0 m -69.57 -30.65 68.49 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.767 -0.843 . . . . 0.0 111.981 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.66 -28.88 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.709 -1.87 . . . . 0.0 110.04 172.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -75.7 -10.39 59.39 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.372 -1.455 . . . . 0.0 111.625 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.03 60.31 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 119.814 -1.804 . . . . 0.0 108.126 168.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.79 -34.92 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.549 -0.719 . . . . 0.0 111.164 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.2 -44.8 79.83 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -67.53 -26.44 66.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -77.47 -35.93 53.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 120.615 -1.303 . . . . 0.0 109.679 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.3 -20.55 60.08 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.728 -0.608 . . . . 0.0 109.52 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.92 -30.09 69.33 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.463 -0.773 . . . . 0.0 111.395 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.61 -42.09 87.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.02 -43.97 93.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.681 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.75 -35.94 77.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.91 -50.98 55.47 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.822 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.54 -36.03 81.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.879 -1.365 . . . . 0.0 110.489 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.22 -43.01 99.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -74.43 -27.81 60.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.24 -44.43 77.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.44 -54.21 5.39 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.74 -63.45 0.46 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-O 117.183 -1.899 . . . . 0.0 116.761 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.24 -162.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 1 C-N-CA 127.98 5.787 . . . . 0.0 118.565 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -55.9 175.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.67 163.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -54.25 -33.19 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.88 58.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.82 89.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 118.395 -1.225 . . . . 0.0 116.141 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -136.53 -52.54 0.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.729 1.764 . . . . 0.0 112.978 165.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -162.73 -177.56 5.62 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 117.635 -1.174 . . . . 0.0 109.96 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.07 118.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.881 1.218 . . . . 0.0 110.347 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.6 m -132.64 177.23 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.23 37.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.63 -18.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.972 -1.08 . . . . 0.0 111.711 173.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.22 -38.04 31.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -28.91 69.63 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 120.719 0.295 . . . . 0.0 110.649 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 93.9 p -77.68 -35.32 52.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.49 -46.81 3.92 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.05 81.41 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.11 -27.89 19.63 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.776 -4.349 . . . . 0.0 114.371 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.88 -29.89 63.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.02 -24.49 64.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.15 -50.35 61.52 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.007 -1.058 . . . . 0.0 110.334 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -55.45 -42.33 74.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.496 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.6 tp -57.35 -61.99 2.09 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.745 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -67.93 -32.85 73.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -170.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 -43.08 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.134 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.84 -42.15 34.55 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.086 -1.009 . . . . 0.0 112.494 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.68 -38.61 91.76 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.9 81.13 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.089 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.45 -48.86 11.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.49 -1.006 . . . . 0.0 112.968 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -86.72 -43.5 12.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -134.87 59.5 1.73 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.9 0.88 . . . . 0.0 108.766 -171.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -49.97 104.51 0.07 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -154.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -147.82 98.96 3.8 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.241 1.817 . . . . 0.0 106.222 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.41 172.06 17.05 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 115.652 -2.432 . . . . 0.0 109.728 167.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.41 118.08 56.15 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -82.19 167.04 16.09 Favored 'Trans proline' 0 C--N 1.352 0.728 0 N-CA-C 114.975 1.106 . . . . 0.0 114.975 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.92 4.2 5.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -69.6 -23.28 63.5 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.33 60.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -66.64 -19.86 65.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.637 -0.664 . . . . 0.0 112.565 -170.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.7 -33.51 40.98 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.22 -37.22 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.767 0.794 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.45 -47.77 84.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.447 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -65.24 -40.38 93.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -55.56 -53.46 56.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.194 0.521 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.43 -25.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.655 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -66.26 -42.36 88.61 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.745 -1.222 . . . . 0.0 111.6 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -41.57 99.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.07 -37.46 85.88 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 123.607 0.567 . . . . 0.0 111.918 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.15 -25.95 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t -122.13 39.56 3.86 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -103.85 136.5 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.93 -44.43 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -59.61 -47.24 86.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.961 0.886 . . . . 0.0 111.962 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -71.93 -43.46 65.26 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.14 -33.08 73.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -75.78 -42.3 50.57 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.027 -1.045 . . . . 0.0 113.094 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.2 p -88.4 -3.23 58.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -57.09 138.92 53.84 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.47 153.4 41.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.98 130.96 40.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.69 -36.97 82.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 -170.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.57 -21.26 62.7 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.505 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -97.29 -14.35 21.39 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.95 -52.34 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.61 -54.54 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.229 -0.294 . . . . 0.0 111.599 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.54 -2.34 35.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 112.654 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.18 -16.97 44.95 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.739 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -106.56 -48.99 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.15 0.976 . . . . 0.0 112.146 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.09 -26.28 2.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--N 1.357 0.981 1 C-N-CA 112.316 -4.656 . . . . 0.0 115.501 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.48 131.9 47.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -125.77 95.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -166.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.0 m -98.01 116.91 31.2 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.21 165.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.37 133.4 47.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.556 -0.715 . . . . 0.0 112.127 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.14 165.11 24.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.701 0.4 . . . . 0.0 110.95 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 144.28 56.69 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.906 -0.497 . . . . 0.0 110.268 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.89 124.34 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.67 -13.4 52.78 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.97 89.08 12.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -171.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -69.27 76.26 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-O 123.395 1.331 . . . . 0.0 113.241 162.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -149.75 -38.38 0.15 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.887 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -135.51 153.05 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.08 152.13 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.126 0.965 . . . . 0.0 112.761 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.09 -174.57 17.67 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.61 112.32 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.253 -1.473 . . . . 0.0 112.432 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 146.77 34.42 Favored Pre-proline 0 C--O 1.245 0.848 1 N-CA-C 97.633 -4.951 . . . . 0.0 97.633 159.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -59.26 -35.24 97.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 CA-C-O 122.65 1.021 . . . . 0.0 113.514 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.82 -0.65 53.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.689 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 t -57.41 -42.57 82.53 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.973 0.892 . . . . 0.0 110.844 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -92.41 0.29 57.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -63.67 -44.46 93.67 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.955 1.252 . . . . 0.0 109.109 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.726 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.97 -40.73 98.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.01 -38.82 92.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.181 0.9 . . . . 0.0 110.427 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 m -62.91 -40.28 97.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.064 -176.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.7 mt -69.76 -43.47 72.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.714 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.61 -32.11 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -164.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -78.2 -33.37 50.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.266 -1.373 . . . . 0.0 110.485 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.03 -14.92 58.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.111 -0.368 . . . . 0.0 111.08 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 55.82 33.16 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.745 1.618 . . . . 0.0 113.162 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.83 154.76 87.05 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.26 150.4 41.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 115.681 -2.413 . . . . 0.0 113.275 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -154.62 172.21 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -126.64 94.2 3.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.645 1.178 . . . . 0.0 108.648 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -75.87 139.69 41.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.447 . . . . 0.0 110.769 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.35 144.34 44.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.47 126.05 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -83.2 122.07 36.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -79.46 70.09 5.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt 53.47 50.69 16.8 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 161.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.36 8.66 65.97 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 114.081 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.99 106.55 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 151.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -137.84 86.42 18.27 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -62.32 173.17 3.55 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 118.007 -0.862 . . . . 0.0 110.837 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -53.01 -37.45 61.51 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -53.63 -53.13 56.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -73.85 -29.39 62.1 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 120.803 -1.185 . . . . 0.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.74 -35.65 81.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 119.274 0.943 . . . . 0.0 110.881 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.81 -20.49 61.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.92 -37.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.836 0.827 . . . . 0.0 111.301 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 t -119.71 120.93 30.19 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 109.872 -170.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.71 -29.6 88.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -97.76 2.11 49.17 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.45 -29.5 2.57 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.038 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.16 72.81 1.4 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.857 1.313 . . . . 0.0 113.181 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.43 155.19 52.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 162.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.81 142.19 56.75 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 114.685 -3.077 . . . . 0.0 110.148 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.67 164.0 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 113.33 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -100.73 88.54 3.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mt -88.46 104.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.48 52.55 13.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.883 0.849 . . . . 0.0 111.377 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t0 60.7 30.61 19.82 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -133.14 151.19 52.0 Favored 'General case' 0 C--N 1.323 -0.573 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 173.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -145.45 150.41 36.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 122.471 2.396 . . . . 0.0 116.741 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.75 150.32 32.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.487 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.46 -12.27 1.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 118.097 2.629 . . . . 0.0 118.097 -169.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -68.49 142.94 55.16 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.047 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -60.56 -27.39 67.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -82.95 -35.45 25.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.223 -0.923 . . . . 0.0 111.088 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -83.67 -14.7 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.293 -0.879 . . . . 0.0 112.29 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 pt -70.85 -6.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.665 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.74 -52.7 8.37 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 157.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.55 -47.06 92.18 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 118.819 2.288 . . . . 0.0 118.819 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -82.57 -27.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -60.69 -44.56 96.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.325 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -65.18 -41.56 94.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 118.414 0.552 . . . . 0.0 110.796 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -58.7 -35.99 73.51 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.839 -1.163 . . . . 0.0 112.301 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.15 17.13 23.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.903 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.07 131.7 80.77 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.05 -12.38 30.34 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 114.586 -3.143 . . . . 0.0 115.024 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -114.78 149.57 42.6 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 118.901 0.773 . . . . 0.0 109.864 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.26 121.78 9.94 Favored 'Trans proline' 0 C--O 1.24 0.59 0 N-CA-C 116.46 1.677 . . . . 0.0 116.46 -148.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.32 161.33 20.01 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.4 mt -139.96 64.95 1.44 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.424 1.107 . . . . 0.0 110.531 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.76 63.13 6.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.517 -0.74 . . . . 0.0 111.815 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 104.25 50.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.89 54.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 124.571 3.514 . . . . 0.0 120.752 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.24 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 116.724 -1.717 . . . . 0.0 115.086 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -34.36 72.49 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.011 -1.681 . . . . 0.0 114.21 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -32.12 73.66 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.729 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 -24.96 55.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.6 p -71.93 -37.19 70.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.41 -49.27 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.61 97.0 Favored Glycine 0 CA--C 1.516 0.149 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.413 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -75.9 -10.0 59.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -78.54 -38.48 40.36 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.78 -1.2 . . . . 0.0 109.901 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.23 -48.15 50.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.689 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -51.28 -53.44 49.19 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -170.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.07 -22.67 16.76 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 114.214 -3.391 . . . . 0.0 114.517 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.6 m -67.33 -38.98 85.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -86.38 -23.94 25.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.67 -33.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -63.76 -45.13 91.17 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.606 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -62.74 -38.16 89.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.5 tp -66.94 -46.32 75.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.297 0.953 . . . . 0.0 111.043 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -69.33 -21.68 63.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.488 0.661 . . . . 0.0 111.619 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.7 t -90.38 138.27 31.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -128.08 30.68 5.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.35 171.53 4.04 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -71.93 59.2 2.85 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 120.711 1.29 . . . . 0.0 114.492 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -60.29 122.19 13.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.109 1.764 . . . . 0.0 112.877 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -152.8 -42.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.235 0.541 . . . . 0.0 109.715 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.64 96.48 Favored Glycine 0 C--O 1.22 -0.745 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.8 p -73.62 -17.63 61.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.392 -1.063 . . . . 0.0 113.062 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.59 -39.24 53.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.833 1.301 . . . . 0.0 107.61 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -79.1 -14.22 59.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.663 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.08 80.23 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.671 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.27 -42.45 93.21 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.98 -43.23 95.24 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.006 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -70.7 -42.15 71.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.73 -33.52 68.79 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 120.146 -1.596 . . . . 0.0 108.983 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.27 -16.43 59.0 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 121.437 -0.789 . . . . 0.0 110.656 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -70.8 -33.52 70.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 119.992 1.269 . . . . 0.0 109.61 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 -39.45 89.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.38 -43.8 93.34 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.173 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.41 -39.07 89.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.538 0.735 . . . . 0.0 110.225 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.4 -51.67 50.4 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -61.35 -38.62 87.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.851 -0.794 . . . . 0.0 112.401 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.81 -39.47 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.537 -0.727 . . . . 0.0 110.717 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -72.66 -24.86 61.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.729 1.604 . . . . 0.0 114.48 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.71 -11.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -118.11 -43.73 2.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.12 -76.32 0.23 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.466 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -67.88 -169.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.063 3.175 . . . . 0.0 117.656 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -53.86 168.66 0.19 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.788 1.635 . . . . 0.0 113.962 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -63.2 -21.79 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -151.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.5 -11.63 53.42 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.186 -0.946 . . . . 0.0 113.338 173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.51 0.48 72.87 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -143.74 -49.54 0.3 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -162.32 176.07 10.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.64 125.79 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.9 p -130.72 -172.3 2.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.64 -31.45 25.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.46 -42.97 81.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 118.784 0.72 . . . . 0.0 110.131 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -66.86 -39.02 87.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.61 -21.53 66.58 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.4 m -91.01 -36.07 14.28 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.98 -49.32 7.43 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.6 48.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.18 -31.34 45.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 113.459 -3.894 . . . . 0.0 113.958 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -30.61 42.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.93 -34.55 76.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.032 0.833 . . . . 0.0 113.19 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -61.9 -43.6 98.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.985 1.266 . . . . 0.0 109.907 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -73.56 -28.54 61.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.146 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.7 -52.24 64.07 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.98 -33.23 75.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.025 -172.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.1 t -72.38 -61.87 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.463 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.28 66.77 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 111.293 -168.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.57 -42.94 77.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.54 -34.47 89.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.874 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -95.06 -16.03 22.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -108.69 -39.9 5.23 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -142.22 58.09 1.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -54.65 116.82 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -134.64 98.44 13.5 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 164.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.41 164.59 32.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 115.124 -2.784 . . . . 0.0 109.29 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.32 117.16 54.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 171.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.68 168.69 24.15 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 117.428 -1.248 . . . . 0.0 112.575 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -4.95 41.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.492 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -66.68 -22.12 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.123 -0.986 . . . . 0.0 110.181 168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.52 50.75 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -56.75 -29.05 62.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.64 -32.6 41.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.578 -1.326 . . . . 0.0 110.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.88 -37.92 70.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.87 -43.79 91.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.072 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -64.7 -38.49 91.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 112.361 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.79 -47.83 84.1 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.949 -0.47 . . . . 0.0 111.764 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.16 -27.34 26.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 O-C-N 120.999 -1.063 . . . . 0.0 111.096 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.97 -33.55 74.86 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.649 -1.282 . . . . 0.0 111.977 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.86 -31.53 71.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.67 0.668 . . . . 0.0 110.229 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.82 -5.77 51.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.384 0.611 . . . . 0.0 112.18 174.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -101.61 9.44 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.0 t -112.11 165.71 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 61.44 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.27 -27.82 69.3 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.138 -0.976 . . . . 0.0 112.341 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 m -56.06 -40.71 73.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -96.56 -50.69 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.496 0.665 . . . . 0.0 109.605 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.87 -43.97 90.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -76.06 -30.53 58.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 52.5 p -75.17 -12.4 60.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.646 -0.659 . . . . 0.0 112.532 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -58.05 132.36 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.47 0.652 . . . . 0.0 110.777 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.04 154.59 39.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.817 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.57 117.28 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.549 1.155 . . . . 0.0 111.188 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.44 -35.52 73.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.3 -37.42 87.1 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.775 -1.203 . . . . 0.0 107.853 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -75.83 -3.97 38.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.533 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.32 -46.51 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.6 -52.28 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.348 1.07 . . . . 0.0 108.17 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.21 27.66 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.138 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -112.71 -46.41 0.73 Allowed Glycine 0 N--CA 1.454 -0.12 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 167.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -53.68 7.45 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -84.61 -1.48 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 120.751 3.612 . . . . 0.0 120.751 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--N 1.358 1.053 1 C-N-CA 111.398 -5.268 . . . . 0.0 112.687 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.237 0.437 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.74 142.13 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.1 mt -134.09 158.56 42.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -171.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -148.43 113.95 5.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.5 164.92 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -52.85 129.42 30.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.1 0.864 . . . . 0.0 112.168 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.02 168.97 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.434 0.635 . . . . 0.0 109.665 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 134.32 56.29 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.08 120.8 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.91 4.93 86.74 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.402 -173.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 88.81 4.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.84 36.06 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.052 1.835 . . . . 0.0 115.323 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -108.91 -19.71 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -151.87 162.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.88 165.29 25.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.191 0.596 . . . . 0.0 111.939 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.76 170.01 27.8 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -75.06 104.13 5.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -115.91 161.34 31.31 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 147.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -65.5 -17.72 58.02 Favored 'Trans proline' 0 C--N 1.348 0.519 0 N-CA-C 116.881 1.839 . . . . 0.0 116.881 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -117.76 7.82 12.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.4 -44.21 92.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.9 0.857 . . . . 0.0 111.985 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -80.26 -13.94 58.8 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.786 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -61.46 -43.74 98.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.956 2.162 . . . . 0.0 112.842 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -46.67 86.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.6 mt -66.24 -39.22 89.39 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.541 -0.725 . . . . 0.0 112.174 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -43.62 95.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.93 -0.481 . . . . 0.0 110.29 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 p -69.18 -38.59 78.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.442 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -46.29 80.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.94 -27.33 36.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.692 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -66.79 -39.64 87.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.473 -1.392 . . . . 0.0 109.381 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -83.83 4.49 28.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.659 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.4 pttm 44.07 47.04 7.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.028 2.131 . . . . 0.0 115.62 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.87 149.9 36.2 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.35 158.44 36.88 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 117.601 -1.133 . . . . 0.0 114.05 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.81 162.13 41.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -144.3 140.91 29.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 t 68.96 123.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 126.227 2.204 . . . . 0.0 111.533 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -141.06 19.04 2.28 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.78 148.99 43.24 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.326 3.084 . . . . 0.0 119.326 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mm -131.03 108.58 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.443 1.897 . . . . 0.0 106.774 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.98 93.25 8.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.286 -1.509 . . . . 0.0 114.201 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt 47.33 48.23 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.518 1.127 . . . . 0.0 112.674 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.03 35.01 45.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.664 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -64.13 107.4 1.27 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 152.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -145.01 79.12 12.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.472 0.653 . . . . 0.0 112.733 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.89 172.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 115.055 -2.83 . . . . 0.0 110.7 165.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.48 -30.58 60.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.236 -0.29 . . . . 0.0 111.571 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -56.16 -51.66 67.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.32 -25.56 59.63 Favored 'General case' 0 C--O 1.218 -0.581 0 O-C-N 120.646 -1.284 . . . . 0.0 111.194 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.13 -25.49 64.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 119.22 0.918 . . . . 0.0 112.081 172.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.79 -29.33 61.06 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.492 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.67 -50.64 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 112.281 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -94.72 118.24 66.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 121.175 -0.953 . . . . 0.0 108.635 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.85 -21.38 38.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 N-CA-C 116.337 1.63 . . . . 0.0 116.337 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -93.69 -14.66 26.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.881 0.848 . . . . 0.0 110.839 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.79 -0.49 61.51 Favored Glycine 0 C--O 1.224 -0.471 0 O-C-N 121.78 -0.575 . . . . 0.0 113.212 -166.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -151.84 32.72 0.55 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.43 144.14 48.44 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.83 149.24 72.47 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 116.188 -2.075 . . . . 0.0 114.058 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.32 168.07 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.14 133.2 67.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 101.813 -3.402 . . . . 0.0 101.813 158.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -117.37 121.32 40.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 163.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -131.41 123.38 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 t70 55.88 35.13 24.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.593 1.187 . . . . 0.0 111.077 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.78 23.04 12.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.457 1.903 . . . . 0.0 115.788 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -121.09 140.73 51.56 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -115.77 153.93 30.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.97 148.13 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -152.03 38.61 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -112.31 149.41 32.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.6 p -58.47 -28.47 65.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.56 -37.77 15.43 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.575 0.584 . . . . 0.0 112.575 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 m -75.98 -17.81 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.914 -1.116 . . . . 0.0 112.722 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.91 -8.0 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.231 -0.293 . . . . 0.0 111.376 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.9 t -105.39 -51.44 8.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 160.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.22 91.95 Favored Glycine 0 C--O 1.228 -0.279 0 N-CA-C 117.941 1.936 . . . . 0.0 117.941 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.6 mt -77.52 -31.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.57 -43.99 96.69 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.481 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.41 -46.99 87.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.793 0.724 . . . . 0.0 109.835 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -66.19 -17.98 65.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -106.78 -5.61 18.32 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.029 0.532 . . . . 0.0 112.295 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -70.04 138.55 87.43 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -30.63 82.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.49 157.96 74.33 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 120.201 1.364 . . . . 0.0 107.949 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.77 141.12 93.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.013 -2.191 . . . . 0.0 114.792 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.56 151.39 52.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 116.919 -1.587 . . . . 0.0 111.415 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.5 mt -130.93 49.99 2.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 63.32 6.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.498 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.5 99.79 45.55 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.14 46.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 N-CA-C 121.231 3.512 . . . . 0.0 121.231 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -78.42 -124.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.225 0 CA-C-N 121.194 1.462 . . . . 0.0 114.237 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.34 -25.35 65.76 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.752 -1.843 . . . . 0.0 113.095 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.68 -42.52 99.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.541 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.45 -34.87 41.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.384 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.5 p -65.34 -34.56 78.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.098 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.56 -43.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.041 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.58 -37.18 93.77 Favored Glycine 0 CA--C 1.52 0.355 0 O-C-N 120.684 -1.26 . . . . 0.0 115.265 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 p -72.2 -15.37 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -77.61 -35.06 53.14 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.468 1.128 . . . . 0.0 110.13 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -77.73 -42.19 28.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.933 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -49.32 -52.68 46.89 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.75 -21.75 12.43 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 114.157 -3.429 . . . . 0.0 114.858 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.9 m -68.22 -43.59 77.66 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.576 -0.702 . . . . 0.0 111.619 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -78.0 -27.7 49.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 118.383 -1.327 . . . . 0.0 113.349 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.09 -29.24 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.15 -40.54 94.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.21 -36.28 81.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.616 -0.677 . . . . 0.0 111.226 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.51 -37.4 85.89 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.296 -0.253 . . . . 0.0 111.53 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -75.83 -27.91 58.07 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.238 -0.914 . . . . 0.0 113.458 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -61.32 137.35 58.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -128.6 29.7 5.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.21 172.53 9.51 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.39 106.17 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 114.234 -3.377 . . . . 0.0 109.939 149.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -125.69 26.57 6.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.44 -36.41 76.6 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.61 -41.06 97.97 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -24.58 59.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.253 1.527 . . . . 0.0 113.176 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.08 -42.05 94.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.229 1.014 . . . . 0.0 108.675 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -76.95 -16.16 59.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.193 -0.942 . . . . 0.0 112.21 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.39 -37.3 71.57 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.51 -41.09 96.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.395 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.25 -47.26 81.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.365 0.416 . . . . 0.0 110.043 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -67.56 -39.56 84.93 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.47 -42.32 95.97 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.097 -1.002 . . . . 0.0 109.871 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.46 -20.44 57.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.137 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.43 -35.28 80.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.535 0.607 . . . . 0.0 111.736 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.06 99.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.194 0.997 . . . . 0.0 109.725 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.14 -35.72 74.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.403 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.294 0.638 . . . . 0.0 112.462 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.66 -39.81 93.85 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.869 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.7 -32.62 72.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -48.43 35.74 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.285 -0.884 . . . . 0.0 110.113 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.01 -8.65 56.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -168.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.86 -10.56 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 167.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -117.45 -45.68 2.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.38 -67.88 0.23 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 119.981 2.753 . . . . 0.0 119.981 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -68.7 -169.33 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.665 2.733 . . . . 0.0 113.92 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -56.08 173.76 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.6 mt -56.83 -40.36 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 112.159 -154.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.86 10.63 2.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.12 -22.69 37.07 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.08 -40.88 0.59 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.06 170.54 21.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.78 123.11 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -128.44 171.77 11.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.85 -32.62 32.68 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.74 -41.64 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 121.641 -0.662 . . . . 0.0 111.437 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.52 -40.86 93.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.03 -21.19 63.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.316 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.2 m -85.6 -34.16 21.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -97.85 -46.25 6.01 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.18 -38.83 72.62 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.7 -31.0 33.59 Favored 'Trans proline' 0 C--N 1.352 0.748 1 C-N-CA 111.838 -4.975 . . . . 0.0 115.465 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -72.11 -30.78 65.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.095 -1.003 . . . . 0.0 108.957 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.9 -34.5 77.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.42 -47.03 83.64 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.174 -0.954 . . . . 0.0 109.063 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.93 -33.63 75.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.643 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.85 -52.72 64.22 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.84 -36.55 79.4 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -169.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.6 m -77.05 -35.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.14 -45.57 56.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.667 0.746 . . . . 0.0 110.304 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.44 -38.52 91.3 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.929 0.492 . . . . 0.0 109.754 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.87 -34.94 89.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.987 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.24 -49.65 11.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.347 0.573 . . . . 0.0 112.487 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -76.89 -47.44 21.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -148.19 66.0 1.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -165.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -54.73 112.67 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -163.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -141.83 91.88 8.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.04 155.74 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 115.286 -2.676 . . . . 0.0 109.473 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.91 123.58 89.65 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.65 154.8 63.98 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.557 -2.495 . . . . 0.0 112.247 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -75.22 2.7 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -71.22 -29.66 65.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.61 58.21 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -27.36 69.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.311 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -64.05 1.0 Allowed 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 167.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.74 -37.24 78.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -159.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.89 -50.93 71.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -76.19 -25.1 54.84 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.171 -0.956 . . . . 0.0 113.136 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.24 -49.47 71.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.548 0.689 . . . . 0.0 109.198 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.7 mt -62.61 -44.65 99.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.45 -48.34 81.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.7 -47.94 76.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 110.283 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.18 -19.26 58.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.25 -32.97 64.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 t -116.81 29.69 7.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.52 0.676 . . . . 0.0 110.573 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -67.82 144.43 55.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.58 -37.63 70.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.645 1.111 . . . . 0.0 110.869 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -58.08 -50.02 74.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -68.05 -40.51 82.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -56.69 -36.91 70.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.562 0.696 . . . . 0.0 110.901 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -82.67 -36.18 26.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 59.5 p -104.83 3.16 30.8 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -170.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.86 141.43 49.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.512 -0.743 . . . . 0.0 111.82 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.49 163.49 27.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.52 127.24 31.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -62.77 -36.24 82.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 111.899 -173.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -61.16 -30.13 70.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.741 0.781 . . . . 0.0 110.552 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -96.44 -5.45 39.62 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.782 -0.574 . . . . 0.0 112.02 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.94 -50.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 162.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.87 -67.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.107 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.99 62.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.57 -1.331 . . . . 0.0 111.917 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.33 -30.55 10.7 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -99.27 -28.93 13.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.91 1.855 . . . . 0.0 111.184 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -73.96 -3.1 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 C--N 1.36 1.137 1 C-N-CA 109.306 -6.663 . . . . 0.0 114.281 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 103.439 -2.801 . . . . 0.0 103.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -132.79 162.39 31.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.35 155.42 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.7 m -115.75 118.37 32.86 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 101.703 -3.443 . . . . 0.0 101.703 164.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.64 159.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -71.92 122.25 20.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 162.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.06 165.37 25.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.58 130.43 46.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.152 0.977 . . . . 0.0 112.179 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.26 123.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -9.93 66.79 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.34 0.896 . . . . 0.0 115.34 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.29 87.38 13.71 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.471 1.136 . . . . 0.0 112.027 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.16 50.87 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.967 3.778 . . . . 0.0 117.01 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.11 -31.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -126.51 158.25 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.86 139.16 58.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.32 1.048 . . . . 0.0 109.522 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.5 -157.92 23.75 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 120.188 2.835 . . . . 0.0 120.188 -172.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.02 31.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.156 2.182 . . . . 0.0 113.803 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.69 121.98 80.0 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.721 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.88 -26.09 52.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 N-CA-C 117.06 1.908 . . . . 0.0 117.06 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.9 2.47 9.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.2 m -64.59 -42.96 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.207 -0.933 . . . . 0.0 111.575 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.16 -15.41 61.97 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.752 -1.179 . . . . 0.0 113.258 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.253 1.388 . . . . 0.0 110.675 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -44.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.29 -29.46 65.08 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 119.274 0.943 . . . . 0.0 112.684 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 p -76.56 -34.56 58.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.043 -1.036 . . . . 0.0 110.175 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.46 -39.47 85.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.114 0.959 . . . . 0.0 113.115 -175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -78.31 -27.19 47.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -67.54 -37.82 83.27 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.763 -1.21 . . . . 0.0 110.014 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -74.95 -17.85 60.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 54.73 36.57 26.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -78.0 165.15 52.79 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -54.41 139.18 74.33 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 119.495 0.855 . . . . 0.0 112.783 162.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.0 173.37 11.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 -143.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -110.21 118.43 36.32 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 112.772 -155.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -161.51 123.27 2.9 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 162.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -138.49 150.32 46.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 160.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.8 mt -108.15 120.55 42.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.182 0.446 . . . . 0.0 111.812 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.54 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -84.53 81.14 8.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.998 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 mt 52.63 31.07 9.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.52 79.42 1.46 Allowed Glycine 0 C--O 1.235 0.186 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -110.36 -74.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.814 0.816 . . . . 0.0 110.269 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.27 149.32 91.59 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.994 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.8 -167.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 116.768 1.795 . . . . 0.0 116.768 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -52.87 -22.4 5.44 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.62 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.595 1.089 . . . . 0.0 111.2 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.75 -34.93 64.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.533 -0.729 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.76 -27.24 62.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.44 -33.25 73.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.441 0.639 . . . . 0.0 110.771 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.8 mm -84.96 -48.51 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.404 0.621 . . . . 0.0 111.268 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -82.6 114.33 51.09 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 122.987 0.515 . . . . 0.0 111.4 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.46 -24.41 31.08 Favored 'Trans proline' 0 C--N 1.347 0.496 0 N-CA-C 117.294 1.998 . . . . 0.0 117.294 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -92.83 -7.47 46.28 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.82 -16.54 11.25 Favored Glycine 0 C--O 1.225 -0.434 0 O-C-N 121.705 -0.622 . . . . 0.0 112.683 -167.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -140.89 24.93 2.16 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.47 163.41 59.2 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.19 142.93 62.76 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.148 -4.768 . . . . 0.0 112.352 161.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.1 t -128.84 132.97 67.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.67 122.45 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.43 1.109 . . . . 0.0 109.625 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -95.32 128.92 42.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.45 91.49 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.4 t0 51.16 51.39 17.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.289 1.042 . . . . 0.0 110.864 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t0 63.16 8.36 3.27 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.66 144.03 34.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 157.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -128.0 124.82 38.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 120.481 1.491 . . . . 0.0 109.167 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.43 156.99 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.94 96.58 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -154.65 153.92 32.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 101.815 -3.402 . . . . 0.0 101.815 167.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.9 p -61.96 -32.57 73.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -95.6 -14.36 23.61 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -81.36 -21.12 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.937 -1.727 . . . . 0.0 108.041 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -21.31 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.143 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -89.1 -48.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.62 -64.7 1.2 Allowed Glycine 0 CA--C 1.519 0.291 0 N-CA-C 120.389 2.915 . . . . 0.0 120.389 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.81 -34.16 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.651 0.739 . . . . 0.0 109.336 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.94 -47.21 87.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.089 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.25 -34.28 77.66 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.09 0.859 . . . . 0.0 112.107 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.46 -28.06 63.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.809 0.844 . . . . 0.0 110.407 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -120.2 21.55 11.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -100.82 76.22 0.14 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.442 0.697 . . . . 0.0 111.647 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.7 5.63 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.748 2 C-N-CA 125.757 4.305 . . . . 0.0 123.119 -131.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.88 172.48 8.9 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 158.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.61 135.42 70.34 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 114.988 -2.875 . . . . 0.0 116.904 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.54 116.8 4.81 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.477 1.451 . . . . 0.0 114.033 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.78 81.7 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.544 1.164 . . . . 0.0 113.528 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -118.27 73.72 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.969 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.19 114.62 63.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -106.7 61.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.64 0 N-CA-C 117.846 2.21 . . . . 0.0 117.846 168.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.95 -132.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 120.03 1.047 . . . . 0.0 112.715 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.06 -37.53 61.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -25.69 68.26 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 120.927 -1.108 . . . . 0.0 112.515 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.55 70.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.8 p -72.53 -33.67 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.68 -49.48 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.507 0.67 . . . . 0.0 109.244 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.64 94.64 Favored Glycine 0 C--O 1.228 -0.234 0 O-C-N 122.094 -0.379 . . . . 0.0 113.915 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.1 p -71.68 -12.37 61.3 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.99 -36.56 27.75 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.98 -1.075 . . . . 0.0 110.313 169.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.97 -46.6 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.353 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -50.0 -54.24 34.93 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -171.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.35 -19.85 12.98 Favored 'Trans proline' 0 C--N 1.349 0.601 1 C-N-CA 112.305 -4.664 . . . . 0.0 114.319 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -66.88 -47.16 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -73.32 -24.47 60.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.006 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.44 -38.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.91 -48.89 76.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.88 -43.92 94.48 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.77 -18.7 62.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.0 0.2 43.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.384 -0.197 . . . . 0.0 110.607 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 t -110.19 142.18 42.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.73 33.53 4.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.65 171.56 10.5 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.84 78.78 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 CA-C-N 120.642 1.265 . . . . 0.0 114.569 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -91.26 26.02 2.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -155.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.3 -35.42 80.3 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.683 -1.886 . . . . 0.0 112.263 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.39 -32.06 68.36 Favored Glycine 0 C--O 1.223 -0.562 0 O-C-N 121.463 -0.773 . . . . 0.0 112.966 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 m -77.98 -30.35 50.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.536 1.168 . . . . 0.0 111.398 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.0 -41.79 99.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.502 1.144 . . . . 0.0 108.351 171.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -73.75 -24.29 59.86 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.172 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.45 99.43 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 120.799 -1.188 . . . . 0.0 108.819 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.0 -44.41 96.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.13 -44.15 97.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -80.84 -30.65 35.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.65 -35.59 60.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.062 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.71 -17.45 57.61 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 120.96 -1.088 . . . . 0.0 109.837 173.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -69.55 -35.66 75.64 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.294 -1.504 . . . . 0.0 110.286 167.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.15 -45.53 93.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.11 -39.54 90.38 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -40.77 98.3 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.927 -1.108 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.95 -35.87 72.65 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.643 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -72.87 -36.84 67.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.483 -1.01 . . . . 0.0 112.631 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.24 -43.25 91.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 109.825 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.32 -19.49 63.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.979 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.68 -25.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.807 0.73 . . . . 0.0 111.095 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -112.46 -35.89 5.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.87 -71.16 0.22 Allowed Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.403 -1.776 . . . . 0.0 114.714 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.44 -160.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.799 4.333 . . . . 0.0 118.486 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -56.92 166.67 0.95 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.286 1.434 . . . . 0.0 112.159 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -52.46 -33.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.53 8.08 4.74 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.97 -33.81 5.49 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.07 -40.22 2.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.747 1.273 . . . . 0.0 112.331 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.41 -178.52 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.977 0.511 . . . . 0.0 110.249 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.8 mt -67.42 121.34 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 m -153.29 171.25 18.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -25.57 -54.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.969 1 N-CA-C 122.677 4.325 . . . . 0.0 122.677 -173.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.17 -35.34 75.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.015 -1.053 . . . . 0.0 110.483 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.32 -43.43 73.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.23 -32.56 73.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.596 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.2 m -71.13 -38.65 72.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.1 tp -100.32 -45.69 5.51 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -170.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.41 -43.13 97.38 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.12 -20.79 24.62 Favored 'Trans proline' 0 C--N 1.35 0.614 1 C-N-CA 111.296 -5.336 . . . . 0.0 114.782 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -78.29 -22.35 48.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 120.931 -1.106 . . . . 0.0 110.556 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 -27.01 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 118.435 0.561 . . . . 0.0 111.092 169.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.7 -44.53 64.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.157 -0.965 . . . . 0.0 110.263 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -62.67 -30.27 71.26 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.875 -0.515 . . . . 0.0 111.211 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.92 -58.36 8.9 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.25 -31.65 72.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.273 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.86 -54.88 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.758 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.86 -41.19 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.1 tp -67.77 -37.82 82.61 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.01 -32.88 81.86 Favored Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -74.95 -48.38 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.39 -45.05 12.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -167.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -149.1 60.98 1.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -52.3 120.64 5.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -162.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -145.48 93.82 5.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 163.01 39.58 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 115.882 -2.279 . . . . 0.0 109.879 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.4 124.81 90.84 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.7 166.44 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 117.105 -1.464 . . . . 0.0 113.92 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.86 -0.14 20.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.436 1.112 . . . . 0.0 112.27 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.31 -14.37 61.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.25 51.95 1.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.9 t -62.77 -26.26 68.62 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.709 -0.62 . . . . 0.0 112.464 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.91 -35.25 62.22 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.696 -1.252 . . . . 0.0 108.066 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.2 -40.39 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 109.368 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.42 -44.66 90.51 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.969 -0.457 . . . . 0.0 111.491 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.52 -23.83 61.06 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.027 -1.046 . . . . 0.0 111.734 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -68.96 -49.17 60.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.905 0.482 . . . . 0.0 110.31 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.64 -33.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 120.906 -1.121 . . . . 0.0 111.372 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.02 -38.9 90.44 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.861 -1.149 . . . . 0.0 111.459 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.61 -42.69 86.48 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.69 -0.631 . . . . 0.0 111.835 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.5 mt -66.18 -46.72 76.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -55.85 -42.43 75.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.9 t -106.32 71.25 0.87 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 111.037 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.58 153.41 43.74 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -57.33 -48.68 78.35 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.809 0.693 . . . . 0.0 110.699 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.0 t -65.58 -43.71 88.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.928 0.87 . . . . 0.0 112.28 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -65.25 -45.26 85.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.641 0.734 . . . . 0.0 110.626 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.98 -37.68 81.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.499 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -69.65 -36.49 76.12 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.0 -1.062 . . . . 0.0 111.984 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 64.2 p -87.93 -0.28 56.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -62.04 141.17 58.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.92 44.73 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.41 122.11 15.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.02 -48.6 73.33 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -166.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -21.71 66.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.692 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -95.64 -1.59 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.58 -44.73 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 164.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.95 -55.08 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.15 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.8 5.45 9.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.509 -0.744 . . . . 0.0 112.819 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.71 -44.26 3.7 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 169.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -91.06 -38.37 12.83 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.34 -20.42 0.58 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.353 0.776 1 C-N-CA 111.761 -5.026 . . . . 0.0 115.372 167.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.517 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.36 139.79 43.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.84 114.36 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.8 m -109.86 130.84 55.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.08 139.82 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 123.991 0.807 . . . . 0.0 112.264 -164.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.48 128.5 36.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.087 0.403 . . . . 0.0 110.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.05 176.34 9.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.202 1.001 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.51 41.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.858 1.313 . . . . 0.0 109.385 167.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.39 109.84 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.354 -170.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.97 23.48 66.4 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.665 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.92 89.29 5.69 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.96 54.52 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.945 3.097 . . . . 0.0 114.245 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -141.43 -28.08 0.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 pt -141.45 168.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 118.445 0.566 . . . . 0.0 110.518 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.27 146.82 45.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.114 1.765 . . . . 0.0 112.748 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.74 -174.6 13.81 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -73.56 92.43 1.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.422 1.106 . . . . 0.0 111.355 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.77 135.72 22.42 Favored Pre-proline 0 C--O 1.246 0.883 1 N-CA-C 99.344 -4.317 . . . . 0.0 99.344 138.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -57.42 -39.62 87.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.21 0.754 . . . . 0.0 112.956 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.24 -23.29 43.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.054 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.53 -34.24 77.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.801 -1.187 . . . . 0.0 113.418 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -80.61 -12.74 59.46 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.565 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -69.0 -41.91 77.18 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -44.95 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mt -64.26 -39.37 93.82 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.748 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.52 -43.3 97.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.569 0.622 . . . . 0.0 111.385 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 p -70.17 -39.13 75.49 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.62 -43.91 88.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -76.24 -29.28 57.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.548 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -68.42 -34.32 75.8 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.528 -1.358 . . . . 0.0 111.401 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.52 -11.46 45.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.47 51.97 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.352 1.461 . . . . 0.0 113.622 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.3 pt -98.8 155.1 37.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.05 145.16 30.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.837 -2.975 . . . . 0.0 111.314 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.54 157.95 41.81 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 121.993 -0.442 . . . . 0.0 110.756 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -110.78 110.51 21.17 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.662 0.385 . . . . 0.0 111.719 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -86.1 128.38 34.87 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.11 93.57 4.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.654 1.182 . . . . 0.0 111.437 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.67 142.91 57.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.889 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.05 94.2 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.5 85.07 5.99 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.495 -0.753 . . . . 0.0 112.039 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt 54.35 45.06 27.98 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.002 0.906 . . . . 0.0 113.164 166.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.72 94.36 1.85 Allowed Glycine 0 C--O 1.238 0.352 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.523 -168.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -124.59 -91.08 0.55 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -69.68 152.38 96.2 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.204 -170.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.97 -175.68 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.552 2.168 . . . . 0.0 115.282 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -64.19 -10.76 25.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -161.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -49.3 -41.04 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.741 0.416 . . . . 0.0 110.094 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -79.84 -28.69 40.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.2 -34.8 78.28 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.895 0.855 . . . . 0.0 110.507 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.89 -36.64 84.59 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 121.362 -0.837 . . . . 0.0 110.362 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.1 mt -75.62 -45.81 38.11 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 C-N-CA 124.038 0.935 . . . . 0.0 112.716 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 60' ' ' VAL . 28.7 t -102.99 129.62 25.27 Favored Pre-proline 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 112.973 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.29 -23.16 28.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 116.655 -1.764 . . . . 0.0 116.39 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.72 -10.96 25.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.788 -1.195 . . . . 0.0 110.718 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 -5.93 67.5 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 121.561 -0.712 . . . . 0.0 113.8 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -144.89 34.43 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -167.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 55' ' ' SER . 11.8 m -119.16 161.81 34.92 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.934 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.63 151.25 58.11 Favored 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 111.417 -5.255 . . . . 0.0 110.081 171.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.6 161.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.29 126.26 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.999 0.818 . . . . 0.0 109.375 160.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.05 87.64 3.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.06 111.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 47.76 56.15 7.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.132 0.895 . . . . 0.0 113.27 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 t70 71.4 -7.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.94 122.85 44.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.047 -1.033 . . . . 0.0 110.147 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -107.07 131.42 54.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.65 144.74 37.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-N 115.256 -0.883 . . . . 0.0 113.331 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.72 115.63 1.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.35 157.08 10.63 Favored 'General case' 0 N--CA 1.472 0.654 1 N-CA-C 96.959 -5.2 . . . . 0.0 96.959 160.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.9 p -57.44 -35.17 69.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.92 -41.17 60.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.059 -0.4 . . . . 0.0 111.907 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -81.64 -17.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.837 -0.539 . . . . 0.0 110.691 -171.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -23.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.63 -47.91 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.083 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.1 62.47 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.4 mt -80.47 -29.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.596 1.698 . . . . 0.0 106.629 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.28 -41.15 92.72 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.718 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.59 -39.75 80.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 112.798 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -60.47 -33.46 72.6 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.131 -0.981 . . . . 0.0 111.454 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.81 10.86 38.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.54 130.99 90.13 Favored Pre-proline 0 C--O 1.247 0.927 0 O-C-N 121.606 -0.683 . . . . 0.0 109.195 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.41 -17.3 30.64 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.129 -1.448 . . . . 0.0 113.779 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.98 161.54 27.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -63.93 144.13 87.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 115.807 -2.329 . . . . 0.0 117.122 -169.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.23 136.52 7.85 Favored 'Trans proline' 0 C--O 1.24 0.584 0 N-CA-C 118.366 2.41 . . . . 0.0 118.366 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.26 41.36 3.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.329 1.052 . . . . 0.0 111.981 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.57 66.76 4.17 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.759 0.824 . . . . 0.0 112.016 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.11 106.08 28.52 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -100.7 75.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 125.158 3.905 . . . . 0.0 118.01 166.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -91.0 -140.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.474 1.449 . . . . 0.0 114.241 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.87 -37.12 29.65 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.05 -25.52 64.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.114 -0.991 . . . . 0.0 112.428 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.49 47.42 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.874 -0.516 . . . . 0.0 111.895 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.1 p -70.12 -32.81 71.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.71 -38.84 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.9 -39.41 93.98 Favored Glycine 0 C--O 1.227 -0.308 0 O-C-N 121.702 -0.624 . . . . 0.0 112.815 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.9 p -76.51 5.92 6.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.083 1.441 . . . . 0.0 114.45 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -104.29 -25.49 12.86 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.419 -0.801 . . . . 0.0 112.535 165.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.3 mt -85.92 -47.89 16.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.955 0.407 . . . . 0.0 111.098 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -50.37 -52.02 58.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.19 -20.97 10.94 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 114.307 -3.328 . . . . 0.0 115.861 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.1 p -79.73 -37.88 34.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -46.8 89.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.494 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.84 -26.7 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 121.39 -0.819 . . . . 0.0 112.318 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -65.45 -43.17 91.21 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.26 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.38 -23.37 63.73 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.3 tp -66.05 -38.83 89.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.774 0.715 . . . . 0.0 110.955 171.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -83.02 -31.27 27.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 t -74.0 131.24 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -114.64 30.61 7.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.298 1.047 . . . . 0.0 109.497 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.35 171.34 8.02 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.013 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.28 95.73 0.69 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 116.249 -2.034 . . . . 0.0 112.447 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -115.3 59.23 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.281 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -94.63 -45.18 7.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.64 -28.01 62.05 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.288 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 p -97.8 -5.1 35.55 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.6 -31.31 66.77 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 161.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -76.73 0.08 21.81 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.947 -1.096 . . . . 0.0 111.596 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.22 69.23 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.19 -35.42 79.6 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.473 -0.767 . . . . 0.0 109.942 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.2 -43.64 92.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.89 -28.77 64.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.18 -36.29 40.54 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.543 -1.348 . . . . 0.0 110.381 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.3 mt -74.37 -25.48 59.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.072 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.74 -34.29 72.76 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 118.55 0.613 . . . . 0.0 111.231 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.7 77.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.12 -36.2 82.53 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.751 0.705 . . . . 0.0 111.936 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.99 -42.12 89.28 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.12 0.568 . . . . 0.0 111.741 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.04 57.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.358 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -36.23 75.28 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.807 0.443 . . . . 0.0 111.521 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -54.09 18.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.678 -0.638 . . . . 0.0 109.937 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.6 -24.24 67.02 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.6 m -79.57 -11.35 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.61 -39.86 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.48 -68.17 0.27 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 121.267 3.267 . . . . 0.0 121.267 173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -74.47 -171.42 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 N-CA-C 120.213 3.121 . . . . 0.0 120.213 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -49.73 154.03 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.028 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -67.2 -32.8 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.692 -124.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.15 -19.48 5.13 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.97 3.51 48.71 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-O 119.224 -0.765 . . . . 0.0 112.18 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -139.61 -62.25 0.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -163.24 178.9 7.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.89 114.05 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 124.143 0.902 . . . . 0.0 110.593 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -120.92 -169.93 1.92 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.5 29.31 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.71 -40.56 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.404 -1.435 . . . . 0.0 111.601 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.5 -39.9 94.65 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.3 -28.98 68.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -70.92 -37.22 72.9 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.084 -1.01 . . . . 0.0 111.719 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.12 -59.93 2.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.88 76.61 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -69.1 -24.33 32.82 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 113.842 -3.639 . . . . 0.0 115.996 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -88.02 -29.41 20.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.294 1.406 . . . . 0.0 108.902 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.85 -35.73 73.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.376 0.535 . . . . 0.0 110.54 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.46 -48.46 71.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -65.36 -40.88 94.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.43 76.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.819 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.67 -28.21 68.28 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.811 1.187 . . . . 0.0 112.888 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.1 m -81.01 -38.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 O-C-N 121.052 -1.03 . . . . 0.0 110.102 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.26 -49.5 19.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.145 0.429 . . . . 0.0 111.979 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.01 -35.41 80.61 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.06 -29.91 76.24 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 115.432 0.933 . . . . 0.0 115.432 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -89.7 -44.1 10.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.371 1.085 . . . . 0.0 113.057 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.17 -37.27 20.36 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -138.5 30.92 2.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.917 0.487 . . . . 0.0 112.277 -163.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -22.93 109.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -152.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -142.22 90.44 8.21 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.869 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.55 160.01 42.03 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 117.121 -1.453 . . . . 0.0 110.344 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.62 121.65 85.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.93 162.43 34.74 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 116.619 -1.788 . . . . 0.0 113.911 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -4.41 30.37 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.317 -0.864 . . . . 0.0 112.949 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -66.62 -22.91 66.11 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.478 0.656 . . . . 0.0 110.206 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.33 66.38 0.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 m -58.53 -36.57 74.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.361 -170.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -51.69 68.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.57 -41.58 80.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -161.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.23 -46.99 65.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.726 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.56 -45.73 89.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.092 -176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -72.6 -29.05 63.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.459 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.59 -40.96 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.857 1.208 . . . . 0.0 110.057 171.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.82 -33.75 74.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.553 -0.717 . . . . 0.0 112.721 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.9 -38.13 79.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.196 0.907 . . . . 0.0 110.869 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.5 -42.02 88.01 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.387 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -50.49 -38.79 46.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -173.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.3 t -120.79 38.55 4.01 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.727 1.251 . . . . 0.0 110.761 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -78.85 143.32 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 161.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -56.55 -45.37 81.28 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.58 1.082 . . . . 0.0 113.653 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -62.22 -44.78 95.81 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -77.07 -38.0 53.41 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.396 -0.815 . . . . 0.0 112.67 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -59.32 -36.46 75.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.045 0.926 . . . . 0.0 110.874 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.01 -40.95 44.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.9 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.7 p -98.47 -3.63 36.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -60.28 140.86 56.84 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.21 150.03 40.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.9 139.01 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -63.93 -39.27 93.79 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.75 -31.04 71.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.568 1.175 . . . . 0.0 109.698 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -96.16 10.19 38.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.526 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -100.85 -51.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.439 156.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.9 -66.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.07 -9.73 58.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.107 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.78 -31.37 29.74 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.442 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -110.6 -28.09 8.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.605 1.202 . . . . 0.0 112.975 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -74.46 -9.7 0.15 Allowed Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 121.618 3.932 . . . . 0.0 121.618 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.36 1.147 1 C-N-CA 111.354 -5.297 . . . . 0.0 114.639 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 tpp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 140.77 37.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.04 1.291 . . . . 0.0 108.289 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.41 142.02 45.56 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.28 0.7 OUTLIER -171.27 -148.49 0.05 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.372 1.442 . . . . 0.0 109.937 160.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.33 143.96 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -133.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -126.15 110.98 14.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.845 -3.391 . . . . 0.0 101.845 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.3 167.24 26.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.76 139.56 44.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.81 156.34 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.03 127.17 30.25 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 164.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.03 119.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.22 75.39 Favored Glycine 0 C--O 1.25 1.102 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.01 76.79 8.63 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.745 -0.727 . . . . 0.0 111.605 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.9 53.7 2.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.623 2.882 . . . . 0.0 116.52 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -128.51 -37.59 1.79 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.483 -0.76 . . . . 0.0 112.13 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.2 mt -95.92 142.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.38 152.39 17.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.25 176.16 48.38 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.44 31.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.551 -1.825 . . . . 0.0 115.573 -172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.7 t -96.01 145.75 30.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.632 -0.667 . . . . 0.0 112.38 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -68.33 -47.96 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 117.028 -1.514 . . . . 0.0 115.191 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -19.93 60.49 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.824 -0.547 . . . . 0.0 110.208 -172.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.4 t -55.7 -55.59 30.45 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.656 0.597 . . . . 0.0 109.708 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.56 -15.14 59.93 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -61.43 -52.74 63.29 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.283 1.401 . . . . 0.0 109.782 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -79.2 -31.84 14.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.691 -174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -62.13 -44.83 95.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.932 0.787 . . . . 0.0 110.444 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.041 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -61.33 -36.33 79.84 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.396 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.2 -40.09 31.66 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.69 -0.631 . . . . 0.0 111.799 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -70.12 -31.25 68.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.32 0.509 . . . . 0.0 111.642 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.34 -34.6 77.66 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.917 -1.114 . . . . 0.0 110.761 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -82.29 -14.32 55.58 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.101 -0.999 . . . . 0.0 112.647 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 56.49 57.87 4.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.647 . . . . 0.0 112.918 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 pt -94.71 161.83 27.47 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.82 151.24 68.67 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 115.858 -2.295 . . . . 0.0 110.942 164.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -147.36 154.84 41.39 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -100.07 -92.77 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -165.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 178.37 7.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -153.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -134.13 174.75 10.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.095 0.958 . . . . 0.0 113.524 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.54 152.32 0.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -94.98 117.92 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 166.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.04 72.28 10.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.5 67.17 1.0 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 167.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.82 -2.41 84.29 Favored Glycine 0 C--O 1.228 -0.279 0 O-C-N 121.186 -0.946 . . . . 0.0 113.411 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -87.19 92.2 8.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -122.08 83.96 45.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 122.132 0.967 . . . . 0.0 113.078 -170.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.69 172.74 13.8 Favored 'Trans proline' 0 C--O 1.238 0.488 0 N-CA-C 110.33 -0.681 . . . . 0.0 110.33 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -55.69 -34.07 64.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -54.63 -53.04 59.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 118.716 0.689 . . . . 0.0 111.884 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -73.33 -29.14 62.47 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.644 -1.285 . . . . 0.0 112.671 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.45 -25.84 64.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.581 1.082 . . . . 0.0 111.855 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -74.34 -41.36 61.2 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.761 -0.587 . . . . 0.0 109.525 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -74.01 -54.64 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -100.86 136.18 19.86 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.871 0.868 . . . . 0.0 111.971 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.59 -24.6 15.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 116.256 -2.029 . . . . 0.0 116.304 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -104.97 -5.37 21.06 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.13 -5.21 51.12 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 122.798 1.221 . . . . 0.0 113.284 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -148.85 37.31 0.8 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.786 1.234 . . . . 0.0 111.629 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.85 136.21 28.47 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -58.26 149.38 73.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 114.354 0.867 . . . . 0.0 114.354 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 m -136.14 169.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.92 141.81 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 156.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -103.27 93.65 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.25 96.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.078 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.07 37.36 24.61 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.545 1.164 . . . . 0.0 112.125 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t0 67.94 41.25 2.13 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 126.156 1.782 . . . . 0.0 115.661 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -131.16 153.02 49.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 167.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.63 126.46 20.77 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.37 149.58 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.12 81.77 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -151.28 152.59 33.43 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 168.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.2 p -55.3 -29.99 59.29 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -165.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.18 -35.52 10.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.286 0.565 . . . . 0.0 112.165 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.53 -37.48 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.604 0.716 . . . . 0.0 110.528 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.17 -29.99 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.8 t -88.45 -49.57 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.493 0.717 . . . . 0.0 111.77 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.83 -34.12 71.48 Favored Glycine 0 C--O 1.235 0.213 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.936 -168.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.26 -30.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.52 -44.25 97.41 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 121.895 -0.503 . . . . 0.0 109.851 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -62.87 -46.3 88.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.349 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.85 -37.17 85.79 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.479 -0.763 . . . . 0.0 112.33 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.59 7.32 46.67 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -81.61 129.23 66.44 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.14 -17.08 22.21 Favored 'Trans proline' 0 C--O 1.244 0.8 0 N-CA-C 116.023 1.509 . . . . 0.0 116.023 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.41 148.87 67.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -60.22 116.78 3.56 Favored 'Trans proline' 0 C--O 1.243 0.753 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.58 170.36 11.66 Favored 'Trans proline' 0 C--O 1.249 1.033 0 N-CA-C 115.114 1.159 . . . . 0.0 115.114 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.5 tp -141.54 69.91 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 122.598 1.19 . . . . 0.0 110.005 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.47 65.06 6.45 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.277 -1.328 . . . . 0.0 112.46 -175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 m -120.12 100.54 47.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.21 86.18 0.06 OUTLIER 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.512 3.475 . . . . 0.0 117.989 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -88.55 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.004 1 C-N-CA 127.23 5.286 . . . . 0.0 111.739 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -45.36 -34.8 3.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.52 -30.17 71.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 120.559 -1.338 . . . . 0.0 112.366 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.35 -28.64 34.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.053 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -72.06 -32.38 67.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.125 0.875 . . . . 0.0 109.638 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.44 -40.62 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.318 -0.864 . . . . 0.0 109.684 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.02 -30.84 70.99 Favored Glycine 0 CA--C 1.521 0.425 0 O-C-N 121.793 -0.567 . . . . 0.0 114.313 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -73.12 -9.49 58.77 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -80.76 -46.62 15.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt -75.63 -42.12 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.925 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.13 -53.26 67.2 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.78 -18.99 21.55 Favored 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 112.637 -4.442 . . . . 0.0 113.636 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.0 t -66.96 -56.55 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.015 0.526 . . . . 0.0 111.804 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -72.92 -23.97 60.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.79 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -68.23 -47.25 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -63.26 -44.39 95.28 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -69.79 -34.89 74.35 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.06 -34.45 76.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.195 0.907 . . . . 0.0 110.286 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.78 -24.89 61.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.631 0.772 . . . . 0.0 111.762 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -87.77 127.54 35.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -116.71 39.13 3.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.51 -175.31 0.18 Allowed Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 127.053 2.141 . . . . 0.0 109.68 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.08 41.26 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 114.675 0.99 . . . . 0.0 114.675 146.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -71.79 105.75 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.653 -1.279 . . . . 0.0 112.595 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.98 -54.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.4 -36.33 93.06 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.654 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.3 p -77.85 -21.92 50.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.383 0.592 . . . . 0.0 112.204 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.63 -35.75 75.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.659 1.695 . . . . 0.0 107.02 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -79.77 -3.69 48.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.72 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.48 -31.33 24.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.882 -1.136 . . . . 0.0 108.081 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.55 -41.24 88.95 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.335 -0.853 . . . . 0.0 110.065 165.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.82 -36.53 72.37 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.91 -0.493 . . . . 0.0 110.925 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -64.0 -36.24 83.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -78.02 -33.71 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.3 -24.59 61.35 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.63 -0.668 . . . . 0.0 111.001 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.09 -33.06 71.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.579 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.28 80.45 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.108 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.94 -34.55 78.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.397 1.094 . . . . 0.0 111.744 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.76 -38.66 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.26 -36.49 93.28 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.803 -1.09 . . . . 0.0 114.665 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -69.15 -46.22 68.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.864 1.332 . . . . 0.0 110.643 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 178' ' ' HIS . 5.8 tt -68.41 -38.39 81.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.558 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -68.74 -20.07 64.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.798 1.181 . . . . 0.0 112.851 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -81.73 -52.26 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.91 -31.84 40.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.17 -81.95 0.3 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-O 117.881 -1.511 . . . . 0.0 114.319 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -77.47 -174.25 2.13 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.214 3.276 . . . . 0.0 114.18 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -33.12 165.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 119.463 3.134 . . . . 0.0 119.463 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.02 -41.37 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 121.232 -0.918 . . . . 0.0 111.113 -152.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.75 -0.27 2.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.94 47.92 Favored Glycine 0 N--CA 1.453 -0.17 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.15 -39.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.692 0.746 . . . . 0.0 112.559 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -160.95 176.84 10.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 114.11 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.2 p -123.12 -168.51 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.82 -24.94 10.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.19 -55.04 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.171 0.896 . . . . 0.0 109.614 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.46 -38.22 84.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.68 -18.93 65.63 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.799 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 97.0 p -86.24 -39.58 16.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.252 0.933 . . . . 0.0 111.957 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.83 -45.45 8.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -168.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.45 91.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -58.67 -35.51 98.54 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 115.988 -2.208 . . . . 0.0 116.548 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -84.98 -22.78 29.0 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.754 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.97 -28.61 68.41 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.145 -0.972 . . . . 0.0 112.697 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.55 -40.02 93.18 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -67.81 -34.56 76.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.731 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.5 tp -60.25 -53.06 62.22 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.169 0.44 . . . . 0.0 109.967 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -68.5 -21.67 64.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.97 -41.19 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.965 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.62 -57.0 4.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.274 -0.891 . . . . 0.0 111.628 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 43.3 tp -64.73 -36.69 85.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.64 -33.29 76.66 Favored Glycine 0 C--O 1.237 0.322 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.372 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -100.39 -42.74 6.49 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -47.43 24.36 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.198 0.908 . . . . 0.0 113.214 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -136.43 64.17 1.56 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.95 114.61 0.95 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -163.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -144.33 93.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.34 158.96 47.7 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.724 -1.718 . . . . 0.0 111.127 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.21 124.41 88.88 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.26 151.22 60.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 117.023 -1.518 . . . . 0.0 112.139 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -77.69 -0.88 28.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -72.64 -24.13 61.01 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.4 62.86 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -58.95 -35.99 74.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.153 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.431 ' CD2' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -60.72 -55.88 27.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.88 -41.64 91.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -165.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 tp -67.33 -44.73 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.2 -45.1 89.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -25.31 43.19 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 118.944 -1.103 . . . . 0.0 112.041 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 13.9 mt -64.71 -32.69 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -62.35 -39.17 92.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.327 0.584 . . . . 0.0 110.613 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.22 -43.68 85.99 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.926 -0.484 . . . . 0.0 110.405 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.73 -31.69 71.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 118.486 0.585 . . . . 0.0 111.788 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.25 -23.84 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.814 -1.179 . . . . 0.0 112.243 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t -147.29 66.33 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -105.41 149.58 26.01 Favored 'General case' 0 CA--C 1.498 -1.034 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 161.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.54 -41.31 89.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.811 0.815 . . . . 0.0 110.4 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -63.8 -46.67 84.1 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.429 -0.794 . . . . 0.0 111.038 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.36 -34.75 74.32 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.891 -0.506 . . . . 0.0 110.203 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -73.55 -38.74 65.13 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.123 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.0 p -90.49 2.17 55.97 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -63.18 145.19 56.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.205 -0.934 . . . . 0.0 111.619 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 166.46 23.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.51 43.86 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -65.34 -50.75 64.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.332 1.063 . . . . 0.0 108.264 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.36 -29.16 68.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.285 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.85 1.93 55.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.2 t -96.53 -45.0 12.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.29 -53.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.917 -1.115 . . . . 0.0 112.15 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.14 23.31 11.8 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.46 -34.9 0.59 Allowed Glycine 0 C--O 1.226 -0.38 0 CA-C-N 114.612 -1.177 . . . . 0.0 114.272 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -97.05 -41.78 8.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.159 0.979 . . . . 0.0 112.785 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.35 -15.22 0.26 Allowed Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 119.412 3.116 . . . . 0.0 119.412 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.9 -23.24 30.36 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 109.882 -6.279 . . . . 0.0 113.833 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -63.13 -38.6 91.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.385 0.993 . . . . 0.0 110.656 170.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.64 -32.22 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.634 0.774 . . . . 0.0 109.42 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.5 -54.25 6.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.528 -2.177 . . . . 0.0 112.513 -176.451 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtp . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.63 -151.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.233 1.013 . . . . 0.0 110.015 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.32 164.68 15.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -136.0 158.39 44.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 160.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.36 126.39 75.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.1 t -128.99 109.09 10.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -128.17 156.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.204 -167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.05 129.95 43.24 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.35 167.65 20.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.38 140.21 58.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.851 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.23 127.33 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.14 86.35 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 117.131 1.612 . . . . 0.0 117.131 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.91 100.14 2.54 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 119.323 1.562 . . . . 0.0 113.699 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.38 0.69 6.43 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 N-CA-C 116.578 1.722 . . . . 0.0 116.578 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 -12.14 45.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.12 166.66 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.055 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -82.03 143.41 31.57 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.077 0.951 . . . . 0.0 111.483 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.26 -166.15 12.16 Favored Glycine 0 N--CA 1.46 0.282 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.17 127.15 30.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.473 1.137 . . . . 0.0 109.976 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.9 t -157.67 134.07 6.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.64 -43.09 41.27 Favored 'Trans proline' 0 C--N 1.345 0.35 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -119.93 2.87 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.03 -44.19 96.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.051 0.929 . . . . 0.0 112.016 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -72.89 -12.14 60.85 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.28 -39.13 85.98 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.773 -1.205 . . . . 0.0 109.544 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.71 -45.91 76.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -39.83 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.763 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.6 -49.35 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 p -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.51 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.22 -25.98 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -69.24 -38.56 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.216 0.916 . . . . 0.0 109.595 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -65.7 -41.77 91.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -75.77 -8.14 56.13 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 53.71 39.02 29.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.565 1.146 . . . . 0.0 113.93 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.57 157.07 39.05 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.66 137.17 22.18 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 114.987 -2.875 . . . . 0.0 113.399 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -150.98 161.26 43.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -105.68 132.95 51.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -84.27 123.83 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -118.85 145.08 45.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.94 135.49 55.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.95 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -76.88 61.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 52.48 52.48 14.06 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.703 1.201 . . . . 0.0 113.717 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 64.95 1.16 Allowed Glycine 0 C--O 1.228 -0.225 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -87.31 -77.51 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -165.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.02 162.5 22.66 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.15 174.11 2.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 118.002 -0.865 . . . . 0.0 114.0 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 5.59 -55.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 1 N-CA-C 122.441 4.238 . . . . 0.0 122.441 171.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -50.57 -38.42 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.433 1.469 . . . . 0.0 112.312 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.82 -20.1 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.92 -25.73 23.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.779 . . . . 0.0 109.242 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -74.33 -31.66 62.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.384 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 mt -63.76 -52.87 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -118.64 129.36 25.43 Favored Pre-proline 0 N--CA 1.469 0.494 0 O-C-N 121.986 -0.446 . . . . 0.0 110.957 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.49 -22.74 44.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 N-CA-C 116.609 1.734 . . . . 0.0 116.609 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.76 0.15 35.36 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.418 0.554 . . . . 0.0 111.135 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.75 69.48 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.073 -1.017 . . . . 0.0 114.292 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -158.25 -29.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.7 m -69.89 152.77 95.89 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 118.77 0.713 . . . . 0.0 111.575 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.74 154.41 59.14 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 117.302 -1.332 . . . . 0.0 113.147 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.7 161.8 23.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.511 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.67 137.61 33.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -106.75 93.61 4.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 55.0 mt -97.19 108.68 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t0 49.01 46.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 123.493 1.616 . . . . 0.0 111.419 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 73.27 4.89 4.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.648 -2.523 . . . . 0.0 117.322 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -112.5 139.31 48.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -98.28 141.29 31.36 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 -168.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.8 t -123.87 123.71 67.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.5 -37.75 1.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -165.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.61 149.87 49.37 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.05 -1.032 . . . . 0.0 110.309 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.3 p -60.08 -34.23 73.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -170.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -88.85 -13.33 39.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.25 -19.57 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 108.854 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.4 mt -66.33 -26.77 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 165.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -84.43 -40.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 120.504 -1.372 . . . . 0.0 111.462 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.45 -64.02 0.83 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 118.883 2.313 . . . . 0.0 118.883 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.78 -34.39 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.328 1.064 . . . . 0.0 111.103 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.31 -46.32 79.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.948 -0.47 . . . . 0.0 110.691 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.23 -40.76 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.507 . . . . 0.0 110.369 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.69 -35.72 81.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -95.34 -12.31 26.3 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.29 127.81 93.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.38 -12.92 37.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.67 162.06 71.9 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.553 -1.342 . . . . 0.0 108.096 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.9 137.52 82.03 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 116.386 -1.943 . . . . 0.0 114.836 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.14 150.94 29.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 116.342 -1.972 . . . . 0.0 113.062 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.5 mt -132.83 66.61 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.944 0.878 . . . . 0.0 110.395 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.64 84.87 2.0 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.1 m -113.78 97.89 45.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -112.93 78.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.513 2.142 . . . . 0.0 114.913 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -91.16 -131.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.657 2.905 . . . . 0.0 113.319 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -54.34 -40.47 68.07 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.178 -0.951 . . . . 0.0 112.254 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.49 -26.46 68.73 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.453 -0.779 . . . . 0.0 111.447 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.68 -28.52 45.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.9 p -81.95 -27.89 33.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.974 0.806 . . . . 0.0 109.153 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.7 -43.79 82.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.83 -30.38 76.95 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 120.829 -1.17 . . . . 0.0 114.181 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.7 p -77.5 -7.06 55.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.378 1.089 . . . . 0.0 113.139 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -93.97 -36.32 12.22 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.783 0.72 . . . . 0.0 110.974 166.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.93 -48.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.619 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -54.57 -54.49 48.26 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.06 -24.88 19.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 113.436 -3.91 . . . . 0.0 113.784 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 t -65.8 -45.25 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -76.36 -29.62 57.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.793 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.9 m -75.57 -26.23 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 118.48 -1.288 . . . . 0.0 110.038 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.61 -43.63 80.0 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.78 -39.45 84.93 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.757 -0.589 . . . . 0.0 111.195 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.2 mt -62.97 -36.51 83.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -92.36 -24.48 18.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.1 t -68.64 142.46 55.09 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -127.02 40.71 3.67 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.924 1.345 . . . . 0.0 107.669 159.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -77.78 173.39 7.67 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -61.73 102.15 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 114.948 -2.901 . . . . 0.0 109.199 146.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -122.92 24.78 8.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.849 -159.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.53 -22.89 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.238 1.018 . . . . 0.0 110.69 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.14 -33.26 54.74 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 m -68.09 -28.02 66.99 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.027 -0.69 . . . . 0.0 111.535 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -65.46 -36.15 83.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.639 -1.288 . . . . 0.0 110.013 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.07 -33.39 61.67 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.8 -0.563 . . . . 0.0 110.677 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.69 88.47 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 110.558 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.25 -46.78 88.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.74 -42.95 99.63 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.721 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.81 -41.88 86.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -69.39 -35.77 76.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.707 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.51 -35.66 77.8 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.502 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.3 -29.68 70.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.691 0.678 . . . . 0.0 111.647 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.26 -51.57 65.65 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.327 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.26 -26.11 63.68 Favored 'General case' 0 C--O 1.221 -0.43 0 O-C-N 121.878 -0.514 . . . . 0.0 111.725 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.01 -39.87 93.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.683 0.393 . . . . 0.0 110.509 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.86 -54.72 26.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.52 -39.96 89.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.89 -45.36 78.27 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.76 -23.01 62.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.404 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.61 -49.39 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.674 -0.641 . . . . 0.0 111.139 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -82.64 -37.93 24.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -77.28 0.26 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-O 116.828 -2.095 . . . . 0.0 116.931 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -60.57 -131.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 1 C-N-CA 127.989 5.793 . . . . 0.0 120.728 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.43 171.68 7.06 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.937 -1.102 . . . . 0.0 111.293 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.72 -17.42 21.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.32 5.25 35.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.27 -24.77 17.46 Favored Glycine 0 C--O 1.227 -0.334 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.44 -54.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.307 1.553 . . . . 0.0 114.535 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -156.81 176.87 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.05 120.55 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.6 p -140.75 -168.57 2.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -40.44 -38.55 0.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 118.279 2.696 . . . . 0.0 118.279 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.88 -43.54 96.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.131 0.967 . . . . 0.0 108.705 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.91 -39.33 79.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.9 mt -61.54 -37.46 83.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.475 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.4 p -77.69 -43.55 30.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.5 tp -95.12 -46.72 6.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -167.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.8 92.92 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.55 -19.41 19.06 Favored 'Trans proline' 0 C--N 1.346 0.446 1 C-N-CA 113.006 -4.196 . . . . 0.0 113.753 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.81 -23.15 20.68 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.983 -1.073 . . . . 0.0 109.587 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.6 mt -63.28 -31.35 72.47 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 165.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.45 -51.08 71.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -63.57 -34.34 77.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.0 -56.0 27.9 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.395 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.94 -51.54 43.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.692 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.69 -42.07 64.64 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.388 -0.82 . . . . 0.0 111.564 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.54 -46.9 86.27 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.26 93.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.033 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.71 -47.18 14.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.629 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -93.76 -34.39 13.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -167.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -137.44 50.47 1.96 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.959 -0.463 . . . . 0.0 110.836 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -53.02 121.71 7.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -156.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -148.15 89.2 5.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.38 153.3 74.42 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 114.639 -3.107 . . . . 0.0 109.87 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.92 126.03 91.79 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.84 155.54 57.93 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 117.142 -1.438 . . . . 0.0 112.31 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.42 -10.03 52.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -67.73 -25.24 65.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.048 -0.408 . . . . 0.0 110.488 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.99 61.54 1.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -31.52 68.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.712 -1.586 . . . . 0.0 113.137 -171.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -43.04 99.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.102 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -38.06 33.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.18 -40.12 88.86 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.631 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.08 -45.7 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.496 -0.753 . . . . 0.0 111.932 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.94 -39.85 95.87 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.64 -32.34 57.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.68 -35.58 78.38 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.167 -0.958 . . . . 0.0 111.057 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.08 -21.05 60.84 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.943 -0.473 . . . . 0.0 111.568 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.13 -8.85 58.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.232 1.015 . . . . 0.0 110.434 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -103.53 23.73 12.18 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.23 -0.919 . . . . 0.0 110.154 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.7 p -124.84 164.43 20.04 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 49.05 150.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 121.225 3.787 . . . . 0.0 121.225 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -56.93 -34.86 68.39 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 120.555 -1.341 . . . . 0.0 114.381 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -18.95 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.09 -44.86 2.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.485 0.66 . . . . 0.0 110.856 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.53 -42.65 99.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.84 -30.91 24.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.201 1.0 . . . . 0.0 109.722 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.7 p -79.01 -12.54 60.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -40.63 119.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 113.078 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.12 138.92 50.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 165.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.43 138.58 58.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.806 0.276 . . . . 0.0 111.233 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.55 -43.78 89.43 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.56 -31.19 67.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.194 0.997 . . . . 0.0 111.141 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -102.68 0.97 33.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.2 -50.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 161.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.4 pt -69.41 -50.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 121.618 -0.676 . . . . 0.0 111.875 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.11 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.336 -0.852 . . . . 0.0 110.291 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.8 -16.17 58.58 Favored Glycine 0 CA--C 1.517 0.173 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -113.15 -54.22 2.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.58 -31.04 8.55 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.39 -29.34 45.79 Favored 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 111.733 -5.045 . . . . 0.0 114.475 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.69 -14.9 58.43 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.571 -0.706 . . . . 0.0 111.455 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.11 -42.03 19.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -64.39 -38.92 92.72 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.941 -0.474 . . . . 0.0 111.578 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 124.162 0.985 . . . . 0.0 109.863 -179.859 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 tpp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.17 155.9 36.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.71 173.24 16.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -124.88 156.32 38.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mt -130.65 113.96 26.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.7 127.3 39.33 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.03 163.06 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 119.655 1.116 . . . . 0.0 112.926 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.49 126.42 29.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.92 172.69 12.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.248 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.04 142.83 58.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.45 134.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.67 -21.61 17.74 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.3 100.8 1.73 Allowed Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.0 96.39 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 116.917 -1.589 . . . . 0.0 114.383 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -159.36 -39.97 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -104.45 158.22 5.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.12 160.09 16.08 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 110.295 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 -179.44 18.37 Favored Glycine 0 CA--C 1.507 -0.436 0 CA-C-N 116.458 -0.337 . . . . 0.0 112.992 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.87 92.89 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.335 1.065 . . . . 0.0 111.165 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.67 132.86 24.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 103.345 -2.835 . . . . 0.0 103.345 165.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.76 -38.03 32.8 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 116.693 -1.738 . . . . 0.0 111.992 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.26 -21.44 36.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.746 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.303 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -74.14 -26.65 60.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.882 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.81 -39.62 89.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.58 1.536 . . . . 0.0 111.151 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.63 -44.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.836 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.28 -38.21 85.96 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.397 -0.814 . . . . 0.0 110.541 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.92 -48.24 79.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 p -72.32 -31.47 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.727 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.4 -46.24 70.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.206 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -65.02 -33.11 75.26 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.793 -0.567 . . . . 0.0 110.579 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.06 -41.92 99.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.373 0.606 . . . . 0.0 112.343 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.82 -16.51 57.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.29 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 59.64 40.5 19.97 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.305 1.442 . . . . 0.0 112.931 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 pt -101.49 154.61 37.14 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.62 118.96 5.98 Favored 'Trans proline' 0 C--N 1.347 0.459 0 N-CA-C 117.375 2.029 . . . . 0.0 117.375 -171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -126.32 156.17 40.86 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.816 0.817 . . . . 0.0 113.072 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.24 110.43 20.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.007 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -84.2 125.51 32.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 118.754 0.706 . . . . 0.0 111.526 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -121.95 139.29 53.84 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.539 0.736 . . . . 0.0 112.194 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.0 120.03 39.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.733 -169.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.05 120.88 45.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -77.65 76.78 4.18 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.822 0.82 . . . . 0.0 112.215 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.1 mt 55.67 27.88 11.25 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 162.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.92 2.35 11.29 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 114.245 0.458 . . . . 0.0 114.245 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -78.21 109.41 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.754 -0.851 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -116.53 87.9 22.41 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.61 169.45 12.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 N-CA-C 109.916 -0.84 . . . . 0.0 109.916 169.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -54.86 -40.19 69.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.196 0.453 . . . . 0.0 111.303 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -62.15 -39.04 91.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.53 -22.25 35.07 Favored 'General case' 0 C--O 1.212 -0.888 0 O-C-N 120.604 -1.31 . . . . 0.0 112.777 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.9 tp -68.22 -40.16 82.15 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 120.009 -1.682 . . . . 0.0 111.216 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.05 -35.2 71.86 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.346 -0.846 . . . . 0.0 112.846 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mt -117.62 22.59 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 121.478 0.656 . . . . 0.0 111.485 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -147.45 119.86 4.72 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.047 -1.658 . . . . 0.0 108.483 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.34 -13.66 37.36 Favored 'Trans proline' 0 C--N 1.352 0.731 0 N-CA-C 118.689 2.534 . . . . 0.0 118.689 -173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -120.83 7.34 10.43 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.92 -0.488 . . . . 0.0 110.117 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.16 2.07 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-O 122.641 1.134 . . . . 0.0 113.143 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -134.07 99.31 4.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.57 146.18 16.17 Favored Pre-proline 0 C--N 1.318 -0.778 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 170.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.9 142.09 38.26 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 116.868 -1.621 . . . . 0.0 111.982 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.81 131.63 50.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.152 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.91 129.9 36.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.41 71.91 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.175 0.988 . . . . 0.0 108.658 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.2 mt -87.66 126.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 54.97 35.58 24.91 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.478 1.111 . . . . 0.0 112.984 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t0 61.62 25.07 15.05 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -115.46 150.59 36.24 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.08 135.98 53.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -172.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.65 123.17 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -174.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.33 8.76 1.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -165.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -99.41 147.67 25.01 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.025 -1.672 . . . . 0.0 109.946 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.2 p -58.72 -33.52 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -83.23 -13.22 55.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.045 1.402 . . . . 0.0 111.615 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.7 -32.23 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.842 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -66.96 -15.61 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 121.759 -0.588 . . . . 0.0 111.177 161.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.0 t -83.2 -46.24 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 120.333 -1.479 . . . . 0.0 110.418 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.74 2.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 121.164 3.225 . . . . 0.0 121.164 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.4 mt -80.95 -26.89 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.78 -1.424 . . . . 0.0 110.558 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.91 -48.3 75.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.71 -39.99 95.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.315 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.68 -34.48 77.2 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.846 -0.534 . . . . 0.0 111.64 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -97.0 -1.33 45.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -82.68 132.37 52.02 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.57 -9.92 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 115.517 -2.522 . . . . 0.0 114.833 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -74.24 158.1 85.86 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.62 124.58 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 116.138 -2.108 . . . . 0.0 115.658 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.37 144.29 28.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 120.641 0.894 . . . . 0.0 112.856 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -138.94 45.1 2.01 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.022 0.915 . . . . 0.0 109.367 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.06 90.44 2.49 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m -125.63 90.74 49.99 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.212 1.005 . . . . 0.0 110.282 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -100.63 63.56 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 1 C-N-CA 125.687 4.258 . . . . 0.0 119.351 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -87.05 -128.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 CA-C-N 119.918 1.006 . . . . 0.0 114.637 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.54 -38.52 74.87 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.921 1.691 . . . . 0.0 113.745 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -64.68 -25.13 67.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.117 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.92 -32.98 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.4 -0.813 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.8 p -75.0 -33.89 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.38 -45.44 82.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.07 83.97 Favored Glycine 0 C--O 1.229 -0.21 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.61 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.3 p -63.28 -17.0 62.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.0 -27.53 13.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.6 mt -79.36 -44.78 23.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -53.36 -48.79 91.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.35 -27.9 10.91 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 111.645 -5.103 . . . . 0.0 113.507 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -67.15 -44.62 79.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -70.85 -20.65 62.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.058 -1.057 . . . . 0.0 112.703 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.2 t -85.35 -41.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -59.27 -46.97 87.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.046 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.68 -24.21 53.18 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -27.27 61.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.268 0.94 . . . . 0.0 110.994 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.98 -3.45 58.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.348 0.659 . . . . 0.0 111.641 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.3 t -121.25 121.96 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -167.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.03 41.79 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.93 -177.54 0.33 Allowed Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.504 1.121 . . . . 0.0 108.848 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.27 61.03 0.5 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 156.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -86.29 80.01 8.87 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.153 -1.592 . . . . 0.0 107.4 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -118.78 -65.35 1.18 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.45 -44.27 96.98 Favored Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.335 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -77.7 -8.79 58.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.28 -32.62 55.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.954 -1.716 . . . . 0.0 106.432 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -79.28 -9.81 59.67 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 120.956 -1.09 . . . . 0.0 111.237 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.84 74.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 165.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.74 -42.51 90.9 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.829 -1.169 . . . . 0.0 109.956 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 tp -56.46 -44.28 80.38 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.59 -27.86 68.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -81.45 -34.21 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.111 -0.993 . . . . 0.0 110.581 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -73.15 -23.58 60.47 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.0 110.481 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -68.31 -29.75 68.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.857 -0.527 . . . . 0.0 110.308 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.66 85.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.63 -39.01 80.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.99 -41.11 91.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.57 0.748 . . . . 0.0 110.027 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.65 -41.76 56.2 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.013 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -62.21 -32.62 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.65 -55.08 11.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.086 0.946 . . . . 0.0 112.624 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -76.67 -10.4 59.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.73 -0.606 . . . . 0.0 112.423 -159.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -79.81 -8.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.67 -40.75 2.86 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.33 -66.53 0.25 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.65 -169.74 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 125.174 3.916 . . . . 0.0 115.689 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -57.82 165.45 1.74 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.086 0.955 . . . . 0.0 111.841 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 pt -65.81 -21.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -146.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.92 -13.29 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.31 -11.42 61.73 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.86 -45.21 0.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -164.17 -179.32 6.08 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.89 121.46 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.4 m -138.95 179.39 6.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -38.75 -38.76 0.44 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -69.13 -39.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 120.741 -1.224 . . . . 0.0 111.792 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.84 -39.5 72.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.26 -7.21 28.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.4 p -104.55 -45.36 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.212 -0.423 . . . . 0.0 112.017 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.48 -50.94 12.76 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.16 81.17 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.02 -18.75 52.01 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 113.605 -3.797 . . . . 0.0 117.317 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -94.74 -24.41 17.12 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.346 -1.471 . . . . 0.0 109.401 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.72 -25.93 67.52 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.396 -0.815 . . . . 0.0 111.902 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -49.0 59.02 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.186 0.903 . . . . 0.0 110.318 166.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -72.98 -21.14 60.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.59 -50.11 70.74 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 122.228 0.211 . . . . 0.0 111.177 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -72.04 -20.66 61.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.806 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.6 t -78.83 -57.35 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.48 -52.26 28.31 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.69 -42.2 91.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.663 0.744 . . . . 0.0 110.642 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.29 -32.35 82.43 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -90.88 -38.33 12.99 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.205 -1.173 . . . . 0.0 114.101 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -81.82 -46.44 14.15 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -145.4 70.49 1.26 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -165.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -53.71 117.77 3.41 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -143.53 89.06 7.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.65 161.94 40.84 Favored 'Trans proline' 0 C--O 1.235 0.34 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.19 127.23 92.42 Favored Pre-proline 0 C--O 1.245 0.852 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.47 154.89 45.49 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.695 -1.736 . . . . 0.0 112.092 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.8 -2.72 31.24 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.563 -0.711 . . . . 0.0 110.731 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -69.5 -21.49 63.67 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.69 -0.631 . . . . 0.0 111.586 166.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.51 65.21 0.71 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.4 m -57.39 -34.95 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.992 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -53.86 53.5 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.569 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.2 t -68.43 -34.86 68.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -168.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.97 -52.0 65.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.351 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.35 -41.55 96.7 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.278 -0.264 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -60.63 -52.01 66.98 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.39 -37.48 79.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 121.859 -0.526 . . . . 0.0 111.312 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.93 -41.78 99.59 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.445 0.64 . . . . 0.0 112.433 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.0 mt -71.52 -40.36 70.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.01 -20.0 63.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.124 0.488 . . . . 0.0 111.429 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.72 -27.91 69.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.419 -0.801 . . . . 0.0 112.373 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 t -136.99 69.93 1.41 Allowed 'General case' 0 C--O 1.243 0.758 0 O-C-N 121.43 -0.794 . . . . 0.0 112.771 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -125.9 138.79 53.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 162.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -59.43 -37.99 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.81 1.641 . . . . 0.0 113.188 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -37.31 78.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -85.16 -34.87 22.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.093 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -70.56 -42.34 71.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.33 -35.2 73.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.688 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.4 p -77.2 -19.29 56.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.896 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -51.96 122.77 8.96 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.248 0.619 . . . . 0.0 111.626 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.15 173.07 9.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.547 0.739 . . . . 0.0 110.308 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.71 126.96 31.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.9 -29.64 69.71 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.587 -0.695 . . . . 0.0 112.242 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.12 -35.68 79.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.145 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -85.77 -6.78 59.06 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.83 -54.3 7.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.0 mt -68.7 -61.39 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.932 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.32 -3.26 39.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.843 -0.536 . . . . 0.0 110.852 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.82 -13.3 61.11 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -99.17 -21.18 16.25 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.911 1.356 . . . . 0.0 111.803 166.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.4 -8.18 0.13 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.34 -17.43 30.77 Favored 'Trans proline' 0 C--N 1.362 1.268 1 C-N-CA 110.851 -5.633 . . . . 0.0 112.852 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -85.33 1.98 46.12 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.978 0.511 . . . . 0.0 111.699 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.18 -44.41 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.419 0.688 . . . . 0.0 111.793 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -71.43 -25.24 62.24 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.689 -0.632 . . . . 0.0 110.275 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.788 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.34 159.6 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.98 172.81 13.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.745 -171.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.88 159.65 40.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.5 mt -129.98 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.57 157.49 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -167.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.21 128.85 34.01 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.175 -0.953 . . . . 0.0 108.622 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.17 158.42 16.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 140.18 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.362 170.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.57 126.85 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.11 0.2 60.4 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 78.15 4.01 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.75 1.775 . . . . 0.0 114.917 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.82 90.79 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 N-CA-C 116.925 1.856 . . . . 0.0 116.925 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -157.25 -49.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.82 157.25 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 103.323 -2.843 . . . . 0.0 103.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.46 166.91 15.14 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.486 1.114 . . . . 0.0 111.739 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.11 -173.82 16.22 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -76.66 99.05 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 122.471 1.129 . . . . 0.0 110.833 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.17 136.07 17.82 Favored Pre-proline 0 C--N 1.319 -0.74 1 N-CA-C 100.134 -4.025 . . . . 0.0 100.134 162.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.29 -36.65 34.89 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 116.22 -2.053 . . . . 0.0 112.047 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -72.57 -26.0 61.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.112 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.54 -41.71 92.75 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.432 1.111 . . . . 0.0 109.863 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.98 -33.77 63.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.518 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.57 -45.99 84.52 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.148 1.34 . . . . 0.0 111.779 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.67 -35.34 65.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.479 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.55 -46.7 25.32 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.316 -0.865 . . . . 0.0 112.941 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -39.6 94.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -64.3 -43.59 94.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 112.084 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -27.14 28.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -75.45 -31.63 60.36 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 118.486 0.584 . . . . 0.0 111.041 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.52 -37.98 89.42 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.388 -1.445 . . . . 0.0 109.515 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.65 -20.4 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 51.56 40.13 26.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 112.346 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.18 135.38 73.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.64 140.95 89.35 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 115.733 -2.378 . . . . 0.0 114.215 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -148.53 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -114.53 124.51 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 167.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -90.82 149.6 21.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -135.28 133.33 38.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.38 110.79 21.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.16 109.2 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.27 78.23 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.709 0.766 . . . . 0.0 112.957 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt 55.27 54.39 8.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.7 160.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.88 15.22 58.26 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.207 -0.906 . . . . 0.0 114.39 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -74.41 114.91 13.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.342 1.071 . . . . 0.0 108.482 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 89.04 11.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -67.45 176.3 5.04 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 115.989 -2.208 . . . . 0.0 109.164 166.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -54.95 -31.45 60.51 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.553 -0.717 . . . . 0.0 112.56 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -56.98 -51.45 69.16 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.964 0.802 . . . . 0.0 112.608 172.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.25 -24.38 61.36 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 120.285 -1.509 . . . . 0.0 111.513 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.24 -35.24 77.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.603 -0.686 . . . . 0.0 112.093 170.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -67.4 -42.74 82.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.458 -0.776 . . . . 0.0 110.134 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.12 -51.79 16.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -104.63 126.41 31.39 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -65.11 -31.91 53.75 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -90.39 -4.41 57.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 120.63 -1.294 . . . . 0.0 110.244 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.93 -34.78 2.34 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-O 121.418 0.454 . . . . 0.0 112.478 -166.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -112.03 0.87 16.13 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 118.993 2.96 . . . . 0.0 118.993 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.0 147.05 72.92 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 120.145 1.338 . . . . 0.0 108.145 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.54 151.15 58.56 Favored 'Trans proline' 0 C--N 1.345 0.394 0 O-C-N 122.721 0.853 . . . . 0.0 111.495 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.87 162.6 20.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.769 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.65 128.44 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -85.49 96.33 9.57 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.73 97.76 7.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 121.014 1.734 . . . . 0.0 106.816 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.36 46.39 25.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.108 0.563 . . . . 0.0 112.507 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 71.86 4.6 5.09 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.67 2.388 . . . . 0.0 115.842 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.21 108.4 19.89 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -94.54 134.46 37.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.148 -166.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.21 134.3 65.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.0 -28.31 2.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -75.97 131.18 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.4 p -67.54 -23.12 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -95.67 -21.32 18.27 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.748 -0.595 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.08 -34.55 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.99 -24.85 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.16 -32.68 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 120.446 -1.408 . . . . 0.0 110.166 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.9 -54.81 0.42 Allowed Glycine 0 C--O 1.226 -0.386 0 N-CA-C 119.609 2.604 . . . . 0.0 119.609 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.82 -31.02 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.211 1.505 . . . . 0.0 110.885 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.88 -34.7 76.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.846 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -73.36 -38.63 65.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.884 -0.51 . . . . 0.0 111.446 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.63 -31.91 73.22 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.411 -0.805 . . . . 0.0 113.127 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 5.4 43.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -98.31 135.45 21.25 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.28 -8.87 24.64 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 116.485 -1.877 . . . . 0.0 116.67 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.05 160.15 76.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.365 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.86 137.14 65.9 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 114.86 -2.96 . . . . 0.0 114.191 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.57 88.59 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 115.967 1.487 . . . . 0.0 115.967 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.59 63.67 7.7 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 120.483 -1.386 . . . . 0.0 112.471 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.73 86.06 2.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 m -125.76 87.74 55.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.575 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -98.61 48.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 122.185 3.879 . . . . 0.0 122.185 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -80.35 -117.93 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.677 1.278 . . . . 0.0 112.289 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -53.42 -35.43 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.11 -37.56 87.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.78 0.8 . . . . 0.0 109.925 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.88 42.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.818 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -67.95 -32.29 72.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.76 -50.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.8 96.39 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.467 -0.873 . . . . 0.0 115.083 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.0 p -73.52 -8.33 55.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -80.01 -35.42 37.37 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.02 -1.05 . . . . 0.0 110.568 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.98 -37.32 9.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.633 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.65 -54.22 38.18 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.93 -24.39 13.01 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 113.423 -3.918 . . . . 0.0 113.036 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -71.73 -39.53 70.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -75.53 -26.15 57.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.787 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.71 -28.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 120.898 -1.126 . . . . 0.0 109.245 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.53 -42.77 99.74 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.768 -1.207 . . . . 0.0 109.444 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -65.21 -40.22 93.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.814 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.92 -39.1 90.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -76.16 -11.04 59.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -87.09 141.99 28.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -127.91 27.79 5.66 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -72.4 170.78 11.62 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.2 52.21 1.85 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-O 122.926 1.136 . . . . 0.0 114.378 167.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -83.67 38.55 0.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -140.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -67.25 -24.71 65.83 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.52 90.73 Favored Glycine 0 N--CA 1.454 -0.123 0 O-C-N 120.835 -1.165 . . . . 0.0 111.325 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 m -74.34 -30.57 62.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.862 -0.787 . . . . 0.0 110.16 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -66.45 -34.51 78.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.862 0.839 . . . . 0.0 111.02 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -76.31 -30.35 57.7 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.64 96.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.296 -0.878 . . . . 0.0 109.523 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.0 tp -63.73 -47.3 81.61 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.98 -43.58 98.6 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.481 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.46 -44.25 83.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.893 0.77 . . . . 0.0 112.11 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.98 -27.72 54.84 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.116 -0.99 . . . . 0.0 112.347 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.01 -22.95 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.634 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -71.7 -31.13 66.42 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.101 -0.999 . . . . 0.0 109.998 168.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.68 90.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 122.0 -0.437 . . . . 0.0 112.11 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.07 -36.81 80.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.632 0.73 . . . . 0.0 110.73 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.26 -52.63 38.87 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.514 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -56.76 -42.29 79.09 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.051 -0.676 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.54 -45.14 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.13 -27.08 62.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.146 1.339 . . . . 0.0 112.677 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.08 -33.84 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 122.808 0.443 . . . . 0.0 110.318 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.56 -35.12 8.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.76 -75.02 0.24 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-O 117.381 -1.788 . . . . 0.0 116.553 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -61.55 -159.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 126.428 4.752 . . . . 0.0 118.994 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.59 167.43 1.47 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.519 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -45.5 -32.74 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.57 -7.55 39.51 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.779 -1.2 . . . . 0.0 114.236 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.05 3.71 90.64 Favored Glycine 0 CA--C 1.511 -0.203 0 O-C-N 121.672 -0.643 . . . . 0.0 113.327 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -142.39 -61.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -158.28 176.01 13.01 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.2 mm -63.12 127.98 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.0 m -142.71 161.98 36.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -171.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.27 -22.97 45.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.61 -23.61 29.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.66 -40.96 22.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.1 mt -70.79 -12.22 61.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.217 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.9 p -96.13 -23.73 16.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.2 tp -100.41 -49.17 4.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.31 -40.7 70.18 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.59 -38.63 93.01 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 114.637 -3.109 . . . . 0.0 118.259 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -87.93 -22.05 24.57 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.366 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.62 -37.74 85.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.095 1.316 . . . . 0.0 111.579 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.6 -50.27 71.93 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.801 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -63.83 -33.37 75.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.446 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.3 tp -63.47 -52.47 61.22 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.728 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.08 -34.59 78.37 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.714 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.83 -54.05 21.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.997 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.22 -44.18 63.31 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.283 -0.885 . . . . 0.0 111.693 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.15 -37.4 75.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.64 -36.57 93.44 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -75.98 -51.64 11.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.206 -1.173 . . . . 0.0 113.028 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -80.54 -36.99 32.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -146.89 53.07 1.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -171.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -34.38 102.79 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -157.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -142.7 85.41 10.22 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 169.74 21.86 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 116.296 -2.002 . . . . 0.0 109.019 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.4 mm -73.25 124.19 90.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.47 163.6 31.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 116.06 -2.16 . . . . 0.0 113.634 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.85 -4.65 36.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.491 -0.756 . . . . 0.0 112.112 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.25 -21.2 66.5 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.09 -1.006 . . . . 0.0 110.123 165.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.53 57.04 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.7 m -57.37 -34.64 69.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.088 -0.383 . . . . 0.0 111.289 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -68.79 -40.66 79.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.88 -43.03 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.137 0.494 . . . . 0.0 110.256 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.93 -43.5 92.58 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.768 -0.583 . . . . 0.0 111.788 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -69.36 -34.33 74.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.609 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -59.07 -49.31 78.36 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.84 -36.64 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.272 -0.893 . . . . 0.0 111.809 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.28 -37.81 88.81 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.523 -1.361 . . . . 0.0 112.592 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.84 -43.98 97.35 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.0 mt -65.77 -41.9 91.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.881 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.35 -33.48 65.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.1 m -115.98 18.49 15.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -66.66 139.61 57.87 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.89 -43.68 81.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.995 0.816 . . . . 0.0 112.545 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 p -67.13 -41.23 86.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -42.75 49.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.661 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -52.83 -44.92 67.07 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.544 -0.723 . . . . 0.0 112.003 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.17 -43.11 99.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.471 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 50.8 p -96.5 -4.04 42.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -56.14 133.61 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.31 148.48 50.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.83 134.7 56.64 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.443 0.464 . . . . 0.0 109.829 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.53 -34.3 72.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.74 -32.45 70.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.139 0.971 . . . . 0.0 111.423 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -94.78 -21.36 18.78 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.415 -0.803 . . . . 0.0 111.941 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.33 -42.41 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.7 -74.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.35 63.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.67 -25.27 33.13 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.06 -0.59 . . . . 0.0 114.143 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 -22.16 12.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.912 0.856 . . . . 0.0 113.177 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.59 -17.37 0.37 Allowed Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.81 -21.18 44.86 Favored 'Trans proline' 0 C--N 1.36 1.132 1 C-N-CA 111.043 -5.504 . . . . 0.0 115.402 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -77.95 -24.06 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.55 -32.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -82.59 9.65 8.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.949 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.806 0 C-N-CA 126.569 1.948 . . . . 0.0 114.375 -178.349 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.34 -170.8 0.11 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.288 1.435 . . . . 0.0 113.472 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.04 161.96 37.45 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.75 146.82 44.47 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 121.922 -0.486 . . . . 0.0 110.518 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.8 mt -111.23 98.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.8 t -101.82 108.71 20.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.7 m -132.58 162.49 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.33 142.64 56.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.41 167.8 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.174 0.443 . . . . 0.0 110.741 176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.97 58.37 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.86 112.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.27 85.46 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 114.634 -1.166 . . . . 0.0 115.461 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.7 82.36 7.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.008 0.904 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.25 43.24 0.71 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 124.666 3.577 . . . . 0.0 115.938 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.78 -8.1 2.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.86 156.57 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.68 154.0 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.26 174.32 45.23 Favored Glycine 0 C--O 1.238 0.345 0 N-CA-C 120.787 3.075 . . . . 0.0 120.787 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.37 75.68 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.755 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.95 133.68 21.18 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.41 -40.56 56.65 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-O 123.092 1.205 . . . . 0.0 111.445 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -77.79 -17.84 57.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -60.8 -48.83 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 111.292 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.17 -12.48 60.9 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.273 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -59.18 -48.92 79.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.958 1.708 . . . . 0.0 109.029 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.74 -50.44 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.206 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.66 -41.84 91.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.053 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.95 -45.87 83.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.1 p -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.509 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 -32.49 33.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.246 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -68.66 -38.14 80.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 118.741 0.7 . . . . 0.0 112.454 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.15 -28.78 69.05 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 120.916 -1.115 . . . . 0.0 111.134 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -91.58 -12.91 32.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 53.17 33.8 16.04 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -81.61 151.97 69.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.87 143.11 44.62 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 115.419 -2.587 . . . . 0.0 112.874 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -150.97 162.5 40.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -124.53 112.35 16.75 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.1 t -80.52 133.06 35.76 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -114.68 130.7 56.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.69 121.04 44.33 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.67 104.18 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.37 90.09 0.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.189 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt 49.25 49.99 18.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.724 1.209 . . . . 0.0 113.784 174.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.33 43.47 38.21 Favored Glycine 0 C--O 1.229 -0.217 0 C-N-CA 119.845 -1.169 . . . . 0.0 112.966 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -75.81 84.25 2.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 161.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -115.47 95.69 43.83 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.383 0.673 . . . . 0.0 111.598 -160.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 169.98 18.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 N-CA-C 109.902 -0.845 . . . . 0.0 109.902 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -55.84 -32.65 63.78 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 0.506 . . . . 0.0 111.768 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -55.07 -52.54 62.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.46 -24.44 59.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 120.882 -1.136 . . . . 0.0 111.478 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.29 -32.17 73.42 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.239 0.543 . . . . 0.0 111.405 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -74.43 -39.23 62.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.663 0.744 . . . . 0.0 111.468 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.41 -37.01 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 t -121.54 143.0 36.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.91 -37.35 86.3 Favored 'Trans proline' 0 C--N 1.355 0.917 0 N-CA-C 116.207 1.579 . . . . 0.0 116.207 170.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -93.96 -21.13 19.39 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.109 -0.994 . . . . 0.0 111.941 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 4.63 90.37 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-O 122.189 0.883 . . . . 0.0 111.513 -167.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -160.68 75.19 0.54 Allowed 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.859 1.264 . . . . 0.0 109.808 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.5 160.52 63.99 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 135.48 32.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 113.473 -3.884 . . . . 0.0 112.382 165.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.35 141.69 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.58 126.34 54.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -92.7 91.06 7.34 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.61 85.09 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.5 t0 53.62 60.07 3.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.294 1.045 . . . . 0.0 112.041 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 67.49 3.69 3.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.751 1.62 . . . . 0.0 115.265 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -103.34 99.77 9.62 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.159 -0.963 . . . . 0.0 109.034 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -80.57 134.71 35.96 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.475 0.71 . . . . 0.0 111.776 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.12 126.15 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.736 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.76 80.91 1.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -148.54 145.33 27.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 162.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -58.37 -34.26 70.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -81.24 -18.17 46.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.57 -20.33 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.14 -9.91 12.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.45 -60.45 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 162.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.89 -36.35 90.94 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.6 mt -86.17 -27.7 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 120.869 -1.371 . . . . 0.0 107.94 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.41 -39.28 94.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.89 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.72 -37.61 87.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.974 0.806 . . . . 0.0 110.788 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.06 -28.42 68.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.771 1.272 . . . . 0.0 112.006 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -102.77 1.64 34.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.505 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -75.56 143.04 74.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.184 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 -16.78 12.87 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 115.59 1.342 . . . . 0.0 115.59 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -90.67 161.79 35.36 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 103.544 -2.762 . . . . 0.0 103.544 174.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.06 142.44 97.21 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 N-CA-C 119.135 2.706 . . . . 0.0 119.135 -163.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.48 106.76 2.32 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 121.585 1.523 . . . . 0.0 115.907 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.04 40.72 2.57 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 122.068 0.937 . . . . 0.0 112.745 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 79.77 5.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.308 -1.495 . . . . 0.0 112.34 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -118.93 94.54 48.25 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.08 82.18 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 124.33 3.353 . . . . 0.0 119.974 165.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.56 -146.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.392 1.395 . . . . 0.0 111.635 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -46.25 -40.32 11.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -62.79 -27.97 69.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.11 -29.04 61.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 76.8 p -76.19 -31.4 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.485 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.06 -40.63 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.546 -1.206 . . . . 0.0 114.131 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.1 p -66.98 -11.16 55.98 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -98.13 -34.01 10.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.2 pt -75.27 -30.85 23.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.042 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.73 -56.15 10.06 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -167.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.91 -20.62 16.9 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 114.618 -3.122 . . . . 0.0 113.661 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.9 t -64.29 -43.29 95.2 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.16 0.984 . . . . 0.0 111.647 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -37.83 84.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.042 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -38.58 81.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.207 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.2 -44.93 95.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.315 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.63 -27.69 61.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.8 -46.03 91.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.232 0.923 . . . . 0.0 112.166 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -72.5 -22.41 61.05 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.066 0.936 . . . . 0.0 112.234 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 t -86.3 143.06 28.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -127.9 32.99 4.85 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 123.44 1.59 . . . . 0.0 109.333 164.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.21 170.8 7.95 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.0 47.02 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.12 101.47 13.83 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.1 -45.01 1.14 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.257 0.623 . . . . 0.0 111.795 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.8 -21.03 79.03 Favored Glycine 0 C--O 1.236 0.248 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.5 p -93.72 -11.97 30.28 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 168.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -67.04 -34.97 78.85 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 119.528 -1.983 . . . . 0.0 105.799 162.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -79.34 3.28 18.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.332 -0.855 . . . . 0.0 113.167 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.45 -28.56 61.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.33 -37.47 85.75 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.959 -1.088 . . . . 0.0 109.925 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.5 tp -61.91 -36.14 80.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.459 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -78.52 -34.88 46.95 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -72.8 -39.26 66.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.711 -1.868 . . . . 0.0 110.266 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 110.444 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -64.06 -35.52 81.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.924 0.783 . . . . 0.0 109.372 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.43 81.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.73 -42.73 97.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.579 -0.701 . . . . 0.0 110.737 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.366 1.066 . . . . 0.0 112.455 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.91 -36.52 41.43 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.578 -0.701 . . . . 0.0 114.01 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.63 -28.13 66.63 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.65 -52.8 27.23 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.392 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.35 -19.44 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.05 -9.14 12.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -113.51 -53.4 2.7 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.69 -59.04 0.47 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -71.39 -164.77 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.959 3.106 . . . . 0.0 115.062 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -54.9 160.07 2.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.7 tp -61.53 -22.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -163.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.23 -11.46 60.91 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.295 -1.503 . . . . 0.0 114.076 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.82 -26.76 8.69 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.12 -44.27 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -161.88 -177.03 5.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.396 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.44 109.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.8 m -128.79 -174.37 3.23 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.14 -38.26 11.32 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.31 -46.75 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 118.868 0.758 . . . . 0.0 110.158 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.92 -39.76 75.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.462 0.649 . . . . 0.0 110.349 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.69 -24.39 66.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.686 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.5 m -82.03 -36.6 27.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 83.6 mt -97.87 -46.25 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.55 36.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.56 -33.96 43.95 Favored 'Trans proline' 0 C--N 1.353 0.8 1 C-N-CA 112.067 -4.822 . . . . 0.0 115.629 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -80.87 -28.32 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.41 -1.432 . . . . 0.0 109.358 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.8 mt -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.244 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.03 -49.92 75.75 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.053 0.842 . . . . 0.0 111.68 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -64.2 -31.77 73.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -54.03 16.53 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 121.598 -0.688 . . . . 0.0 109.713 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -30.8 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.02 -35.4 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.076 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.56 -43.54 15.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.46 -36.6 84.39 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.408 0.683 . . . . 0.0 109.624 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.72 -35.17 91.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.539 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -74.47 -51.19 15.54 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.778 -0.837 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -77.67 -47.4 19.31 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -149.42 74.94 1.26 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -168.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.69 115.97 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -161.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -131.83 97.12 19.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 148.5 46.44 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 115.644 -2.437 . . . . 0.0 113.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.32 120.75 72.65 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -71.23 167.44 26.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 N-CA-C 116.776 1.798 . . . . 0.0 116.776 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.98 -16.34 63.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.958 0.903 . . . . 0.0 111.169 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -72.64 -13.52 61.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.516 0.726 . . . . 0.0 111.963 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.53 52.06 1.0 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -25.8 68.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -54.41 43.55 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.73 -36.08 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.62 -49.25 78.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -69.23 -37.27 77.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.821 0.343 . . . . 0.0 111.772 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -62.17 -49.2 76.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.81 0.844 . . . . 0.0 110.136 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 80.4 mt -71.95 -29.55 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.268 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.47 -46.21 87.24 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.966 -1.084 . . . . 0.0 111.277 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.59 -35.28 78.68 Favored 'General case' 0 C--O 1.216 -0.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.543 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.97 -37.07 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.029 0.918 . . . . 0.0 110.417 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -67.32 -27.56 67.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.64 -0.663 . . . . 0.0 111.338 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 t -145.35 72.81 1.33 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.989 0.899 . . . . 0.0 112.712 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -127.15 139.84 52.68 Favored 'General case' 0 N--CA 1.468 0.452 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 168.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -60.57 -39.68 88.89 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.7 p -61.57 -33.45 73.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.883 0.849 . . . . 0.0 112.681 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.4 -36.12 20.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.255 0.55 . . . . 0.0 110.892 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -62.47 -38.94 91.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.47 -28.6 46.54 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.236 1.017 . . . . 0.0 112.567 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 p -95.4 -0.48 52.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -61.44 144.98 53.2 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.37 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.56 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 134.31 48.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.14 -42.39 89.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 111.747 -167.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -62.14 -22.92 66.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.72 -9.42 46.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.56 -0.712 . . . . 0.0 110.762 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.46 -43.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 168.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -60.58 -66.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.25 0.548 . . . . 0.0 109.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.99 60.64 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.932 -1.105 . . . . 0.0 111.643 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.71 -26.6 45.44 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.285 -0.959 . . . . 0.0 114.113 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -88.23 -38.89 14.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.461 1.124 . . . . 0.0 109.42 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.91 -18.05 0.43 Allowed Pre-proline 0 C--N 1.321 -0.636 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.355 0.87 1 C-N-CA 110.516 -5.856 . . . . 0.0 114.403 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -73.28 -31.37 64.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.2 t -84.05 -46.87 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.595 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -79.07 -30.17 43.79 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -171.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.619 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.1 163.51 27.5 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -155.81 170.0 23.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.55 0.614 . . . . 0.0 111.621 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -108.24 137.84 45.54 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.1 mt -110.27 117.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 m -110.71 129.66 55.77 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.77 159.99 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.16 130.02 41.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.94 0.496 . . . . 0.0 110.005 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.88 170.97 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 111.84 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 132.11 49.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.165 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.65 112.85 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.79 -28.8 6.04 Favored Glycine 0 C--O 1.242 0.652 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.417 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.24 93.39 2.7 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.278 1.031 . . . . 0.0 112.594 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.27 72.87 5.24 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 121.181 1.254 . . . . 0.0 114.873 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -142.98 13.44 1.86 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.384 -1.448 . . . . 0.0 111.77 166.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.69 152.93 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 1 N-CA-C 99.409 -4.293 . . . . 0.0 99.409 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.37 158.43 26.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.938 1.295 . . . . 0.0 112.404 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.1 175.78 15.85 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -79.11 90.92 4.86 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.555 1.169 . . . . 0.0 109.958 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 124.94 29.15 Favored Pre-proline 0 C--N 1.319 -0.739 1 N-CA-C 97.161 -5.125 . . . . 0.0 97.161 161.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -66.42 -30.04 44.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 115.63 -2.446 . . . . 0.0 116.121 -168.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.73 -24.72 53.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.779 -0.575 . . . . 0.0 111.445 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.56 -40.72 97.74 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 123.121 1.439 . . . . 0.0 110.217 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -72.47 -16.01 61.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.587 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.15 -34.97 75.83 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.283 -0.885 . . . . 0.0 110.442 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.19 -41.36 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 122.554 1.169 . . . . 0.0 107.957 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.46 -44.93 85.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.816 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.17 -43.53 91.42 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.485 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -67.43 -39.2 85.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.428 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.95 -38.19 69.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.31 -26.58 62.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.111 0.414 . . . . 0.0 110.892 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -39.0 73.53 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.217 -0.927 . . . . 0.0 112.706 169.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -79.93 -10.03 59.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.509 -0.744 . . . . 0.0 112.66 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 55.44 35.51 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.749 1.219 . . . . 0.0 111.946 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 pt -89.05 154.78 49.73 Favored Pre-proline 0 C--O 1.242 0.701 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.93 153.21 58.18 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 114.215 -3.39 . . . . 0.0 112.666 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.04 157.26 41.42 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.68 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.88 118.16 33.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 171.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.9 t -91.02 120.46 32.03 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -114.2 112.45 23.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.426 1.108 . . . . 0.0 110.913 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.1 mt -96.57 109.93 22.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.407 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -83.36 116.41 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -72.33 54.07 0.3 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.658 1.983 . . . . 0.0 114.821 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt 54.4 54.46 9.38 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.856 1.663 . . . . 0.0 109.183 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.29 70.41 1.22 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.5 116.36 28.95 Favored 'General case' 0 C--N 1.32 -0.686 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 163.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -123.78 60.08 19.1 Favored Pre-proline 0 C--O 1.248 0.983 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.87 174.68 11.93 Favored 'Trans proline' 0 C--O 1.239 0.555 1 C-N-CA 113.118 -4.121 . . . . 0.0 110.41 161.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -55.0 -36.46 65.46 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.774 0.43 . . . . 0.0 110.572 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -55.8 -52.58 63.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -74.99 -27.2 60.06 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.213 -0.929 . . . . 0.0 111.817 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.03 -32.04 72.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.594 1.088 . . . . 0.0 111.624 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.91 -39.42 83.57 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.734 -0.604 . . . . 0.0 109.864 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.95 -37.23 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.85 0.86 . . . . 0.0 112.408 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -128.46 128.15 23.61 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.3 -14.3 31.21 Favored 'Trans proline' 0 C--O 1.242 0.714 0 N-CA-C 118.148 2.326 . . . . 0.0 118.148 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -102.97 -7.65 21.28 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.088 0.858 . . . . 0.0 110.767 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.8 8.23 72.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -159.86 55.64 0.37 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.382 1.073 . . . . 0.0 111.851 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.45 155.66 81.17 Favored Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 120.736 -1.228 . . . . 0.0 109.635 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.19 148.14 30.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 114.387 -3.275 . . . . 0.0 113.83 168.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.17 166.0 30.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.96 123.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 154.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -114.4 95.02 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mt -101.23 122.92 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 50.64 43.58 27.67 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.004 0.522 . . . . 0.0 111.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 68.39 12.87 8.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.13 2.641 . . . . 0.0 118.13 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -115.76 122.86 46.73 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.695 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -104.65 147.12 28.01 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -124.58 152.09 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.42 38.9 0.64 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 119.29 3.07 . . . . 0.0 119.29 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.19 153.72 31.34 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.882 1.673 . . . . 0.0 107.867 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -58.43 -32.65 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.54 -40.72 41.59 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.82 -0.55 . . . . 0.0 111.651 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -82.03 -20.31 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.2 pt -71.46 -3.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.854 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.55 -48.34 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 159.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.24 -36.31 91.57 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.0 mt -87.01 -30.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 120.227 2.013 . . . . 0.0 106.065 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.53 -49.42 74.81 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.656 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -60.5 -37.25 80.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.441 1.473 . . . . 0.0 112.255 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.5 -21.12 64.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -112.46 -6.34 14.0 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -76.79 135.55 67.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.55 -19.85 27.77 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 116.545 1.71 . . . . 0.0 116.545 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -75.7 160.89 78.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.029 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.44 129.19 33.84 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.78 130.32 3.67 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 N-CA-C 116.683 1.763 . . . . 0.0 116.683 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.92 48.5 2.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.72 1.208 . . . . 0.0 112.617 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.53 75.18 10.3 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.081 -1.637 . . . . 0.0 108.58 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -116.29 102.42 53.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.15 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -108.32 72.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.208 3.272 . . . . 0.0 118.21 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -82.36 -148.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 1 C-N-CA 125.681 4.254 . . . . 0.0 111.177 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.54 -29.95 28.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.71 -25.23 65.56 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 120.334 -1.479 . . . . 0.0 113.275 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.97 -34.04 59.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.8 p -72.29 -35.69 68.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -45.09 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.1 82.91 Favored Glycine 0 C--O 1.229 -0.162 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.793 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 p -70.18 -13.95 62.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -82.3 -40.6 21.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.481 -0.762 . . . . 0.0 109.671 170.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.36 -33.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -54.65 -51.87 74.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.98 -25.42 16.34 Favored 'Trans proline' 0 C--N 1.351 0.669 1 C-N-CA 112.615 -4.457 . . . . 0.0 114.042 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -69.0 -38.55 79.34 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . 0.262 0.4 OUTLIER -77.7 -27.23 50.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 118.511 -1.276 . . . . 0.0 113.703 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.74 -28.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.576 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -61.19 -44.77 96.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.492 -0.755 . . . . 0.0 110.944 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -65.7 -41.26 92.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.84 -38.91 83.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.993 -0.442 . . . . 0.0 111.615 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.4 27.35 1.47 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 t -121.13 122.0 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -113.75 26.5 10.3 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.34 168.2 30.0 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.06 94.28 0.73 Allowed 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 117.198 -1.402 . . . . 0.0 108.84 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.49 26.39 9.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 123.413 1.578 . . . . 0.0 110.993 -150.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.92 -28.49 69.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.957 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.24 -24.55 76.22 Favored Glycine 0 CA--C 1.519 0.326 0 O-C-N 121.165 -0.96 . . . . 0.0 114.156 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -91.35 -24.08 19.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.08 0.94 . . . . 0.0 111.098 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.21 -44.52 95.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 163.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -76.75 -12.73 60.03 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.752 -1.218 . . . . 0.0 114.252 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.56 -31.13 61.99 Favored 'General case' 0 C--O 1.217 -0.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.699 168.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.01 -42.36 99.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.77 -45.65 91.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.401 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -75.47 -36.78 60.6 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -76.82 -35.13 57.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.626 -1.296 . . . . 0.0 108.656 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.65 -19.03 58.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.346 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.58 -35.89 82.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.537 1.062 . . . . 0.0 110.412 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.3 mt -63.6 -37.96 89.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.937 -1.102 . . . . 0.0 113.564 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.14 -43.12 92.91 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.759 -0.588 . . . . 0.0 110.89 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.58 40.7 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.557 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -62.54 -38.06 88.53 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.432 -0.452 . . . . 0.0 111.61 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.7 -40.75 69.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.257 -0.902 . . . . 0.0 112.971 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.04 -16.65 64.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.977 1.262 . . . . 0.0 112.265 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.63 -53.84 37.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 O-C-N 121.437 -0.789 . . . . 0.0 109.363 165.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.45 -51.12 9.77 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.57 -72.23 0.29 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.554 -1.692 . . . . 0.0 115.48 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -69.35 176.86 5.91 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.012 2.475 . . . . 0.0 116.236 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -42.17 154.54 0.05 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.71 1.604 . . . . 0.0 114.411 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.65 -37.03 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.379 1.071 . . . . 0.0 112.672 -142.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.64 -22.22 65.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 117.465 2.395 . . . . 0.0 117.465 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.97 3.49 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 117.364 1.705 . . . . 0.0 117.364 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -129.6 -41.56 1.34 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.793 1.796 . . . . 0.0 114.015 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -159.87 -179.89 8.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.17 131.78 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.614 0.643 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.3 m -145.88 171.89 14.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -35.64 -39.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.51 -40.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.38 -38.92 74.79 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.04 -15.54 63.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 98.3 p -96.35 -34.41 11.58 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.63 -48.99 9.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.2 92.98 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -63.46 -36.2 56.14 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 112.85 -4.3 . . . . 0.0 116.762 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -78.76 -30.76 45.86 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.982 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.85 -29.33 70.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -63.47 -50.62 69.0 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 123.248 1.499 . . . . 0.0 109.11 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -77.1 -20.18 56.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.618 -170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 tp -64.14 -51.45 63.81 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.099 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.04 -34.0 77.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.381 1.446 . . . . 0.0 112.213 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.4 -52.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.78 41.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.546 -0.722 . . . . 0.0 111.549 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 tp -66.1 -42.69 88.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.704 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.83 -35.47 92.06 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.022 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -74.24 -47.35 35.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.746 -0.855 . . . . 0.0 111.528 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -87.0 -52.28 5.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -129.96 76.12 1.7 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.265 1.426 . . . . 0.0 108.089 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -56.14 121.36 9.24 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -168.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -151.0 92.76 3.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.7 163.59 36.89 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 114.994 -2.871 . . . . 0.0 109.963 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.57 118.99 65.55 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.24 166.22 26.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.714 -1.057 . . . . 0.0 111.996 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.68 3.0 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -68.12 -21.61 64.93 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.606 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -112.28 68.42 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.8 m -55.37 -38.17 68.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -55.17 -59.42 4.8 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.27 -34.51 70.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -166.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.5 tp -62.82 -44.34 96.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.28 -0.888 . . . . 0.0 113.323 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -78.78 -30.3 45.46 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.884 -1.135 . . . . 0.0 111.173 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.45 -49.2 77.78 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.666 0.787 . . . . 0.0 110.434 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.7 mm -69.88 -32.3 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.479 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.22 -38.54 91.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.047 -1.033 . . . . 0.0 112.738 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.56 -31.81 65.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 110.954 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.01 -11.43 59.55 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.637 -0.665 . . . . 0.0 111.952 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -92.73 27.38 2.37 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 122.716 1.246 . . . . 0.0 111.597 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.3 5.24 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 176.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 60.7 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.87 -32.67 67.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.924 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 m -50.8 -30.26 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -115.17 -42.68 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.494 1.14 . . . . 0.0 111.006 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.47 -31.47 62.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -94.19 -24.61 17.43 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.3 p -90.79 -21.94 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.3 126.58 27.91 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.291 0.567 . . . . 0.0 110.332 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.35 167.02 21.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.3 49.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -69.08 -37.4 78.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -162.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.45 -40.51 91.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.263 1.03 . . . . 0.0 109.748 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -78.09 -13.55 59.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.11 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.17 -50.32 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.09 -55.08 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.044 0.926 . . . . 0.0 111.494 -172.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.75 -3.09 36.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.404 1.081 . . . . 0.0 111.18 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.33 -29.9 26.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.34 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -102.96 -39.95 6.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.606 . . . . 0.0 113.22 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -59.72 -29.67 6.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.12 -18.71 30.54 Favored 'Trans proline' 0 C--N 1.357 0.989 1 C-N-CA 111.81 -4.994 . . . . 0.0 114.238 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -81.35 -16.87 51.04 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.0 -38.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.453 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -82.05 -44.13 17.0 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.84 0 CA-C-O 113.261 -3.257 . . . . 0.0 113.949 -171.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.13 159.93 39.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 165.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.23 -179.42 3.67 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.33 138.33 44.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 168.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.43 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -125.82 111.3 14.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.28 155.96 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.67 125.64 24.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.64 164.24 23.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.59 127.09 30.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.351 0.596 . . . . 0.0 110.802 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.39 94.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.994 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.12 -19.45 7.28 Favored Glycine 0 C--O 1.235 0.163 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.795 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.1 69.56 23.05 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.47 74.14 5.26 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 N-CA-C 116.664 1.756 . . . . 0.0 116.664 -169.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -146.22 10.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.212 1.006 . . . . 0.0 109.442 167.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -135.03 155.78 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.33 143.48 57.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.707 0.685 . . . . 0.0 109.952 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 167.67 12.44 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 118.702 2.241 . . . . 0.0 118.702 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -65.39 103.97 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.929 -1.636 . . . . 0.0 113.781 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.2 t -166.36 141.37 3.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -62.98 -40.65 33.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 116.706 -1.729 . . . . 0.0 112.674 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.54 -27.14 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.743 -1.571 . . . . 0.0 111.471 -171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.88 -62.42 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.653 0.74 . . . . 0.0 109.644 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -70.4 -27.49 64.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.029 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -57.33 -46.16 83.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.598 1.09 . . . . 0.0 111.693 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -76.99 -35.92 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.222 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.36 -44.46 87.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.09 -39.17 93.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.466 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -39.54 93.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.685 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -33.5 54.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.958 -172.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -77.52 -33.58 54.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -67.05 -39.24 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.694 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.42 -6.46 58.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.716 -0.615 . . . . 0.0 112.402 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.26 41.63 31.9 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 113.213 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -97.6 146.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.33 152.63 34.94 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 114.738 -3.041 . . . . 0.0 113.829 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -150.58 156.6 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.937 0.875 . . . . 0.0 112.582 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.5 t -139.57 124.65 18.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.938 1.245 . . . . 0.0 112.95 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -114.18 124.85 53.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.85 108.04 20.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -83.77 95.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -67.64 97.31 0.6 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.92 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.9 mt 31.91 48.81 0.11 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.24 47.09 3.65 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.811 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -68.91 101.79 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 160.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -137.43 75.51 45.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -165.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -66.24 171.44 10.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 116.798 -1.668 . . . . 0.0 109.885 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -56.08 -36.61 68.31 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.691 -0.631 . . . . 0.0 112.313 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.95 -42.37 79.97 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -79.96 -31.44 39.94 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.086 -1.009 . . . . 0.0 111.418 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 mt -67.1 -24.67 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.296 -0.252 . . . . 0.0 111.67 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -66.75 -37.49 84.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.163 0.506 . . . . 0.0 110.962 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -88.91 -52.08 11.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-O 121.193 0.521 . . . . 0.0 111.806 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -87.35 117.06 68.07 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 120.886 -1.134 . . . . 0.0 111.302 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.33 -23.87 65.21 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 118.505 2.463 . . . . 0.0 118.505 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.4 -10.8 18.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.883 -1.136 . . . . 0.0 112.538 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -0.39 37.9 Favored Glycine 0 C--O 1.224 -0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 113.414 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -146.25 34.82 0.98 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.87 0.843 . . . . 0.0 110.708 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.8 141.2 37.48 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.68 147.85 90.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 116.131 -2.113 . . . . 0.0 113.063 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.93 162.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 132.78 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -105.81 136.53 45.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.88 91.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.1 t0 50.55 52.96 13.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.124 0.964 . . . . 0.0 111.391 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 t70 62.15 24.27 14.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -110.91 163.94 13.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -146.76 159.64 43.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.848 2.113 . . . . 0.0 115.447 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.42 162.27 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.66 -116.13 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.6 173.37 1.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 p -58.3 -30.05 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -158.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -77.92 -26.17 48.82 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.851 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -83.3 -34.85 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.87 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.306 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.81 -45.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.875 0.761 . . . . 0.0 111.646 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.43 -33.92 51.72 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -118.39 -51.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.5 -40.36 85.2 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.998 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.02 -38.36 85.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.238 0.926 . . . . 0.0 109.367 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.21 -31.82 71.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.01 1.26 49.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.54 135.87 83.73 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 -21.68 72.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 116.607 -1.795 . . . . 0.0 116.589 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -93.37 161.02 32.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.19 144.44 90.52 Favored 'Trans proline' 0 C--N 1.354 0.847 0 N-CA-C 116.705 1.771 . . . . 0.0 116.705 -156.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -84.95 29.16 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.029 1.819 . . . . 0.0 115.317 -163.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.33 111.58 3.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.81 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.15 26.55 2.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.244 1.021 . . . . 0.0 110.461 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.67 123.68 58.92 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -170.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -114.74 62.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.605 0 N-CA-C 116.452 1.674 . . . . 0.0 116.452 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -83.38 -132.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 121.192 1.261 . . . . 0.0 113.845 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.91 -32.98 70.03 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.442 -1.411 . . . . 0.0 110.638 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -62.55 -31.81 72.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.321 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.6 20.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.166 -0.334 . . . . 0.0 110.746 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.4 p -68.3 -39.26 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.537 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.76 -46.5 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.598 -0.689 . . . . 0.0 109.431 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.28 74.55 Favored Glycine 0 CA--C 1.516 0.097 0 N-CA-C 115.549 0.98 . . . . 0.0 115.549 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -66.77 -17.93 65.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -81.91 -33.65 30.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 110.757 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.97 -43.67 81.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -50.52 -59.79 6.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.59 -16.13 15.09 Favored 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 112.195 -4.737 . . . . 0.0 114.578 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -61.98 -37.4 84.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.531 1.06 . . . . 0.0 111.182 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -84.63 -24.9 28.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.985 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.72 -42.3 80.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -55.89 -47.69 76.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.514 0.725 . . . . 0.0 109.601 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.87 -41.51 97.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.58 -40.21 92.5 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -84.94 -8.31 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 t -87.91 144.07 26.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.17 39.45 2.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 123.144 1.449 . . . . 0.0 108.192 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.67 -179.36 0.51 Allowed Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 112.559 -2.11 . . . . 0.0 108.994 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -63.42 89.24 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 115.654 -2.431 . . . . 0.0 112.404 151.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -88.85 98.16 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.23 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.02 -49.08 0.46 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.025 -0.422 . . . . 0.0 110.681 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.2 -35.67 92.38 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -82.82 -36.71 25.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.44 1.114 . . . . 0.0 108.221 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.31 -31.85 73.2 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.161 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.09 73.54 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.692 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.11 -47.47 84.48 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.05 -47.8 83.08 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.88 -37.33 73.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -69.12 -44.12 73.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.24 -22.87 62.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.079 -1.013 . . . . 0.0 111.372 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.74 -33.56 75.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.473 0.579 . . . . 0.0 110.368 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.92 -46.11 79.47 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.511 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.2 mt -67.1 -38.58 85.93 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.552 -0.717 . . . . 0.0 111.239 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.002 0.521 . . . . 0.0 110.343 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.96 -51.81 50.24 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -60.94 -38.32 85.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.47 -51.39 67.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.382 0.611 . . . . 0.0 111.828 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.68 -16.1 61.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -165.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.02 -27.75 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.51 0.724 . . . . 0.0 110.778 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -106.42 -45.11 4.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 -59.71 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 119.013 2.365 . . . . 0.0 119.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -67.97 -154.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 122.019 2.909 . . . . 0.0 115.897 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -58.91 168.98 1.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.909 0.884 . . . . 0.0 112.939 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.77 -36.36 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -163.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.27 -3.58 4.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.95 -30.62 9.87 Favored Glycine 0 CA--C 1.51 -0.279 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -124.6 -43.96 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -159.17 172.22 18.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.68 118.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 m -139.84 -175.9 4.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -45.26 -41.06 8.16 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 118.736 2.865 . . . . 0.0 118.736 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.11 -39.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 119.391 0.996 . . . . 0.0 110.314 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -71.13 -35.69 71.83 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.26 -24.63 67.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.983 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.4 p -97.83 -41.68 7.93 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.13 -47.46 43.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.43 97.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.79 -25.32 20.38 Favored 'Trans proline' 0 C--N 1.347 0.493 1 C-N-CA 111.202 -5.398 . . . . 0.0 114.924 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -72.89 -31.82 64.94 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 119.916 -1.74 . . . . 0.0 109.22 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.79 -29.52 68.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -63.86 -47.65 79.89 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.886 -1.134 . . . . 0.0 110.589 168.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -62.24 -31.81 72.41 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.86 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.73 -59.15 3.82 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.279 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.02 -35.15 79.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.256 0.934 . . . . 0.0 111.743 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -57.21 -41.12 77.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.163 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.48 -35.08 14.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.66 -41.44 92.5 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.275 -0.891 . . . . 0.0 112.148 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.82 69.5 Favored Glycine 0 C--O 1.228 -0.239 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -73.27 -49.01 29.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -100.99 -29.11 12.37 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.697 2.481 . . . . 0.0 117.697 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -124.51 20.14 8.73 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.228 0.467 . . . . 0.0 110.831 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -13.25 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 -153.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -115.06 92.63 31.84 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.46 155.96 62.53 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 113.819 -3.654 . . . . 0.0 108.951 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.9 mt -65.92 125.77 90.57 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.79 153.62 58.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 117.418 -1.254 . . . . 0.0 111.317 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.69 0.98 11.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.82 -27.73 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 165.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.99 67.45 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -33.06 69.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.508 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -62.73 1.5 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.16 -35.23 67.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -160.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.45 -41.81 84.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.625 -0.672 . . . . 0.0 111.886 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -67.4 -37.04 82.5 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.469 -0.769 . . . . 0.0 110.46 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.2 -41.19 97.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.941 0.896 . . . . 0.0 112.88 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.38 -31.44 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.668 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.28 -41.5 98.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.408 -1.432 . . . . 0.0 111.159 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.36 -34.92 78.3 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.539 -0.726 . . . . 0.0 111.784 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.11 -49.78 76.28 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -70.14 -15.7 63.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.6 t -75.68 -49.32 18.71 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -85.03 144.34 28.34 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.65 -24.1 67.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.179 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.7 m -51.99 -36.58 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.82 -40.64 6.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.952 0.882 . . . . 0.0 109.2 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.29 -33.93 73.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.23 -33.56 32.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -93.77 -10.33 34.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -54.99 135.79 48.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.414 1.102 . . . . 0.0 111.778 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.08 150.92 47.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.408 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.32 121.79 13.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -40.26 93.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -169.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.47 -30.52 71.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 122.684 1.231 . . . . 0.0 108.979 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.75 9.37 39.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.627 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.66 -44.01 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.1 pt -66.04 -37.66 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.216 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.93 -3.54 45.38 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.19 -32.05 13.05 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -101.52 -55.96 2.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.87 -30.59 4.54 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 -172.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -27.88 47.05 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 111.539 -5.174 . . . . 0.0 114.381 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -69.29 -34.2 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.622 0.646 . . . . 0.0 110.661 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.87 -39.08 74.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -68.01 -44.3 76.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.448 1.099 . . . . 0.0 110.707 179.468 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.2 -161.99 0.06 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.723 1.209 . . . . 0.0 113.933 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.75 169.19 23.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -132.47 169.68 16.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -133.78 142.17 42.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -124.64 133.84 53.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.374 -2.824 . . . . 0.0 103.374 162.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.48 160.05 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.803 1.183 . . . . 0.0 109.586 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.69 133.98 51.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.928 0.331 . . . . 0.0 110.715 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.06 165.36 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.018 0.437 . . . . 0.0 110.028 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.25 127.99 33.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.31 129.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.61 -19.78 51.94 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-O 118.776 -1.013 . . . . 0.0 114.675 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.06 81.92 7.31 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 118.385 1.093 . . . . 0.0 113.327 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.06 71.0 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 N-CA-C 115.849 1.442 . . . . 0.0 115.849 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -142.58 -11.08 0.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.057 164.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -131.4 168.95 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.2 1.0 . . . . 0.0 109.231 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 mt -75.26 147.68 40.06 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.35 171.61 15.39 Favored Glycine 0 C--O 1.237 0.285 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.17 97.19 8.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.915 0.864 . . . . 0.0 109.252 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 132.31 20.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 166.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -67.77 -43.37 5.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 115.331 -2.646 . . . . 0.0 115.211 -168.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -26.1 64.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.848 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -64.34 -44.5 91.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.985 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.48 -41.97 88.16 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.5 -0.75 . . . . 0.0 110.491 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 tpt85 -58.62 -41.13 85.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.54 -41.78 80.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.253 0.933 . . . . 0.0 112.459 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.59 -39.42 84.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.389 0.614 . . . . 0.0 111.179 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.45 -41.84 99.03 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.39 95.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.751 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.7 -40.72 72.72 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.219 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -70.87 -36.97 73.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.507 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -68.91 -39.54 79.63 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.057 -1.027 . . . . 0.0 110.475 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -79.16 -4.52 50.85 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 56.1 34.87 24.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.821 1.248 . . . . 0.0 114.152 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.18 135.74 23.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.9 148.62 25.3 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 116.023 -2.184 . . . . 0.0 114.979 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -144.91 153.81 41.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.034 0.921 . . . . 0.0 112.418 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.34 117.16 32.35 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.9 123.18 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 123.995 0.809 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -111.12 94.22 4.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.33 135.65 52.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.764 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -85.25 110.82 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -78.73 53.4 1.34 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.852 1.261 . . . . 0.0 112.661 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 mt 51.05 38.97 22.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 112.843 177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.85 72.96 0.2 Allowed Glycine 0 CA--C 1.512 -0.141 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.75 -178.45 6.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 111.648 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.79 150.13 91.65 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 124.337 1.055 . . . . 0.0 113.395 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -20.03 -137.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.258 2 C-N-CA 128.975 6.45 . . . . 0.0 125.304 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -66.61 -26.9 67.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.963 -1.71 . . . . 0.0 113.975 -161.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -61.24 -44.27 97.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 110.553 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.27 -33.92 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.156 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.29 -29.35 67.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -70.15 -30.77 68.0 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.243 -0.911 . . . . 0.0 110.703 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.36 -58.94 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.041 0.448 . . . . 0.0 111.73 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 121.31 76.15 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 120.845 -1.159 . . . . 0.0 108.56 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.07 -21.79 31.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 N-CA-C 117.098 1.922 . . . . 0.0 117.098 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.1 -9.41 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.823 -1.173 . . . . 0.0 110.221 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -31.15 2.38 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.362 -162.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -118.59 31.37 6.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.81 155.1 60.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.2 171.0 17.73 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 117.247 -1.369 . . . . 0.0 113.262 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.61 159.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 163.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.25 130.45 48.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 146.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -105.32 90.81 3.54 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 mt -100.36 113.25 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 52.68 41.9 31.5 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.787 0.803 . . . . 0.0 111.596 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.29 37.76 20.18 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -136.72 148.36 47.26 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -133.95 140.72 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 119.554 3.168 . . . . 0.0 119.554 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.33 139.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.76 1.224 . . . . 0.0 108.337 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.19 15.91 0.47 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 155.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -63.57 139.14 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.734 -1.228 . . . . 0.0 108.169 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -154.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.97 -37.98 17.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.782 0.801 . . . . 0.0 109.641 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.94 -36.41 75.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.887 0.851 . . . . 0.0 111.115 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -25.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.997 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.87 -40.37 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.87 -59.08 1.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.77 . . . . 0.0 114.572 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -66.95 -39.5 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.423 -0.799 . . . . 0.0 112.806 -169.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -61.47 -44.31 97.33 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 120.109 1.322 . . . . 0.0 108.77 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -67.75 -35.07 78.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.218 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.23 -17.7 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.169 -0.957 . . . . 0.0 113.056 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -109.04 3.24 21.86 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.738 -0.601 . . . . 0.0 111.434 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -76.96 126.71 85.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.75 -8.99 22.14 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 116.62 -1.787 . . . . 0.0 114.199 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.1 162.99 17.99 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.8 138.51 85.84 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 N-CA-C 118.003 2.27 . . . . 0.0 118.003 -158.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.79 87.29 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.674 1.582 . . . . 0.0 115.709 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.31 53.4 0.96 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 123.103 1.43 . . . . 0.0 111.638 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.26 77.92 8.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.856 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.1 m -122.51 95.32 46.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 O-C-N 121.762 -0.586 . . . . 0.0 110.43 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.29 73.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 123.722 2.948 . . . . 0.0 116.458 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -84.41 -138.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 119.081 0.707 . . . . 0.0 113.221 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.95 -35.75 59.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -66.26 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.548 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.18 -32.19 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.2 p -71.94 -38.08 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.077 0.853 . . . . 0.0 109.129 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.07 -39.62 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.98 -33.05 67.68 Favored Glycine 0 C--O 1.224 -0.485 0 O-C-N 121.477 -0.764 . . . . 0.0 113.702 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.8 p -71.06 -11.81 61.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.432 1.116 . . . . 0.0 113.607 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -96.77 -26.42 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 109.516 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.25 -56.26 7.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.261 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -59.39 -55.14 49.11 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -165.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.03 -20.46 19.29 Favored 'Trans proline' 0 C--N 1.351 0.667 1 C-N-CA 113.006 -4.196 . . . . 0.0 112.716 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -69.46 -36.1 76.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.819 -0.551 . . . . 0.0 110.119 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.88 -35.97 77.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.085 -1.009 . . . . 0.0 112.018 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.0 -42.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -57.11 -49.12 76.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.304 0.642 . . . . 0.0 111.786 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -81.62 -11.16 59.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 tp -77.99 -36.95 48.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.557 0.694 . . . . 0.0 111.333 165.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -70.2 -25.45 63.42 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.304 -0.873 . . . . 0.0 111.453 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 t -88.93 149.12 23.47 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -132.05 40.58 3.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 123.105 1.431 . . . . 0.0 109.085 161.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.42 171.82 3.09 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.57 72.5 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 CA-C-O 123.158 1.233 . . . . 0.0 114.161 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -85.33 101.79 12.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.933 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.61 -52.58 0.35 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.66 -30.75 78.55 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.8 p -77.36 -24.22 50.69 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 118.452 1.126 . . . . 0.0 112.867 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -73.22 -35.91 66.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -67.42 -31.47 71.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.29 -35.85 80.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 120.506 -1.371 . . . . 0.0 111.093 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.82 -37.99 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.163 -0.335 . . . . 0.0 110.178 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.69 -41.1 89.94 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -67.88 -33.3 74.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.869 -1.144 . . . . 0.0 112.604 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -64.96 -40.65 95.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.58 -23.99 61.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.551 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.09 -26.48 66.74 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 118.626 0.648 . . . . 0.0 110.668 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.15 -46.64 70.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.35 -40.67 85.87 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 121.414 -0.803 . . . . 0.0 111.169 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.23 -39.63 87.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.33 -47.31 85.87 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-O 119.489 -0.617 . . . . 0.0 112.734 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -64.0 -41.56 97.45 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.029 0.914 . . . . 0.0 108.991 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -44.51 82.53 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.25 -0.906 . . . . 0.0 112.333 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.31 -12.62 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.0 m -96.57 -8.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.582 0.628 . . . . 0.0 112.254 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.72 -43.59 4.01 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.61 -76.19 0.24 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -69.37 -176.09 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 CA-C-N 120.909 2.354 . . . . 0.0 118.047 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -54.89 161.45 1.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.32 -30.04 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.972 -116.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.27 18.8 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.86 85.79 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -144.56 -48.6 0.26 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -172.95 175.02 3.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -166.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.3 mm -61.14 121.41 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -135.98 178.59 6.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.48 -27.37 24.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.0 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.422 0.629 . . . . 0.0 110.517 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.56 -39.8 94.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.96 -21.6 61.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.06 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.2 p -87.5 -36.56 17.57 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.674 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.18 -47.25 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.52 94.62 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.8 -29.33 12.65 Favored 'Trans proline' 0 C--N 1.352 0.73 1 C-N-CA 111.849 -4.967 . . . . 0.0 113.696 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.23 -25.87 42.56 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.135 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.07 -35.57 80.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.095 0.861 . . . . 0.0 111.494 167.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.86 -47.46 80.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -63.09 -35.09 79.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.35 -51.4 57.57 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.388 -0.82 . . . . 0.0 111.0 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -65.01 -30.88 71.89 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.751 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.17 -58.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 117.902 0.319 . . . . 0.0 110.489 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.74 67.22 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.134 -0.979 . . . . 0.0 113.127 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.03 -35.14 74.08 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.39 -37.5 94.56 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.907 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -66.07 -42.07 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.269 -0.548 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -100.74 -42.95 6.29 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 118.504 2.779 . . . . 0.0 118.504 -164.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -140.89 57.52 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -47.35 122.08 4.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -152.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -155.0 93.22 2.77 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.44 165.56 32.16 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 115.848 -2.301 . . . . 0.0 109.64 166.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.82 121.12 71.79 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.41 161.68 41.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 116.5 -1.867 . . . . 0.0 113.345 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -73.35 1.37 9.73 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.5 -21.65 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.667 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.43 78.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -40.35 82.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -54.52 39.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -66.0 -43.79 92.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.69 -47.03 85.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -75.35 -33.97 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.653 -0.654 . . . . 0.0 112.6 -174.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.36 -20.67 50.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.02 -42.03 94.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -63.45 -33.5 75.7 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.496 -1.378 . . . . 0.0 111.261 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.0 -42.87 75.89 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.932 -0.48 . . . . 0.0 111.511 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.16 -18.91 22.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.38 -35.72 70.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.7 t -128.11 68.2 1.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.597 165.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -103.84 140.39 37.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.083 -3.673 . . . . 0.0 101.083 154.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.05 -45.87 68.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.8 t -61.64 -45.48 93.89 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.303 1.049 . . . . 0.0 112.518 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.73 -41.07 68.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.764 -174.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.78 -40.11 82.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.782 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -78.44 -35.3 47.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 36.4 p -88.55 -15.97 33.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -65.36 150.12 48.83 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.614 -0.678 . . . . 0.0 112.604 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.84 160.19 30.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.19 143.55 50.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -56.84 -42.95 80.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -59.71 -40.45 88.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 0.0 110.964 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.05 -12.5 60.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.58 -48.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -68.11 -51.45 48.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.323 1.059 . . . . 0.0 108.578 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.5 -5.75 44.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.18 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.77 -29.54 15.59 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 119.517 -0.602 . . . . 0.0 114.313 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -106.82 -26.07 11.42 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -64.87 -18.8 0.47 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 119.522 3.156 . . . . 0.0 119.522 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 -14.48 44.45 Favored 'Trans proline' 0 C--N 1.358 1.034 1 C-N-CA 112.905 -4.263 . . . . 0.0 116.282 168.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -98.64 7.39 46.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 111.3 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 98.9 t -111.36 -40.38 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -76.83 -10.84 59.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.617 1.339 . . . . 0.0 114.617 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 178.535 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 145.73 49.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -147.21 167.96 22.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -114.65 141.55 47.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.848 1.204 . . . . 0.0 112.323 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.51 96.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 t -96.16 118.62 33.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.22 163.7 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -166.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -67.88 130.88 44.34 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.634 -0.666 . . . . 0.0 112.553 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.3 166.53 22.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.479 174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.88 139.72 56.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.65 126.83 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.885 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.04 -16.17 17.57 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.21 76.45 13.4 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -75.33 42.24 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 118.391 2.42 . . . . 0.0 118.391 -170.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -112.12 -12.56 13.65 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -125.84 159.33 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.63 135.44 57.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.839 1.255 . . . . 0.0 111.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.32 -163.7 36.99 Favored Glycine 0 CA--C 1.511 -0.198 0 N-CA-C 119.307 2.483 . . . . 0.0 119.307 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -76.35 76.38 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.157 1.383 . . . . 0.0 109.774 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -141.35 82.98 13.93 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 121.221 -0.925 . . . . 0.0 113.147 -171.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.27 -22.71 75.4 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 116.079 -2.147 . . . . 0.0 115.571 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -68.85 -38.43 79.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -69.55 -40.45 76.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.69 -35.32 79.3 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 118.381 -0.818 . . . . 0.0 112.275 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -57.59 -39.81 77.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.725 1.602 . . . . 0.0 110.767 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.42 -52.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.42 0.629 . . . . 0.0 110.293 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.09 -37.78 88.7 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.81 -41.78 97.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -66.89 -32.49 73.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.308 0.575 . . . . 0.0 111.29 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.43 -46.38 48.82 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.146 -0.346 . . . . 0.0 111.112 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -72.52 -34.37 67.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -36.31 83.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.021 -1.05 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -86.22 -7.08 58.81 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 59.55 29.33 18.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.487 1.515 . . . . 0.0 114.121 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -80.84 136.18 51.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.82 153.18 53.31 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.178 -1.415 . . . . 0.0 114.214 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -156.57 171.69 19.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.37 124.9 48.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 t -83.5 145.81 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -139.66 146.43 39.69 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 102.799 -3.037 . . . . 0.0 102.799 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.6 mt -114.73 132.34 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.73 119.89 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.32 72.79 7.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.55 1.167 . . . . 0.0 109.937 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 mt 57.22 27.16 13.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.6 33.64 Favored Glycine 0 C--O 1.226 -0.351 0 O-C-N 121.871 -0.518 . . . . 0.0 113.537 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -68.33 117.41 10.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 154.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -140.1 101.16 7.01 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.3 175.68 7.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.972 -0.885 . . . . 0.0 111.133 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -56.49 -36.48 69.17 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 122.146 -0.346 . . . . 0.0 111.017 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -56.6 -40.58 75.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -71.52 -31.81 67.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.142 -0.974 . . . . 0.0 108.959 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.29 -23.62 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.34 -35.29 79.1 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.303 -0.873 . . . . 0.0 110.241 172.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.05 -53.03 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -90.59 139.05 26.42 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 121.661 -0.649 . . . . 0.0 111.004 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.12 -22.91 46.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 116.974 -1.551 . . . . 0.0 115.858 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -108.11 -6.24 16.57 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 0.0 111.992 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.54 4.35 38.22 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.373 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.65 58.44 1.12 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.968 0.907 . . . . 0.0 110.819 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.82 159.17 69.83 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 100.343 -3.947 . . . . 0.0 100.343 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -69.16 147.98 67.95 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 114.081 -3.479 . . . . 0.0 111.47 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.1 155.54 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.164 0.507 . . . . 0.0 109.966 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -123.33 109.18 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.67 84.98 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.8 95.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.153 0.981 . . . . 0.0 108.361 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.3 t0 51.94 46.85 25.89 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.434 1.111 . . . . 0.0 111.779 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t0 58.99 30.55 20.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -114.85 165.85 12.4 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 166.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -150.58 149.79 30.37 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.06 157.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -115.52 -121.65 0.3 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.66 -176.91 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -166.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -54.41 -36.44 63.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.67 -20.43 53.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.943 0.878 . . . . 0.0 110.006 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.6 t -91.87 -43.89 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -42.04 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.71 -0.619 . . . . 0.0 111.14 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.32 -13.85 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.66 0.743 . . . . 0.0 112.299 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.04 -64.04 0.71 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.42 -47.39 45.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.631 -168.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.08 -40.45 94.67 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.606 1.548 . . . . 0.0 108.702 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -63.42 -42.66 98.72 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.704 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.95 -40.19 94.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -87.12 4.96 40.15 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.933 -0.48 . . . . 0.0 111.968 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.45 135.91 93.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.987 -0.445 . . . . 0.0 111.516 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.44 -6.07 16.05 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.891 1.073 . . . . 0.0 114.891 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -112.11 162.32 21.87 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.38 130.89 39.75 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 116.381 -1.946 . . . . 0.0 116.791 -161.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.8 146.02 32.99 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 116.763 -1.691 . . . . 0.0 111.914 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.26 45.74 2.73 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.24 80.26 7.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.3 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.2 p -114.31 106.02 53.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -98.51 59.16 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.357 2.705 . . . . 0.0 118.71 163.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.18 -146.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 120.112 1.076 . . . . 0.0 113.107 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -51.43 -32.27 26.0 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -68.6 -30.57 69.33 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.417 -0.802 . . . . 0.0 111.599 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.46 47.48 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.247 -0.283 . . . . 0.0 110.642 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.5 p -74.85 -30.52 61.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.731 -0.605 . . . . 0.0 112.531 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.1 t -75.12 -40.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.08 91.25 Favored Glycine 0 C--O 1.222 -0.605 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.252 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.3 p -71.47 -11.66 60.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -81.21 -32.39 33.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.628 1.204 . . . . 0.0 110.004 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.3 -43.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.179 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.66 -56.83 19.18 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.3 -13.21 13.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 113.973 -3.551 . . . . 0.0 113.464 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 t -69.55 -49.51 53.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.992 -0.443 . . . . 0.0 109.808 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -70.72 -26.99 63.63 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.608 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.33 -44.51 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.2 -44.82 87.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.74 -25.96 59.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.0 -37.33 55.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.092 0.86 . . . . 0.0 110.667 174.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -87.94 40.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t -152.02 144.81 24.34 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -131.16 34.41 4.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.34 168.63 7.51 Favored Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 163.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.61 44.3 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 N-CA-C 115.959 1.484 . . . . 0.0 115.959 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.71 116.69 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.765 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -150.88 -55.49 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.74 -40.6 97.54 Favored Glycine 0 C--O 1.217 -0.906 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.1 p -69.42 -27.55 65.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.86 1.33 . . . . 0.0 112.56 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -73.73 -29.35 62.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.778 1.275 . . . . 0.0 108.372 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -83.98 -24.55 30.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.715 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.46 86.27 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.755 -1.216 . . . . 0.0 108.632 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.985 -0.447 . . . . 0.0 111.455 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.59 -40.23 86.78 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -67.33 -34.46 77.38 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.975 -1.078 . . . . 0.0 113.496 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -65.58 -42.36 91.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.718 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.8 mt -65.9 -35.52 80.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.927 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -64.98 -28.96 69.87 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.607 0.363 . . . . 0.0 111.932 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 -44.74 93.33 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.821 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 -38.35 80.41 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.908 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.12 -42.92 95.79 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.653 1.115 . . . . 0.0 111.732 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -34.14 89.11 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.952 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -77.16 -43.49 33.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.655 -0.909 . . . . 0.0 110.363 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -41.35 74.08 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -70.58 -20.76 62.75 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.896 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.94 -47.03 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 167.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -73.96 -46.18 45.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.22 -73.95 0.22 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 116.784 -2.12 . . . . 0.0 117.407 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -61.46 -164.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 126.268 4.645 . . . . 0.0 118.932 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -58.3 172.98 0.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.776 0.83 . . . . 0.0 113.123 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.29 -39.26 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.302 0.641 . . . . 0.0 112.283 -160.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.08 4.88 1.87 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.17 -14.02 66.27 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -134.58 -49.42 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -166.17 179.01 5.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 120.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -129.87 -164.09 1.37 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 171.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.75 -38.55 15.73 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.84 -40.19 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 123.033 1.397 . . . . 0.0 111.303 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -73.28 -32.31 64.58 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 120.992 -1.067 . . . . 0.0 109.915 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.9 -33.18 71.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.803 -0.561 . . . . 0.0 110.361 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.0 p -80.08 -45.96 17.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -81.18 -42.87 20.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.68 -37.83 60.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.9 -22.48 23.28 Favored 'Trans proline' 0 C--N 1.35 0.628 1 C-N-CA 111.893 -4.938 . . . . 0.0 114.731 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -74.72 -31.8 61.96 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 108.796 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.65 -31.71 71.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.502 0.592 . . . . 0.0 112.217 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -62.65 -51.38 67.5 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.418 -0.801 . . . . 0.0 109.753 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -65.58 -28.64 69.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.531 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.61 -52.36 65.5 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.602 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.36 -38.34 84.65 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.902 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.63 -49.47 84.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.31 11.43 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 120.571 -1.331 . . . . 0.0 114.191 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.07 -37.56 87.94 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.274 -0.891 . . . . 0.0 110.016 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.18 79.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -86.68 -36.02 18.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.074 0.937 . . . . 0.0 110.846 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -91.68 -37.29 13.11 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 -173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -150.31 62.04 0.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -52.81 128.56 27.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.261 -159.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -138.61 97.98 9.03 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.96 151.22 82.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 114.164 -3.424 . . . . 0.0 110.791 167.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.8 mt -71.6 126.84 91.56 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.68 160.7 47.41 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 117.092 -1.472 . . . . 0.0 112.781 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -74.05 -1.57 20.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.09 -1.18 57.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.515 0.674 . . . . 0.0 109.71 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.6 mt -121.71 55.56 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.0 m -58.39 -33.43 69.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -59.87 4.06 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.39 -38.61 81.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.9 tp -63.32 -45.52 90.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.585 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -83.32 -24.34 32.17 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.008 -0.433 . . . . 0.0 110.208 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.22 -47.82 82.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.58 -48.34 87.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -61.82 -35.45 78.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.17 -45.61 66.37 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.791 -0.568 . . . . 0.0 111.171 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.3 -20.83 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.35 -22.75 54.56 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.051 0.54 . . . . 0.0 112.12 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 t -128.02 67.42 1.35 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.394 1.093 . . . . 0.0 109.635 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.12 142.37 47.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 155.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -59.94 -38.78 83.41 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.671 0.607 . . . . 0.0 111.203 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.7 p -57.5 -46.13 84.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.523 0.601 . . . . 0.0 111.521 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -49.57 55.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.866 0.365 . . . . 0.0 111.698 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.33 -47.13 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -71.94 -24.24 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 112.824 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 70.4 p -120.36 27.32 8.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.914 0.864 . . . . 0.0 111.328 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -63.19 157.4 22.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.351 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 160.97 30.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.41 109.68 5.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -60.4 -36.45 78.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.16 -36.16 76.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.977 0.894 . . . . 0.0 109.69 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -90.8 -8.0 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.879 -0.513 . . . . 0.0 111.086 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.33 -50.71 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 163.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . 0.265 19.7 pt -69.5 -50.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.734 -172.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.26 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.302 -0.874 . . . . 0.0 111.464 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.93 -31.95 13.84 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -95.61 -42.64 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -20.63 0.6 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 120.566 3.543 . . . . 0.0 120.566 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.54 -21.97 59.22 Favored 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 111.337 -5.308 . . . . 0.0 113.779 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -79.14 -33.08 44.47 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 122.041 -0.412 . . . . 0.0 111.285 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.46 -39.54 76.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -75.32 -13.8 60.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.754 176.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.28 167.26 17.96 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.931 0.892 . . . . 0.0 109.376 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -148.55 165.65 30.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -143.85 155.43 44.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.506 1.048 . . . . 0.0 109.487 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.98 106.07 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.33 1.062 . . . . 0.0 113.062 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.2 m -87.44 64.54 8.23 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.375 -0.828 . . . . 0.0 112.993 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 m -71.47 152.22 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.61 134.75 38.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.56 171.5 12.29 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.94 137.36 58.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.803 0.811 . . . . 0.0 112.502 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.16 118.4 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.95 82.97 Favored Glycine 0 C--O 1.246 0.864 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.54 100.01 4.43 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.81 80.11 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 CA-C-O 122.701 1.042 . . . . 0.0 113.926 169.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -148.51 -31.19 0.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.482 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.38 162.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.7 158.13 35.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.24 -178.78 15.46 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.76 105.84 10.34 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.8 m -128.68 153.03 79.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 149.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.18 -39.78 65.77 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.475 -1.884 . . . . 0.0 109.755 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -14.91 63.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.77 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.7 -58.02 3.46 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.69 -26.22 66.07 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.59 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -47.36 -45.95 25.32 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 120.996 1.725 . . . . 0.0 113.161 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.36 -34.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.05 -39.88 96.06 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.538 -1.351 . . . . 0.0 110.13 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.6 -33.55 72.85 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -74.71 -46.74 35.54 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.727 -0.608 . . . . 0.0 109.592 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -40.81 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.808 0.731 . . . . 0.0 111.054 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -69.03 -43.24 75.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.872 -1.142 . . . . 0.0 108.271 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.59 -12.18 60.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.066 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtmm 54.67 42.94 30.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.073 1.349 . . . . 0.0 111.874 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -95.09 157.95 35.66 Favored Pre-proline 0 C--O 1.242 0.682 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.795 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.5 119.74 6.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 117.05 -1.5 . . . . 0.0 113.909 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -136.45 154.59 50.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.566 0.698 . . . . 0.0 109.128 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.36 150.62 37.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 t -119.44 139.74 51.55 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 122.267 1.032 . . . . 0.0 113.234 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.06 97.71 5.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.385 1.474 . . . . 0.0 111.278 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.3 mt -70.67 127.96 34.45 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.563 0.697 . . . . 0.0 112.619 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.15 108.0 22.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -78.29 69.32 4.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.583 1.182 . . . . 0.0 110.45 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 58.4 41.58 22.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.791 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.69 85.02 1.4 Allowed Glycine 0 C--O 1.24 0.491 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -129.24 -76.75 0.55 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -155.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -71.7 152.08 93.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -58.22 -160.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 2 C-N-CA 127.266 5.31 . . . . 0.0 123.527 -170.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.27 -13.87 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -52.22 -47.17 65.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.822 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -81.6 -38.17 26.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 112.215 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.57 -27.37 67.68 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.4 -0.813 . . . . 0.0 112.027 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.75 -34.29 75.34 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.6 mt -97.41 -46.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.965 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -76.04 127.82 84.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.42 -31.75 13.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 115.672 -2.419 . . . . 0.0 116.506 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -86.9 -21.37 26.36 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.578 -1.326 . . . . 0.0 110.277 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.23 85.08 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.288 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -147.15 27.23 1.05 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.973 0.909 . . . . 0.0 111.837 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.24 143.68 27.09 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.333 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.38 159.19 53.52 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 117.353 -1.298 . . . . 0.0 113.542 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t 77.72 153.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 128.428 2.691 . . . . 0.0 109.714 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.6 33.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.769 1.628 . . . . 0.0 113.547 149.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -153.24 125.67 8.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.537 3.162 . . . . 0.0 119.537 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -147.1 134.65 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 109.506 166.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.55 39.3 24.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.031 0.933 . . . . 0.0 113.191 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.37 20.38 10.97 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.734 1.614 . . . . 0.0 114.031 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -125.33 165.79 17.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.733 1.613 . . . . 0.0 106.914 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -112.09 118.45 35.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.21 129.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 112.123 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.26 112.71 2.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.399 1.08 . . . . 0.0 111.94 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -164.11 151.46 12.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 162.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.3 p -54.56 -37.86 65.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.6 -33.09 28.08 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.015 0.912 . . . . 0.0 109.954 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -72.31 -40.7 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -73.03 -11.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -103.19 -5.46 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.627 0.649 . . . . 0.0 111.435 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.36 -66.91 0.13 Allowed Glycine 0 CA--C 1.519 0.32 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.9 -35.12 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.8 -1.412 . . . . 0.0 110.084 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.6 -38.26 86.92 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.738 -1.226 . . . . 0.0 111.726 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.77 -31.79 68.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.254 0.549 . . . . 0.0 110.528 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -65.41 -27.74 68.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.019 0.914 . . . . 0.0 111.471 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.24 6.41 40.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.867 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.44 144.04 91.23 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.05 -28.89 18.57 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 115.24 -2.706 . . . . 0.0 115.087 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.4 165.71 48.58 Favored Pre-proline 0 N--CA 1.473 0.681 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.11 142.88 76.48 Favored 'Trans proline' 0 C--N 1.354 0.868 0 N-CA-C 117.688 2.149 . . . . 0.0 117.688 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.9 90.91 0.88 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.003 1.136 . . . . 0.0 114.955 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -108.94 79.07 1.18 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.843 1.306 . . . . 0.0 111.758 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.26 73.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.841 -173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -115.63 116.15 41.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.001 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -98.35 74.67 0.07 OUTLIER 'Trans proline' 0 CA--C 1.558 1.723 1 C-N-CA 127.194 5.263 . . . . 0.0 119.032 164.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -85.13 -149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 121.304 1.336 . . . . 0.0 113.504 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.24 -38.6 12.57 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -66.22 -26.1 67.22 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.44 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.31 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.756 -0.59 . . . . 0.0 111.328 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.3 p -75.1 -34.39 61.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.91 -39.25 83.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -32.52 80.72 Favored Glycine 0 C--O 1.226 -0.387 0 O-C-N 121.435 -0.791 . . . . 0.0 114.202 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -70.43 -6.64 37.23 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -104.11 -35.07 8.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.502 0.667 . . . . 0.0 110.988 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.57 -51.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.432 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -56.04 -52.1 75.33 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -69.04 -26.4 31.01 Favored 'Trans proline' 0 C--N 1.35 0.606 1 C-N-CA 112.118 -4.788 . . . . 0.0 113.178 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -65.48 -42.57 92.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . 0.287 10.7 p90 -78.98 -18.12 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.441 -177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -79.33 -37.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.953 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.25 -40.45 90.35 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.773 -0.579 . . . . 0.0 111.607 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -64.71 -40.21 94.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.094 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.23 -35.75 82.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.142 0.496 . . . . 0.0 112.167 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.67 -0.31 26.21 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.3 t -107.0 127.82 53.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -166.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -116.64 34.37 5.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 123.272 1.51 . . . . 0.0 109.05 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.44 168.56 13.6 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 166.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.91 63.74 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-O 123.172 1.238 . . . . 0.0 113.516 159.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -80.38 69.52 6.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -167.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.92 -40.33 20.28 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.554 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 -38.84 91.81 Favored Glycine 0 C--O 1.228 -0.241 0 O-C-N 121.837 -0.539 . . . . 0.0 112.93 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 -28.48 64.01 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.288 -0.536 . . . . 0.0 110.41 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.22 -38.8 82.27 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.41 -1.431 . . . . 0.0 109.996 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -78.95 -12.48 60.03 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.114 -0.991 . . . . 0.0 113.113 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.31 76.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.9 mt -60.34 -44.27 95.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.513 0.673 . . . . 0.0 109.325 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.87 -51.64 68.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.04 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.26 -29.26 47.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -70.51 -40.49 73.49 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 mt -68.63 -24.43 64.55 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.122 -0.986 . . . . 0.0 112.354 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -61.6 -32.97 73.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.429 0.558 . . . . 0.0 112.261 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -43.07 89.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.93 -27.74 63.99 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.844 -0.535 . . . . 0.0 111.569 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.98 -48.91 72.31 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.696 -0.627 . . . . 0.0 111.838 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.12 -36.42 91.85 Favored Glycine 0 C--O 1.235 0.2 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.592 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -35.53 80.81 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 122.369 -0.489 . . . . 0.0 111.237 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -73.26 -10.21 59.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -162.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.9 m -82.03 -12.36 12.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -112.71 -49.09 2.96 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.28 -60.65 0.35 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -79.22 -177.82 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.771 2.314 . . . . 0.0 116.728 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -40.64 151.86 0.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 pt -74.45 3.24 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -141.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.05 -8.9 57.82 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.632 1.206 . . . . 0.0 109.258 162.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.88 6.22 65.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.622 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -143.26 -49.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -165.97 -174.69 3.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.479 1.112 . . . . 0.0 108.163 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.89 123.07 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.3 m -139.36 172.24 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.29 5.07 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.29 -37.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -78.45 -40.56 35.27 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.098 -1.001 . . . . 0.0 108.41 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.91 -16.26 61.02 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.831 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.8 m -77.3 -35.04 55.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.82 -38.68 6.01 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -47.96 -42.41 48.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -57.35 -37.66 96.94 Favored 'Trans proline' 0 C--N 1.354 0.864 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -99.32 -17.33 18.1 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.615 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.51 -32.69 72.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 118.506 0.594 . . . . 0.0 110.926 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.28 -52.87 63.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -68.99 -19.33 64.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.51 -47.49 72.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -36.28 80.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.276 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 -50.07 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.4 -51.67 34.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.39 -0.819 . . . . 0.0 110.34 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.82 -41.39 83.12 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.233 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.09 71.14 Favored Glycine 0 C--O 1.234 0.127 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.682 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -90.41 -40.53 12.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -96.53 -41.01 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -137.53 71.95 1.41 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.966 1.306 . . . . 0.0 108.847 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -67.84 86.32 0.23 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -154.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -121.65 99.14 45.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 110.931 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.78 168.26 23.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 118.374 -0.617 . . . . 0.0 112.676 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.54 122.02 86.01 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.6 161.88 43.94 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 116.716 -1.723 . . . . 0.0 111.319 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -69.18 -15.05 63.31 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.286 -0.884 . . . . 0.0 111.712 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.63 -25.17 68.1 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.364 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.25 61.87 0.6 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.78 1.276 . . . . 0.0 109.289 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -22.78 66.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -171.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -50.19 74.82 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -25.3 16.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.688 -168.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -61.28 -48.41 81.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.443 170.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.78 -40.45 88.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.004 0.907 . . . . 0.0 112.39 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -66.85 -49.27 66.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.053 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.4 mm -66.76 -33.89 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.52 -46.83 88.71 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.329 -0.857 . . . . 0.0 111.846 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.6 mt -66.96 -43.14 83.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.903 0.383 . . . . 0.0 111.14 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.54 -32.36 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.484 1.114 . . . . 0.0 111.849 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -62.7 -29.3 70.56 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.372 -0.83 . . . . 0.0 113.144 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -144.0 57.46 1.34 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -90.28 144.5 25.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 150.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.72 -39.65 85.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.908 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -59.02 -44.05 91.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.095 0.95 . . . . 0.0 111.297 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.24 -41.94 60.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.056 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.1 -39.83 93.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.237 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -74.32 -32.27 62.78 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.2 p -101.23 0.56 37.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 117.724 2.491 . . . . 0.0 117.724 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -58.02 150.29 21.21 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.59 167.45 20.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.742 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.77 127.19 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.99 -38.59 91.63 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 117.846 0.294 . . . . 0.0 111.081 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.29 -40.41 74.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 109.028 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -94.41 -1.78 53.07 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.5 t -77.66 -53.41 14.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 163.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.4 mt -67.74 -56.88 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.597 0.713 . . . . 0.0 110.344 -171.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.4 -4.85 44.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.02 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.03 -23.8 36.99 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.374 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -102.27 -35.99 8.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.69 -23.66 1.13 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.36 -18.76 22.87 Favored 'Trans proline' 0 C--N 1.356 0.96 1 C-N-CA 112.852 -4.299 . . . . 0.0 114.746 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.23 -9.44 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.877 -1.139 . . . . 0.0 110.765 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.08 -45.92 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.07 -23.23 33.22 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.392 0 CA-C-O 116.59 -1.671 . . . . 0.0 108.69 -172.024 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.036 0.446 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.6 160.78 41.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.1 168.59 25.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.645 0.657 . . . . 0.0 111.702 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -123.53 136.5 54.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.16 125.62 57.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 175.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.4 m -129.63 105.59 8.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.19 160.77 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -169.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 130.7 45.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.07 172.03 14.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.937 0.398 . . . . 0.0 111.271 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 137.94 58.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.72 141.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.354 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.32 -38.2 3.01 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.12 81.45 6.19 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 123.107 0.563 . . . . 0.0 110.49 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.49 89.47 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 N-CA-C 117.956 2.252 . . . . 0.0 117.956 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -144.74 -33.43 0.38 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -88.98 164.29 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.34 146.17 49.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.458 1.503 . . . . 0.0 111.253 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.33 173.04 22.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 122.579 3.792 . . . . 0.0 122.579 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -81.13 78.58 7.92 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 t -128.61 135.66 27.92 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.57 -42.59 52.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 119.074 0.705 . . . . 0.0 113.703 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -12.61 60.02 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.9 t -60.47 -45.47 93.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.541 0.686 . . . . 0.0 111.247 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.96 -7.45 59.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -63.18 -43.95 96.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -42.55 67.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.734 -1.576 . . . . 0.0 111.169 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.75 -43.71 79.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.131 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.06 -40.18 87.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.255 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.2 m -62.86 -34.42 77.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.348 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -46.7 32.61 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 112.526 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.8 -24.91 61.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.735 0.303 . . . . 0.0 111.401 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.65 -31.8 71.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.28 -0.887 . . . . 0.0 111.584 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -95.81 -16.15 22.05 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 50.1 46.13 24.9 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -76.55 137.15 67.33 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 163.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.91 148.42 70.46 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 115.834 -2.311 . . . . 0.0 113.425 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -141.95 151.63 42.74 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 122.775 1.274 . . . . 0.0 113.481 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -91.97 117.61 29.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.305 -1.77 . . . . 0.0 107.494 169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 t -99.16 121.2 40.7 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -114.96 140.0 49.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.46 126.62 53.69 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -90.4 104.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -73.06 71.64 1.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.763 0.825 . . . . 0.0 113.153 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.0 mt 56.08 52.84 9.83 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.88 1.272 . . . . 0.0 113.082 169.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.21 80.19 1.01 Allowed Glycine 0 CA--C 1.51 -0.229 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.695 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -116.01 -88.86 0.58 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -148.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -74.73 159.13 83.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 119.209 -0.425 . . . . 0.0 111.729 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -60.01 -165.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.199 2.599 . . . . 0.0 118.021 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -42.21 -37.57 1.51 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -50.11 -45.99 53.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.406 0.548 . . . . 0.0 111.439 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.34 -22.37 41.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.82 -23.31 60.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.393 0.616 . . . . 0.0 110.314 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.41 -41.04 49.1 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.854 -0.529 . . . . 0.0 110.853 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.25 -40.98 86.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -116.43 128.17 26.2 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.462 1.483 . . . . 0.0 111.758 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.34 -16.51 31.19 Favored 'Trans proline' 0 C--N 1.35 0.628 0 N-CA-C 117.003 1.886 . . . . 0.0 117.003 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -100.39 -4.88 28.15 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.842 0.746 . . . . 0.0 112.147 166.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.27 -28.2 3.84 Favored Glycine 0 CA--C 1.52 0.353 0 O-C-N 122.048 -0.407 . . . . 0.0 114.081 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 33.17 2.62 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.28 148.89 35.26 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 151.13 73.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 117.222 -1.385 . . . . 0.0 113.794 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.86 169.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.336 175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.8 t -124.25 138.04 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 153.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -104.68 96.37 6.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.14 129.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t0 60.26 34.18 20.92 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.78 1.276 . . . . 0.0 111.018 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.27 21.38 12.03 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.782 2.433 . . . . 0.0 114.299 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -127.56 127.88 44.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.681 0.792 . . . . 0.0 110.047 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -108.02 144.0 35.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.6 t -131.46 140.09 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.79 -0.43 2.34 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.06 139.73 30.23 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.08 -1.013 . . . . 0.0 111.143 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.5 p -75.03 -26.17 59.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 -152.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -80.65 -35.18 34.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -91.47 -10.48 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.777 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -76.53 2.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.468 -0.77 . . . . 0.0 110.389 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.1 -56.66 5.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 O-C-N 121.688 -0.633 . . . . 0.0 110.229 152.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.11 -42.79 99.43 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 120.111 2.804 . . . . 0.0 120.111 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.58 -37.4 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 118.937 1.368 . . . . 0.0 107.466 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -40.93 97.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.02 -42.2 98.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.745 0.702 . . . . 0.0 111.222 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -61.49 -34.09 74.9 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 111.462 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.03 16.4 19.69 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.09 116.95 52.74 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.49 -13.76 38.25 Favored 'Trans proline' 0 C--O 1.245 0.86 1 N-CA-C 123.16 4.254 . . . . 0.0 123.16 -167.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.43 155.37 74.09 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-N 121.357 1.89 . . . . 0.0 107.126 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.77 125.53 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 116.635 -1.777 . . . . 0.0 116.306 -168.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.19 152.84 18.53 Favored 'Trans proline' 0 C--O 1.243 0.768 0 N-CA-C 116.569 1.719 . . . . 0.0 116.569 -175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -130.76 56.87 1.76 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 69.96 8.85 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.458 -1.401 . . . . 0.0 114.251 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 m -122.31 98.43 44.11 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 123.499 0.72 . . . . 0.0 110.962 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.01 80.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.509 2.806 . . . . 0.0 116.188 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -82.76 -138.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.561 1.508 . . . . 0.0 113.487 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.65 -34.84 69.78 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 125.022 1.329 . . . . 0.0 111.931 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -65.17 -28.46 69.42 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.431 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.34 -19.25 30.08 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.912 -0.492 . . . . 0.0 110.94 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.7 p -71.56 -38.96 70.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.41 -41.67 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.12 -37.46 80.1 Favored Glycine 0 C--O 1.226 -0.406 0 CA-C-N 116.49 -0.323 . . . . 0.0 113.129 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.3 p -73.03 -9.89 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.24 -39.77 14.19 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.111 0.414 . . . . 0.0 111.633 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.6 -32.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -56.06 -51.96 76.51 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.48 -11.54 15.72 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 113.612 -3.792 . . . . 0.0 113.837 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -75.09 -44.05 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.233 -0.917 . . . . 0.0 110.97 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -20.86 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.199 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.37 -42.22 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.78 -44.34 90.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.29 -32.24 73.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.44 -41.99 92.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -97.91 -16.42 19.75 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -167.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -106.95 30.06 6.5 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.176 0.989 . . . . 0.0 111.254 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.55 165.59 18.32 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.458 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.68 70.95 4.91 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.387 1.391 . . . . 0.0 113.884 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.9 81.2 8.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -163.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -99.73 -37.71 8.99 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.04 -40.41 97.03 Favored Glycine 0 N--CA 1.453 -0.228 0 O-C-N 121.733 -0.604 . . . . 0.0 111.673 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.6 m -71.31 -32.58 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.027 0.414 . . . . 0.0 110.741 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.77 -41.38 97.98 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.918 -1.114 . . . . 0.0 109.713 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -76.18 -15.26 60.09 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.456 -0.777 . . . . 0.0 110.941 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.71 -41.83 71.41 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.41 -41.04 96.85 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.342 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 tp -58.19 -36.15 72.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -81.3 -38.07 27.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.62 -38.16 80.32 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.716 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.9 mt -74.04 -19.63 60.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.829 -1.169 . . . . 0.0 110.659 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -66.25 -32.28 73.6 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.95 -42.43 80.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -41.17 98.97 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.17 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.09 -38.67 83.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.526 0.603 . . . . 0.0 110.42 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -55.54 24.69 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -61.07 -40.45 93.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.877 -0.778 . . . . 0.0 110.555 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.716 -0.615 . . . . 0.0 111.45 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.3 -27.19 62.3 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.9 -49.85 65.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.68 -44.19 19.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.54 -69.29 0.24 Allowed Glycine 0 C--O 1.25 1.139 0 CA-C-O 116.797 -2.113 . . . . 0.0 116.06 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -72.43 -159.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 125.212 3.941 . . . . 0.0 114.499 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -54.33 163.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.82 -21.95 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -161.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.22 -19.32 63.04 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.791 -1.193 . . . . 0.0 113.255 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.41 -13.45 33.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.356 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -143.39 -47.44 0.3 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -162.54 179.62 7.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mm -71.36 114.43 9.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -129.91 -169.35 2.11 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.83 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.65 -49.96 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.335 1.064 . . . . 0.0 110.746 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.99 -36.93 67.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.819 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.97 -20.55 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.167 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.2 m -83.61 -48.62 10.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.19 -48.73 15.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.91 93.57 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.29 -36.07 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 1 C-N-CA 112.599 -4.467 . . . . 0.0 114.852 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -79.22 -26.94 42.46 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.526 -1.359 . . . . 0.0 110.483 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.32 -33.76 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.973 0.806 . . . . 0.0 111.333 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -66.15 -38.19 87.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.288 -1.507 . . . . 0.0 113.767 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -67.53 -35.95 80.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.1 tp -62.41 -51.89 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.636 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -65.95 -26.12 67.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -170.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.67 -50.44 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 118.499 0.591 . . . . 0.0 111.614 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.95 -43.07 75.78 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.681 -0.637 . . . . 0.0 111.139 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.86 -42.09 67.29 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.35 93.27 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 119.92 -1.134 . . . . 0.0 114.538 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.58 -49.61 14.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.349 1.075 . . . . 0.0 112.878 173.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -87.53 -37.24 17.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -136.71 62.47 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.152 -0.967 . . . . 0.0 110.509 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -53.55 110.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -161.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -146.5 94.48 4.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.36 168.14 25.5 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 114.9 -2.933 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.55 119.55 57.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.41 162.38 30.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 115.632 -2.445 . . . . 0.0 113.396 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.9 6.3 3.44 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.363 -0.836 . . . . 0.0 112.847 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -70.51 -22.83 62.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.423 0.63 . . . . 0.0 109.357 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.88 60.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.1 m -54.27 -38.0 65.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.015 -0.428 . . . . 0.0 111.779 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -71.85 -26.93 62.56 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 120.809 -1.182 . . . . 0.0 111.938 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.6 -34.09 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.413 1.006 . . . . 0.0 110.625 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.67 -44.37 93.96 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 120.831 -1.168 . . . . 0.0 109.641 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -70.0 -31.7 69.52 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.714 -0.616 . . . . 0.0 112.464 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 121.953 -0.467 . . . . 0.0 111.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -30.9 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 118.57 0.623 . . . . 0.0 111.121 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -68.41 -37.85 80.7 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.186 -0.946 . . . . 0.0 112.453 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.57 -34.2 73.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.45 -39.79 94.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.74 13.89 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.1 t -96.63 -52.7 3.83 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -94.03 157.05 16.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.185 -1.572 . . . . 0.0 112.594 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.38 -21.34 49.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -53.27 -30.89 40.92 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.719 0.771 . . . . 0.0 111.47 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -103.58 -44.32 5.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.697 0.761 . . . . 0.0 112.235 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -61.13 -29.69 69.93 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -85.8 -29.98 23.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 48.4 p -86.02 -18.01 33.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -60.79 140.31 57.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.691 0.758 . . . . 0.0 111.574 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.49 170.59 15.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.28 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.81 117.73 7.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.4 pm0 -60.82 -35.58 76.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -63.91 -40.03 95.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.573 -0.704 . . . . 0.0 109.216 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -78.88 -13.54 59.75 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.29 -50.37 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -45.89 47.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.782 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.6 -23.48 65.39 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.84 -16.53 57.99 Favored Glycine 0 C--O 1.24 0.469 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -89.01 -35.21 16.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 117.607 0.703 . . . . 0.0 111.614 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.95 -23.91 1.35 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 120.307 3.447 . . . . 0.0 120.307 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.73 -21.73 64.66 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 111.105 -5.463 . . . . 0.0 115.874 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.85 -9.44 59.6 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 120.787 -1.196 . . . . 0.0 112.917 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.07 -27.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -83.8 -32.64 25.24 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.38 -172.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.2 mtp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.16 146.58 47.31 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.502 0.592 . . . . 0.0 110.636 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.02 167.77 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.8 144.14 47.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.85 116.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.0 m -116.3 114.39 24.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.87 160.76 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.99 124.36 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 164.62 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.898 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 142.21 58.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.73 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 127.22 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.48 -25.1 29.57 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.401 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.53 99.43 2.27 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 117.742 0.771 . . . . 0.0 111.338 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.98 55.51 5.33 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 114.546 0.941 . . . . 0.0 114.546 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -120.12 1.31 10.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.591 -0.693 . . . . 0.0 112.292 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.5 tt -148.79 160.85 5.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.47 145.5 51.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.338 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.67 -176.69 44.24 Favored Glycine 0 C--O 1.237 0.307 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.39 64.92 2.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 111.549 -2.325 . . . . 0.0 108.205 170.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.9 t -132.1 101.84 14.84 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 112.38 -2.191 . . . . 0.0 107.812 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.42 -38.31 64.98 Favored 'Trans proline' 0 C--N 1.346 0.422 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -72.2 -32.56 66.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.2 m -63.29 -43.07 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.989 0.9 . . . . 0.0 111.887 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.38 -20.99 62.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.855 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -61.4 -33.52 73.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.675 -0.64 . . . . 0.0 110.212 174.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.47 -49.07 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.412 0.625 . . . . 0.0 111.131 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.45 -37.58 88.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.2 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.45 -41.79 90.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.6 p -73.29 -40.75 64.29 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -27.33 48.85 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.522 -0.736 . . . . 0.0 111.679 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -71.03 -35.24 71.91 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 118.8 0.727 . . . . 0.0 112.439 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -68.11 -35.66 78.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 119.112 0.869 . . . . 0.0 110.203 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -71.85 -20.77 61.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 56.09 37.12 28.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.596 1.159 . . . . 0.0 109.715 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -86.72 148.67 46.63 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.22 146.73 32.23 Favored 'Trans proline' 0 C--N 1.35 0.608 1 C-N-CA 113.225 -4.05 . . . . 0.0 113.733 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.89 161.23 41.5 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.73 113.83 27.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.27 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -83.91 124.31 30.86 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 122.697 0.399 . . . . 0.0 110.97 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -116.02 124.35 50.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.42 119.91 37.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.3 mt -88.09 107.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.01 80.48 2.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.08 0.943 . . . . 0.0 110.577 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.5 mt 56.09 53.15 9.41 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.535 167.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.75 35.5 10.12 Favored Glycine 0 C--O 1.236 0.274 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.171 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.87 113.59 10.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -146.55 84.68 7.6 Favored Pre-proline 0 C--O 1.254 1.296 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -161.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.92 166.96 20.97 Favored 'Trans proline' 0 C--O 1.235 0.356 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 158.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -57.83 -33.34 68.51 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.552 0.341 . . . . 0.0 111.227 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -54.66 -45.52 73.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.361 0.6 . . . . 0.0 112.468 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -77.79 -27.27 50.16 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -65.97 -34.77 78.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.007 0.432 . . . . 0.0 111.547 171.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -67.97 -43.87 77.98 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.101 -0.999 . . . . 0.0 110.273 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -70.1 -51.89 35.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -104.2 121.14 48.58 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-N 120.611 1.55 . . . . 0.0 114.743 -167.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.52 -24.61 30.58 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 118.932 2.628 . . . . 0.0 118.932 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -101.47 -5.37 25.34 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.3 1.409 . . . . 0.0 110.68 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.5 -47.5 3.85 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.255 -164.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -119.94 64.75 0.82 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.599 1.19 . . . . 0.0 113.604 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.52 155.86 73.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 165.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.92 154.3 58.23 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 113.564 -3.824 . . . . 0.0 111.476 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.16 142.57 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.93 125.61 67.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 165.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -98.85 89.09 4.2 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.2 101.46 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.61 47.54 22.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.748 0.819 . . . . 0.0 112.944 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t0 65.04 22.18 12.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 -173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -109.85 127.73 54.88 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.068 -1.02 . . . . 0.0 108.55 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -105.24 117.34 33.77 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.841 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.0 138.7 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.617 0.644 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.24 19.54 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 118.816 2.895 . . . . 0.0 118.816 -164.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.64 148.36 29.44 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.754 -1.216 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.1 p -63.78 -25.25 68.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -165.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -82.57 -35.06 27.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.304 -0.247 . . . . 0.0 111.539 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.63 -19.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.63 -0.669 . . . . 0.0 112.392 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 pt -77.37 4.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.11 0.481 . . . . 0.0 111.175 172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.94 -51.0 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.31 -55.19 7.09 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 120.249 2.86 . . . . 0.0 120.249 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.55 -29.57 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.35 1.575 . . . . 0.0 107.198 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -58.82 -43.84 90.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.76 -40.18 76.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.882 0.849 . . . . 0.0 110.664 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -63.03 -34.96 78.69 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.37 3.66 52.76 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -70.45 128.7 90.97 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.759 -0.588 . . . . 0.0 110.84 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.46 -4.99 15.69 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 N-CA-C 115.709 1.388 . . . . 0.0 115.709 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.12 155.7 37.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -59.72 122.02 10.79 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 116.603 -1.798 . . . . 0.0 116.497 -163.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.76 151.83 25.07 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 116.802 -1.665 . . . . 0.0 115.518 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.2 mt -136.87 49.9 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.942 1.697 . . . . 0.0 109.509 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.9 77.94 4.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 m -114.37 101.57 54.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -96.59 67.13 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.754 1 C-N-CA 126.045 4.497 . . . . 0.0 118.613 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.66 -113.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 116.914 -1.591 . . . . 0.0 114.134 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -63.91 -31.28 72.41 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 119.425 -2.047 . . . . 0.0 115.173 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.45 -11.77 60.57 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.358 -1.463 . . . . 0.0 111.825 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.36 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 119.762 -1.837 . . . . 0.0 110.132 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -48.25 45.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.54 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.137 0.494 . . . . 0.0 110.374 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.33 91.22 Favored Glycine 0 C--O 1.224 -0.506 0 O-C-N 120.944 -1.098 . . . . 0.0 111.764 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.1 p -70.59 -2.69 15.05 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -99.03 -36.52 9.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.722 0.772 . . . . 0.0 110.471 171.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.89 -50.16 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.685 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.78 -53.9 59.76 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.03 -17.42 31.85 Favored 'Trans proline' 0 C--N 1.349 0.579 1 C-N-CA 112.751 -4.366 . . . . 0.0 113.702 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -68.38 -56.12 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.815 0.734 . . . . 0.0 111.04 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -76.96 -25.23 52.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.428 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.27 -38.94 82.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -72.77 -44.36 61.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -68.95 -30.87 69.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.298 0.954 . . . . 0.0 112.696 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.9 tp -67.46 -38.41 84.42 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.207 -0.933 . . . . 0.0 110.762 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.9 -25.33 61.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.219 0.533 . . . . 0.0 111.98 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -90.65 109.93 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -93.59 67.87 3.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.26 176.7 1.73 Allowed Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.41 61.06 2.68 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 CA-C-N 120.195 1.105 . . . . 0.0 113.29 161.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.26 116.71 17.21 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -153.2 -57.04 0.12 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.38 -33.01 84.92 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 170.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -74.32 -30.58 62.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.047 1.424 . . . . 0.0 114.831 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.51 -32.07 70.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.251 -1.53 . . . . 0.0 107.316 174.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -77.95 -12.64 60.0 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.979 -1.075 . . . . 0.0 112.707 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.27 -34.67 31.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.224 -1.547 . . . . 0.0 107.673 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.1 tp -64.1 -35.66 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.79 -39.91 78.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.33 173.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -68.9 -35.03 76.37 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.997 0.817 . . . . 0.0 111.959 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.07 -38.56 88.62 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.416 -1.428 . . . . 0.0 110.757 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.05 -20.35 49.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.04 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.22 -36.6 82.03 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.267 0.94 . . . . 0.0 110.571 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.45 -39.18 93.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.18 -50.42 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.025 0.53 . . . . 0.0 111.873 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.98 -34.99 64.88 Favored Glycine 0 C--O 1.234 0.141 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.573 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -57.51 -42.5 82.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 122.026 0.917 . . . . 0.0 110.577 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -35.11 65.22 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -73.21 -18.48 61.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 m -89.7 4.3 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -121.44 -45.77 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.29 -70.96 0.23 Allowed Glycine 0 CA--C 1.531 1.076 0 N-CA-C 120.941 3.136 . . . . 0.0 120.941 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.22 -164.95 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.723 1 C-N-CA 127.896 5.731 . . . . 0.0 118.822 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.09 166.8 7.21 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 169.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.8 mt -78.53 -24.63 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -128.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.7 -6.44 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.39 -17.22 37.25 Favored Glycine 0 C--O 1.23 -0.146 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.05 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -130.44 -44.8 1.11 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -166.45 178.1 6.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.25 126.23 16.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.7 p -131.63 -170.18 2.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.88 -36.04 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -35.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.946 -1.096 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.27 -42.91 96.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.46 -32.91 74.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 81.5 p -72.9 -37.64 67.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -97.73 -42.88 7.4 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -166.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.45 57.4 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.12 -29.87 14.05 Favored 'Trans proline' 0 C--N 1.35 0.618 1 C-N-CA 111.781 -5.013 . . . . 0.0 115.701 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -76.59 -28.72 56.3 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 119.979 -1.701 . . . . 0.0 108.366 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.6 tp -66.44 -34.32 77.69 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.45 0.568 . . . . 0.0 111.783 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.35 -46.8 81.88 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.629 -0.67 . . . . 0.0 109.73 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -60.87 -33.58 73.31 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.16 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.92 -50.58 61.95 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.618 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -30.35 71.37 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.71 1.141 . . . . 0.0 111.607 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 94.5 t -73.06 -57.46 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.352 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -44.67 65.46 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.745 -1.222 . . . . 0.0 111.418 -166.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.41 -34.41 70.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.8 93.68 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.911 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -76.87 -46.87 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.622 -0.928 . . . . 0.0 112.37 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.96 -47.53 12.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -171.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.55 63.06 1.45 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -40.68 112.41 0.29 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -161.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -144.99 81.01 10.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.803 0.841 . . . . 0.0 111.959 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.47 154.78 40.56 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 113.303 -3.998 . . . . 0.0 110.118 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.23 129.9 91.55 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.41 163.65 31.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.711 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -76.82 6.51 6.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.257 1.503 . . . . 0.0 113.048 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.82 -15.99 42.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.372 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.2 mt -120.21 47.56 1.74 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 108.398 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.3 t -62.91 -18.82 63.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -160.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -48.66 80.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.264 1.847 . . . . 0.0 108.405 174.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.94 -33.03 50.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 118.042 -1.463 . . . . 0.0 107.883 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.2 -52.25 59.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.95 -39.53 94.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.577 0.703 . . . . 0.0 109.784 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.28 -22.78 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.752 -0.592 . . . . 0.0 111.948 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.6 mm -65.66 -34.59 71.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.456 1.025 . . . . 0.0 108.982 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.3 -33.48 75.37 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 111.159 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.06 -45.18 74.57 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.65 -30.17 70.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -67.92 -23.18 65.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.215 -0.928 . . . . 0.0 110.841 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -144.99 69.77 1.26 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.802 0.81 . . . . 0.0 111.071 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -131.99 144.54 50.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.55 -37.38 78.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -166.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.7 t -72.51 -50.48 25.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.94 1.352 . . . . 0.0 110.43 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.9 -28.98 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.698 -165.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.5 -43.39 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.302 1.041 . . . . 0.0 111.509 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.97 -37.17 78.62 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.47 -0.769 . . . . 0.0 112.17 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 32.1 p -81.72 -0.72 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -55.0 119.79 5.96 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.828 -0.545 . . . . 0.0 110.927 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.78 153.96 42.57 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.24 130.46 46.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -61.01 -36.12 78.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.065 0.46 . . . . 0.0 111.021 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -83.61 -25.51 30.78 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.857 -0.527 . . . . 0.0 109.649 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.39 -58.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -43.21 64.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 120.945 -1.097 . . . . 0.0 111.664 -168.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.79 0.09 48.84 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.605 -0.684 . . . . 0.0 111.591 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.09 -34.98 7.29 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -77.73 -41.73 36.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.676 -0.896 . . . . 0.0 112.376 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.44 -36.82 50.73 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.53 -19.83 65.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 114.956 -2.896 . . . . 0.0 114.545 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -84.94 -29.84 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.151 -0.968 . . . . 0.0 111.69 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.52 -49.26 72.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 118.333 0.515 . . . . 0.0 110.402 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.23 -32.44 24.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -167.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.646 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.526 -164.702 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.609 0.242 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 171.16 0.07 Allowed 'General case' 0 C--O 1.25 1.092 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 166.52 24.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.329 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -121.32 142.66 49.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.56 149.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -140.46 130.27 24.47 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.7 165.7 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -58.71 118.33 5.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.54 173.12 12.91 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.24 0.543 . . . . 0.0 111.189 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.03 124.64 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.09 55.93 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 64.26 12.99 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 119.163 1.482 . . . . 0.0 112.452 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.38 108.03 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 115.617 -2.456 . . . . 0.0 115.864 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -172.71 -53.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.4 mt -99.65 144.32 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 108.573 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.67 150.51 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.184 1.394 . . . . 0.0 114.599 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -156.09 11.79 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -84.71 116.82 23.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.18 -1.188 . . . . 0.0 110.394 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -165.38 140.4 4.17 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 173.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.81 -55.29 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.827 -2.982 . . . . 0.0 112.514 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -66.26 -29.31 69.52 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.29 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -44.13 -59.0 2.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -86.17 -11.65 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.924 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.39 -48.8 79.57 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 m -68.82 -43.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.457 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.99 -41.52 90.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.551 -173.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.19 -46.8 76.07 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.185 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.1 p -65.3 -42.44 93.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 119.593 1.088 . . . . 0.0 112.533 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.72 -36.17 73.08 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.056 -1.027 . . . . 0.0 111.775 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -76.81 -29.91 56.18 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.654 -0.654 . . . . 0.0 111.816 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.67 -29.64 70.23 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.643 -1.286 . . . . 0.0 111.265 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.18 -8.45 57.81 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.14 37.48 26.35 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.61 1.564 . . . . 0.0 113.63 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.47 157.58 67.38 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.353 0.524 . . . . 0.0 111.076 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.57 127.18 10.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -147.26 167.65 23.71 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.211 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.69 148.77 28.98 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t 72.44 143.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.852 2.061 . . . . 0.0 114.235 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.98 71.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 110.894 170.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.24 143.15 18.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.97 146.58 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.055 1.742 . . . . 0.0 108.399 158.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -88.75 80.24 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt 53.77 35.44 21.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.848 0.832 . . . . 0.0 113.209 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 1.37 83.72 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -82.87 78.82 9.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.343 1.571 . . . . 0.0 113.174 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -134.41 159.85 70.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.05 -176.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 114.662 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.29 -28.36 27.68 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -45.88 -40.71 10.38 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -85.96 -28.93 23.94 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 112.329 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.22 -22.55 63.86 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.847 0.832 . . . . 0.0 111.098 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -76.07 -3.67 37.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 112.097 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.16 -67.91 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 t -73.45 126.03 90.25 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -158.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.23 -24.26 27.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 N-CA-C 117.538 2.091 . . . . 0.0 117.538 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -100.76 -5.16 26.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.903 0.859 . . . . 0.0 111.089 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 -29.32 2.17 Favored Glycine 0 C--O 1.225 -0.427 0 O-C-N 121.806 -0.559 . . . . 0.0 113.813 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -130.81 45.61 2.79 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.149 0.974 . . . . 0.0 112.862 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.93 155.86 60.17 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.448 -0.783 . . . . 0.0 110.057 170.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.64 153.21 78.78 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 123.323 1.17 . . . . 0.0 113.706 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.21 159.34 36.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.71 124.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -92.88 80.91 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.065 0.848 . . . . 0.0 109.325 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mt -83.42 105.58 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t0 53.33 45.81 27.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.288 1.042 . . . . 0.0 109.679 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 68.7 9.87 7.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -121.84 128.15 51.33 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -94.71 144.1 25.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.09 132.55 55.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 176.77 132.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.257 1.823 . . . . 0.0 115.249 148.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -175.7 177.31 1.74 Allowed 'General case' 0 N--CA 1.48 1.034 1 N-CA-C 97.404 -5.036 . . . . 0.0 97.404 170.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.34 58.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -84.38 -24.28 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 120.695 -1.253 . . . . 0.0 110.702 -163.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.01 -24.1 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 tp -80.63 -13.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 120.791 -1.193 . . . . 0.0 109.329 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.4 t -82.72 -39.22 15.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.963 171.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.73 -55.2 0.62 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -69.08 -39.66 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.357 1.079 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.66 -37.55 81.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.657 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -68.88 -45.72 70.27 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.031 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -61.96 -37.12 83.55 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -85.86 10.17 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -100.63 133.55 21.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.063 -0.398 . . . . 0.0 111.51 175.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -66.43 -24.82 49.19 Favored 'Trans proline' 0 C--O 1.24 0.614 0 N-CA-C 116.781 1.8 . . . . 0.0 116.781 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -75.41 157.45 84.62 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.45 126.64 23.16 Favored 'Trans proline' 0 C--O 1.243 0.746 0 N-CA-C 114.741 1.016 . . . . 0.0 114.741 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.9 150.43 26.88 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 117.904 -0.931 . . . . 0.0 112.318 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 tp -142.04 64.7 1.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.841 1.305 . . . . 0.0 112.495 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.21 70.75 9.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.41 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -117.56 106.27 46.7 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.599 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -95.32 74.67 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 125.913 4.408 . . . . 0.0 119.001 164.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -87.1 -113.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 CA-C-N 119.198 0.749 . . . . 0.0 112.089 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -61.8 -43.07 99.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.998 -1.064 . . . . 0.0 112.658 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.33 -11.13 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.96 -48.75 13.95 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.617 -1.302 . . . . 0.0 111.919 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.8 p -77.89 -30.84 50.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.7 t -85.25 -36.12 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.39 -33.1 83.38 Favored Glycine 0 C--O 1.228 -0.24 0 O-C-N 121.077 -1.014 . . . . 0.0 114.078 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.4 p -75.65 -3.45 34.61 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -83.53 -34.84 25.17 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.824 -1.172 . . . . 0.0 110.777 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -38.8 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.266 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -52.72 -52.88 60.16 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 C--N 1.35 0.617 1 C-N-CA 113.186 -4.076 . . . . 0.0 114.294 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -67.41 -40.1 85.55 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.091 -1.006 . . . . 0.0 111.273 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -75.03 -33.32 61.76 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.901 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.38 -29.83 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -67.34 -42.99 82.62 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.737 -0.602 . . . . 0.0 109.995 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.52 -37.56 85.28 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.379 -0.826 . . . . 0.0 112.838 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.1 tp -63.99 -36.56 84.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.59 -30.98 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.4 t -89.43 110.57 21.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -98.09 44.15 1.05 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.782 1.277 . . . . 0.0 108.435 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -72.59 174.32 4.54 Favored Pre-proline 0 C--O 1.255 1.376 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 172.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.8 60.48 2.91 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 117.845 -0.97 . . . . 0.0 113.157 159.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -77.35 92.76 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -92.45 -38.3 12.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 162.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.02 -43.62 90.52 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.733 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 m -72.28 -26.28 61.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.369 1.085 . . . . 0.0 110.623 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.32 -41.39 85.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -76.78 -12.46 59.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.475 -0.766 . . . . 0.0 112.831 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.21 61.5 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.67 -42.11 95.6 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.32 -41.85 97.69 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -65.95 -46.47 78.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.926 0.869 . . . . 0.0 113.096 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -74.16 -35.05 64.01 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.97 -20.15 56.45 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.717 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -67.68 -33.34 74.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.076 1.307 . . . . 0.0 109.384 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.23 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.0 -34.8 79.3 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -38.9 90.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.845 0.858 . . . . 0.0 108.986 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -53.51 38.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.325 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -59.94 -29.65 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.021 -0.694 . . . . 0.0 112.016 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.6 -57.82 6.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -73.96 -12.33 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -166.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.9 t -61.71 -49.0 86.08 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 121.043 -1.035 . . . . 0.0 110.429 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -100.39 -39.65 7.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.41 -45.69 1.28 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.09 -163.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.112 2.956 . . . . 0.0 114.557 170.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.27 164.35 1.82 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.351 0.66 . . . . 0.0 109.885 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 mt -71.17 -22.87 22.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 121.48 -0.762 . . . . 0.0 110.389 -165.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.3 -35.19 59.85 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 167.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.21 -30.86 4.64 Favored Glycine 0 CA--C 1.518 0.259 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -129.76 -43.8 1.22 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -160.71 177.95 9.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.41 101.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 119.688 1.131 . . . . 0.0 109.471 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 175.78 5.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.89 60.77 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.59 -31.14 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.38 -0.825 . . . . 0.0 112.485 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.21 -37.53 28.48 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.598 -1.314 . . . . 0.0 108.11 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.96 -16.9 64.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.161 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.6 m -79.97 -36.4 36.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.92 -36.39 11.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.19 76.43 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -68.81 -19.91 40.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 113.809 -3.661 . . . . 0.0 116.807 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -94.26 -22.83 18.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.078 -1.014 . . . . 0.0 111.532 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.19 -36.64 84.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.72 -43.25 94.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.371 -0.83 . . . . 0.0 112.887 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -71.65 -29.22 64.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.301 -0.874 . . . . 0.0 112.443 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.3 -49.5 73.76 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.31 -37.58 83.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.6 m -80.07 -27.04 12.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.424 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.22 -44.11 7.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.09 -41.31 97.35 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.92 -38.68 95.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.748 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -73.98 -41.19 62.3 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.145 -1.209 . . . . 0.0 113.368 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -107.17 -46.55 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.25 61.05 0.75 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -165.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.14 104.09 0.22 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -142.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -150.02 100.73 3.22 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 123.465 0.706 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.5 160.42 41.59 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 115.647 -2.435 . . . . 0.0 110.087 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.3 130.59 90.87 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.63 158.32 39.78 Favored 'Trans proline' 0 C--N 1.346 0.409 0 N-CA-C 114.878 1.069 . . . . 0.0 114.878 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.66 2.85 49.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -68.21 -23.11 64.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 159.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.5 mt -114.65 42.23 2.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.333 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 51.9 m -53.41 -31.72 46.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.974 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -61.19 -36.04 78.79 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.292 -1.505 . . . . 0.0 113.234 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 -40.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.7 tp -60.05 -39.47 86.07 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.52 -0.737 . . . . 0.0 111.773 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -72.75 -23.8 60.88 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.616 -0.678 . . . . 0.0 112.164 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -38.85 61.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.5 mm -65.87 -39.61 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.11 -37.56 87.87 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.543 -1.348 . . . . 0.0 112.787 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.81 -44.85 88.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.7 -44.6 86.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.875 0.735 . . . . 0.0 110.798 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.85 -21.45 29.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.49 39.98 3.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.874 0.369 . . . . 0.0 111.465 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -72.18 143.09 49.02 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 100.445 -3.909 . . . . 0.0 100.445 155.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.03 -34.11 77.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 119.785 1.175 . . . . 0.0 110.213 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -61.65 -43.36 99.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.719 0.771 . . . . 0.0 111.006 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -70.87 -37.45 73.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.902 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.01 -44.45 82.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.0 -30.39 31.59 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.8 p -104.72 11.28 34.15 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -76.59 153.4 35.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.606 -0.684 . . . . 0.0 111.562 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.72 152.06 33.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.91 133.13 47.8 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.39 -34.29 76.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -160.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -56.81 -20.03 20.42 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -175.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -116.9 15.82 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 110.949 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.96 -46.74 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 101.794 -3.409 . . . . 0.0 101.794 156.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.23 -60.79 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.501 0.32 . . . . 0.0 110.76 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.07 60.42 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.118 -1.614 . . . . 0.0 114.173 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.96 -28.56 11.76 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 118.127 2.011 . . . . 0.0 118.127 -171.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -101.15 -24.33 14.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 111.581 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -71.56 -6.58 0.1 Allowed Pre-proline 0 C--O 1.242 0.679 0 N-CA-C 121.737 3.977 . . . . 0.0 121.737 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.35 -20.68 42.15 Favored 'Trans proline' 0 C--N 1.357 1.011 1 C-N-CA 109.944 -6.237 . . . . 0.0 114.474 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.62 -12.71 59.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.145 -0.972 . . . . 0.0 111.45 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 89.3 t -82.69 -43.86 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.88 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -114.27 -19.72 11.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.491 -2.195 . . . . 0.0 108.938 179.613 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.4 171.69 14.45 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 167.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.4 139.75 53.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -173.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.63 164.5 19.14 Favored 'General case' 0 C--O 1.245 0.854 1 N-CA-C 96.289 -5.449 . . . . 0.0 96.289 178.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -151.34 -10.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.0 122.54 7.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.369 2.35 . . . . 0.0 117.341 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.56 158.52 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.606 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.75 134.13 44.85 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.12 165.66 20.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 138.48 58.35 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.64 132.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.22 -50.97 4.33 Favored Glycine 0 CA--C 1.516 0.122 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.62 76.64 69.82 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 122.588 0.355 . . . . 0.0 111.418 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.25 114.11 2.71 Favored 'Trans proline' 0 C--O 1.234 0.278 0 CA-C-O 122.352 0.897 . . . . 0.0 111.62 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -166.96 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.69 159.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.2 tp -44.91 142.53 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.847 1.259 . . . . 0.0 112.084 160.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.96 -169.68 30.93 Favored Glycine 0 C--O 1.23 -0.111 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -72.85 98.2 2.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.447 1.117 . . . . 0.0 108.602 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -142.04 105.0 5.67 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.045 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.62 -44.44 48.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 115.346 1.248 . . . . 0.0 115.346 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -78.18 -29.78 48.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.9 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.1 m -65.77 -46.12 79.96 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.694 -0.629 . . . . 0.0 112.405 -169.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.27 -12.47 60.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.359 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.33 -44.81 95.62 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.86 -46.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.37 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.87 -39.91 87.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.2 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.8 -40.49 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.787 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.6 p -68.86 -34.25 75.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.646 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -40.35 42.93 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.07 -0.394 . . . . 0.0 110.869 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -73.08 -29.74 63.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.714 -0.616 . . . . 0.0 112.309 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.1 -33.47 75.87 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.295 -1.503 . . . . 0.0 110.587 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -87.27 0.07 55.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 53.21 32.38 13.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.439 1.896 . . . . 0.0 114.618 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.7 121.23 66.5 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.05 142.14 34.01 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 115.703 -2.398 . . . . 0.0 112.475 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -140.45 176.39 8.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.823 0.849 . . . . 0.0 109.064 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.77 155.12 28.39 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 t -154.29 138.43 16.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 119.678 1.126 . . . . 0.0 110.823 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -96.64 136.38 37.25 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.26 105.67 16.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.6 mm -79.25 95.03 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -78.55 80.83 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.239 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 52.62 51.8 15.34 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 155.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.47 34.02 6.87 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.696 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.86 -58.54 5.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -106.28 142.73 25.5 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.356 -160.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.75 -166.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.241 0.654 0 N-CA-C 116.166 1.564 . . . . 0.0 116.166 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -41.74 -31.73 0.33 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 118.833 2.901 . . . . 0.0 118.833 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -51.81 -42.03 62.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.472 1.033 . . . . 0.0 113.184 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -24.56 22.43 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.971 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.56 -26.01 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.608 0.718 . . . . 0.0 110.783 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.32 -30.3 70.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.75 -44.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.805 -170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -88.33 118.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 121.641 -0.662 . . . . 0.0 110.815 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -34.36 97.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 116.377 1.645 . . . . 0.0 116.377 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.2 4.15 39.09 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.282 -0.886 . . . . 0.0 110.611 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.23 -15.51 8.8 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -142.69 24.2 1.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.31 156.13 47.57 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 156.2 51.45 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 117.198 -1.401 . . . . 0.0 113.358 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -145.48 123.18 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.784 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.7 t -88.82 119.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.99 130.44 34.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 161.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.94 103.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t0 61.69 39.12 14.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.457 1.123 . . . . 0.0 112.813 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 t0 58.87 36.58 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.777 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.23 144.94 50.59 Favored 'General case' 0 C--N 1.323 -0.568 1 N-CA-C 98.684 -4.561 . . . . 0.0 98.684 164.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -128.84 156.31 43.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.02 123.97 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.32 81.53 0.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.79 148.58 26.49 Favored 'General case' 0 N--CA 1.471 0.581 1 N-CA-C 98.649 -4.574 . . . . 0.0 98.649 162.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -60.26 -28.85 68.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -166.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.2 -28.96 17.5 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.629 -0.67 . . . . 0.0 112.446 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.49 -22.99 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.156 -0.965 . . . . 0.0 110.483 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.93 -0.88 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.752 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.34 -60.16 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.376 165.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -50.0 36.4 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.37 -26.55 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.5 tp -63.5 -39.44 94.45 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.432 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.9 -34.41 77.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.363 1.438 . . . . 0.0 111.033 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.82 -36.95 85.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.969 0.89 . . . . 0.0 111.36 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -91.09 -3.86 56.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -70.31 133.17 87.49 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.8 -15.65 26.64 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 115.254 -2.698 . . . . 0.0 114.864 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -87.89 170.64 11.15 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.48 139.08 86.57 Favored 'Trans proline' 0 C--N 1.353 0.768 0 N-CA-C 117.128 1.934 . . . . 0.0 117.128 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.63 110.47 2.41 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 114.014 0.736 . . . . 0.0 114.014 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.8 mt -118.58 56.88 0.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.73 88.0 2.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -116.42 123.75 30.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 166.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -94.49 67.07 0.32 Allowed 'Trans proline' 0 CA--C 1.556 1.593 0 N-CA-C 119.253 2.751 . . . . 0.0 119.253 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.35 -167.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.764 -1.024 . . . . 0.0 111.028 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 14.71 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 1 N-CA-C 122.286 4.18 . . . . 0.0 122.286 167.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.33 -22.16 62.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.639 -0.663 . . . . 0.0 111.697 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.49 75.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.377 0.535 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -44.98 89.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.235 0.54 . . . . 0.0 109.755 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.56 -41.03 85.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.831 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.31 90.42 Favored Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.602 -0.686 . . . . 0.0 112.245 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -70.63 -8.79 54.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -101.55 -33.89 9.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 111.133 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.13 -42.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 122.891 0.477 . . . . 0.0 110.27 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -54.56 55.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.48 -30.36 79.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 114.961 -2.892 . . . . 0.0 114.52 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -61.59 -54.3 44.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.922 0.328 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -70.98 -27.72 63.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 117.916 -1.513 . . . . 0.0 113.906 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 m -74.03 -36.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.962 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -62.47 -51.32 67.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.93 -42.19 85.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.761 1.619 . . . . 0.0 112.302 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -71.52 -30.77 66.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.439 0.638 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -81.57 138.16 35.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.172 0.987 . . . . 0.0 113.641 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -124.84 30.75 5.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.29 173.42 7.02 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.44 51.76 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 CA-C-N 121.492 1.569 . . . . 0.0 116.126 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -75.45 106.41 6.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.39 -51.49 1.01 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 -40.14 94.85 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -18.02 59.48 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 120.607 -1.525 . . . . 0.0 114.237 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.76 -33.05 71.89 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.74 3.79 15.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.056 -1.028 . . . . 0.0 113.222 173.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.77 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 119.836 -1.79 . . . . 0.0 107.417 165.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.06 -37.88 81.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.496 -0.753 . . . . 0.0 109.705 171.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.28 -43.54 83.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -69.82 -34.65 73.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.72 -37.06 79.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.374 -1.454 . . . . 0.0 110.696 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.16 -20.88 59.13 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.267 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -71.27 -32.68 68.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.722 -1.237 . . . . 0.0 110.579 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.37 93.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.8 -41.38 97.91 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.557 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.9 -37.66 80.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.161 0.985 . . . . 0.0 110.838 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.29 -51.7 47.06 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.94 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -64.97 -32.73 74.59 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.604 -0.939 . . . . 0.0 111.062 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.3 -46.98 78.23 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.253 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.13 -24.59 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.885 1.221 . . . . 0.0 112.677 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -76.02 -49.25 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 122.128 -0.357 . . . . 0.0 111.501 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -83.7 -26.11 30.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.78 -93.6 1.12 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -71.57 -177.73 2.63 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 118.496 2.46 . . . . 0.0 118.496 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -36.65 148.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.081 2.153 . . . . 0.0 114.001 170.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 pt -77.37 23.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -149.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.44 -20.37 60.05 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.302 -1.499 . . . . 0.0 109.405 149.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.39 67.86 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -145.57 -54.93 0.29 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -163.21 -173.71 3.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.9 mt -77.1 114.94 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -138.93 -170.23 2.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -39.66 -45.36 1.66 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 119.62 3.193 . . . . 0.0 119.62 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.55 -39.27 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.239 . . . . 0.0 110.365 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.81 -44.64 66.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.336 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.43 -19.03 65.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.445 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -81.24 -44.65 17.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 27.6 tp -87.91 -45.79 9.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.2 -37.59 55.05 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.26 -36.9 26.35 Favored 'Trans proline' 0 C--N 1.354 0.842 1 C-N-CA 111.519 -5.187 . . . . 0.0 113.47 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -77.77 -24.26 49.01 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.63 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.74 -34.84 76.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.597 1.09 . . . . 0.0 112.434 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -66.17 -44.67 83.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.258 -0.901 . . . . 0.0 110.521 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -66.42 -31.62 72.5 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.0 -54.04 47.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -71.11 -34.32 70.97 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.96 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.11 -36.37 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.02 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.55 12.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.532 1.06 . . . . 0.0 110.232 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.34 -35.84 81.38 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.17 92.89 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.629 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -85.57 -24.94 27.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.363 -1.081 . . . . 0.0 113.439 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -101.55 -40.48 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -139.43 47.75 1.87 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 109.987 -172.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -34.31 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 -149.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -146.36 107.23 4.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.61 169.07 15.64 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 118.378 0.456 . . . . 0.0 111.935 162.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 93.8 mt -67.3 124.51 89.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -73.02 164.65 34.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.52 -8.35 57.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.505 0.669 . . . . 0.0 110.493 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.29 -24.12 67.11 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.669 166.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -118.5 44.47 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.8 t -63.12 -18.33 63.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -165.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.41 -33.93 65.23 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.915 -1.741 . . . . 0.0 109.371 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.88 -46.49 79.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.3 -41.79 98.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.286 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -65.06 -48.27 74.38 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 120.862 -1.149 . . . . 0.0 111.436 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -31.77 70.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.24 -175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.01 -31.13 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 119.575 1.079 . . . . 0.0 111.716 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -71.09 -34.66 71.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.104 -1.622 . . . . 0.0 111.16 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.71 -41.39 92.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.33 -38.74 91.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -54.57 -41.08 69.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.579 0.627 . . . . 0.0 111.201 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 t -91.25 -0.11 57.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -64.99 144.2 57.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -58.4 -43.25 88.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.322 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.6 t -60.36 -46.87 88.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -42.78 79.93 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.531 -0.73 . . . . 0.0 111.803 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.64 -42.05 82.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.919 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -77.12 -31.69 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.6 p -99.92 -9.05 23.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -64.88 142.74 58.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.123 0.874 . . . . 0.0 112.409 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.75 161.44 30.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.79 133.97 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.72 -35.29 79.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -52.5 -39.56 61.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.621 0.768 . . . . 0.0 112.661 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.72 -14.84 29.31 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.712 -0.618 . . . . 0.0 111.893 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 43.3 t -74.5 -37.59 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.4 mt -66.32 -37.74 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.295 -0.878 . . . . 0.0 108.703 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.45 -5.97 12.98 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.477 -0.764 . . . . 0.0 112.622 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.91 73.49 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.777 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -93.09 -23.24 18.69 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 118.619 1.209 . . . . 0.0 109.927 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.37 128.88 94.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.719 0.408 . . . . 0.0 111.424 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.14 4.27 0.76 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 CA-C-N 119.674 0.919 . . . . 0.0 112.446 -65.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -54.63 -29.74 52.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . 0.285 27.8 m 47.59 12.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.947 2.499 . . . . 0.0 117.109 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 43.3 t30 49.21 -0.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.994 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.744 -174.329 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 tpp . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.04 4.12 1.93 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 mp -131.95 -21.24 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -87.67 -4.82 58.91 Favored 'General case' 0 C--N 1.322 -0.595 1 N-CA-C 124.968 5.173 . . . . 0.0 124.968 -146.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mm -87.93 126.89 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 122.647 2.476 . . . . 0.0 112.38 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.64 121.11 26.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 152.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 m -137.2 156.14 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.685 1.129 . . . . 0.0 113.812 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.96 133.29 55.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.3 165.48 13.41 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 144.4 57.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.69 131.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -44.84 3.41 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 118.851 -0.971 . . . . 0.0 114.925 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.32 85.04 52.03 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -72.85 62.24 3.87 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 121.397 1.398 . . . . 0.0 115.291 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -141.57 -10.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.047 1.339 . . . . 0.0 111.002 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.3 tt -135.42 156.23 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.83 156.6 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.01 0.924 . . . . 0.0 112.39 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.81 156.06 17.94 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.42 95.12 5.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.792 0.806 . . . . 0.0 112.685 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 75.0 m -100.16 150.23 36.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 139.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.16 -34.69 98.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.034 -1.511 . . . . 0.0 114.053 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.24 -31.04 70.83 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.96 -51.91 67.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -30.04 63.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.297 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -59.8 -40.1 87.21 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.01 -1.056 . . . . 0.0 111.494 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.46 -50.6 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -60.87 -39.13 88.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 tp -58.07 -45.18 87.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.798 0.726 . . . . 0.0 110.988 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.0 p -66.13 -36.7 83.84 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.16 -0.963 . . . . 0.0 111.5 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.08 -41.68 70.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.907 -0.496 . . . . 0.0 111.465 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -32.13 58.78 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.927 -0.483 . . . . 0.0 112.251 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.7 -37.22 81.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.173 -0.954 . . . . 0.0 111.6 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -91.92 1.97 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.507 0.67 . . . . 0.0 111.349 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 57.62 26.3 12.72 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.136 1.774 . . . . 0.0 114.71 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.56 141.71 48.97 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -68.01 164.81 30.43 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 116.377 -1.948 . . . . 0.0 110.78 175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -154.28 151.31 28.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -79.91 148.48 31.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -128.38 125.75 39.28 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.107 0.88 . . . . 0.0 110.591 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -111.9 112.22 23.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -80.84 134.23 35.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.64 116.93 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -79.32 79.18 5.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 112.658 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt 57.3 39.43 28.5 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.26 69.63 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.24 -0.981 . . . . 0.0 114.215 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.85 118.17 14.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 149.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.26 122.72 7.58 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.616 0.246 . . . . 0.0 111.619 -172.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.1 176.32 10.09 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.378 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -55.66 -37.27 68.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.863 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -53.62 -45.72 70.21 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -80.11 -22.73 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.676 -1.265 . . . . 0.0 112.488 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.241 -0.912 . . . . 0.0 111.049 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.05 -11.56 60.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.439 -0.788 . . . . 0.0 112.13 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.94 -61.06 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.654 0.74 . . . . 0.0 112.358 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -86.86 129.97 50.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 -166.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.02 -28.65 41.39 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 116.082 -2.146 . . . . 0.0 114.03 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -89.28 -10.49 46.67 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.042 -1.036 . . . . 0.0 111.077 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.01 -7.2 36.97 Favored Glycine 0 C--O 1.22 -0.726 0 O-C-N 121.709 -0.619 . . . . 0.0 113.003 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -144.85 16.27 1.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.47 143.13 28.76 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -59.18 156.48 34.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 N-CA-C 114.676 0.991 . . . . 0.0 114.676 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 m -134.98 169.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.5 m -106.76 142.7 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 160.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -126.67 53.48 1.67 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 123.033 1.397 . . . . 0.0 111.112 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -68.35 126.8 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 57.17 30.77 18.89 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.193 0.997 . . . . 0.0 111.864 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.13 18.13 11.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.082 1.753 . . . . 0.0 113.482 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -106.25 112.2 25.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.19 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -74.9 140.29 43.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.45 130.02 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.16 41.52 1.51 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -157.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.78 144.63 39.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.557 -1.34 . . . . 0.0 108.331 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -58.83 -32.35 69.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -75.97 -31.75 59.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.241 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.75 -11.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.635 -1.291 . . . . 0.0 110.342 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.12 -26.51 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 t -73.79 -44.01 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.388 -1.445 . . . . 0.0 110.447 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.54 -64.77 0.83 Allowed Glycine 0 CA--C 1.519 0.341 0 N-CA-C 119.986 2.754 . . . . 0.0 119.986 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.53 -38.06 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.969 0.884 . . . . 0.0 111.748 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.14 -45.76 83.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.888 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.87 -28.05 60.5 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.641 -1.224 . . . . 0.0 113.316 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -63.14 -40.99 99.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.56 -7.91 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -68.15 119.11 65.16 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 160.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.15 0.65 9.51 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 116.064 1.524 . . . . 0.0 116.064 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.92 162.55 67.63 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.66 132.48 49.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 115.956 1.483 . . . . 0.0 115.956 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.16 140.28 19.7 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 116.878 -1.615 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.7 mt -137.25 43.23 2.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.308 0.575 . . . . 0.0 111.501 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 80.14 4.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.968 0.89 . . . . 0.0 110.437 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.8 m -116.59 93.54 40.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -90.73 81.18 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.08 3.187 . . . . 0.0 117.543 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -87.97 -137.37 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.528 0.867 . . . . 0.0 112.704 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.45 -30.95 68.87 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.941 -1.1 . . . . 0.0 112.874 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -63.26 -29.75 71.02 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.553 -0.717 . . . . 0.0 110.597 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.91 -28.73 25.72 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.095 -0.378 . . . . 0.0 111.995 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.2 p -73.53 -33.08 64.57 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.69 -49.17 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.65 62.24 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -60.39 -26.5 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -81.44 -42.62 20.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.049 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.98 -41.06 79.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.022 -166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.48 -56.29 33.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.08 -20.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 113.827 -3.648 . . . . 0.0 113.856 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -64.76 -49.88 69.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.583 1.083 . . . . 0.0 109.943 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -72.14 -31.19 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.68 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.81 -40.01 80.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.32 -40.53 81.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.425 -1.422 . . . . 0.0 111.959 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.91 -26.71 67.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.206 0.912 . . . . 0.0 111.944 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.83 -50.67 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -70.1 -24.88 63.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.5 t -75.84 141.35 42.47 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.707 -0.62 . . . . 0.0 110.795 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -130.0 32.66 4.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.58 167.99 2.12 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 162.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -65.89 92.11 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 116.953 -1.565 . . . . 0.0 112.222 165.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.42 106.84 18.77 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.561 -169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -148.0 -48.87 0.16 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.788 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.44 -33.29 86.09 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.4 p -76.77 -20.31 56.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.594 -0.945 . . . . 0.0 113.381 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -75.3 -31.08 60.56 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.38 -28.38 59.48 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 172.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.27 95.19 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.906 -1.121 . . . . 0.0 110.09 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.53 -38.98 93.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.739 -0.601 . . . . 0.0 110.815 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -43.68 94.04 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.525 173.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -67.4 -36.97 82.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.406 1.003 . . . . 0.0 112.977 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.67 -45.7 81.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.89 -20.32 61.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 120.823 -1.173 . . . . 0.0 110.597 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.56 -28.77 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.753 -1.217 . . . . 0.0 111.557 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 -42.31 89.83 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.1 -38.39 85.59 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.01 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.96 -38.65 89.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.3 0.64 . . . . 0.0 109.808 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.59 -54.87 23.39 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.151 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -62.27 -28.18 69.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.822 -0.81 . . . . 0.0 112.577 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.27 -54.66 13.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.823 -0.548 . . . . 0.0 110.103 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.85 -22.29 65.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.21 -9.76 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.119 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -119.65 -44.53 2.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.53 -46.38 1.18 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 119.639 2.616 . . . . 0.0 119.639 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -68.79 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.695 3.248 . . . . 0.0 116.744 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -58.0 175.1 0.22 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.326 1.05 . . . . 0.0 112.444 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.63 -32.26 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.431 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.57 -3.81 5.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.28 -5.29 60.2 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -137.24 -53.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.692 1.246 . . . . 0.0 113.171 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.49 177.6 5.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 100.984 -3.71 . . . . 0.0 100.984 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.92 126.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.18 1.354 . . . . 0.0 109.181 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 m -143.29 174.39 10.76 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -41.59 -40.26 1.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.66 -32.01 56.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 120.495 1.498 . . . . 0.0 110.942 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.92 -39.23 79.76 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.27 -34.85 78.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.2 p -74.07 -37.24 64.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.74 -46.94 3.7 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -167.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.59 92.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.31 -13.73 18.65 Favored 'Trans proline' 0 C--N 1.349 0.591 1 C-N-CA 111.987 -4.876 . . . . 0.0 113.327 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -91.87 -26.67 18.37 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.909 -0.494 . . . . 0.0 110.477 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.7 -34.18 76.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.947 -0.47 . . . . 0.0 110.635 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.58 -50.14 63.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.468 1.128 . . . . 0.0 108.988 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -73.52 -14.89 61.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.718 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.3 tp -65.76 -54.27 29.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.216 0.916 . . . . 0.0 109.674 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.98 -26.85 63.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.437 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.9 -58.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 121.67 -0.644 . . . . 0.0 110.233 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.75 54.48 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.015 -1.053 . . . . 0.0 111.581 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.4 -37.92 83.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.51 95.66 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.993 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -72.31 -34.18 67.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.011 1.405 . . . . 0.0 113.418 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.03 -33.95 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 118.818 2.896 . . . . 0.0 118.818 -172.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.02 61.97 1.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -53.86 114.54 1.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -158.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -133.61 97.35 15.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 160.25 40.86 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.034 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 84.2 mt -73.11 122.4 87.56 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.59 165.36 25.08 Favored 'Trans proline' 0 C--N 1.346 0.438 0 N-CA-C 114.526 0.933 . . . . 0.0 114.526 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.22 -5.71 45.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.801 -0.562 . . . . 0.0 112.007 175.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.11 -21.87 64.92 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.985 -0.447 . . . . 0.0 110.801 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.65 58.68 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.48 72.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.451 -167.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -78.02 -35.62 49.61 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.989 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.8 -39.2 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.57 -42.38 91.84 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.592 -0.693 . . . . 0.0 111.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.99 -36.02 81.25 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 120.997 -1.065 . . . . 0.0 110.083 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -64.75 -43.32 93.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.0 -25.72 30.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 O-C-N 120.404 -1.435 . . . . 0.0 110.514 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.93 -25.94 66.61 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.065 -1.647 . . . . 0.0 112.091 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -71.67 -30.51 65.79 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.696 0.68 . . . . 0.0 109.176 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.26 -28.45 42.39 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.824 0.345 . . . . 0.0 110.263 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -79.48 13.2 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 120.835 -1.166 . . . . 0.0 111.124 170.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.4 t -134.67 171.09 14.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 60.16 136.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.04 -32.35 67.89 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.376 -0.828 . . . . 0.0 112.772 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.5 m -55.76 -32.59 63.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -102.23 -46.16 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.391 1.091 . . . . 0.0 110.49 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.15 -33.29 75.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -79.61 -32.25 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.497 -0.752 . . . . 0.0 110.898 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 41.0 p -91.67 -16.89 26.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.36 148.57 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.863 . . . . 0.0 111.967 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.93 152.81 37.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.596 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.32 51.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.33 -33.91 76.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.43 -35.34 80.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.511 1.148 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -80.76 -22.54 40.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.219 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.67 -51.79 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.4 pt -73.47 -36.02 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.71 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -20.07 65.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.51 13.11 Favored Glycine 0 CA--C 1.517 0.18 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -95.81 -25.77 15.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.369 1.585 . . . . 0.0 115.069 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -94.32 -10.27 0.15 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 121.507 3.892 . . . . 0.0 121.507 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.63 -17.67 23.1 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 113.674 -3.75 . . . . 0.0 117.077 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -102.44 4.39 38.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.702 0.683 . . . . 0.0 109.781 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.9 t -98.81 -46.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.909 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -101.23 6.49 42.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.808 0.813 . . . . 0.0 111.635 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.9 -157.7 0.1 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.952 1.301 . . . . 0.0 113.174 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.16 161.11 30.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -138.14 126.24 22.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.75 103.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -166.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -98.43 71.42 2.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.042 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -93.01 157.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.298 -170.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -62.87 142.91 58.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.21 161.88 22.58 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.31 143.85 54.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.868 1.318 . . . . 0.0 113.849 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.44 130.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -4.78 48.84 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.978 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.39 78.59 4.6 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.305 1.053 . . . . 0.0 112.369 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.51 45.47 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 119.043 2.67 . . . . 0.0 119.043 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -131.01 -7.16 3.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 114.187 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.28 159.18 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.7 mt -61.18 142.55 56.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.24 153.43 22.22 Favored Glycine 0 CA--C 1.508 -0.383 0 O-C-N 121.514 -0.741 . . . . 0.0 114.9 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.93 103.13 10.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.655 1.217 . . . . 0.0 108.814 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 t -132.69 137.63 30.2 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 170.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.36 -29.13 72.08 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 115.32 -2.653 . . . . 0.0 112.304 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -80.9 -16.87 52.41 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.452 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -70.23 -52.01 26.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.84 -20.08 65.12 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.943 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -61.02 -43.75 98.43 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.668 2.031 . . . . 0.0 111.554 167.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.01 -54.61 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.03 -37.82 86.84 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.6 -39.5 88.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.3 p -70.59 -40.2 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 112.416 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -48.14 76.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.539 -177.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -74.57 -28.94 61.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.515 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -71.19 -36.39 71.93 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.59 -0.694 . . . . 0.0 111.191 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.17 -5.53 59.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 53.64 36.81 24.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 113.724 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.7 pt -84.25 153.44 62.6 Favored Pre-proline 0 C--O 1.246 0.879 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.795 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.4 137.61 25.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.068 -1.488 . . . . 0.0 114.689 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -151.77 161.58 42.43 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.3 126.41 52.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.2 t -88.62 135.08 33.68 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -137.2 129.56 29.72 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -107.07 132.08 53.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.7 mm -105.48 101.32 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.789 1.236 . . . . 0.0 111.018 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -69.59 83.21 0.42 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.421 1.088 . . . . 0.0 113.486 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 51.12 48.26 23.37 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 122.921 1.343 . . . . 0.0 113.61 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 57.72 1.93 Allowed Glycine 0 CA--C 1.518 0.261 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.266 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.35 85.55 7.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.9 86.44 57.41 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-O 122.021 0.915 . . . . 0.0 112.219 -157.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.93 -176.51 3.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.073 -1.484 . . . . 0.0 108.31 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -47.55 -40.73 19.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.551 0.74 . . . . 0.0 112.602 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -55.87 -47.06 78.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -89.68 -21.75 22.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.11 -43.6 94.82 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -70.79 -38.8 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.502 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.3 mt -110.77 87.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.523 0.678 . . . . 0.0 112.381 -172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t 174.26 145.92 0.21 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.1 -25.12 77.09 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 116.876 1.837 . . . . 0.0 116.876 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -125.96 -14.09 6.17 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.07 -9.42 67.82 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-O 122.335 0.964 . . . . 0.0 111.642 -168.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -155.47 88.75 1.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.12 0.968 . . . . 0.0 110.534 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -143.37 150.35 51.25 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -67.09 98.51 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 115.913 -2.258 . . . . 0.0 113.145 162.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.6 t -91.55 137.72 21.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.455 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.58 113.47 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.77 126.32 33.92 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 t0 50.42 56.46 7.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.781 0.801 . . . . 0.0 112.821 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 65.5 24.31 11.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -124.97 144.13 50.53 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -123.71 132.38 53.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 118.817 0.735 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.07 134.03 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -170.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.52 -22.16 0.33 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.2 138.97 58.72 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -62.98 -29.16 70.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -165.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -85.9 -7.3 58.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.61 -10.6 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.2 -0.938 . . . . 0.0 110.16 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.07 -36.28 76.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.58 -39.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.37 -73.51 1.16 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 120.371 2.909 . . . . 0.0 120.371 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.57 -38.14 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.687 -0.89 . . . . 0.0 111.986 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.57 -41.84 95.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.795 0.725 . . . . 0.0 109.638 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.58 -34.33 73.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.39 -35.39 75.74 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.006 -1.059 . . . . 0.0 111.108 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.01 7.51 45.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.38 137.19 97.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.73 -29.11 82.92 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 117.134 -1.444 . . . . 0.0 115.299 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -81.09 169.26 19.94 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 109.811 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -57.42 134.33 62.9 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 116.811 -1.659 . . . . 0.0 116.021 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.6 135.45 3.0 Favored 'Trans proline' 0 C--O 1.247 0.962 0 N-CA-C 118.3 2.385 . . . . 0.0 118.3 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.3 mt -135.37 43.5 2.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.81 82.01 2.74 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.484 -1.385 . . . . 0.0 111.611 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -118.65 94.83 48.22 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.569 1.148 . . . . 0.0 113.775 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -106.15 59.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.905 0 N-CA-C 122.248 3.903 . . . . 0.0 122.248 -174.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -82.25 -126.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.691 0.928 . . . . 0.0 114.049 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -57.29 -32.23 66.43 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 120.982 -1.074 . . . . 0.0 112.677 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.16 -32.79 74.44 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.146 -0.972 . . . . 0.0 111.847 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.52 -33.19 60.71 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.612 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.1 p -71.27 -34.6 70.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.96 -45.42 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 123.024 0.202 . . . . 0.0 110.516 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.94 87.38 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.377 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -73.51 -0.4 14.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -94.14 -33.93 13.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 167.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.7 mt -82.26 -39.52 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.68 0.753 . . . . 0.0 110.416 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.64 -50.41 77.38 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.69 -33.75 12.56 Favored 'Trans proline' 0 C--N 1.347 0.478 1 C-N-CA 111.648 -5.101 . . . . 0.0 114.543 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -72.5 -39.77 67.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.253 0.479 . . . . 0.0 111.104 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -68.8 -30.0 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.908 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.54 -47.81 62.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -61.98 -44.12 97.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -75.28 -37.14 61.04 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.428 -174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -34.3 78.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.85 0.833 . . . . 0.0 110.579 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -76.65 0.05 21.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.124 0.97 . . . . 0.0 112.108 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -121.05 114.31 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -87.39 49.55 1.83 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.566 1.651 . . . . 0.0 110.309 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -88.51 170.47 11.18 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.62 50.31 2.67 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 CA-C-N 120.174 1.098 . . . . 0.0 114.938 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.04 100.39 4.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.897 1.279 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.9 -45.96 0.86 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 -38.09 93.67 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 166.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.0 m -69.57 -30.65 68.49 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.767 -0.843 . . . . 0.0 111.981 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.66 -28.88 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.709 -1.87 . . . . 0.0 110.04 172.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -75.7 -10.39 59.39 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.372 -1.455 . . . . 0.0 111.625 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.03 60.31 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 119.814 -1.804 . . . . 0.0 108.126 168.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.79 -34.92 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.549 -0.719 . . . . 0.0 111.164 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.2 -44.8 79.83 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -67.53 -26.44 66.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -77.47 -35.93 53.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 120.615 -1.303 . . . . 0.0 109.679 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.3 -20.55 60.08 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.728 -0.608 . . . . 0.0 109.52 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.92 -30.09 69.33 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.463 -0.773 . . . . 0.0 111.395 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.61 -42.09 87.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.02 -43.97 93.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.681 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.75 -35.94 77.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.91 -50.98 55.47 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.822 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.54 -36.03 81.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.879 -1.365 . . . . 0.0 110.489 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.22 -43.01 99.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -74.43 -27.81 60.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.24 -44.43 77.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.44 -54.21 5.39 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.74 -63.45 0.46 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-O 117.183 -1.899 . . . . 0.0 116.761 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.24 -162.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 1 C-N-CA 127.98 5.787 . . . . 0.0 118.565 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -55.9 175.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.67 163.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -54.25 -33.19 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.88 58.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.82 89.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 118.395 -1.225 . . . . 0.0 116.141 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -136.53 -52.54 0.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.729 1.764 . . . . 0.0 112.978 165.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -162.73 -177.56 5.62 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 117.635 -1.174 . . . . 0.0 109.96 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.07 118.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.881 1.218 . . . . 0.0 110.347 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.6 m -132.64 177.23 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.23 37.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.63 -18.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.972 -1.08 . . . . 0.0 111.711 173.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.22 -38.04 31.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -28.91 69.63 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 120.719 0.295 . . . . 0.0 110.649 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 93.9 p -77.68 -35.32 52.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.49 -46.81 3.92 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.05 81.41 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.11 -27.89 19.63 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.776 -4.349 . . . . 0.0 114.371 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.88 -29.89 63.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.02 -24.49 64.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.15 -50.35 61.52 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.007 -1.058 . . . . 0.0 110.334 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -55.45 -42.33 74.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.496 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.6 tp -57.35 -61.99 2.09 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.745 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -67.93 -32.85 73.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -170.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 -43.08 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.134 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.84 -42.15 34.55 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.086 -1.009 . . . . 0.0 112.494 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.68 -38.61 91.76 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.9 81.13 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.089 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.45 -48.86 11.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.49 -1.006 . . . . 0.0 112.968 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -86.72 -43.5 12.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -134.87 59.5 1.73 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.9 0.88 . . . . 0.0 108.766 -171.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -49.97 104.51 0.07 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -154.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -147.82 98.96 3.8 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.241 1.817 . . . . 0.0 106.222 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.41 172.06 17.05 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 115.652 -2.432 . . . . 0.0 109.728 167.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.41 118.08 56.15 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -82.19 167.04 16.09 Favored 'Trans proline' 0 C--N 1.352 0.728 0 N-CA-C 114.975 1.106 . . . . 0.0 114.975 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.92 4.2 5.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -69.6 -23.28 63.5 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.33 60.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -66.64 -19.86 65.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.637 -0.664 . . . . 0.0 112.565 -170.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.7 -33.51 40.98 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.22 -37.22 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.767 0.794 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.45 -47.77 84.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.447 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -65.24 -40.38 93.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -55.56 -53.46 56.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.194 0.521 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.43 -25.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.655 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -66.26 -42.36 88.61 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.745 -1.222 . . . . 0.0 111.6 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -41.57 99.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.07 -37.46 85.88 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 123.607 0.567 . . . . 0.0 111.918 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.15 -25.95 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t -122.13 39.56 3.86 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -103.85 136.5 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.93 -44.43 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -59.61 -47.24 86.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.961 0.886 . . . . 0.0 111.962 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -71.93 -43.46 65.26 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.14 -33.08 73.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -75.78 -42.3 50.57 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.027 -1.045 . . . . 0.0 113.094 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.2 p -88.4 -3.23 58.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -57.09 138.92 53.84 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.47 153.4 41.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.98 130.96 40.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.69 -36.97 82.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 -170.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.57 -21.26 62.7 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.505 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -97.29 -14.35 21.39 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.95 -52.34 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.61 -54.54 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.229 -0.294 . . . . 0.0 111.599 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.54 -2.34 35.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 112.654 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.18 -16.97 44.95 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.739 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -106.56 -48.99 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.15 0.976 . . . . 0.0 112.146 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.09 -26.28 2.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -66.81 -17.48 52.11 Favored 'Trans proline' 0 C--N 1.357 0.981 1 C-N-CA 112.316 -4.656 . . . . 0.0 115.501 173.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.37 -19.13 25.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.333 -1.479 . . . . 0.0 110.185 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.29 -47.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 110.601 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.83 6.52 23.49 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.27 143.24 30.92 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.4 138.17 54.39 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.48 131.9 47.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -125.77 95.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -166.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.0 m -98.01 116.91 31.2 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.21 165.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.37 133.4 47.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.556 -0.715 . . . . 0.0 112.127 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.14 165.11 24.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.701 0.4 . . . . 0.0 110.95 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 144.28 56.69 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.906 -0.497 . . . . 0.0 110.268 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.89 124.34 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.67 -13.4 52.78 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.97 89.08 12.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -171.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -69.27 76.26 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-O 123.395 1.331 . . . . 0.0 113.241 162.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -149.75 -38.38 0.15 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.887 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -135.51 153.05 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.08 152.13 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.126 0.965 . . . . 0.0 112.761 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.09 -174.57 17.67 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.61 112.32 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.253 -1.473 . . . . 0.0 112.432 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 146.77 34.42 Favored Pre-proline 0 C--O 1.245 0.848 1 N-CA-C 97.633 -4.951 . . . . 0.0 97.633 159.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -59.26 -35.24 97.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 CA-C-O 122.65 1.021 . . . . 0.0 113.514 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.82 -0.65 53.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.689 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 t -57.41 -42.57 82.53 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.973 0.892 . . . . 0.0 110.844 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -92.41 0.29 57.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -63.67 -44.46 93.67 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.955 1.252 . . . . 0.0 109.109 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.726 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.97 -40.73 98.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.01 -38.82 92.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.181 0.9 . . . . 0.0 110.427 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 m -62.91 -40.28 97.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.064 -176.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.7 mt -69.76 -43.47 72.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.714 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.61 -32.11 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -164.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -78.2 -33.37 50.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.266 -1.373 . . . . 0.0 110.485 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.03 -14.92 58.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.111 -0.368 . . . . 0.0 111.08 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 55.82 33.16 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.745 1.618 . . . . 0.0 113.162 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.83 154.76 87.05 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.26 150.4 41.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 115.681 -2.413 . . . . 0.0 113.275 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -154.62 172.21 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -126.64 94.2 3.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.645 1.178 . . . . 0.0 108.648 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -75.87 139.69 41.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.447 . . . . 0.0 110.769 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.35 144.34 44.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.47 126.05 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -83.2 122.07 36.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -79.46 70.09 5.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt 53.47 50.69 16.8 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 161.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.36 8.66 65.97 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 114.081 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.99 106.55 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 151.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -137.84 86.42 18.27 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -62.32 173.17 3.55 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 118.007 -0.862 . . . . 0.0 110.837 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -53.01 -37.45 61.51 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -53.63 -53.13 56.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -73.85 -29.39 62.1 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 120.803 -1.185 . . . . 0.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.74 -35.65 81.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 119.274 0.943 . . . . 0.0 110.881 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.81 -20.49 61.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.92 -37.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.836 0.827 . . . . 0.0 111.301 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 t -119.71 120.93 30.19 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 109.872 -170.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.71 -29.6 88.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -97.76 2.11 49.17 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.45 -29.5 2.57 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.038 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.16 72.81 1.4 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.857 1.313 . . . . 0.0 113.181 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.43 155.19 52.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 162.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.81 142.19 56.75 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 114.685 -3.077 . . . . 0.0 110.148 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.67 164.0 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 113.33 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -100.73 88.54 3.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mt -88.46 104.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.48 52.55 13.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.883 0.849 . . . . 0.0 111.377 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t0 60.7 30.61 19.82 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -133.14 151.19 52.0 Favored 'General case' 0 C--N 1.323 -0.573 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 173.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -145.45 150.41 36.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 122.471 2.396 . . . . 0.0 116.741 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.75 150.32 32.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.487 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.46 -12.27 1.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 118.097 2.629 . . . . 0.0 118.097 -169.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -68.49 142.94 55.16 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.047 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -60.56 -27.39 67.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -82.95 -35.45 25.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.223 -0.923 . . . . 0.0 111.088 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -83.67 -14.7 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.293 -0.879 . . . . 0.0 112.29 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 pt -70.85 -6.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.665 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.74 -52.7 8.37 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 157.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.55 -47.06 92.18 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 118.819 2.288 . . . . 0.0 118.819 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -82.57 -27.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -60.69 -44.56 96.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.325 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -65.18 -41.56 94.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 118.414 0.552 . . . . 0.0 110.796 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -58.7 -35.99 73.51 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.839 -1.163 . . . . 0.0 112.301 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.15 17.13 23.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.903 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.07 131.7 80.77 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.05 -12.38 30.34 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 114.586 -3.143 . . . . 0.0 115.024 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -114.78 149.57 42.6 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 118.901 0.773 . . . . 0.0 109.864 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.26 121.78 9.94 Favored 'Trans proline' 0 C--O 1.24 0.59 0 N-CA-C 116.46 1.677 . . . . 0.0 116.46 -148.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.32 161.33 20.01 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.4 mt -139.96 64.95 1.44 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.424 1.107 . . . . 0.0 110.531 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.76 63.13 6.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.517 -0.74 . . . . 0.0 111.815 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 104.25 50.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.89 54.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 124.571 3.514 . . . . 0.0 120.752 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.24 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 116.724 -1.717 . . . . 0.0 115.086 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -34.36 72.49 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.011 -1.681 . . . . 0.0 114.21 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -32.12 73.66 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.729 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 -24.96 55.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.6 p -71.93 -37.19 70.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.41 -49.27 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.61 97.0 Favored Glycine 0 CA--C 1.516 0.149 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.413 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -75.9 -10.0 59.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -78.54 -38.48 40.36 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.78 -1.2 . . . . 0.0 109.901 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.23 -48.15 50.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.689 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -51.28 -53.44 49.19 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -170.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.07 -22.67 16.76 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 114.214 -3.391 . . . . 0.0 114.517 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.6 m -67.33 -38.98 85.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -86.38 -23.94 25.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.67 -33.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -63.76 -45.13 91.17 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.606 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -62.74 -38.16 89.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.5 tp -66.94 -46.32 75.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.297 0.953 . . . . 0.0 111.043 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -69.33 -21.68 63.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.488 0.661 . . . . 0.0 111.619 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.7 t -90.38 138.27 31.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -128.08 30.68 5.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.35 171.53 4.04 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -71.93 59.2 2.85 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 120.711 1.29 . . . . 0.0 114.492 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -60.29 122.19 13.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.109 1.764 . . . . 0.0 112.877 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -152.8 -42.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.235 0.541 . . . . 0.0 109.715 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.64 96.48 Favored Glycine 0 C--O 1.22 -0.745 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.8 p -73.62 -17.63 61.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.392 -1.063 . . . . 0.0 113.062 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.59 -39.24 53.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.833 1.301 . . . . 0.0 107.61 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -79.1 -14.22 59.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.663 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.08 80.23 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.671 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.27 -42.45 93.21 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.98 -43.23 95.24 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.006 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -70.7 -42.15 71.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.73 -33.52 68.79 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 120.146 -1.596 . . . . 0.0 108.983 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.27 -16.43 59.0 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 121.437 -0.789 . . . . 0.0 110.656 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -70.8 -33.52 70.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 119.992 1.269 . . . . 0.0 109.61 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 -39.45 89.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.38 -43.8 93.34 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.173 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.41 -39.07 89.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.538 0.735 . . . . 0.0 110.225 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.4 -51.67 50.4 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -61.35 -38.62 87.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.851 -0.794 . . . . 0.0 112.401 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.81 -39.47 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.537 -0.727 . . . . 0.0 110.717 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -72.66 -24.86 61.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.729 1.604 . . . . 0.0 114.48 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.71 -11.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -118.11 -43.73 2.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.12 -76.32 0.23 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.466 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -67.88 -169.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.063 3.175 . . . . 0.0 117.656 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -53.86 168.66 0.19 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.788 1.635 . . . . 0.0 113.962 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -63.2 -21.79 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -151.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.5 -11.63 53.42 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.186 -0.946 . . . . 0.0 113.338 173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.51 0.48 72.87 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -143.74 -49.54 0.3 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -162.32 176.07 10.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.64 125.79 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.9 p -130.72 -172.3 2.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.64 -31.45 25.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.46 -42.97 81.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 118.784 0.72 . . . . 0.0 110.131 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -66.86 -39.02 87.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.61 -21.53 66.58 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.4 m -91.01 -36.07 14.28 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.98 -49.32 7.43 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.6 48.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.18 -31.34 45.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 113.459 -3.894 . . . . 0.0 113.958 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -30.61 42.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.93 -34.55 76.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.032 0.833 . . . . 0.0 113.19 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -61.9 -43.6 98.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.985 1.266 . . . . 0.0 109.907 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -73.56 -28.54 61.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.146 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.7 -52.24 64.07 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.98 -33.23 75.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.025 -172.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.1 t -72.38 -61.87 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.463 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.28 66.77 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 111.293 -168.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.57 -42.94 77.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.54 -34.47 89.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.874 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -95.06 -16.03 22.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -108.69 -39.9 5.23 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -142.22 58.09 1.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -54.65 116.82 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -134.64 98.44 13.5 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 164.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.41 164.59 32.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 115.124 -2.784 . . . . 0.0 109.29 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.32 117.16 54.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 171.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.68 168.69 24.15 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 117.428 -1.248 . . . . 0.0 112.575 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -4.95 41.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.492 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -66.68 -22.12 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.123 -0.986 . . . . 0.0 110.181 168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.52 50.75 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -56.75 -29.05 62.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.64 -32.6 41.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.578 -1.326 . . . . 0.0 110.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.88 -37.92 70.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.87 -43.79 91.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.072 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -64.7 -38.49 91.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 112.361 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.79 -47.83 84.1 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.949 -0.47 . . . . 0.0 111.764 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.16 -27.34 26.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 O-C-N 120.999 -1.063 . . . . 0.0 111.096 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.97 -33.55 74.86 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.649 -1.282 . . . . 0.0 111.977 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.86 -31.53 71.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.67 0.668 . . . . 0.0 110.229 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.82 -5.77 51.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.384 0.611 . . . . 0.0 112.18 174.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -101.61 9.44 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.0 t -112.11 165.71 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 61.44 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.27 -27.82 69.3 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.138 -0.976 . . . . 0.0 112.341 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 m -56.06 -40.71 73.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -96.56 -50.69 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.496 0.665 . . . . 0.0 109.605 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.87 -43.97 90.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -76.06 -30.53 58.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 52.5 p -75.17 -12.4 60.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.646 -0.659 . . . . 0.0 112.532 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -58.05 132.36 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.47 0.652 . . . . 0.0 110.777 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.04 154.59 39.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.817 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.57 117.28 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.549 1.155 . . . . 0.0 111.188 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.44 -35.52 73.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.3 -37.42 87.1 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.775 -1.203 . . . . 0.0 107.853 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -75.83 -3.97 38.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.533 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.32 -46.51 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.6 -52.28 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.348 1.07 . . . . 0.0 108.17 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.21 27.66 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.138 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -112.71 -46.41 0.73 Allowed Glycine 0 N--CA 1.454 -0.12 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 167.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -53.68 7.45 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -84.61 -1.48 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 120.751 3.612 . . . . 0.0 120.751 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.39 -18.91 43.98 Favored 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 111.398 -5.268 . . . . 0.0 112.687 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.98 -2.22 39.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -104.42 -39.21 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -83.9 -19.87 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.747 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -179.565 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 tpp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.014 -0.041 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.74 150.72 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.76 140.99 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.74 142.13 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.1 mt -134.09 158.56 42.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -171.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -148.43 113.95 5.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.5 164.92 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -52.85 129.42 30.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.1 0.864 . . . . 0.0 112.168 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.02 168.97 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.434 0.635 . . . . 0.0 109.665 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 134.32 56.29 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.08 120.8 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.91 4.93 86.74 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.402 -173.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 88.81 4.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.84 36.06 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.052 1.835 . . . . 0.0 115.323 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -108.91 -19.71 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -151.87 162.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.88 165.29 25.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.191 0.596 . . . . 0.0 111.939 178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.76 170.01 27.8 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -75.06 104.13 5.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -115.91 161.34 31.31 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 147.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -65.5 -17.72 58.02 Favored 'Trans proline' 0 C--N 1.348 0.519 0 N-CA-C 116.881 1.839 . . . . 0.0 116.881 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -117.76 7.82 12.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.4 -44.21 92.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.9 0.857 . . . . 0.0 111.985 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -80.26 -13.94 58.8 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.786 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -61.46 -43.74 98.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.956 2.162 . . . . 0.0 112.842 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -46.67 86.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.6 mt -66.24 -39.22 89.39 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.541 -0.725 . . . . 0.0 112.174 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -43.62 95.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.93 -0.481 . . . . 0.0 110.29 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 p -69.18 -38.59 78.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.442 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -46.29 80.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.94 -27.33 36.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.692 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -66.79 -39.64 87.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.473 -1.392 . . . . 0.0 109.381 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -83.83 4.49 28.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.659 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.4 pttm 44.07 47.04 7.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.028 2.131 . . . . 0.0 115.62 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.87 149.9 36.2 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.35 158.44 36.88 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 117.601 -1.133 . . . . 0.0 114.05 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.81 162.13 41.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -144.3 140.91 29.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 t 68.96 123.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 126.227 2.204 . . . . 0.0 111.533 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -141.06 19.04 2.28 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.78 148.99 43.24 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.326 3.084 . . . . 0.0 119.326 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.4 mm -131.03 108.58 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.443 1.897 . . . . 0.0 106.774 162.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.98 93.25 8.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.286 -1.509 . . . . 0.0 114.201 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt 47.33 48.23 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.518 1.127 . . . . 0.0 112.674 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.03 35.01 45.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.664 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -64.13 107.4 1.27 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 152.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -145.01 79.12 12.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.472 0.653 . . . . 0.0 112.733 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.89 172.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 115.055 -2.83 . . . . 0.0 110.7 165.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.48 -30.58 60.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.236 -0.29 . . . . 0.0 111.571 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -56.16 -51.66 67.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.32 -25.56 59.63 Favored 'General case' 0 C--O 1.218 -0.581 0 O-C-N 120.646 -1.284 . . . . 0.0 111.194 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.13 -25.49 64.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 119.22 0.918 . . . . 0.0 112.081 172.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.79 -29.33 61.06 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.492 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.67 -50.64 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 112.281 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -94.72 118.24 66.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 121.175 -0.953 . . . . 0.0 108.635 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.85 -21.38 38.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 N-CA-C 116.337 1.63 . . . . 0.0 116.337 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -93.69 -14.66 26.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.881 0.848 . . . . 0.0 110.839 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.79 -0.49 61.51 Favored Glycine 0 C--O 1.224 -0.471 0 O-C-N 121.78 -0.575 . . . . 0.0 113.212 -166.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -151.84 32.72 0.55 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.43 144.14 48.44 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.83 149.24 72.47 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 116.188 -2.075 . . . . 0.0 114.058 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.32 168.07 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.14 133.2 67.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 101.813 -3.402 . . . . 0.0 101.813 158.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -117.37 121.32 40.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 163.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -131.41 123.38 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 t70 55.88 35.13 24.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.593 1.187 . . . . 0.0 111.077 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.78 23.04 12.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.457 1.903 . . . . 0.0 115.788 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -121.09 140.73 51.56 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -115.77 153.93 30.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.97 148.13 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -152.03 38.61 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -112.31 149.41 32.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.6 p -58.47 -28.47 65.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.56 -37.77 15.43 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.575 0.584 . . . . 0.0 112.575 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 m -75.98 -17.81 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.914 -1.116 . . . . 0.0 112.722 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.91 -8.0 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.231 -0.293 . . . . 0.0 111.376 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.9 t -105.39 -51.44 8.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 160.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.22 91.95 Favored Glycine 0 C--O 1.228 -0.279 0 N-CA-C 117.941 1.936 . . . . 0.0 117.941 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.6 mt -77.52 -31.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.57 -43.99 96.69 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.481 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.41 -46.99 87.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.793 0.724 . . . . 0.0 109.835 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -66.19 -17.98 65.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -106.78 -5.61 18.32 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.029 0.532 . . . . 0.0 112.295 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -70.04 138.55 87.43 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -30.63 82.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.49 157.96 74.33 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 120.201 1.364 . . . . 0.0 107.949 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.77 141.12 93.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.013 -2.191 . . . . 0.0 114.792 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.56 151.39 52.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 116.919 -1.587 . . . . 0.0 111.415 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.5 mt -130.93 49.99 2.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 63.32 6.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.498 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.5 99.79 45.55 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.14 46.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 N-CA-C 121.231 3.512 . . . . 0.0 121.231 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -78.42 -124.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.225 0 CA-C-N 121.194 1.462 . . . . 0.0 114.237 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.34 -25.35 65.76 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.752 -1.843 . . . . 0.0 113.095 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.68 -42.52 99.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.541 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.45 -34.87 41.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.384 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.5 p -65.34 -34.56 78.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.098 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.56 -43.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.041 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.58 -37.18 93.77 Favored Glycine 0 CA--C 1.52 0.355 0 O-C-N 120.684 -1.26 . . . . 0.0 115.265 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 p -72.2 -15.37 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -77.61 -35.06 53.14 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.468 1.128 . . . . 0.0 110.13 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -77.73 -42.19 28.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.933 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -49.32 -52.68 46.89 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.75 -21.75 12.43 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 114.157 -3.429 . . . . 0.0 114.858 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.9 m -68.22 -43.59 77.66 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.576 -0.702 . . . . 0.0 111.619 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -78.0 -27.7 49.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 118.383 -1.327 . . . . 0.0 113.349 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.09 -29.24 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.15 -40.54 94.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.21 -36.28 81.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.616 -0.677 . . . . 0.0 111.226 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.51 -37.4 85.89 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.296 -0.253 . . . . 0.0 111.53 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -75.83 -27.91 58.07 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.238 -0.914 . . . . 0.0 113.458 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -61.32 137.35 58.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -128.6 29.7 5.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.21 172.53 9.51 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.39 106.17 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 114.234 -3.377 . . . . 0.0 109.939 149.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -125.69 26.57 6.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.44 -36.41 76.6 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.61 -41.06 97.97 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -24.58 59.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.253 1.527 . . . . 0.0 113.176 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.08 -42.05 94.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.229 1.014 . . . . 0.0 108.675 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -76.95 -16.16 59.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.193 -0.942 . . . . 0.0 112.21 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.39 -37.3 71.57 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.51 -41.09 96.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.395 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.25 -47.26 81.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.365 0.416 . . . . 0.0 110.043 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -67.56 -39.56 84.93 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.47 -42.32 95.97 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.097 -1.002 . . . . 0.0 109.871 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.46 -20.44 57.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.137 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.43 -35.28 80.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.535 0.607 . . . . 0.0 111.736 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.06 99.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.194 0.997 . . . . 0.0 109.725 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.14 -35.72 74.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.403 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.294 0.638 . . . . 0.0 112.462 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.66 -39.81 93.85 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.869 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.7 -32.62 72.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -48.43 35.74 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.285 -0.884 . . . . 0.0 110.113 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.01 -8.65 56.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -168.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.86 -10.56 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 167.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -117.45 -45.68 2.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.38 -67.88 0.23 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 119.981 2.753 . . . . 0.0 119.981 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -68.7 -169.33 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.665 2.733 . . . . 0.0 113.92 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -56.08 173.76 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.6 mt -56.83 -40.36 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 112.159 -154.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.86 10.63 2.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.12 -22.69 37.07 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.08 -40.88 0.59 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.06 170.54 21.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.78 123.11 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -128.44 171.77 11.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.85 -32.62 32.68 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.74 -41.64 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 121.641 -0.662 . . . . 0.0 111.437 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.52 -40.86 93.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.03 -21.19 63.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.316 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.2 m -85.6 -34.16 21.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -97.85 -46.25 6.01 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.18 -38.83 72.62 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.7 -31.0 33.59 Favored 'Trans proline' 0 C--N 1.352 0.748 1 C-N-CA 111.838 -4.975 . . . . 0.0 115.465 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -72.11 -30.78 65.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.095 -1.003 . . . . 0.0 108.957 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.9 -34.5 77.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.42 -47.03 83.64 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.174 -0.954 . . . . 0.0 109.063 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.93 -33.63 75.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.643 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.85 -52.72 64.22 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.84 -36.55 79.4 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -169.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.6 m -77.05 -35.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.14 -45.57 56.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.667 0.746 . . . . 0.0 110.304 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.44 -38.52 91.3 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.929 0.492 . . . . 0.0 109.754 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.87 -34.94 89.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.987 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.24 -49.65 11.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.347 0.573 . . . . 0.0 112.487 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -76.89 -47.44 21.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -148.19 66.0 1.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -165.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -54.73 112.67 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -163.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -141.83 91.88 8.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.04 155.74 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 115.286 -2.676 . . . . 0.0 109.473 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.91 123.58 89.65 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.65 154.8 63.98 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.557 -2.495 . . . . 0.0 112.247 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -75.22 2.7 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -71.22 -29.66 65.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.61 58.21 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -27.36 69.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.311 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -64.05 1.0 Allowed 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 167.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.74 -37.24 78.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -159.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.89 -50.93 71.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -76.19 -25.1 54.84 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.171 -0.956 . . . . 0.0 113.136 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.24 -49.47 71.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.548 0.689 . . . . 0.0 109.198 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.7 mt -62.61 -44.65 99.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.45 -48.34 81.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.7 -47.94 76.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 110.283 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.18 -19.26 58.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.25 -32.97 64.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 t -116.81 29.69 7.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.52 0.676 . . . . 0.0 110.573 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -67.82 144.43 55.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.58 -37.63 70.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.645 1.111 . . . . 0.0 110.869 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -58.08 -50.02 74.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -68.05 -40.51 82.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -56.69 -36.91 70.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.562 0.696 . . . . 0.0 110.901 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -82.67 -36.18 26.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 59.5 p -104.83 3.16 30.8 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -170.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.86 141.43 49.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.512 -0.743 . . . . 0.0 111.82 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.49 163.49 27.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.52 127.24 31.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -62.77 -36.24 82.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 111.899 -173.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -61.16 -30.13 70.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.741 0.781 . . . . 0.0 110.552 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -96.44 -5.45 39.62 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.782 -0.574 . . . . 0.0 112.02 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.94 -50.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 162.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.87 -67.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.107 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.99 62.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.57 -1.331 . . . . 0.0 111.917 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.33 -30.55 10.7 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -99.27 -28.93 13.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.91 1.855 . . . . 0.0 111.184 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -73.96 -3.1 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -67.74 -19.32 47.49 Favored 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 109.306 -6.663 . . . . 0.0 114.281 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -74.33 -23.08 58.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.348 0.976 . . . . 0.0 113.084 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.19 -31.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -100.12 27.43 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.962 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.816 1.646 . . . . 0.0 114.863 -174.735 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 119.705 -0.188 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.98 138.97 46.36 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.192 -0.942 . . . . 0.0 109.415 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 mp -124.87 140.37 52.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 103.439 -2.801 . . . . 0.0 103.439 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -132.79 162.39 31.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.35 155.42 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.7 m -115.75 118.37 32.86 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 101.703 -3.443 . . . . 0.0 101.703 164.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.64 159.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -71.92 122.25 20.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 162.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.06 165.37 25.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.58 130.43 46.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.152 0.977 . . . . 0.0 112.179 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.26 123.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -9.93 66.79 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.34 0.896 . . . . 0.0 115.34 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.29 87.38 13.71 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.471 1.136 . . . . 0.0 112.027 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.16 50.87 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.967 3.778 . . . . 0.0 117.01 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.11 -31.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -126.51 158.25 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.86 139.16 58.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.32 1.048 . . . . 0.0 109.522 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.5 -157.92 23.75 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 120.188 2.835 . . . . 0.0 120.188 -172.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.02 31.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.156 2.182 . . . . 0.0 113.803 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.5 t -66.69 121.98 80.0 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.721 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.88 -26.09 52.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 N-CA-C 117.06 1.908 . . . . 0.0 117.06 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.9 2.47 9.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.2 m -64.59 -42.96 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.207 -0.933 . . . . 0.0 111.575 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.16 -15.41 61.97 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.752 -1.179 . . . . 0.0 113.258 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.253 1.388 . . . . 0.0 110.675 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -44.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.29 -29.46 65.08 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 119.274 0.943 . . . . 0.0 112.684 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 p -76.56 -34.56 58.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.043 -1.036 . . . . 0.0 110.175 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.46 -39.47 85.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.114 0.959 . . . . 0.0 113.115 -175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -78.31 -27.19 47.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -67.54 -37.82 83.27 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.763 -1.21 . . . . 0.0 110.014 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -74.95 -17.85 60.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 54.73 36.57 26.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -78.0 165.15 52.79 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -54.41 139.18 74.33 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 119.495 0.855 . . . . 0.0 112.783 162.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.0 173.37 11.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 -143.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -110.21 118.43 36.32 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 112.772 -155.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -161.51 123.27 2.9 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 162.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -138.49 150.32 46.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 160.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.8 mt -108.15 120.55 42.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.182 0.446 . . . . 0.0 111.812 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.54 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -84.53 81.14 8.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.998 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 mt 52.63 31.07 9.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.52 79.42 1.46 Allowed Glycine 0 C--O 1.235 0.186 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -110.36 -74.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.814 0.816 . . . . 0.0 110.269 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.27 149.32 91.59 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.994 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.8 -167.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 116.768 1.795 . . . . 0.0 116.768 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -52.87 -22.4 5.44 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.62 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.595 1.089 . . . . 0.0 111.2 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.75 -34.93 64.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.533 -0.729 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.76 -27.24 62.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.44 -33.25 73.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.441 0.639 . . . . 0.0 110.771 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.8 mm -84.96 -48.51 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.404 0.621 . . . . 0.0 111.268 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -82.6 114.33 51.09 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 122.987 0.515 . . . . 0.0 111.4 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.46 -24.41 31.08 Favored 'Trans proline' 0 C--N 1.347 0.496 0 N-CA-C 117.294 1.998 . . . . 0.0 117.294 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -92.83 -7.47 46.28 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.82 -16.54 11.25 Favored Glycine 0 C--O 1.225 -0.434 0 O-C-N 121.705 -0.622 . . . . 0.0 112.683 -167.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -140.89 24.93 2.16 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.47 163.41 59.2 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.19 142.93 62.76 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.148 -4.768 . . . . 0.0 112.352 161.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.1 t -128.84 132.97 67.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.67 122.45 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.43 1.109 . . . . 0.0 109.625 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -95.32 128.92 42.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.45 91.49 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.4 t0 51.16 51.39 17.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.289 1.042 . . . . 0.0 110.864 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t0 63.16 8.36 3.27 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.66 144.03 34.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 157.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -128.0 124.82 38.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 120.481 1.491 . . . . 0.0 109.167 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.43 156.99 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.94 96.58 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -154.65 153.92 32.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 101.815 -3.402 . . . . 0.0 101.815 167.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.9 p -61.96 -32.57 73.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -95.6 -14.36 23.61 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -81.36 -21.12 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.937 -1.727 . . . . 0.0 108.041 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -21.31 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.143 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -89.1 -48.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.62 -64.7 1.2 Allowed Glycine 0 CA--C 1.519 0.291 0 N-CA-C 120.389 2.915 . . . . 0.0 120.389 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.81 -34.16 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.651 0.739 . . . . 0.0 109.336 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.94 -47.21 87.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.089 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.25 -34.28 77.66 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.09 0.859 . . . . 0.0 112.107 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.46 -28.06 63.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.809 0.844 . . . . 0.0 110.407 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -120.2 21.55 11.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -100.82 76.22 0.14 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.442 0.697 . . . . 0.0 111.647 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.7 5.63 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.748 2 C-N-CA 125.757 4.305 . . . . 0.0 123.119 -131.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.88 172.48 8.9 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 158.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.61 135.42 70.34 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 114.988 -2.875 . . . . 0.0 116.904 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.54 116.8 4.81 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.477 1.451 . . . . 0.0 114.033 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.78 81.7 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.544 1.164 . . . . 0.0 113.528 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -118.27 73.72 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.969 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.19 114.62 63.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -106.7 61.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.64 0 N-CA-C 117.846 2.21 . . . . 0.0 117.846 168.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.95 -132.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 120.03 1.047 . . . . 0.0 112.715 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.06 -37.53 61.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -25.69 68.26 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 120.927 -1.108 . . . . 0.0 112.515 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.55 70.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.8 p -72.53 -33.67 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.68 -49.48 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.507 0.67 . . . . 0.0 109.244 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.64 94.64 Favored Glycine 0 C--O 1.228 -0.234 0 O-C-N 122.094 -0.379 . . . . 0.0 113.915 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.1 p -71.68 -12.37 61.3 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.99 -36.56 27.75 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.98 -1.075 . . . . 0.0 110.313 169.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.97 -46.6 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.353 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -50.0 -54.24 34.93 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -171.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.35 -19.85 12.98 Favored 'Trans proline' 0 C--N 1.349 0.601 1 C-N-CA 112.305 -4.664 . . . . 0.0 114.319 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -66.88 -47.16 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -73.32 -24.47 60.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.006 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.44 -38.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.91 -48.89 76.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.88 -43.92 94.48 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.77 -18.7 62.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.0 0.2 43.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.384 -0.197 . . . . 0.0 110.607 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 t -110.19 142.18 42.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.73 33.53 4.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.65 171.56 10.5 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.84 78.78 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 CA-C-N 120.642 1.265 . . . . 0.0 114.569 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -91.26 26.02 2.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -155.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.3 -35.42 80.3 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.683 -1.886 . . . . 0.0 112.263 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.39 -32.06 68.36 Favored Glycine 0 C--O 1.223 -0.562 0 O-C-N 121.463 -0.773 . . . . 0.0 112.966 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 m -77.98 -30.35 50.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.536 1.168 . . . . 0.0 111.398 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.0 -41.79 99.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.502 1.144 . . . . 0.0 108.351 171.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -73.75 -24.29 59.86 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.172 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.45 99.43 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 120.799 -1.188 . . . . 0.0 108.819 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.0 -44.41 96.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.13 -44.15 97.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -80.84 -30.65 35.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.65 -35.59 60.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.062 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.71 -17.45 57.61 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 120.96 -1.088 . . . . 0.0 109.837 173.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -69.55 -35.66 75.64 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.294 -1.504 . . . . 0.0 110.286 167.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.15 -45.53 93.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.11 -39.54 90.38 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -40.77 98.3 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.927 -1.108 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.95 -35.87 72.65 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.643 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -72.87 -36.84 67.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.483 -1.01 . . . . 0.0 112.631 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.24 -43.25 91.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 109.825 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.32 -19.49 63.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.979 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.68 -25.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.807 0.73 . . . . 0.0 111.095 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -112.46 -35.89 5.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.87 -71.16 0.22 Allowed Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.403 -1.776 . . . . 0.0 114.714 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.44 -160.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.799 4.333 . . . . 0.0 118.486 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -56.92 166.67 0.95 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.286 1.434 . . . . 0.0 112.159 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -52.46 -33.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.53 8.08 4.74 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.97 -33.81 5.49 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.07 -40.22 2.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.747 1.273 . . . . 0.0 112.331 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.41 -178.52 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.977 0.511 . . . . 0.0 110.249 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.8 mt -67.42 121.34 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 m -153.29 171.25 18.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -25.57 -54.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.969 1 N-CA-C 122.677 4.325 . . . . 0.0 122.677 -173.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.17 -35.34 75.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.015 -1.053 . . . . 0.0 110.483 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.32 -43.43 73.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.23 -32.56 73.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.596 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.2 m -71.13 -38.65 72.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.1 tp -100.32 -45.69 5.51 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -170.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.41 -43.13 97.38 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.12 -20.79 24.62 Favored 'Trans proline' 0 C--N 1.35 0.614 1 C-N-CA 111.296 -5.336 . . . . 0.0 114.782 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -78.29 -22.35 48.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 120.931 -1.106 . . . . 0.0 110.556 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 -27.01 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 118.435 0.561 . . . . 0.0 111.092 169.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.7 -44.53 64.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.157 -0.965 . . . . 0.0 110.263 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -62.67 -30.27 71.26 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.875 -0.515 . . . . 0.0 111.211 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.92 -58.36 8.9 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.25 -31.65 72.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.273 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.86 -54.88 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.758 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.86 -41.19 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.1 tp -67.77 -37.82 82.61 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.01 -32.88 81.86 Favored Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -74.95 -48.38 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.39 -45.05 12.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -167.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -149.1 60.98 1.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -52.3 120.64 5.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -162.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -145.48 93.82 5.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 163.01 39.58 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 115.882 -2.279 . . . . 0.0 109.879 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.4 124.81 90.84 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.7 166.44 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 117.105 -1.464 . . . . 0.0 113.92 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.86 -0.14 20.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.436 1.112 . . . . 0.0 112.27 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.31 -14.37 61.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.25 51.95 1.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.9 t -62.77 -26.26 68.62 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.709 -0.62 . . . . 0.0 112.464 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.91 -35.25 62.22 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.696 -1.252 . . . . 0.0 108.066 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.2 -40.39 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 109.368 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.42 -44.66 90.51 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.969 -0.457 . . . . 0.0 111.491 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.52 -23.83 61.06 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.027 -1.046 . . . . 0.0 111.734 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -68.96 -49.17 60.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.905 0.482 . . . . 0.0 110.31 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.64 -33.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 120.906 -1.121 . . . . 0.0 111.372 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.02 -38.9 90.44 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.861 -1.149 . . . . 0.0 111.459 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.61 -42.69 86.48 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.69 -0.631 . . . . 0.0 111.835 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.5 mt -66.18 -46.72 76.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -55.85 -42.43 75.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.9 t -106.32 71.25 0.87 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 111.037 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.58 153.41 43.74 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -57.33 -48.68 78.35 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.809 0.693 . . . . 0.0 110.699 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.0 t -65.58 -43.71 88.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.928 0.87 . . . . 0.0 112.28 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -65.25 -45.26 85.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.641 0.734 . . . . 0.0 110.626 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.98 -37.68 81.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.499 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -69.65 -36.49 76.12 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.0 -1.062 . . . . 0.0 111.984 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 64.2 p -87.93 -0.28 56.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -62.04 141.17 58.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.92 44.73 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.41 122.11 15.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.02 -48.6 73.33 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -166.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -21.71 66.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.692 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -95.64 -1.59 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.58 -44.73 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 164.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.95 -55.08 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.15 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.8 5.45 9.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.509 -0.744 . . . . 0.0 112.819 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.71 -44.26 3.7 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 169.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -91.06 -38.37 12.83 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.34 -20.42 0.58 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.34 -24.58 71.53 Favored 'Trans proline' 0 C--N 1.353 0.776 1 C-N-CA 111.761 -5.026 . . . . 0.0 115.372 167.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -79.63 -36.47 37.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.175 1.807 . . . . 0.0 111.226 172.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.61 -35.54 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 121.614 -0.679 . . . . 0.0 110.345 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.12 -16.0 20.69 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-N 119.141 0.882 . . . . 0.0 113.168 -171.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.373 0.13 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.38 154.81 43.06 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 109.25 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp -139.0 160.71 39.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.36 139.79 43.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.84 114.36 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.8 m -109.86 130.84 55.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.08 139.82 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 123.991 0.807 . . . . 0.0 112.264 -164.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.48 128.5 36.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.087 0.403 . . . . 0.0 110.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.05 176.34 9.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.202 1.001 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.51 41.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.858 1.313 . . . . 0.0 109.385 167.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.39 109.84 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.354 -170.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.97 23.48 66.4 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.665 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.92 89.29 5.69 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.96 54.52 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.945 3.097 . . . . 0.0 114.245 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -141.43 -28.08 0.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 pt -141.45 168.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 118.445 0.566 . . . . 0.0 110.518 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.27 146.82 45.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.114 1.765 . . . . 0.0 112.748 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.74 -174.6 13.81 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -73.56 92.43 1.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.422 1.106 . . . . 0.0 111.355 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.77 135.72 22.42 Favored Pre-proline 0 C--O 1.246 0.883 1 N-CA-C 99.344 -4.317 . . . . 0.0 99.344 138.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -57.42 -39.62 87.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.21 0.754 . . . . 0.0 112.956 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.24 -23.29 43.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.054 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.53 -34.24 77.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.801 -1.187 . . . . 0.0 113.418 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -80.61 -12.74 59.46 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.565 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -69.0 -41.91 77.18 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -44.95 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mt -64.26 -39.37 93.82 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.748 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.52 -43.3 97.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.569 0.622 . . . . 0.0 111.385 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 p -70.17 -39.13 75.49 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.62 -43.91 88.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -76.24 -29.28 57.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.548 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -68.42 -34.32 75.8 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.528 -1.358 . . . . 0.0 111.401 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.52 -11.46 45.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.47 51.97 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.352 1.461 . . . . 0.0 113.622 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.3 pt -98.8 155.1 37.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.05 145.16 30.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.837 -2.975 . . . . 0.0 111.314 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.54 157.95 41.81 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 121.993 -0.442 . . . . 0.0 110.756 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -110.78 110.51 21.17 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.662 0.385 . . . . 0.0 111.719 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -86.1 128.38 34.87 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.11 93.57 4.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.654 1.182 . . . . 0.0 111.437 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.67 142.91 57.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.889 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.05 94.2 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.5 85.07 5.99 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.495 -0.753 . . . . 0.0 112.039 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt 54.35 45.06 27.98 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.002 0.906 . . . . 0.0 113.164 166.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.72 94.36 1.85 Allowed Glycine 0 C--O 1.238 0.352 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.523 -168.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -124.59 -91.08 0.55 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -69.68 152.38 96.2 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.204 -170.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.97 -175.68 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.552 2.168 . . . . 0.0 115.282 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -64.19 -10.76 25.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -161.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -49.3 -41.04 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.741 0.416 . . . . 0.0 110.094 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -79.84 -28.69 40.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.2 -34.8 78.28 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.895 0.855 . . . . 0.0 110.507 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.89 -36.64 84.59 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 121.362 -0.837 . . . . 0.0 110.362 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.1 mt -75.62 -45.81 38.11 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 C-N-CA 124.038 0.935 . . . . 0.0 112.716 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 60' ' ' VAL . 28.7 t -102.99 129.62 25.27 Favored Pre-proline 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 112.973 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.29 -23.16 28.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 116.655 -1.764 . . . . 0.0 116.39 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.72 -10.96 25.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.788 -1.195 . . . . 0.0 110.718 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 -5.93 67.5 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 121.561 -0.712 . . . . 0.0 113.8 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -144.89 34.43 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -167.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 55' ' ' SER . 11.8 m -119.16 161.81 34.92 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.934 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.63 151.25 58.11 Favored 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 111.417 -5.255 . . . . 0.0 110.081 171.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.6 161.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.29 126.26 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.999 0.818 . . . . 0.0 109.375 160.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.05 87.64 3.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.06 111.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 47.76 56.15 7.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.132 0.895 . . . . 0.0 113.27 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 t70 71.4 -7.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.94 122.85 44.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.047 -1.033 . . . . 0.0 110.147 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -107.07 131.42 54.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.65 144.74 37.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-N 115.256 -0.883 . . . . 0.0 113.331 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.72 115.63 1.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.35 157.08 10.63 Favored 'General case' 0 N--CA 1.472 0.654 1 N-CA-C 96.959 -5.2 . . . . 0.0 96.959 160.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.9 p -57.44 -35.17 69.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.92 -41.17 60.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.059 -0.4 . . . . 0.0 111.907 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -81.64 -17.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.837 -0.539 . . . . 0.0 110.691 -171.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -23.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.63 -47.91 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.083 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.1 62.47 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.4 mt -80.47 -29.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.596 1.698 . . . . 0.0 106.629 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.28 -41.15 92.72 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.718 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.59 -39.75 80.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 112.798 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -60.47 -33.46 72.6 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.131 -0.981 . . . . 0.0 111.454 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.81 10.86 38.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.54 130.99 90.13 Favored Pre-proline 0 C--O 1.247 0.927 0 O-C-N 121.606 -0.683 . . . . 0.0 109.195 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.41 -17.3 30.64 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.129 -1.448 . . . . 0.0 113.779 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.98 161.54 27.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -63.93 144.13 87.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 115.807 -2.329 . . . . 0.0 117.122 -169.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.23 136.52 7.85 Favored 'Trans proline' 0 C--O 1.24 0.584 0 N-CA-C 118.366 2.41 . . . . 0.0 118.366 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.26 41.36 3.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.329 1.052 . . . . 0.0 111.981 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.57 66.76 4.17 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.759 0.824 . . . . 0.0 112.016 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.11 106.08 28.52 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -100.7 75.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 125.158 3.905 . . . . 0.0 118.01 166.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -91.0 -140.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.474 1.449 . . . . 0.0 114.241 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.87 -37.12 29.65 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.05 -25.52 64.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.114 -0.991 . . . . 0.0 112.428 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.49 47.42 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.874 -0.516 . . . . 0.0 111.895 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.1 p -70.12 -32.81 71.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.71 -38.84 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.9 -39.41 93.98 Favored Glycine 0 C--O 1.227 -0.308 0 O-C-N 121.702 -0.624 . . . . 0.0 112.815 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.9 p -76.51 5.92 6.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.083 1.441 . . . . 0.0 114.45 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -104.29 -25.49 12.86 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.419 -0.801 . . . . 0.0 112.535 165.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.3 mt -85.92 -47.89 16.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.955 0.407 . . . . 0.0 111.098 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -50.37 -52.02 58.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.19 -20.97 10.94 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 114.307 -3.328 . . . . 0.0 115.861 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.1 p -79.73 -37.88 34.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -46.8 89.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.494 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.84 -26.7 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 121.39 -0.819 . . . . 0.0 112.318 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -65.45 -43.17 91.21 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.26 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.38 -23.37 63.73 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.3 tp -66.05 -38.83 89.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.774 0.715 . . . . 0.0 110.955 171.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -83.02 -31.27 27.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 t -74.0 131.24 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -114.64 30.61 7.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.298 1.047 . . . . 0.0 109.497 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.35 171.34 8.02 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.013 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.28 95.73 0.69 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 116.249 -2.034 . . . . 0.0 112.447 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -115.3 59.23 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.281 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -94.63 -45.18 7.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.64 -28.01 62.05 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.288 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 p -97.8 -5.1 35.55 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.6 -31.31 66.77 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 161.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -76.73 0.08 21.81 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.947 -1.096 . . . . 0.0 111.596 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.22 69.23 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.19 -35.42 79.6 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.473 -0.767 . . . . 0.0 109.942 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.2 -43.64 92.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.89 -28.77 64.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.18 -36.29 40.54 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.543 -1.348 . . . . 0.0 110.381 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.3 mt -74.37 -25.48 59.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.072 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.74 -34.29 72.76 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 118.55 0.613 . . . . 0.0 111.231 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.7 77.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.12 -36.2 82.53 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.751 0.705 . . . . 0.0 111.936 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.99 -42.12 89.28 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.12 0.568 . . . . 0.0 111.741 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.04 57.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.358 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -36.23 75.28 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.807 0.443 . . . . 0.0 111.521 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -54.09 18.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.678 -0.638 . . . . 0.0 109.937 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.6 -24.24 67.02 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.6 m -79.57 -11.35 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.61 -39.86 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.48 -68.17 0.27 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 121.267 3.267 . . . . 0.0 121.267 173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -74.47 -171.42 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 N-CA-C 120.213 3.121 . . . . 0.0 120.213 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -49.73 154.03 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.028 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -67.2 -32.8 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.692 -124.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.15 -19.48 5.13 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.97 3.51 48.71 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-O 119.224 -0.765 . . . . 0.0 112.18 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -139.61 -62.25 0.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -163.24 178.9 7.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.89 114.05 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 124.143 0.902 . . . . 0.0 110.593 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -120.92 -169.93 1.92 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.5 29.31 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.71 -40.56 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.404 -1.435 . . . . 0.0 111.601 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.5 -39.9 94.65 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.3 -28.98 68.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -70.92 -37.22 72.9 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.084 -1.01 . . . . 0.0 111.719 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.12 -59.93 2.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.88 76.61 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -69.1 -24.33 32.82 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 113.842 -3.639 . . . . 0.0 115.996 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -88.02 -29.41 20.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.294 1.406 . . . . 0.0 108.902 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.85 -35.73 73.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.376 0.535 . . . . 0.0 110.54 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.46 -48.46 71.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -65.36 -40.88 94.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.43 76.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.819 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.67 -28.21 68.28 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.811 1.187 . . . . 0.0 112.888 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.1 m -81.01 -38.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 O-C-N 121.052 -1.03 . . . . 0.0 110.102 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.26 -49.5 19.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.145 0.429 . . . . 0.0 111.979 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.01 -35.41 80.61 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.06 -29.91 76.24 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 115.432 0.933 . . . . 0.0 115.432 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -89.7 -44.1 10.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.371 1.085 . . . . 0.0 113.057 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.17 -37.27 20.36 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -138.5 30.92 2.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.917 0.487 . . . . 0.0 112.277 -163.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -22.93 109.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -152.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -142.22 90.44 8.21 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.869 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.55 160.01 42.03 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 117.121 -1.453 . . . . 0.0 110.344 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.62 121.65 85.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.93 162.43 34.74 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 116.619 -1.788 . . . . 0.0 113.911 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -4.41 30.37 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.317 -0.864 . . . . 0.0 112.949 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -66.62 -22.91 66.11 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.478 0.656 . . . . 0.0 110.206 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.33 66.38 0.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 m -58.53 -36.57 74.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.361 -170.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -51.69 68.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.57 -41.58 80.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -161.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.23 -46.99 65.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.726 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.56 -45.73 89.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.092 -176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -72.6 -29.05 63.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.459 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.59 -40.96 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.857 1.208 . . . . 0.0 110.057 171.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.82 -33.75 74.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.553 -0.717 . . . . 0.0 112.721 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.9 -38.13 79.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.196 0.907 . . . . 0.0 110.869 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.5 -42.02 88.01 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.387 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -50.49 -38.79 46.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -173.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.3 t -120.79 38.55 4.01 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.727 1.251 . . . . 0.0 110.761 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -78.85 143.32 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 161.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -56.55 -45.37 81.28 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.58 1.082 . . . . 0.0 113.653 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -62.22 -44.78 95.81 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -77.07 -38.0 53.41 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.396 -0.815 . . . . 0.0 112.67 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -59.32 -36.46 75.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.045 0.926 . . . . 0.0 110.874 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.01 -40.95 44.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.9 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.7 p -98.47 -3.63 36.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -60.28 140.86 56.84 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.21 150.03 40.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.9 139.01 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -63.93 -39.27 93.79 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.75 -31.04 71.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.568 1.175 . . . . 0.0 109.698 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -96.16 10.19 38.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.526 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -100.85 -51.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.439 156.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.9 -66.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.07 -9.73 58.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.107 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.78 -31.37 29.74 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.442 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -110.6 -28.09 8.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.605 1.202 . . . . 0.0 112.975 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -74.46 -9.7 0.15 Allowed Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 121.618 3.932 . . . . 0.0 121.618 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.92 -20.36 57.94 Favored 'Trans proline' 0 C--N 1.36 1.147 1 C-N-CA 111.354 -5.297 . . . . 0.0 114.639 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -73.31 -27.97 61.82 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.346 -0.846 . . . . 0.0 113.204 172.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.2 t -72.56 -34.88 49.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.489 1.138 . . . . 0.0 108.216 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -79.26 2.48 21.12 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.381 0 C-N-CA 128.545 2.738 . . . . 0.0 115.872 -179.034 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.217 -0.657 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.28 0.7 OUTLIER -171.27 -148.49 0.05 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.372 1.442 . . . . 0.0 109.937 160.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.33 143.96 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -133.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -126.15 110.98 14.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.845 -3.391 . . . . 0.0 101.845 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.3 167.24 26.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.76 139.56 44.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.81 156.34 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.03 127.17 30.25 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 164.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.03 119.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.22 75.39 Favored Glycine 0 C--O 1.25 1.102 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.01 76.79 8.63 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.745 -0.727 . . . . 0.0 111.605 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.9 53.7 2.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.623 2.882 . . . . 0.0 116.52 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -128.51 -37.59 1.79 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.483 -0.76 . . . . 0.0 112.13 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.2 mt -95.92 142.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.38 152.39 17.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.25 176.16 48.38 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.44 31.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.551 -1.825 . . . . 0.0 115.573 -172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.7 t -96.01 145.75 30.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.632 -0.667 . . . . 0.0 112.38 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -68.33 -47.96 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 117.028 -1.514 . . . . 0.0 115.191 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -19.93 60.49 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.824 -0.547 . . . . 0.0 110.208 -172.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.4 t -55.7 -55.59 30.45 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.656 0.597 . . . . 0.0 109.708 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.56 -15.14 59.93 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 96.0 mtt180 -61.43 -52.74 63.29 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.283 1.401 . . . . 0.0 109.782 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HG12 ' A' ' 76' ' ' ILE . 16.4 m -79.2 -31.84 14.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.691 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -62.13 -44.83 95.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.932 0.787 . . . . 0.0 110.444 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.041 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -61.33 -36.33 79.84 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.396 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.2 -40.09 31.66 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.69 -0.631 . . . . 0.0 111.799 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -70.12 -31.25 68.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.32 0.509 . . . . 0.0 111.642 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.34 -34.6 77.66 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.917 -1.114 . . . . 0.0 110.761 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -82.29 -14.32 55.58 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.101 -0.999 . . . . 0.0 112.647 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 56.49 57.87 4.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.647 . . . . 0.0 112.918 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 pt -94.71 161.83 27.47 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.82 151.24 68.67 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 115.858 -2.295 . . . . 0.0 110.942 164.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -147.36 154.84 41.39 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -100.07 -92.77 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -165.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 178.37 7.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -153.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -134.13 174.75 10.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.095 0.958 . . . . 0.0 113.524 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.54 152.32 0.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -94.98 117.92 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 166.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.04 72.28 10.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.5 67.17 1.0 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 167.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.82 -2.41 84.29 Favored Glycine 0 C--O 1.228 -0.279 0 O-C-N 121.186 -0.946 . . . . 0.0 113.411 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -87.19 92.2 8.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -122.08 83.96 45.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 122.132 0.967 . . . . 0.0 113.078 -170.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.69 172.74 13.8 Favored 'Trans proline' 0 C--O 1.238 0.488 0 N-CA-C 110.33 -0.681 . . . . 0.0 110.33 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -55.69 -34.07 64.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -54.63 -53.04 59.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 118.716 0.689 . . . . 0.0 111.884 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -73.33 -29.14 62.47 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.644 -1.285 . . . . 0.0 112.671 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.45 -25.84 64.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.581 1.082 . . . . 0.0 111.855 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -74.34 -41.36 61.2 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.761 -0.587 . . . . 0.0 109.525 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -74.01 -54.64 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -100.86 136.18 19.86 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.871 0.868 . . . . 0.0 111.971 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.59 -24.6 15.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 116.256 -2.029 . . . . 0.0 116.304 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -104.97 -5.37 21.06 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.13 -5.21 51.12 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 122.798 1.221 . . . . 0.0 113.284 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -148.85 37.31 0.8 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.786 1.234 . . . . 0.0 111.629 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.85 136.21 28.47 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -58.26 149.38 73.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 114.354 0.867 . . . . 0.0 114.354 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 m -136.14 169.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.92 141.81 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 156.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -103.27 93.65 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.25 96.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.078 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.07 37.36 24.61 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.545 1.164 . . . . 0.0 112.125 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t0 67.94 41.25 2.13 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 126.156 1.782 . . . . 0.0 115.661 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -131.16 153.02 49.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 167.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.63 126.46 20.77 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.37 149.58 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.12 81.77 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -151.28 152.59 33.43 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 168.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.2 p -55.3 -29.99 59.29 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -165.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.18 -35.52 10.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.286 0.565 . . . . 0.0 112.165 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.53 -37.48 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.604 0.716 . . . . 0.0 110.528 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG12 HG11 ' A' ' 26' ' ' VAL . 11.8 tt -60.17 -29.99 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.629 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.8 t -88.45 -49.57 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.493 0.717 . . . . 0.0 111.77 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.83 -34.12 71.48 Favored Glycine 0 C--O 1.235 0.213 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.936 -168.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.26 -30.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.52 -44.25 97.41 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 121.895 -0.503 . . . . 0.0 109.851 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -62.87 -46.3 88.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.349 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.85 -37.17 85.79 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.479 -0.763 . . . . 0.0 112.33 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.59 7.32 46.67 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -81.61 129.23 66.44 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.14 -17.08 22.21 Favored 'Trans proline' 0 C--O 1.244 0.8 0 N-CA-C 116.023 1.509 . . . . 0.0 116.023 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.41 148.87 67.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -60.22 116.78 3.56 Favored 'Trans proline' 0 C--O 1.243 0.753 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.58 170.36 11.66 Favored 'Trans proline' 0 C--O 1.249 1.033 0 N-CA-C 115.114 1.159 . . . . 0.0 115.114 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 HG22 ' A' ' 147' ' ' THR . 12.5 tp -141.54 69.91 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 122.598 1.19 . . . . 0.0 110.005 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.47 65.06 6.45 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.277 -1.328 . . . . 0.0 112.46 -175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 m -120.12 100.54 47.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.21 86.18 0.06 OUTLIER 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.512 3.475 . . . . 0.0 117.989 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -88.55 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.004 1 C-N-CA 127.23 5.286 . . . . 0.0 111.739 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -45.36 -34.8 3.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.52 -30.17 71.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 120.559 -1.338 . . . . 0.0 112.366 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.35 -28.64 34.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.053 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -72.06 -32.38 67.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.125 0.875 . . . . 0.0 109.638 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.44 -40.62 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.318 -0.864 . . . . 0.0 109.684 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.02 -30.84 70.99 Favored Glycine 0 CA--C 1.521 0.425 0 O-C-N 121.793 -0.567 . . . . 0.0 114.313 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -73.12 -9.49 58.77 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -80.76 -46.62 15.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt -75.63 -42.12 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.925 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.13 -53.26 67.2 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.78 -18.99 21.55 Favored 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 112.637 -4.442 . . . . 0.0 113.636 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.0 t -66.96 -56.55 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.015 0.526 . . . . 0.0 111.804 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -72.92 -23.97 60.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.79 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -68.23 -47.25 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -63.26 -44.39 95.28 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -69.79 -34.89 74.35 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.06 -34.45 76.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.195 0.907 . . . . 0.0 110.286 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.78 -24.89 61.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.631 0.772 . . . . 0.0 111.762 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -87.77 127.54 35.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -116.71 39.13 3.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.51 -175.31 0.18 Allowed Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 127.053 2.141 . . . . 0.0 109.68 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.08 41.26 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 114.675 0.99 . . . . 0.0 114.675 146.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -71.79 105.75 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.653 -1.279 . . . . 0.0 112.595 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.98 -54.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.4 -36.33 93.06 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.654 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.3 p -77.85 -21.92 50.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.383 0.592 . . . . 0.0 112.204 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.63 -35.75 75.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.659 1.695 . . . . 0.0 107.02 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -79.77 -3.69 48.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.72 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.48 -31.33 24.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.882 -1.136 . . . . 0.0 108.081 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.55 -41.24 88.95 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.335 -0.853 . . . . 0.0 110.065 165.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.82 -36.53 72.37 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.91 -0.493 . . . . 0.0 110.925 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -64.0 -36.24 83.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -78.02 -33.71 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.3 -24.59 61.35 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.63 -0.668 . . . . 0.0 111.001 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.09 -33.06 71.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.579 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.28 80.45 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.108 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.94 -34.55 78.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.397 1.094 . . . . 0.0 111.744 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.76 -38.66 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.26 -36.49 93.28 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.803 -1.09 . . . . 0.0 114.665 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -69.15 -46.22 68.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.864 1.332 . . . . 0.0 110.643 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 178' ' ' HIS . 5.8 tt -68.41 -38.39 81.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.558 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -68.74 -20.07 64.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.798 1.181 . . . . 0.0 112.851 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -81.73 -52.26 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.91 -31.84 40.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.17 -81.95 0.3 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-O 117.881 -1.511 . . . . 0.0 114.319 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -77.47 -174.25 2.13 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.214 3.276 . . . . 0.0 114.18 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -33.12 165.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 119.463 3.134 . . . . 0.0 119.463 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.02 -41.37 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 121.232 -0.918 . . . . 0.0 111.113 -152.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.75 -0.27 2.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.94 47.92 Favored Glycine 0 N--CA 1.453 -0.17 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.15 -39.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.692 0.746 . . . . 0.0 112.559 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -160.95 176.84 10.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 114.11 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 89' ' ' LEU . 27.2 p -123.12 -168.51 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.82 -24.94 10.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.19 -55.04 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.171 0.896 . . . . 0.0 109.614 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.46 -38.22 84.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.68 -18.93 65.63 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.799 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 97.0 p -86.24 -39.58 16.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.252 0.933 . . . . 0.0 111.957 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.83 -45.45 8.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -168.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.45 91.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 25' ' ' ARG . 76.7 Cg_exo -58.67 -35.51 98.54 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 115.988 -2.208 . . . . 0.0 116.548 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -84.98 -22.78 29.0 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.754 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.97 -28.61 68.41 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.145 -0.972 . . . . 0.0 112.697 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.55 -40.02 93.18 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -67.81 -34.56 76.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.731 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 HD22 ' A' ' 164' ' ' LEU . 44.5 tp -60.25 -53.06 62.22 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.169 0.44 . . . . 0.0 109.967 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -68.5 -21.67 64.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.97 -41.19 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.965 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.62 -57.0 4.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.274 -0.891 . . . . 0.0 111.628 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.418 HD22 HD11 ' A' ' 160' ' ' LEU . 43.3 tp -64.73 -36.69 85.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.64 -33.29 76.66 Favored Glycine 0 C--O 1.237 0.322 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.372 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -100.39 -42.74 6.49 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -47.43 24.36 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.198 0.908 . . . . 0.0 113.214 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -136.43 64.17 1.56 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.95 114.61 0.95 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -163.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -144.33 93.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.34 158.96 47.7 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.724 -1.718 . . . . 0.0 111.127 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.21 124.41 88.88 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.26 151.22 60.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 117.023 -1.518 . . . . 0.0 112.139 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -77.69 -0.88 28.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -72.64 -24.13 61.01 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.4 62.86 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -58.95 -35.99 74.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.153 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.544 ' CD2' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -60.72 -55.88 27.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.88 -41.64 91.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -165.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 tp -67.33 -44.73 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.2 -45.1 89.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -25.31 43.19 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 118.944 -1.103 . . . . 0.0 112.041 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 13.9 mt -64.71 -32.69 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -62.35 -39.17 92.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.327 0.584 . . . . 0.0 110.613 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.22 -43.68 85.99 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.926 -0.484 . . . . 0.0 110.405 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.73 -31.69 71.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 118.486 0.585 . . . . 0.0 111.788 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.25 -23.84 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.814 -1.179 . . . . 0.0 112.243 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t -147.29 66.33 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -105.41 149.58 26.01 Favored 'General case' 0 CA--C 1.498 -1.034 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 161.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.54 -41.31 89.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.811 0.815 . . . . 0.0 110.4 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -63.8 -46.67 84.1 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.429 -0.794 . . . . 0.0 111.038 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.36 -34.75 74.32 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.891 -0.506 . . . . 0.0 110.203 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -73.55 -38.74 65.13 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.123 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.0 p -90.49 2.17 55.97 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -63.18 145.19 56.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.205 -0.934 . . . . 0.0 111.619 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 166.46 23.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.51 43.86 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -65.34 -50.75 64.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.332 1.063 . . . . 0.0 108.264 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.36 -29.16 68.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.285 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.85 1.93 55.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.2 t -96.53 -45.0 12.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.29 -53.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.917 -1.115 . . . . 0.0 112.15 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.14 23.31 11.8 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.46 -34.9 0.59 Allowed Glycine 0 C--O 1.226 -0.38 0 CA-C-N 114.612 -1.177 . . . . 0.0 114.272 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -97.05 -41.78 8.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.159 0.979 . . . . 0.0 112.785 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.35 -15.22 0.26 Allowed Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 119.412 3.116 . . . . 0.0 119.412 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 C--N 1.359 1.129 1 C-N-CA 109.882 -6.279 . . . . 0.0 113.833 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -136.0 158.39 44.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 160.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.36 126.39 75.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.1 t -128.99 109.09 10.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -128.17 156.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.204 -167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.05 129.95 43.24 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.35 167.65 20.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.38 140.21 58.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.851 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.23 127.33 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.14 86.35 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 117.131 1.612 . . . . 0.0 117.131 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.91 100.14 2.54 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 119.323 1.562 . . . . 0.0 113.699 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.38 0.69 6.43 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 N-CA-C 116.578 1.722 . . . . 0.0 116.578 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 -12.14 45.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.12 166.66 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.055 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -82.03 143.41 31.57 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.077 0.951 . . . . 0.0 111.483 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.26 -166.15 12.16 Favored Glycine 0 N--CA 1.46 0.282 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.17 127.15 30.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.473 1.137 . . . . 0.0 109.976 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.9 t -157.67 134.07 6.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.64 -43.09 41.27 Favored 'Trans proline' 0 C--N 1.345 0.35 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -119.93 2.87 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.03 -44.19 96.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.051 0.929 . . . . 0.0 112.016 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -72.89 -12.14 60.85 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.28 -39.13 85.98 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.773 -1.205 . . . . 0.0 109.544 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.71 -45.91 76.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -39.83 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.763 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.6 -49.35 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 p -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.51 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.22 -25.98 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -69.24 -38.56 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.216 0.916 . . . . 0.0 109.595 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -65.7 -41.77 91.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -75.77 -8.14 56.13 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 53.71 39.02 29.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.565 1.146 . . . . 0.0 113.93 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.57 157.07 39.05 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.66 137.17 22.18 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 114.987 -2.875 . . . . 0.0 113.399 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -150.98 161.26 43.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -105.68 132.95 51.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -84.27 123.83 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -118.85 145.08 45.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.94 135.49 55.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.95 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -76.88 61.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 52.48 52.48 14.06 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.703 1.201 . . . . 0.0 113.717 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 64.95 1.16 Allowed Glycine 0 C--O 1.228 -0.225 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -87.31 -77.51 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -165.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.02 162.5 22.66 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.15 174.11 2.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 118.002 -0.865 . . . . 0.0 114.0 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 5.59 -55.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 1 N-CA-C 122.441 4.238 . . . . 0.0 122.441 171.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -50.57 -38.42 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.433 1.469 . . . . 0.0 112.312 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.82 -20.1 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.92 -25.73 23.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.779 . . . . 0.0 109.242 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -74.33 -31.66 62.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.384 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 mt -63.76 -52.87 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -118.64 129.36 25.43 Favored Pre-proline 0 N--CA 1.469 0.494 0 O-C-N 121.986 -0.446 . . . . 0.0 110.957 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.49 -22.74 44.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 N-CA-C 116.609 1.734 . . . . 0.0 116.609 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.76 0.15 35.36 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.418 0.554 . . . . 0.0 111.135 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.75 69.48 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.073 -1.017 . . . . 0.0 114.292 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -158.25 -29.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.7 m -69.89 152.77 95.89 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 118.77 0.713 . . . . 0.0 111.575 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.74 154.41 59.14 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 117.302 -1.332 . . . . 0.0 113.147 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.7 161.8 23.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.511 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.67 137.61 33.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -106.75 93.61 4.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 55.0 mt -97.19 108.68 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t0 49.01 46.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 123.493 1.616 . . . . 0.0 111.419 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 73.27 4.89 4.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.648 -2.523 . . . . 0.0 117.322 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -112.5 139.31 48.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -98.28 141.29 31.36 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 -168.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.8 t -123.87 123.71 67.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.5 -37.75 1.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -165.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.61 149.87 49.37 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.05 -1.032 . . . . 0.0 110.309 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.3 p -60.08 -34.23 73.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -170.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -88.85 -13.33 39.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.25 -19.57 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 108.854 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.4 mt -66.33 -26.77 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 165.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -84.43 -40.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 120.504 -1.372 . . . . 0.0 111.462 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.45 -64.02 0.83 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 118.883 2.313 . . . . 0.0 118.883 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.78 -34.39 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.328 1.064 . . . . 0.0 111.103 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.31 -46.32 79.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.948 -0.47 . . . . 0.0 110.691 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.23 -40.76 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.507 . . . . 0.0 110.369 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.69 -35.72 81.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -95.34 -12.31 26.3 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.29 127.81 93.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.38 -12.92 37.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.67 162.06 71.9 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.553 -1.342 . . . . 0.0 108.096 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.9 137.52 82.03 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 116.386 -1.943 . . . . 0.0 114.836 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.14 150.94 29.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 116.342 -1.972 . . . . 0.0 113.062 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.5 mt -132.83 66.61 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.944 0.878 . . . . 0.0 110.395 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -108.64 84.87 2.0 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.1 m -113.78 97.89 45.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -112.93 78.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.513 2.142 . . . . 0.0 114.913 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -91.16 -131.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.657 2.905 . . . . 0.0 113.319 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -54.34 -40.47 68.07 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.178 -0.951 . . . . 0.0 112.254 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.49 -26.46 68.73 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.453 -0.779 . . . . 0.0 111.447 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.68 -28.52 45.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.9 p -81.95 -27.89 33.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.974 0.806 . . . . 0.0 109.153 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.7 -43.79 82.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.83 -30.38 76.95 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 120.829 -1.17 . . . . 0.0 114.181 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.7 p -77.5 -7.06 55.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.378 1.089 . . . . 0.0 113.139 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -93.97 -36.32 12.22 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.783 0.72 . . . . 0.0 110.974 166.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.93 -48.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.619 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -54.57 -54.49 48.26 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HA ' HG22 ' A' ' 107' ' ' VAL . 93.5 Cg_endo -72.06 -24.88 19.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 113.436 -3.91 . . . . 0.0 113.784 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 t -65.8 -45.25 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -76.36 -29.62 57.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.793 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 104' ' ' PRO . 21.9 m -75.57 -26.23 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 118.48 -1.288 . . . . 0.0 110.038 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.61 -43.63 80.0 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.78 -39.45 84.93 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.757 -0.589 . . . . 0.0 111.195 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.2 mt -62.97 -36.51 83.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -92.36 -24.48 18.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.1 t -68.64 142.46 55.09 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -127.02 40.71 3.67 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.924 1.345 . . . . 0.0 107.669 159.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -77.78 173.39 7.67 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -61.73 102.15 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 114.948 -2.901 . . . . 0.0 109.199 146.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -122.92 24.78 8.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.849 -159.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.53 -22.89 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.238 1.018 . . . . 0.0 110.69 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.14 -33.26 54.74 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 m -68.09 -28.02 66.99 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.027 -0.69 . . . . 0.0 111.535 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -65.46 -36.15 83.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.639 -1.288 . . . . 0.0 110.013 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.07 -33.39 61.67 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.8 -0.563 . . . . 0.0 110.677 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.69 88.47 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 110.558 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.25 -46.78 88.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.74 -42.95 99.63 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.721 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.81 -41.88 86.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -69.39 -35.77 76.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.707 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.51 -35.66 77.8 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.502 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.3 -29.68 70.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.691 0.678 . . . . 0.0 111.647 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.26 -51.57 65.65 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.327 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.26 -26.11 63.68 Favored 'General case' 0 C--O 1.221 -0.43 0 O-C-N 121.878 -0.514 . . . . 0.0 111.725 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.01 -39.87 93.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.683 0.393 . . . . 0.0 110.509 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.86 -54.72 26.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.52 -39.96 89.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.89 -45.36 78.27 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.76 -23.01 62.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.404 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.61 -49.39 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.674 -0.641 . . . . 0.0 111.139 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -82.64 -37.93 24.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -77.28 0.26 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-O 116.828 -2.095 . . . . 0.0 116.931 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -60.57 -131.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 1 C-N-CA 127.989 5.793 . . . . 0.0 120.728 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.43 171.68 7.06 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.937 -1.102 . . . . 0.0 111.293 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.72 -17.42 21.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.32 5.25 35.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.27 -24.77 17.46 Favored Glycine 0 C--O 1.227 -0.334 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.44 -54.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.307 1.553 . . . . 0.0 114.535 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -156.81 176.87 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.05 120.55 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.6 p -140.75 -168.57 2.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -40.44 -38.55 0.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 118.279 2.696 . . . . 0.0 118.279 173.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.88 -43.54 96.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.131 0.967 . . . . 0.0 108.705 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.91 -39.33 79.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.9 mt -61.54 -37.46 83.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.475 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.4 p -77.69 -43.55 30.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.5 tp -95.12 -46.72 6.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -167.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.8 92.92 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.55 -19.41 19.06 Favored 'Trans proline' 0 C--N 1.346 0.446 1 C-N-CA 113.006 -4.196 . . . . 0.0 113.753 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.81 -23.15 20.68 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.983 -1.073 . . . . 0.0 109.587 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.6 mt -63.28 -31.35 72.47 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 165.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.45 -51.08 71.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -63.57 -34.34 77.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.0 -56.0 27.9 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.395 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.94 -51.54 43.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.692 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.69 -42.07 64.64 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.388 -0.82 . . . . 0.0 111.564 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.54 -46.9 86.27 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.26 93.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.033 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.71 -47.18 14.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.629 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -93.76 -34.39 13.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -167.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -137.44 50.47 1.96 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.959 -0.463 . . . . 0.0 110.836 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -53.02 121.71 7.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -156.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -148.15 89.2 5.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.38 153.3 74.42 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 114.639 -3.107 . . . . 0.0 109.87 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.92 126.03 91.79 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.84 155.54 57.93 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 117.142 -1.438 . . . . 0.0 112.31 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.42 -10.03 52.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -67.73 -25.24 65.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.048 -0.408 . . . . 0.0 110.488 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.99 61.54 1.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -31.52 68.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.712 -1.586 . . . . 0.0 113.137 -171.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -43.04 99.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.102 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -38.06 33.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.18 -40.12 88.86 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.631 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.08 -45.7 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.496 -0.753 . . . . 0.0 111.932 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.94 -39.85 95.87 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.64 -32.34 57.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.68 -35.58 78.38 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.167 -0.958 . . . . 0.0 111.057 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.08 -21.05 60.84 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.943 -0.473 . . . . 0.0 111.568 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.13 -8.85 58.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.232 1.015 . . . . 0.0 110.434 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -103.53 23.73 12.18 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.23 -0.919 . . . . 0.0 110.154 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.7 p -124.84 164.43 20.04 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 49.05 150.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 121.225 3.787 . . . . 0.0 121.225 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -56.93 -34.86 68.39 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 120.555 -1.341 . . . . 0.0 114.381 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -18.95 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.09 -44.86 2.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.485 0.66 . . . . 0.0 110.856 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.53 -42.65 99.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.84 -30.91 24.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.201 1.0 . . . . 0.0 109.722 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.7 p -79.01 -12.54 60.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -40.63 119.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 113.078 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.12 138.92 50.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 165.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.43 138.58 58.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.806 0.276 . . . . 0.0 111.233 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.55 -43.78 89.43 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.56 -31.19 67.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.194 0.997 . . . . 0.0 111.141 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -102.68 0.97 33.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.2 -50.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 161.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.4 pt -69.41 -50.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 121.618 -0.676 . . . . 0.0 111.875 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.11 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.336 -0.852 . . . . 0.0 110.291 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.8 -16.17 58.58 Favored Glycine 0 CA--C 1.517 0.173 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -113.15 -54.22 2.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.58 -31.04 8.55 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--N 1.357 1.006 1 C-N-CA 111.733 -5.045 . . . . 0.0 114.475 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -124.88 156.32 38.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.403 HD11 ' HG ' ' A' ' 30' ' ' LEU . 44.8 mt -130.65 113.96 26.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.7 127.3 39.33 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.03 163.06 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 119.655 1.116 . . . . 0.0 112.926 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.49 126.42 29.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -82.92 172.69 12.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.04 142.83 58.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.45 134.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.67 -21.61 17.74 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.3 100.8 1.73 Allowed Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.0 96.39 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 116.917 -1.589 . . . . 0.0 114.383 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -159.36 -39.97 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -104.45 158.22 5.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.12 160.09 16.08 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 110.295 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 -179.44 18.37 Favored Glycine 0 CA--C 1.507 -0.436 0 CA-C-N 116.458 -0.337 . . . . 0.0 112.992 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.87 92.89 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.335 1.065 . . . . 0.0 111.165 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.67 132.86 24.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 103.345 -2.835 . . . . 0.0 103.345 165.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.76 -38.03 32.8 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 116.693 -1.738 . . . . 0.0 111.992 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.26 -21.44 36.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.746 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.303 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -74.14 -26.65 60.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.882 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.81 -39.62 89.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.58 1.536 . . . . 0.0 111.151 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.63 -44.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.836 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.28 -38.21 85.96 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.397 -0.814 . . . . 0.0 110.541 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.92 -48.24 79.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 p -72.32 -31.47 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.727 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 5' ' ' ILE . 4.0 mm? -68.4 -46.24 70.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.206 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -65.02 -33.11 75.26 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.793 -0.567 . . . . 0.0 110.579 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.06 -41.92 99.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.373 0.606 . . . . 0.0 112.343 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.82 -16.51 57.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.29 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 59.64 40.5 19.97 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.305 1.442 . . . . 0.0 112.931 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 pt -101.49 154.61 37.14 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.62 118.96 5.98 Favored 'Trans proline' 0 C--N 1.347 0.459 0 N-CA-C 117.375 2.029 . . . . 0.0 117.375 -171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -126.32 156.17 40.86 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.816 0.817 . . . . 0.0 113.072 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.24 110.43 20.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.007 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -84.2 125.51 32.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 118.754 0.706 . . . . 0.0 111.526 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -121.95 139.29 53.84 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.539 0.736 . . . . 0.0 112.194 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 2.6 mm? -102.0 120.03 39.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.733 -169.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.05 120.88 45.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -77.65 76.78 4.18 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.822 0.82 . . . . 0.0 112.215 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.1 mt 55.67 27.88 11.25 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 162.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.92 2.35 11.29 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 114.245 0.458 . . . . 0.0 114.245 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -78.21 109.41 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.754 -0.851 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -116.53 87.9 22.41 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.61 169.45 12.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 N-CA-C 109.916 -0.84 . . . . 0.0 109.916 169.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.86 -40.19 69.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.196 0.453 . . . . 0.0 111.303 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -62.15 -39.04 91.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.53 -22.25 35.07 Favored 'General case' 0 C--O 1.212 -0.888 0 O-C-N 120.604 -1.31 . . . . 0.0 112.777 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.9 tp -68.22 -40.16 82.15 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 120.009 -1.682 . . . . 0.0 111.216 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.05 -35.2 71.86 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.346 -0.846 . . . . 0.0 112.846 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mt -117.62 22.59 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 121.478 0.656 . . . . 0.0 111.485 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -147.45 119.86 4.72 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.047 -1.658 . . . . 0.0 108.483 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.34 -13.66 37.36 Favored 'Trans proline' 0 C--N 1.352 0.731 0 N-CA-C 118.689 2.534 . . . . 0.0 118.689 -173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -120.83 7.34 10.43 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.92 -0.488 . . . . 0.0 110.117 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.16 2.07 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-O 122.641 1.134 . . . . 0.0 113.143 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -134.07 99.31 4.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.57 146.18 16.17 Favored Pre-proline 0 C--N 1.318 -0.778 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 170.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.9 142.09 38.26 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 116.868 -1.621 . . . . 0.0 111.982 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.81 131.63 50.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.152 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.91 129.9 36.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.41 71.91 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.175 0.988 . . . . 0.0 108.658 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.2 mt -87.66 126.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 54.97 35.58 24.91 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.478 1.111 . . . . 0.0 112.984 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t0 61.62 25.07 15.05 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -115.46 150.59 36.24 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.08 135.98 53.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -172.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.65 123.17 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -174.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.33 8.76 1.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -165.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -99.41 147.67 25.01 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.025 -1.672 . . . . 0.0 109.946 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.2 p -58.72 -33.52 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -83.23 -13.22 55.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.045 1.402 . . . . 0.0 111.615 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.7 -32.23 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.842 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -66.96 -15.61 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 121.759 -0.588 . . . . 0.0 111.177 161.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.0 t -83.2 -46.24 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 120.333 -1.479 . . . . 0.0 110.418 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.74 2.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 121.164 3.225 . . . . 0.0 121.164 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.4 mt -80.95 -26.89 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.78 -1.424 . . . . 0.0 110.558 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.91 -48.3 75.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.71 -39.99 95.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.315 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.68 -34.48 77.2 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.846 -0.534 . . . . 0.0 111.64 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -97.0 -1.33 45.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -82.68 132.37 52.02 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.57 -9.92 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 115.517 -2.522 . . . . 0.0 114.833 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -74.24 158.1 85.86 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.62 124.58 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 116.138 -2.108 . . . . 0.0 115.658 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.37 144.29 28.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 120.641 0.894 . . . . 0.0 112.856 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -138.94 45.1 2.01 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.022 0.915 . . . . 0.0 109.367 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.06 90.44 2.49 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m -125.63 90.74 49.99 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.212 1.005 . . . . 0.0 110.282 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -100.63 63.56 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 1 C-N-CA 125.687 4.258 . . . . 0.0 119.351 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -87.05 -128.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 CA-C-N 119.918 1.006 . . . . 0.0 114.637 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.54 -38.52 74.87 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.921 1.691 . . . . 0.0 113.745 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -64.68 -25.13 67.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.117 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.92 -32.98 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.4 -0.813 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.8 p -75.0 -33.89 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.38 -45.44 82.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.07 83.97 Favored Glycine 0 C--O 1.229 -0.21 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.61 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.3 p -63.28 -17.0 62.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.0 -27.53 13.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.6 mt -79.36 -44.78 23.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -53.36 -48.79 91.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.35 -27.9 10.91 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 111.645 -5.103 . . . . 0.0 113.507 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -67.15 -44.62 79.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -70.85 -20.65 62.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.058 -1.057 . . . . 0.0 112.703 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.2 t -85.35 -41.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -59.27 -46.97 87.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.046 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.68 -24.21 53.18 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -27.27 61.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.268 0.94 . . . . 0.0 110.994 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.98 -3.45 58.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.348 0.659 . . . . 0.0 111.641 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.3 t -121.25 121.96 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -167.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.03 41.79 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.93 -177.54 0.33 Allowed Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.504 1.121 . . . . 0.0 108.848 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.27 61.03 0.5 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 156.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -86.29 80.01 8.87 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.153 -1.592 . . . . 0.0 107.4 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -118.78 -65.35 1.18 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.45 -44.27 96.98 Favored Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.335 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -77.7 -8.79 58.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.28 -32.62 55.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.954 -1.716 . . . . 0.0 106.432 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -79.28 -9.81 59.67 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 120.956 -1.09 . . . . 0.0 111.237 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.84 74.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 165.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.74 -42.51 90.9 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.829 -1.169 . . . . 0.0 109.956 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 tp -56.46 -44.28 80.38 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.59 -27.86 68.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -81.45 -34.21 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.111 -0.993 . . . . 0.0 110.581 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -73.15 -23.58 60.47 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.0 110.481 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -68.31 -29.75 68.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.857 -0.527 . . . . 0.0 110.308 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.66 85.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.63 -39.01 80.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.99 -41.11 91.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.57 0.748 . . . . 0.0 110.027 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.65 -41.76 56.2 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.013 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -62.21 -32.62 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.65 -55.08 11.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.086 0.946 . . . . 0.0 112.624 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -76.67 -10.4 59.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.73 -0.606 . . . . 0.0 112.423 -159.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -79.81 -8.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.67 -40.75 2.86 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.33 -66.53 0.25 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.65 -169.74 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 125.174 3.916 . . . . 0.0 115.689 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -57.82 165.45 1.74 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.086 0.955 . . . . 0.0 111.841 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 pt -65.81 -21.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -146.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.92 -13.29 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.31 -11.42 61.73 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.86 -45.21 0.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -164.17 -179.32 6.08 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.89 121.46 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.4 m -138.95 179.39 6.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -38.75 -38.76 0.44 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -69.13 -39.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 120.741 -1.224 . . . . 0.0 111.792 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.84 -39.5 72.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.26 -7.21 28.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.4 p -104.55 -45.36 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.212 -0.423 . . . . 0.0 112.017 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.48 -50.94 12.76 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.16 81.17 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.02 -18.75 52.01 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 113.605 -3.797 . . . . 0.0 117.317 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -94.74 -24.41 17.12 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.346 -1.471 . . . . 0.0 109.401 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.72 -25.93 67.52 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.396 -0.815 . . . . 0.0 111.902 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -49.0 59.02 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.186 0.903 . . . . 0.0 110.318 166.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -72.98 -21.14 60.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.59 -50.11 70.74 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 122.228 0.211 . . . . 0.0 111.177 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -72.04 -20.66 61.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.806 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.6 t -78.83 -57.35 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.48 -52.26 28.31 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.69 -42.2 91.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.663 0.744 . . . . 0.0 110.642 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.29 -32.35 82.43 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -90.88 -38.33 12.99 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.205 -1.173 . . . . 0.0 114.101 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -81.82 -46.44 14.15 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -145.4 70.49 1.26 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -165.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -53.71 117.77 3.41 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -143.53 89.06 7.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.65 161.94 40.84 Favored 'Trans proline' 0 C--O 1.235 0.34 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.19 127.23 92.42 Favored Pre-proline 0 C--O 1.245 0.852 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.47 154.89 45.49 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.695 -1.736 . . . . 0.0 112.092 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.8 -2.72 31.24 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.563 -0.711 . . . . 0.0 110.731 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -69.5 -21.49 63.67 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.69 -0.631 . . . . 0.0 111.586 166.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.51 65.21 0.71 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.4 m -57.39 -34.95 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.992 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -53.86 53.5 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.569 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.2 t -68.43 -34.86 68.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -168.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.97 -52.0 65.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.351 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.35 -41.55 96.7 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.278 -0.264 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -60.63 -52.01 66.98 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.39 -37.48 79.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 121.859 -0.526 . . . . 0.0 111.312 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.93 -41.78 99.59 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.445 0.64 . . . . 0.0 112.433 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.0 mt -71.52 -40.36 70.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.01 -20.0 63.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.124 0.488 . . . . 0.0 111.429 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.72 -27.91 69.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.419 -0.801 . . . . 0.0 112.373 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 t -136.99 69.93 1.41 Allowed 'General case' 0 C--O 1.243 0.758 0 O-C-N 121.43 -0.794 . . . . 0.0 112.771 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -125.9 138.79 53.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 162.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -59.43 -37.99 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.81 1.641 . . . . 0.0 113.188 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -37.31 78.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -85.16 -34.87 22.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.093 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -70.56 -42.34 71.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.33 -35.2 73.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.688 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.4 p -77.2 -19.29 56.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.896 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -51.96 122.77 8.96 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.248 0.619 . . . . 0.0 111.626 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.15 173.07 9.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.547 0.739 . . . . 0.0 110.308 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.71 126.96 31.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.9 -29.64 69.71 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.587 -0.695 . . . . 0.0 112.242 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.12 -35.68 79.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.145 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -85.77 -6.78 59.06 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.83 -54.3 7.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.0 mt -68.7 -61.39 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.932 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.32 -3.26 39.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.843 -0.536 . . . . 0.0 110.852 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.82 -13.3 61.11 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -99.17 -21.18 16.25 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.911 1.356 . . . . 0.0 111.803 166.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.4 -8.18 0.13 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.362 1.268 1 C-N-CA 110.851 -5.633 . . . . 0.0 112.852 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.221 -0.406 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.88 159.65 40.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.5 mt -129.98 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.57 157.49 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -167.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.21 128.85 34.01 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.175 -0.953 . . . . 0.0 108.622 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.17 158.42 16.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 140.18 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.362 170.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.57 126.85 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.11 0.2 60.4 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 78.15 4.01 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.75 1.775 . . . . 0.0 114.917 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.82 90.79 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 N-CA-C 116.925 1.856 . . . . 0.0 116.925 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -157.25 -49.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.82 157.25 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 103.323 -2.843 . . . . 0.0 103.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.46 166.91 15.14 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.486 1.114 . . . . 0.0 111.739 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.11 -173.82 16.22 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -76.66 99.05 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 122.471 1.129 . . . . 0.0 110.833 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.17 136.07 17.82 Favored Pre-proline 0 C--N 1.319 -0.74 1 N-CA-C 100.134 -4.025 . . . . 0.0 100.134 162.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.29 -36.65 34.89 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 116.22 -2.053 . . . . 0.0 112.047 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -72.57 -26.0 61.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.112 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.54 -41.71 92.75 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.432 1.111 . . . . 0.0 109.863 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.98 -33.77 63.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.518 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.57 -45.99 84.52 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.148 1.34 . . . . 0.0 111.779 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.67 -35.34 65.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.479 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.55 -46.7 25.32 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.316 -0.865 . . . . 0.0 112.941 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -39.6 94.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -64.3 -43.59 94.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 112.084 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -27.14 28.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -75.45 -31.63 60.36 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 118.486 0.584 . . . . 0.0 111.041 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.52 -37.98 89.42 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.388 -1.445 . . . . 0.0 109.515 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.65 -20.4 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 51.56 40.13 26.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 112.346 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.18 135.38 73.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.64 140.95 89.35 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 115.733 -2.378 . . . . 0.0 114.215 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -148.53 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -114.53 124.51 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 167.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -90.82 149.6 21.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -135.28 133.33 38.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.38 110.79 21.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.16 109.2 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.27 78.23 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.709 0.766 . . . . 0.0 112.957 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt 55.27 54.39 8.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.7 160.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.88 15.22 58.26 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.207 -0.906 . . . . 0.0 114.39 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -74.41 114.91 13.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.342 1.071 . . . . 0.0 108.482 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 89.04 11.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -67.45 176.3 5.04 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 115.989 -2.208 . . . . 0.0 109.164 166.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -54.95 -31.45 60.51 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.553 -0.717 . . . . 0.0 112.56 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -56.98 -51.45 69.16 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.964 0.802 . . . . 0.0 112.608 172.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.25 -24.38 61.36 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 120.285 -1.509 . . . . 0.0 111.513 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.24 -35.24 77.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.603 -0.686 . . . . 0.0 112.093 170.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -67.4 -42.74 82.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.458 -0.776 . . . . 0.0 110.134 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.12 -51.79 16.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -104.63 126.41 31.39 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -65.11 -31.91 53.75 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -90.39 -4.41 57.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 120.63 -1.294 . . . . 0.0 110.244 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.93 -34.78 2.34 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-O 121.418 0.454 . . . . 0.0 112.478 -166.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -112.03 0.87 16.13 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 118.993 2.96 . . . . 0.0 118.993 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.0 147.05 72.92 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 120.145 1.338 . . . . 0.0 108.145 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.54 151.15 58.56 Favored 'Trans proline' 0 C--N 1.345 0.394 0 O-C-N 122.721 0.853 . . . . 0.0 111.495 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.87 162.6 20.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.769 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.65 128.44 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -85.49 96.33 9.57 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.73 97.76 7.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 121.014 1.734 . . . . 0.0 106.816 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.36 46.39 25.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.108 0.563 . . . . 0.0 112.507 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 71.86 4.6 5.09 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.67 2.388 . . . . 0.0 115.842 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.21 108.4 19.89 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -94.54 134.46 37.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.148 -166.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.21 134.3 65.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.0 -28.31 2.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -75.97 131.18 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.4 p -67.54 -23.12 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -95.67 -21.32 18.27 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.748 -0.595 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.08 -34.55 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.99 -24.85 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.16 -32.68 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 120.446 -1.408 . . . . 0.0 110.166 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.9 -54.81 0.42 Allowed Glycine 0 C--O 1.226 -0.386 0 N-CA-C 119.609 2.604 . . . . 0.0 119.609 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.82 -31.02 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.211 1.505 . . . . 0.0 110.885 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.88 -34.7 76.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.846 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -73.36 -38.63 65.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.884 -0.51 . . . . 0.0 111.446 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.63 -31.91 73.22 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.411 -0.805 . . . . 0.0 113.127 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 5.4 43.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -98.31 135.45 21.25 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.28 -8.87 24.64 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 116.485 -1.877 . . . . 0.0 116.67 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.05 160.15 76.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.365 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.86 137.14 65.9 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 114.86 -2.96 . . . . 0.0 114.191 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.57 88.59 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 115.967 1.487 . . . . 0.0 115.967 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.59 63.67 7.7 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 120.483 -1.386 . . . . 0.0 112.471 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.73 86.06 2.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 m -125.76 87.74 55.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.575 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -98.61 48.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 122.185 3.879 . . . . 0.0 122.185 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -80.35 -117.93 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.677 1.278 . . . . 0.0 112.289 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -53.42 -35.43 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.11 -37.56 87.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.78 0.8 . . . . 0.0 109.925 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.88 42.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.818 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -67.95 -32.29 72.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.76 -50.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.8 96.39 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.467 -0.873 . . . . 0.0 115.083 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.0 p -73.52 -8.33 55.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -80.01 -35.42 37.37 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.02 -1.05 . . . . 0.0 110.568 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.98 -37.32 9.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.633 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.65 -54.22 38.18 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.93 -24.39 13.01 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 113.423 -3.918 . . . . 0.0 113.036 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -71.73 -39.53 70.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HD13 ' A' ' 123' ' ' LEU . 3.3 p90 -75.53 -26.15 57.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.787 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.71 -28.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 120.898 -1.126 . . . . 0.0 109.245 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.53 -42.77 99.74 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.768 -1.207 . . . . 0.0 109.444 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -65.21 -40.22 93.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.814 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.92 -39.1 90.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -76.16 -11.04 59.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -87.09 141.99 28.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -127.91 27.79 5.66 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -72.4 170.78 11.62 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.2 52.21 1.85 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-O 122.926 1.136 . . . . 0.0 114.378 167.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -83.67 38.55 0.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -140.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -67.25 -24.71 65.83 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.52 90.73 Favored Glycine 0 N--CA 1.454 -0.123 0 O-C-N 120.835 -1.165 . . . . 0.0 111.325 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 m -74.34 -30.57 62.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.862 -0.787 . . . . 0.0 110.16 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -66.45 -34.51 78.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.862 0.839 . . . . 0.0 111.02 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -76.31 -30.35 57.7 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.64 96.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.296 -0.878 . . . . 0.0 109.523 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 17.0 tp -63.73 -47.3 81.61 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.98 -43.58 98.6 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.481 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.46 -44.25 83.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.893 0.77 . . . . 0.0 112.11 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.98 -27.72 54.84 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.116 -0.99 . . . . 0.0 112.347 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.01 -22.95 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.634 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -71.7 -31.13 66.42 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.101 -0.999 . . . . 0.0 109.998 168.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.68 90.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 122.0 -0.437 . . . . 0.0 112.11 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.07 -36.81 80.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.632 0.73 . . . . 0.0 110.73 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.26 -52.63 38.87 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.514 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -56.76 -42.29 79.09 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.051 -0.676 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.54 -45.14 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.13 -27.08 62.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.146 1.339 . . . . 0.0 112.677 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.08 -33.84 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 122.808 0.443 . . . . 0.0 110.318 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.56 -35.12 8.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.76 -75.02 0.24 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-O 117.381 -1.788 . . . . 0.0 116.553 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -61.55 -159.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 126.428 4.752 . . . . 0.0 118.994 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.59 167.43 1.47 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.519 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -45.5 -32.74 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.57 -7.55 39.51 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.779 -1.2 . . . . 0.0 114.236 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.05 3.71 90.64 Favored Glycine 0 CA--C 1.511 -0.203 0 O-C-N 121.672 -0.643 . . . . 0.0 113.327 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -142.39 -61.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -158.28 176.01 13.01 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.2 mm -63.12 127.98 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.0 m -142.71 161.98 36.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -171.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.27 -22.97 45.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.61 -23.61 29.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.66 -40.96 22.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.1 mt -70.79 -12.22 61.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.217 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.9 p -96.13 -23.73 16.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.2 tp -100.41 -49.17 4.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.31 -40.7 70.18 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.59 -38.63 93.01 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 114.637 -3.109 . . . . 0.0 118.259 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -87.93 -22.05 24.57 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.366 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.62 -37.74 85.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.095 1.316 . . . . 0.0 111.579 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.6 -50.27 71.93 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.801 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -63.83 -33.37 75.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.446 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.3 tp -63.47 -52.47 61.22 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.728 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.08 -34.59 78.37 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.714 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.83 -54.05 21.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.997 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.22 -44.18 63.31 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.283 -0.885 . . . . 0.0 111.693 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.15 -37.4 75.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.64 -36.57 93.44 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -75.98 -51.64 11.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.206 -1.173 . . . . 0.0 113.028 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -80.54 -36.99 32.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -146.89 53.07 1.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -171.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -34.38 102.79 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -157.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -142.7 85.41 10.22 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 169.74 21.86 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 116.296 -2.002 . . . . 0.0 109.019 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.4 mm -73.25 124.19 90.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.47 163.6 31.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 116.06 -2.16 . . . . 0.0 113.634 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.85 -4.65 36.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.491 -0.756 . . . . 0.0 112.112 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.25 -21.2 66.5 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.09 -1.006 . . . . 0.0 110.123 165.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.53 57.04 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.7 m -57.37 -34.64 69.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.088 -0.383 . . . . 0.0 111.289 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -68.79 -40.66 79.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.88 -43.03 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.137 0.494 . . . . 0.0 110.256 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.93 -43.5 92.58 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.768 -0.583 . . . . 0.0 111.788 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -69.36 -34.33 74.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.609 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -59.07 -49.31 78.36 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.84 -36.64 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.272 -0.893 . . . . 0.0 111.809 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.28 -37.81 88.81 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.523 -1.361 . . . . 0.0 112.592 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.84 -43.98 97.35 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.0 mt -65.77 -41.9 91.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.881 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.35 -33.48 65.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.1 m -115.98 18.49 15.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -66.66 139.61 57.87 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.89 -43.68 81.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.995 0.816 . . . . 0.0 112.545 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 p -67.13 -41.23 86.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -42.75 49.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.661 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 196' ' ' ARG . 37.6 ttmt -52.83 -44.92 67.07 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.544 -0.723 . . . . 0.0 112.003 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.17 -43.11 99.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.471 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 50.8 p -96.5 -4.04 42.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 193' ' ' LYS . 55.9 mtp180 -56.14 133.61 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.31 148.48 50.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.83 134.7 56.64 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.443 0.464 . . . . 0.0 109.829 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.53 -34.3 72.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.74 -32.45 70.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.139 0.971 . . . . 0.0 111.423 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -94.78 -21.36 18.78 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.415 -0.803 . . . . 0.0 111.941 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.33 -42.41 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.7 -74.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.35 63.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.67 -25.27 33.13 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.06 -0.59 . . . . 0.0 114.143 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 -22.16 12.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.912 0.856 . . . . 0.0 113.177 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.59 -17.37 0.37 Allowed Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--N 1.36 1.132 1 C-N-CA 111.043 -5.504 . . . . 0.0 115.402 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.238 0.495 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.75 146.82 44.47 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 121.922 -0.486 . . . . 0.0 110.518 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.8 mt -111.23 98.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.8 t -101.82 108.71 20.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.7 m -132.58 162.49 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.33 142.64 56.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -97.41 167.8 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.174 0.443 . . . . 0.0 110.741 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.97 58.37 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.86 112.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.27 85.46 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 114.634 -1.166 . . . . 0.0 115.461 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.7 82.36 7.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.008 0.904 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.25 43.24 0.71 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 124.666 3.577 . . . . 0.0 115.938 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.78 -8.1 2.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.86 156.57 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.68 154.0 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.26 174.32 45.23 Favored Glycine 0 C--O 1.238 0.345 0 N-CA-C 120.787 3.075 . . . . 0.0 120.787 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.37 75.68 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.755 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.95 133.68 21.18 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.41 -40.56 56.65 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-O 123.092 1.205 . . . . 0.0 111.445 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -77.79 -17.84 57.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -60.8 -48.83 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 111.292 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.17 -12.48 60.9 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.273 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -59.18 -48.92 79.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.958 1.708 . . . . 0.0 109.029 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.74 -50.44 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.206 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.66 -41.84 91.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.053 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.95 -45.87 83.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.1 p -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.509 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 -32.49 33.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.246 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -68.66 -38.14 80.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 118.741 0.7 . . . . 0.0 112.454 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.15 -28.78 69.05 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 120.916 -1.115 . . . . 0.0 111.134 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -91.58 -12.91 32.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 53.17 33.8 16.04 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -81.61 151.97 69.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.87 143.11 44.62 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 115.419 -2.587 . . . . 0.0 112.874 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -150.97 162.5 40.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -124.53 112.35 16.75 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.1 t -80.52 133.06 35.76 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -114.68 130.7 56.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 3.8 mm? -109.69 121.04 44.33 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -172.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.67 104.18 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.37 90.09 0.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.189 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt 49.25 49.99 18.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.724 1.209 . . . . 0.0 113.784 174.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.33 43.47 38.21 Favored Glycine 0 C--O 1.229 -0.217 0 C-N-CA 119.845 -1.169 . . . . 0.0 112.966 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -75.81 84.25 2.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 161.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -115.47 95.69 43.83 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.383 0.673 . . . . 0.0 111.598 -160.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 169.98 18.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 N-CA-C 109.902 -0.845 . . . . 0.0 109.902 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -55.84 -32.65 63.78 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 0.506 . . . . 0.0 111.768 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -55.07 -52.54 62.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.46 -24.44 59.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 120.882 -1.136 . . . . 0.0 111.478 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.29 -32.17 73.42 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.239 0.543 . . . . 0.0 111.405 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -74.43 -39.23 62.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.663 0.744 . . . . 0.0 111.468 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.41 -37.01 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 t -121.54 143.0 36.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.91 -37.35 86.3 Favored 'Trans proline' 0 C--N 1.355 0.917 0 N-CA-C 116.207 1.579 . . . . 0.0 116.207 170.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -93.96 -21.13 19.39 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.109 -0.994 . . . . 0.0 111.941 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 4.63 90.37 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-O 122.189 0.883 . . . . 0.0 111.513 -167.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -160.68 75.19 0.54 Allowed 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.859 1.264 . . . . 0.0 109.808 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.5 160.52 63.99 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 135.48 32.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 113.473 -3.884 . . . . 0.0 112.382 165.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.35 141.69 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.58 126.34 54.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -92.7 91.06 7.34 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.61 85.09 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.5 t0 53.62 60.07 3.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.294 1.045 . . . . 0.0 112.041 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 67.49 3.69 3.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.751 1.62 . . . . 0.0 115.265 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -103.34 99.77 9.62 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.159 -0.963 . . . . 0.0 109.034 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -80.57 134.71 35.96 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.475 0.71 . . . . 0.0 111.776 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.12 126.15 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.736 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.76 80.91 1.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -148.54 145.33 27.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 162.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -58.37 -34.26 70.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -81.24 -18.17 46.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.57 -20.33 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.14 -9.91 12.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.45 -60.45 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 162.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.89 -36.35 90.94 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.6 mt -86.17 -27.7 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 120.869 -1.371 . . . . 0.0 107.94 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.41 -39.28 94.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.89 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.72 -37.61 87.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.974 0.806 . . . . 0.0 110.788 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.06 -28.42 68.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.771 1.272 . . . . 0.0 112.006 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -102.77 1.64 34.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.505 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -75.56 143.04 74.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.184 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 -16.78 12.87 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 115.59 1.342 . . . . 0.0 115.59 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -90.67 161.79 35.36 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 103.544 -2.762 . . . . 0.0 103.544 174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.06 142.44 97.21 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 N-CA-C 119.135 2.706 . . . . 0.0 119.135 -163.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.48 106.76 2.32 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 121.585 1.523 . . . . 0.0 115.907 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.04 40.72 2.57 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 122.068 0.937 . . . . 0.0 112.745 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 79.77 5.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.308 -1.495 . . . . 0.0 112.34 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -118.93 94.54 48.25 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.08 82.18 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 124.33 3.353 . . . . 0.0 119.974 165.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.56 -146.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.392 1.395 . . . . 0.0 111.635 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -46.25 -40.32 11.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -62.79 -27.97 69.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.11 -29.04 61.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 76.8 p -76.19 -31.4 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.485 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.06 -40.63 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.546 -1.206 . . . . 0.0 114.131 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.1 p -66.98 -11.16 55.98 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -98.13 -34.01 10.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.2 pt -75.27 -30.85 23.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.042 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.73 -56.15 10.06 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -167.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.91 -20.62 16.9 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 114.618 -3.122 . . . . 0.0 113.661 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.9 t -64.29 -43.29 95.2 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.16 0.984 . . . . 0.0 111.647 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -37.83 84.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.042 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 107' ' ' VAL . 0.5 OUTLIER -67.3 -38.58 81.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.207 176.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.2 -44.93 95.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.315 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.63 -27.69 61.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.8 -46.03 91.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.232 0.923 . . . . 0.0 112.166 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -72.5 -22.41 61.05 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.066 0.936 . . . . 0.0 112.234 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 t -86.3 143.06 28.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -127.9 32.99 4.85 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 123.44 1.59 . . . . 0.0 109.333 164.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.21 170.8 7.95 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.0 47.02 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.12 101.47 13.83 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.1 -45.01 1.14 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.257 0.623 . . . . 0.0 111.795 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.8 -21.03 79.03 Favored Glycine 0 C--O 1.236 0.248 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.5 p -93.72 -11.97 30.28 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 168.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -67.04 -34.97 78.85 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 119.528 -1.983 . . . . 0.0 105.799 162.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -79.34 3.28 18.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.332 -0.855 . . . . 0.0 113.167 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.45 -28.56 61.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.33 -37.47 85.75 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.959 -1.088 . . . . 0.0 109.925 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.5 tp -61.91 -36.14 80.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.459 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -78.52 -34.88 46.95 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -72.8 -39.26 66.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.711 -1.868 . . . . 0.0 110.266 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 110.444 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -64.06 -35.52 81.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.924 0.783 . . . . 0.0 109.372 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.43 81.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.73 -42.73 97.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.579 -0.701 . . . . 0.0 110.737 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.366 1.066 . . . . 0.0 112.455 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.91 -36.52 41.43 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.578 -0.701 . . . . 0.0 114.01 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.63 -28.13 66.63 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.65 -52.8 27.23 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.392 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.35 -19.44 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.05 -9.14 12.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -113.51 -53.4 2.7 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.69 -59.04 0.47 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -71.39 -164.77 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.959 3.106 . . . . 0.0 115.062 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -54.9 160.07 2.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.7 tp -61.53 -22.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -163.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.23 -11.46 60.91 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.295 -1.503 . . . . 0.0 114.076 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.82 -26.76 8.69 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.12 -44.27 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -161.88 -177.03 5.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.396 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.44 109.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.8 m -128.79 -174.37 3.23 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 147' ' ' THR . . . -47.14 -38.26 11.32 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.31 -46.75 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 118.868 0.758 . . . . 0.0 110.158 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.92 -39.76 75.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.462 0.649 . . . . 0.0 110.349 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.69 -24.39 66.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.686 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.5 m -82.03 -36.6 27.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 83.6 mt -97.87 -46.25 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.55 36.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.56 -33.96 43.95 Favored 'Trans proline' 0 C--N 1.353 0.8 1 C-N-CA 112.067 -4.822 . . . . 0.0 115.629 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -80.87 -28.32 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.41 -1.432 . . . . 0.0 109.358 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.8 mt -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.244 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.03 -49.92 75.75 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.053 0.842 . . . . 0.0 111.68 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -64.2 -31.77 73.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -54.03 16.53 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 121.598 -0.688 . . . . 0.0 109.713 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -30.8 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.02 -35.4 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.076 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.56 -43.54 15.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.46 -36.6 84.39 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.408 0.683 . . . . 0.0 109.624 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.72 -35.17 91.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.539 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -74.47 -51.19 15.54 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.778 -0.837 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -77.67 -47.4 19.31 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -149.42 74.94 1.26 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -168.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.69 115.97 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -161.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -131.83 97.12 19.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 148.5 46.44 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 115.644 -2.437 . . . . 0.0 113.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.32 120.75 72.65 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -71.23 167.44 26.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 N-CA-C 116.776 1.798 . . . . 0.0 116.776 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.98 -16.34 63.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.958 0.903 . . . . 0.0 111.169 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -72.64 -13.52 61.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.516 0.726 . . . . 0.0 111.963 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.53 52.06 1.0 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -25.8 68.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -54.41 43.55 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.73 -36.08 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.62 -49.25 78.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -69.23 -37.27 77.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.821 0.343 . . . . 0.0 111.772 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -62.17 -49.2 76.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.81 0.844 . . . . 0.0 110.136 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 80.4 mt -71.95 -29.55 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.268 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.47 -46.21 87.24 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.966 -1.084 . . . . 0.0 111.277 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.59 -35.28 78.68 Favored 'General case' 0 C--O 1.216 -0.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.543 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.97 -37.07 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.029 0.918 . . . . 0.0 110.417 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -67.32 -27.56 67.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.64 -0.663 . . . . 0.0 111.338 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 t -145.35 72.81 1.33 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.989 0.899 . . . . 0.0 112.712 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -127.15 139.84 52.68 Favored 'General case' 0 N--CA 1.468 0.452 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 168.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -60.57 -39.68 88.89 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.7 p -61.57 -33.45 73.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.883 0.849 . . . . 0.0 112.681 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.4 -36.12 20.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.255 0.55 . . . . 0.0 110.892 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -62.47 -38.94 91.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.47 -28.6 46.54 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.236 1.017 . . . . 0.0 112.567 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 p -95.4 -0.48 52.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -61.44 144.98 53.2 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.37 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.56 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 134.31 48.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.14 -42.39 89.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 111.747 -167.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -62.14 -22.92 66.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.72 -9.42 46.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.56 -0.712 . . . . 0.0 110.762 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.46 -43.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 168.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -60.58 -66.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.25 0.548 . . . . 0.0 109.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.99 60.64 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.932 -1.105 . . . . 0.0 111.643 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.71 -26.6 45.44 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.285 -0.959 . . . . 0.0 114.113 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -88.23 -38.89 14.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.461 1.124 . . . . 0.0 109.42 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.91 -18.05 0.43 Allowed Pre-proline 0 C--N 1.321 -0.636 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 C--N 1.355 0.87 1 C-N-CA 110.516 -5.856 . . . . 0.0 114.403 171.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.878 0.371 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -108.24 137.84 45.54 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 30' ' ' LEU . 56.1 mt -110.27 117.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 173.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 m -110.71 129.66 55.77 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.77 159.99 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.16 130.02 41.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.94 0.496 . . . . 0.0 110.005 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -73.88 170.97 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 111.84 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 132.11 49.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.165 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.65 112.85 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.79 -28.8 6.04 Favored Glycine 0 C--O 1.242 0.652 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.417 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.24 93.39 2.7 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.278 1.031 . . . . 0.0 112.594 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.27 72.87 5.24 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 121.181 1.254 . . . . 0.0 114.873 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -142.98 13.44 1.86 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.384 -1.448 . . . . 0.0 111.77 166.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.69 152.93 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 1 N-CA-C 99.409 -4.293 . . . . 0.0 99.409 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 3.5 pp -65.37 158.43 26.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.938 1.295 . . . . 0.0 112.404 169.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.1 175.78 15.85 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -79.11 90.92 4.86 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.555 1.169 . . . . 0.0 109.958 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 124.94 29.15 Favored Pre-proline 0 C--N 1.319 -0.739 1 N-CA-C 97.161 -5.125 . . . . 0.0 97.161 161.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -66.42 -30.04 44.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 115.63 -2.446 . . . . 0.0 116.121 -168.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.73 -24.72 53.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.779 -0.575 . . . . 0.0 111.445 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.56 -40.72 97.74 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 123.121 1.439 . . . . 0.0 110.217 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -72.47 -16.01 61.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.587 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.15 -34.97 75.83 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.283 -0.885 . . . . 0.0 110.442 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.19 -41.36 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 122.554 1.169 . . . . 0.0 107.957 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.46 -44.93 85.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.816 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.17 -43.53 91.42 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.485 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -67.43 -39.2 85.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.428 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 5' ' ' ILE . 3.0 mp -71.95 -38.19 69.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.31 -26.58 62.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.111 0.414 . . . . 0.0 110.892 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -39.0 73.53 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.217 -0.927 . . . . 0.0 112.706 169.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -79.93 -10.03 59.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.509 -0.744 . . . . 0.0 112.66 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 55.44 35.51 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.749 1.219 . . . . 0.0 111.946 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 pt -89.05 154.78 49.73 Favored Pre-proline 0 C--O 1.242 0.701 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.93 153.21 58.18 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 114.215 -3.39 . . . . 0.0 112.666 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.04 157.26 41.42 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.68 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.88 118.16 33.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 171.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.9 t -91.02 120.46 32.03 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -114.2 112.45 23.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.426 1.108 . . . . 0.0 110.913 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.1 mt -96.57 109.93 22.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.407 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -83.36 116.41 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -72.33 54.07 0.3 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.658 1.983 . . . . 0.0 114.821 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt 54.4 54.46 9.38 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.856 1.663 . . . . 0.0 109.183 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.29 70.41 1.22 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.5 116.36 28.95 Favored 'General case' 0 C--N 1.32 -0.686 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 163.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -123.78 60.08 19.1 Favored Pre-proline 0 C--O 1.248 0.983 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.87 174.68 11.93 Favored 'Trans proline' 0 C--O 1.239 0.555 1 C-N-CA 113.118 -4.121 . . . . 0.0 110.41 161.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -55.0 -36.46 65.46 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.774 0.43 . . . . 0.0 110.572 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -55.8 -52.58 63.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -74.99 -27.2 60.06 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.213 -0.929 . . . . 0.0 111.817 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.03 -32.04 72.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.594 1.088 . . . . 0.0 111.624 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.91 -39.42 83.57 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.734 -0.604 . . . . 0.0 109.864 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.95 -37.23 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.85 0.86 . . . . 0.0 112.408 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -128.46 128.15 23.61 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.3 -14.3 31.21 Favored 'Trans proline' 0 C--O 1.242 0.714 0 N-CA-C 118.148 2.326 . . . . 0.0 118.148 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -102.97 -7.65 21.28 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.088 0.858 . . . . 0.0 110.767 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.8 8.23 72.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -159.86 55.64 0.37 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.382 1.073 . . . . 0.0 111.851 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.45 155.66 81.17 Favored Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 120.736 -1.228 . . . . 0.0 109.635 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.19 148.14 30.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 114.387 -3.275 . . . . 0.0 113.83 168.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.17 166.0 30.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.96 123.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 154.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -114.4 95.02 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mt -101.23 122.92 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 50.64 43.58 27.67 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.004 0.522 . . . . 0.0 111.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 68.39 12.87 8.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.13 2.641 . . . . 0.0 118.13 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -115.76 122.86 46.73 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.695 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -104.65 147.12 28.01 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -124.58 152.09 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.42 38.9 0.64 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 119.29 3.07 . . . . 0.0 119.29 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.19 153.72 31.34 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.882 1.673 . . . . 0.0 107.867 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -58.43 -32.65 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.54 -40.72 41.59 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.82 -0.55 . . . . 0.0 111.651 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -82.03 -20.31 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.2 pt -71.46 -3.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.854 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.55 -48.34 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 159.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.24 -36.31 91.57 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.0 mt -87.01 -30.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 120.227 2.013 . . . . 0.0 106.065 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.53 -49.42 74.81 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.656 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -60.5 -37.25 80.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.441 1.473 . . . . 0.0 112.255 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.5 -21.12 64.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -112.46 -6.34 14.0 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -76.79 135.55 67.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.55 -19.85 27.77 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 116.545 1.71 . . . . 0.0 116.545 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -75.7 160.89 78.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.029 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.44 129.19 33.84 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.78 130.32 3.67 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 N-CA-C 116.683 1.763 . . . . 0.0 116.683 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB3' HG23 ' A' ' 147' ' ' THR . 95.7 mt -125.92 48.5 2.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.72 1.208 . . . . 0.0 112.617 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.53 75.18 10.3 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.081 -1.637 . . . . 0.0 108.58 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -116.29 102.42 53.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.15 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -108.32 72.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.208 3.272 . . . . 0.0 118.21 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -82.36 -148.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 1 C-N-CA 125.681 4.254 . . . . 0.0 111.177 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.54 -29.95 28.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.71 -25.23 65.56 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 120.334 -1.479 . . . . 0.0 113.275 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.97 -34.04 59.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.8 p -72.29 -35.69 68.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -45.09 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.1 82.91 Favored Glycine 0 C--O 1.229 -0.162 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.793 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 p -70.18 -13.95 62.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -82.3 -40.6 21.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.481 -0.762 . . . . 0.0 109.671 170.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.36 -33.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 74.9 t80 -54.65 -51.87 74.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.98 -25.42 16.34 Favored 'Trans proline' 0 C--N 1.351 0.669 1 C-N-CA 112.615 -4.457 . . . . 0.0 114.042 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -69.0 -38.55 79.34 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE 0.262 0.4 OUTLIER -77.7 -27.23 50.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 118.511 -1.276 . . . . 0.0 113.703 178.806 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.74 -28.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.576 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -61.19 -44.77 96.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.492 -0.755 . . . . 0.0 110.944 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -65.7 -41.26 92.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.84 -38.91 83.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.993 -0.442 . . . . 0.0 111.615 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.4 27.35 1.47 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 t -121.13 122.0 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -113.75 26.5 10.3 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.34 168.2 30.0 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.06 94.28 0.73 Allowed 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 117.198 -1.402 . . . . 0.0 108.84 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.49 26.39 9.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 123.413 1.578 . . . . 0.0 110.993 -150.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.92 -28.49 69.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.957 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.24 -24.55 76.22 Favored Glycine 0 CA--C 1.519 0.326 0 O-C-N 121.165 -0.96 . . . . 0.0 114.156 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -91.35 -24.08 19.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.08 0.94 . . . . 0.0 111.098 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.21 -44.52 95.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 163.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -76.75 -12.73 60.03 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.752 -1.218 . . . . 0.0 114.252 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.56 -31.13 61.99 Favored 'General case' 0 C--O 1.217 -0.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.699 168.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.01 -42.36 99.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.77 -45.65 91.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.401 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -75.47 -36.78 60.6 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -76.82 -35.13 57.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.626 -1.296 . . . . 0.0 108.656 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.65 -19.03 58.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.346 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.58 -35.89 82.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.537 1.062 . . . . 0.0 110.412 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.3 mt -63.6 -37.96 89.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.937 -1.102 . . . . 0.0 113.564 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.14 -43.12 92.91 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.759 -0.588 . . . . 0.0 110.89 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.58 40.7 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.557 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -62.54 -38.06 88.53 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.432 -0.452 . . . . 0.0 111.61 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.7 -40.75 69.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.257 -0.902 . . . . 0.0 112.971 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.04 -16.65 64.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.977 1.262 . . . . 0.0 112.265 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.63 -53.84 37.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 O-C-N 121.437 -0.789 . . . . 0.0 109.363 165.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.45 -51.12 9.77 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.57 -72.23 0.29 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.554 -1.692 . . . . 0.0 115.48 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -69.35 176.86 5.91 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.012 2.475 . . . . 0.0 116.236 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -42.17 154.54 0.05 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.71 1.604 . . . . 0.0 114.411 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.65 -37.03 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.379 1.071 . . . . 0.0 112.672 -142.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.64 -22.22 65.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 117.465 2.395 . . . . 0.0 117.465 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.97 3.49 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 117.364 1.705 . . . . 0.0 117.364 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -129.6 -41.56 1.34 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.793 1.796 . . . . 0.0 114.015 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -159.87 -179.89 8.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.17 131.78 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.614 0.643 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 89' ' ' LEU . 80.3 m -145.88 171.89 14.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -35.64 -39.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.51 -40.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.38 -38.92 74.79 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.04 -15.54 63.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 98.3 p -96.35 -34.41 11.58 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.63 -48.99 9.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.2 92.98 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 59.3 Cg_endo -63.46 -36.2 56.14 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 112.85 -4.3 . . . . 0.0 116.762 -178.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -78.76 -30.76 45.86 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.982 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.85 -29.33 70.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 155' ' ' PRO . 42.4 m-85 -63.47 -50.62 69.0 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 123.248 1.499 . . . . 0.0 109.11 173.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -77.1 -20.18 56.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.618 -170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 tp -64.14 -51.45 63.81 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.099 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.04 -34.0 77.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.381 1.446 . . . . 0.0 112.213 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.4 -52.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.78 41.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.546 -0.722 . . . . 0.0 111.549 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 tp -66.1 -42.69 88.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.704 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.83 -35.47 92.06 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.022 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -74.24 -47.35 35.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.746 -0.855 . . . . 0.0 111.528 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -87.0 -52.28 5.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -129.96 76.12 1.7 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.265 1.426 . . . . 0.0 108.089 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -56.14 121.36 9.24 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -168.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -151.0 92.76 3.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.7 163.59 36.89 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 114.994 -2.871 . . . . 0.0 109.963 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.57 118.99 65.55 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.24 166.22 26.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.714 -1.057 . . . . 0.0 111.996 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.68 3.0 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -68.12 -21.61 64.93 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.606 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -112.28 68.42 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.8 m -55.37 -38.17 68.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -55.17 -59.42 4.8 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.27 -34.51 70.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -166.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.5 tp -62.82 -44.34 96.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.28 -0.888 . . . . 0.0 113.323 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -78.78 -30.3 45.46 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.884 -1.135 . . . . 0.0 111.173 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.45 -49.2 77.78 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.666 0.787 . . . . 0.0 110.434 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.7 mm -69.88 -32.3 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.479 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.22 -38.54 91.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.047 -1.033 . . . . 0.0 112.738 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.56 -31.81 65.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 110.954 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.01 -11.43 59.55 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.637 -0.665 . . . . 0.0 111.952 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -92.73 27.38 2.37 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 122.716 1.246 . . . . 0.0 111.597 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.3 5.24 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 176.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 60.7 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.87 -32.67 67.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.924 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 m -50.8 -30.26 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -115.17 -42.68 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.494 1.14 . . . . 0.0 111.006 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.47 -31.47 62.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -94.19 -24.61 17.43 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.3 p -90.79 -21.94 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.3 126.58 27.91 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.291 0.567 . . . . 0.0 110.332 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.35 167.02 21.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.3 49.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -69.08 -37.4 78.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -162.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.45 -40.51 91.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.263 1.03 . . . . 0.0 109.748 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -78.09 -13.55 59.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.11 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.17 -50.32 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.09 -55.08 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.044 0.926 . . . . 0.0 111.494 -172.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.75 -3.09 36.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.404 1.081 . . . . 0.0 111.18 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.33 -29.9 26.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.34 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -102.96 -39.95 6.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.606 . . . . 0.0 113.22 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -59.72 -29.67 6.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--N 1.357 0.989 1 C-N-CA 111.81 -4.994 . . . . 0.0 114.238 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--O 1.232 0.156 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.33 138.33 44.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 168.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.43 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -125.82 111.3 14.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.28 155.96 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.67 125.64 24.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.64 164.24 23.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.59 127.09 30.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.351 0.596 . . . . 0.0 110.802 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.39 94.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.994 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.12 -19.45 7.28 Favored Glycine 0 C--O 1.235 0.163 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.795 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.1 69.56 23.05 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.47 74.14 5.26 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 N-CA-C 116.664 1.756 . . . . 0.0 116.664 -169.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -146.22 10.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.212 1.006 . . . . 0.0 109.442 167.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -135.03 155.78 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.33 143.48 57.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.707 0.685 . . . . 0.0 109.952 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 167.67 12.44 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 118.702 2.241 . . . . 0.0 118.702 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -65.39 103.97 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.929 -1.636 . . . . 0.0 113.781 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.2 t -166.36 141.37 3.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -62.98 -40.65 33.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 116.706 -1.729 . . . . 0.0 112.674 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.54 -27.14 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.743 -1.571 . . . . 0.0 111.471 -171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.88 -62.42 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.653 0.74 . . . . 0.0 109.644 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -70.4 -27.49 64.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.029 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -57.33 -46.16 83.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.598 1.09 . . . . 0.0 111.693 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -76.99 -35.92 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.222 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.36 -44.46 87.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.09 -39.17 93.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.466 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -39.54 93.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.685 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -33.5 54.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.958 -172.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -77.52 -33.58 54.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -67.05 -39.24 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.694 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.42 -6.46 58.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.716 -0.615 . . . . 0.0 112.402 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.26 41.63 31.9 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 113.213 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -97.6 146.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.33 152.63 34.94 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 114.738 -3.041 . . . . 0.0 113.829 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -150.58 156.6 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.937 0.875 . . . . 0.0 112.582 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.5 t -139.57 124.65 18.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.938 1.245 . . . . 0.0 112.95 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -114.18 124.85 53.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.85 108.04 20.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -83.77 95.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -67.64 97.31 0.6 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.92 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.9 mt 31.91 48.81 0.11 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.24 47.09 3.65 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.811 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -68.91 101.79 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 160.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -137.43 75.51 45.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -165.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -66.24 171.44 10.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 116.798 -1.668 . . . . 0.0 109.885 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -56.08 -36.61 68.31 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.691 -0.631 . . . . 0.0 112.313 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.95 -42.37 79.97 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -79.96 -31.44 39.94 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.086 -1.009 . . . . 0.0 111.418 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 mt -67.1 -24.67 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.296 -0.252 . . . . 0.0 111.67 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -66.75 -37.49 84.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.163 0.506 . . . . 0.0 110.962 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -88.91 -52.08 11.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-O 121.193 0.521 . . . . 0.0 111.806 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -87.35 117.06 68.07 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 120.886 -1.134 . . . . 0.0 111.302 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.33 -23.87 65.21 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 118.505 2.463 . . . . 0.0 118.505 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.4 -10.8 18.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.883 -1.136 . . . . 0.0 112.538 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -0.39 37.9 Favored Glycine 0 C--O 1.224 -0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 113.414 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -146.25 34.82 0.98 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.87 0.843 . . . . 0.0 110.708 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.8 141.2 37.48 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.68 147.85 90.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 116.131 -2.113 . . . . 0.0 113.063 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.93 162.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 132.78 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -105.81 136.53 45.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.88 91.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.1 t0 50.55 52.96 13.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.124 0.964 . . . . 0.0 111.391 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 t70 62.15 24.27 14.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -110.91 163.94 13.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -146.76 159.64 43.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.848 2.113 . . . . 0.0 115.447 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.42 162.27 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.66 -116.13 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.6 173.37 1.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 p -58.3 -30.05 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -158.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -77.92 -26.17 48.82 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.851 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -83.3 -34.85 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.87 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.306 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.81 -45.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.875 0.761 . . . . 0.0 111.646 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.43 -33.92 51.72 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -118.39 -51.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.5 -40.36 85.2 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.998 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.02 -38.36 85.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.238 0.926 . . . . 0.0 109.367 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.21 -31.82 71.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.01 1.26 49.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.54 135.87 83.73 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 -21.68 72.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 116.607 -1.795 . . . . 0.0 116.589 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -93.37 161.02 32.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.19 144.44 90.52 Favored 'Trans proline' 0 C--N 1.354 0.847 0 N-CA-C 116.705 1.771 . . . . 0.0 116.705 -156.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -84.95 29.16 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.029 1.819 . . . . 0.0 115.317 -163.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.33 111.58 3.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.81 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.15 26.55 2.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.244 1.021 . . . . 0.0 110.461 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.67 123.68 58.92 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -170.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -114.74 62.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.605 0 N-CA-C 116.452 1.674 . . . . 0.0 116.452 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -83.38 -132.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 121.192 1.261 . . . . 0.0 113.845 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.91 -32.98 70.03 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.442 -1.411 . . . . 0.0 110.638 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -62.55 -31.81 72.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.321 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.6 20.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.166 -0.334 . . . . 0.0 110.746 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.4 p -68.3 -39.26 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.537 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.76 -46.5 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.598 -0.689 . . . . 0.0 109.431 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.28 74.55 Favored Glycine 0 CA--C 1.516 0.097 0 N-CA-C 115.549 0.98 . . . . 0.0 115.549 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -66.77 -17.93 65.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -81.91 -33.65 30.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 110.757 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.97 -43.67 81.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -50.52 -59.79 6.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.59 -16.13 15.09 Favored 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 112.195 -4.737 . . . . 0.0 114.578 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -61.98 -37.4 84.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.531 1.06 . . . . 0.0 111.182 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -84.63 -24.9 28.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.985 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.72 -42.3 80.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -55.89 -47.69 76.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.514 0.725 . . . . 0.0 109.601 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.87 -41.51 97.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.58 -40.21 92.5 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -84.94 -8.31 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 t -87.91 144.07 26.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.17 39.45 2.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 123.144 1.449 . . . . 0.0 108.192 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.67 -179.36 0.51 Allowed Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 112.559 -2.11 . . . . 0.0 108.994 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -63.42 89.24 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 115.654 -2.431 . . . . 0.0 112.404 151.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -88.85 98.16 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.23 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.02 -49.08 0.46 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.025 -0.422 . . . . 0.0 110.681 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.2 -35.67 92.38 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -82.82 -36.71 25.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.44 1.114 . . . . 0.0 108.221 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.31 -31.85 73.2 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.161 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.09 73.54 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.692 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.11 -47.47 84.48 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.05 -47.8 83.08 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.88 -37.33 73.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -69.12 -44.12 73.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.24 -22.87 62.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.079 -1.013 . . . . 0.0 111.372 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.74 -33.56 75.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.473 0.579 . . . . 0.0 110.368 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.92 -46.11 79.47 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.511 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.2 mt -67.1 -38.58 85.93 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.552 -0.717 . . . . 0.0 111.239 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.002 0.521 . . . . 0.0 110.343 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.96 -51.81 50.24 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -60.94 -38.32 85.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.47 -51.39 67.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.382 0.611 . . . . 0.0 111.828 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.68 -16.1 61.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -165.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.02 -27.75 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.51 0.724 . . . . 0.0 110.778 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -106.42 -45.11 4.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 -59.71 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 119.013 2.365 . . . . 0.0 119.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -67.97 -154.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 122.019 2.909 . . . . 0.0 115.897 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -58.91 168.98 1.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.909 0.884 . . . . 0.0 112.939 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.77 -36.36 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -163.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.27 -3.58 4.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.95 -30.62 9.87 Favored Glycine 0 CA--C 1.51 -0.279 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -124.6 -43.96 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -159.17 172.22 18.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.68 118.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.1 m -139.84 -175.9 4.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 147' ' ' THR . . . -45.26 -41.06 8.16 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 118.736 2.865 . . . . 0.0 118.736 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.11 -39.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 119.391 0.996 . . . . 0.0 110.314 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -71.13 -35.69 71.83 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.26 -24.63 67.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.983 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.4 p -97.83 -41.68 7.93 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.13 -47.46 43.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.43 97.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.79 -25.32 20.38 Favored 'Trans proline' 0 C--N 1.347 0.493 1 C-N-CA 111.202 -5.398 . . . . 0.0 114.924 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -72.89 -31.82 64.94 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 119.916 -1.74 . . . . 0.0 109.22 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.79 -29.52 68.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -63.86 -47.65 79.89 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.886 -1.134 . . . . 0.0 110.589 168.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -62.24 -31.81 72.41 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.86 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.73 -59.15 3.82 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.279 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.02 -35.15 79.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.256 0.934 . . . . 0.0 111.743 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -57.21 -41.12 77.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.163 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.48 -35.08 14.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.66 -41.44 92.5 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.275 -0.891 . . . . 0.0 112.148 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.82 69.5 Favored Glycine 0 C--O 1.228 -0.239 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -73.27 -49.01 29.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -100.99 -29.11 12.37 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.697 2.481 . . . . 0.0 117.697 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -124.51 20.14 8.73 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.228 0.467 . . . . 0.0 110.831 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -13.25 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 -153.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -115.06 92.63 31.84 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.46 155.96 62.53 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 113.819 -3.654 . . . . 0.0 108.951 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.9 mt -65.92 125.77 90.57 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.79 153.62 58.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 117.418 -1.254 . . . . 0.0 111.317 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.69 0.98 11.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.82 -27.73 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 165.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.99 67.45 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -33.06 69.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.508 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -62.73 1.5 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.16 -35.23 67.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -160.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.45 -41.81 84.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.625 -0.672 . . . . 0.0 111.886 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -67.4 -37.04 82.5 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.469 -0.769 . . . . 0.0 110.46 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.2 -41.19 97.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.941 0.896 . . . . 0.0 112.88 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.38 -31.44 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.668 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.28 -41.5 98.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.408 -1.432 . . . . 0.0 111.159 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.36 -34.92 78.3 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.539 -0.726 . . . . 0.0 111.784 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.11 -49.78 76.28 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -70.14 -15.7 63.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.6 t -75.68 -49.32 18.71 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -85.03 144.34 28.34 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.65 -24.1 67.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.179 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.7 m -51.99 -36.58 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.82 -40.64 6.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.952 0.882 . . . . 0.0 109.2 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.29 -33.93 73.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.23 -33.56 32.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -93.77 -10.33 34.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -54.99 135.79 48.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.414 1.102 . . . . 0.0 111.778 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.08 150.92 47.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.408 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.32 121.79 13.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -40.26 93.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -169.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.47 -30.52 71.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 122.684 1.231 . . . . 0.0 108.979 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.75 9.37 39.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.627 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.66 -44.01 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.1 pt -66.04 -37.66 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.216 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.93 -3.54 45.38 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.19 -32.05 13.05 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -101.52 -55.96 2.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.87 -30.59 4.54 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 -172.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--N 1.351 0.71 1 C-N-CA 111.539 -5.174 . . . . 0.0 114.381 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.235 0.313 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -132.47 169.68 16.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -133.78 142.17 42.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -124.64 133.84 53.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.374 -2.824 . . . . 0.0 103.374 162.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.48 160.05 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.803 1.183 . . . . 0.0 109.586 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.69 133.98 51.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.928 0.331 . . . . 0.0 110.715 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.06 165.36 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.018 0.437 . . . . 0.0 110.028 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.25 127.99 33.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.31 129.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.61 -19.78 51.94 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-O 118.776 -1.013 . . . . 0.0 114.675 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.06 81.92 7.31 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 118.385 1.093 . . . . 0.0 113.327 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.06 71.0 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 N-CA-C 115.849 1.442 . . . . 0.0 115.849 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -142.58 -11.08 0.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.057 164.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -131.4 168.95 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.2 1.0 . . . . 0.0 109.231 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 mt -75.26 147.68 40.06 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.35 171.61 15.39 Favored Glycine 0 C--O 1.237 0.285 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.17 97.19 8.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.915 0.864 . . . . 0.0 109.252 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 132.31 20.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 166.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -67.77 -43.37 5.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 115.331 -2.646 . . . . 0.0 115.211 -168.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -26.1 64.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.848 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -64.34 -44.5 91.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.985 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.48 -41.97 88.16 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.5 -0.75 . . . . 0.0 110.491 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 tpt85 -58.62 -41.13 85.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.54 -41.78 80.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.253 0.933 . . . . 0.0 112.459 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.59 -39.42 84.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.389 0.614 . . . . 0.0 111.179 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.45 -41.84 99.03 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.39 95.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.751 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.7 -40.72 72.72 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.219 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -70.87 -36.97 73.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.507 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -68.91 -39.54 79.63 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.057 -1.027 . . . . 0.0 110.475 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HG3' HD21 ' A' ' 84' ' ' ASN . 67.1 mmtt -79.16 -4.52 50.85 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 56.1 34.87 24.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.821 1.248 . . . . 0.0 114.152 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.18 135.74 23.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.9 148.62 25.3 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 116.023 -2.184 . . . . 0.0 114.979 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -144.91 153.81 41.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.034 0.921 . . . . 0.0 112.418 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.34 117.16 32.35 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.9 123.18 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 123.995 0.809 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -111.12 94.22 4.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.33 135.65 52.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.764 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -85.25 110.82 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -78.73 53.4 1.34 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.852 1.261 . . . . 0.0 112.661 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 mt 51.05 38.97 22.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 112.843 177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.85 72.96 0.2 Allowed Glycine 0 CA--C 1.512 -0.141 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.75 -178.45 6.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 111.648 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.79 150.13 91.65 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 124.337 1.055 . . . . 0.0 113.395 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -20.03 -137.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.258 2 C-N-CA 128.975 6.45 . . . . 0.0 125.304 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -66.61 -26.9 67.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.963 -1.71 . . . . 0.0 113.975 -161.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -61.24 -44.27 97.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 110.553 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.27 -33.92 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.156 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.29 -29.35 67.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -70.15 -30.77 68.0 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.243 -0.911 . . . . 0.0 110.703 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.36 -58.94 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.041 0.448 . . . . 0.0 111.73 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 121.31 76.15 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 120.845 -1.159 . . . . 0.0 108.56 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.07 -21.79 31.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 N-CA-C 117.098 1.922 . . . . 0.0 117.098 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.1 -9.41 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.823 -1.173 . . . . 0.0 110.221 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -31.15 2.38 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.362 -162.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -118.59 31.37 6.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.81 155.1 60.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.2 171.0 17.73 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 117.247 -1.369 . . . . 0.0 113.262 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.61 159.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 163.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.25 130.45 48.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 146.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -105.32 90.81 3.54 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 mt -100.36 113.25 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 52.68 41.9 31.5 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.787 0.803 . . . . 0.0 111.596 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.29 37.76 20.18 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -136.72 148.36 47.26 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -133.95 140.72 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 119.554 3.168 . . . . 0.0 119.554 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.33 139.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.76 1.224 . . . . 0.0 108.337 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.19 15.91 0.47 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 155.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -63.57 139.14 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.734 -1.228 . . . . 0.0 108.169 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -154.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.97 -37.98 17.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.782 0.801 . . . . 0.0 109.641 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.94 -36.41 75.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.887 0.851 . . . . 0.0 111.115 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -25.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.997 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.87 -40.37 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.87 -59.08 1.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.77 . . . . 0.0 114.572 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -66.95 -39.5 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.423 -0.799 . . . . 0.0 112.806 -169.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -61.47 -44.31 97.33 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 120.109 1.322 . . . . 0.0 108.77 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -67.75 -35.07 78.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.218 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.23 -17.7 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.169 -0.957 . . . . 0.0 113.056 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -109.04 3.24 21.86 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.738 -0.601 . . . . 0.0 111.434 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.456 HD21 ' HG3' ' A' ' 33' ' ' LYS . 31.2 t-20 -76.96 126.71 85.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.75 -8.99 22.14 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 116.62 -1.787 . . . . 0.0 114.199 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.1 162.99 17.99 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.8 138.51 85.84 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 N-CA-C 118.003 2.27 . . . . 0.0 118.003 -158.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.79 87.29 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.674 1.582 . . . . 0.0 115.709 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.31 53.4 0.96 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 123.103 1.43 . . . . 0.0 111.638 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.26 77.92 8.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.856 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.1 m -122.51 95.32 46.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 O-C-N 121.762 -0.586 . . . . 0.0 110.43 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.29 73.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 123.722 2.948 . . . . 0.0 116.458 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -84.41 -138.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 119.081 0.707 . . . . 0.0 113.221 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.95 -35.75 59.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -66.26 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.548 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.18 -32.19 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.2 p -71.94 -38.08 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.077 0.853 . . . . 0.0 109.129 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.07 -39.62 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.98 -33.05 67.68 Favored Glycine 0 C--O 1.224 -0.485 0 O-C-N 121.477 -0.764 . . . . 0.0 113.702 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.8 p -71.06 -11.81 61.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.432 1.116 . . . . 0.0 113.607 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -96.77 -26.42 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 109.516 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.25 -56.26 7.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.261 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -59.39 -55.14 49.11 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -165.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.03 -20.46 19.29 Favored 'Trans proline' 0 C--N 1.351 0.667 1 C-N-CA 113.006 -4.196 . . . . 0.0 112.716 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -69.46 -36.1 76.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.819 -0.551 . . . . 0.0 110.119 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.88 -35.97 77.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.085 -1.009 . . . . 0.0 112.018 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.0 -42.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -57.11 -49.12 76.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.304 0.642 . . . . 0.0 111.786 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -81.62 -11.16 59.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 tp -77.99 -36.95 48.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.557 0.694 . . . . 0.0 111.333 165.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -70.2 -25.45 63.42 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.304 -0.873 . . . . 0.0 111.453 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 t -88.93 149.12 23.47 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -132.05 40.58 3.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 123.105 1.431 . . . . 0.0 109.085 161.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.42 171.82 3.09 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.57 72.5 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 CA-C-O 123.158 1.233 . . . . 0.0 114.161 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -85.33 101.79 12.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.933 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.61 -52.58 0.35 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.66 -30.75 78.55 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.8 p -77.36 -24.22 50.69 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 118.452 1.126 . . . . 0.0 112.867 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -73.22 -35.91 66.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -67.42 -31.47 71.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.29 -35.85 80.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 120.506 -1.371 . . . . 0.0 111.093 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.82 -37.99 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.163 -0.335 . . . . 0.0 110.178 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.69 -41.1 89.94 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -67.88 -33.3 74.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.869 -1.144 . . . . 0.0 112.604 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -64.96 -40.65 95.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.58 -23.99 61.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.551 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.09 -26.48 66.74 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 118.626 0.648 . . . . 0.0 110.668 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.15 -46.64 70.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.35 -40.67 85.87 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 121.414 -0.803 . . . . 0.0 111.169 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.23 -39.63 87.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.33 -47.31 85.87 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-O 119.489 -0.617 . . . . 0.0 112.734 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.0 -41.56 97.45 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.029 0.914 . . . . 0.0 108.991 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -44.51 82.53 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.25 -0.906 . . . . 0.0 112.333 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.31 -12.62 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.0 m -96.57 -8.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.582 0.628 . . . . 0.0 112.254 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -109.72 -43.59 4.01 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.61 -76.19 0.24 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -69.37 -176.09 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 CA-C-N 120.909 2.354 . . . . 0.0 118.047 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -54.89 161.45 1.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.32 -30.04 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.972 -116.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.27 18.8 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.86 85.79 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -144.56 -48.6 0.26 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -172.95 175.02 3.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -166.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.3 mm -61.14 121.41 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -135.98 178.59 6.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.48 -27.37 24.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.0 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.422 0.629 . . . . 0.0 110.517 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.56 -39.8 94.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.96 -21.6 61.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.06 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.2 p -87.5 -36.56 17.57 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.674 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.18 -47.25 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.52 94.62 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.8 -29.33 12.65 Favored 'Trans proline' 0 C--N 1.352 0.73 1 C-N-CA 111.849 -4.967 . . . . 0.0 113.696 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.23 -25.87 42.56 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.135 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.07 -35.57 80.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.095 0.861 . . . . 0.0 111.494 167.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.86 -47.46 80.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -63.09 -35.09 79.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.35 -51.4 57.57 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.388 -0.82 . . . . 0.0 111.0 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -65.01 -30.88 71.89 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.751 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.17 -58.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 117.902 0.319 . . . . 0.0 110.489 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.74 67.22 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.134 -0.979 . . . . 0.0 113.127 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.03 -35.14 74.08 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.39 -37.5 94.56 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.907 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -66.07 -42.07 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.269 -0.548 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -100.74 -42.95 6.29 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 118.504 2.779 . . . . 0.0 118.504 -164.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -140.89 57.52 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -47.35 122.08 4.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -152.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -155.0 93.22 2.77 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.44 165.56 32.16 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 115.848 -2.301 . . . . 0.0 109.64 166.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.82 121.12 71.79 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.41 161.68 41.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 116.5 -1.867 . . . . 0.0 113.345 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -73.35 1.37 9.73 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.5 -21.65 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.667 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.43 78.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -40.35 82.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -54.52 39.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -66.0 -43.79 92.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.69 -47.03 85.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -75.35 -33.97 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.653 -0.654 . . . . 0.0 112.6 -174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.36 -20.67 50.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.02 -42.03 94.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -63.45 -33.5 75.7 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.496 -1.378 . . . . 0.0 111.261 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.0 -42.87 75.89 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.932 -0.48 . . . . 0.0 111.511 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.16 -18.91 22.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.38 -35.72 70.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.7 t -128.11 68.2 1.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.597 165.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -103.84 140.39 37.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.083 -3.673 . . . . 0.0 101.083 154.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.05 -45.87 68.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.8 t -61.64 -45.48 93.89 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.303 1.049 . . . . 0.0 112.518 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.73 -41.07 68.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.764 -174.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.78 -40.11 82.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.782 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -78.44 -35.3 47.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 36.4 p -88.55 -15.97 33.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -65.36 150.12 48.83 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.614 -0.678 . . . . 0.0 112.604 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.84 160.19 30.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.19 143.55 50.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -56.84 -42.95 80.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -59.71 -40.45 88.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 0.0 110.964 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.05 -12.5 60.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.58 -48.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -68.11 -51.45 48.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.323 1.059 . . . . 0.0 108.578 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.5 -5.75 44.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.18 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.77 -29.54 15.59 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 119.517 -0.602 . . . . 0.0 114.313 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -106.82 -26.07 11.42 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -64.87 -18.8 0.47 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 119.522 3.156 . . . . 0.0 119.522 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.358 1.034 1 C-N-CA 112.905 -4.263 . . . . 0.0 116.282 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.23 0.052 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -114.65 141.55 47.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.848 1.204 . . . . 0.0 112.323 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.51 96.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 t -96.16 118.62 33.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.22 163.7 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -166.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -67.88 130.88 44.34 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.634 -0.666 . . . . 0.0 112.553 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.3 166.53 22.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.479 174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.88 139.72 56.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.65 126.83 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.885 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.04 -16.17 17.57 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.21 76.45 13.4 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 50.7 Cg_endo -75.33 42.24 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 118.391 2.42 . . . . 0.0 118.391 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -112.12 -12.56 13.65 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -125.84 159.33 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.63 135.44 57.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.839 1.255 . . . . 0.0 111.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.32 -163.7 36.99 Favored Glycine 0 CA--C 1.511 -0.198 0 N-CA-C 119.307 2.483 . . . . 0.0 119.307 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -76.35 76.38 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.157 1.383 . . . . 0.0 109.774 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -141.35 82.98 13.93 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 121.221 -0.925 . . . . 0.0 113.147 -171.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.27 -22.71 75.4 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 116.079 -2.147 . . . . 0.0 115.571 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -68.85 -38.43 79.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -69.55 -40.45 76.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.69 -35.32 79.3 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 118.381 -0.818 . . . . 0.0 112.275 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -57.59 -39.81 77.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.725 1.602 . . . . 0.0 110.767 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.42 -52.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.42 0.629 . . . . 0.0 110.293 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.09 -37.78 88.7 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.81 -41.78 97.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -66.89 -32.49 73.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.308 0.575 . . . . 0.0 111.29 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.43 -46.38 48.82 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.146 -0.346 . . . . 0.0 111.112 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -72.52 -34.37 67.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -36.31 83.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.021 -1.05 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -86.22 -7.08 58.81 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 59.55 29.33 18.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.487 1.515 . . . . 0.0 114.121 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -80.84 136.18 51.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.82 153.18 53.31 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.178 -1.415 . . . . 0.0 114.214 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -156.57 171.69 19.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.37 124.9 48.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 t -83.5 145.81 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -139.66 146.43 39.69 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 102.799 -3.037 . . . . 0.0 102.799 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.6 mt -114.73 132.34 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.73 119.89 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.32 72.79 7.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.55 1.167 . . . . 0.0 109.937 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 mt 57.22 27.16 13.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.6 33.64 Favored Glycine 0 C--O 1.226 -0.351 0 O-C-N 121.871 -0.518 . . . . 0.0 113.537 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -68.33 117.41 10.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 154.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -140.1 101.16 7.01 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.3 175.68 7.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.972 -0.885 . . . . 0.0 111.133 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -56.49 -36.48 69.17 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 122.146 -0.346 . . . . 0.0 111.017 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -56.6 -40.58 75.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -71.52 -31.81 67.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.142 -0.974 . . . . 0.0 108.959 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.29 -23.62 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.34 -35.29 79.1 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.303 -0.873 . . . . 0.0 110.241 172.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.05 -53.03 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -90.59 139.05 26.42 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 121.661 -0.649 . . . . 0.0 111.004 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.12 -22.91 46.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 116.974 -1.551 . . . . 0.0 115.858 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -108.11 -6.24 16.57 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 0.0 111.992 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.54 4.35 38.22 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.373 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.65 58.44 1.12 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.968 0.907 . . . . 0.0 110.819 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.82 159.17 69.83 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 100.343 -3.947 . . . . 0.0 100.343 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -69.16 147.98 67.95 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 114.081 -3.479 . . . . 0.0 111.47 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.1 155.54 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.164 0.507 . . . . 0.0 109.966 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -123.33 109.18 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.67 84.98 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.8 95.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.153 0.981 . . . . 0.0 108.361 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.3 t0 51.94 46.85 25.89 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.434 1.111 . . . . 0.0 111.779 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t0 58.99 30.55 20.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -114.85 165.85 12.4 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 166.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -150.58 149.79 30.37 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.06 157.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -115.52 -121.65 0.3 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.66 -176.91 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -166.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -54.41 -36.44 63.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.67 -20.43 53.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.943 0.878 . . . . 0.0 110.006 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.6 t -91.87 -43.89 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -42.04 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.71 -0.619 . . . . 0.0 111.14 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.32 -13.85 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.66 0.743 . . . . 0.0 112.299 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.04 -64.04 0.71 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.42 -47.39 45.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.631 -168.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.08 -40.45 94.67 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.606 1.548 . . . . 0.0 108.702 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -63.42 -42.66 98.72 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.704 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.95 -40.19 94.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -87.12 4.96 40.15 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.933 -0.48 . . . . 0.0 111.968 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.45 135.91 93.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.987 -0.445 . . . . 0.0 111.516 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.44 -6.07 16.05 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.891 1.073 . . . . 0.0 114.891 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -112.11 162.32 21.87 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.38 130.89 39.75 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 116.381 -1.946 . . . . 0.0 116.791 -161.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.8 146.02 32.99 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 116.763 -1.691 . . . . 0.0 111.914 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.26 45.74 2.73 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.24 80.26 7.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.3 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.2 p -114.31 106.02 53.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -98.51 59.16 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.357 2.705 . . . . 0.0 118.71 163.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.18 -146.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 120.112 1.076 . . . . 0.0 113.107 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -51.43 -32.27 26.0 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -68.6 -30.57 69.33 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.417 -0.802 . . . . 0.0 111.599 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.46 47.48 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.247 -0.283 . . . . 0.0 110.642 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.5 p -74.85 -30.52 61.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.731 -0.605 . . . . 0.0 112.531 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.1 t -75.12 -40.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.08 91.25 Favored Glycine 0 C--O 1.222 -0.605 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.252 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.3 p -71.47 -11.66 60.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -81.21 -32.39 33.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.628 1.204 . . . . 0.0 110.004 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.3 -43.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.179 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.66 -56.83 19.18 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.3 -13.21 13.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 113.973 -3.551 . . . . 0.0 113.464 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 t -69.55 -49.51 53.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.992 -0.443 . . . . 0.0 109.808 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -70.72 -26.99 63.63 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.608 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.33 -44.51 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.2 -44.82 87.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.74 -25.96 59.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.0 OUTLIER -77.0 -37.33 55.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.092 0.86 . . . . 0.0 110.667 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -87.94 40.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t -152.02 144.81 24.34 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -131.16 34.41 4.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.34 168.63 7.51 Favored Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 163.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.61 44.3 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 N-CA-C 115.959 1.484 . . . . 0.0 115.959 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.71 116.69 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.765 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -150.88 -55.49 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.74 -40.6 97.54 Favored Glycine 0 C--O 1.217 -0.906 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.1 p -69.42 -27.55 65.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.86 1.33 . . . . 0.0 112.56 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -73.73 -29.35 62.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.778 1.275 . . . . 0.0 108.372 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -83.98 -24.55 30.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.715 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.46 86.27 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.755 -1.216 . . . . 0.0 108.632 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.985 -0.447 . . . . 0.0 111.455 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.59 -40.23 86.78 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -67.33 -34.46 77.38 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.975 -1.078 . . . . 0.0 113.496 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -65.58 -42.36 91.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.718 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.8 mt -65.9 -35.52 80.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.927 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -64.98 -28.96 69.87 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.607 0.363 . . . . 0.0 111.932 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 -44.74 93.33 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.821 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 -38.35 80.41 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.908 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.12 -42.92 95.79 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.653 1.115 . . . . 0.0 111.732 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -34.14 89.11 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.952 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -77.16 -43.49 33.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.655 -0.909 . . . . 0.0 110.363 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -41.35 74.08 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -70.58 -20.76 62.75 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.896 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.94 -47.03 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 167.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -73.96 -46.18 45.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.22 -73.95 0.22 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 116.784 -2.12 . . . . 0.0 117.407 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -61.46 -164.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 126.268 4.645 . . . . 0.0 118.932 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -58.3 172.98 0.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.776 0.83 . . . . 0.0 113.123 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.29 -39.26 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.302 0.641 . . . . 0.0 112.283 -160.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.08 4.88 1.87 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.17 -14.02 66.27 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -134.58 -49.42 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -166.17 179.01 5.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -171.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 120.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -129.87 -164.09 1.37 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 171.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.75 -38.55 15.73 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.84 -40.19 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 123.033 1.397 . . . . 0.0 111.303 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -73.28 -32.31 64.58 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 120.992 -1.067 . . . . 0.0 109.915 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.9 -33.18 71.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.803 -0.561 . . . . 0.0 110.361 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.0 p -80.08 -45.96 17.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -81.18 -42.87 20.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.68 -37.83 60.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.9 -22.48 23.28 Favored 'Trans proline' 0 C--N 1.35 0.628 1 C-N-CA 111.893 -4.938 . . . . 0.0 114.731 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -74.72 -31.8 61.96 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 108.796 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.65 -31.71 71.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.502 0.592 . . . . 0.0 112.217 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -62.65 -51.38 67.5 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.418 -0.801 . . . . 0.0 109.753 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -65.58 -28.64 69.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.531 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 110' ' ' LEU . 40.1 tp -60.61 -52.36 65.5 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.602 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.36 -38.34 84.65 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.902 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.63 -49.47 84.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 203' ' ' ILE . . . -78.89 -50.31 11.43 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 120.571 -1.331 . . . . 0.0 114.191 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.07 -37.56 87.94 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.274 -0.891 . . . . 0.0 110.016 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.18 79.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -86.68 -36.02 18.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.074 0.937 . . . . 0.0 110.846 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 203' ' ' ILE . 32.3 m-85 -91.68 -37.29 13.11 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -150.31 62.04 0.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -52.81 128.56 27.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.261 -159.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -138.61 97.98 9.03 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.96 151.22 82.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 114.164 -3.424 . . . . 0.0 110.791 167.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.8 mt -71.6 126.84 91.56 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.68 160.7 47.41 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 117.092 -1.472 . . . . 0.0 112.781 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -74.05 -1.57 20.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.09 -1.18 57.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.515 0.674 . . . . 0.0 109.71 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.6 mt -121.71 55.56 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.0 m -58.39 -33.43 69.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -59.87 4.06 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.39 -38.61 81.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.9 tp -63.32 -45.52 90.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.585 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -83.32 -24.34 32.17 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.008 -0.433 . . . . 0.0 110.208 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.22 -47.82 82.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.58 -48.34 87.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -61.82 -35.45 78.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.17 -45.61 66.37 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.791 -0.568 . . . . 0.0 111.171 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.3 -20.83 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.35 -22.75 54.56 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.051 0.54 . . . . 0.0 112.12 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 t -128.02 67.42 1.35 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.394 1.093 . . . . 0.0 109.635 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.12 142.37 47.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 155.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -59.94 -38.78 83.41 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.671 0.607 . . . . 0.0 111.203 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.7 p -57.5 -46.13 84.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.523 0.601 . . . . 0.0 111.521 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -49.57 55.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.866 0.365 . . . . 0.0 111.698 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.33 -47.13 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -71.94 -24.24 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 112.824 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 70.4 p -120.36 27.32 8.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.914 0.864 . . . . 0.0 111.328 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -63.19 157.4 22.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.351 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 160.97 30.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.41 109.68 5.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -60.4 -36.45 78.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.16 -36.16 76.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.977 0.894 . . . . 0.0 109.69 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -90.8 -8.0 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.879 -0.513 . . . . 0.0 111.086 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.33 -50.71 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 163.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 163' ' ' ALA 0.265 19.7 pt -69.5 -50.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.734 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.26 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.302 -0.874 . . . . 0.0 111.464 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.93 -31.95 13.84 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -95.61 -42.64 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -20.63 0.6 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 120.566 3.543 . . . . 0.0 120.566 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.353 0.769 1 C-N-CA 111.337 -5.308 . . . . 0.0 113.779 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--O 1.234 0.264 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -143.85 155.43 44.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.506 1.048 . . . . 0.0 109.487 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.98 106.07 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.33 1.062 . . . . 0.0 113.062 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.2 m -87.44 64.54 8.23 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.375 -0.828 . . . . 0.0 112.993 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 m -71.47 152.22 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.61 134.75 38.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.56 171.5 12.29 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.94 137.36 58.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.803 0.811 . . . . 0.0 112.502 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.16 118.4 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.95 82.97 Favored Glycine 0 C--O 1.246 0.864 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.54 100.01 4.43 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.81 80.11 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 CA-C-O 122.701 1.042 . . . . 0.0 113.926 169.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -148.51 -31.19 0.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.482 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.38 162.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.7 158.13 35.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.24 -178.78 15.46 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.76 105.84 10.34 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.8 m -128.68 153.03 79.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 149.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.18 -39.78 65.77 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.475 -1.884 . . . . 0.0 109.755 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -14.91 63.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.77 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.7 -58.02 3.46 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.69 -26.22 66.07 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.59 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -47.36 -45.95 25.32 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 120.996 1.725 . . . . 0.0 113.161 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.36 -34.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.05 -39.88 96.06 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.538 -1.351 . . . . 0.0 110.13 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.6 -33.55 72.85 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -74.71 -46.74 35.54 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.727 -0.608 . . . . 0.0 109.592 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -40.81 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.808 0.731 . . . . 0.0 111.054 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -69.03 -43.24 75.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.872 -1.142 . . . . 0.0 108.271 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.59 -12.18 60.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.066 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtmm 54.67 42.94 30.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.073 1.349 . . . . 0.0 111.874 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -95.09 157.95 35.66 Favored Pre-proline 0 C--O 1.242 0.682 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.795 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.5 119.74 6.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 117.05 -1.5 . . . . 0.0 113.909 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -136.45 154.59 50.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.566 0.698 . . . . 0.0 109.128 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.36 150.62 37.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 t -119.44 139.74 51.55 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 122.267 1.032 . . . . 0.0 113.234 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.06 97.71 5.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.385 1.474 . . . . 0.0 111.278 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.3 mt -70.67 127.96 34.45 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.563 0.697 . . . . 0.0 112.619 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.15 108.0 22.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -78.29 69.32 4.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.583 1.182 . . . . 0.0 110.45 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 58.4 41.58 22.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.791 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.69 85.02 1.4 Allowed Glycine 0 C--O 1.24 0.491 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -129.24 -76.75 0.55 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -155.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 71.5 mmtt -71.7 152.08 93.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 74.6 Cg_exo -58.22 -160.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 2 C-N-CA 127.266 5.31 . . . . 0.0 123.527 -170.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.27 -13.87 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -52.22 -47.17 65.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.822 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -81.6 -38.17 26.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 112.215 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.57 -27.37 67.68 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.4 -0.813 . . . . 0.0 112.027 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.75 -34.29 75.34 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.6 mt -97.41 -46.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.965 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -76.04 127.82 84.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.42 -31.75 13.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 115.672 -2.419 . . . . 0.0 116.506 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -86.9 -21.37 26.36 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.578 -1.326 . . . . 0.0 110.277 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.23 85.08 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.288 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -147.15 27.23 1.05 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.973 0.909 . . . . 0.0 111.837 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.24 143.68 27.09 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.333 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.38 159.19 53.52 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 117.353 -1.298 . . . . 0.0 113.542 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t 77.72 153.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 128.428 2.691 . . . . 0.0 109.714 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.6 33.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.769 1.628 . . . . 0.0 113.547 149.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -153.24 125.67 8.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.537 3.162 . . . . 0.0 119.537 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -147.1 134.65 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 109.506 166.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.55 39.3 24.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.031 0.933 . . . . 0.0 113.191 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.37 20.38 10.97 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.734 1.614 . . . . 0.0 114.031 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -125.33 165.79 17.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.733 1.613 . . . . 0.0 106.914 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -112.09 118.45 35.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.21 129.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 112.123 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.26 112.71 2.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.399 1.08 . . . . 0.0 111.94 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -164.11 151.46 12.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 162.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.3 p -54.56 -37.86 65.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.6 -33.09 28.08 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.015 0.912 . . . . 0.0 109.954 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -72.31 -40.7 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -73.03 -11.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -103.19 -5.46 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.627 0.649 . . . . 0.0 111.435 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.36 -66.91 0.13 Allowed Glycine 0 CA--C 1.519 0.32 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.9 -35.12 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.8 -1.412 . . . . 0.0 110.084 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.6 -38.26 86.92 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.738 -1.226 . . . . 0.0 111.726 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.77 -31.79 68.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.254 0.549 . . . . 0.0 110.528 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -65.41 -27.74 68.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.019 0.914 . . . . 0.0 111.471 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.24 6.41 40.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.867 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.44 144.04 91.23 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.05 -28.89 18.57 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 115.24 -2.706 . . . . 0.0 115.087 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.4 165.71 48.58 Favored Pre-proline 0 N--CA 1.473 0.681 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.11 142.88 76.48 Favored 'Trans proline' 0 C--N 1.354 0.868 0 N-CA-C 117.688 2.149 . . . . 0.0 117.688 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.9 90.91 0.88 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.003 1.136 . . . . 0.0 114.955 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -108.94 79.07 1.18 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.843 1.306 . . . . 0.0 111.758 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.26 73.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.841 -173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -115.63 116.15 41.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.001 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -98.35 74.67 0.07 OUTLIER 'Trans proline' 0 CA--C 1.558 1.723 1 C-N-CA 127.194 5.263 . . . . 0.0 119.032 164.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -85.13 -149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 121.304 1.336 . . . . 0.0 113.504 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.24 -38.6 12.57 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.7 m-85 -66.22 -26.1 67.22 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.44 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.31 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.756 -0.59 . . . . 0.0 111.328 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.3 p -75.1 -34.39 61.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.91 -39.25 83.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -32.52 80.72 Favored Glycine 0 C--O 1.226 -0.387 0 O-C-N 121.435 -0.791 . . . . 0.0 114.202 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -70.43 -6.64 37.23 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -104.11 -35.07 8.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.502 0.667 . . . . 0.0 110.988 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.57 -51.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.432 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 89.2 t80 -56.04 -52.1 75.33 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -69.04 -26.4 31.01 Favored 'Trans proline' 0 C--N 1.35 0.606 1 C-N-CA 112.118 -4.788 . . . . 0.0 113.178 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -65.48 -42.57 92.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 103' ' ' PHE 0.287 10.7 p90 -78.98 -18.12 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.441 -177.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -79.33 -37.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.953 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.25 -40.45 90.35 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.773 -0.579 . . . . 0.0 111.607 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -64.71 -40.21 94.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.094 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.23 -35.75 82.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.142 0.496 . . . . 0.0 112.167 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.67 -0.31 26.21 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.3 t -107.0 127.82 53.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -166.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -116.64 34.37 5.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 123.272 1.51 . . . . 0.0 109.05 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.44 168.56 13.6 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 166.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.91 63.74 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-O 123.172 1.238 . . . . 0.0 113.516 159.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -80.38 69.52 6.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -167.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.92 -40.33 20.28 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.554 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 -38.84 91.81 Favored Glycine 0 C--O 1.228 -0.241 0 O-C-N 121.837 -0.539 . . . . 0.0 112.93 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 -28.48 64.01 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.288 -0.536 . . . . 0.0 110.41 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.22 -38.8 82.27 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.41 -1.431 . . . . 0.0 109.996 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -78.95 -12.48 60.03 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.114 -0.991 . . . . 0.0 113.113 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.31 76.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.9 mt -60.34 -44.27 95.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.513 0.673 . . . . 0.0 109.325 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.87 -51.64 68.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.04 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.26 -29.26 47.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -70.51 -40.49 73.49 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 mt -68.63 -24.43 64.55 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.122 -0.986 . . . . 0.0 112.354 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -61.6 -32.97 73.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.429 0.558 . . . . 0.0 112.261 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -43.07 89.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.93 -27.74 63.99 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.844 -0.535 . . . . 0.0 111.569 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.98 -48.91 72.31 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.696 -0.627 . . . . 0.0 111.838 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.12 -36.42 91.85 Favored Glycine 0 C--O 1.235 0.2 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.592 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -35.53 80.81 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 122.369 -0.489 . . . . 0.0 111.237 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -73.26 -10.21 59.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -162.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.9 m -82.03 -12.36 12.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -112.71 -49.09 2.96 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.28 -60.65 0.35 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -79.22 -177.82 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.771 2.314 . . . . 0.0 116.728 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -40.64 151.86 0.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 pt -74.45 3.24 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -141.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.05 -8.9 57.82 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.632 1.206 . . . . 0.0 109.258 162.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.88 6.22 65.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.622 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -143.26 -49.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -165.97 -174.69 3.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.479 1.112 . . . . 0.0 108.163 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.89 123.07 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.3 m -139.36 172.24 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.29 5.07 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 95' ' ' PHE . 7.4 p -60.29 -37.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -78.45 -40.56 35.27 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.098 -1.001 . . . . 0.0 108.41 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.91 -16.26 61.02 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.831 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.8 m -77.3 -35.04 55.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.82 -38.68 6.01 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -47.96 -42.41 48.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -57.35 -37.66 96.94 Favored 'Trans proline' 0 C--N 1.354 0.864 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -99.32 -17.33 18.1 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.615 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.51 -32.69 72.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 118.506 0.594 . . . . 0.0 110.926 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.28 -52.87 63.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -68.99 -19.33 64.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.51 -47.49 72.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -36.28 80.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.276 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 -50.07 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.4 -51.67 34.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.39 -0.819 . . . . 0.0 110.34 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.82 -41.39 83.12 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.233 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.09 71.14 Favored Glycine 0 C--O 1.234 0.127 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.682 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -90.41 -40.53 12.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -96.53 -41.01 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -137.53 71.95 1.41 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.966 1.306 . . . . 0.0 108.847 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -67.84 86.32 0.23 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -154.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -121.65 99.14 45.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 110.931 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.78 168.26 23.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 118.374 -0.617 . . . . 0.0 112.676 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.54 122.02 86.01 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.6 161.88 43.94 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 116.716 -1.723 . . . . 0.0 111.319 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -69.18 -15.05 63.31 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.286 -0.884 . . . . 0.0 111.712 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.63 -25.17 68.1 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.364 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.25 61.87 0.6 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.78 1.276 . . . . 0.0 109.289 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -22.78 66.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -171.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -50.19 74.82 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -25.3 16.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.688 -168.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -61.28 -48.41 81.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.443 170.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.78 -40.45 88.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.004 0.907 . . . . 0.0 112.39 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -66.85 -49.27 66.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.053 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.4 mm -66.76 -33.89 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.52 -46.83 88.71 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.329 -0.857 . . . . 0.0 111.846 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.6 mt -66.96 -43.14 83.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.903 0.383 . . . . 0.0 111.14 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.54 -32.36 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.484 1.114 . . . . 0.0 111.849 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -62.7 -29.3 70.56 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.372 -0.83 . . . . 0.0 113.144 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -144.0 57.46 1.34 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -90.28 144.5 25.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 150.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.72 -39.65 85.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.908 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -59.02 -44.05 91.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.095 0.95 . . . . 0.0 111.297 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.24 -41.94 60.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.056 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.1 -39.83 93.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.237 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -74.32 -32.27 62.78 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.2 p -101.23 0.56 37.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 117.724 2.491 . . . . 0.0 117.724 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -58.02 150.29 21.21 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.59 167.45 20.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.742 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.77 127.19 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.99 -38.59 91.63 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 117.846 0.294 . . . . 0.0 111.081 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.29 -40.41 74.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 109.028 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -94.41 -1.78 53.07 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.5 t -77.66 -53.41 14.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 163.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.4 mt -67.74 -56.88 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.597 0.713 . . . . 0.0 110.344 -171.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . . . -76.4 -4.85 44.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.02 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.03 -23.8 36.99 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.374 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -102.27 -35.99 8.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 204' ' ' ALA . 8.8 pt-20 -63.69 -23.66 1.13 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.356 0.96 1 C-N-CA 112.852 -4.299 . . . . 0.0 114.746 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -123.53 136.5 54.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.16 125.62 57.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 175.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.4 m -129.63 105.59 8.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.19 160.77 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -169.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 130.7 45.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.07 172.03 14.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.937 0.398 . . . . 0.0 111.271 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 137.94 58.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.72 141.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.354 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.32 -38.2 3.01 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.12 81.45 6.19 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 123.107 0.563 . . . . 0.0 110.49 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.49 89.47 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 N-CA-C 117.956 2.252 . . . . 0.0 117.956 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -144.74 -33.43 0.38 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -88.98 164.29 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.34 146.17 49.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.458 1.503 . . . . 0.0 111.253 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.33 173.04 22.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 122.579 3.792 . . . . 0.0 122.579 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -81.13 78.58 7.92 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 t -128.61 135.66 27.92 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.57 -42.59 52.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 119.074 0.705 . . . . 0.0 113.703 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -12.61 60.02 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.9 t -60.47 -45.47 93.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.541 0.686 . . . . 0.0 111.247 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.96 -7.45 59.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -63.18 -43.95 96.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -42.55 67.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.734 -1.576 . . . . 0.0 111.169 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.75 -43.71 79.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.131 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.06 -40.18 87.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.255 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.2 m -62.86 -34.42 77.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.348 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -46.7 32.61 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 112.526 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.8 -24.91 61.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.735 0.303 . . . . 0.0 111.401 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.65 -31.8 71.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.28 -0.887 . . . . 0.0 111.584 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -95.81 -16.15 22.05 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 50.1 46.13 24.9 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -76.55 137.15 67.33 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 163.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.91 148.42 70.46 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 115.834 -2.311 . . . . 0.0 113.425 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -141.95 151.63 42.74 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 122.775 1.274 . . . . 0.0 113.481 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -91.97 117.61 29.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.305 -1.77 . . . . 0.0 107.494 169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 t -99.16 121.2 40.7 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -114.96 140.0 49.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.46 126.62 53.69 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -90.4 104.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -73.06 71.64 1.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.763 0.825 . . . . 0.0 113.153 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.0 mt 56.08 52.84 9.83 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.88 1.272 . . . . 0.0 113.082 169.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.21 80.19 1.01 Allowed Glycine 0 CA--C 1.51 -0.229 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.695 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -116.01 -88.86 0.58 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -148.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -74.73 159.13 83.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 119.209 -0.425 . . . . 0.0 111.729 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -60.01 -165.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.199 2.599 . . . . 0.0 118.021 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -42.21 -37.57 1.51 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -50.11 -45.99 53.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.406 0.548 . . . . 0.0 111.439 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.34 -22.37 41.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.82 -23.31 60.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.393 0.616 . . . . 0.0 110.314 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.41 -41.04 49.1 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.854 -0.529 . . . . 0.0 110.853 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.25 -40.98 86.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -116.43 128.17 26.2 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.462 1.483 . . . . 0.0 111.758 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.34 -16.51 31.19 Favored 'Trans proline' 0 C--N 1.35 0.628 0 N-CA-C 117.003 1.886 . . . . 0.0 117.003 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -100.39 -4.88 28.15 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.842 0.746 . . . . 0.0 112.147 166.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.27 -28.2 3.84 Favored Glycine 0 CA--C 1.52 0.353 0 O-C-N 122.048 -0.407 . . . . 0.0 114.081 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 33.17 2.62 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.28 148.89 35.26 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 151.13 73.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 117.222 -1.385 . . . . 0.0 113.794 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' A' ' 71' ' ' ALA . 33.8 m -133.86 169.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.336 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.8 t -124.25 138.04 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 153.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -104.68 96.37 6.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.14 129.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t0 60.26 34.18 20.92 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.78 1.276 . . . . 0.0 111.018 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.27 21.38 12.03 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.782 2.433 . . . . 0.0 114.299 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -127.56 127.88 44.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.681 0.792 . . . . 0.0 110.047 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -108.02 144.0 35.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.6 t -131.46 140.09 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -136.79 -0.43 2.34 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.06 139.73 30.23 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.08 -1.013 . . . . 0.0 111.143 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.5 p -75.03 -26.17 59.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 -152.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -80.65 -35.18 34.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -91.47 -10.48 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.777 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -76.53 2.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.468 -0.77 . . . . 0.0 110.389 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.1 -56.66 5.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 O-C-N 121.688 -0.633 . . . . 0.0 110.229 152.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.11 -42.79 99.43 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 120.111 2.804 . . . . 0.0 120.111 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.58 -37.4 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 118.937 1.368 . . . . 0.0 107.466 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -40.93 97.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.02 -42.2 98.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.745 0.702 . . . . 0.0 111.222 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -61.49 -34.09 74.9 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 111.462 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.03 16.4 19.69 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.09 116.95 52.74 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.49 -13.76 38.25 Favored 'Trans proline' 0 C--O 1.245 0.86 1 N-CA-C 123.16 4.254 . . . . 0.0 123.16 -167.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.43 155.37 74.09 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-N 121.357 1.89 . . . . 0.0 107.126 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.77 125.53 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 116.635 -1.777 . . . . 0.0 116.306 -168.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.19 152.84 18.53 Favored 'Trans proline' 0 C--O 1.243 0.768 0 N-CA-C 116.569 1.719 . . . . 0.0 116.569 -175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -130.76 56.87 1.76 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 69.96 8.85 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.458 -1.401 . . . . 0.0 114.251 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 m -122.31 98.43 44.11 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 123.499 0.72 . . . . 0.0 110.962 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.01 80.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.509 2.806 . . . . 0.0 116.188 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -82.76 -138.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.561 1.508 . . . . 0.0 113.487 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.65 -34.84 69.78 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 125.022 1.329 . . . . 0.0 111.931 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -65.17 -28.46 69.42 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.431 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.34 -19.25 30.08 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.912 -0.492 . . . . 0.0 110.94 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.7 p -71.56 -38.96 70.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.41 -41.67 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.12 -37.46 80.1 Favored Glycine 0 C--O 1.226 -0.406 0 CA-C-N 116.49 -0.323 . . . . 0.0 113.129 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.3 p -73.03 -9.89 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.24 -39.77 14.19 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.111 0.414 . . . . 0.0 111.633 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.6 -32.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -56.06 -51.96 76.51 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.48 -11.54 15.72 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 113.612 -3.792 . . . . 0.0 113.837 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -75.09 -44.05 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.233 -0.917 . . . . 0.0 110.97 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -20.86 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.199 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.37 -42.22 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.78 -44.34 90.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.29 -32.24 73.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.44 -41.99 92.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -97.91 -16.42 19.75 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -167.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -106.95 30.06 6.5 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.176 0.989 . . . . 0.0 111.254 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.55 165.59 18.32 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.458 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.68 70.95 4.91 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.387 1.391 . . . . 0.0 113.884 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.9 81.2 8.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -163.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -99.73 -37.71 8.99 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.04 -40.41 97.03 Favored Glycine 0 N--CA 1.453 -0.228 0 O-C-N 121.733 -0.604 . . . . 0.0 111.673 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.6 m -71.31 -32.58 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.027 0.414 . . . . 0.0 110.741 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.77 -41.38 97.98 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.918 -1.114 . . . . 0.0 109.713 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -76.18 -15.26 60.09 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.456 -0.777 . . . . 0.0 110.941 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.71 -41.83 71.41 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.41 -41.04 96.85 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.342 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 tp -58.19 -36.15 72.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -81.3 -38.07 27.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.62 -38.16 80.32 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.716 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.9 mt -74.04 -19.63 60.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.829 -1.169 . . . . 0.0 110.659 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -66.25 -32.28 73.6 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.95 -42.43 80.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -41.17 98.97 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.17 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.09 -38.67 83.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.526 0.603 . . . . 0.0 110.42 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -55.54 24.69 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -61.07 -40.45 93.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.877 -0.778 . . . . 0.0 110.555 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.716 -0.615 . . . . 0.0 111.45 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.3 -27.19 62.3 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.9 -49.85 65.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.68 -44.19 19.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.54 -69.29 0.24 Allowed Glycine 0 C--O 1.25 1.139 0 CA-C-O 116.797 -2.113 . . . . 0.0 116.06 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -72.43 -159.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 125.212 3.941 . . . . 0.0 114.499 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -54.33 163.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.82 -21.95 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -161.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.22 -19.32 63.04 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.791 -1.193 . . . . 0.0 113.255 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.41 -13.45 33.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.356 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -143.39 -47.44 0.3 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -162.54 179.62 7.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mm -71.36 114.43 9.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -129.91 -169.35 2.11 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.83 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.65 -49.96 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.335 1.064 . . . . 0.0 110.746 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.99 -36.93 67.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.819 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.97 -20.55 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.167 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.2 m -83.61 -48.62 10.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.19 -48.73 15.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.91 93.57 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.29 -36.07 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 1 C-N-CA 112.599 -4.467 . . . . 0.0 114.852 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -79.22 -26.94 42.46 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.526 -1.359 . . . . 0.0 110.483 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.32 -33.76 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.973 0.806 . . . . 0.0 111.333 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -66.15 -38.19 87.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.288 -1.507 . . . . 0.0 113.767 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -67.53 -35.95 80.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.1 tp -62.41 -51.89 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.636 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -65.95 -26.12 67.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -170.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.67 -50.44 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 118.499 0.591 . . . . 0.0 111.614 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.95 -43.07 75.78 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.681 -0.637 . . . . 0.0 111.139 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.86 -42.09 67.29 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.35 93.27 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 119.92 -1.134 . . . . 0.0 114.538 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.58 -49.61 14.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.349 1.075 . . . . 0.0 112.878 173.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -87.53 -37.24 17.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -136.71 62.47 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.152 -0.967 . . . . 0.0 110.509 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -53.55 110.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -161.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -146.5 94.48 4.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.36 168.14 25.5 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 114.9 -2.933 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.55 119.55 57.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.41 162.38 30.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 115.632 -2.445 . . . . 0.0 113.396 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.9 6.3 3.44 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.363 -0.836 . . . . 0.0 112.847 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -70.51 -22.83 62.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.423 0.63 . . . . 0.0 109.357 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.88 60.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.1 m -54.27 -38.0 65.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.015 -0.428 . . . . 0.0 111.779 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -71.85 -26.93 62.56 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 120.809 -1.182 . . . . 0.0 111.938 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.6 -34.09 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.413 1.006 . . . . 0.0 110.625 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.67 -44.37 93.96 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 120.831 -1.168 . . . . 0.0 109.641 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -70.0 -31.7 69.52 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.714 -0.616 . . . . 0.0 112.464 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 121.953 -0.467 . . . . 0.0 111.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -30.9 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 118.57 0.623 . . . . 0.0 111.121 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -68.41 -37.85 80.7 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.186 -0.946 . . . . 0.0 112.453 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.57 -34.2 73.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.45 -39.79 94.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.74 13.89 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.1 t -96.63 -52.7 3.83 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -94.03 157.05 16.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.185 -1.572 . . . . 0.0 112.594 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.38 -21.34 49.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -53.27 -30.89 40.92 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.719 0.771 . . . . 0.0 111.47 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -103.58 -44.32 5.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.697 0.761 . . . . 0.0 112.235 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -61.13 -29.69 69.93 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -85.8 -29.98 23.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 48.4 p -86.02 -18.01 33.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -60.79 140.31 57.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.691 0.758 . . . . 0.0 111.574 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.49 170.59 15.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.28 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.81 117.73 7.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.4 pm0 -60.82 -35.58 76.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -63.91 -40.03 95.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.573 -0.704 . . . . 0.0 109.216 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -78.88 -13.54 59.75 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.29 -50.37 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -45.89 47.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.782 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.6 -23.48 65.39 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.84 -16.53 57.99 Favored Glycine 0 C--O 1.24 0.469 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -89.01 -35.21 16.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 117.607 0.703 . . . . 0.0 111.614 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.95 -23.91 1.35 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 120.307 3.447 . . . . 0.0 120.307 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.353 0.797 1 C-N-CA 111.105 -5.463 . . . . 0.0 115.874 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.8 144.14 47.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.85 116.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.0 m -116.3 114.39 24.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.87 160.76 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.99 124.36 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 164.62 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.898 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 142.21 58.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.73 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 127.22 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.48 -25.1 29.57 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.401 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.53 99.43 2.27 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 117.742 0.771 . . . . 0.0 111.338 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.98 55.51 5.33 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 114.546 0.941 . . . . 0.0 114.546 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -120.12 1.31 10.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.591 -0.693 . . . . 0.0 112.292 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.5 tt -148.79 160.85 5.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.47 145.5 51.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.338 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.67 -176.69 44.24 Favored Glycine 0 C--O 1.237 0.307 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.39 64.92 2.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 111.549 -2.325 . . . . 0.0 108.205 170.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.9 t -132.1 101.84 14.84 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 112.38 -2.191 . . . . 0.0 107.812 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.42 -38.31 64.98 Favored 'Trans proline' 0 C--N 1.346 0.422 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -72.2 -32.56 66.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.2 m -63.29 -43.07 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.989 0.9 . . . . 0.0 111.887 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.38 -20.99 62.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.855 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -61.4 -33.52 73.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.675 -0.64 . . . . 0.0 110.212 174.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.47 -49.07 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.412 0.625 . . . . 0.0 111.131 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.45 -37.58 88.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.2 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.45 -41.79 90.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 151' ' ' LEU . 73.6 p -73.29 -40.75 64.29 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.299 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -27.33 48.85 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.522 -0.736 . . . . 0.0 111.679 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -71.03 -35.24 71.91 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 118.8 0.727 . . . . 0.0 112.439 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -68.11 -35.66 78.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 119.112 0.869 . . . . 0.0 110.203 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -71.85 -20.77 61.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 56.09 37.12 28.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.596 1.159 . . . . 0.0 109.715 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -86.72 148.67 46.63 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.22 146.73 32.23 Favored 'Trans proline' 0 C--N 1.35 0.608 1 C-N-CA 113.225 -4.05 . . . . 0.0 113.733 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.89 161.23 41.5 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.73 113.83 27.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.27 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -83.91 124.31 30.86 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 122.697 0.399 . . . . 0.0 110.97 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -116.02 124.35 50.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.42 119.91 37.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.3 mt -88.09 107.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.01 80.48 2.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.08 0.943 . . . . 0.0 110.577 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.5 mt 56.09 53.15 9.41 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.535 167.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.75 35.5 10.12 Favored Glycine 0 C--O 1.236 0.274 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.171 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.87 113.59 10.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -146.55 84.68 7.6 Favored Pre-proline 0 C--O 1.254 1.296 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -161.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.92 166.96 20.97 Favored 'Trans proline' 0 C--O 1.235 0.356 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 158.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -57.83 -33.34 68.51 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.552 0.341 . . . . 0.0 111.227 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -54.66 -45.52 73.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.361 0.6 . . . . 0.0 112.468 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -77.79 -27.27 50.16 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -65.97 -34.77 78.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.007 0.432 . . . . 0.0 111.547 171.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -67.97 -43.87 77.98 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.101 -0.999 . . . . 0.0 110.273 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -70.1 -51.89 35.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -104.2 121.14 48.58 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-N 120.611 1.55 . . . . 0.0 114.743 -167.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.52 -24.61 30.58 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 118.932 2.628 . . . . 0.0 118.932 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -101.47 -5.37 25.34 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.3 1.409 . . . . 0.0 110.68 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.5 -47.5 3.85 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.255 -164.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -119.94 64.75 0.82 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.599 1.19 . . . . 0.0 113.604 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.52 155.86 73.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 165.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.92 154.3 58.23 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 113.564 -3.824 . . . . 0.0 111.476 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.16 142.57 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.93 125.61 67.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 165.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -98.85 89.09 4.2 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.2 101.46 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.61 47.54 22.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.748 0.819 . . . . 0.0 112.944 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t0 65.04 22.18 12.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 -173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -109.85 127.73 54.88 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.068 -1.02 . . . . 0.0 108.55 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -105.24 117.34 33.77 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.841 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.0 138.7 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.617 0.644 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.24 19.54 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 118.816 2.895 . . . . 0.0 118.816 -164.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.64 148.36 29.44 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.754 -1.216 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.1 p -63.78 -25.25 68.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -165.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -82.57 -35.06 27.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.304 -0.247 . . . . 0.0 111.539 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.63 -19.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.63 -0.669 . . . . 0.0 112.392 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 pt -77.37 4.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.11 0.481 . . . . 0.0 111.175 172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.94 -51.0 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.31 -55.19 7.09 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 120.249 2.86 . . . . 0.0 120.249 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.55 -29.57 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.35 1.575 . . . . 0.0 107.198 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -58.82 -43.84 90.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.76 -40.18 76.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.882 0.849 . . . . 0.0 110.664 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -63.03 -34.96 78.69 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.37 3.66 52.76 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -70.45 128.7 90.97 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.759 -0.588 . . . . 0.0 110.84 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.46 -4.99 15.69 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 N-CA-C 115.709 1.388 . . . . 0.0 115.709 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.12 155.7 37.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -59.72 122.02 10.79 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 116.603 -1.798 . . . . 0.0 116.497 -163.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.76 151.83 25.07 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 116.802 -1.665 . . . . 0.0 115.518 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.2 mt -136.87 49.9 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.942 1.697 . . . . 0.0 109.509 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.9 77.94 4.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 m -114.37 101.57 54.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -96.59 67.13 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.754 1 C-N-CA 126.045 4.497 . . . . 0.0 118.613 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.66 -113.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 116.914 -1.591 . . . . 0.0 114.134 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -63.91 -31.28 72.41 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 119.425 -2.047 . . . . 0.0 115.173 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.45 -11.77 60.57 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.358 -1.463 . . . . 0.0 111.825 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.36 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 119.762 -1.837 . . . . 0.0 110.132 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -48.25 45.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.54 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.137 0.494 . . . . 0.0 110.374 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.33 91.22 Favored Glycine 0 C--O 1.224 -0.506 0 O-C-N 120.944 -1.098 . . . . 0.0 111.764 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.1 p -70.59 -2.69 15.05 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -99.03 -36.52 9.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.722 0.772 . . . . 0.0 110.471 171.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.89 -50.16 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.685 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.78 -53.9 59.76 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.03 -17.42 31.85 Favored 'Trans proline' 0 C--N 1.349 0.579 1 C-N-CA 112.751 -4.366 . . . . 0.0 113.702 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -68.38 -56.12 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.815 0.734 . . . . 0.0 111.04 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -76.96 -25.23 52.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.428 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.27 -38.94 82.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -72.77 -44.36 61.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -68.95 -30.87 69.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.298 0.954 . . . . 0.0 112.696 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.9 tp -67.46 -38.41 84.42 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.207 -0.933 . . . . 0.0 110.762 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.9 -25.33 61.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.219 0.533 . . . . 0.0 111.98 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -90.65 109.93 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -93.59 67.87 3.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.26 176.7 1.73 Allowed Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.41 61.06 2.68 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 CA-C-N 120.195 1.105 . . . . 0.0 113.29 161.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.26 116.71 17.21 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -153.2 -57.04 0.12 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.38 -33.01 84.92 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 170.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -74.32 -30.58 62.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.047 1.424 . . . . 0.0 114.831 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.51 -32.07 70.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.251 -1.53 . . . . 0.0 107.316 174.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -77.95 -12.64 60.0 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.979 -1.075 . . . . 0.0 112.707 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.27 -34.67 31.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.224 -1.547 . . . . 0.0 107.673 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.1 tp -64.1 -35.66 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.79 -39.91 78.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.33 173.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -68.9 -35.03 76.37 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.997 0.817 . . . . 0.0 111.959 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.07 -38.56 88.62 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.416 -1.428 . . . . 0.0 110.757 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.05 -20.35 49.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.04 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.22 -36.6 82.03 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.267 0.94 . . . . 0.0 110.571 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.45 -39.18 93.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.18 -50.42 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.025 0.53 . . . . 0.0 111.873 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.98 -34.99 64.88 Favored Glycine 0 C--O 1.234 0.141 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.573 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -57.51 -42.5 82.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 122.026 0.917 . . . . 0.0 110.577 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -35.11 65.22 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -73.21 -18.48 61.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 m -89.7 4.3 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -121.44 -45.77 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.29 -70.96 0.23 Allowed Glycine 0 CA--C 1.531 1.076 0 N-CA-C 120.941 3.136 . . . . 0.0 120.941 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.22 -164.95 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.723 1 C-N-CA 127.896 5.731 . . . . 0.0 118.822 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.09 166.8 7.21 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 169.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.8 mt -78.53 -24.63 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -128.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.7 -6.44 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.39 -17.22 37.25 Favored Glycine 0 C--O 1.23 -0.146 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.05 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -130.44 -44.8 1.11 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -166.45 178.1 6.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.25 126.23 16.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.7 p -131.63 -170.18 2.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.88 -36.04 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -35.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.946 -1.096 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.27 -42.91 96.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 29' ' ' SER . 92.0 mt -63.46 -32.91 74.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 81.5 p -72.9 -37.64 67.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -97.73 -42.88 7.4 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -166.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.45 57.4 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.12 -29.87 14.05 Favored 'Trans proline' 0 C--N 1.35 0.618 1 C-N-CA 111.781 -5.013 . . . . 0.0 115.701 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -76.59 -28.72 56.3 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 119.979 -1.701 . . . . 0.0 108.366 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.6 tp -66.44 -34.32 77.69 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.45 0.568 . . . . 0.0 111.783 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.35 -46.8 81.88 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.629 -0.67 . . . . 0.0 109.73 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -60.87 -33.58 73.31 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.16 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.92 -50.58 61.95 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.618 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -30.35 71.37 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.71 1.141 . . . . 0.0 111.607 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 94.5 t -73.06 -57.46 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.352 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -44.67 65.46 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.745 -1.222 . . . . 0.0 111.418 -166.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.41 -34.41 70.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.8 93.68 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.911 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -76.87 -46.87 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.622 -0.928 . . . . 0.0 112.37 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.96 -47.53 12.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -171.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.55 63.06 1.45 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -40.68 112.41 0.29 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -161.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -144.99 81.01 10.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.803 0.841 . . . . 0.0 111.959 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.47 154.78 40.56 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 113.303 -3.998 . . . . 0.0 110.118 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.23 129.9 91.55 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.41 163.65 31.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.711 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -76.82 6.51 6.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.257 1.503 . . . . 0.0 113.048 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.82 -15.99 42.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.372 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.2 mt -120.21 47.56 1.74 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 108.398 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.3 t -62.91 -18.82 63.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -160.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -48.66 80.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.264 1.847 . . . . 0.0 108.405 174.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.94 -33.03 50.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 118.042 -1.463 . . . . 0.0 107.883 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.2 -52.25 59.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.95 -39.53 94.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.577 0.703 . . . . 0.0 109.784 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.28 -22.78 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.752 -0.592 . . . . 0.0 111.948 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.6 mm -65.66 -34.59 71.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.456 1.025 . . . . 0.0 108.982 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.3 -33.48 75.37 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 111.159 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.06 -45.18 74.57 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.65 -30.17 70.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -67.92 -23.18 65.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.215 -0.928 . . . . 0.0 110.841 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -144.99 69.77 1.26 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.802 0.81 . . . . 0.0 111.071 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -131.99 144.54 50.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.55 -37.38 78.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -166.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.7 t -72.51 -50.48 25.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.94 1.352 . . . . 0.0 110.43 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.9 -28.98 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.698 -165.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.5 -43.39 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.302 1.041 . . . . 0.0 111.509 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.97 -37.17 78.62 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.47 -0.769 . . . . 0.0 112.17 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 32.1 p -81.72 -0.72 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -55.0 119.79 5.96 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.828 -0.545 . . . . 0.0 110.927 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.78 153.96 42.57 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.24 130.46 46.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -61.01 -36.12 78.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.065 0.46 . . . . 0.0 111.021 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -83.61 -25.51 30.78 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.857 -0.527 . . . . 0.0 109.649 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.39 -58.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -43.21 64.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 120.945 -1.097 . . . . 0.0 111.664 -168.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.79 0.09 48.84 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.605 -0.684 . . . . 0.0 111.591 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.09 -34.98 7.29 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -77.73 -41.73 36.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.676 -0.896 . . . . 0.0 112.376 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.44 -36.82 50.73 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo . . . . . 0 C--N 1.349 0.578 0 C-N-CA 114.956 -2.896 . . . . 0.0 114.545 176.283 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.685 0.279 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -121.32 142.66 49.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.56 149.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -140.46 130.27 24.47 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 34.5 m -132.7 165.7 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -58.71 118.33 5.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.54 173.12 12.91 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.24 0.543 . . . . 0.0 111.189 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.03 124.64 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.09 55.93 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 64.26 12.99 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 119.163 1.482 . . . . 0.0 112.452 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.38 108.03 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 115.617 -2.456 . . . . 0.0 115.864 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -172.71 -53.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.4 mt -99.65 144.32 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 108.573 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.67 150.51 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.184 1.394 . . . . 0.0 114.599 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -156.09 11.79 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 10.0 t70 -84.71 116.82 23.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.18 -1.188 . . . . 0.0 110.394 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -165.38 140.4 4.17 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 173.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.81 -55.29 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.827 -2.982 . . . . 0.0 112.514 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -66.26 -29.31 69.52 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.29 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -44.13 -59.0 2.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -86.17 -11.65 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.924 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.39 -48.8 79.57 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 m -68.82 -43.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.457 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.99 -41.52 90.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.551 -173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.19 -46.8 76.07 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.185 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.1 p -65.3 -42.44 93.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 119.593 1.088 . . . . 0.0 112.533 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.72 -36.17 73.08 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.056 -1.027 . . . . 0.0 111.775 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -76.81 -29.91 56.18 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.654 -0.654 . . . . 0.0 111.816 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.67 -29.64 70.23 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.643 -1.286 . . . . 0.0 111.265 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.18 -8.45 57.81 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.14 37.48 26.35 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.61 1.564 . . . . 0.0 113.63 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.47 157.58 67.38 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.353 0.524 . . . . 0.0 111.076 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.57 127.18 10.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -147.26 167.65 23.71 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.211 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.69 148.77 28.98 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t 72.44 143.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.852 2.061 . . . . 0.0 114.235 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.98 71.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 110.894 170.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.24 143.15 18.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.97 146.58 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.055 1.742 . . . . 0.0 108.399 158.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -88.75 80.24 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt 53.77 35.44 21.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.848 0.832 . . . . 0.0 113.209 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 1.37 83.72 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -82.87 78.82 9.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.343 1.571 . . . . 0.0 113.174 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -134.41 159.85 70.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.05 -176.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 114.662 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.29 -28.36 27.68 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -45.88 -40.71 10.38 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -85.96 -28.93 23.94 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 112.329 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.22 -22.55 63.86 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.847 0.832 . . . . 0.0 111.098 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -76.07 -3.67 37.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 112.097 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.16 -67.91 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 t -73.45 126.03 90.25 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -158.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.23 -24.26 27.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 N-CA-C 117.538 2.091 . . . . 0.0 117.538 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -100.76 -5.16 26.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.903 0.859 . . . . 0.0 111.089 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 -29.32 2.17 Favored Glycine 0 C--O 1.225 -0.427 0 O-C-N 121.806 -0.559 . . . . 0.0 113.813 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -130.81 45.61 2.79 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.149 0.974 . . . . 0.0 112.862 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.93 155.86 60.17 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.448 -0.783 . . . . 0.0 110.057 170.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . 72.8 Cg_endo -66.64 153.21 78.78 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 123.323 1.17 . . . . 0.0 113.706 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.21 159.34 36.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.71 124.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -92.88 80.91 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.065 0.848 . . . . 0.0 109.325 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mt -83.42 105.58 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t0 53.33 45.81 27.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.288 1.042 . . . . 0.0 109.679 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 68.7 9.87 7.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -121.84 128.15 51.33 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -94.71 144.1 25.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.09 132.55 55.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 176.77 132.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.257 1.823 . . . . 0.0 115.249 148.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -175.7 177.31 1.74 Allowed 'General case' 0 N--CA 1.48 1.034 1 N-CA-C 97.404 -5.036 . . . . 0.0 97.404 170.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.34 58.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -84.38 -24.28 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 120.695 -1.253 . . . . 0.0 110.702 -163.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.01 -24.1 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.443 HG13 HD22 ' A' ' 80' ' ' LEU . 2.2 tp -80.63 -13.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 120.791 -1.193 . . . . 0.0 109.329 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.4 t -82.72 -39.22 15.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.963 171.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.73 -55.2 0.62 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -69.08 -39.66 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.357 1.079 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 HG13 ' A' ' 76' ' ' ILE . 21.7 tp -60.66 -37.55 81.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.657 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -68.88 -45.72 70.27 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.031 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -61.96 -37.12 83.55 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -85.86 10.17 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -100.63 133.55 21.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.063 -0.398 . . . . 0.0 111.51 175.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -66.43 -24.82 49.19 Favored 'Trans proline' 0 C--O 1.24 0.614 0 N-CA-C 116.781 1.8 . . . . 0.0 116.781 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -75.41 157.45 84.62 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.45 126.64 23.16 Favored 'Trans proline' 0 C--O 1.243 0.746 0 N-CA-C 114.741 1.016 . . . . 0.0 114.741 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.9 150.43 26.88 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 117.904 -0.931 . . . . 0.0 112.318 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 tp -142.04 64.7 1.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.841 1.305 . . . . 0.0 112.495 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.21 70.75 9.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.41 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -117.56 106.27 46.7 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.599 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -95.32 74.67 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 125.913 4.408 . . . . 0.0 119.001 164.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -87.1 -113.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 CA-C-N 119.198 0.749 . . . . 0.0 112.089 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -61.8 -43.07 99.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.998 -1.064 . . . . 0.0 112.658 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.33 -11.13 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.96 -48.75 13.95 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.617 -1.302 . . . . 0.0 111.919 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.8 p -77.89 -30.84 50.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.7 t -85.25 -36.12 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.39 -33.1 83.38 Favored Glycine 0 C--O 1.228 -0.24 0 O-C-N 121.077 -1.014 . . . . 0.0 114.078 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.4 p -75.65 -3.45 34.61 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -83.53 -34.84 25.17 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.824 -1.172 . . . . 0.0 110.777 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -38.8 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.266 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 69.7 t80 -52.72 -52.88 60.16 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 C--N 1.35 0.617 1 C-N-CA 113.186 -4.076 . . . . 0.0 114.294 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -67.41 -40.1 85.55 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.091 -1.006 . . . . 0.0 111.273 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 10.0 p90 -75.03 -33.32 61.76 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.901 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.38 -29.83 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -67.34 -42.99 82.62 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.737 -0.602 . . . . 0.0 109.995 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.52 -37.56 85.28 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.379 -0.826 . . . . 0.0 112.838 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.1 tp -63.99 -36.56 84.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.59 -30.98 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.4 t -89.43 110.57 21.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -98.09 44.15 1.05 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.782 1.277 . . . . 0.0 108.435 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -72.59 174.32 4.54 Favored Pre-proline 0 C--O 1.255 1.376 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 172.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.8 60.48 2.91 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 117.845 -0.97 . . . . 0.0 113.157 159.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -77.35 92.76 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -92.45 -38.3 12.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 162.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.02 -43.62 90.52 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.733 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 m -72.28 -26.28 61.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.369 1.085 . . . . 0.0 110.623 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.32 -41.39 85.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -76.78 -12.46 59.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.475 -0.766 . . . . 0.0 112.831 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.21 61.5 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.67 -42.11 95.6 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.32 -41.85 97.69 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -65.95 -46.47 78.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.926 0.869 . . . . 0.0 113.096 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -74.16 -35.05 64.01 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.97 -20.15 56.45 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.717 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -67.68 -33.34 74.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.076 1.307 . . . . 0.0 109.384 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.23 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.0 -34.8 79.3 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -38.9 90.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.845 0.858 . . . . 0.0 108.986 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -53.51 38.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.325 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -59.94 -29.65 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.021 -0.694 . . . . 0.0 112.016 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.6 -57.82 6.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -73.96 -12.33 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -166.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.9 t -61.71 -49.0 86.08 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 121.043 -1.035 . . . . 0.0 110.429 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -100.39 -39.65 7.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.41 -45.69 1.28 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.09 -163.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.112 2.956 . . . . 0.0 114.557 170.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.27 164.35 1.82 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.351 0.66 . . . . 0.0 109.885 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 mt -71.17 -22.87 22.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 121.48 -0.762 . . . . 0.0 110.389 -165.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -53.3 -35.19 59.85 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 167.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.21 -30.86 4.64 Favored Glycine 0 CA--C 1.518 0.259 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -129.76 -43.8 1.22 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -160.71 177.95 9.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.41 101.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 119.688 1.131 . . . . 0.0 109.471 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 175.78 5.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.89 60.77 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.59 -31.14 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.38 -0.825 . . . . 0.0 112.485 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 6.3 t0 -81.21 -37.53 28.48 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.598 -1.314 . . . . 0.0 108.11 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.96 -16.9 64.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.161 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.6 m -79.97 -36.4 36.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.92 -36.39 11.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.19 76.43 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -68.81 -19.91 40.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 113.809 -3.661 . . . . 0.0 116.807 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -94.26 -22.83 18.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.078 -1.014 . . . . 0.0 111.532 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.19 -36.64 84.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.72 -43.25 94.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.371 -0.83 . . . . 0.0 112.887 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 12.3 m-70 -71.65 -29.22 64.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.301 -0.874 . . . . 0.0 112.443 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.3 -49.5 73.76 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.31 -37.58 83.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.6 m -80.07 -27.04 12.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.424 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.22 -44.11 7.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.09 -41.31 97.35 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.92 -38.68 95.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.748 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -73.98 -41.19 62.3 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.145 -1.209 . . . . 0.0 113.368 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -107.17 -46.55 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.25 61.05 0.75 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -165.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.14 104.09 0.22 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -142.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -150.02 100.73 3.22 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 123.465 0.706 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.5 160.42 41.59 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 115.647 -2.435 . . . . 0.0 110.087 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.3 130.59 90.87 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.63 158.32 39.78 Favored 'Trans proline' 0 C--N 1.346 0.409 0 N-CA-C 114.878 1.069 . . . . 0.0 114.878 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.66 2.85 49.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -68.21 -23.11 64.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 159.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.5 mt -114.65 42.23 2.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.333 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 51.9 m -53.41 -31.72 46.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.974 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -61.19 -36.04 78.79 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.292 -1.505 . . . . 0.0 113.234 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 -40.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.7 tp -60.05 -39.47 86.07 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.52 -0.737 . . . . 0.0 111.773 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -72.75 -23.8 60.88 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.616 -0.678 . . . . 0.0 112.164 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -38.85 61.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.5 mm -65.87 -39.61 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.11 -37.56 87.87 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.543 -1.348 . . . . 0.0 112.787 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.81 -44.85 88.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.7 -44.6 86.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.875 0.735 . . . . 0.0 110.798 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.85 -21.45 29.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.49 39.98 3.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.874 0.369 . . . . 0.0 111.465 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -72.18 143.09 49.02 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 100.445 -3.909 . . . . 0.0 100.445 155.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.03 -34.11 77.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 119.785 1.175 . . . . 0.0 110.213 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -61.65 -43.36 99.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.719 0.771 . . . . 0.0 111.006 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -70.87 -37.45 73.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.902 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.01 -44.45 82.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.0 -30.39 31.59 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.8 p -104.72 11.28 34.15 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -76.59 153.4 35.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.606 -0.684 . . . . 0.0 111.562 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.72 152.06 33.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.91 133.13 47.8 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.39 -34.29 76.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -160.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -56.81 -20.03 20.42 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -175.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -116.9 15.82 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 110.949 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.96 -46.74 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 101.794 -3.409 . . . . 0.0 101.794 156.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.23 -60.79 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.501 0.32 . . . . 0.0 110.76 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.07 60.42 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.118 -1.614 . . . . 0.0 114.173 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.96 -28.56 11.76 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 118.127 2.011 . . . . 0.0 118.127 -171.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -101.15 -24.33 14.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 111.581 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -71.56 -6.58 0.1 Allowed Pre-proline 0 C--O 1.242 0.679 0 N-CA-C 121.737 3.977 . . . . 0.0 121.737 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--N 1.357 1.011 1 C-N-CA 109.944 -6.237 . . . . 0.0 114.474 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -165.63 164.5 19.14 Favored 'General case' 0 C--O 1.245 0.854 1 N-CA-C 96.289 -5.449 . . . . 0.0 96.289 178.124 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -151.34 -10.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.0 122.54 7.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.369 2.35 . . . . 0.0 117.341 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.56 158.52 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.606 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.75 134.13 44.85 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.12 165.66 20.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 138.48 58.35 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.64 132.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.22 -50.97 4.33 Favored Glycine 0 CA--C 1.516 0.122 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.62 76.64 69.82 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 122.588 0.355 . . . . 0.0 111.418 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.25 114.11 2.71 Favored 'Trans proline' 0 C--O 1.234 0.278 0 CA-C-O 122.352 0.897 . . . . 0.0 111.62 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -166.96 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.69 159.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.2 tp -44.91 142.53 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.847 1.259 . . . . 0.0 112.084 160.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.96 -169.68 30.93 Favored Glycine 0 C--O 1.23 -0.111 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -72.85 98.2 2.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.447 1.117 . . . . 0.0 108.602 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -142.04 105.0 5.67 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.045 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.62 -44.44 48.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 115.346 1.248 . . . . 0.0 115.346 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -78.18 -29.78 48.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.9 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.1 m -65.77 -46.12 79.96 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.694 -0.629 . . . . 0.0 112.405 -169.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.27 -12.47 60.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.359 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.33 -44.81 95.62 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.86 -46.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.37 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.87 -39.91 87.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.2 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.8 -40.49 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.787 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.6 p -68.86 -34.25 75.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.646 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -40.35 42.93 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.07 -0.394 . . . . 0.0 110.869 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -73.08 -29.74 63.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.714 -0.616 . . . . 0.0 112.309 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.1 -33.47 75.87 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.295 -1.503 . . . . 0.0 110.587 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -87.27 0.07 55.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 53.21 32.38 13.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.439 1.896 . . . . 0.0 114.618 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.7 121.23 66.5 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.05 142.14 34.01 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 115.703 -2.398 . . . . 0.0 112.475 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -140.45 176.39 8.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.823 0.849 . . . . 0.0 109.064 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.77 155.12 28.39 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 t -154.29 138.43 16.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 119.678 1.126 . . . . 0.0 110.823 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -96.64 136.38 37.25 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.26 105.67 16.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.6 mm -79.25 95.03 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -78.55 80.83 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.239 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 52.62 51.8 15.34 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 155.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.47 34.02 6.87 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.696 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.86 -58.54 5.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -106.28 142.73 25.5 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.356 -160.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.75 -166.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.241 0.654 0 N-CA-C 116.166 1.564 . . . . 0.0 116.166 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -41.74 -31.73 0.33 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 118.833 2.901 . . . . 0.0 118.833 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -51.81 -42.03 62.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.472 1.033 . . . . 0.0 113.184 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -24.56 22.43 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.971 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.56 -26.01 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.608 0.718 . . . . 0.0 110.783 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.32 -30.3 70.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.75 -44.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.805 -170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -88.33 118.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 121.641 -0.662 . . . . 0.0 110.815 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -34.36 97.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 116.377 1.645 . . . . 0.0 116.377 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.2 4.15 39.09 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.282 -0.886 . . . . 0.0 110.611 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.23 -15.51 8.8 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -142.69 24.2 1.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.31 156.13 47.57 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 156.2 51.45 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 117.198 -1.401 . . . . 0.0 113.358 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -145.48 123.18 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.784 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 4' ' ' GLU . 43.7 t -88.82 119.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 173.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.99 130.44 34.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 161.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.94 103.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t0 61.69 39.12 14.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.457 1.123 . . . . 0.0 112.813 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 t0 58.87 36.58 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.777 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.23 144.94 50.59 Favored 'General case' 0 C--N 1.323 -0.568 1 N-CA-C 98.684 -4.561 . . . . 0.0 98.684 164.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -128.84 156.31 43.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.02 123.97 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.32 81.53 0.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.79 148.58 26.49 Favored 'General case' 0 N--CA 1.471 0.581 1 N-CA-C 98.649 -4.574 . . . . 0.0 98.649 162.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -60.26 -28.85 68.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -166.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.2 -28.96 17.5 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.629 -0.67 . . . . 0.0 112.446 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.49 -22.99 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.156 -0.965 . . . . 0.0 110.483 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.93 -0.88 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.752 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.34 -60.16 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.376 165.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -50.0 36.4 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.37 -26.55 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.5 tp -63.5 -39.44 94.45 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.432 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.9 -34.41 77.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.363 1.438 . . . . 0.0 111.033 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.82 -36.95 85.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.969 0.89 . . . . 0.0 111.36 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -91.09 -3.86 56.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -70.31 133.17 87.49 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.8 -15.65 26.64 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 115.254 -2.698 . . . . 0.0 114.864 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -87.89 170.64 11.15 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.48 139.08 86.57 Favored 'Trans proline' 0 C--N 1.353 0.768 0 N-CA-C 117.128 1.934 . . . . 0.0 117.128 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.63 110.47 2.41 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 114.014 0.736 . . . . 0.0 114.014 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.8 mt -118.58 56.88 0.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.73 88.0 2.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -116.42 123.75 30.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 166.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -94.49 67.07 0.32 Allowed 'Trans proline' 0 CA--C 1.556 1.593 0 N-CA-C 119.253 2.751 . . . . 0.0 119.253 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.35 -167.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.764 -1.024 . . . . 0.0 111.028 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 14.71 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 1 N-CA-C 122.286 4.18 . . . . 0.0 122.286 167.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.33 -22.16 62.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.639 -0.663 . . . . 0.0 111.697 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.49 75.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.377 0.535 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -44.98 89.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.235 0.54 . . . . 0.0 109.755 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.56 -41.03 85.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.831 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.31 90.42 Favored Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.602 -0.686 . . . . 0.0 112.245 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -70.63 -8.79 54.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -101.55 -33.89 9.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 111.133 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.13 -42.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 122.891 0.477 . . . . 0.0 110.27 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -54.56 55.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.48 -30.36 79.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 114.961 -2.892 . . . . 0.0 114.52 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -61.59 -54.3 44.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.922 0.328 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -70.98 -27.72 63.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 117.916 -1.513 . . . . 0.0 113.906 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 m -74.03 -36.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.962 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -62.47 -51.32 67.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.93 -42.19 85.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.761 1.619 . . . . 0.0 112.302 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -71.52 -30.77 66.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.439 0.638 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -81.57 138.16 35.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.172 0.987 . . . . 0.0 113.641 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -124.84 30.75 5.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.29 173.42 7.02 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.44 51.76 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 CA-C-N 121.492 1.569 . . . . 0.0 116.126 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -75.45 106.41 6.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.39 -51.49 1.01 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 -40.14 94.85 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -18.02 59.48 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 120.607 -1.525 . . . . 0.0 114.237 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.76 -33.05 71.89 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.74 3.79 15.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.056 -1.028 . . . . 0.0 113.222 173.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.77 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 119.836 -1.79 . . . . 0.0 107.417 165.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.06 -37.88 81.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.496 -0.753 . . . . 0.0 109.705 171.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.28 -43.54 83.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -69.82 -34.65 73.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.72 -37.06 79.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.374 -1.454 . . . . 0.0 110.696 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.16 -20.88 59.13 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.267 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -71.27 -32.68 68.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.722 -1.237 . . . . 0.0 110.579 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.37 93.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.8 -41.38 97.91 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.557 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.9 -37.66 80.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.161 0.985 . . . . 0.0 110.838 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.29 -51.7 47.06 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.94 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -64.97 -32.73 74.59 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.604 -0.939 . . . . 0.0 111.062 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.3 -46.98 78.23 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.253 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.13 -24.59 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.885 1.221 . . . . 0.0 112.677 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -76.02 -49.25 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 122.128 -0.357 . . . . 0.0 111.501 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -83.7 -26.11 30.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.78 -93.6 1.12 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -71.57 -177.73 2.63 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 118.496 2.46 . . . . 0.0 118.496 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -36.65 148.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.081 2.153 . . . . 0.0 114.001 170.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 pt -77.37 23.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -149.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.44 -20.37 60.05 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.302 -1.499 . . . . 0.0 109.405 149.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.39 67.86 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -145.57 -54.93 0.29 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -163.21 -173.71 3.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.9 mt -77.1 114.94 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -138.93 -170.23 2.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -39.66 -45.36 1.66 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 119.62 3.193 . . . . 0.0 119.62 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.55 -39.27 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.239 . . . . 0.0 110.365 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.81 -44.64 66.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.336 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.43 -19.03 65.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.445 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -81.24 -44.65 17.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 27.6 tp -87.91 -45.79 9.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.2 -37.59 55.05 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.26 -36.9 26.35 Favored 'Trans proline' 0 C--N 1.354 0.842 1 C-N-CA 111.519 -5.187 . . . . 0.0 113.47 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -77.77 -24.26 49.01 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.63 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.74 -34.84 76.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.597 1.09 . . . . 0.0 112.434 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -66.17 -44.67 83.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.258 -0.901 . . . . 0.0 110.521 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -66.42 -31.62 72.5 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.0 -54.04 47.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -71.11 -34.32 70.97 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.96 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.11 -36.37 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.02 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.55 12.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.532 1.06 . . . . 0.0 110.232 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.34 -35.84 81.38 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.17 92.89 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.629 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -85.57 -24.94 27.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.363 -1.081 . . . . 0.0 113.439 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -101.55 -40.48 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -139.43 47.75 1.87 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 109.987 -172.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -34.31 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 -149.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -146.36 107.23 4.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.61 169.07 15.64 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 118.378 0.456 . . . . 0.0 111.935 162.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 93.8 mt -67.3 124.51 89.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -73.02 164.65 34.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.52 -8.35 57.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.505 0.669 . . . . 0.0 110.493 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.29 -24.12 67.11 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.669 166.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -118.5 44.47 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.8 t -63.12 -18.33 63.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -165.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.41 -33.93 65.23 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.915 -1.741 . . . . 0.0 109.371 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.88 -46.49 79.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.3 -41.79 98.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.286 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -65.06 -48.27 74.38 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 120.862 -1.149 . . . . 0.0 111.436 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -31.77 70.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.24 -175.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.01 -31.13 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 119.575 1.079 . . . . 0.0 111.716 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -71.09 -34.66 71.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.104 -1.622 . . . . 0.0 111.16 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.71 -41.39 92.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.33 -38.74 91.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -54.57 -41.08 69.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.579 0.627 . . . . 0.0 111.201 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 t -91.25 -0.11 57.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -64.99 144.2 57.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -58.4 -43.25 88.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.322 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.6 t -60.36 -46.87 88.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -42.78 79.93 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.531 -0.73 . . . . 0.0 111.803 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.64 -42.05 82.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.919 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -77.12 -31.69 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.6 p -99.92 -9.05 23.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -64.88 142.74 58.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.123 0.874 . . . . 0.0 112.409 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.75 161.44 30.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.79 133.97 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.72 -35.29 79.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -52.5 -39.56 61.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.621 0.768 . . . . 0.0 112.661 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.72 -14.84 29.31 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.712 -0.618 . . . . 0.0 111.893 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 43.3 t -74.5 -37.59 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.4 mt -66.32 -37.74 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.295 -0.878 . . . . 0.0 108.703 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.45 -5.97 12.98 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.477 -0.764 . . . . 0.0 112.622 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.91 73.49 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.777 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -93.09 -23.24 18.69 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 118.619 1.209 . . . . 0.0 109.927 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.37 128.88 94.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.719 0.408 . . . . 0.0 111.424 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 CA--C 1.533 0.446 0 CA-C-N 119.674 0.919 . . . . 0.0 112.446 -65.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -87.67 -4.82 58.91 Favored 'General case' 0 C--N 1.322 -0.595 1 N-CA-C 124.968 5.173 . . . . 0.0 124.968 -146.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.502 HG23 HG13 ' A' ' 7' ' ' VAL . 10.1 mm -87.93 126.89 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 122.647 2.476 . . . . 0.0 112.38 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.401 ' HB2' HG22 ' A' ' 62' ' ' VAL . 72.4 m -129.64 121.11 26.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 152.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.502 HG13 HG23 ' A' ' 5' ' ' ILE . 11.7 m -137.2 156.14 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.685 1.129 . . . . 0.0 113.812 -174.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.96 133.29 55.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.3 165.48 13.41 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 144.4 57.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.69 131.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -44.84 3.41 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 118.851 -0.971 . . . . 0.0 114.925 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.32 85.04 52.03 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -72.85 62.24 3.87 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 121.397 1.398 . . . . 0.0 115.291 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -141.57 -10.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.047 1.339 . . . . 0.0 111.002 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.3 tt -135.42 156.23 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.83 156.6 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.01 0.924 . . . . 0.0 112.39 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.81 156.06 17.94 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.42 95.12 5.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.792 0.806 . . . . 0.0 112.685 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 75.0 m -100.16 150.23 36.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 139.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.16 -34.69 98.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.034 -1.511 . . . . 0.0 114.053 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.24 -31.04 70.83 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.96 -51.91 67.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -30.04 63.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.297 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -59.8 -40.1 87.21 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.01 -1.056 . . . . 0.0 111.494 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.46 -50.6 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -60.87 -39.13 88.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 tp -58.07 -45.18 87.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.798 0.726 . . . . 0.0 110.988 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.0 p -66.13 -36.7 83.84 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.16 -0.963 . . . . 0.0 111.5 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.08 -41.68 70.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.907 -0.496 . . . . 0.0 111.465 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -32.13 58.78 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.927 -0.483 . . . . 0.0 112.251 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.7 -37.22 81.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.173 -0.954 . . . . 0.0 111.6 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -91.92 1.97 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.507 0.67 . . . . 0.0 111.349 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 57.62 26.3 12.72 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.136 1.774 . . . . 0.0 114.71 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.56 141.71 48.97 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -68.01 164.81 30.43 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 116.377 -1.948 . . . . 0.0 110.78 175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -154.28 151.31 28.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -79.91 148.48 31.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -128.38 125.75 39.28 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.107 0.88 . . . . 0.0 110.591 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -111.9 112.22 23.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -80.84 134.23 35.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.64 116.93 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -79.32 79.18 5.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 112.658 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt 57.3 39.43 28.5 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.26 69.63 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.24 -0.981 . . . . 0.0 114.215 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.85 118.17 14.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 149.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.26 122.72 7.58 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.616 0.246 . . . . 0.0 111.619 -172.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.1 176.32 10.09 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.378 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -55.66 -37.27 68.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.863 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -53.62 -45.72 70.21 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -80.11 -22.73 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.676 -1.265 . . . . 0.0 112.488 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.241 -0.912 . . . . 0.0 111.049 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.05 -11.56 60.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.439 -0.788 . . . . 0.0 112.13 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.94 -61.06 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.654 0.74 . . . . 0.0 112.358 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -86.86 129.97 50.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 -166.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.02 -28.65 41.39 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 116.082 -2.146 . . . . 0.0 114.03 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -89.28 -10.49 46.67 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.042 -1.036 . . . . 0.0 111.077 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.01 -7.2 36.97 Favored Glycine 0 C--O 1.22 -0.726 0 O-C-N 121.709 -0.619 . . . . 0.0 113.003 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -144.85 16.27 1.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.47 143.13 28.76 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -59.18 156.48 34.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 N-CA-C 114.676 0.991 . . . . 0.0 114.676 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 6' ' ' CYS . 24.4 m -134.98 169.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.5 m -106.76 142.7 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 160.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -126.67 53.48 1.67 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 123.033 1.397 . . . . 0.0 111.112 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -68.35 126.8 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 57.17 30.77 18.89 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.193 0.997 . . . . 0.0 111.864 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.13 18.13 11.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.082 1.753 . . . . 0.0 113.482 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -106.25 112.2 25.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.19 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -74.9 140.29 43.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.45 130.02 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.16 41.52 1.51 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -157.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.78 144.63 39.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.557 -1.34 . . . . 0.0 108.331 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -58.83 -32.35 69.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -75.97 -31.75 59.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.241 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.75 -11.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.635 -1.291 . . . . 0.0 110.342 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.12 -26.51 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 t -73.79 -44.01 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.388 -1.445 . . . . 0.0 110.447 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.54 -64.77 0.83 Allowed Glycine 0 CA--C 1.519 0.341 0 N-CA-C 119.986 2.754 . . . . 0.0 119.986 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.53 -38.06 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.969 0.884 . . . . 0.0 111.748 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.14 -45.76 83.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.888 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.87 -28.05 60.5 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.641 -1.224 . . . . 0.0 113.316 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -63.14 -40.99 99.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.56 -7.91 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -68.15 119.11 65.16 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 160.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.15 0.65 9.51 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 116.064 1.524 . . . . 0.0 116.064 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.92 162.55 67.63 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.66 132.48 49.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 115.956 1.483 . . . . 0.0 115.956 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.16 140.28 19.7 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 116.878 -1.615 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.7 mt -137.25 43.23 2.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.308 0.575 . . . . 0.0 111.501 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 80.14 4.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.968 0.89 . . . . 0.0 110.437 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.8 m -116.59 93.54 40.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -90.73 81.18 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.08 3.187 . . . . 0.0 117.543 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -87.97 -137.37 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.528 0.867 . . . . 0.0 112.704 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.45 -30.95 68.87 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.941 -1.1 . . . . 0.0 112.874 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -63.26 -29.75 71.02 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.553 -0.717 . . . . 0.0 110.597 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.91 -28.73 25.72 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.095 -0.378 . . . . 0.0 111.995 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.2 p -73.53 -33.08 64.57 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.69 -49.17 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.65 62.24 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -60.39 -26.5 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -81.44 -42.62 20.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.049 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.98 -41.06 79.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.022 -166.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.48 -56.29 33.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.08 -20.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 113.827 -3.648 . . . . 0.0 113.856 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -64.76 -49.88 69.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.583 1.083 . . . . 0.0 109.943 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -72.14 -31.19 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.68 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.81 -40.01 80.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.32 -40.53 81.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.425 -1.422 . . . . 0.0 111.959 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.91 -26.71 67.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.206 0.912 . . . . 0.0 111.944 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.83 -50.67 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -70.1 -24.88 63.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.5 t -75.84 141.35 42.47 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.707 -0.62 . . . . 0.0 110.795 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -130.0 32.66 4.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.58 167.99 2.12 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 162.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -65.89 92.11 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 116.953 -1.565 . . . . 0.0 112.222 165.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.42 106.84 18.77 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.561 -169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -148.0 -48.87 0.16 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.788 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.44 -33.29 86.09 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.4 p -76.77 -20.31 56.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.594 -0.945 . . . . 0.0 113.381 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -75.3 -31.08 60.56 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.38 -28.38 59.48 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 172.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.27 95.19 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.906 -1.121 . . . . 0.0 110.09 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.53 -38.98 93.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.739 -0.601 . . . . 0.0 110.815 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -43.68 94.04 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.525 173.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -67.4 -36.97 82.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.406 1.003 . . . . 0.0 112.977 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.67 -45.7 81.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.89 -20.32 61.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 120.823 -1.173 . . . . 0.0 110.597 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.56 -28.77 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.753 -1.217 . . . . 0.0 111.557 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 -42.31 89.83 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.1 -38.39 85.59 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.01 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.96 -38.65 89.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.3 0.64 . . . . 0.0 109.808 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.59 -54.87 23.39 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.151 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -62.27 -28.18 69.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.822 -0.81 . . . . 0.0 112.577 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.27 -54.66 13.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.823 -0.548 . . . . 0.0 110.103 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.85 -22.29 65.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.21 -9.76 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.119 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -119.65 -44.53 2.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.53 -46.38 1.18 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 119.639 2.616 . . . . 0.0 119.639 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -68.79 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.695 3.248 . . . . 0.0 116.744 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -58.0 175.1 0.22 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.326 1.05 . . . . 0.0 112.444 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.63 -32.26 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.431 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.57 -3.81 5.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.28 -5.29 60.2 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -137.24 -53.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.692 1.246 . . . . 0.0 113.171 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.49 177.6 5.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 100.984 -3.71 . . . . 0.0 100.984 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.92 126.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.18 1.354 . . . . 0.0 109.181 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 m -143.29 174.39 10.76 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -41.59 -40.26 1.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.66 -32.01 56.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 120.495 1.498 . . . . 0.0 110.942 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.92 -39.23 79.76 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.27 -34.85 78.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.2 p -74.07 -37.24 64.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.74 -46.94 3.7 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -167.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.59 92.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.31 -13.73 18.65 Favored 'Trans proline' 0 C--N 1.349 0.591 1 C-N-CA 111.987 -4.876 . . . . 0.0 113.327 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -91.87 -26.67 18.37 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.909 -0.494 . . . . 0.0 110.477 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.7 -34.18 76.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.947 -0.47 . . . . 0.0 110.635 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.58 -50.14 63.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.468 1.128 . . . . 0.0 108.988 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -73.52 -14.89 61.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.718 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.3 tp -65.76 -54.27 29.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.216 0.916 . . . . 0.0 109.674 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.98 -26.85 63.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.437 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.9 -58.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 121.67 -0.644 . . . . 0.0 110.233 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.75 54.48 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.015 -1.053 . . . . 0.0 111.581 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.4 -37.92 83.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.51 95.66 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.993 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -72.31 -34.18 67.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.011 1.405 . . . . 0.0 113.418 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.03 -33.95 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 118.818 2.896 . . . . 0.0 118.818 -172.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.02 61.97 1.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -53.86 114.54 1.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -158.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -133.61 97.35 15.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 160.25 40.86 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.034 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 84.2 mt -73.11 122.4 87.56 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.59 165.36 25.08 Favored 'Trans proline' 0 C--N 1.346 0.438 0 N-CA-C 114.526 0.933 . . . . 0.0 114.526 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.22 -5.71 45.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.801 -0.562 . . . . 0.0 112.007 175.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.11 -21.87 64.92 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.985 -0.447 . . . . 0.0 110.801 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.65 58.68 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.48 72.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.451 -167.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -78.02 -35.62 49.61 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.989 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.8 -39.2 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.57 -42.38 91.84 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.592 -0.693 . . . . 0.0 111.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.99 -36.02 81.25 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 120.997 -1.065 . . . . 0.0 110.083 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -64.75 -43.32 93.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.0 -25.72 30.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 O-C-N 120.404 -1.435 . . . . 0.0 110.514 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.93 -25.94 66.61 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.065 -1.647 . . . . 0.0 112.091 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -71.67 -30.51 65.79 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.696 0.68 . . . . 0.0 109.176 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.26 -28.45 42.39 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.824 0.345 . . . . 0.0 110.263 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -79.48 13.2 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 120.835 -1.166 . . . . 0.0 111.124 170.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.4 t -134.67 171.09 14.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 60.16 136.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.04 -32.35 67.89 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.376 -0.828 . . . . 0.0 112.772 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.5 m -55.76 -32.59 63.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -102.23 -46.16 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.391 1.091 . . . . 0.0 110.49 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.15 -33.29 75.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -79.61 -32.25 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.497 -0.752 . . . . 0.0 110.898 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 41.0 p -91.67 -16.89 26.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.36 148.57 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.863 . . . . 0.0 111.967 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.93 152.81 37.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.596 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.32 51.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.33 -33.91 76.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.43 -35.34 80.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.511 1.148 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -80.76 -22.54 40.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.219 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.67 -51.79 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.4 pt -73.47 -36.02 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.71 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -20.07 65.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.51 13.11 Favored Glycine 0 CA--C 1.517 0.18 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -95.81 -25.77 15.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.369 1.585 . . . . 0.0 115.069 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -94.32 -10.27 0.15 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 121.507 3.892 . . . . 0.0 121.507 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 C--N 1.356 0.938 0 C-N-CA 113.674 -3.75 . . . . 0.0 117.077 -172.56 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.233 0.187 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -138.14 126.24 22.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 HG13 ' A' ' 7' ' ' VAL . 40.4 mm -110.75 103.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -166.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -98.43 71.42 2.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.042 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 5' ' ' ILE . 18.7 m -93.01 157.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.298 -170.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 20' ' ' CYS . 37.0 mtmt -62.87 142.91 58.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -82.21 161.88 22.58 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 171.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.31 143.85 54.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.868 1.318 . . . . 0.0 113.849 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.44 130.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -4.78 48.84 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.978 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.39 78.59 4.6 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.305 1.053 . . . . 0.0 112.369 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 75.6 Cg_endo -72.51 45.47 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 119.043 2.67 . . . . 0.0 119.043 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -131.01 -7.16 3.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 114.187 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.28 159.18 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.7 mt -61.18 142.55 56.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.24 153.43 22.22 Favored Glycine 0 CA--C 1.508 -0.383 0 O-C-N 121.514 -0.741 . . . . 0.0 114.9 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.93 103.13 10.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.655 1.217 . . . . 0.0 108.814 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 23.5 t -132.69 137.63 30.2 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.36 -29.13 72.08 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 115.32 -2.653 . . . . 0.0 112.304 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -80.9 -16.87 52.41 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.452 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -70.23 -52.01 26.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.84 -20.08 65.12 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.943 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -61.02 -43.75 98.43 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.668 2.031 . . . . 0.0 111.554 167.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.01 -54.61 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.03 -37.82 86.84 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.6 -39.5 88.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.3 p -70.59 -40.2 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 112.416 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -48.14 76.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.539 -177.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -74.57 -28.94 61.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.515 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -71.19 -36.39 71.93 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.59 -0.694 . . . . 0.0 111.191 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.17 -5.53 59.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 53.64 36.81 24.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 113.724 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.7 pt -84.25 153.44 62.6 Favored Pre-proline 0 C--O 1.246 0.879 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.795 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.4 137.61 25.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.068 -1.488 . . . . 0.0 114.689 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -151.77 161.58 42.43 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.3 126.41 52.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.2 t -88.62 135.08 33.68 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -137.2 129.56 29.72 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 71.4 mt -107.07 132.08 53.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -173.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.7 mm -105.48 101.32 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.789 1.236 . . . . 0.0 111.018 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -69.59 83.21 0.42 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.421 1.088 . . . . 0.0 113.486 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 51.12 48.26 23.37 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 122.921 1.343 . . . . 0.0 113.61 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 57.72 1.93 Allowed Glycine 0 CA--C 1.518 0.261 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.266 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.35 85.55 7.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.9 86.44 57.41 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-O 122.021 0.915 . . . . 0.0 112.219 -157.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.93 -176.51 3.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.073 -1.484 . . . . 0.0 108.31 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -47.55 -40.73 19.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.551 0.74 . . . . 0.0 112.602 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -55.87 -47.06 78.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -89.68 -21.75 22.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.11 -43.6 94.82 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -70.79 -38.8 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.502 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.3 mt -110.77 87.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.523 0.678 . . . . 0.0 112.381 -172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t 174.26 145.92 0.21 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.1 -25.12 77.09 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 116.876 1.837 . . . . 0.0 116.876 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -125.96 -14.09 6.17 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.07 -9.42 67.82 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-O 122.335 0.964 . . . . 0.0 111.642 -168.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -155.47 88.75 1.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.12 0.968 . . . . 0.0 110.534 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -143.37 150.35 51.25 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -67.09 98.51 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 115.913 -2.258 . . . . 0.0 113.145 162.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.6 t -91.55 137.72 21.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.455 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.58 113.47 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.77 126.32 33.92 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 t0 50.42 56.46 7.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.781 0.801 . . . . 0.0 112.821 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 65.5 24.31 11.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -124.97 144.13 50.53 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -123.71 132.38 53.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 118.817 0.735 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.07 134.03 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.52 -22.16 0.33 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.2 138.97 58.72 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -62.98 -29.16 70.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -165.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -85.9 -7.3 58.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.61 -10.6 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.2 -0.938 . . . . 0.0 110.16 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.07 -36.28 76.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.58 -39.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.37 -73.51 1.16 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 120.371 2.909 . . . . 0.0 120.371 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.57 -38.14 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.687 -0.89 . . . . 0.0 111.986 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.57 -41.84 95.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.795 0.725 . . . . 0.0 109.638 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.58 -34.33 73.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.39 -35.39 75.74 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.006 -1.059 . . . . 0.0 111.108 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.01 7.51 45.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.38 137.19 97.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.73 -29.11 82.92 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 117.134 -1.444 . . . . 0.0 115.299 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -81.09 169.26 19.94 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 109.811 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -57.42 134.33 62.9 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 116.811 -1.659 . . . . 0.0 116.021 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.6 135.45 3.0 Favored 'Trans proline' 0 C--O 1.247 0.962 0 N-CA-C 118.3 2.385 . . . . 0.0 118.3 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.3 mt -135.37 43.5 2.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.81 82.01 2.74 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.484 -1.385 . . . . 0.0 111.611 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -118.65 94.83 48.22 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.569 1.148 . . . . 0.0 113.775 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -106.15 59.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.905 0 N-CA-C 122.248 3.903 . . . . 0.0 122.248 -174.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -82.25 -126.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.691 0.928 . . . . 0.0 114.049 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -57.29 -32.23 66.43 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 120.982 -1.074 . . . . 0.0 112.677 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.16 -32.79 74.44 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.146 -0.972 . . . . 0.0 111.847 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.52 -33.19 60.71 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.612 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.1 p -71.27 -34.6 70.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.96 -45.42 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 123.024 0.202 . . . . 0.0 110.516 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.94 87.38 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.377 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -73.51 -0.4 14.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -94.14 -33.93 13.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 167.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.7 mt -82.26 -39.52 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.68 0.753 . . . . 0.0 110.416 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 19.9 t80 -51.64 -50.41 77.38 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.69 -33.75 12.56 Favored 'Trans proline' 0 C--N 1.347 0.478 1 C-N-CA 111.648 -5.101 . . . . 0.0 114.543 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -72.5 -39.77 67.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.253 0.479 . . . . 0.0 111.104 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 1.9 p90 -68.8 -30.0 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.908 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.54 -47.81 62.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -61.98 -44.12 97.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -75.28 -37.14 61.04 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.428 -174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -34.3 78.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.85 0.833 . . . . 0.0 110.579 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -76.65 0.05 21.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.124 0.97 . . . . 0.0 112.108 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -121.05 114.31 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -87.39 49.55 1.83 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.566 1.651 . . . . 0.0 110.309 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -88.51 170.47 11.18 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.62 50.31 2.67 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 CA-C-N 120.174 1.098 . . . . 0.0 114.938 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.04 100.39 4.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.897 1.279 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.9 -45.96 0.86 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 -38.09 93.67 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 166.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.0 m -69.57 -30.65 68.49 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.767 -0.843 . . . . 0.0 111.981 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.66 -28.88 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.709 -1.87 . . . . 0.0 110.04 172.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -75.7 -10.39 59.39 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.372 -1.455 . . . . 0.0 111.625 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.03 60.31 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 119.814 -1.804 . . . . 0.0 108.126 168.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.79 -34.92 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.549 -0.719 . . . . 0.0 111.164 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.2 -44.8 79.83 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -67.53 -26.44 66.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -77.47 -35.93 53.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 120.615 -1.303 . . . . 0.0 109.679 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.3 -20.55 60.08 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.728 -0.608 . . . . 0.0 109.52 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.92 -30.09 69.33 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.463 -0.773 . . . . 0.0 111.395 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.61 -42.09 87.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.02 -43.97 93.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.681 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.75 -35.94 77.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.91 -50.98 55.47 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.822 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.54 -36.03 81.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.879 -1.365 . . . . 0.0 110.489 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.22 -43.01 99.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -74.43 -27.81 60.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.24 -44.43 77.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.44 -54.21 5.39 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.74 -63.45 0.46 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-O 117.183 -1.899 . . . . 0.0 116.761 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.24 -162.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 1 C-N-CA 127.98 5.787 . . . . 0.0 118.565 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -55.9 175.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.67 163.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -54.25 -33.19 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.88 58.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.82 89.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 118.395 -1.225 . . . . 0.0 116.141 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -136.53 -52.54 0.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.729 1.764 . . . . 0.0 112.978 165.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -162.73 -177.56 5.62 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 117.635 -1.174 . . . . 0.0 109.96 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.07 118.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.881 1.218 . . . . 0.0 110.347 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.6 m -132.64 177.23 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.23 37.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.63 -18.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.972 -1.08 . . . . 0.0 111.711 173.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.22 -38.04 31.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -28.91 69.63 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 120.719 0.295 . . . . 0.0 110.649 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 93.9 p -77.68 -35.32 52.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.49 -46.81 3.92 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.05 81.41 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.11 -27.89 19.63 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.776 -4.349 . . . . 0.0 114.371 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.88 -29.89 63.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.02 -24.49 64.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.15 -50.35 61.52 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.007 -1.058 . . . . 0.0 110.334 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -55.45 -42.33 74.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.496 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.6 tp -57.35 -61.99 2.09 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.745 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -67.93 -32.85 73.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -170.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 -43.08 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.134 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.84 -42.15 34.55 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.086 -1.009 . . . . 0.0 112.494 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.68 -38.61 91.76 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.9 81.13 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.089 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.45 -48.86 11.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.49 -1.006 . . . . 0.0 112.968 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -86.72 -43.5 12.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -134.87 59.5 1.73 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.9 0.88 . . . . 0.0 108.766 -171.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -49.97 104.51 0.07 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -154.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -147.82 98.96 3.8 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.241 1.817 . . . . 0.0 106.222 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.41 172.06 17.05 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 115.652 -2.432 . . . . 0.0 109.728 167.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.41 118.08 56.15 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -82.19 167.04 16.09 Favored 'Trans proline' 0 C--N 1.352 0.728 0 N-CA-C 114.975 1.106 . . . . 0.0 114.975 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.92 4.2 5.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -69.6 -23.28 63.5 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.33 60.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -66.64 -19.86 65.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.637 -0.664 . . . . 0.0 112.565 -170.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.7 -33.51 40.98 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.22 -37.22 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.767 0.794 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.45 -47.77 84.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.447 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -65.24 -40.38 93.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -55.56 -53.46 56.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.194 0.521 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.43 -25.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.655 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -66.26 -42.36 88.61 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.745 -1.222 . . . . 0.0 111.6 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -41.57 99.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.07 -37.46 85.88 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 123.607 0.567 . . . . 0.0 111.918 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.15 -25.95 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t -122.13 39.56 3.86 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -103.85 136.5 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.93 -44.43 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -59.61 -47.24 86.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.961 0.886 . . . . 0.0 111.962 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -71.93 -43.46 65.26 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.14 -33.08 73.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -75.78 -42.3 50.57 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.027 -1.045 . . . . 0.0 113.094 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.2 p -88.4 -3.23 58.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -57.09 138.92 53.84 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.47 153.4 41.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.98 130.96 40.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.69 -36.97 82.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 -170.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.57 -21.26 62.7 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.505 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -97.29 -14.35 21.39 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.95 -52.34 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.61 -54.54 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.229 -0.294 . . . . 0.0 111.599 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.54 -2.34 35.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 112.654 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.18 -16.97 44.95 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.739 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -106.56 -48.99 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.15 0.976 . . . . 0.0 112.146 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.09 -26.28 2.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--N 1.357 0.981 1 C-N-CA 112.316 -4.656 . . . . 0.0 115.501 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.48 131.9 47.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -125.77 95.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -166.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.0 m -98.01 116.91 31.2 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.21 165.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.37 133.4 47.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.556 -0.715 . . . . 0.0 112.127 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.14 165.11 24.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.701 0.4 . . . . 0.0 110.95 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 144.28 56.69 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.906 -0.497 . . . . 0.0 110.268 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.89 124.34 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.67 -13.4 52.78 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.97 89.08 12.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -171.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -69.27 76.26 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-O 123.395 1.331 . . . . 0.0 113.241 162.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -149.75 -38.38 0.15 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.887 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -135.51 153.05 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.08 152.13 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.126 0.965 . . . . 0.0 112.761 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.09 -174.57 17.67 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 202' ' ' VAL . 20.7 t70 -77.61 112.32 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.253 -1.473 . . . . 0.0 112.432 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 146.77 34.42 Favored Pre-proline 0 C--O 1.245 0.848 1 N-CA-C 97.633 -4.951 . . . . 0.0 97.633 159.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -59.26 -35.24 97.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 CA-C-O 122.65 1.021 . . . . 0.0 113.514 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.82 -0.65 53.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.689 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 t -57.41 -42.57 82.53 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.973 0.892 . . . . 0.0 110.844 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -92.41 0.29 57.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -63.67 -44.46 93.67 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.955 1.252 . . . . 0.0 109.109 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.726 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.97 -40.73 98.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.01 -38.82 92.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.181 0.9 . . . . 0.0 110.427 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 m -62.91 -40.28 97.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.064 -176.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.7 mt -69.76 -43.47 72.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.714 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.61 -32.11 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -164.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -78.2 -33.37 50.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.266 -1.373 . . . . 0.0 110.485 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.03 -14.92 58.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.111 -0.368 . . . . 0.0 111.08 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 55.82 33.16 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.745 1.618 . . . . 0.0 113.162 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.83 154.76 87.05 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.26 150.4 41.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 115.681 -2.413 . . . . 0.0 113.275 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -154.62 172.21 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -126.64 94.2 3.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.645 1.178 . . . . 0.0 108.648 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -75.87 139.69 41.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.447 . . . . 0.0 110.769 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.35 144.34 44.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.47 126.05 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -83.2 122.07 36.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -79.46 70.09 5.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt 53.47 50.69 16.8 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 161.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.36 8.66 65.97 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 114.081 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.99 106.55 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 151.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -137.84 86.42 18.27 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -62.32 173.17 3.55 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 118.007 -0.862 . . . . 0.0 110.837 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -53.01 -37.45 61.51 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -53.63 -53.13 56.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -73.85 -29.39 62.1 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 120.803 -1.185 . . . . 0.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.74 -35.65 81.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 119.274 0.943 . . . . 0.0 110.881 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.81 -20.49 61.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.92 -37.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.836 0.827 . . . . 0.0 111.301 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 t -119.71 120.93 30.19 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 109.872 -170.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.71 -29.6 88.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -97.76 2.11 49.17 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.45 -29.5 2.57 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.038 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.16 72.81 1.4 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.857 1.313 . . . . 0.0 113.181 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.43 155.19 52.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 162.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.81 142.19 56.75 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 114.685 -3.077 . . . . 0.0 110.148 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.67 164.0 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 113.33 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -100.73 88.54 3.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mt -88.46 104.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.48 52.55 13.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.883 0.849 . . . . 0.0 111.377 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t0 60.7 30.61 19.82 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -133.14 151.19 52.0 Favored 'General case' 0 C--N 1.323 -0.573 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 173.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -145.45 150.41 36.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 122.471 2.396 . . . . 0.0 116.741 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.75 150.32 32.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.487 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.46 -12.27 1.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 118.097 2.629 . . . . 0.0 118.097 -169.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -68.49 142.94 55.16 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.047 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -60.56 -27.39 67.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -82.95 -35.45 25.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.223 -0.923 . . . . 0.0 111.088 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -83.67 -14.7 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.293 -0.879 . . . . 0.0 112.29 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 pt -70.85 -6.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.665 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.74 -52.7 8.37 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 157.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.55 -47.06 92.18 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 118.819 2.288 . . . . 0.0 118.819 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -82.57 -27.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -60.69 -44.56 96.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.325 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -65.18 -41.56 94.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 118.414 0.552 . . . . 0.0 110.796 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -58.7 -35.99 73.51 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.839 -1.163 . . . . 0.0 112.301 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.15 17.13 23.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.903 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.07 131.7 80.77 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.05 -12.38 30.34 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 114.586 -3.143 . . . . 0.0 115.024 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -114.78 149.57 42.6 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 118.901 0.773 . . . . 0.0 109.864 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.26 121.78 9.94 Favored 'Trans proline' 0 C--O 1.24 0.59 0 N-CA-C 116.46 1.677 . . . . 0.0 116.46 -148.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.32 161.33 20.01 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.4 mt -139.96 64.95 1.44 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.424 1.107 . . . . 0.0 110.531 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.76 63.13 6.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.517 -0.74 . . . . 0.0 111.815 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 104.25 50.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.89 54.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 124.571 3.514 . . . . 0.0 120.752 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.24 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 116.724 -1.717 . . . . 0.0 115.086 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -34.36 72.49 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.011 -1.681 . . . . 0.0 114.21 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -32.12 73.66 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.729 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 -24.96 55.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.6 p -71.93 -37.19 70.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.41 -49.27 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.61 97.0 Favored Glycine 0 CA--C 1.516 0.149 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.413 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -75.9 -10.0 59.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -78.54 -38.48 40.36 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.78 -1.2 . . . . 0.0 109.901 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.23 -48.15 50.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.689 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -51.28 -53.44 49.19 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -170.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.07 -22.67 16.76 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 114.214 -3.391 . . . . 0.0 114.517 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.6 m -67.33 -38.98 85.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -86.38 -23.94 25.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.67 -33.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -63.76 -45.13 91.17 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.606 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -62.74 -38.16 89.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.5 tp -66.94 -46.32 75.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.297 0.953 . . . . 0.0 111.043 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -69.33 -21.68 63.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.488 0.661 . . . . 0.0 111.619 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.7 t -90.38 138.27 31.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -128.08 30.68 5.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.35 171.53 4.04 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -71.93 59.2 2.85 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 120.711 1.29 . . . . 0.0 114.492 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -60.29 122.19 13.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.109 1.764 . . . . 0.0 112.877 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -152.8 -42.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.235 0.541 . . . . 0.0 109.715 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.64 96.48 Favored Glycine 0 C--O 1.22 -0.745 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.8 p -73.62 -17.63 61.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.392 -1.063 . . . . 0.0 113.062 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.59 -39.24 53.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.833 1.301 . . . . 0.0 107.61 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -79.1 -14.22 59.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.663 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.08 80.23 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.671 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.27 -42.45 93.21 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.98 -43.23 95.24 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.006 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -70.7 -42.15 71.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.73 -33.52 68.79 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 120.146 -1.596 . . . . 0.0 108.983 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.27 -16.43 59.0 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 121.437 -0.789 . . . . 0.0 110.656 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -70.8 -33.52 70.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 119.992 1.269 . . . . 0.0 109.61 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 -39.45 89.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.38 -43.8 93.34 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.173 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.41 -39.07 89.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.538 0.735 . . . . 0.0 110.225 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.4 -51.67 50.4 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -61.35 -38.62 87.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.851 -0.794 . . . . 0.0 112.401 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.81 -39.47 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.537 -0.727 . . . . 0.0 110.717 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -72.66 -24.86 61.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.729 1.604 . . . . 0.0 114.48 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.71 -11.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -118.11 -43.73 2.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.12 -76.32 0.23 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.466 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -67.88 -169.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.063 3.175 . . . . 0.0 117.656 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -53.86 168.66 0.19 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.788 1.635 . . . . 0.0 113.962 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -63.2 -21.79 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -151.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.5 -11.63 53.42 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.186 -0.946 . . . . 0.0 113.338 173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.51 0.48 72.87 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -143.74 -49.54 0.3 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -162.32 176.07 10.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.64 125.79 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.9 p -130.72 -172.3 2.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.64 -31.45 25.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.46 -42.97 81.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 118.784 0.72 . . . . 0.0 110.131 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -66.86 -39.02 87.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.61 -21.53 66.58 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.4 m -91.01 -36.07 14.28 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.98 -49.32 7.43 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.6 48.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.18 -31.34 45.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 113.459 -3.894 . . . . 0.0 113.958 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -30.61 42.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.93 -34.55 76.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.032 0.833 . . . . 0.0 113.19 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -61.9 -43.6 98.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.985 1.266 . . . . 0.0 109.907 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -73.56 -28.54 61.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.146 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.7 -52.24 64.07 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.98 -33.23 75.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.025 -172.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.1 t -72.38 -61.87 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.463 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.28 66.77 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 111.293 -168.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.57 -42.94 77.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.54 -34.47 89.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.874 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -95.06 -16.03 22.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -108.69 -39.9 5.23 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -142.22 58.09 1.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -54.65 116.82 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -134.64 98.44 13.5 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 164.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.41 164.59 32.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 115.124 -2.784 . . . . 0.0 109.29 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.32 117.16 54.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 171.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.68 168.69 24.15 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 117.428 -1.248 . . . . 0.0 112.575 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -4.95 41.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.492 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -66.68 -22.12 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.123 -0.986 . . . . 0.0 110.181 168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.52 50.75 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -56.75 -29.05 62.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -79.64 -32.6 41.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.578 -1.326 . . . . 0.0 110.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.88 -37.92 70.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.87 -43.79 91.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.072 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -64.7 -38.49 91.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 112.361 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.79 -47.83 84.1 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.949 -0.47 . . . . 0.0 111.764 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.16 -27.34 26.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 O-C-N 120.999 -1.063 . . . . 0.0 111.096 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.97 -33.55 74.86 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.649 -1.282 . . . . 0.0 111.977 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.86 -31.53 71.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.67 0.668 . . . . 0.0 110.229 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.82 -5.77 51.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.384 0.611 . . . . 0.0 112.18 174.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -101.61 9.44 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.0 t -112.11 165.71 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 61.44 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.27 -27.82 69.3 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.138 -0.976 . . . . 0.0 112.341 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 m -56.06 -40.71 73.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -96.56 -50.69 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.496 0.665 . . . . 0.0 109.605 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.87 -43.97 90.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -76.06 -30.53 58.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 52.5 p -75.17 -12.4 60.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.646 -0.659 . . . . 0.0 112.532 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -58.05 132.36 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.47 0.652 . . . . 0.0 110.777 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.04 154.59 39.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.817 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.57 117.28 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.549 1.155 . . . . 0.0 111.188 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.44 -35.52 73.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.3 -37.42 87.1 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.775 -1.203 . . . . 0.0 107.853 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -75.83 -3.97 38.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.533 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 58.5 t -86.32 -46.51 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.6 -52.28 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.348 1.07 . . . . 0.0 108.17 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.21 27.66 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.138 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -112.71 -46.41 0.73 Allowed Glycine 0 N--CA 1.454 -0.12 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 167.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -53.68 7.45 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -84.61 -1.48 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 120.751 3.612 . . . . 0.0 120.751 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--N 1.358 1.053 1 C-N-CA 111.398 -5.268 . . . . 0.0 112.687 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.237 0.437 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.74 142.13 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.1 mt -134.09 158.56 42.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -171.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -148.43 113.95 5.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.5 164.92 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -52.85 129.42 30.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.1 0.864 . . . . 0.0 112.168 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -79.02 168.97 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.434 0.635 . . . . 0.0 109.665 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' ' CG ' ' A' ' 201' ' ' HIS . . . -62.4 134.32 56.29 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.08 120.8 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.91 4.93 86.74 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.402 -173.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 88.81 4.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.84 36.06 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.052 1.835 . . . . 0.0 115.323 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -108.91 -19.71 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -151.87 162.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -73.88 165.29 25.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.191 0.596 . . . . 0.0 111.939 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.76 170.01 27.8 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -75.06 104.13 5.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -115.91 161.34 31.31 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 147.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -65.5 -17.72 58.02 Favored 'Trans proline' 0 C--N 1.348 0.519 0 N-CA-C 116.881 1.839 . . . . 0.0 116.881 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -117.76 7.82 12.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.4 -44.21 92.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.9 0.857 . . . . 0.0 111.985 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -80.26 -13.94 58.8 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.786 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -61.46 -43.74 98.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.956 2.162 . . . . 0.0 112.842 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -66.41 -46.67 86.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.6 mt -66.24 -39.22 89.39 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.541 -0.725 . . . . 0.0 112.174 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -43.62 95.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.93 -0.481 . . . . 0.0 110.29 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 p -69.18 -38.59 78.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.442 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -46.29 80.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.94 -27.33 36.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.692 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -66.79 -39.64 87.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.473 -1.392 . . . . 0.0 109.381 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -83.83 4.49 28.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.659 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.4 pttm 44.07 47.04 7.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.028 2.131 . . . . 0.0 115.62 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.87 149.9 36.2 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.35 158.44 36.88 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 117.601 -1.133 . . . . 0.0 114.05 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.81 162.13 41.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -144.3 140.91 29.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 t 68.96 123.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 126.227 2.204 . . . . 0.0 111.533 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -141.06 19.04 2.28 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.78 148.99 43.24 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.326 3.084 . . . . 0.0 119.326 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 45' ' ' GLY . 35.4 mm -131.03 108.58 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.443 1.897 . . . . 0.0 106.774 162.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.98 93.25 8.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.286 -1.509 . . . . 0.0 114.201 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt 47.33 48.23 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.518 1.127 . . . . 0.0 112.674 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 76.03 35.01 45.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.664 -175.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -64.13 107.4 1.27 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 152.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -145.01 79.12 12.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.472 0.653 . . . . 0.0 112.733 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.89 172.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 115.055 -2.83 . . . . 0.0 110.7 165.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.48 -30.58 60.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.236 -0.29 . . . . 0.0 111.571 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -56.16 -51.66 67.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.32 -25.56 59.63 Favored 'General case' 0 C--O 1.218 -0.581 0 O-C-N 120.646 -1.284 . . . . 0.0 111.194 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.13 -25.49 64.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 119.22 0.918 . . . . 0.0 112.081 172.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.79 -29.33 61.06 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.492 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.67 -50.64 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 112.281 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -94.72 118.24 66.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 121.175 -0.953 . . . . 0.0 108.635 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.85 -21.38 38.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 N-CA-C 116.337 1.63 . . . . 0.0 116.337 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -93.69 -14.66 26.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.881 0.848 . . . . 0.0 110.839 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.79 -0.49 61.51 Favored Glycine 0 C--O 1.224 -0.471 0 O-C-N 121.78 -0.575 . . . . 0.0 113.212 -166.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -151.84 32.72 0.55 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.43 144.14 48.44 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.83 149.24 72.47 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 116.188 -2.075 . . . . 0.0 114.058 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.32 168.07 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.14 133.2 67.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 101.813 -3.402 . . . . 0.0 101.813 158.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -117.37 121.32 40.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 163.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -131.41 123.38 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 t70 55.88 35.13 24.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.593 1.187 . . . . 0.0 111.077 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.78 23.04 12.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.457 1.903 . . . . 0.0 115.788 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -121.09 140.73 51.56 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -115.77 153.93 30.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.97 148.13 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -152.03 38.61 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -112.31 149.41 32.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.6 p -58.47 -28.47 65.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.56 -37.77 15.43 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.575 0.584 . . . . 0.0 112.575 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 m -75.98 -17.81 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.914 -1.116 . . . . 0.0 112.722 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.91 -8.0 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.231 -0.293 . . . . 0.0 111.376 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.9 t -105.39 -51.44 8.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 160.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.22 91.95 Favored Glycine 0 C--O 1.228 -0.279 0 N-CA-C 117.941 1.936 . . . . 0.0 117.941 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.6 mt -77.52 -31.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.57 -43.99 96.69 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.481 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.41 -46.99 87.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.793 0.724 . . . . 0.0 109.835 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -66.19 -17.98 65.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -106.78 -5.61 18.32 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.029 0.532 . . . . 0.0 112.295 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -70.04 138.55 87.43 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -30.63 82.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.49 157.96 74.33 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 120.201 1.364 . . . . 0.0 107.949 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.77 141.12 93.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.013 -2.191 . . . . 0.0 114.792 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.56 151.39 52.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 116.919 -1.587 . . . . 0.0 111.415 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.5 mt -130.93 49.99 2.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 63.32 6.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.498 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.5 99.79 45.55 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.14 46.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 N-CA-C 121.231 3.512 . . . . 0.0 121.231 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -78.42 -124.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.225 0 CA-C-N 121.194 1.462 . . . . 0.0 114.237 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.34 -25.35 65.76 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.752 -1.843 . . . . 0.0 113.095 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.68 -42.52 99.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.541 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.45 -34.87 41.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.384 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.5 p -65.34 -34.56 78.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.098 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.56 -43.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.041 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.58 -37.18 93.77 Favored Glycine 0 CA--C 1.52 0.355 0 O-C-N 120.684 -1.26 . . . . 0.0 115.265 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 p -72.2 -15.37 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -77.61 -35.06 53.14 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.468 1.128 . . . . 0.0 110.13 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -77.73 -42.19 28.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.933 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -49.32 -52.68 46.89 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.75 -21.75 12.43 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 114.157 -3.429 . . . . 0.0 114.858 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.9 m -68.22 -43.59 77.66 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.576 -0.702 . . . . 0.0 111.619 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -78.0 -27.7 49.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 118.383 -1.327 . . . . 0.0 113.349 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.09 -29.24 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.15 -40.54 94.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.21 -36.28 81.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.616 -0.677 . . . . 0.0 111.226 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.51 -37.4 85.89 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.296 -0.253 . . . . 0.0 111.53 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -75.83 -27.91 58.07 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.238 -0.914 . . . . 0.0 113.458 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -61.32 137.35 58.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -128.6 29.7 5.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.21 172.53 9.51 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.39 106.17 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 114.234 -3.377 . . . . 0.0 109.939 149.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -125.69 26.57 6.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.44 -36.41 76.6 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.61 -41.06 97.97 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -24.58 59.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.253 1.527 . . . . 0.0 113.176 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.08 -42.05 94.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.229 1.014 . . . . 0.0 108.675 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -76.95 -16.16 59.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.193 -0.942 . . . . 0.0 112.21 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.39 -37.3 71.57 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.51 -41.09 96.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.395 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.25 -47.26 81.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.365 0.416 . . . . 0.0 110.043 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -67.56 -39.56 84.93 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.47 -42.32 95.97 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.097 -1.002 . . . . 0.0 109.871 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.46 -20.44 57.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.137 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.43 -35.28 80.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.535 0.607 . . . . 0.0 111.736 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.06 99.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.194 0.997 . . . . 0.0 109.725 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.14 -35.72 74.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.403 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.294 0.638 . . . . 0.0 112.462 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.66 -39.81 93.85 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.869 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.7 -32.62 72.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -48.43 35.74 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.285 -0.884 . . . . 0.0 110.113 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.01 -8.65 56.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -168.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.86 -10.56 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 167.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -117.45 -45.68 2.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.38 -67.88 0.23 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 119.981 2.753 . . . . 0.0 119.981 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -68.7 -169.33 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.665 2.733 . . . . 0.0 113.92 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -56.08 173.76 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.6 mt -56.83 -40.36 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 112.159 -154.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.86 10.63 2.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.12 -22.69 37.07 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.08 -40.88 0.59 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.06 170.54 21.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.78 123.11 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -128.44 171.77 11.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.85 -32.62 32.68 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.74 -41.64 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 121.641 -0.662 . . . . 0.0 111.437 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.52 -40.86 93.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.03 -21.19 63.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.316 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.2 m -85.6 -34.16 21.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -97.85 -46.25 6.01 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.18 -38.83 72.62 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.7 -31.0 33.59 Favored 'Trans proline' 0 C--N 1.352 0.748 1 C-N-CA 111.838 -4.975 . . . . 0.0 115.465 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -72.11 -30.78 65.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.095 -1.003 . . . . 0.0 108.957 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.9 -34.5 77.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.42 -47.03 83.64 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.174 -0.954 . . . . 0.0 109.063 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.93 -33.63 75.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.643 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.85 -52.72 64.22 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.84 -36.55 79.4 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -169.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.6 m -77.05 -35.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.14 -45.57 56.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.667 0.746 . . . . 0.0 110.304 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.44 -38.52 91.3 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.929 0.492 . . . . 0.0 109.754 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.87 -34.94 89.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.987 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.24 -49.65 11.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.347 0.573 . . . . 0.0 112.487 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -76.89 -47.44 21.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -148.19 66.0 1.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -165.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -54.73 112.67 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -163.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -141.83 91.88 8.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.04 155.74 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 115.286 -2.676 . . . . 0.0 109.473 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.91 123.58 89.65 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.65 154.8 63.98 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.557 -2.495 . . . . 0.0 112.247 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -75.22 2.7 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -71.22 -29.66 65.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.61 58.21 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -27.36 69.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.311 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -64.05 1.0 Allowed 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 167.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.74 -37.24 78.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -159.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.89 -50.93 71.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -76.19 -25.1 54.84 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.171 -0.956 . . . . 0.0 113.136 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.24 -49.47 71.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.548 0.689 . . . . 0.0 109.198 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.7 mt -62.61 -44.65 99.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.45 -48.34 81.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.7 -47.94 76.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 110.283 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.18 -19.26 58.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.25 -32.97 64.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 t -116.81 29.69 7.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.52 0.676 . . . . 0.0 110.573 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -67.82 144.43 55.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.58 -37.63 70.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.645 1.111 . . . . 0.0 110.869 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -58.08 -50.02 74.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -68.05 -40.51 82.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -56.69 -36.91 70.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.562 0.696 . . . . 0.0 110.901 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -82.67 -36.18 26.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 59.5 p -104.83 3.16 30.8 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -170.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.86 141.43 49.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.512 -0.743 . . . . 0.0 111.82 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.49 163.49 27.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.52 127.24 31.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -62.77 -36.24 82.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 111.899 -173.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -61.16 -30.13 70.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.741 0.781 . . . . 0.0 110.552 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' CG ' ' HB1' ' A' ' 10' ' ' ALA . 88.2 m-70 -96.44 -5.45 39.62 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.782 -0.574 . . . . 0.0 112.02 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.94 -50.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 162.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.87 -67.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.107 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.99 62.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.57 -1.331 . . . . 0.0 111.917 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.33 -30.55 10.7 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -99.27 -28.93 13.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.91 1.855 . . . . 0.0 111.184 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -73.96 -3.1 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 C--N 1.36 1.137 1 C-N-CA 109.306 -6.663 . . . . 0.0 114.281 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 103.439 -2.801 . . . . 0.0 103.439 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -132.79 162.39 31.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.35 155.42 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.7 m -115.75 118.37 32.86 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 101.703 -3.443 . . . . 0.0 101.703 164.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.64 159.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -71.92 122.25 20.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 162.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -75.06 165.37 25.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.58 130.43 46.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.152 0.977 . . . . 0.0 112.179 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.26 123.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -9.93 66.79 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.34 0.896 . . . . 0.0 115.34 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.29 87.38 13.71 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.471 1.136 . . . . 0.0 112.027 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.16 50.87 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.967 3.778 . . . . 0.0 117.01 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.11 -31.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -126.51 158.25 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.86 139.16 58.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.32 1.048 . . . . 0.0 109.522 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' CYS . . . -104.5 -157.92 23.75 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 120.188 2.835 . . . . 0.0 120.188 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.02 31.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.156 2.182 . . . . 0.0 113.803 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLY . 40.5 t -66.69 121.98 80.0 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.721 177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.88 -26.09 52.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 N-CA-C 117.06 1.908 . . . . 0.0 117.06 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.9 2.47 9.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 61' ' ' PRO . 68.2 m -64.59 -42.96 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.207 -0.933 . . . . 0.0 111.575 -174.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.16 -15.41 61.97 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.752 -1.179 . . . . 0.0 113.258 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.253 1.388 . . . . 0.0 110.675 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -44.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.29 -29.46 65.08 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 119.274 0.943 . . . . 0.0 112.684 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 p -76.56 -34.56 58.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.043 -1.036 . . . . 0.0 110.175 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.46 -39.47 85.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.114 0.959 . . . . 0.0 113.115 -175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -78.31 -27.19 47.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -67.54 -37.82 83.27 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.763 -1.21 . . . . 0.0 110.014 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -74.95 -17.85 60.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 54.73 36.57 26.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -78.0 165.15 52.79 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -54.41 139.18 74.33 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 119.495 0.855 . . . . 0.0 112.783 162.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.0 173.37 11.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 -143.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -110.21 118.43 36.32 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 112.772 -155.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -161.51 123.27 2.9 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 162.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -138.49 150.32 46.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 160.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 93.8 mt -108.15 120.55 42.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.182 0.446 . . . . 0.0 111.812 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.54 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -84.53 81.14 8.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.998 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 mt 52.63 31.07 9.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.52 79.42 1.46 Allowed Glycine 0 C--O 1.235 0.186 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -110.36 -74.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.814 0.816 . . . . 0.0 110.269 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.27 149.32 91.59 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.994 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.8 -167.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 116.768 1.795 . . . . 0.0 116.768 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -52.87 -22.4 5.44 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.62 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.595 1.089 . . . . 0.0 111.2 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.75 -34.93 64.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.533 -0.729 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.76 -27.24 62.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.44 -33.25 73.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.441 0.639 . . . . 0.0 110.771 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.8 mm -84.96 -48.51 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.404 0.621 . . . . 0.0 111.268 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -82.6 114.33 51.09 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 122.987 0.515 . . . . 0.0 111.4 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.46 -24.41 31.08 Favored 'Trans proline' 0 C--N 1.347 0.496 0 N-CA-C 117.294 1.998 . . . . 0.0 117.294 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -92.83 -7.47 46.28 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.82 -16.54 11.25 Favored Glycine 0 C--O 1.225 -0.434 0 O-C-N 121.705 -0.622 . . . . 0.0 112.683 -167.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -140.89 24.93 2.16 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.47 163.41 59.2 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 58.4 Cg_endo -67.19 142.93 62.76 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.148 -4.768 . . . . 0.0 112.352 161.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.1 t -128.84 132.97 67.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.67 122.45 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.43 1.109 . . . . 0.0 109.625 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -95.32 128.92 42.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.45 91.49 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.4 t0 51.16 51.39 17.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.289 1.042 . . . . 0.0 110.864 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t0 63.16 8.36 3.27 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.66 144.03 34.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 157.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -128.0 124.82 38.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 120.481 1.491 . . . . 0.0 109.167 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.43 156.99 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.94 96.58 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -154.65 153.92 32.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 101.815 -3.402 . . . . 0.0 101.815 167.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.9 p -61.96 -32.57 73.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -95.6 -14.36 23.61 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -81.36 -21.12 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.937 -1.727 . . . . 0.0 108.041 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -21.31 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.143 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -89.1 -48.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.62 -64.7 1.2 Allowed Glycine 0 CA--C 1.519 0.291 0 N-CA-C 120.389 2.915 . . . . 0.0 120.389 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.81 -34.16 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.651 0.739 . . . . 0.0 109.336 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.94 -47.21 87.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.089 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.25 -34.28 77.66 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.09 0.859 . . . . 0.0 112.107 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.46 -28.06 63.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.809 0.844 . . . . 0.0 110.407 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -120.2 21.55 11.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -100.82 76.22 0.14 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.442 0.697 . . . . 0.0 111.647 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.7 5.63 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.748 2 C-N-CA 125.757 4.305 . . . . 0.0 123.119 -131.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.88 172.48 8.9 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 158.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.61 135.42 70.34 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 114.988 -2.875 . . . . 0.0 116.904 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.54 116.8 4.81 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.477 1.451 . . . . 0.0 114.033 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.78 81.7 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.544 1.164 . . . . 0.0 113.528 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -118.27 73.72 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.969 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.19 114.62 63.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -106.7 61.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.64 0 N-CA-C 117.846 2.21 . . . . 0.0 117.846 168.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.95 -132.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 120.03 1.047 . . . . 0.0 112.715 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.06 -37.53 61.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -25.69 68.26 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 120.927 -1.108 . . . . 0.0 112.515 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.55 70.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.8 p -72.53 -33.67 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.68 -49.48 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.507 0.67 . . . . 0.0 109.244 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.64 94.64 Favored Glycine 0 C--O 1.228 -0.234 0 O-C-N 122.094 -0.379 . . . . 0.0 113.915 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.1 p -71.68 -12.37 61.3 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.99 -36.56 27.75 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.98 -1.075 . . . . 0.0 110.313 169.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.97 -46.6 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.353 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -50.0 -54.24 34.93 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -171.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.35 -19.85 12.98 Favored 'Trans proline' 0 C--N 1.349 0.601 1 C-N-CA 112.305 -4.664 . . . . 0.0 114.319 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -66.88 -47.16 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -73.32 -24.47 60.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.006 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.44 -38.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.91 -48.89 76.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.88 -43.92 94.48 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.77 -18.7 62.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.0 0.2 43.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.384 -0.197 . . . . 0.0 110.607 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 t -110.19 142.18 42.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.73 33.53 4.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.65 171.56 10.5 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.84 78.78 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 CA-C-N 120.642 1.265 . . . . 0.0 114.569 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -91.26 26.02 2.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -155.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.3 -35.42 80.3 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.683 -1.886 . . . . 0.0 112.263 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.39 -32.06 68.36 Favored Glycine 0 C--O 1.223 -0.562 0 O-C-N 121.463 -0.773 . . . . 0.0 112.966 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 m -77.98 -30.35 50.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.536 1.168 . . . . 0.0 111.398 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.0 -41.79 99.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.502 1.144 . . . . 0.0 108.351 171.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -73.75 -24.29 59.86 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.172 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.45 99.43 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 120.799 -1.188 . . . . 0.0 108.819 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.0 -44.41 96.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.13 -44.15 97.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -80.84 -30.65 35.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.65 -35.59 60.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.062 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.71 -17.45 57.61 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 120.96 -1.088 . . . . 0.0 109.837 173.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -69.55 -35.66 75.64 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.294 -1.504 . . . . 0.0 110.286 167.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.15 -45.53 93.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.11 -39.54 90.38 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -40.77 98.3 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.927 -1.108 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.95 -35.87 72.65 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.643 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -72.87 -36.84 67.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.483 -1.01 . . . . 0.0 112.631 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.24 -43.25 91.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 109.825 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.32 -19.49 63.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.979 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.68 -25.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.807 0.73 . . . . 0.0 111.095 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -112.46 -35.89 5.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.87 -71.16 0.22 Allowed Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.403 -1.776 . . . . 0.0 114.714 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.44 -160.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.799 4.333 . . . . 0.0 118.486 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -56.92 166.67 0.95 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.286 1.434 . . . . 0.0 112.159 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -52.46 -33.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.53 8.08 4.74 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.97 -33.81 5.49 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.07 -40.22 2.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.747 1.273 . . . . 0.0 112.331 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.41 -178.52 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.977 0.511 . . . . 0.0 110.249 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.8 mt -67.42 121.34 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 m -153.29 171.25 18.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -25.57 -54.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.969 1 N-CA-C 122.677 4.325 . . . . 0.0 122.677 -173.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.17 -35.34 75.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.015 -1.053 . . . . 0.0 110.483 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.32 -43.43 73.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.23 -32.56 73.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.596 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.2 m -71.13 -38.65 72.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.1 tp -100.32 -45.69 5.51 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -170.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.41 -43.13 97.38 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.12 -20.79 24.62 Favored 'Trans proline' 0 C--N 1.35 0.614 1 C-N-CA 111.296 -5.336 . . . . 0.0 114.782 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -78.29 -22.35 48.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 120.931 -1.106 . . . . 0.0 110.556 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 -27.01 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 118.435 0.561 . . . . 0.0 111.092 169.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.7 -44.53 64.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.157 -0.965 . . . . 0.0 110.263 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -62.67 -30.27 71.26 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.875 -0.515 . . . . 0.0 111.211 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.92 -58.36 8.9 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.25 -31.65 72.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.273 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.86 -54.88 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.758 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.86 -41.19 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.1 tp -67.77 -37.82 82.61 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.01 -32.88 81.86 Favored Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -74.95 -48.38 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.39 -45.05 12.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -167.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -149.1 60.98 1.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -52.3 120.64 5.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -162.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -145.48 93.82 5.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 163.01 39.58 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 115.882 -2.279 . . . . 0.0 109.879 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.4 124.81 90.84 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.7 166.44 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 117.105 -1.464 . . . . 0.0 113.92 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.86 -0.14 20.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.436 1.112 . . . . 0.0 112.27 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.31 -14.37 61.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.25 51.95 1.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.9 t -62.77 -26.26 68.62 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.709 -0.62 . . . . 0.0 112.464 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.91 -35.25 62.22 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.696 -1.252 . . . . 0.0 108.066 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.2 -40.39 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 109.368 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.42 -44.66 90.51 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.969 -0.457 . . . . 0.0 111.491 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.52 -23.83 61.06 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.027 -1.046 . . . . 0.0 111.734 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.405 ' CZ ' HD11 ' A' ' 186' ' ' LEU . 17.3 t80 -68.96 -49.17 60.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.905 0.482 . . . . 0.0 110.31 173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.64 -33.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 120.906 -1.121 . . . . 0.0 111.372 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.02 -38.9 90.44 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.861 -1.149 . . . . 0.0 111.459 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.61 -42.69 86.48 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.69 -0.631 . . . . 0.0 111.835 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.405 HD11 ' CZ ' ' A' ' 182' ' ' TYR . 40.5 mt -66.18 -46.72 76.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -55.85 -42.43 75.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.9 t -106.32 71.25 0.87 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 111.037 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.58 153.41 43.74 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -57.33 -48.68 78.35 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.809 0.693 . . . . 0.0 110.699 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.0 t -65.58 -43.71 88.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.928 0.87 . . . . 0.0 112.28 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -65.25 -45.26 85.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.641 0.734 . . . . 0.0 110.626 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.98 -37.68 81.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.499 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -69.65 -36.49 76.12 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.0 -1.062 . . . . 0.0 111.984 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 64.2 p -87.93 -0.28 56.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -62.04 141.17 58.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.92 44.73 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.41 122.11 15.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.02 -48.6 73.33 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -166.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 200' ' ' GLU . 0.9 OUTLIER -64.68 -21.71 66.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -95.64 -1.59 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.58 -44.73 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 164.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.95 -55.08 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.15 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.8 5.45 9.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.509 -0.744 . . . . 0.0 112.819 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.71 -44.26 3.7 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 169.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -91.06 -38.37 12.83 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.34 -20.42 0.58 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.353 0.776 1 C-N-CA 111.761 -5.026 . . . . 0.0 115.372 167.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.517 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.36 139.79 43.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.84 114.36 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.8 m -109.86 130.84 55.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.08 139.82 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 123.991 0.807 . . . . 0.0 112.264 -164.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.48 128.5 36.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.087 0.403 . . . . 0.0 110.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.05 176.34 9.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.202 1.001 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . . . -61.39 148.51 41.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.858 1.313 . . . . 0.0 109.385 167.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.39 109.84 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.354 -170.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.97 23.48 66.4 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.665 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . . . -146.92 89.29 5.69 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.96 54.52 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.945 3.097 . . . . 0.0 114.245 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -141.43 -28.08 0.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 pt -141.45 168.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 118.445 0.566 . . . . 0.0 110.518 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.27 146.82 45.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.114 1.765 . . . . 0.0 112.748 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.74 -174.6 13.81 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -73.56 92.43 1.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.422 1.106 . . . . 0.0 111.355 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.77 135.72 22.42 Favored Pre-proline 0 C--O 1.246 0.883 1 N-CA-C 99.344 -4.317 . . . . 0.0 99.344 138.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -57.42 -39.62 87.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.21 0.754 . . . . 0.0 112.956 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.24 -23.29 43.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.054 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.53 -34.24 77.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.801 -1.187 . . . . 0.0 113.418 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -80.61 -12.74 59.46 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.565 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' A' ' 155' ' ' PRO . 89.0 mtt180 -69.0 -41.91 77.18 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -44.95 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mt -64.26 -39.37 93.82 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.748 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.52 -43.3 97.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.569 0.622 . . . . 0.0 111.385 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 p -70.17 -39.13 75.49 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.62 -43.91 88.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -76.24 -29.28 57.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.548 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -68.42 -34.32 75.8 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.528 -1.358 . . . . 0.0 111.401 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG3' HD21 ' A' ' 84' ' ' ASN . 33.9 mmtp -88.52 -11.46 45.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.47 51.97 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.352 1.461 . . . . 0.0 113.622 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.3 pt -98.8 155.1 37.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.05 145.16 30.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.837 -2.975 . . . . 0.0 111.314 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.54 157.95 41.81 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 121.993 -0.442 . . . . 0.0 110.756 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -110.78 110.51 21.17 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.662 0.385 . . . . 0.0 111.719 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -86.1 128.38 34.87 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.11 93.57 4.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.654 1.182 . . . . 0.0 111.437 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.67 142.91 57.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.889 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.05 94.2 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.5 85.07 5.99 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.495 -0.753 . . . . 0.0 112.039 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt 54.35 45.06 27.98 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.002 0.906 . . . . 0.0 113.164 166.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.72 94.36 1.85 Allowed Glycine 0 C--O 1.238 0.352 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.523 -168.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -124.59 -91.08 0.55 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -69.68 152.38 96.2 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.204 -170.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.97 -175.68 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.552 2.168 . . . . 0.0 115.282 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -64.19 -10.76 25.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -161.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -49.3 -41.04 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.741 0.416 . . . . 0.0 110.094 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -79.84 -28.69 40.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.2 -34.8 78.28 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.895 0.855 . . . . 0.0 110.507 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.89 -36.64 84.59 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 121.362 -0.837 . . . . 0.0 110.362 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.1 mt -75.62 -45.81 38.11 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 C-N-CA 124.038 0.935 . . . . 0.0 112.716 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.586 ' OG ' HG22 ' A' ' 60' ' ' VAL . 28.7 t -102.99 129.62 25.27 Favored Pre-proline 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 112.973 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.29 -23.16 28.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 116.655 -1.764 . . . . 0.0 116.39 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.72 -10.96 25.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.788 -1.195 . . . . 0.0 110.718 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 -5.93 67.5 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 121.561 -0.712 . . . . 0.0 113.8 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -144.89 34.43 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -167.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' OG ' ' A' ' 55' ' ' SER . 11.8 m -119.16 161.81 34.92 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.934 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.63 151.25 58.11 Favored 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 111.417 -5.255 . . . . 0.0 110.081 171.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.6 161.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.29 126.26 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.999 0.818 . . . . 0.0 109.375 160.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.05 87.64 3.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.06 111.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 47.76 56.15 7.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.132 0.895 . . . . 0.0 113.27 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 t70 71.4 -7.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.94 122.85 44.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.047 -1.033 . . . . 0.0 110.147 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -107.07 131.42 54.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.65 144.74 37.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-N 115.256 -0.883 . . . . 0.0 113.331 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.72 115.63 1.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.35 157.08 10.63 Favored 'General case' 0 N--CA 1.472 0.654 1 N-CA-C 96.959 -5.2 . . . . 0.0 96.959 160.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.9 p -57.44 -35.17 69.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.92 -41.17 60.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.059 -0.4 . . . . 0.0 111.907 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -81.64 -17.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.837 -0.539 . . . . 0.0 110.691 -171.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -23.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.63 -47.91 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.083 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.1 62.47 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.4 mt -80.47 -29.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.596 1.698 . . . . 0.0 106.629 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.28 -41.15 92.72 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.718 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.59 -39.75 80.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 112.798 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -60.47 -33.46 72.6 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.131 -0.981 . . . . 0.0 111.454 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.81 10.86 38.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.446 HD21 ' HG3' ' A' ' 33' ' ' LYS . 33.8 t-20 -69.54 130.99 90.13 Favored Pre-proline 0 C--O 1.247 0.927 0 O-C-N 121.606 -0.683 . . . . 0.0 109.195 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.41 -17.3 30.64 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.129 -1.448 . . . . 0.0 113.779 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.98 161.54 27.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -63.93 144.13 87.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 115.807 -2.329 . . . . 0.0 117.122 -169.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.23 136.52 7.85 Favored 'Trans proline' 0 C--O 1.24 0.584 0 N-CA-C 118.366 2.41 . . . . 0.0 118.366 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.26 41.36 3.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.329 1.052 . . . . 0.0 111.981 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.57 66.76 4.17 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.759 0.824 . . . . 0.0 112.016 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.11 106.08 28.52 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -100.7 75.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 125.158 3.905 . . . . 0.0 118.01 166.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -91.0 -140.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.474 1.449 . . . . 0.0 114.241 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.87 -37.12 29.65 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.05 -25.52 64.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.114 -0.991 . . . . 0.0 112.428 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.49 47.42 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.874 -0.516 . . . . 0.0 111.895 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.1 p -70.12 -32.81 71.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.71 -38.84 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.9 -39.41 93.98 Favored Glycine 0 C--O 1.227 -0.308 0 O-C-N 121.702 -0.624 . . . . 0.0 112.815 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.9 p -76.51 5.92 6.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.083 1.441 . . . . 0.0 114.45 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -104.29 -25.49 12.86 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.419 -0.801 . . . . 0.0 112.535 165.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.3 mt -85.92 -47.89 16.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.955 0.407 . . . . 0.0 111.098 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -50.37 -52.02 58.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.19 -20.97 10.94 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 114.307 -3.328 . . . . 0.0 115.861 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.1 p -79.73 -37.88 34.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -46.8 89.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.494 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.84 -26.7 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 121.39 -0.819 . . . . 0.0 112.318 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -65.45 -43.17 91.21 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.26 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.38 -23.37 63.73 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.3 tp -66.05 -38.83 89.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.774 0.715 . . . . 0.0 110.955 171.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -83.02 -31.27 27.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 t -74.0 131.24 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -114.64 30.61 7.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.298 1.047 . . . . 0.0 109.497 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.35 171.34 8.02 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.013 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.28 95.73 0.69 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 116.249 -2.034 . . . . 0.0 112.447 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -115.3 59.23 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.281 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -94.63 -45.18 7.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.64 -28.01 62.05 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.288 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 p -97.8 -5.1 35.55 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.6 -31.31 66.77 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 161.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -76.73 0.08 21.81 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.947 -1.096 . . . . 0.0 111.596 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.22 69.23 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.19 -35.42 79.6 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.473 -0.767 . . . . 0.0 109.942 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.2 -43.64 92.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.89 -28.77 64.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.18 -36.29 40.54 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.543 -1.348 . . . . 0.0 110.381 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.3 mt -74.37 -25.48 59.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.072 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.74 -34.29 72.76 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 118.55 0.613 . . . . 0.0 111.231 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.7 77.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.12 -36.2 82.53 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.751 0.705 . . . . 0.0 111.936 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.99 -42.12 89.28 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.12 0.568 . . . . 0.0 111.741 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.04 57.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.358 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -36.23 75.28 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.807 0.443 . . . . 0.0 111.521 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -54.09 18.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.678 -0.638 . . . . 0.0 109.937 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.6 -24.24 67.02 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.6 m -79.57 -11.35 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -114.61 -39.86 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.48 -68.17 0.27 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 121.267 3.267 . . . . 0.0 121.267 173.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -74.47 -171.42 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 N-CA-C 120.213 3.121 . . . . 0.0 120.213 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -49.73 154.03 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.028 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -67.2 -32.8 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.692 -124.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.15 -19.48 5.13 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.97 3.51 48.71 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-O 119.224 -0.765 . . . . 0.0 112.18 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -139.61 -62.25 0.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -163.24 178.9 7.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.89 114.05 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 124.143 0.902 . . . . 0.0 110.593 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -120.92 -169.93 1.92 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.5 29.31 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.71 -40.56 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.404 -1.435 . . . . 0.0 111.601 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.5 -39.9 94.65 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.3 -28.98 68.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -70.92 -37.22 72.9 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.084 -1.01 . . . . 0.0 111.719 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.12 -59.93 2.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.88 76.61 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 25' ' ' ARG . 89.8 Cg_endo -69.1 -24.33 32.82 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 113.842 -3.639 . . . . 0.0 115.996 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -88.02 -29.41 20.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.294 1.406 . . . . 0.0 108.902 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.85 -35.73 73.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.376 0.535 . . . . 0.0 110.54 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.46 -48.46 71.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -65.36 -40.88 94.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.43 76.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.819 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.67 -28.21 68.28 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.811 1.187 . . . . 0.0 112.888 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.1 m -81.01 -38.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 O-C-N 121.052 -1.03 . . . . 0.0 110.102 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.26 -49.5 19.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.145 0.429 . . . . 0.0 111.979 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.01 -35.41 80.61 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.06 -29.91 76.24 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 115.432 0.933 . . . . 0.0 115.432 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -89.7 -44.1 10.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.371 1.085 . . . . 0.0 113.057 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.17 -37.27 20.36 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -138.5 30.92 2.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.917 0.487 . . . . 0.0 112.277 -163.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -22.93 109.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -152.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -142.22 90.44 8.21 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.869 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.55 160.01 42.03 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 117.121 -1.453 . . . . 0.0 110.344 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.62 121.65 85.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.93 162.43 34.74 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 116.619 -1.788 . . . . 0.0 113.911 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -4.41 30.37 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.317 -0.864 . . . . 0.0 112.949 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -66.62 -22.91 66.11 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.478 0.656 . . . . 0.0 110.206 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.33 66.38 0.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 m -58.53 -36.57 74.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.361 -170.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -51.69 68.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.57 -41.58 80.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -161.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.23 -46.99 65.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.726 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.56 -45.73 89.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.092 -176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -72.6 -29.05 63.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.459 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.59 -40.96 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.857 1.208 . . . . 0.0 110.057 171.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.82 -33.75 74.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.553 -0.717 . . . . 0.0 112.721 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.9 -38.13 79.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.196 0.907 . . . . 0.0 110.869 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.5 -42.02 88.01 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.387 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -50.49 -38.79 46.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -173.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.3 t -120.79 38.55 4.01 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.727 1.251 . . . . 0.0 110.761 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -78.85 143.32 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 161.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -56.55 -45.37 81.28 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.58 1.082 . . . . 0.0 113.653 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -62.22 -44.78 95.81 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -77.07 -38.0 53.41 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.396 -0.815 . . . . 0.0 112.67 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -59.32 -36.46 75.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.045 0.926 . . . . 0.0 110.874 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.01 -40.95 44.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.9 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.7 p -98.47 -3.63 36.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -60.28 140.86 56.84 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.21 150.03 40.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.9 139.01 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -63.93 -39.27 93.79 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.75 -31.04 71.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.568 1.175 . . . . 0.0 109.698 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -96.16 10.19 38.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.526 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -100.85 -51.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.439 156.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.9 -66.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.07 -9.73 58.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.107 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.78 -31.37 29.74 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.442 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -110.6 -28.09 8.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.605 1.202 . . . . 0.0 112.975 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -74.46 -9.7 0.15 Allowed Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 121.618 3.932 . . . . 0.0 121.618 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.36 1.147 1 C-N-CA 111.354 -5.297 . . . . 0.0 114.639 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 tpp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 140.77 37.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.04 1.291 . . . . 0.0 108.289 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.41 142.02 45.56 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.28 0.7 OUTLIER -171.27 -148.49 0.05 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.372 1.442 . . . . 0.0 109.937 160.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.33 143.96 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -133.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -126.15 110.98 14.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.845 -3.391 . . . . 0.0 101.845 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.3 167.24 26.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.76 139.56 44.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.81 156.34 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.03 127.17 30.25 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 164.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.03 119.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.22 75.39 Favored Glycine 0 C--O 1.25 1.102 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.01 76.79 8.63 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.745 -0.727 . . . . 0.0 111.605 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.9 53.7 2.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.623 2.882 . . . . 0.0 116.52 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -128.51 -37.59 1.79 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.483 -0.76 . . . . 0.0 112.13 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.2 mt -95.92 142.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.38 152.39 17.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.25 176.16 48.38 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.44 31.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.551 -1.825 . . . . 0.0 115.573 -172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.7 t -96.01 145.75 30.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.632 -0.667 . . . . 0.0 112.38 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -68.33 -47.96 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 117.028 -1.514 . . . . 0.0 115.191 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -19.93 60.49 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.824 -0.547 . . . . 0.0 110.208 -172.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.4 t -55.7 -55.59 30.45 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.656 0.597 . . . . 0.0 109.708 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.56 -15.14 59.93 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 96.0 mtt180 -61.43 -52.74 63.29 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.283 1.401 . . . . 0.0 109.782 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HG12 ' A' ' 76' ' ' ILE . 16.4 m -79.2 -31.84 14.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.691 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -62.13 -44.83 95.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.932 0.787 . . . . 0.0 110.444 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.041 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -61.33 -36.33 79.84 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.396 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.2 -40.09 31.66 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.69 -0.631 . . . . 0.0 111.799 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -70.12 -31.25 68.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.32 0.509 . . . . 0.0 111.642 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.34 -34.6 77.66 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.917 -1.114 . . . . 0.0 110.761 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -82.29 -14.32 55.58 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.101 -0.999 . . . . 0.0 112.647 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 56.49 57.87 4.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.647 . . . . 0.0 112.918 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 pt -94.71 161.83 27.47 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.82 151.24 68.67 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 115.858 -2.295 . . . . 0.0 110.942 164.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -147.36 154.84 41.39 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -100.07 -92.77 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -165.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 178.37 7.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -153.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -134.13 174.75 10.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.095 0.958 . . . . 0.0 113.524 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.54 152.32 0.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -94.98 117.92 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 166.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.04 72.28 10.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.5 67.17 1.0 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 167.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.82 -2.41 84.29 Favored Glycine 0 C--O 1.228 -0.279 0 O-C-N 121.186 -0.946 . . . . 0.0 113.411 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -87.19 92.2 8.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -122.08 83.96 45.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 122.132 0.967 . . . . 0.0 113.078 -170.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.69 172.74 13.8 Favored 'Trans proline' 0 C--O 1.238 0.488 0 N-CA-C 110.33 -0.681 . . . . 0.0 110.33 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -55.69 -34.07 64.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -54.63 -53.04 59.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 118.716 0.689 . . . . 0.0 111.884 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -73.33 -29.14 62.47 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.644 -1.285 . . . . 0.0 112.671 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.45 -25.84 64.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.581 1.082 . . . . 0.0 111.855 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -74.34 -41.36 61.2 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.761 -0.587 . . . . 0.0 109.525 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -74.01 -54.64 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -100.86 136.18 19.86 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.871 0.868 . . . . 0.0 111.971 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.59 -24.6 15.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 116.256 -2.029 . . . . 0.0 116.304 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -104.97 -5.37 21.06 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.13 -5.21 51.12 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 122.798 1.221 . . . . 0.0 113.284 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -148.85 37.31 0.8 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.786 1.234 . . . . 0.0 111.629 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.85 136.21 28.47 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -58.26 149.38 73.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 114.354 0.867 . . . . 0.0 114.354 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 m -136.14 169.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.92 141.81 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 156.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -103.27 93.65 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.25 96.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.078 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.07 37.36 24.61 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.545 1.164 . . . . 0.0 112.125 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t0 67.94 41.25 2.13 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 126.156 1.782 . . . . 0.0 115.661 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -131.16 153.02 49.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 167.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.63 126.46 20.77 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.37 149.58 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.12 81.77 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -151.28 152.59 33.43 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 168.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.2 p -55.3 -29.99 59.29 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -165.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.18 -35.52 10.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.286 0.565 . . . . 0.0 112.165 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.53 -37.48 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.604 0.716 . . . . 0.0 110.528 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG12 HG11 ' A' ' 26' ' ' VAL . 11.8 tt -60.17 -29.99 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.629 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.8 t -88.45 -49.57 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.493 0.717 . . . . 0.0 111.77 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.83 -34.12 71.48 Favored Glycine 0 C--O 1.235 0.213 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.936 -168.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.26 -30.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.52 -44.25 97.41 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 121.895 -0.503 . . . . 0.0 109.851 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -62.87 -46.3 88.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.349 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.85 -37.17 85.79 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.479 -0.763 . . . . 0.0 112.33 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.59 7.32 46.67 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -81.61 129.23 66.44 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.14 -17.08 22.21 Favored 'Trans proline' 0 C--O 1.244 0.8 0 N-CA-C 116.023 1.509 . . . . 0.0 116.023 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.41 148.87 67.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -60.22 116.78 3.56 Favored 'Trans proline' 0 C--O 1.243 0.753 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.58 170.36 11.66 Favored 'Trans proline' 0 C--O 1.249 1.033 0 N-CA-C 115.114 1.159 . . . . 0.0 115.114 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 HG22 ' A' ' 147' ' ' THR . 12.5 tp -141.54 69.91 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 122.598 1.19 . . . . 0.0 110.005 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.47 65.06 6.45 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.277 -1.328 . . . . 0.0 112.46 -175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 m -120.12 100.54 47.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.21 86.18 0.06 OUTLIER 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.512 3.475 . . . . 0.0 117.989 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -88.55 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.004 1 C-N-CA 127.23 5.286 . . . . 0.0 111.739 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -45.36 -34.8 3.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.52 -30.17 71.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 120.559 -1.338 . . . . 0.0 112.366 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.35 -28.64 34.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.053 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -72.06 -32.38 67.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.125 0.875 . . . . 0.0 109.638 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.44 -40.62 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.318 -0.864 . . . . 0.0 109.684 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.02 -30.84 70.99 Favored Glycine 0 CA--C 1.521 0.425 0 O-C-N 121.793 -0.567 . . . . 0.0 114.313 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -73.12 -9.49 58.77 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -80.76 -46.62 15.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt -75.63 -42.12 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.925 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.13 -53.26 67.2 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.78 -18.99 21.55 Favored 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 112.637 -4.442 . . . . 0.0 113.636 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.0 t -66.96 -56.55 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.015 0.526 . . . . 0.0 111.804 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -72.92 -23.97 60.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.79 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -68.23 -47.25 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -63.26 -44.39 95.28 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -69.79 -34.89 74.35 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.06 -34.45 76.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.195 0.907 . . . . 0.0 110.286 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.78 -24.89 61.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.631 0.772 . . . . 0.0 111.762 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -87.77 127.54 35.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -116.71 39.13 3.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.51 -175.31 0.18 Allowed Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 127.053 2.141 . . . . 0.0 109.68 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.08 41.26 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 114.675 0.99 . . . . 0.0 114.675 146.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -71.79 105.75 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.653 -1.279 . . . . 0.0 112.595 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.98 -54.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.4 -36.33 93.06 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.654 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.3 p -77.85 -21.92 50.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.383 0.592 . . . . 0.0 112.204 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.63 -35.75 75.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.659 1.695 . . . . 0.0 107.02 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -79.77 -3.69 48.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.72 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.48 -31.33 24.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.882 -1.136 . . . . 0.0 108.081 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.55 -41.24 88.95 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.335 -0.853 . . . . 0.0 110.065 165.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.82 -36.53 72.37 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.91 -0.493 . . . . 0.0 110.925 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -64.0 -36.24 83.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -78.02 -33.71 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.3 -24.59 61.35 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.63 -0.668 . . . . 0.0 111.001 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.09 -33.06 71.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.579 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.28 80.45 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.108 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.94 -34.55 78.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.397 1.094 . . . . 0.0 111.744 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.76 -38.66 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.26 -36.49 93.28 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.803 -1.09 . . . . 0.0 114.665 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -69.15 -46.22 68.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.864 1.332 . . . . 0.0 110.643 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 178' ' ' HIS . 5.8 tt -68.41 -38.39 81.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.558 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -68.74 -20.07 64.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.798 1.181 . . . . 0.0 112.851 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -81.73 -52.26 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.91 -31.84 40.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.17 -81.95 0.3 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-O 117.881 -1.511 . . . . 0.0 114.319 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -77.47 -174.25 2.13 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.214 3.276 . . . . 0.0 114.18 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -33.12 165.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 119.463 3.134 . . . . 0.0 119.463 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.02 -41.37 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 121.232 -0.918 . . . . 0.0 111.113 -152.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.75 -0.27 2.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.94 47.92 Favored Glycine 0 N--CA 1.453 -0.17 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.15 -39.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.692 0.746 . . . . 0.0 112.559 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -160.95 176.84 10.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 114.11 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 89' ' ' LEU . 27.2 p -123.12 -168.51 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.82 -24.94 10.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.19 -55.04 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.171 0.896 . . . . 0.0 109.614 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.46 -38.22 84.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.68 -18.93 65.63 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.799 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 97.0 p -86.24 -39.58 16.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.252 0.933 . . . . 0.0 111.957 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.83 -45.45 8.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -168.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.45 91.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 25' ' ' ARG . 76.7 Cg_exo -58.67 -35.51 98.54 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 115.988 -2.208 . . . . 0.0 116.548 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -84.98 -22.78 29.0 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.754 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.97 -28.61 68.41 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.145 -0.972 . . . . 0.0 112.697 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.55 -40.02 93.18 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -67.81 -34.56 76.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.731 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 HD22 ' A' ' 164' ' ' LEU . 44.5 tp -60.25 -53.06 62.22 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.169 0.44 . . . . 0.0 109.967 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -68.5 -21.67 64.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.97 -41.19 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.965 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.62 -57.0 4.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.274 -0.891 . . . . 0.0 111.628 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.418 HD22 HD11 ' A' ' 160' ' ' LEU . 43.3 tp -64.73 -36.69 85.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.64 -33.29 76.66 Favored Glycine 0 C--O 1.237 0.322 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.372 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -100.39 -42.74 6.49 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -47.43 24.36 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.198 0.908 . . . . 0.0 113.214 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -136.43 64.17 1.56 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.95 114.61 0.95 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -163.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -144.33 93.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.34 158.96 47.7 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.724 -1.718 . . . . 0.0 111.127 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.21 124.41 88.88 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.26 151.22 60.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 117.023 -1.518 . . . . 0.0 112.139 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -77.69 -0.88 28.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -72.64 -24.13 61.01 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.4 62.86 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -58.95 -35.99 74.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.153 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.544 ' CD2' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -60.72 -55.88 27.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.88 -41.64 91.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -165.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 tp -67.33 -44.73 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.2 -45.1 89.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -25.31 43.19 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 118.944 -1.103 . . . . 0.0 112.041 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 13.9 mt -64.71 -32.69 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -62.35 -39.17 92.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.327 0.584 . . . . 0.0 110.613 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.22 -43.68 85.99 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.926 -0.484 . . . . 0.0 110.405 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.73 -31.69 71.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 118.486 0.585 . . . . 0.0 111.788 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.25 -23.84 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.814 -1.179 . . . . 0.0 112.243 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t -147.29 66.33 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -105.41 149.58 26.01 Favored 'General case' 0 CA--C 1.498 -1.034 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 161.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.54 -41.31 89.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.811 0.815 . . . . 0.0 110.4 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -63.8 -46.67 84.1 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.429 -0.794 . . . . 0.0 111.038 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.36 -34.75 74.32 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.891 -0.506 . . . . 0.0 110.203 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -73.55 -38.74 65.13 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.123 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.0 p -90.49 2.17 55.97 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -63.18 145.19 56.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.205 -0.934 . . . . 0.0 111.619 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 166.46 23.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.51 43.86 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -65.34 -50.75 64.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.332 1.063 . . . . 0.0 108.264 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.36 -29.16 68.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.285 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.85 1.93 55.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.2 t -96.53 -45.0 12.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.29 -53.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.917 -1.115 . . . . 0.0 112.15 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.14 23.31 11.8 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.46 -34.9 0.59 Allowed Glycine 0 C--O 1.226 -0.38 0 CA-C-N 114.612 -1.177 . . . . 0.0 114.272 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -97.05 -41.78 8.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.159 0.979 . . . . 0.0 112.785 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.35 -15.22 0.26 Allowed Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 119.412 3.116 . . . . 0.0 119.412 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.9 -23.24 30.36 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 109.882 -6.279 . . . . 0.0 113.833 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -63.13 -38.6 91.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.385 0.993 . . . . 0.0 110.656 170.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.64 -32.22 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.634 0.774 . . . . 0.0 109.42 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.5 -54.25 6.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.528 -2.177 . . . . 0.0 112.513 -176.451 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtp . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.63 -151.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.233 1.013 . . . . 0.0 110.015 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.32 164.68 15.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -136.0 158.39 44.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 160.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.36 126.39 75.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.1 t -128.99 109.09 10.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -128.17 156.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.204 -167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.05 129.95 43.24 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.35 167.65 20.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.38 140.21 58.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.851 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.23 127.33 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.14 86.35 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 117.131 1.612 . . . . 0.0 117.131 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.91 100.14 2.54 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 119.323 1.562 . . . . 0.0 113.699 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.38 0.69 6.43 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 N-CA-C 116.578 1.722 . . . . 0.0 116.578 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 -12.14 45.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.12 166.66 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.055 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -82.03 143.41 31.57 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.077 0.951 . . . . 0.0 111.483 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.26 -166.15 12.16 Favored Glycine 0 N--CA 1.46 0.282 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.17 127.15 30.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.473 1.137 . . . . 0.0 109.976 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.9 t -157.67 134.07 6.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.64 -43.09 41.27 Favored 'Trans proline' 0 C--N 1.345 0.35 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -119.93 2.87 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.03 -44.19 96.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.051 0.929 . . . . 0.0 112.016 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -72.89 -12.14 60.85 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.28 -39.13 85.98 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.773 -1.205 . . . . 0.0 109.544 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.71 -45.91 76.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -39.83 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.763 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.6 -49.35 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 p -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.51 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.22 -25.98 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -69.24 -38.56 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.216 0.916 . . . . 0.0 109.595 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -65.7 -41.77 91.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -75.77 -8.14 56.13 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 53.71 39.02 29.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.565 1.146 . . . . 0.0 113.93 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.57 157.07 39.05 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.66 137.17 22.18 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 114.987 -2.875 . . . . 0.0 113.399 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -150.98 161.26 43.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -105.68 132.95 51.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -84.27 123.83 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -118.85 145.08 45.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.94 135.49 55.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.95 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -76.88 61.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 52.48 52.48 14.06 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.703 1.201 . . . . 0.0 113.717 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 64.95 1.16 Allowed Glycine 0 C--O 1.228 -0.225 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -87.31 -77.51 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -165.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.02 162.5 22.66 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.15 174.11 2.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 118.002 -0.865 . . . . 0.0 114.0 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 5.59 -55.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 1 N-CA-C 122.441 4.238 . . . . 0.0 122.441 171.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -50.57 -38.42 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.433 1.469 . . . . 0.0 112.312 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.82 -20.1 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.92 -25.73 23.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.779 . . . . 0.0 109.242 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -74.33 -31.66 62.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.384 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 mt -63.76 -52.87 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -118.64 129.36 25.43 Favored Pre-proline 0 N--CA 1.469 0.494 0 O-C-N 121.986 -0.446 . . . . 0.0 110.957 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.49 -22.74 44.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 N-CA-C 116.609 1.734 . . . . 0.0 116.609 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.76 0.15 35.36 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.418 0.554 . . . . 0.0 111.135 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.75 69.48 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.073 -1.017 . . . . 0.0 114.292 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -158.25 -29.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.7 m -69.89 152.77 95.89 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 118.77 0.713 . . . . 0.0 111.575 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.74 154.41 59.14 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 117.302 -1.332 . . . . 0.0 113.147 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.7 161.8 23.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.511 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.67 137.61 33.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -106.75 93.61 4.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 55.0 mt -97.19 108.68 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t0 49.01 46.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 123.493 1.616 . . . . 0.0 111.419 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 73.27 4.89 4.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.648 -2.523 . . . . 0.0 117.322 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -112.5 139.31 48.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -98.28 141.29 31.36 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 -168.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.8 t -123.87 123.71 67.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.5 -37.75 1.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -165.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.61 149.87 49.37 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.05 -1.032 . . . . 0.0 110.309 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.3 p -60.08 -34.23 73.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -170.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -88.85 -13.33 39.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.25 -19.57 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 108.854 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.4 mt -66.33 -26.77 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 165.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -84.43 -40.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 120.504 -1.372 . . . . 0.0 111.462 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.45 -64.02 0.83 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 118.883 2.313 . . . . 0.0 118.883 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.78 -34.39 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.328 1.064 . . . . 0.0 111.103 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.31 -46.32 79.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.948 -0.47 . . . . 0.0 110.691 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.23 -40.76 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.507 . . . . 0.0 110.369 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.69 -35.72 81.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -95.34 -12.31 26.3 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.29 127.81 93.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.38 -12.92 37.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.67 162.06 71.9 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.553 -1.342 . . . . 0.0 108.096 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.9 137.52 82.03 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 116.386 -1.943 . . . . 0.0 114.836 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.14 150.94 29.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 116.342 -1.972 . . . . 0.0 113.062 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.5 mt -132.83 66.61 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.944 0.878 . . . . 0.0 110.395 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -108.64 84.87 2.0 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.1 m -113.78 97.89 45.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -112.93 78.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.513 2.142 . . . . 0.0 114.913 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -91.16 -131.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.657 2.905 . . . . 0.0 113.319 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -54.34 -40.47 68.07 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.178 -0.951 . . . . 0.0 112.254 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.49 -26.46 68.73 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.453 -0.779 . . . . 0.0 111.447 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.68 -28.52 45.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.9 p -81.95 -27.89 33.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.974 0.806 . . . . 0.0 109.153 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.7 -43.79 82.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.83 -30.38 76.95 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 120.829 -1.17 . . . . 0.0 114.181 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.7 p -77.5 -7.06 55.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.378 1.089 . . . . 0.0 113.139 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -93.97 -36.32 12.22 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.783 0.72 . . . . 0.0 110.974 166.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.93 -48.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.619 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -54.57 -54.49 48.26 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HA ' HG22 ' A' ' 107' ' ' VAL . 93.5 Cg_endo -72.06 -24.88 19.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 113.436 -3.91 . . . . 0.0 113.784 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 t -65.8 -45.25 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -76.36 -29.62 57.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.793 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 104' ' ' PRO . 21.9 m -75.57 -26.23 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 118.48 -1.288 . . . . 0.0 110.038 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.61 -43.63 80.0 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.78 -39.45 84.93 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.757 -0.589 . . . . 0.0 111.195 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.2 mt -62.97 -36.51 83.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -92.36 -24.48 18.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.1 t -68.64 142.46 55.09 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -127.02 40.71 3.67 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.924 1.345 . . . . 0.0 107.669 159.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -77.78 173.39 7.67 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -61.73 102.15 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 114.948 -2.901 . . . . 0.0 109.199 146.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -122.92 24.78 8.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.849 -159.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.53 -22.89 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.238 1.018 . . . . 0.0 110.69 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.14 -33.26 54.74 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 m -68.09 -28.02 66.99 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.027 -0.69 . . . . 0.0 111.535 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -65.46 -36.15 83.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.639 -1.288 . . . . 0.0 110.013 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.07 -33.39 61.67 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.8 -0.563 . . . . 0.0 110.677 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.69 88.47 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 110.558 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.25 -46.78 88.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.74 -42.95 99.63 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.721 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.81 -41.88 86.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -69.39 -35.77 76.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.707 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.51 -35.66 77.8 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.502 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.3 -29.68 70.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.691 0.678 . . . . 0.0 111.647 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.26 -51.57 65.65 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.327 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.26 -26.11 63.68 Favored 'General case' 0 C--O 1.221 -0.43 0 O-C-N 121.878 -0.514 . . . . 0.0 111.725 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.01 -39.87 93.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.683 0.393 . . . . 0.0 110.509 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.86 -54.72 26.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.52 -39.96 89.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.89 -45.36 78.27 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.76 -23.01 62.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.404 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.61 -49.39 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.674 -0.641 . . . . 0.0 111.139 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -82.64 -37.93 24.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -77.28 0.26 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-O 116.828 -2.095 . . . . 0.0 116.931 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -60.57 -131.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 1 C-N-CA 127.989 5.793 . . . . 0.0 120.728 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.43 171.68 7.06 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.937 -1.102 . . . . 0.0 111.293 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.72 -17.42 21.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.32 5.25 35.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.27 -24.77 17.46 Favored Glycine 0 C--O 1.227 -0.334 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.44 -54.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.307 1.553 . . . . 0.0 114.535 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -156.81 176.87 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.05 120.55 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.6 p -140.75 -168.57 2.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -40.44 -38.55 0.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 118.279 2.696 . . . . 0.0 118.279 173.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.88 -43.54 96.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.131 0.967 . . . . 0.0 108.705 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.91 -39.33 79.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.9 mt -61.54 -37.46 83.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.475 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.4 p -77.69 -43.55 30.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.5 tp -95.12 -46.72 6.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -167.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.8 92.92 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.55 -19.41 19.06 Favored 'Trans proline' 0 C--N 1.346 0.446 1 C-N-CA 113.006 -4.196 . . . . 0.0 113.753 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.81 -23.15 20.68 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.983 -1.073 . . . . 0.0 109.587 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.6 mt -63.28 -31.35 72.47 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 165.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.45 -51.08 71.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -63.57 -34.34 77.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.0 -56.0 27.9 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.395 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.94 -51.54 43.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.692 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.69 -42.07 64.64 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.388 -0.82 . . . . 0.0 111.564 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.54 -46.9 86.27 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.26 93.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.033 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.71 -47.18 14.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.629 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -93.76 -34.39 13.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -167.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -137.44 50.47 1.96 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.959 -0.463 . . . . 0.0 110.836 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -53.02 121.71 7.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -156.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -148.15 89.2 5.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.38 153.3 74.42 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 114.639 -3.107 . . . . 0.0 109.87 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.92 126.03 91.79 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.84 155.54 57.93 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 117.142 -1.438 . . . . 0.0 112.31 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.42 -10.03 52.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -67.73 -25.24 65.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.048 -0.408 . . . . 0.0 110.488 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.99 61.54 1.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -31.52 68.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.712 -1.586 . . . . 0.0 113.137 -171.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -43.04 99.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.102 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -38.06 33.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.18 -40.12 88.86 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.631 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.08 -45.7 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.496 -0.753 . . . . 0.0 111.932 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.94 -39.85 95.87 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.64 -32.34 57.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.68 -35.58 78.38 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.167 -0.958 . . . . 0.0 111.057 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.08 -21.05 60.84 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.943 -0.473 . . . . 0.0 111.568 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.13 -8.85 58.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.232 1.015 . . . . 0.0 110.434 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -103.53 23.73 12.18 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.23 -0.919 . . . . 0.0 110.154 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.7 p -124.84 164.43 20.04 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 49.05 150.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 121.225 3.787 . . . . 0.0 121.225 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -56.93 -34.86 68.39 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 120.555 -1.341 . . . . 0.0 114.381 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -18.95 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.09 -44.86 2.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.485 0.66 . . . . 0.0 110.856 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.53 -42.65 99.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.84 -30.91 24.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.201 1.0 . . . . 0.0 109.722 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.7 p -79.01 -12.54 60.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -40.63 119.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 113.078 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.12 138.92 50.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 165.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.43 138.58 58.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.806 0.276 . . . . 0.0 111.233 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.55 -43.78 89.43 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.56 -31.19 67.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.194 0.997 . . . . 0.0 111.141 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -102.68 0.97 33.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.2 -50.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 161.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.4 pt -69.41 -50.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 121.618 -0.676 . . . . 0.0 111.875 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.11 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.336 -0.852 . . . . 0.0 110.291 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.8 -16.17 58.58 Favored Glycine 0 CA--C 1.517 0.173 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -113.15 -54.22 2.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.58 -31.04 8.55 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.39 -29.34 45.79 Favored 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 111.733 -5.045 . . . . 0.0 114.475 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.69 -14.9 58.43 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.571 -0.706 . . . . 0.0 111.455 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.11 -42.03 19.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -64.39 -38.92 92.72 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.941 -0.474 . . . . 0.0 111.578 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 124.162 0.985 . . . . 0.0 109.863 -179.859 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 tpp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.17 155.9 36.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.71 173.24 16.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -124.88 156.32 38.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.403 HD11 ' HG ' ' A' ' 30' ' ' LEU . 44.8 mt -130.65 113.96 26.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.7 127.3 39.33 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.03 163.06 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 119.655 1.116 . . . . 0.0 112.926 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.49 126.42 29.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -82.92 172.69 12.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.04 142.83 58.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.45 134.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.67 -21.61 17.74 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.3 100.8 1.73 Allowed Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.0 96.39 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 116.917 -1.589 . . . . 0.0 114.383 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -159.36 -39.97 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -104.45 158.22 5.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.12 160.09 16.08 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 110.295 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 -179.44 18.37 Favored Glycine 0 CA--C 1.507 -0.436 0 CA-C-N 116.458 -0.337 . . . . 0.0 112.992 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.87 92.89 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.335 1.065 . . . . 0.0 111.165 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.67 132.86 24.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 103.345 -2.835 . . . . 0.0 103.345 165.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.76 -38.03 32.8 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 116.693 -1.738 . . . . 0.0 111.992 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.26 -21.44 36.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.746 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.303 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -74.14 -26.65 60.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.882 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.81 -39.62 89.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.58 1.536 . . . . 0.0 111.151 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.63 -44.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.836 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.28 -38.21 85.96 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.397 -0.814 . . . . 0.0 110.541 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.92 -48.24 79.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 p -72.32 -31.47 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.727 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 5' ' ' ILE . 4.0 mm? -68.4 -46.24 70.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.206 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -65.02 -33.11 75.26 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.793 -0.567 . . . . 0.0 110.579 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.06 -41.92 99.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.373 0.606 . . . . 0.0 112.343 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.82 -16.51 57.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.29 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 59.64 40.5 19.97 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.305 1.442 . . . . 0.0 112.931 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 pt -101.49 154.61 37.14 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.62 118.96 5.98 Favored 'Trans proline' 0 C--N 1.347 0.459 0 N-CA-C 117.375 2.029 . . . . 0.0 117.375 -171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -126.32 156.17 40.86 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.816 0.817 . . . . 0.0 113.072 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.24 110.43 20.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.007 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -84.2 125.51 32.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 118.754 0.706 . . . . 0.0 111.526 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -121.95 139.29 53.84 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.539 0.736 . . . . 0.0 112.194 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 2.6 mm? -102.0 120.03 39.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.733 -169.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.05 120.88 45.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -77.65 76.78 4.18 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.822 0.82 . . . . 0.0 112.215 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.1 mt 55.67 27.88 11.25 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 162.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.92 2.35 11.29 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 114.245 0.458 . . . . 0.0 114.245 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -78.21 109.41 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.754 -0.851 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -116.53 87.9 22.41 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.61 169.45 12.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 N-CA-C 109.916 -0.84 . . . . 0.0 109.916 169.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -54.86 -40.19 69.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.196 0.453 . . . . 0.0 111.303 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -62.15 -39.04 91.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.53 -22.25 35.07 Favored 'General case' 0 C--O 1.212 -0.888 0 O-C-N 120.604 -1.31 . . . . 0.0 112.777 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.9 tp -68.22 -40.16 82.15 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 120.009 -1.682 . . . . 0.0 111.216 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.05 -35.2 71.86 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.346 -0.846 . . . . 0.0 112.846 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mt -117.62 22.59 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 121.478 0.656 . . . . 0.0 111.485 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -147.45 119.86 4.72 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.047 -1.658 . . . . 0.0 108.483 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.34 -13.66 37.36 Favored 'Trans proline' 0 C--N 1.352 0.731 0 N-CA-C 118.689 2.534 . . . . 0.0 118.689 -173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -120.83 7.34 10.43 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.92 -0.488 . . . . 0.0 110.117 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.16 2.07 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-O 122.641 1.134 . . . . 0.0 113.143 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -134.07 99.31 4.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.57 146.18 16.17 Favored Pre-proline 0 C--N 1.318 -0.778 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 170.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.9 142.09 38.26 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 116.868 -1.621 . . . . 0.0 111.982 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.81 131.63 50.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.152 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.91 129.9 36.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.41 71.91 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.175 0.988 . . . . 0.0 108.658 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.2 mt -87.66 126.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 54.97 35.58 24.91 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.478 1.111 . . . . 0.0 112.984 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t0 61.62 25.07 15.05 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -115.46 150.59 36.24 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.08 135.98 53.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -172.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.65 123.17 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -174.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.33 8.76 1.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -165.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -99.41 147.67 25.01 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.025 -1.672 . . . . 0.0 109.946 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.2 p -58.72 -33.52 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -83.23 -13.22 55.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.045 1.402 . . . . 0.0 111.615 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.7 -32.23 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.842 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -66.96 -15.61 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 121.759 -0.588 . . . . 0.0 111.177 161.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.0 t -83.2 -46.24 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 120.333 -1.479 . . . . 0.0 110.418 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.74 2.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 121.164 3.225 . . . . 0.0 121.164 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.4 mt -80.95 -26.89 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.78 -1.424 . . . . 0.0 110.558 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.91 -48.3 75.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.71 -39.99 95.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.315 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.68 -34.48 77.2 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.846 -0.534 . . . . 0.0 111.64 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -97.0 -1.33 45.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -82.68 132.37 52.02 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.57 -9.92 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 115.517 -2.522 . . . . 0.0 114.833 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -74.24 158.1 85.86 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.62 124.58 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 116.138 -2.108 . . . . 0.0 115.658 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.37 144.29 28.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 120.641 0.894 . . . . 0.0 112.856 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -138.94 45.1 2.01 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.022 0.915 . . . . 0.0 109.367 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.06 90.44 2.49 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m -125.63 90.74 49.99 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.212 1.005 . . . . 0.0 110.282 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -100.63 63.56 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 1 C-N-CA 125.687 4.258 . . . . 0.0 119.351 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -87.05 -128.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 CA-C-N 119.918 1.006 . . . . 0.0 114.637 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.54 -38.52 74.87 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.921 1.691 . . . . 0.0 113.745 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -64.68 -25.13 67.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.117 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.92 -32.98 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.4 -0.813 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.8 p -75.0 -33.89 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.38 -45.44 82.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.07 83.97 Favored Glycine 0 C--O 1.229 -0.21 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.61 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.3 p -63.28 -17.0 62.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.0 -27.53 13.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.6 mt -79.36 -44.78 23.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -53.36 -48.79 91.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.35 -27.9 10.91 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 111.645 -5.103 . . . . 0.0 113.507 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -67.15 -44.62 79.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -70.85 -20.65 62.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.058 -1.057 . . . . 0.0 112.703 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.2 t -85.35 -41.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -59.27 -46.97 87.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.046 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.68 -24.21 53.18 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -27.27 61.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.268 0.94 . . . . 0.0 110.994 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.98 -3.45 58.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.348 0.659 . . . . 0.0 111.641 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.3 t -121.25 121.96 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -167.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.03 41.79 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.93 -177.54 0.33 Allowed Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.504 1.121 . . . . 0.0 108.848 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.27 61.03 0.5 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 156.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -86.29 80.01 8.87 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.153 -1.592 . . . . 0.0 107.4 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -118.78 -65.35 1.18 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.45 -44.27 96.98 Favored Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.335 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -77.7 -8.79 58.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.28 -32.62 55.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.954 -1.716 . . . . 0.0 106.432 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -79.28 -9.81 59.67 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 120.956 -1.09 . . . . 0.0 111.237 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.84 74.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 165.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.74 -42.51 90.9 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.829 -1.169 . . . . 0.0 109.956 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 tp -56.46 -44.28 80.38 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.59 -27.86 68.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -81.45 -34.21 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.111 -0.993 . . . . 0.0 110.581 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -73.15 -23.58 60.47 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.0 110.481 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -68.31 -29.75 68.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.857 -0.527 . . . . 0.0 110.308 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.66 85.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.63 -39.01 80.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.99 -41.11 91.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.57 0.748 . . . . 0.0 110.027 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.65 -41.76 56.2 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.013 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -62.21 -32.62 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.65 -55.08 11.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.086 0.946 . . . . 0.0 112.624 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -76.67 -10.4 59.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.73 -0.606 . . . . 0.0 112.423 -159.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -79.81 -8.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.67 -40.75 2.86 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.33 -66.53 0.25 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.65 -169.74 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 125.174 3.916 . . . . 0.0 115.689 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -57.82 165.45 1.74 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.086 0.955 . . . . 0.0 111.841 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 pt -65.81 -21.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -146.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.92 -13.29 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.31 -11.42 61.73 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.86 -45.21 0.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -164.17 -179.32 6.08 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.89 121.46 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.4 m -138.95 179.39 6.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -38.75 -38.76 0.44 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -69.13 -39.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 120.741 -1.224 . . . . 0.0 111.792 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.84 -39.5 72.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.26 -7.21 28.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.4 p -104.55 -45.36 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.212 -0.423 . . . . 0.0 112.017 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.48 -50.94 12.76 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.16 81.17 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.02 -18.75 52.01 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 113.605 -3.797 . . . . 0.0 117.317 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -94.74 -24.41 17.12 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.346 -1.471 . . . . 0.0 109.401 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.72 -25.93 67.52 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.396 -0.815 . . . . 0.0 111.902 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -49.0 59.02 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.186 0.903 . . . . 0.0 110.318 166.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -72.98 -21.14 60.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.59 -50.11 70.74 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 122.228 0.211 . . . . 0.0 111.177 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -72.04 -20.66 61.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.806 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.6 t -78.83 -57.35 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.48 -52.26 28.31 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.69 -42.2 91.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.663 0.744 . . . . 0.0 110.642 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.29 -32.35 82.43 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -90.88 -38.33 12.99 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.205 -1.173 . . . . 0.0 114.101 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -81.82 -46.44 14.15 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -145.4 70.49 1.26 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -165.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -53.71 117.77 3.41 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -143.53 89.06 7.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.65 161.94 40.84 Favored 'Trans proline' 0 C--O 1.235 0.34 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.19 127.23 92.42 Favored Pre-proline 0 C--O 1.245 0.852 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.47 154.89 45.49 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.695 -1.736 . . . . 0.0 112.092 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.8 -2.72 31.24 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.563 -0.711 . . . . 0.0 110.731 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -69.5 -21.49 63.67 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.69 -0.631 . . . . 0.0 111.586 166.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.51 65.21 0.71 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.4 m -57.39 -34.95 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.992 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -53.86 53.5 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.569 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.2 t -68.43 -34.86 68.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -168.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.97 -52.0 65.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.351 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.35 -41.55 96.7 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.278 -0.264 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -60.63 -52.01 66.98 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.39 -37.48 79.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 121.859 -0.526 . . . . 0.0 111.312 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.93 -41.78 99.59 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.445 0.64 . . . . 0.0 112.433 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.0 mt -71.52 -40.36 70.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.01 -20.0 63.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.124 0.488 . . . . 0.0 111.429 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.72 -27.91 69.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.419 -0.801 . . . . 0.0 112.373 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 t -136.99 69.93 1.41 Allowed 'General case' 0 C--O 1.243 0.758 0 O-C-N 121.43 -0.794 . . . . 0.0 112.771 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -125.9 138.79 53.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 162.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -59.43 -37.99 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.81 1.641 . . . . 0.0 113.188 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -37.31 78.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -85.16 -34.87 22.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.093 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -70.56 -42.34 71.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.33 -35.2 73.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.688 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.4 p -77.2 -19.29 56.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.896 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -51.96 122.77 8.96 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.248 0.619 . . . . 0.0 111.626 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.15 173.07 9.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.547 0.739 . . . . 0.0 110.308 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.71 126.96 31.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.9 -29.64 69.71 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.587 -0.695 . . . . 0.0 112.242 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.12 -35.68 79.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.145 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -85.77 -6.78 59.06 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.83 -54.3 7.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.0 mt -68.7 -61.39 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.932 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.32 -3.26 39.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.843 -0.536 . . . . 0.0 110.852 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.82 -13.3 61.11 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -99.17 -21.18 16.25 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.911 1.356 . . . . 0.0 111.803 166.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.4 -8.18 0.13 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.34 -17.43 30.77 Favored 'Trans proline' 0 C--N 1.362 1.268 1 C-N-CA 110.851 -5.633 . . . . 0.0 112.852 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -85.33 1.98 46.12 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.978 0.511 . . . . 0.0 111.699 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.18 -44.41 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.419 0.688 . . . . 0.0 111.793 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -71.43 -25.24 62.24 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.689 -0.632 . . . . 0.0 110.275 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.788 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.34 159.6 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.98 172.81 13.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.745 -171.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.88 159.65 40.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.5 mt -129.98 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.57 157.49 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -167.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.21 128.85 34.01 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.175 -0.953 . . . . 0.0 108.622 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.17 158.42 16.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 140.18 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.362 170.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.57 126.85 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.11 0.2 60.4 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 78.15 4.01 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.75 1.775 . . . . 0.0 114.917 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.82 90.79 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 N-CA-C 116.925 1.856 . . . . 0.0 116.925 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -157.25 -49.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.82 157.25 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 103.323 -2.843 . . . . 0.0 103.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.46 166.91 15.14 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.486 1.114 . . . . 0.0 111.739 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.11 -173.82 16.22 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -76.66 99.05 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 122.471 1.129 . . . . 0.0 110.833 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.17 136.07 17.82 Favored Pre-proline 0 C--N 1.319 -0.74 1 N-CA-C 100.134 -4.025 . . . . 0.0 100.134 162.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.29 -36.65 34.89 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 116.22 -2.053 . . . . 0.0 112.047 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -72.57 -26.0 61.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.112 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.54 -41.71 92.75 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.432 1.111 . . . . 0.0 109.863 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.98 -33.77 63.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.518 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.57 -45.99 84.52 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.148 1.34 . . . . 0.0 111.779 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.67 -35.34 65.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.479 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.55 -46.7 25.32 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.316 -0.865 . . . . 0.0 112.941 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -39.6 94.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -64.3 -43.59 94.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 112.084 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -27.14 28.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -75.45 -31.63 60.36 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 118.486 0.584 . . . . 0.0 111.041 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.52 -37.98 89.42 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.388 -1.445 . . . . 0.0 109.515 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.65 -20.4 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 51.56 40.13 26.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 112.346 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.18 135.38 73.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.64 140.95 89.35 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 115.733 -2.378 . . . . 0.0 114.215 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -148.53 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -114.53 124.51 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 167.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -90.82 149.6 21.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -135.28 133.33 38.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.38 110.79 21.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.16 109.2 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.27 78.23 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.709 0.766 . . . . 0.0 112.957 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt 55.27 54.39 8.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.7 160.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.88 15.22 58.26 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.207 -0.906 . . . . 0.0 114.39 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -74.41 114.91 13.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.342 1.071 . . . . 0.0 108.482 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 89.04 11.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -67.45 176.3 5.04 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 115.989 -2.208 . . . . 0.0 109.164 166.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -54.95 -31.45 60.51 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.553 -0.717 . . . . 0.0 112.56 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -56.98 -51.45 69.16 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.964 0.802 . . . . 0.0 112.608 172.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.25 -24.38 61.36 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 120.285 -1.509 . . . . 0.0 111.513 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.24 -35.24 77.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.603 -0.686 . . . . 0.0 112.093 170.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -67.4 -42.74 82.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.458 -0.776 . . . . 0.0 110.134 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.12 -51.79 16.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -104.63 126.41 31.39 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -65.11 -31.91 53.75 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -90.39 -4.41 57.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 120.63 -1.294 . . . . 0.0 110.244 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.93 -34.78 2.34 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-O 121.418 0.454 . . . . 0.0 112.478 -166.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -112.03 0.87 16.13 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 118.993 2.96 . . . . 0.0 118.993 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.0 147.05 72.92 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 120.145 1.338 . . . . 0.0 108.145 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.54 151.15 58.56 Favored 'Trans proline' 0 C--N 1.345 0.394 0 O-C-N 122.721 0.853 . . . . 0.0 111.495 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.87 162.6 20.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.769 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.65 128.44 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -85.49 96.33 9.57 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.73 97.76 7.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 121.014 1.734 . . . . 0.0 106.816 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.36 46.39 25.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.108 0.563 . . . . 0.0 112.507 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 71.86 4.6 5.09 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.67 2.388 . . . . 0.0 115.842 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.21 108.4 19.89 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -94.54 134.46 37.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.148 -166.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.21 134.3 65.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.0 -28.31 2.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -75.97 131.18 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.4 p -67.54 -23.12 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -95.67 -21.32 18.27 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.748 -0.595 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.08 -34.55 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.99 -24.85 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.16 -32.68 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 120.446 -1.408 . . . . 0.0 110.166 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.9 -54.81 0.42 Allowed Glycine 0 C--O 1.226 -0.386 0 N-CA-C 119.609 2.604 . . . . 0.0 119.609 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.82 -31.02 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.211 1.505 . . . . 0.0 110.885 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.88 -34.7 76.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.846 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -73.36 -38.63 65.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.884 -0.51 . . . . 0.0 111.446 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.63 -31.91 73.22 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.411 -0.805 . . . . 0.0 113.127 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 5.4 43.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -98.31 135.45 21.25 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.28 -8.87 24.64 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 116.485 -1.877 . . . . 0.0 116.67 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.05 160.15 76.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.365 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.86 137.14 65.9 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 114.86 -2.96 . . . . 0.0 114.191 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.57 88.59 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 115.967 1.487 . . . . 0.0 115.967 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.59 63.67 7.7 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 120.483 -1.386 . . . . 0.0 112.471 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.73 86.06 2.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 m -125.76 87.74 55.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.575 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -98.61 48.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 122.185 3.879 . . . . 0.0 122.185 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -80.35 -117.93 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.677 1.278 . . . . 0.0 112.289 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -53.42 -35.43 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.11 -37.56 87.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.78 0.8 . . . . 0.0 109.925 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.88 42.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.818 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -67.95 -32.29 72.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.76 -50.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.8 96.39 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.467 -0.873 . . . . 0.0 115.083 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.0 p -73.52 -8.33 55.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -80.01 -35.42 37.37 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.02 -1.05 . . . . 0.0 110.568 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.98 -37.32 9.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.633 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.65 -54.22 38.18 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.93 -24.39 13.01 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 113.423 -3.918 . . . . 0.0 113.036 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -71.73 -39.53 70.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HD13 ' A' ' 123' ' ' LEU . 3.3 p90 -75.53 -26.15 57.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.787 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.71 -28.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 120.898 -1.126 . . . . 0.0 109.245 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.53 -42.77 99.74 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.768 -1.207 . . . . 0.0 109.444 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -65.21 -40.22 93.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.814 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.92 -39.1 90.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -76.16 -11.04 59.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -87.09 141.99 28.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -127.91 27.79 5.66 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -72.4 170.78 11.62 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.2 52.21 1.85 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-O 122.926 1.136 . . . . 0.0 114.378 167.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -83.67 38.55 0.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -140.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -67.25 -24.71 65.83 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.52 90.73 Favored Glycine 0 N--CA 1.454 -0.123 0 O-C-N 120.835 -1.165 . . . . 0.0 111.325 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 m -74.34 -30.57 62.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.862 -0.787 . . . . 0.0 110.16 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -66.45 -34.51 78.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.862 0.839 . . . . 0.0 111.02 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -76.31 -30.35 57.7 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.64 96.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.296 -0.878 . . . . 0.0 109.523 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 17.0 tp -63.73 -47.3 81.61 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.98 -43.58 98.6 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.481 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.46 -44.25 83.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.893 0.77 . . . . 0.0 112.11 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.98 -27.72 54.84 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.116 -0.99 . . . . 0.0 112.347 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.01 -22.95 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.634 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -71.7 -31.13 66.42 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.101 -0.999 . . . . 0.0 109.998 168.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.68 90.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 122.0 -0.437 . . . . 0.0 112.11 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.07 -36.81 80.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.632 0.73 . . . . 0.0 110.73 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.26 -52.63 38.87 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.514 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -56.76 -42.29 79.09 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.051 -0.676 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.54 -45.14 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.13 -27.08 62.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.146 1.339 . . . . 0.0 112.677 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.08 -33.84 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 122.808 0.443 . . . . 0.0 110.318 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.56 -35.12 8.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.76 -75.02 0.24 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-O 117.381 -1.788 . . . . 0.0 116.553 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -61.55 -159.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 126.428 4.752 . . . . 0.0 118.994 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.59 167.43 1.47 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.519 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -45.5 -32.74 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.57 -7.55 39.51 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.779 -1.2 . . . . 0.0 114.236 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.05 3.71 90.64 Favored Glycine 0 CA--C 1.511 -0.203 0 O-C-N 121.672 -0.643 . . . . 0.0 113.327 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -142.39 -61.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -158.28 176.01 13.01 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.2 mm -63.12 127.98 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.0 m -142.71 161.98 36.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -171.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.27 -22.97 45.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.61 -23.61 29.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.66 -40.96 22.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.1 mt -70.79 -12.22 61.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.217 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.9 p -96.13 -23.73 16.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.2 tp -100.41 -49.17 4.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.31 -40.7 70.18 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.59 -38.63 93.01 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 114.637 -3.109 . . . . 0.0 118.259 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -87.93 -22.05 24.57 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.366 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.62 -37.74 85.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.095 1.316 . . . . 0.0 111.579 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.6 -50.27 71.93 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.801 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -63.83 -33.37 75.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.446 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.3 tp -63.47 -52.47 61.22 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.728 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.08 -34.59 78.37 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.714 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.83 -54.05 21.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.997 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.22 -44.18 63.31 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.283 -0.885 . . . . 0.0 111.693 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.15 -37.4 75.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.64 -36.57 93.44 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -75.98 -51.64 11.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.206 -1.173 . . . . 0.0 113.028 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -80.54 -36.99 32.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -146.89 53.07 1.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -171.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -34.38 102.79 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -157.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -142.7 85.41 10.22 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 169.74 21.86 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 116.296 -2.002 . . . . 0.0 109.019 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.4 mm -73.25 124.19 90.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.47 163.6 31.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 116.06 -2.16 . . . . 0.0 113.634 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.85 -4.65 36.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.491 -0.756 . . . . 0.0 112.112 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.25 -21.2 66.5 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.09 -1.006 . . . . 0.0 110.123 165.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.53 57.04 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.7 m -57.37 -34.64 69.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.088 -0.383 . . . . 0.0 111.289 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -68.79 -40.66 79.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.88 -43.03 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.137 0.494 . . . . 0.0 110.256 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.93 -43.5 92.58 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.768 -0.583 . . . . 0.0 111.788 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -69.36 -34.33 74.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.609 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -59.07 -49.31 78.36 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.84 -36.64 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.272 -0.893 . . . . 0.0 111.809 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.28 -37.81 88.81 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.523 -1.361 . . . . 0.0 112.592 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.84 -43.98 97.35 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.0 mt -65.77 -41.9 91.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.881 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.35 -33.48 65.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.1 m -115.98 18.49 15.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -66.66 139.61 57.87 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.89 -43.68 81.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.995 0.816 . . . . 0.0 112.545 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 p -67.13 -41.23 86.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -42.75 49.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.661 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 196' ' ' ARG . 37.6 ttmt -52.83 -44.92 67.07 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.544 -0.723 . . . . 0.0 112.003 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.17 -43.11 99.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.471 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 50.8 p -96.5 -4.04 42.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 193' ' ' LYS . 55.9 mtp180 -56.14 133.61 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.31 148.48 50.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.83 134.7 56.64 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.443 0.464 . . . . 0.0 109.829 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.53 -34.3 72.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.74 -32.45 70.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.139 0.971 . . . . 0.0 111.423 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -94.78 -21.36 18.78 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.415 -0.803 . . . . 0.0 111.941 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.33 -42.41 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.7 -74.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.35 63.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.67 -25.27 33.13 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.06 -0.59 . . . . 0.0 114.143 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 -22.16 12.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.912 0.856 . . . . 0.0 113.177 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.59 -17.37 0.37 Allowed Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.81 -21.18 44.86 Favored 'Trans proline' 0 C--N 1.36 1.132 1 C-N-CA 111.043 -5.504 . . . . 0.0 115.402 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -77.95 -24.06 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.55 -32.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -82.59 9.65 8.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.949 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.806 0 C-N-CA 126.569 1.948 . . . . 0.0 114.375 -178.349 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.34 -170.8 0.11 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.288 1.435 . . . . 0.0 113.472 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.04 161.96 37.45 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.75 146.82 44.47 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 121.922 -0.486 . . . . 0.0 110.518 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.8 mt -111.23 98.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.8 t -101.82 108.71 20.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.7 m -132.58 162.49 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.33 142.64 56.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -97.41 167.8 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.174 0.443 . . . . 0.0 110.741 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.97 58.37 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.86 112.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.27 85.46 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 114.634 -1.166 . . . . 0.0 115.461 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.7 82.36 7.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.008 0.904 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.25 43.24 0.71 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 124.666 3.577 . . . . 0.0 115.938 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.78 -8.1 2.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.86 156.57 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.68 154.0 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.26 174.32 45.23 Favored Glycine 0 C--O 1.238 0.345 0 N-CA-C 120.787 3.075 . . . . 0.0 120.787 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.37 75.68 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.755 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.95 133.68 21.18 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.41 -40.56 56.65 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-O 123.092 1.205 . . . . 0.0 111.445 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -77.79 -17.84 57.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -60.8 -48.83 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 111.292 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.17 -12.48 60.9 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.273 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -59.18 -48.92 79.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.958 1.708 . . . . 0.0 109.029 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.74 -50.44 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.206 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.66 -41.84 91.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.053 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.95 -45.87 83.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.1 p -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.509 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 -32.49 33.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.246 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -68.66 -38.14 80.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 118.741 0.7 . . . . 0.0 112.454 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.15 -28.78 69.05 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 120.916 -1.115 . . . . 0.0 111.134 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -91.58 -12.91 32.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 53.17 33.8 16.04 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -81.61 151.97 69.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.87 143.11 44.62 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 115.419 -2.587 . . . . 0.0 112.874 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -150.97 162.5 40.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -124.53 112.35 16.75 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.1 t -80.52 133.06 35.76 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -114.68 130.7 56.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 3.8 mm? -109.69 121.04 44.33 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -172.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.67 104.18 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.37 90.09 0.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.189 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt 49.25 49.99 18.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.724 1.209 . . . . 0.0 113.784 174.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.33 43.47 38.21 Favored Glycine 0 C--O 1.229 -0.217 0 C-N-CA 119.845 -1.169 . . . . 0.0 112.966 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -75.81 84.25 2.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 161.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -115.47 95.69 43.83 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.383 0.673 . . . . 0.0 111.598 -160.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 169.98 18.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 N-CA-C 109.902 -0.845 . . . . 0.0 109.902 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -55.84 -32.65 63.78 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 0.506 . . . . 0.0 111.768 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -55.07 -52.54 62.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.46 -24.44 59.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 120.882 -1.136 . . . . 0.0 111.478 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.29 -32.17 73.42 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.239 0.543 . . . . 0.0 111.405 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -74.43 -39.23 62.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.663 0.744 . . . . 0.0 111.468 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.41 -37.01 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 t -121.54 143.0 36.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.91 -37.35 86.3 Favored 'Trans proline' 0 C--N 1.355 0.917 0 N-CA-C 116.207 1.579 . . . . 0.0 116.207 170.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -93.96 -21.13 19.39 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.109 -0.994 . . . . 0.0 111.941 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 4.63 90.37 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-O 122.189 0.883 . . . . 0.0 111.513 -167.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -160.68 75.19 0.54 Allowed 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.859 1.264 . . . . 0.0 109.808 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.5 160.52 63.99 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 135.48 32.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 113.473 -3.884 . . . . 0.0 112.382 165.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.35 141.69 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.58 126.34 54.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -92.7 91.06 7.34 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.61 85.09 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.5 t0 53.62 60.07 3.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.294 1.045 . . . . 0.0 112.041 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 67.49 3.69 3.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.751 1.62 . . . . 0.0 115.265 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -103.34 99.77 9.62 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.159 -0.963 . . . . 0.0 109.034 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -80.57 134.71 35.96 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.475 0.71 . . . . 0.0 111.776 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.12 126.15 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.736 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.76 80.91 1.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -148.54 145.33 27.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 162.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -58.37 -34.26 70.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -81.24 -18.17 46.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.57 -20.33 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.14 -9.91 12.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.45 -60.45 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 162.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.89 -36.35 90.94 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.6 mt -86.17 -27.7 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 120.869 -1.371 . . . . 0.0 107.94 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.41 -39.28 94.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.89 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.72 -37.61 87.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.974 0.806 . . . . 0.0 110.788 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.06 -28.42 68.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.771 1.272 . . . . 0.0 112.006 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -102.77 1.64 34.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.505 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -75.56 143.04 74.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.184 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 -16.78 12.87 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 115.59 1.342 . . . . 0.0 115.59 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -90.67 161.79 35.36 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 103.544 -2.762 . . . . 0.0 103.544 174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.06 142.44 97.21 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 N-CA-C 119.135 2.706 . . . . 0.0 119.135 -163.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.48 106.76 2.32 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 121.585 1.523 . . . . 0.0 115.907 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.04 40.72 2.57 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 122.068 0.937 . . . . 0.0 112.745 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 79.77 5.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.308 -1.495 . . . . 0.0 112.34 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -118.93 94.54 48.25 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.08 82.18 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 124.33 3.353 . . . . 0.0 119.974 165.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.56 -146.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.392 1.395 . . . . 0.0 111.635 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -46.25 -40.32 11.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -62.79 -27.97 69.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.11 -29.04 61.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 76.8 p -76.19 -31.4 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.485 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.06 -40.63 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.546 -1.206 . . . . 0.0 114.131 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.1 p -66.98 -11.16 55.98 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -98.13 -34.01 10.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.2 pt -75.27 -30.85 23.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.042 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.73 -56.15 10.06 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -167.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.91 -20.62 16.9 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 114.618 -3.122 . . . . 0.0 113.661 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.9 t -64.29 -43.29 95.2 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.16 0.984 . . . . 0.0 111.647 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -37.83 84.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.042 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 107' ' ' VAL . 0.5 OUTLIER -67.3 -38.58 81.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.207 176.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.2 -44.93 95.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.315 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.63 -27.69 61.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.8 -46.03 91.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.232 0.923 . . . . 0.0 112.166 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -72.5 -22.41 61.05 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.066 0.936 . . . . 0.0 112.234 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 t -86.3 143.06 28.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -127.9 32.99 4.85 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 123.44 1.59 . . . . 0.0 109.333 164.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.21 170.8 7.95 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.0 47.02 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.12 101.47 13.83 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.1 -45.01 1.14 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.257 0.623 . . . . 0.0 111.795 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.8 -21.03 79.03 Favored Glycine 0 C--O 1.236 0.248 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.5 p -93.72 -11.97 30.28 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 168.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -67.04 -34.97 78.85 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 119.528 -1.983 . . . . 0.0 105.799 162.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -79.34 3.28 18.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.332 -0.855 . . . . 0.0 113.167 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.45 -28.56 61.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.33 -37.47 85.75 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.959 -1.088 . . . . 0.0 109.925 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.5 tp -61.91 -36.14 80.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.459 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -78.52 -34.88 46.95 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -72.8 -39.26 66.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.711 -1.868 . . . . 0.0 110.266 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 110.444 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -64.06 -35.52 81.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.924 0.783 . . . . 0.0 109.372 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.43 81.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.73 -42.73 97.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.579 -0.701 . . . . 0.0 110.737 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.366 1.066 . . . . 0.0 112.455 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.91 -36.52 41.43 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.578 -0.701 . . . . 0.0 114.01 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.63 -28.13 66.63 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.65 -52.8 27.23 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.392 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.35 -19.44 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.05 -9.14 12.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -113.51 -53.4 2.7 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.69 -59.04 0.47 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -71.39 -164.77 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.959 3.106 . . . . 0.0 115.062 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -54.9 160.07 2.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.7 tp -61.53 -22.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -163.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.23 -11.46 60.91 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.295 -1.503 . . . . 0.0 114.076 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.82 -26.76 8.69 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.12 -44.27 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -161.88 -177.03 5.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.396 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.44 109.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.8 m -128.79 -174.37 3.23 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 147' ' ' THR . . . -47.14 -38.26 11.32 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.31 -46.75 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 118.868 0.758 . . . . 0.0 110.158 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.92 -39.76 75.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.462 0.649 . . . . 0.0 110.349 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.69 -24.39 66.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.686 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.5 m -82.03 -36.6 27.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 83.6 mt -97.87 -46.25 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.55 36.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.56 -33.96 43.95 Favored 'Trans proline' 0 C--N 1.353 0.8 1 C-N-CA 112.067 -4.822 . . . . 0.0 115.629 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -80.87 -28.32 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.41 -1.432 . . . . 0.0 109.358 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.8 mt -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.244 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.03 -49.92 75.75 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.053 0.842 . . . . 0.0 111.68 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -64.2 -31.77 73.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -54.03 16.53 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 121.598 -0.688 . . . . 0.0 109.713 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -30.8 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.02 -35.4 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.076 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.56 -43.54 15.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.46 -36.6 84.39 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.408 0.683 . . . . 0.0 109.624 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.72 -35.17 91.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.539 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -74.47 -51.19 15.54 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.778 -0.837 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -77.67 -47.4 19.31 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -149.42 74.94 1.26 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -168.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.69 115.97 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -161.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -131.83 97.12 19.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 148.5 46.44 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 115.644 -2.437 . . . . 0.0 113.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.32 120.75 72.65 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -71.23 167.44 26.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 N-CA-C 116.776 1.798 . . . . 0.0 116.776 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.98 -16.34 63.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.958 0.903 . . . . 0.0 111.169 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -72.64 -13.52 61.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.516 0.726 . . . . 0.0 111.963 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.53 52.06 1.0 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -25.8 68.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -54.41 43.55 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.73 -36.08 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.62 -49.25 78.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -69.23 -37.27 77.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.821 0.343 . . . . 0.0 111.772 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -62.17 -49.2 76.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.81 0.844 . . . . 0.0 110.136 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 80.4 mt -71.95 -29.55 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.268 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.47 -46.21 87.24 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.966 -1.084 . . . . 0.0 111.277 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.59 -35.28 78.68 Favored 'General case' 0 C--O 1.216 -0.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.543 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.97 -37.07 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.029 0.918 . . . . 0.0 110.417 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -67.32 -27.56 67.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.64 -0.663 . . . . 0.0 111.338 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 t -145.35 72.81 1.33 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.989 0.899 . . . . 0.0 112.712 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -127.15 139.84 52.68 Favored 'General case' 0 N--CA 1.468 0.452 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 168.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -60.57 -39.68 88.89 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.7 p -61.57 -33.45 73.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.883 0.849 . . . . 0.0 112.681 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.4 -36.12 20.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.255 0.55 . . . . 0.0 110.892 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -62.47 -38.94 91.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.47 -28.6 46.54 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.236 1.017 . . . . 0.0 112.567 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 p -95.4 -0.48 52.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -61.44 144.98 53.2 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.37 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.56 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 134.31 48.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.14 -42.39 89.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 111.747 -167.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -62.14 -22.92 66.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.72 -9.42 46.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.56 -0.712 . . . . 0.0 110.762 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.46 -43.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 168.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -60.58 -66.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.25 0.548 . . . . 0.0 109.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.99 60.64 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.932 -1.105 . . . . 0.0 111.643 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.71 -26.6 45.44 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.285 -0.959 . . . . 0.0 114.113 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -88.23 -38.89 14.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.461 1.124 . . . . 0.0 109.42 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.91 -18.05 0.43 Allowed Pre-proline 0 C--N 1.321 -0.636 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.355 0.87 1 C-N-CA 110.516 -5.856 . . . . 0.0 114.403 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -73.28 -31.37 64.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.2 t -84.05 -46.87 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.595 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -79.07 -30.17 43.79 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -171.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.619 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.501 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.1 163.51 27.5 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -155.81 170.0 23.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.55 0.614 . . . . 0.0 111.621 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -108.24 137.84 45.54 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 30' ' ' LEU . 56.1 mt -110.27 117.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 173.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 m -110.71 129.66 55.77 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.77 159.99 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.16 130.02 41.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.94 0.496 . . . . 0.0 110.005 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -73.88 170.97 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 111.84 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 132.11 49.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.165 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.65 112.85 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.79 -28.8 6.04 Favored Glycine 0 C--O 1.242 0.652 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.417 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.24 93.39 2.7 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.278 1.031 . . . . 0.0 112.594 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.27 72.87 5.24 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 121.181 1.254 . . . . 0.0 114.873 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -142.98 13.44 1.86 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.384 -1.448 . . . . 0.0 111.77 166.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.69 152.93 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 1 N-CA-C 99.409 -4.293 . . . . 0.0 99.409 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 3.5 pp -65.37 158.43 26.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.938 1.295 . . . . 0.0 112.404 169.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.1 175.78 15.85 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -79.11 90.92 4.86 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.555 1.169 . . . . 0.0 109.958 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 124.94 29.15 Favored Pre-proline 0 C--N 1.319 -0.739 1 N-CA-C 97.161 -5.125 . . . . 0.0 97.161 161.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -66.42 -30.04 44.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 115.63 -2.446 . . . . 0.0 116.121 -168.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.73 -24.72 53.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.779 -0.575 . . . . 0.0 111.445 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.56 -40.72 97.74 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 123.121 1.439 . . . . 0.0 110.217 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -72.47 -16.01 61.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.587 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.15 -34.97 75.83 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.283 -0.885 . . . . 0.0 110.442 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.19 -41.36 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 122.554 1.169 . . . . 0.0 107.957 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.46 -44.93 85.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.816 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.17 -43.53 91.42 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.485 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -67.43 -39.2 85.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.428 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 5' ' ' ILE . 3.0 mp -71.95 -38.19 69.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.31 -26.58 62.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.111 0.414 . . . . 0.0 110.892 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -39.0 73.53 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.217 -0.927 . . . . 0.0 112.706 169.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -79.93 -10.03 59.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.509 -0.744 . . . . 0.0 112.66 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 55.44 35.51 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.749 1.219 . . . . 0.0 111.946 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 pt -89.05 154.78 49.73 Favored Pre-proline 0 C--O 1.242 0.701 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.93 153.21 58.18 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 114.215 -3.39 . . . . 0.0 112.666 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.04 157.26 41.42 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.68 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.88 118.16 33.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 171.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.9 t -91.02 120.46 32.03 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -114.2 112.45 23.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.426 1.108 . . . . 0.0 110.913 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.1 mt -96.57 109.93 22.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.407 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -83.36 116.41 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -72.33 54.07 0.3 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.658 1.983 . . . . 0.0 114.821 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt 54.4 54.46 9.38 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.856 1.663 . . . . 0.0 109.183 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.29 70.41 1.22 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.5 116.36 28.95 Favored 'General case' 0 C--N 1.32 -0.686 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 163.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -123.78 60.08 19.1 Favored Pre-proline 0 C--O 1.248 0.983 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.87 174.68 11.93 Favored 'Trans proline' 0 C--O 1.239 0.555 1 C-N-CA 113.118 -4.121 . . . . 0.0 110.41 161.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -55.0 -36.46 65.46 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.774 0.43 . . . . 0.0 110.572 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -55.8 -52.58 63.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -74.99 -27.2 60.06 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.213 -0.929 . . . . 0.0 111.817 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.03 -32.04 72.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.594 1.088 . . . . 0.0 111.624 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.91 -39.42 83.57 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.734 -0.604 . . . . 0.0 109.864 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.95 -37.23 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.85 0.86 . . . . 0.0 112.408 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -128.46 128.15 23.61 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.3 -14.3 31.21 Favored 'Trans proline' 0 C--O 1.242 0.714 0 N-CA-C 118.148 2.326 . . . . 0.0 118.148 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -102.97 -7.65 21.28 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.088 0.858 . . . . 0.0 110.767 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.8 8.23 72.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -159.86 55.64 0.37 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.382 1.073 . . . . 0.0 111.851 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.45 155.66 81.17 Favored Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 120.736 -1.228 . . . . 0.0 109.635 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.19 148.14 30.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 114.387 -3.275 . . . . 0.0 113.83 168.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.17 166.0 30.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.96 123.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 154.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -114.4 95.02 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mt -101.23 122.92 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 50.64 43.58 27.67 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.004 0.522 . . . . 0.0 111.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 68.39 12.87 8.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.13 2.641 . . . . 0.0 118.13 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -115.76 122.86 46.73 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.695 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -104.65 147.12 28.01 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -124.58 152.09 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.42 38.9 0.64 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 119.29 3.07 . . . . 0.0 119.29 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.19 153.72 31.34 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.882 1.673 . . . . 0.0 107.867 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -58.43 -32.65 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.54 -40.72 41.59 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.82 -0.55 . . . . 0.0 111.651 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -82.03 -20.31 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.2 pt -71.46 -3.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.854 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.55 -48.34 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 159.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.24 -36.31 91.57 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.0 mt -87.01 -30.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 120.227 2.013 . . . . 0.0 106.065 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.53 -49.42 74.81 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.656 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -60.5 -37.25 80.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.441 1.473 . . . . 0.0 112.255 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.5 -21.12 64.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -112.46 -6.34 14.0 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -76.79 135.55 67.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.55 -19.85 27.77 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 116.545 1.71 . . . . 0.0 116.545 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -75.7 160.89 78.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.029 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.44 129.19 33.84 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.78 130.32 3.67 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 N-CA-C 116.683 1.763 . . . . 0.0 116.683 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB3' HG23 ' A' ' 147' ' ' THR . 95.7 mt -125.92 48.5 2.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.72 1.208 . . . . 0.0 112.617 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.53 75.18 10.3 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.081 -1.637 . . . . 0.0 108.58 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -116.29 102.42 53.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.15 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -108.32 72.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.208 3.272 . . . . 0.0 118.21 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -82.36 -148.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 1 C-N-CA 125.681 4.254 . . . . 0.0 111.177 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.54 -29.95 28.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.71 -25.23 65.56 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 120.334 -1.479 . . . . 0.0 113.275 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.97 -34.04 59.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.8 p -72.29 -35.69 68.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -45.09 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.1 82.91 Favored Glycine 0 C--O 1.229 -0.162 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.793 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 p -70.18 -13.95 62.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -82.3 -40.6 21.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.481 -0.762 . . . . 0.0 109.671 170.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.36 -33.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 74.9 t80 -54.65 -51.87 74.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.98 -25.42 16.34 Favored 'Trans proline' 0 C--N 1.351 0.669 1 C-N-CA 112.615 -4.457 . . . . 0.0 114.042 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -69.0 -38.55 79.34 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE 0.262 0.4 OUTLIER -77.7 -27.23 50.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 118.511 -1.276 . . . . 0.0 113.703 178.806 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.74 -28.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.576 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -61.19 -44.77 96.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.492 -0.755 . . . . 0.0 110.944 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -65.7 -41.26 92.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.84 -38.91 83.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.993 -0.442 . . . . 0.0 111.615 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.4 27.35 1.47 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 t -121.13 122.0 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -113.75 26.5 10.3 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.34 168.2 30.0 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.06 94.28 0.73 Allowed 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 117.198 -1.402 . . . . 0.0 108.84 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.49 26.39 9.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 123.413 1.578 . . . . 0.0 110.993 -150.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.92 -28.49 69.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.957 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.24 -24.55 76.22 Favored Glycine 0 CA--C 1.519 0.326 0 O-C-N 121.165 -0.96 . . . . 0.0 114.156 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -91.35 -24.08 19.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.08 0.94 . . . . 0.0 111.098 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.21 -44.52 95.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 163.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -76.75 -12.73 60.03 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.752 -1.218 . . . . 0.0 114.252 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.56 -31.13 61.99 Favored 'General case' 0 C--O 1.217 -0.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.699 168.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.01 -42.36 99.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.77 -45.65 91.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.401 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -75.47 -36.78 60.6 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -76.82 -35.13 57.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.626 -1.296 . . . . 0.0 108.656 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.65 -19.03 58.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.346 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.58 -35.89 82.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.537 1.062 . . . . 0.0 110.412 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.3 mt -63.6 -37.96 89.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.937 -1.102 . . . . 0.0 113.564 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.14 -43.12 92.91 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.759 -0.588 . . . . 0.0 110.89 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.58 40.7 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.557 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -62.54 -38.06 88.53 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.432 -0.452 . . . . 0.0 111.61 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.7 -40.75 69.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.257 -0.902 . . . . 0.0 112.971 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.04 -16.65 64.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.977 1.262 . . . . 0.0 112.265 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.63 -53.84 37.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 O-C-N 121.437 -0.789 . . . . 0.0 109.363 165.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.45 -51.12 9.77 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.57 -72.23 0.29 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.554 -1.692 . . . . 0.0 115.48 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -69.35 176.86 5.91 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.012 2.475 . . . . 0.0 116.236 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -42.17 154.54 0.05 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.71 1.604 . . . . 0.0 114.411 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.65 -37.03 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.379 1.071 . . . . 0.0 112.672 -142.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.64 -22.22 65.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 117.465 2.395 . . . . 0.0 117.465 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.97 3.49 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 117.364 1.705 . . . . 0.0 117.364 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -129.6 -41.56 1.34 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.793 1.796 . . . . 0.0 114.015 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -159.87 -179.89 8.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.17 131.78 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.614 0.643 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 89' ' ' LEU . 80.3 m -145.88 171.89 14.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -35.64 -39.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.51 -40.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.38 -38.92 74.79 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.04 -15.54 63.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 98.3 p -96.35 -34.41 11.58 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.63 -48.99 9.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.2 92.98 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 59.3 Cg_endo -63.46 -36.2 56.14 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 112.85 -4.3 . . . . 0.0 116.762 -178.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -78.76 -30.76 45.86 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.982 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.85 -29.33 70.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 155' ' ' PRO . 42.4 m-85 -63.47 -50.62 69.0 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 123.248 1.499 . . . . 0.0 109.11 173.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -77.1 -20.18 56.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.618 -170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 tp -64.14 -51.45 63.81 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.099 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.04 -34.0 77.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.381 1.446 . . . . 0.0 112.213 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.4 -52.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.78 41.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.546 -0.722 . . . . 0.0 111.549 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 tp -66.1 -42.69 88.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.704 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.83 -35.47 92.06 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.022 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -74.24 -47.35 35.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.746 -0.855 . . . . 0.0 111.528 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -87.0 -52.28 5.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -129.96 76.12 1.7 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.265 1.426 . . . . 0.0 108.089 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -56.14 121.36 9.24 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -168.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -151.0 92.76 3.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.7 163.59 36.89 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 114.994 -2.871 . . . . 0.0 109.963 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.57 118.99 65.55 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.24 166.22 26.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.714 -1.057 . . . . 0.0 111.996 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.68 3.0 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -68.12 -21.61 64.93 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.606 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -112.28 68.42 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.8 m -55.37 -38.17 68.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -55.17 -59.42 4.8 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.27 -34.51 70.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -166.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.5 tp -62.82 -44.34 96.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.28 -0.888 . . . . 0.0 113.323 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -78.78 -30.3 45.46 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.884 -1.135 . . . . 0.0 111.173 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.45 -49.2 77.78 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.666 0.787 . . . . 0.0 110.434 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.7 mm -69.88 -32.3 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.479 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.22 -38.54 91.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.047 -1.033 . . . . 0.0 112.738 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.56 -31.81 65.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 110.954 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.01 -11.43 59.55 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.637 -0.665 . . . . 0.0 111.952 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -92.73 27.38 2.37 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 122.716 1.246 . . . . 0.0 111.597 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.3 5.24 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 176.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 60.7 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.87 -32.67 67.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.924 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 m -50.8 -30.26 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -115.17 -42.68 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.494 1.14 . . . . 0.0 111.006 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.47 -31.47 62.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -94.19 -24.61 17.43 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.3 p -90.79 -21.94 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.3 126.58 27.91 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.291 0.567 . . . . 0.0 110.332 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.35 167.02 21.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.3 49.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -69.08 -37.4 78.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -162.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.45 -40.51 91.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.263 1.03 . . . . 0.0 109.748 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -78.09 -13.55 59.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.11 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.17 -50.32 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.09 -55.08 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.044 0.926 . . . . 0.0 111.494 -172.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.75 -3.09 36.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.404 1.081 . . . . 0.0 111.18 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.33 -29.9 26.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.34 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -102.96 -39.95 6.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.606 . . . . 0.0 113.22 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -59.72 -29.67 6.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.12 -18.71 30.54 Favored 'Trans proline' 0 C--N 1.357 0.989 1 C-N-CA 111.81 -4.994 . . . . 0.0 114.238 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -81.35 -16.87 51.04 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.0 -38.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.453 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -82.05 -44.13 17.0 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.84 0 CA-C-O 113.261 -3.257 . . . . 0.0 113.949 -171.865 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.13 159.93 39.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 165.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.23 -179.42 3.67 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.33 138.33 44.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 168.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.43 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -125.82 111.3 14.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.28 155.96 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.67 125.64 24.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.64 164.24 23.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.59 127.09 30.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.351 0.596 . . . . 0.0 110.802 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.39 94.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.994 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.12 -19.45 7.28 Favored Glycine 0 C--O 1.235 0.163 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.795 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.1 69.56 23.05 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.47 74.14 5.26 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 N-CA-C 116.664 1.756 . . . . 0.0 116.664 -169.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -146.22 10.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.212 1.006 . . . . 0.0 109.442 167.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -135.03 155.78 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.33 143.48 57.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.707 0.685 . . . . 0.0 109.952 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 167.67 12.44 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 118.702 2.241 . . . . 0.0 118.702 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -65.39 103.97 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.929 -1.636 . . . . 0.0 113.781 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.2 t -166.36 141.37 3.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -62.98 -40.65 33.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 116.706 -1.729 . . . . 0.0 112.674 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.54 -27.14 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.743 -1.571 . . . . 0.0 111.471 -171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.88 -62.42 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.653 0.74 . . . . 0.0 109.644 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -70.4 -27.49 64.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.029 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -57.33 -46.16 83.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.598 1.09 . . . . 0.0 111.693 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -76.99 -35.92 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.222 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.36 -44.46 87.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.09 -39.17 93.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.466 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -39.54 93.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.685 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -33.5 54.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.958 -172.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -77.52 -33.58 54.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -67.05 -39.24 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.694 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.42 -6.46 58.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.716 -0.615 . . . . 0.0 112.402 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.26 41.63 31.9 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 113.213 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -97.6 146.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.33 152.63 34.94 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 114.738 -3.041 . . . . 0.0 113.829 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -150.58 156.6 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.937 0.875 . . . . 0.0 112.582 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.5 t -139.57 124.65 18.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.938 1.245 . . . . 0.0 112.95 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -114.18 124.85 53.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.85 108.04 20.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -83.77 95.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -67.64 97.31 0.6 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.92 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.9 mt 31.91 48.81 0.11 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.24 47.09 3.65 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.811 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -68.91 101.79 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 160.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -137.43 75.51 45.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -165.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -66.24 171.44 10.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 116.798 -1.668 . . . . 0.0 109.885 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -56.08 -36.61 68.31 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.691 -0.631 . . . . 0.0 112.313 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.95 -42.37 79.97 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -79.96 -31.44 39.94 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.086 -1.009 . . . . 0.0 111.418 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 mt -67.1 -24.67 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.296 -0.252 . . . . 0.0 111.67 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -66.75 -37.49 84.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.163 0.506 . . . . 0.0 110.962 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -88.91 -52.08 11.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-O 121.193 0.521 . . . . 0.0 111.806 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -87.35 117.06 68.07 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 120.886 -1.134 . . . . 0.0 111.302 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.33 -23.87 65.21 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 118.505 2.463 . . . . 0.0 118.505 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.4 -10.8 18.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.883 -1.136 . . . . 0.0 112.538 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -0.39 37.9 Favored Glycine 0 C--O 1.224 -0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 113.414 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -146.25 34.82 0.98 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.87 0.843 . . . . 0.0 110.708 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.8 141.2 37.48 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.68 147.85 90.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 116.131 -2.113 . . . . 0.0 113.063 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.93 162.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 132.78 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -105.81 136.53 45.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.88 91.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.1 t0 50.55 52.96 13.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.124 0.964 . . . . 0.0 111.391 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 t70 62.15 24.27 14.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -110.91 163.94 13.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -146.76 159.64 43.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.848 2.113 . . . . 0.0 115.447 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.42 162.27 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.66 -116.13 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.6 173.37 1.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 p -58.3 -30.05 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -158.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -77.92 -26.17 48.82 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.851 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -83.3 -34.85 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.87 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.306 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.81 -45.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.875 0.761 . . . . 0.0 111.646 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.43 -33.92 51.72 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -118.39 -51.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.5 -40.36 85.2 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.998 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.02 -38.36 85.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.238 0.926 . . . . 0.0 109.367 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.21 -31.82 71.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.01 1.26 49.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.54 135.87 83.73 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 -21.68 72.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 116.607 -1.795 . . . . 0.0 116.589 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -93.37 161.02 32.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.19 144.44 90.52 Favored 'Trans proline' 0 C--N 1.354 0.847 0 N-CA-C 116.705 1.771 . . . . 0.0 116.705 -156.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -84.95 29.16 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.029 1.819 . . . . 0.0 115.317 -163.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.33 111.58 3.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.81 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.15 26.55 2.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.244 1.021 . . . . 0.0 110.461 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.67 123.68 58.92 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -170.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -114.74 62.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.605 0 N-CA-C 116.452 1.674 . . . . 0.0 116.452 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -83.38 -132.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 121.192 1.261 . . . . 0.0 113.845 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.91 -32.98 70.03 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.442 -1.411 . . . . 0.0 110.638 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -62.55 -31.81 72.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.321 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.6 20.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.166 -0.334 . . . . 0.0 110.746 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.4 p -68.3 -39.26 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.537 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.76 -46.5 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.598 -0.689 . . . . 0.0 109.431 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.28 74.55 Favored Glycine 0 CA--C 1.516 0.097 0 N-CA-C 115.549 0.98 . . . . 0.0 115.549 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -66.77 -17.93 65.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -81.91 -33.65 30.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 110.757 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.97 -43.67 81.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -50.52 -59.79 6.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.59 -16.13 15.09 Favored 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 112.195 -4.737 . . . . 0.0 114.578 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -61.98 -37.4 84.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.531 1.06 . . . . 0.0 111.182 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -84.63 -24.9 28.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.985 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.72 -42.3 80.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -55.89 -47.69 76.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.514 0.725 . . . . 0.0 109.601 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.87 -41.51 97.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.58 -40.21 92.5 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -84.94 -8.31 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 t -87.91 144.07 26.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.17 39.45 2.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 123.144 1.449 . . . . 0.0 108.192 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.67 -179.36 0.51 Allowed Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 112.559 -2.11 . . . . 0.0 108.994 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -63.42 89.24 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 115.654 -2.431 . . . . 0.0 112.404 151.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -88.85 98.16 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.23 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.02 -49.08 0.46 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.025 -0.422 . . . . 0.0 110.681 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.2 -35.67 92.38 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -82.82 -36.71 25.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.44 1.114 . . . . 0.0 108.221 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.31 -31.85 73.2 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.161 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.09 73.54 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.692 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.11 -47.47 84.48 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.05 -47.8 83.08 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.88 -37.33 73.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -69.12 -44.12 73.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.24 -22.87 62.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.079 -1.013 . . . . 0.0 111.372 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.74 -33.56 75.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.473 0.579 . . . . 0.0 110.368 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.92 -46.11 79.47 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.511 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.2 mt -67.1 -38.58 85.93 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.552 -0.717 . . . . 0.0 111.239 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.002 0.521 . . . . 0.0 110.343 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.96 -51.81 50.24 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -60.94 -38.32 85.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.47 -51.39 67.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.382 0.611 . . . . 0.0 111.828 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.68 -16.1 61.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -165.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.02 -27.75 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.51 0.724 . . . . 0.0 110.778 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -106.42 -45.11 4.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 -59.71 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 119.013 2.365 . . . . 0.0 119.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -67.97 -154.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 122.019 2.909 . . . . 0.0 115.897 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -58.91 168.98 1.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.909 0.884 . . . . 0.0 112.939 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.77 -36.36 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -163.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.27 -3.58 4.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.95 -30.62 9.87 Favored Glycine 0 CA--C 1.51 -0.279 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -124.6 -43.96 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -159.17 172.22 18.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.68 118.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.1 m -139.84 -175.9 4.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 147' ' ' THR . . . -45.26 -41.06 8.16 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 118.736 2.865 . . . . 0.0 118.736 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.11 -39.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 119.391 0.996 . . . . 0.0 110.314 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -71.13 -35.69 71.83 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.26 -24.63 67.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.983 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.4 p -97.83 -41.68 7.93 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.13 -47.46 43.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.43 97.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.79 -25.32 20.38 Favored 'Trans proline' 0 C--N 1.347 0.493 1 C-N-CA 111.202 -5.398 . . . . 0.0 114.924 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -72.89 -31.82 64.94 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 119.916 -1.74 . . . . 0.0 109.22 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.79 -29.52 68.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -63.86 -47.65 79.89 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.886 -1.134 . . . . 0.0 110.589 168.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -62.24 -31.81 72.41 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.86 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.73 -59.15 3.82 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.279 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.02 -35.15 79.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.256 0.934 . . . . 0.0 111.743 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -57.21 -41.12 77.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.163 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.48 -35.08 14.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.66 -41.44 92.5 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.275 -0.891 . . . . 0.0 112.148 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.82 69.5 Favored Glycine 0 C--O 1.228 -0.239 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -73.27 -49.01 29.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -100.99 -29.11 12.37 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.697 2.481 . . . . 0.0 117.697 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -124.51 20.14 8.73 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.228 0.467 . . . . 0.0 110.831 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -13.25 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 -153.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -115.06 92.63 31.84 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.46 155.96 62.53 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 113.819 -3.654 . . . . 0.0 108.951 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.9 mt -65.92 125.77 90.57 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.79 153.62 58.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 117.418 -1.254 . . . . 0.0 111.317 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.69 0.98 11.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.82 -27.73 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 165.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.99 67.45 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -33.06 69.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.508 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -62.73 1.5 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.16 -35.23 67.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -160.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.45 -41.81 84.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.625 -0.672 . . . . 0.0 111.886 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -67.4 -37.04 82.5 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.469 -0.769 . . . . 0.0 110.46 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.2 -41.19 97.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.941 0.896 . . . . 0.0 112.88 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.38 -31.44 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.668 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.28 -41.5 98.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.408 -1.432 . . . . 0.0 111.159 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.36 -34.92 78.3 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.539 -0.726 . . . . 0.0 111.784 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.11 -49.78 76.28 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -70.14 -15.7 63.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.6 t -75.68 -49.32 18.71 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -85.03 144.34 28.34 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.65 -24.1 67.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.179 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.7 m -51.99 -36.58 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.82 -40.64 6.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.952 0.882 . . . . 0.0 109.2 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.29 -33.93 73.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.23 -33.56 32.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -93.77 -10.33 34.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -54.99 135.79 48.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.414 1.102 . . . . 0.0 111.778 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.08 150.92 47.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.408 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.32 121.79 13.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -40.26 93.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -169.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.47 -30.52 71.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 122.684 1.231 . . . . 0.0 108.979 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.75 9.37 39.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.627 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.66 -44.01 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.1 pt -66.04 -37.66 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.216 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.93 -3.54 45.38 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.19 -32.05 13.05 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -101.52 -55.96 2.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.87 -30.59 4.54 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 -172.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -27.88 47.05 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 111.539 -5.174 . . . . 0.0 114.381 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -69.29 -34.2 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.622 0.646 . . . . 0.0 110.661 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.87 -39.08 74.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -68.01 -44.3 76.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.448 1.099 . . . . 0.0 110.707 179.468 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.2 -161.99 0.06 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.723 1.209 . . . . 0.0 113.933 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.75 169.19 23.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -132.47 169.68 16.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -133.78 142.17 42.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -124.64 133.84 53.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.374 -2.824 . . . . 0.0 103.374 162.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.48 160.05 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.803 1.183 . . . . 0.0 109.586 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.69 133.98 51.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.928 0.331 . . . . 0.0 110.715 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.06 165.36 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.018 0.437 . . . . 0.0 110.028 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.25 127.99 33.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.31 129.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.61 -19.78 51.94 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-O 118.776 -1.013 . . . . 0.0 114.675 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.06 81.92 7.31 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 118.385 1.093 . . . . 0.0 113.327 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.06 71.0 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 N-CA-C 115.849 1.442 . . . . 0.0 115.849 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -142.58 -11.08 0.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.057 164.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -131.4 168.95 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.2 1.0 . . . . 0.0 109.231 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 mt -75.26 147.68 40.06 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.35 171.61 15.39 Favored Glycine 0 C--O 1.237 0.285 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.17 97.19 8.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.915 0.864 . . . . 0.0 109.252 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 132.31 20.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 166.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -67.77 -43.37 5.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 115.331 -2.646 . . . . 0.0 115.211 -168.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -26.1 64.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.848 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -64.34 -44.5 91.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.985 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.48 -41.97 88.16 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.5 -0.75 . . . . 0.0 110.491 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 tpt85 -58.62 -41.13 85.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.54 -41.78 80.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.253 0.933 . . . . 0.0 112.459 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.59 -39.42 84.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.389 0.614 . . . . 0.0 111.179 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.45 -41.84 99.03 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.39 95.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.751 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.7 -40.72 72.72 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.219 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -70.87 -36.97 73.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.507 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -68.91 -39.54 79.63 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.057 -1.027 . . . . 0.0 110.475 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HG3' HD21 ' A' ' 84' ' ' ASN . 67.1 mmtt -79.16 -4.52 50.85 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 56.1 34.87 24.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.821 1.248 . . . . 0.0 114.152 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.18 135.74 23.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.9 148.62 25.3 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 116.023 -2.184 . . . . 0.0 114.979 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -144.91 153.81 41.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.034 0.921 . . . . 0.0 112.418 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.34 117.16 32.35 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.9 123.18 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 123.995 0.809 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -111.12 94.22 4.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.33 135.65 52.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.764 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -85.25 110.82 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -78.73 53.4 1.34 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.852 1.261 . . . . 0.0 112.661 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 mt 51.05 38.97 22.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 112.843 177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.85 72.96 0.2 Allowed Glycine 0 CA--C 1.512 -0.141 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.75 -178.45 6.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 111.648 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.79 150.13 91.65 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 124.337 1.055 . . . . 0.0 113.395 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -20.03 -137.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.258 2 C-N-CA 128.975 6.45 . . . . 0.0 125.304 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -66.61 -26.9 67.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.963 -1.71 . . . . 0.0 113.975 -161.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -61.24 -44.27 97.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 110.553 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.27 -33.92 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.156 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.29 -29.35 67.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -70.15 -30.77 68.0 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.243 -0.911 . . . . 0.0 110.703 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.36 -58.94 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.041 0.448 . . . . 0.0 111.73 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 121.31 76.15 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 120.845 -1.159 . . . . 0.0 108.56 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.07 -21.79 31.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 N-CA-C 117.098 1.922 . . . . 0.0 117.098 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.1 -9.41 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.823 -1.173 . . . . 0.0 110.221 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -31.15 2.38 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.362 -162.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -118.59 31.37 6.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.81 155.1 60.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.2 171.0 17.73 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 117.247 -1.369 . . . . 0.0 113.262 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.61 159.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 163.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.25 130.45 48.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 146.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -105.32 90.81 3.54 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 mt -100.36 113.25 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 52.68 41.9 31.5 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.787 0.803 . . . . 0.0 111.596 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.29 37.76 20.18 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -136.72 148.36 47.26 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -133.95 140.72 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 119.554 3.168 . . . . 0.0 119.554 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.33 139.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.76 1.224 . . . . 0.0 108.337 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.19 15.91 0.47 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 155.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -63.57 139.14 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.734 -1.228 . . . . 0.0 108.169 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -154.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.97 -37.98 17.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.782 0.801 . . . . 0.0 109.641 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.94 -36.41 75.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.887 0.851 . . . . 0.0 111.115 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -25.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.997 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.87 -40.37 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.87 -59.08 1.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.77 . . . . 0.0 114.572 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -66.95 -39.5 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.423 -0.799 . . . . 0.0 112.806 -169.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -61.47 -44.31 97.33 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 120.109 1.322 . . . . 0.0 108.77 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -67.75 -35.07 78.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.218 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.23 -17.7 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.169 -0.957 . . . . 0.0 113.056 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -109.04 3.24 21.86 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.738 -0.601 . . . . 0.0 111.434 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.456 HD21 ' HG3' ' A' ' 33' ' ' LYS . 31.2 t-20 -76.96 126.71 85.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.75 -8.99 22.14 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 116.62 -1.787 . . . . 0.0 114.199 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.1 162.99 17.99 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.8 138.51 85.84 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 N-CA-C 118.003 2.27 . . . . 0.0 118.003 -158.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.79 87.29 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.674 1.582 . . . . 0.0 115.709 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.31 53.4 0.96 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 123.103 1.43 . . . . 0.0 111.638 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.26 77.92 8.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.856 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.1 m -122.51 95.32 46.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 O-C-N 121.762 -0.586 . . . . 0.0 110.43 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.29 73.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 123.722 2.948 . . . . 0.0 116.458 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -84.41 -138.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 119.081 0.707 . . . . 0.0 113.221 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.95 -35.75 59.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -66.26 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.548 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.18 -32.19 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.2 p -71.94 -38.08 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.077 0.853 . . . . 0.0 109.129 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.07 -39.62 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.98 -33.05 67.68 Favored Glycine 0 C--O 1.224 -0.485 0 O-C-N 121.477 -0.764 . . . . 0.0 113.702 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.8 p -71.06 -11.81 61.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.432 1.116 . . . . 0.0 113.607 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -96.77 -26.42 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 109.516 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.25 -56.26 7.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.261 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -59.39 -55.14 49.11 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -165.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.03 -20.46 19.29 Favored 'Trans proline' 0 C--N 1.351 0.667 1 C-N-CA 113.006 -4.196 . . . . 0.0 112.716 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -69.46 -36.1 76.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.819 -0.551 . . . . 0.0 110.119 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.88 -35.97 77.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.085 -1.009 . . . . 0.0 112.018 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.0 -42.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -57.11 -49.12 76.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.304 0.642 . . . . 0.0 111.786 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -81.62 -11.16 59.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 tp -77.99 -36.95 48.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.557 0.694 . . . . 0.0 111.333 165.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -70.2 -25.45 63.42 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.304 -0.873 . . . . 0.0 111.453 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 t -88.93 149.12 23.47 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -132.05 40.58 3.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 123.105 1.431 . . . . 0.0 109.085 161.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.42 171.82 3.09 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.57 72.5 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 CA-C-O 123.158 1.233 . . . . 0.0 114.161 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -85.33 101.79 12.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.933 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.61 -52.58 0.35 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.66 -30.75 78.55 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.8 p -77.36 -24.22 50.69 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 118.452 1.126 . . . . 0.0 112.867 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -73.22 -35.91 66.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -67.42 -31.47 71.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.29 -35.85 80.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 120.506 -1.371 . . . . 0.0 111.093 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.82 -37.99 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.163 -0.335 . . . . 0.0 110.178 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.69 -41.1 89.94 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -67.88 -33.3 74.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.869 -1.144 . . . . 0.0 112.604 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -64.96 -40.65 95.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.58 -23.99 61.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.551 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.09 -26.48 66.74 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 118.626 0.648 . . . . 0.0 110.668 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.15 -46.64 70.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.35 -40.67 85.87 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 121.414 -0.803 . . . . 0.0 111.169 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.23 -39.63 87.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.33 -47.31 85.87 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-O 119.489 -0.617 . . . . 0.0 112.734 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.0 -41.56 97.45 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.029 0.914 . . . . 0.0 108.991 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -44.51 82.53 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.25 -0.906 . . . . 0.0 112.333 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.31 -12.62 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.0 m -96.57 -8.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.582 0.628 . . . . 0.0 112.254 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -109.72 -43.59 4.01 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.61 -76.19 0.24 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -69.37 -176.09 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 CA-C-N 120.909 2.354 . . . . 0.0 118.047 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -54.89 161.45 1.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.32 -30.04 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.972 -116.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.27 18.8 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.86 85.79 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -144.56 -48.6 0.26 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -172.95 175.02 3.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -166.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.3 mm -61.14 121.41 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -135.98 178.59 6.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.48 -27.37 24.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.0 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.422 0.629 . . . . 0.0 110.517 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.56 -39.8 94.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.96 -21.6 61.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.06 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.2 p -87.5 -36.56 17.57 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.674 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.18 -47.25 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.52 94.62 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.8 -29.33 12.65 Favored 'Trans proline' 0 C--N 1.352 0.73 1 C-N-CA 111.849 -4.967 . . . . 0.0 113.696 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.23 -25.87 42.56 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.135 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.07 -35.57 80.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.095 0.861 . . . . 0.0 111.494 167.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.86 -47.46 80.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -63.09 -35.09 79.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.35 -51.4 57.57 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.388 -0.82 . . . . 0.0 111.0 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -65.01 -30.88 71.89 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.751 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.17 -58.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 117.902 0.319 . . . . 0.0 110.489 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.74 67.22 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.134 -0.979 . . . . 0.0 113.127 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.03 -35.14 74.08 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.39 -37.5 94.56 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.907 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -66.07 -42.07 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.269 -0.548 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -100.74 -42.95 6.29 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 118.504 2.779 . . . . 0.0 118.504 -164.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -140.89 57.52 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -47.35 122.08 4.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -152.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -155.0 93.22 2.77 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.44 165.56 32.16 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 115.848 -2.301 . . . . 0.0 109.64 166.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.82 121.12 71.79 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.41 161.68 41.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 116.5 -1.867 . . . . 0.0 113.345 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -73.35 1.37 9.73 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.5 -21.65 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.667 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.43 78.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -40.35 82.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -54.52 39.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -66.0 -43.79 92.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.69 -47.03 85.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -75.35 -33.97 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.653 -0.654 . . . . 0.0 112.6 -174.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.36 -20.67 50.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.02 -42.03 94.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -63.45 -33.5 75.7 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.496 -1.378 . . . . 0.0 111.261 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.0 -42.87 75.89 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.932 -0.48 . . . . 0.0 111.511 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.16 -18.91 22.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.38 -35.72 70.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.7 t -128.11 68.2 1.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.597 165.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -103.84 140.39 37.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.083 -3.673 . . . . 0.0 101.083 154.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.05 -45.87 68.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.8 t -61.64 -45.48 93.89 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.303 1.049 . . . . 0.0 112.518 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.73 -41.07 68.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.764 -174.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.78 -40.11 82.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.782 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -78.44 -35.3 47.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 36.4 p -88.55 -15.97 33.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -65.36 150.12 48.83 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.614 -0.678 . . . . 0.0 112.604 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.84 160.19 30.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.19 143.55 50.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -56.84 -42.95 80.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -59.71 -40.45 88.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 0.0 110.964 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.05 -12.5 60.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.58 -48.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -68.11 -51.45 48.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.323 1.059 . . . . 0.0 108.578 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.5 -5.75 44.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.18 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.77 -29.54 15.59 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 119.517 -0.602 . . . . 0.0 114.313 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -106.82 -26.07 11.42 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -64.87 -18.8 0.47 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 119.522 3.156 . . . . 0.0 119.522 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 -14.48 44.45 Favored 'Trans proline' 0 C--N 1.358 1.034 1 C-N-CA 112.905 -4.263 . . . . 0.0 116.282 168.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -98.64 7.39 46.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 111.3 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 98.9 t -111.36 -40.38 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -76.83 -10.84 59.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.617 1.339 . . . . 0.0 114.617 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 178.535 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 145.73 49.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -147.21 167.96 22.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -114.65 141.55 47.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.848 1.204 . . . . 0.0 112.323 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.51 96.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 t -96.16 118.62 33.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.22 163.7 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -166.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -67.88 130.88 44.34 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.634 -0.666 . . . . 0.0 112.553 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.3 166.53 22.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.479 174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.88 139.72 56.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.65 126.83 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.885 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.04 -16.17 17.57 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.21 76.45 13.4 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 50.7 Cg_endo -75.33 42.24 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 118.391 2.42 . . . . 0.0 118.391 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -112.12 -12.56 13.65 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -125.84 159.33 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.63 135.44 57.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.839 1.255 . . . . 0.0 111.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.32 -163.7 36.99 Favored Glycine 0 CA--C 1.511 -0.198 0 N-CA-C 119.307 2.483 . . . . 0.0 119.307 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -76.35 76.38 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.157 1.383 . . . . 0.0 109.774 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -141.35 82.98 13.93 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 121.221 -0.925 . . . . 0.0 113.147 -171.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.27 -22.71 75.4 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 116.079 -2.147 . . . . 0.0 115.571 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -68.85 -38.43 79.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -69.55 -40.45 76.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.69 -35.32 79.3 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 118.381 -0.818 . . . . 0.0 112.275 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -57.59 -39.81 77.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.725 1.602 . . . . 0.0 110.767 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.42 -52.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.42 0.629 . . . . 0.0 110.293 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.09 -37.78 88.7 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.81 -41.78 97.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -66.89 -32.49 73.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.308 0.575 . . . . 0.0 111.29 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.43 -46.38 48.82 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.146 -0.346 . . . . 0.0 111.112 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -72.52 -34.37 67.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -36.31 83.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.021 -1.05 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -86.22 -7.08 58.81 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 59.55 29.33 18.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.487 1.515 . . . . 0.0 114.121 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -80.84 136.18 51.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.82 153.18 53.31 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.178 -1.415 . . . . 0.0 114.214 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -156.57 171.69 19.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.37 124.9 48.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 t -83.5 145.81 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -139.66 146.43 39.69 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 102.799 -3.037 . . . . 0.0 102.799 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.6 mt -114.73 132.34 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.73 119.89 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.32 72.79 7.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.55 1.167 . . . . 0.0 109.937 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 mt 57.22 27.16 13.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.6 33.64 Favored Glycine 0 C--O 1.226 -0.351 0 O-C-N 121.871 -0.518 . . . . 0.0 113.537 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -68.33 117.41 10.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 154.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -140.1 101.16 7.01 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.3 175.68 7.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.972 -0.885 . . . . 0.0 111.133 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -56.49 -36.48 69.17 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 122.146 -0.346 . . . . 0.0 111.017 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -56.6 -40.58 75.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -71.52 -31.81 67.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.142 -0.974 . . . . 0.0 108.959 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.29 -23.62 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.34 -35.29 79.1 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.303 -0.873 . . . . 0.0 110.241 172.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.05 -53.03 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -90.59 139.05 26.42 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 121.661 -0.649 . . . . 0.0 111.004 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.12 -22.91 46.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 116.974 -1.551 . . . . 0.0 115.858 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -108.11 -6.24 16.57 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 0.0 111.992 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.54 4.35 38.22 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.373 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.65 58.44 1.12 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.968 0.907 . . . . 0.0 110.819 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.82 159.17 69.83 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 100.343 -3.947 . . . . 0.0 100.343 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -69.16 147.98 67.95 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 114.081 -3.479 . . . . 0.0 111.47 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.1 155.54 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.164 0.507 . . . . 0.0 109.966 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -123.33 109.18 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.67 84.98 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.8 95.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.153 0.981 . . . . 0.0 108.361 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.3 t0 51.94 46.85 25.89 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.434 1.111 . . . . 0.0 111.779 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t0 58.99 30.55 20.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -114.85 165.85 12.4 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 166.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -150.58 149.79 30.37 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.06 157.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -115.52 -121.65 0.3 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.66 -176.91 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -166.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -54.41 -36.44 63.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.67 -20.43 53.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.943 0.878 . . . . 0.0 110.006 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.6 t -91.87 -43.89 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -42.04 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.71 -0.619 . . . . 0.0 111.14 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.32 -13.85 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.66 0.743 . . . . 0.0 112.299 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.04 -64.04 0.71 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.42 -47.39 45.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.631 -168.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.08 -40.45 94.67 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.606 1.548 . . . . 0.0 108.702 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -63.42 -42.66 98.72 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.704 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.95 -40.19 94.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -87.12 4.96 40.15 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.933 -0.48 . . . . 0.0 111.968 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.45 135.91 93.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.987 -0.445 . . . . 0.0 111.516 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.44 -6.07 16.05 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.891 1.073 . . . . 0.0 114.891 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -112.11 162.32 21.87 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.38 130.89 39.75 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 116.381 -1.946 . . . . 0.0 116.791 -161.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.8 146.02 32.99 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 116.763 -1.691 . . . . 0.0 111.914 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.26 45.74 2.73 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.24 80.26 7.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.3 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.2 p -114.31 106.02 53.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -98.51 59.16 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.357 2.705 . . . . 0.0 118.71 163.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.18 -146.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 120.112 1.076 . . . . 0.0 113.107 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -51.43 -32.27 26.0 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -68.6 -30.57 69.33 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.417 -0.802 . . . . 0.0 111.599 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.46 47.48 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.247 -0.283 . . . . 0.0 110.642 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.5 p -74.85 -30.52 61.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.731 -0.605 . . . . 0.0 112.531 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.1 t -75.12 -40.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.08 91.25 Favored Glycine 0 C--O 1.222 -0.605 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.252 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.3 p -71.47 -11.66 60.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -81.21 -32.39 33.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.628 1.204 . . . . 0.0 110.004 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.3 -43.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.179 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.66 -56.83 19.18 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.3 -13.21 13.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 113.973 -3.551 . . . . 0.0 113.464 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 t -69.55 -49.51 53.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.992 -0.443 . . . . 0.0 109.808 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -70.72 -26.99 63.63 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.608 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.33 -44.51 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.2 -44.82 87.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.74 -25.96 59.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.0 OUTLIER -77.0 -37.33 55.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.092 0.86 . . . . 0.0 110.667 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -87.94 40.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t -152.02 144.81 24.34 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -131.16 34.41 4.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.34 168.63 7.51 Favored Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 163.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.61 44.3 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 N-CA-C 115.959 1.484 . . . . 0.0 115.959 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.71 116.69 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.765 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -150.88 -55.49 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.74 -40.6 97.54 Favored Glycine 0 C--O 1.217 -0.906 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.1 p -69.42 -27.55 65.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.86 1.33 . . . . 0.0 112.56 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -73.73 -29.35 62.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.778 1.275 . . . . 0.0 108.372 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -83.98 -24.55 30.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.715 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.46 86.27 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.755 -1.216 . . . . 0.0 108.632 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.985 -0.447 . . . . 0.0 111.455 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.59 -40.23 86.78 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -67.33 -34.46 77.38 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.975 -1.078 . . . . 0.0 113.496 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -65.58 -42.36 91.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.718 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.8 mt -65.9 -35.52 80.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.927 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -64.98 -28.96 69.87 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.607 0.363 . . . . 0.0 111.932 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 -44.74 93.33 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.821 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 -38.35 80.41 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.908 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.12 -42.92 95.79 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.653 1.115 . . . . 0.0 111.732 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -34.14 89.11 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.952 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -77.16 -43.49 33.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.655 -0.909 . . . . 0.0 110.363 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -41.35 74.08 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -70.58 -20.76 62.75 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.896 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.94 -47.03 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 167.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -73.96 -46.18 45.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.22 -73.95 0.22 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 116.784 -2.12 . . . . 0.0 117.407 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -61.46 -164.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 126.268 4.645 . . . . 0.0 118.932 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -58.3 172.98 0.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.776 0.83 . . . . 0.0 113.123 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.29 -39.26 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.302 0.641 . . . . 0.0 112.283 -160.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.08 4.88 1.87 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.17 -14.02 66.27 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -134.58 -49.42 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -166.17 179.01 5.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -171.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 120.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -129.87 -164.09 1.37 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 171.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.75 -38.55 15.73 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.84 -40.19 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 123.033 1.397 . . . . 0.0 111.303 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -73.28 -32.31 64.58 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 120.992 -1.067 . . . . 0.0 109.915 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.9 -33.18 71.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.803 -0.561 . . . . 0.0 110.361 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.0 p -80.08 -45.96 17.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -81.18 -42.87 20.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.68 -37.83 60.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.9 -22.48 23.28 Favored 'Trans proline' 0 C--N 1.35 0.628 1 C-N-CA 111.893 -4.938 . . . . 0.0 114.731 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -74.72 -31.8 61.96 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 108.796 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.65 -31.71 71.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.502 0.592 . . . . 0.0 112.217 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -62.65 -51.38 67.5 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.418 -0.801 . . . . 0.0 109.753 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -65.58 -28.64 69.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.531 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 110' ' ' LEU . 40.1 tp -60.61 -52.36 65.5 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.602 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.36 -38.34 84.65 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.902 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.63 -49.47 84.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 203' ' ' ILE . . . -78.89 -50.31 11.43 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 120.571 -1.331 . . . . 0.0 114.191 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.07 -37.56 87.94 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.274 -0.891 . . . . 0.0 110.016 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.18 79.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -86.68 -36.02 18.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.074 0.937 . . . . 0.0 110.846 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 203' ' ' ILE . 32.3 m-85 -91.68 -37.29 13.11 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -150.31 62.04 0.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -52.81 128.56 27.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.261 -159.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -138.61 97.98 9.03 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.96 151.22 82.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 114.164 -3.424 . . . . 0.0 110.791 167.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.8 mt -71.6 126.84 91.56 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.68 160.7 47.41 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 117.092 -1.472 . . . . 0.0 112.781 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -74.05 -1.57 20.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.09 -1.18 57.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.515 0.674 . . . . 0.0 109.71 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.6 mt -121.71 55.56 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.0 m -58.39 -33.43 69.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -59.87 4.06 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.39 -38.61 81.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.9 tp -63.32 -45.52 90.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.585 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -83.32 -24.34 32.17 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.008 -0.433 . . . . 0.0 110.208 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.22 -47.82 82.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.58 -48.34 87.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -61.82 -35.45 78.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.17 -45.61 66.37 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.791 -0.568 . . . . 0.0 111.171 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.3 -20.83 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.35 -22.75 54.56 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.051 0.54 . . . . 0.0 112.12 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 t -128.02 67.42 1.35 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.394 1.093 . . . . 0.0 109.635 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.12 142.37 47.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 155.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -59.94 -38.78 83.41 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.671 0.607 . . . . 0.0 111.203 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.7 p -57.5 -46.13 84.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.523 0.601 . . . . 0.0 111.521 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -49.57 55.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.866 0.365 . . . . 0.0 111.698 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.33 -47.13 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -71.94 -24.24 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 112.824 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 70.4 p -120.36 27.32 8.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.914 0.864 . . . . 0.0 111.328 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -63.19 157.4 22.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.351 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 160.97 30.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.41 109.68 5.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -60.4 -36.45 78.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.16 -36.16 76.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.977 0.894 . . . . 0.0 109.69 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -90.8 -8.0 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.879 -0.513 . . . . 0.0 111.086 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.33 -50.71 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 163.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 163' ' ' ALA 0.265 19.7 pt -69.5 -50.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.734 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.26 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.302 -0.874 . . . . 0.0 111.464 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.93 -31.95 13.84 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -95.61 -42.64 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -20.63 0.6 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 120.566 3.543 . . . . 0.0 120.566 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.54 -21.97 59.22 Favored 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 111.337 -5.308 . . . . 0.0 113.779 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -79.14 -33.08 44.47 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 122.041 -0.412 . . . . 0.0 111.285 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.46 -39.54 76.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -75.32 -13.8 60.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.754 176.899 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.28 167.26 17.96 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.931 0.892 . . . . 0.0 109.376 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -148.55 165.65 30.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -143.85 155.43 44.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.506 1.048 . . . . 0.0 109.487 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.98 106.07 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.33 1.062 . . . . 0.0 113.062 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.2 m -87.44 64.54 8.23 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.375 -0.828 . . . . 0.0 112.993 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 m -71.47 152.22 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.61 134.75 38.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.56 171.5 12.29 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.94 137.36 58.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.803 0.811 . . . . 0.0 112.502 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.16 118.4 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.95 82.97 Favored Glycine 0 C--O 1.246 0.864 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.54 100.01 4.43 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.81 80.11 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 CA-C-O 122.701 1.042 . . . . 0.0 113.926 169.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -148.51 -31.19 0.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.482 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.38 162.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.7 158.13 35.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.24 -178.78 15.46 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.76 105.84 10.34 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.8 m -128.68 153.03 79.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 149.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.18 -39.78 65.77 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.475 -1.884 . . . . 0.0 109.755 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -14.91 63.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.77 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.7 -58.02 3.46 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.69 -26.22 66.07 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.59 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -47.36 -45.95 25.32 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 120.996 1.725 . . . . 0.0 113.161 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.36 -34.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.05 -39.88 96.06 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.538 -1.351 . . . . 0.0 110.13 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.6 -33.55 72.85 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -74.71 -46.74 35.54 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.727 -0.608 . . . . 0.0 109.592 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -40.81 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.808 0.731 . . . . 0.0 111.054 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -69.03 -43.24 75.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.872 -1.142 . . . . 0.0 108.271 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.59 -12.18 60.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.066 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtmm 54.67 42.94 30.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.073 1.349 . . . . 0.0 111.874 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -95.09 157.95 35.66 Favored Pre-proline 0 C--O 1.242 0.682 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.795 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.5 119.74 6.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 117.05 -1.5 . . . . 0.0 113.909 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -136.45 154.59 50.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.566 0.698 . . . . 0.0 109.128 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.36 150.62 37.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 t -119.44 139.74 51.55 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 122.267 1.032 . . . . 0.0 113.234 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.06 97.71 5.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.385 1.474 . . . . 0.0 111.278 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.3 mt -70.67 127.96 34.45 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.563 0.697 . . . . 0.0 112.619 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.15 108.0 22.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -78.29 69.32 4.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.583 1.182 . . . . 0.0 110.45 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 58.4 41.58 22.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.791 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.69 85.02 1.4 Allowed Glycine 0 C--O 1.24 0.491 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -129.24 -76.75 0.55 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -155.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 71.5 mmtt -71.7 152.08 93.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 74.6 Cg_exo -58.22 -160.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 2 C-N-CA 127.266 5.31 . . . . 0.0 123.527 -170.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.27 -13.87 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -52.22 -47.17 65.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.822 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -81.6 -38.17 26.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 112.215 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.57 -27.37 67.68 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.4 -0.813 . . . . 0.0 112.027 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.75 -34.29 75.34 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.6 mt -97.41 -46.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.965 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -76.04 127.82 84.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.42 -31.75 13.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 115.672 -2.419 . . . . 0.0 116.506 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -86.9 -21.37 26.36 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.578 -1.326 . . . . 0.0 110.277 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.23 85.08 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.288 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -147.15 27.23 1.05 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.973 0.909 . . . . 0.0 111.837 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.24 143.68 27.09 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.333 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.38 159.19 53.52 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 117.353 -1.298 . . . . 0.0 113.542 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t 77.72 153.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 128.428 2.691 . . . . 0.0 109.714 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.6 33.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.769 1.628 . . . . 0.0 113.547 149.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -153.24 125.67 8.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.537 3.162 . . . . 0.0 119.537 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -147.1 134.65 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 109.506 166.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.55 39.3 24.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.031 0.933 . . . . 0.0 113.191 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.37 20.38 10.97 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.734 1.614 . . . . 0.0 114.031 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -125.33 165.79 17.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.733 1.613 . . . . 0.0 106.914 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -112.09 118.45 35.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.21 129.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 112.123 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.26 112.71 2.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.399 1.08 . . . . 0.0 111.94 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -164.11 151.46 12.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 162.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.3 p -54.56 -37.86 65.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.6 -33.09 28.08 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.015 0.912 . . . . 0.0 109.954 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -72.31 -40.7 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -73.03 -11.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -103.19 -5.46 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.627 0.649 . . . . 0.0 111.435 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.36 -66.91 0.13 Allowed Glycine 0 CA--C 1.519 0.32 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.9 -35.12 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.8 -1.412 . . . . 0.0 110.084 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.6 -38.26 86.92 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.738 -1.226 . . . . 0.0 111.726 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.77 -31.79 68.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.254 0.549 . . . . 0.0 110.528 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -65.41 -27.74 68.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.019 0.914 . . . . 0.0 111.471 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.24 6.41 40.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.867 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.44 144.04 91.23 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.05 -28.89 18.57 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 115.24 -2.706 . . . . 0.0 115.087 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.4 165.71 48.58 Favored Pre-proline 0 N--CA 1.473 0.681 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.11 142.88 76.48 Favored 'Trans proline' 0 C--N 1.354 0.868 0 N-CA-C 117.688 2.149 . . . . 0.0 117.688 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.9 90.91 0.88 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.003 1.136 . . . . 0.0 114.955 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -108.94 79.07 1.18 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.843 1.306 . . . . 0.0 111.758 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.26 73.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.841 -173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -115.63 116.15 41.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.001 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -98.35 74.67 0.07 OUTLIER 'Trans proline' 0 CA--C 1.558 1.723 1 C-N-CA 127.194 5.263 . . . . 0.0 119.032 164.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -85.13 -149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 121.304 1.336 . . . . 0.0 113.504 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.24 -38.6 12.57 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.7 m-85 -66.22 -26.1 67.22 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.44 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.31 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.756 -0.59 . . . . 0.0 111.328 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.3 p -75.1 -34.39 61.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.91 -39.25 83.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -32.52 80.72 Favored Glycine 0 C--O 1.226 -0.387 0 O-C-N 121.435 -0.791 . . . . 0.0 114.202 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -70.43 -6.64 37.23 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -104.11 -35.07 8.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.502 0.667 . . . . 0.0 110.988 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.57 -51.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.432 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 89.2 t80 -56.04 -52.1 75.33 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -69.04 -26.4 31.01 Favored 'Trans proline' 0 C--N 1.35 0.606 1 C-N-CA 112.118 -4.788 . . . . 0.0 113.178 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -65.48 -42.57 92.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 103' ' ' PHE 0.287 10.7 p90 -78.98 -18.12 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.441 -177.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -79.33 -37.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.953 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.25 -40.45 90.35 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.773 -0.579 . . . . 0.0 111.607 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -64.71 -40.21 94.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.094 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.23 -35.75 82.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.142 0.496 . . . . 0.0 112.167 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.67 -0.31 26.21 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.3 t -107.0 127.82 53.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -166.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -116.64 34.37 5.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 123.272 1.51 . . . . 0.0 109.05 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.44 168.56 13.6 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 166.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.91 63.74 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-O 123.172 1.238 . . . . 0.0 113.516 159.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -80.38 69.52 6.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -167.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.92 -40.33 20.28 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.554 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 -38.84 91.81 Favored Glycine 0 C--O 1.228 -0.241 0 O-C-N 121.837 -0.539 . . . . 0.0 112.93 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 -28.48 64.01 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.288 -0.536 . . . . 0.0 110.41 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.22 -38.8 82.27 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.41 -1.431 . . . . 0.0 109.996 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -78.95 -12.48 60.03 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.114 -0.991 . . . . 0.0 113.113 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.31 76.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.9 mt -60.34 -44.27 95.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.513 0.673 . . . . 0.0 109.325 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.87 -51.64 68.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.04 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.26 -29.26 47.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -70.51 -40.49 73.49 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 mt -68.63 -24.43 64.55 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.122 -0.986 . . . . 0.0 112.354 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -61.6 -32.97 73.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.429 0.558 . . . . 0.0 112.261 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -43.07 89.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.93 -27.74 63.99 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.844 -0.535 . . . . 0.0 111.569 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.98 -48.91 72.31 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.696 -0.627 . . . . 0.0 111.838 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.12 -36.42 91.85 Favored Glycine 0 C--O 1.235 0.2 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.592 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -35.53 80.81 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 122.369 -0.489 . . . . 0.0 111.237 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -73.26 -10.21 59.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -162.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.9 m -82.03 -12.36 12.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -112.71 -49.09 2.96 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.28 -60.65 0.35 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -79.22 -177.82 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.771 2.314 . . . . 0.0 116.728 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -40.64 151.86 0.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 pt -74.45 3.24 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -141.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.05 -8.9 57.82 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.632 1.206 . . . . 0.0 109.258 162.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.88 6.22 65.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.622 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -143.26 -49.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -165.97 -174.69 3.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.479 1.112 . . . . 0.0 108.163 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.89 123.07 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.3 m -139.36 172.24 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.29 5.07 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 95' ' ' PHE . 7.4 p -60.29 -37.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -78.45 -40.56 35.27 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.098 -1.001 . . . . 0.0 108.41 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.91 -16.26 61.02 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.831 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.8 m -77.3 -35.04 55.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.82 -38.68 6.01 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -47.96 -42.41 48.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -57.35 -37.66 96.94 Favored 'Trans proline' 0 C--N 1.354 0.864 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -99.32 -17.33 18.1 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.615 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.51 -32.69 72.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 118.506 0.594 . . . . 0.0 110.926 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.28 -52.87 63.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -68.99 -19.33 64.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.51 -47.49 72.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -36.28 80.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.276 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 -50.07 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.4 -51.67 34.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.39 -0.819 . . . . 0.0 110.34 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.82 -41.39 83.12 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.233 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.09 71.14 Favored Glycine 0 C--O 1.234 0.127 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.682 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -90.41 -40.53 12.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -96.53 -41.01 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -137.53 71.95 1.41 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.966 1.306 . . . . 0.0 108.847 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -67.84 86.32 0.23 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -154.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -121.65 99.14 45.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 110.931 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.78 168.26 23.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 118.374 -0.617 . . . . 0.0 112.676 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.54 122.02 86.01 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.6 161.88 43.94 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 116.716 -1.723 . . . . 0.0 111.319 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -69.18 -15.05 63.31 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.286 -0.884 . . . . 0.0 111.712 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.63 -25.17 68.1 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.364 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.25 61.87 0.6 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.78 1.276 . . . . 0.0 109.289 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -22.78 66.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -171.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -50.19 74.82 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -25.3 16.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.688 -168.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -61.28 -48.41 81.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.443 170.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.78 -40.45 88.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.004 0.907 . . . . 0.0 112.39 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -66.85 -49.27 66.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.053 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.4 mm -66.76 -33.89 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.52 -46.83 88.71 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.329 -0.857 . . . . 0.0 111.846 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.6 mt -66.96 -43.14 83.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.903 0.383 . . . . 0.0 111.14 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.54 -32.36 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.484 1.114 . . . . 0.0 111.849 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -62.7 -29.3 70.56 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.372 -0.83 . . . . 0.0 113.144 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -144.0 57.46 1.34 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -90.28 144.5 25.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 150.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.72 -39.65 85.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.908 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -59.02 -44.05 91.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.095 0.95 . . . . 0.0 111.297 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.24 -41.94 60.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.056 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.1 -39.83 93.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.237 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -74.32 -32.27 62.78 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.2 p -101.23 0.56 37.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 117.724 2.491 . . . . 0.0 117.724 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -58.02 150.29 21.21 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.59 167.45 20.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.742 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.77 127.19 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.99 -38.59 91.63 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 117.846 0.294 . . . . 0.0 111.081 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.29 -40.41 74.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 109.028 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -94.41 -1.78 53.07 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.5 t -77.66 -53.41 14.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 163.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.4 mt -67.74 -56.88 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.597 0.713 . . . . 0.0 110.344 -171.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . . . -76.4 -4.85 44.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.02 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.03 -23.8 36.99 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.374 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -102.27 -35.99 8.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 204' ' ' ALA . 8.8 pt-20 -63.69 -23.66 1.13 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.36 -18.76 22.87 Favored 'Trans proline' 0 C--N 1.356 0.96 1 C-N-CA 112.852 -4.299 . . . . 0.0 114.746 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.23 -9.44 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.877 -1.139 . . . . 0.0 110.765 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.08 -45.92 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.07 -23.23 33.22 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.392 0 CA-C-O 116.59 -1.671 . . . . 0.0 108.69 -172.024 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.036 0.446 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.6 160.78 41.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.1 168.59 25.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.645 0.657 . . . . 0.0 111.702 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -123.53 136.5 54.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.16 125.62 57.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 175.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.4 m -129.63 105.59 8.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.19 160.77 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -169.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 130.7 45.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.07 172.03 14.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.937 0.398 . . . . 0.0 111.271 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 137.94 58.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.72 141.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.354 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.32 -38.2 3.01 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.12 81.45 6.19 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 123.107 0.563 . . . . 0.0 110.49 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.49 89.47 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 N-CA-C 117.956 2.252 . . . . 0.0 117.956 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -144.74 -33.43 0.38 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -88.98 164.29 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.34 146.17 49.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.458 1.503 . . . . 0.0 111.253 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.33 173.04 22.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 122.579 3.792 . . . . 0.0 122.579 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -81.13 78.58 7.92 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 t -128.61 135.66 27.92 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.57 -42.59 52.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 119.074 0.705 . . . . 0.0 113.703 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -12.61 60.02 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.9 t -60.47 -45.47 93.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.541 0.686 . . . . 0.0 111.247 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.96 -7.45 59.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -63.18 -43.95 96.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -42.55 67.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.734 -1.576 . . . . 0.0 111.169 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.75 -43.71 79.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.131 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.06 -40.18 87.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.255 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.2 m -62.86 -34.42 77.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.348 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -46.7 32.61 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 112.526 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.8 -24.91 61.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.735 0.303 . . . . 0.0 111.401 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.65 -31.8 71.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.28 -0.887 . . . . 0.0 111.584 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -95.81 -16.15 22.05 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 50.1 46.13 24.9 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -76.55 137.15 67.33 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 163.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.91 148.42 70.46 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 115.834 -2.311 . . . . 0.0 113.425 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -141.95 151.63 42.74 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 122.775 1.274 . . . . 0.0 113.481 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -91.97 117.61 29.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.305 -1.77 . . . . 0.0 107.494 169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 t -99.16 121.2 40.7 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -114.96 140.0 49.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.46 126.62 53.69 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -90.4 104.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -73.06 71.64 1.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.763 0.825 . . . . 0.0 113.153 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.0 mt 56.08 52.84 9.83 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.88 1.272 . . . . 0.0 113.082 169.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.21 80.19 1.01 Allowed Glycine 0 CA--C 1.51 -0.229 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.695 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -116.01 -88.86 0.58 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -148.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -74.73 159.13 83.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 119.209 -0.425 . . . . 0.0 111.729 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -60.01 -165.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.199 2.599 . . . . 0.0 118.021 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -42.21 -37.57 1.51 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -50.11 -45.99 53.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.406 0.548 . . . . 0.0 111.439 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.34 -22.37 41.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.82 -23.31 60.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.393 0.616 . . . . 0.0 110.314 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.41 -41.04 49.1 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.854 -0.529 . . . . 0.0 110.853 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.25 -40.98 86.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -116.43 128.17 26.2 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.462 1.483 . . . . 0.0 111.758 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.34 -16.51 31.19 Favored 'Trans proline' 0 C--N 1.35 0.628 0 N-CA-C 117.003 1.886 . . . . 0.0 117.003 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -100.39 -4.88 28.15 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.842 0.746 . . . . 0.0 112.147 166.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.27 -28.2 3.84 Favored Glycine 0 CA--C 1.52 0.353 0 O-C-N 122.048 -0.407 . . . . 0.0 114.081 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 33.17 2.62 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.28 148.89 35.26 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 151.13 73.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 117.222 -1.385 . . . . 0.0 113.794 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' A' ' 71' ' ' ALA . 33.8 m -133.86 169.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.336 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.8 t -124.25 138.04 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 153.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -104.68 96.37 6.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.14 129.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t0 60.26 34.18 20.92 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.78 1.276 . . . . 0.0 111.018 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.27 21.38 12.03 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.782 2.433 . . . . 0.0 114.299 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -127.56 127.88 44.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.681 0.792 . . . . 0.0 110.047 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -108.02 144.0 35.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.6 t -131.46 140.09 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -136.79 -0.43 2.34 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.06 139.73 30.23 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.08 -1.013 . . . . 0.0 111.143 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.5 p -75.03 -26.17 59.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 -152.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -80.65 -35.18 34.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -91.47 -10.48 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.777 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -76.53 2.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.468 -0.77 . . . . 0.0 110.389 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.1 -56.66 5.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 O-C-N 121.688 -0.633 . . . . 0.0 110.229 152.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.11 -42.79 99.43 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 120.111 2.804 . . . . 0.0 120.111 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.58 -37.4 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 118.937 1.368 . . . . 0.0 107.466 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -40.93 97.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.02 -42.2 98.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.745 0.702 . . . . 0.0 111.222 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -61.49 -34.09 74.9 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 111.462 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.03 16.4 19.69 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.09 116.95 52.74 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.49 -13.76 38.25 Favored 'Trans proline' 0 C--O 1.245 0.86 1 N-CA-C 123.16 4.254 . . . . 0.0 123.16 -167.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.43 155.37 74.09 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-N 121.357 1.89 . . . . 0.0 107.126 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.77 125.53 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 116.635 -1.777 . . . . 0.0 116.306 -168.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.19 152.84 18.53 Favored 'Trans proline' 0 C--O 1.243 0.768 0 N-CA-C 116.569 1.719 . . . . 0.0 116.569 -175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -130.76 56.87 1.76 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 69.96 8.85 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.458 -1.401 . . . . 0.0 114.251 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 m -122.31 98.43 44.11 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 123.499 0.72 . . . . 0.0 110.962 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.01 80.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.509 2.806 . . . . 0.0 116.188 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -82.76 -138.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.561 1.508 . . . . 0.0 113.487 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.65 -34.84 69.78 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 125.022 1.329 . . . . 0.0 111.931 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -65.17 -28.46 69.42 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.431 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.34 -19.25 30.08 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.912 -0.492 . . . . 0.0 110.94 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.7 p -71.56 -38.96 70.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.41 -41.67 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.12 -37.46 80.1 Favored Glycine 0 C--O 1.226 -0.406 0 CA-C-N 116.49 -0.323 . . . . 0.0 113.129 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.3 p -73.03 -9.89 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.24 -39.77 14.19 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.111 0.414 . . . . 0.0 111.633 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.6 -32.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -56.06 -51.96 76.51 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.48 -11.54 15.72 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 113.612 -3.792 . . . . 0.0 113.837 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -75.09 -44.05 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.233 -0.917 . . . . 0.0 110.97 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -20.86 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.199 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.37 -42.22 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.78 -44.34 90.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.29 -32.24 73.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.44 -41.99 92.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.493 ' HA ' HG12 ' A' ' 210' ' ' VAL . 60.2 pttt -97.91 -16.42 19.75 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -167.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -106.95 30.06 6.5 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.176 0.989 . . . . 0.0 111.254 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.55 165.59 18.32 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.458 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.68 70.95 4.91 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.387 1.391 . . . . 0.0 113.884 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.9 81.2 8.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -163.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -99.73 -37.71 8.99 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.04 -40.41 97.03 Favored Glycine 0 N--CA 1.453 -0.228 0 O-C-N 121.733 -0.604 . . . . 0.0 111.673 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.6 m -71.31 -32.58 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.027 0.414 . . . . 0.0 110.741 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.77 -41.38 97.98 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.918 -1.114 . . . . 0.0 109.713 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -76.18 -15.26 60.09 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.456 -0.777 . . . . 0.0 110.941 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.71 -41.83 71.41 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.41 -41.04 96.85 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.342 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 tp -58.19 -36.15 72.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -81.3 -38.07 27.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.62 -38.16 80.32 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.716 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.9 mt -74.04 -19.63 60.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.829 -1.169 . . . . 0.0 110.659 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -66.25 -32.28 73.6 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.95 -42.43 80.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -41.17 98.97 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.17 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.09 -38.67 83.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.526 0.603 . . . . 0.0 110.42 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -55.54 24.69 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -61.07 -40.45 93.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.877 -0.778 . . . . 0.0 110.555 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.716 -0.615 . . . . 0.0 111.45 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.3 -27.19 62.3 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.9 -49.85 65.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.68 -44.19 19.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.54 -69.29 0.24 Allowed Glycine 0 C--O 1.25 1.139 0 CA-C-O 116.797 -2.113 . . . . 0.0 116.06 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -72.43 -159.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 125.212 3.941 . . . . 0.0 114.499 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -54.33 163.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.82 -21.95 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -161.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.22 -19.32 63.04 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.791 -1.193 . . . . 0.0 113.255 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.41 -13.45 33.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.356 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -143.39 -47.44 0.3 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -162.54 179.62 7.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mm -71.36 114.43 9.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -129.91 -169.35 2.11 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.83 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.65 -49.96 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.335 1.064 . . . . 0.0 110.746 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.99 -36.93 67.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.819 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.97 -20.55 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.167 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.2 m -83.61 -48.62 10.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.19 -48.73 15.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.91 93.57 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.29 -36.07 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 1 C-N-CA 112.599 -4.467 . . . . 0.0 114.852 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -79.22 -26.94 42.46 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.526 -1.359 . . . . 0.0 110.483 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.32 -33.76 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.973 0.806 . . . . 0.0 111.333 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -66.15 -38.19 87.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.288 -1.507 . . . . 0.0 113.767 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -67.53 -35.95 80.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.1 tp -62.41 -51.89 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.636 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -65.95 -26.12 67.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -170.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.67 -50.44 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 118.499 0.591 . . . . 0.0 111.614 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.95 -43.07 75.78 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.681 -0.637 . . . . 0.0 111.139 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.86 -42.09 67.29 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.35 93.27 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 119.92 -1.134 . . . . 0.0 114.538 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.58 -49.61 14.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.349 1.075 . . . . 0.0 112.878 173.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -87.53 -37.24 17.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -136.71 62.47 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.152 -0.967 . . . . 0.0 110.509 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -53.55 110.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -161.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -146.5 94.48 4.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.36 168.14 25.5 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 114.9 -2.933 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.55 119.55 57.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.41 162.38 30.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 115.632 -2.445 . . . . 0.0 113.396 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.9 6.3 3.44 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.363 -0.836 . . . . 0.0 112.847 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -70.51 -22.83 62.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.423 0.63 . . . . 0.0 109.357 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.88 60.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.1 m -54.27 -38.0 65.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.015 -0.428 . . . . 0.0 111.779 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -71.85 -26.93 62.56 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 120.809 -1.182 . . . . 0.0 111.938 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.6 -34.09 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.413 1.006 . . . . 0.0 110.625 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.67 -44.37 93.96 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 120.831 -1.168 . . . . 0.0 109.641 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -70.0 -31.7 69.52 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.714 -0.616 . . . . 0.0 112.464 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 121.953 -0.467 . . . . 0.0 111.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -30.9 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 118.57 0.623 . . . . 0.0 111.121 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -68.41 -37.85 80.7 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.186 -0.946 . . . . 0.0 112.453 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.57 -34.2 73.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.45 -39.79 94.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.74 13.89 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.1 t -96.63 -52.7 3.83 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -94.03 157.05 16.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.185 -1.572 . . . . 0.0 112.594 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.38 -21.34 49.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -53.27 -30.89 40.92 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.719 0.771 . . . . 0.0 111.47 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -103.58 -44.32 5.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.697 0.761 . . . . 0.0 112.235 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -61.13 -29.69 69.93 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -85.8 -29.98 23.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 48.4 p -86.02 -18.01 33.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -60.79 140.31 57.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.691 0.758 . . . . 0.0 111.574 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.49 170.59 15.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.28 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.81 117.73 7.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.4 pm0 -60.82 -35.58 76.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -63.91 -40.03 95.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.573 -0.704 . . . . 0.0 109.216 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -78.88 -13.54 59.75 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.29 -50.37 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -45.89 47.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.782 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.6 -23.48 65.39 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.84 -16.53 57.99 Favored Glycine 0 C--O 1.24 0.469 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -89.01 -35.21 16.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 117.607 0.703 . . . . 0.0 111.614 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.95 -23.91 1.35 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 120.307 3.447 . . . . 0.0 120.307 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.73 -21.73 64.66 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 111.105 -5.463 . . . . 0.0 115.874 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.85 -9.44 59.6 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 120.787 -1.196 . . . . 0.0 112.917 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -98.07 -27.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -83.8 -32.64 25.24 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.38 -172.845 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.2 mtp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.16 146.58 47.31 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.502 0.592 . . . . 0.0 110.636 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.02 167.77 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.8 144.14 47.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.85 116.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.0 m -116.3 114.39 24.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.87 160.76 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.99 124.36 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 164.62 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.898 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 142.21 58.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.73 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 127.22 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.48 -25.1 29.57 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.401 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.53 99.43 2.27 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 117.742 0.771 . . . . 0.0 111.338 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.98 55.51 5.33 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 114.546 0.941 . . . . 0.0 114.546 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -120.12 1.31 10.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.591 -0.693 . . . . 0.0 112.292 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.5 tt -148.79 160.85 5.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.47 145.5 51.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.338 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.67 -176.69 44.24 Favored Glycine 0 C--O 1.237 0.307 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.39 64.92 2.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 111.549 -2.325 . . . . 0.0 108.205 170.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.9 t -132.1 101.84 14.84 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 112.38 -2.191 . . . . 0.0 107.812 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.42 -38.31 64.98 Favored 'Trans proline' 0 C--N 1.346 0.422 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -72.2 -32.56 66.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.2 m -63.29 -43.07 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.989 0.9 . . . . 0.0 111.887 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.38 -20.99 62.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.855 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -61.4 -33.52 73.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.675 -0.64 . . . . 0.0 110.212 174.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.47 -49.07 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.412 0.625 . . . . 0.0 111.131 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.45 -37.58 88.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.2 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.45 -41.79 90.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 151' ' ' LEU . 73.6 p -73.29 -40.75 64.29 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.299 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -27.33 48.85 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.522 -0.736 . . . . 0.0 111.679 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -71.03 -35.24 71.91 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 118.8 0.727 . . . . 0.0 112.439 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -68.11 -35.66 78.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 119.112 0.869 . . . . 0.0 110.203 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -71.85 -20.77 61.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 56.09 37.12 28.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.596 1.159 . . . . 0.0 109.715 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -86.72 148.67 46.63 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.22 146.73 32.23 Favored 'Trans proline' 0 C--N 1.35 0.608 1 C-N-CA 113.225 -4.05 . . . . 0.0 113.733 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.89 161.23 41.5 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.73 113.83 27.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.27 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -83.91 124.31 30.86 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 122.697 0.399 . . . . 0.0 110.97 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -116.02 124.35 50.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.42 119.91 37.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.3 mt -88.09 107.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.01 80.48 2.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.08 0.943 . . . . 0.0 110.577 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.5 mt 56.09 53.15 9.41 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.535 167.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.75 35.5 10.12 Favored Glycine 0 C--O 1.236 0.274 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.171 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.87 113.59 10.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -146.55 84.68 7.6 Favored Pre-proline 0 C--O 1.254 1.296 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -161.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.92 166.96 20.97 Favored 'Trans proline' 0 C--O 1.235 0.356 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 158.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -57.83 -33.34 68.51 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.552 0.341 . . . . 0.0 111.227 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -54.66 -45.52 73.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.361 0.6 . . . . 0.0 112.468 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -77.79 -27.27 50.16 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -65.97 -34.77 78.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.007 0.432 . . . . 0.0 111.547 171.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -67.97 -43.87 77.98 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.101 -0.999 . . . . 0.0 110.273 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -70.1 -51.89 35.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -104.2 121.14 48.58 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-N 120.611 1.55 . . . . 0.0 114.743 -167.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.52 -24.61 30.58 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 118.932 2.628 . . . . 0.0 118.932 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -101.47 -5.37 25.34 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.3 1.409 . . . . 0.0 110.68 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.5 -47.5 3.85 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.255 -164.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -119.94 64.75 0.82 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.599 1.19 . . . . 0.0 113.604 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.52 155.86 73.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 165.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.92 154.3 58.23 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 113.564 -3.824 . . . . 0.0 111.476 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.16 142.57 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.93 125.61 67.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 165.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -98.85 89.09 4.2 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.2 101.46 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.61 47.54 22.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.748 0.819 . . . . 0.0 112.944 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t0 65.04 22.18 12.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 -173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -109.85 127.73 54.88 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.068 -1.02 . . . . 0.0 108.55 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -105.24 117.34 33.77 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.841 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.0 138.7 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.617 0.644 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.24 19.54 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 118.816 2.895 . . . . 0.0 118.816 -164.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.64 148.36 29.44 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.754 -1.216 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.1 p -63.78 -25.25 68.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -165.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -82.57 -35.06 27.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.304 -0.247 . . . . 0.0 111.539 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.63 -19.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.63 -0.669 . . . . 0.0 112.392 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 pt -77.37 4.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.11 0.481 . . . . 0.0 111.175 172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.94 -51.0 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.31 -55.19 7.09 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 120.249 2.86 . . . . 0.0 120.249 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.55 -29.57 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.35 1.575 . . . . 0.0 107.198 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -58.82 -43.84 90.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.76 -40.18 76.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.882 0.849 . . . . 0.0 110.664 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -63.03 -34.96 78.69 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.37 3.66 52.76 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -70.45 128.7 90.97 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.759 -0.588 . . . . 0.0 110.84 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.46 -4.99 15.69 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 N-CA-C 115.709 1.388 . . . . 0.0 115.709 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.12 155.7 37.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -59.72 122.02 10.79 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 116.603 -1.798 . . . . 0.0 116.497 -163.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.76 151.83 25.07 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 116.802 -1.665 . . . . 0.0 115.518 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.2 mt -136.87 49.9 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.942 1.697 . . . . 0.0 109.509 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.9 77.94 4.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 m -114.37 101.57 54.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -96.59 67.13 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.754 1 C-N-CA 126.045 4.497 . . . . 0.0 118.613 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.66 -113.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 116.914 -1.591 . . . . 0.0 114.134 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -63.91 -31.28 72.41 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 119.425 -2.047 . . . . 0.0 115.173 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.45 -11.77 60.57 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.358 -1.463 . . . . 0.0 111.825 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.36 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 119.762 -1.837 . . . . 0.0 110.132 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -48.25 45.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.54 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.137 0.494 . . . . 0.0 110.374 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.33 91.22 Favored Glycine 0 C--O 1.224 -0.506 0 O-C-N 120.944 -1.098 . . . . 0.0 111.764 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.1 p -70.59 -2.69 15.05 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -99.03 -36.52 9.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.722 0.772 . . . . 0.0 110.471 171.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.89 -50.16 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.685 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.78 -53.9 59.76 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.03 -17.42 31.85 Favored 'Trans proline' 0 C--N 1.349 0.579 1 C-N-CA 112.751 -4.366 . . . . 0.0 113.702 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -68.38 -56.12 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.815 0.734 . . . . 0.0 111.04 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -76.96 -25.23 52.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.428 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.27 -38.94 82.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -72.77 -44.36 61.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -68.95 -30.87 69.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.298 0.954 . . . . 0.0 112.696 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.9 tp -67.46 -38.41 84.42 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.207 -0.933 . . . . 0.0 110.762 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.9 -25.33 61.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.219 0.533 . . . . 0.0 111.98 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -90.65 109.93 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -93.59 67.87 3.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.26 176.7 1.73 Allowed Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.41 61.06 2.68 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 CA-C-N 120.195 1.105 . . . . 0.0 113.29 161.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.26 116.71 17.21 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -153.2 -57.04 0.12 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.38 -33.01 84.92 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 170.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -74.32 -30.58 62.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.047 1.424 . . . . 0.0 114.831 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.51 -32.07 70.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.251 -1.53 . . . . 0.0 107.316 174.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -77.95 -12.64 60.0 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.979 -1.075 . . . . 0.0 112.707 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.27 -34.67 31.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.224 -1.547 . . . . 0.0 107.673 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.1 tp -64.1 -35.66 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.79 -39.91 78.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.33 173.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -68.9 -35.03 76.37 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.997 0.817 . . . . 0.0 111.959 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.07 -38.56 88.62 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.416 -1.428 . . . . 0.0 110.757 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.05 -20.35 49.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.04 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.22 -36.6 82.03 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.267 0.94 . . . . 0.0 110.571 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.45 -39.18 93.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.18 -50.42 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.025 0.53 . . . . 0.0 111.873 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.98 -34.99 64.88 Favored Glycine 0 C--O 1.234 0.141 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.573 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -57.51 -42.5 82.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 122.026 0.917 . . . . 0.0 110.577 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -35.11 65.22 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -73.21 -18.48 61.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 m -89.7 4.3 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -121.44 -45.77 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.29 -70.96 0.23 Allowed Glycine 0 CA--C 1.531 1.076 0 N-CA-C 120.941 3.136 . . . . 0.0 120.941 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.22 -164.95 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.723 1 C-N-CA 127.896 5.731 . . . . 0.0 118.822 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.09 166.8 7.21 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 169.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.8 mt -78.53 -24.63 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -128.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.7 -6.44 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.39 -17.22 37.25 Favored Glycine 0 C--O 1.23 -0.146 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.05 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -130.44 -44.8 1.11 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -166.45 178.1 6.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.25 126.23 16.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.7 p -131.63 -170.18 2.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.88 -36.04 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -35.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.946 -1.096 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.27 -42.91 96.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 29' ' ' SER . 92.0 mt -63.46 -32.91 74.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 81.5 p -72.9 -37.64 67.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -97.73 -42.88 7.4 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -166.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.45 57.4 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.12 -29.87 14.05 Favored 'Trans proline' 0 C--N 1.35 0.618 1 C-N-CA 111.781 -5.013 . . . . 0.0 115.701 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -76.59 -28.72 56.3 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 119.979 -1.701 . . . . 0.0 108.366 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.6 tp -66.44 -34.32 77.69 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.45 0.568 . . . . 0.0 111.783 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.35 -46.8 81.88 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.629 -0.67 . . . . 0.0 109.73 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -60.87 -33.58 73.31 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.16 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.92 -50.58 61.95 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.618 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -30.35 71.37 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.71 1.141 . . . . 0.0 111.607 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 94.5 t -73.06 -57.46 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.352 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -44.67 65.46 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.745 -1.222 . . . . 0.0 111.418 -166.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.41 -34.41 70.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.8 93.68 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.911 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -76.87 -46.87 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.622 -0.928 . . . . 0.0 112.37 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.96 -47.53 12.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -171.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.55 63.06 1.45 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -40.68 112.41 0.29 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -161.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -144.99 81.01 10.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.803 0.841 . . . . 0.0 111.959 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.47 154.78 40.56 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 113.303 -3.998 . . . . 0.0 110.118 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.23 129.9 91.55 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.41 163.65 31.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.711 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -76.82 6.51 6.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.257 1.503 . . . . 0.0 113.048 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.82 -15.99 42.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.372 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.2 mt -120.21 47.56 1.74 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 108.398 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.3 t -62.91 -18.82 63.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -160.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -48.66 80.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.264 1.847 . . . . 0.0 108.405 174.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.94 -33.03 50.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 118.042 -1.463 . . . . 0.0 107.883 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.2 -52.25 59.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.95 -39.53 94.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.577 0.703 . . . . 0.0 109.784 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.28 -22.78 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.752 -0.592 . . . . 0.0 111.948 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.6 mm -65.66 -34.59 71.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.456 1.025 . . . . 0.0 108.982 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.3 -33.48 75.37 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 111.159 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.06 -45.18 74.57 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.65 -30.17 70.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -67.92 -23.18 65.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.215 -0.928 . . . . 0.0 110.841 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -144.99 69.77 1.26 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.802 0.81 . . . . 0.0 111.071 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -131.99 144.54 50.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.55 -37.38 78.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -166.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.7 t -72.51 -50.48 25.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.94 1.352 . . . . 0.0 110.43 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.9 -28.98 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.698 -165.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.5 -43.39 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.302 1.041 . . . . 0.0 111.509 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.97 -37.17 78.62 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.47 -0.769 . . . . 0.0 112.17 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 32.1 p -81.72 -0.72 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -55.0 119.79 5.96 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.828 -0.545 . . . . 0.0 110.927 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.78 153.96 42.57 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.24 130.46 46.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -61.01 -36.12 78.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.065 0.46 . . . . 0.0 111.021 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -83.61 -25.51 30.78 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.857 -0.527 . . . . 0.0 109.649 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.39 -58.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -43.21 64.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 120.945 -1.097 . . . . 0.0 111.664 -168.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.79 0.09 48.84 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.605 -0.684 . . . . 0.0 111.591 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.09 -34.98 7.29 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -77.73 -41.73 36.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.676 -0.896 . . . . 0.0 112.376 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.44 -36.82 50.73 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.53 -19.83 65.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 114.956 -2.896 . . . . 0.0 114.545 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -84.94 -29.84 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.151 -0.968 . . . . 0.0 111.69 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.52 -49.26 72.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 118.333 0.515 . . . . 0.0 110.402 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.23 -32.44 24.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -167.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.646 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.526 -164.702 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.609 0.242 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 171.16 0.07 Allowed 'General case' 0 C--O 1.25 1.092 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 166.52 24.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.329 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -121.32 142.66 49.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.56 149.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -140.46 130.27 24.47 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 34.5 m -132.7 165.7 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -58.71 118.33 5.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.54 173.12 12.91 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.24 0.543 . . . . 0.0 111.189 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.03 124.64 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.09 55.93 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 64.26 12.99 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 119.163 1.482 . . . . 0.0 112.452 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.38 108.03 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 115.617 -2.456 . . . . 0.0 115.864 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -172.71 -53.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.4 mt -99.65 144.32 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 108.573 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.67 150.51 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.184 1.394 . . . . 0.0 114.599 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -156.09 11.79 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 10.0 t70 -84.71 116.82 23.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.18 -1.188 . . . . 0.0 110.394 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -165.38 140.4 4.17 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 173.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.81 -55.29 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.827 -2.982 . . . . 0.0 112.514 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -66.26 -29.31 69.52 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.29 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -44.13 -59.0 2.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -86.17 -11.65 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.924 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.39 -48.8 79.57 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 m -68.82 -43.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.457 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.99 -41.52 90.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.551 -173.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.19 -46.8 76.07 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.185 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.1 p -65.3 -42.44 93.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 119.593 1.088 . . . . 0.0 112.533 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.72 -36.17 73.08 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.056 -1.027 . . . . 0.0 111.775 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -76.81 -29.91 56.18 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.654 -0.654 . . . . 0.0 111.816 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.67 -29.64 70.23 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.643 -1.286 . . . . 0.0 111.265 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.18 -8.45 57.81 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.14 37.48 26.35 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.61 1.564 . . . . 0.0 113.63 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.47 157.58 67.38 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.353 0.524 . . . . 0.0 111.076 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.57 127.18 10.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -147.26 167.65 23.71 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.211 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.69 148.77 28.98 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t 72.44 143.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.852 2.061 . . . . 0.0 114.235 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.98 71.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 110.894 170.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.24 143.15 18.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.97 146.58 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.055 1.742 . . . . 0.0 108.399 158.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -88.75 80.24 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt 53.77 35.44 21.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.848 0.832 . . . . 0.0 113.209 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 1.37 83.72 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -82.87 78.82 9.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.343 1.571 . . . . 0.0 113.174 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -134.41 159.85 70.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.05 -176.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 114.662 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.29 -28.36 27.68 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -45.88 -40.71 10.38 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -85.96 -28.93 23.94 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 112.329 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.22 -22.55 63.86 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.847 0.832 . . . . 0.0 111.098 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -76.07 -3.67 37.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 112.097 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.16 -67.91 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 t -73.45 126.03 90.25 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -158.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.23 -24.26 27.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 N-CA-C 117.538 2.091 . . . . 0.0 117.538 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -100.76 -5.16 26.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.903 0.859 . . . . 0.0 111.089 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 -29.32 2.17 Favored Glycine 0 C--O 1.225 -0.427 0 O-C-N 121.806 -0.559 . . . . 0.0 113.813 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -130.81 45.61 2.79 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.149 0.974 . . . . 0.0 112.862 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.93 155.86 60.17 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.448 -0.783 . . . . 0.0 110.057 170.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . 72.8 Cg_endo -66.64 153.21 78.78 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 123.323 1.17 . . . . 0.0 113.706 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.21 159.34 36.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.71 124.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -92.88 80.91 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.065 0.848 . . . . 0.0 109.325 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mt -83.42 105.58 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t0 53.33 45.81 27.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.288 1.042 . . . . 0.0 109.679 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 68.7 9.87 7.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -121.84 128.15 51.33 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -94.71 144.1 25.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.09 132.55 55.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 176.77 132.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.257 1.823 . . . . 0.0 115.249 148.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -175.7 177.31 1.74 Allowed 'General case' 0 N--CA 1.48 1.034 1 N-CA-C 97.404 -5.036 . . . . 0.0 97.404 170.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.34 58.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -84.38 -24.28 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 120.695 -1.253 . . . . 0.0 110.702 -163.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.01 -24.1 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.443 HG13 HD22 ' A' ' 80' ' ' LEU . 2.2 tp -80.63 -13.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 120.791 -1.193 . . . . 0.0 109.329 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.4 t -82.72 -39.22 15.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.963 171.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.73 -55.2 0.62 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -69.08 -39.66 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.357 1.079 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 HG13 ' A' ' 76' ' ' ILE . 21.7 tp -60.66 -37.55 81.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.657 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -68.88 -45.72 70.27 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.031 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -61.96 -37.12 83.55 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -85.86 10.17 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -100.63 133.55 21.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.063 -0.398 . . . . 0.0 111.51 175.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -66.43 -24.82 49.19 Favored 'Trans proline' 0 C--O 1.24 0.614 0 N-CA-C 116.781 1.8 . . . . 0.0 116.781 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -75.41 157.45 84.62 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.45 126.64 23.16 Favored 'Trans proline' 0 C--O 1.243 0.746 0 N-CA-C 114.741 1.016 . . . . 0.0 114.741 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.9 150.43 26.88 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 117.904 -0.931 . . . . 0.0 112.318 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 tp -142.04 64.7 1.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.841 1.305 . . . . 0.0 112.495 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.21 70.75 9.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.41 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -117.56 106.27 46.7 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.599 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -95.32 74.67 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 125.913 4.408 . . . . 0.0 119.001 164.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -87.1 -113.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 CA-C-N 119.198 0.749 . . . . 0.0 112.089 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -61.8 -43.07 99.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.998 -1.064 . . . . 0.0 112.658 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.33 -11.13 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.96 -48.75 13.95 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.617 -1.302 . . . . 0.0 111.919 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.8 p -77.89 -30.84 50.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.7 t -85.25 -36.12 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.39 -33.1 83.38 Favored Glycine 0 C--O 1.228 -0.24 0 O-C-N 121.077 -1.014 . . . . 0.0 114.078 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.4 p -75.65 -3.45 34.61 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -83.53 -34.84 25.17 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.824 -1.172 . . . . 0.0 110.777 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -38.8 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.266 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 69.7 t80 -52.72 -52.88 60.16 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 C--N 1.35 0.617 1 C-N-CA 113.186 -4.076 . . . . 0.0 114.294 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -67.41 -40.1 85.55 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.091 -1.006 . . . . 0.0 111.273 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 10.0 p90 -75.03 -33.32 61.76 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.901 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.38 -29.83 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -67.34 -42.99 82.62 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.737 -0.602 . . . . 0.0 109.995 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.52 -37.56 85.28 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.379 -0.826 . . . . 0.0 112.838 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.1 tp -63.99 -36.56 84.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.59 -30.98 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.4 t -89.43 110.57 21.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -98.09 44.15 1.05 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.782 1.277 . . . . 0.0 108.435 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -72.59 174.32 4.54 Favored Pre-proline 0 C--O 1.255 1.376 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 172.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.8 60.48 2.91 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 117.845 -0.97 . . . . 0.0 113.157 159.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -77.35 92.76 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -92.45 -38.3 12.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 162.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.02 -43.62 90.52 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.733 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 m -72.28 -26.28 61.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.369 1.085 . . . . 0.0 110.623 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.32 -41.39 85.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -76.78 -12.46 59.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.475 -0.766 . . . . 0.0 112.831 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.21 61.5 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.67 -42.11 95.6 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.32 -41.85 97.69 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -65.95 -46.47 78.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.926 0.869 . . . . 0.0 113.096 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -74.16 -35.05 64.01 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.97 -20.15 56.45 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.717 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -67.68 -33.34 74.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.076 1.307 . . . . 0.0 109.384 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.23 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.0 -34.8 79.3 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -38.9 90.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.845 0.858 . . . . 0.0 108.986 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -53.51 38.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.325 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -59.94 -29.65 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.021 -0.694 . . . . 0.0 112.016 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.6 -57.82 6.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -73.96 -12.33 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -166.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.9 t -61.71 -49.0 86.08 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 121.043 -1.035 . . . . 0.0 110.429 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -100.39 -39.65 7.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.41 -45.69 1.28 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.09 -163.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.112 2.956 . . . . 0.0 114.557 170.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.27 164.35 1.82 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.351 0.66 . . . . 0.0 109.885 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 mt -71.17 -22.87 22.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 121.48 -0.762 . . . . 0.0 110.389 -165.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -53.3 -35.19 59.85 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 167.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.21 -30.86 4.64 Favored Glycine 0 CA--C 1.518 0.259 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -129.76 -43.8 1.22 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -160.71 177.95 9.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.41 101.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 119.688 1.131 . . . . 0.0 109.471 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 175.78 5.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.89 60.77 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.59 -31.14 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.38 -0.825 . . . . 0.0 112.485 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 6.3 t0 -81.21 -37.53 28.48 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.598 -1.314 . . . . 0.0 108.11 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.96 -16.9 64.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.161 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.6 m -79.97 -36.4 36.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.92 -36.39 11.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.19 76.43 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -68.81 -19.91 40.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 113.809 -3.661 . . . . 0.0 116.807 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -94.26 -22.83 18.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.078 -1.014 . . . . 0.0 111.532 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.19 -36.64 84.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.72 -43.25 94.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.371 -0.83 . . . . 0.0 112.887 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 12.3 m-70 -71.65 -29.22 64.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.301 -0.874 . . . . 0.0 112.443 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.3 -49.5 73.76 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.31 -37.58 83.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.6 m -80.07 -27.04 12.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.424 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.22 -44.11 7.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.09 -41.31 97.35 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.92 -38.68 95.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.748 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -73.98 -41.19 62.3 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.145 -1.209 . . . . 0.0 113.368 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -107.17 -46.55 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.25 61.05 0.75 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -165.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.14 104.09 0.22 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -142.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -150.02 100.73 3.22 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 123.465 0.706 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.5 160.42 41.59 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 115.647 -2.435 . . . . 0.0 110.087 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.3 130.59 90.87 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.63 158.32 39.78 Favored 'Trans proline' 0 C--N 1.346 0.409 0 N-CA-C 114.878 1.069 . . . . 0.0 114.878 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.66 2.85 49.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -68.21 -23.11 64.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 159.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.5 mt -114.65 42.23 2.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.333 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 51.9 m -53.41 -31.72 46.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.974 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -61.19 -36.04 78.79 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.292 -1.505 . . . . 0.0 113.234 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 -40.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.7 tp -60.05 -39.47 86.07 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.52 -0.737 . . . . 0.0 111.773 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -72.75 -23.8 60.88 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.616 -0.678 . . . . 0.0 112.164 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -38.85 61.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.5 mm -65.87 -39.61 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.11 -37.56 87.87 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.543 -1.348 . . . . 0.0 112.787 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.81 -44.85 88.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.7 -44.6 86.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.875 0.735 . . . . 0.0 110.798 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.85 -21.45 29.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.49 39.98 3.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.874 0.369 . . . . 0.0 111.465 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -72.18 143.09 49.02 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 100.445 -3.909 . . . . 0.0 100.445 155.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.03 -34.11 77.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 119.785 1.175 . . . . 0.0 110.213 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -61.65 -43.36 99.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.719 0.771 . . . . 0.0 111.006 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -70.87 -37.45 73.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.902 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.01 -44.45 82.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.0 -30.39 31.59 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.8 p -104.72 11.28 34.15 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -76.59 153.4 35.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.606 -0.684 . . . . 0.0 111.562 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.72 152.06 33.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.91 133.13 47.8 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.39 -34.29 76.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -160.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -56.81 -20.03 20.42 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -175.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -116.9 15.82 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 110.949 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.96 -46.74 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 101.794 -3.409 . . . . 0.0 101.794 156.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.23 -60.79 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.501 0.32 . . . . 0.0 110.76 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.07 60.42 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.118 -1.614 . . . . 0.0 114.173 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.96 -28.56 11.76 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 118.127 2.011 . . . . 0.0 118.127 -171.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -101.15 -24.33 14.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 111.581 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -71.56 -6.58 0.1 Allowed Pre-proline 0 C--O 1.242 0.679 0 N-CA-C 121.737 3.977 . . . . 0.0 121.737 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.35 -20.68 42.15 Favored 'Trans proline' 0 C--N 1.357 1.011 1 C-N-CA 109.944 -6.237 . . . . 0.0 114.474 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.62 -12.71 59.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.145 -0.972 . . . . 0.0 111.45 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 89.3 t -82.69 -43.86 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.88 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -114.27 -19.72 11.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.491 -2.195 . . . . 0.0 108.938 179.613 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.4 171.69 14.45 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 167.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.4 139.75 53.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -173.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -165.63 164.5 19.14 Favored 'General case' 0 C--O 1.245 0.854 1 N-CA-C 96.289 -5.449 . . . . 0.0 96.289 178.124 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -151.34 -10.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.0 122.54 7.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.369 2.35 . . . . 0.0 117.341 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.56 158.52 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.606 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.75 134.13 44.85 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.12 165.66 20.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 138.48 58.35 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.64 132.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.22 -50.97 4.33 Favored Glycine 0 CA--C 1.516 0.122 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.62 76.64 69.82 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 122.588 0.355 . . . . 0.0 111.418 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.25 114.11 2.71 Favored 'Trans proline' 0 C--O 1.234 0.278 0 CA-C-O 122.352 0.897 . . . . 0.0 111.62 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -166.96 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.69 159.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.2 tp -44.91 142.53 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.847 1.259 . . . . 0.0 112.084 160.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.96 -169.68 30.93 Favored Glycine 0 C--O 1.23 -0.111 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -72.85 98.2 2.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.447 1.117 . . . . 0.0 108.602 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -142.04 105.0 5.67 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.045 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.62 -44.44 48.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 115.346 1.248 . . . . 0.0 115.346 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -78.18 -29.78 48.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.9 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.1 m -65.77 -46.12 79.96 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.694 -0.629 . . . . 0.0 112.405 -169.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.27 -12.47 60.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.359 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.33 -44.81 95.62 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.86 -46.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.37 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.87 -39.91 87.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.2 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.8 -40.49 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.787 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.6 p -68.86 -34.25 75.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.646 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -40.35 42.93 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.07 -0.394 . . . . 0.0 110.869 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -73.08 -29.74 63.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.714 -0.616 . . . . 0.0 112.309 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.1 -33.47 75.87 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.295 -1.503 . . . . 0.0 110.587 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -87.27 0.07 55.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 53.21 32.38 13.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.439 1.896 . . . . 0.0 114.618 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.7 121.23 66.5 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.05 142.14 34.01 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 115.703 -2.398 . . . . 0.0 112.475 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -140.45 176.39 8.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.823 0.849 . . . . 0.0 109.064 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.77 155.12 28.39 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 t -154.29 138.43 16.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 119.678 1.126 . . . . 0.0 110.823 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -96.64 136.38 37.25 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.26 105.67 16.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.6 mm -79.25 95.03 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -78.55 80.83 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.239 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 52.62 51.8 15.34 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 155.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.47 34.02 6.87 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.696 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.86 -58.54 5.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -106.28 142.73 25.5 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.356 -160.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.75 -166.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.241 0.654 0 N-CA-C 116.166 1.564 . . . . 0.0 116.166 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -41.74 -31.73 0.33 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 118.833 2.901 . . . . 0.0 118.833 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -51.81 -42.03 62.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.472 1.033 . . . . 0.0 113.184 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -24.56 22.43 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.971 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.56 -26.01 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.608 0.718 . . . . 0.0 110.783 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.32 -30.3 70.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.75 -44.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.805 -170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -88.33 118.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 121.641 -0.662 . . . . 0.0 110.815 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -34.36 97.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 116.377 1.645 . . . . 0.0 116.377 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.2 4.15 39.09 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.282 -0.886 . . . . 0.0 110.611 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.23 -15.51 8.8 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -142.69 24.2 1.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.31 156.13 47.57 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 156.2 51.45 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 117.198 -1.401 . . . . 0.0 113.358 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -145.48 123.18 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.784 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 4' ' ' GLU . 43.7 t -88.82 119.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 173.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.99 130.44 34.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 161.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.94 103.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t0 61.69 39.12 14.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.457 1.123 . . . . 0.0 112.813 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 t0 58.87 36.58 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.777 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.23 144.94 50.59 Favored 'General case' 0 C--N 1.323 -0.568 1 N-CA-C 98.684 -4.561 . . . . 0.0 98.684 164.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -128.84 156.31 43.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.02 123.97 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.32 81.53 0.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.79 148.58 26.49 Favored 'General case' 0 N--CA 1.471 0.581 1 N-CA-C 98.649 -4.574 . . . . 0.0 98.649 162.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -60.26 -28.85 68.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -166.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.2 -28.96 17.5 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.629 -0.67 . . . . 0.0 112.446 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.49 -22.99 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.156 -0.965 . . . . 0.0 110.483 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.93 -0.88 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.752 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.34 -60.16 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.376 165.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -50.0 36.4 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.37 -26.55 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.5 tp -63.5 -39.44 94.45 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.432 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.9 -34.41 77.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.363 1.438 . . . . 0.0 111.033 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.82 -36.95 85.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.969 0.89 . . . . 0.0 111.36 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -91.09 -3.86 56.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -70.31 133.17 87.49 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.8 -15.65 26.64 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 115.254 -2.698 . . . . 0.0 114.864 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -87.89 170.64 11.15 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.48 139.08 86.57 Favored 'Trans proline' 0 C--N 1.353 0.768 0 N-CA-C 117.128 1.934 . . . . 0.0 117.128 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.63 110.47 2.41 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 114.014 0.736 . . . . 0.0 114.014 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.8 mt -118.58 56.88 0.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.73 88.0 2.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -116.42 123.75 30.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 166.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -94.49 67.07 0.32 Allowed 'Trans proline' 0 CA--C 1.556 1.593 0 N-CA-C 119.253 2.751 . . . . 0.0 119.253 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.35 -167.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.764 -1.024 . . . . 0.0 111.028 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 14.71 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 1 N-CA-C 122.286 4.18 . . . . 0.0 122.286 167.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.33 -22.16 62.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.639 -0.663 . . . . 0.0 111.697 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.49 75.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.377 0.535 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -44.98 89.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.235 0.54 . . . . 0.0 109.755 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.56 -41.03 85.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.831 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.31 90.42 Favored Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.602 -0.686 . . . . 0.0 112.245 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -70.63 -8.79 54.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -101.55 -33.89 9.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 111.133 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.13 -42.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 122.891 0.477 . . . . 0.0 110.27 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -54.56 55.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.48 -30.36 79.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 114.961 -2.892 . . . . 0.0 114.52 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -61.59 -54.3 44.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.922 0.328 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -70.98 -27.72 63.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 117.916 -1.513 . . . . 0.0 113.906 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 m -74.03 -36.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.962 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -62.47 -51.32 67.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.93 -42.19 85.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.761 1.619 . . . . 0.0 112.302 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -71.52 -30.77 66.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.439 0.638 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -81.57 138.16 35.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.172 0.987 . . . . 0.0 113.641 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -124.84 30.75 5.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.29 173.42 7.02 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.44 51.76 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 CA-C-N 121.492 1.569 . . . . 0.0 116.126 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -75.45 106.41 6.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.39 -51.49 1.01 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 -40.14 94.85 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -18.02 59.48 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 120.607 -1.525 . . . . 0.0 114.237 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.76 -33.05 71.89 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.74 3.79 15.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.056 -1.028 . . . . 0.0 113.222 173.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.77 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 119.836 -1.79 . . . . 0.0 107.417 165.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.06 -37.88 81.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.496 -0.753 . . . . 0.0 109.705 171.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.28 -43.54 83.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -69.82 -34.65 73.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.72 -37.06 79.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.374 -1.454 . . . . 0.0 110.696 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.16 -20.88 59.13 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.267 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -71.27 -32.68 68.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.722 -1.237 . . . . 0.0 110.579 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.37 93.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.8 -41.38 97.91 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.557 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.9 -37.66 80.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.161 0.985 . . . . 0.0 110.838 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.29 -51.7 47.06 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.94 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -64.97 -32.73 74.59 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.604 -0.939 . . . . 0.0 111.062 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.3 -46.98 78.23 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.253 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.13 -24.59 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.885 1.221 . . . . 0.0 112.677 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -76.02 -49.25 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 122.128 -0.357 . . . . 0.0 111.501 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -83.7 -26.11 30.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.78 -93.6 1.12 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -71.57 -177.73 2.63 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 118.496 2.46 . . . . 0.0 118.496 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -36.65 148.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.081 2.153 . . . . 0.0 114.001 170.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 pt -77.37 23.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -149.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.44 -20.37 60.05 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.302 -1.499 . . . . 0.0 109.405 149.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.39 67.86 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -145.57 -54.93 0.29 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -163.21 -173.71 3.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.9 mt -77.1 114.94 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -138.93 -170.23 2.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -39.66 -45.36 1.66 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 119.62 3.193 . . . . 0.0 119.62 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.55 -39.27 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.239 . . . . 0.0 110.365 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.81 -44.64 66.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.336 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.43 -19.03 65.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.445 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -81.24 -44.65 17.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 27.6 tp -87.91 -45.79 9.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.2 -37.59 55.05 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.26 -36.9 26.35 Favored 'Trans proline' 0 C--N 1.354 0.842 1 C-N-CA 111.519 -5.187 . . . . 0.0 113.47 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -77.77 -24.26 49.01 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.63 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.74 -34.84 76.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.597 1.09 . . . . 0.0 112.434 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -66.17 -44.67 83.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.258 -0.901 . . . . 0.0 110.521 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -66.42 -31.62 72.5 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.0 -54.04 47.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -71.11 -34.32 70.97 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.96 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.11 -36.37 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.02 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.55 12.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.532 1.06 . . . . 0.0 110.232 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.34 -35.84 81.38 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.17 92.89 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.629 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -85.57 -24.94 27.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.363 -1.081 . . . . 0.0 113.439 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -101.55 -40.48 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -139.43 47.75 1.87 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 109.987 -172.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -34.31 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 -149.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -146.36 107.23 4.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.61 169.07 15.64 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 118.378 0.456 . . . . 0.0 111.935 162.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 93.8 mt -67.3 124.51 89.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -73.02 164.65 34.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.52 -8.35 57.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.505 0.669 . . . . 0.0 110.493 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.29 -24.12 67.11 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.669 166.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -118.5 44.47 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.8 t -63.12 -18.33 63.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -165.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.41 -33.93 65.23 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.915 -1.741 . . . . 0.0 109.371 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.88 -46.49 79.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.3 -41.79 98.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.286 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -65.06 -48.27 74.38 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 120.862 -1.149 . . . . 0.0 111.436 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -31.77 70.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.24 -175.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.01 -31.13 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 119.575 1.079 . . . . 0.0 111.716 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -71.09 -34.66 71.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.104 -1.622 . . . . 0.0 111.16 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.71 -41.39 92.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.33 -38.74 91.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -54.57 -41.08 69.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.579 0.627 . . . . 0.0 111.201 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 t -91.25 -0.11 57.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -64.99 144.2 57.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -58.4 -43.25 88.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.322 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.6 t -60.36 -46.87 88.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -42.78 79.93 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.531 -0.73 . . . . 0.0 111.803 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.64 -42.05 82.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.919 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -77.12 -31.69 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.6 p -99.92 -9.05 23.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -64.88 142.74 58.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.123 0.874 . . . . 0.0 112.409 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.75 161.44 30.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.79 133.97 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.72 -35.29 79.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -52.5 -39.56 61.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.621 0.768 . . . . 0.0 112.661 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.72 -14.84 29.31 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.712 -0.618 . . . . 0.0 111.893 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 43.3 t -74.5 -37.59 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.4 mt -66.32 -37.74 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.295 -0.878 . . . . 0.0 108.703 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.45 -5.97 12.98 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.477 -0.764 . . . . 0.0 112.622 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.91 73.49 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.777 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -93.09 -23.24 18.69 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 118.619 1.209 . . . . 0.0 109.927 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.37 128.88 94.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.719 0.408 . . . . 0.0 111.424 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.14 4.27 0.76 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 CA-C-N 119.674 0.919 . . . . 0.0 112.446 -65.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -54.63 -29.74 52.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . 0.285 27.8 m 47.59 12.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.947 2.499 . . . . 0.0 117.109 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 43.3 t30 49.21 -0.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.994 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.744 -174.329 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 tpp . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.04 4.12 1.93 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 mp -131.95 -21.24 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -87.67 -4.82 58.91 Favored 'General case' 0 C--N 1.322 -0.595 1 N-CA-C 124.968 5.173 . . . . 0.0 124.968 -146.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.502 HG23 HG13 ' A' ' 7' ' ' VAL . 10.1 mm -87.93 126.89 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 122.647 2.476 . . . . 0.0 112.38 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.401 ' HB2' HG22 ' A' ' 62' ' ' VAL . 72.4 m -129.64 121.11 26.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 152.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.502 HG13 HG23 ' A' ' 5' ' ' ILE . 11.7 m -137.2 156.14 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.685 1.129 . . . . 0.0 113.812 -174.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.96 133.29 55.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.3 165.48 13.41 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 144.4 57.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.69 131.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -44.84 3.41 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 118.851 -0.971 . . . . 0.0 114.925 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.32 85.04 52.03 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -72.85 62.24 3.87 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 121.397 1.398 . . . . 0.0 115.291 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -141.57 -10.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.047 1.339 . . . . 0.0 111.002 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.3 tt -135.42 156.23 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.83 156.6 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.01 0.924 . . . . 0.0 112.39 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.81 156.06 17.94 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.42 95.12 5.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.792 0.806 . . . . 0.0 112.685 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 75.0 m -100.16 150.23 36.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 139.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.16 -34.69 98.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.034 -1.511 . . . . 0.0 114.053 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.24 -31.04 70.83 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.96 -51.91 67.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -30.04 63.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.297 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -59.8 -40.1 87.21 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.01 -1.056 . . . . 0.0 111.494 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.46 -50.6 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -60.87 -39.13 88.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 tp -58.07 -45.18 87.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.798 0.726 . . . . 0.0 110.988 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.0 p -66.13 -36.7 83.84 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.16 -0.963 . . . . 0.0 111.5 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.08 -41.68 70.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.907 -0.496 . . . . 0.0 111.465 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -32.13 58.78 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.927 -0.483 . . . . 0.0 112.251 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.7 -37.22 81.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.173 -0.954 . . . . 0.0 111.6 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -91.92 1.97 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.507 0.67 . . . . 0.0 111.349 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 57.62 26.3 12.72 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.136 1.774 . . . . 0.0 114.71 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.56 141.71 48.97 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -68.01 164.81 30.43 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 116.377 -1.948 . . . . 0.0 110.78 175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -154.28 151.31 28.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -79.91 148.48 31.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -128.38 125.75 39.28 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.107 0.88 . . . . 0.0 110.591 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -111.9 112.22 23.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -80.84 134.23 35.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.64 116.93 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -79.32 79.18 5.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 112.658 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt 57.3 39.43 28.5 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.26 69.63 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.24 -0.981 . . . . 0.0 114.215 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.85 118.17 14.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 149.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.26 122.72 7.58 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.616 0.246 . . . . 0.0 111.619 -172.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.1 176.32 10.09 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.378 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -55.66 -37.27 68.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.863 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -53.62 -45.72 70.21 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -80.11 -22.73 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.676 -1.265 . . . . 0.0 112.488 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.241 -0.912 . . . . 0.0 111.049 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.05 -11.56 60.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.439 -0.788 . . . . 0.0 112.13 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.94 -61.06 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.654 0.74 . . . . 0.0 112.358 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -86.86 129.97 50.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 -166.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.02 -28.65 41.39 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 116.082 -2.146 . . . . 0.0 114.03 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -89.28 -10.49 46.67 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.042 -1.036 . . . . 0.0 111.077 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.01 -7.2 36.97 Favored Glycine 0 C--O 1.22 -0.726 0 O-C-N 121.709 -0.619 . . . . 0.0 113.003 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -144.85 16.27 1.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.47 143.13 28.76 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -59.18 156.48 34.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 N-CA-C 114.676 0.991 . . . . 0.0 114.676 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 6' ' ' CYS . 24.4 m -134.98 169.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.5 m -106.76 142.7 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 160.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -126.67 53.48 1.67 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 123.033 1.397 . . . . 0.0 111.112 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -68.35 126.8 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 57.17 30.77 18.89 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.193 0.997 . . . . 0.0 111.864 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.13 18.13 11.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.082 1.753 . . . . 0.0 113.482 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -106.25 112.2 25.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.19 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -74.9 140.29 43.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.45 130.02 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.16 41.52 1.51 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -157.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.78 144.63 39.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.557 -1.34 . . . . 0.0 108.331 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -58.83 -32.35 69.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -75.97 -31.75 59.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.241 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.75 -11.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.635 -1.291 . . . . 0.0 110.342 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.12 -26.51 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 t -73.79 -44.01 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.388 -1.445 . . . . 0.0 110.447 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.54 -64.77 0.83 Allowed Glycine 0 CA--C 1.519 0.341 0 N-CA-C 119.986 2.754 . . . . 0.0 119.986 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.53 -38.06 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.969 0.884 . . . . 0.0 111.748 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.14 -45.76 83.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.888 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.87 -28.05 60.5 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.641 -1.224 . . . . 0.0 113.316 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -63.14 -40.99 99.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.56 -7.91 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -68.15 119.11 65.16 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 160.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.15 0.65 9.51 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 116.064 1.524 . . . . 0.0 116.064 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.92 162.55 67.63 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.66 132.48 49.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 115.956 1.483 . . . . 0.0 115.956 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.16 140.28 19.7 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 116.878 -1.615 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.7 mt -137.25 43.23 2.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.308 0.575 . . . . 0.0 111.501 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 80.14 4.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.968 0.89 . . . . 0.0 110.437 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.8 m -116.59 93.54 40.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -90.73 81.18 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.08 3.187 . . . . 0.0 117.543 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -87.97 -137.37 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.528 0.867 . . . . 0.0 112.704 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.45 -30.95 68.87 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.941 -1.1 . . . . 0.0 112.874 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -63.26 -29.75 71.02 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.553 -0.717 . . . . 0.0 110.597 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.91 -28.73 25.72 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.095 -0.378 . . . . 0.0 111.995 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.2 p -73.53 -33.08 64.57 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.69 -49.17 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.65 62.24 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -60.39 -26.5 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -81.44 -42.62 20.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.049 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.98 -41.06 79.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.022 -166.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.48 -56.29 33.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.08 -20.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 113.827 -3.648 . . . . 0.0 113.856 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -64.76 -49.88 69.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.583 1.083 . . . . 0.0 109.943 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -72.14 -31.19 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.68 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.81 -40.01 80.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.32 -40.53 81.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.425 -1.422 . . . . 0.0 111.959 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.91 -26.71 67.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.206 0.912 . . . . 0.0 111.944 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.83 -50.67 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -70.1 -24.88 63.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.5 t -75.84 141.35 42.47 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.707 -0.62 . . . . 0.0 110.795 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -130.0 32.66 4.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.58 167.99 2.12 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 162.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -65.89 92.11 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 116.953 -1.565 . . . . 0.0 112.222 165.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.42 106.84 18.77 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.561 -169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -148.0 -48.87 0.16 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.788 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.44 -33.29 86.09 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.4 p -76.77 -20.31 56.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.594 -0.945 . . . . 0.0 113.381 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -75.3 -31.08 60.56 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.38 -28.38 59.48 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 172.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.27 95.19 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.906 -1.121 . . . . 0.0 110.09 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.53 -38.98 93.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.739 -0.601 . . . . 0.0 110.815 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -43.68 94.04 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.525 173.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -67.4 -36.97 82.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.406 1.003 . . . . 0.0 112.977 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.67 -45.7 81.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.89 -20.32 61.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 120.823 -1.173 . . . . 0.0 110.597 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.56 -28.77 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.753 -1.217 . . . . 0.0 111.557 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 -42.31 89.83 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.1 -38.39 85.59 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.01 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.96 -38.65 89.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.3 0.64 . . . . 0.0 109.808 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.59 -54.87 23.39 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.151 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -62.27 -28.18 69.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.822 -0.81 . . . . 0.0 112.577 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.27 -54.66 13.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.823 -0.548 . . . . 0.0 110.103 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.85 -22.29 65.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.21 -9.76 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.119 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -119.65 -44.53 2.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.53 -46.38 1.18 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 119.639 2.616 . . . . 0.0 119.639 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -68.79 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.695 3.248 . . . . 0.0 116.744 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -58.0 175.1 0.22 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.326 1.05 . . . . 0.0 112.444 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.63 -32.26 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.431 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.57 -3.81 5.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.28 -5.29 60.2 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -137.24 -53.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.692 1.246 . . . . 0.0 113.171 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.49 177.6 5.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 100.984 -3.71 . . . . 0.0 100.984 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.92 126.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.18 1.354 . . . . 0.0 109.181 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 m -143.29 174.39 10.76 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -41.59 -40.26 1.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.66 -32.01 56.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 120.495 1.498 . . . . 0.0 110.942 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.92 -39.23 79.76 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.27 -34.85 78.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.2 p -74.07 -37.24 64.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.74 -46.94 3.7 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -167.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.59 92.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.31 -13.73 18.65 Favored 'Trans proline' 0 C--N 1.349 0.591 1 C-N-CA 111.987 -4.876 . . . . 0.0 113.327 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -91.87 -26.67 18.37 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.909 -0.494 . . . . 0.0 110.477 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.7 -34.18 76.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.947 -0.47 . . . . 0.0 110.635 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.58 -50.14 63.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.468 1.128 . . . . 0.0 108.988 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -73.52 -14.89 61.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.718 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.3 tp -65.76 -54.27 29.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.216 0.916 . . . . 0.0 109.674 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.98 -26.85 63.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.437 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.9 -58.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 121.67 -0.644 . . . . 0.0 110.233 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.75 54.48 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.015 -1.053 . . . . 0.0 111.581 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.4 -37.92 83.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.51 95.66 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.993 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -72.31 -34.18 67.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.011 1.405 . . . . 0.0 113.418 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.03 -33.95 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 118.818 2.896 . . . . 0.0 118.818 -172.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.02 61.97 1.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -53.86 114.54 1.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -158.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -133.61 97.35 15.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 160.25 40.86 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.034 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 84.2 mt -73.11 122.4 87.56 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.59 165.36 25.08 Favored 'Trans proline' 0 C--N 1.346 0.438 0 N-CA-C 114.526 0.933 . . . . 0.0 114.526 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.22 -5.71 45.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.801 -0.562 . . . . 0.0 112.007 175.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.11 -21.87 64.92 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.985 -0.447 . . . . 0.0 110.801 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.65 58.68 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.48 72.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.451 -167.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -78.02 -35.62 49.61 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.989 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.8 -39.2 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.57 -42.38 91.84 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.592 -0.693 . . . . 0.0 111.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.99 -36.02 81.25 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 120.997 -1.065 . . . . 0.0 110.083 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -64.75 -43.32 93.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.0 -25.72 30.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 O-C-N 120.404 -1.435 . . . . 0.0 110.514 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.93 -25.94 66.61 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.065 -1.647 . . . . 0.0 112.091 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -71.67 -30.51 65.79 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.696 0.68 . . . . 0.0 109.176 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.26 -28.45 42.39 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.824 0.345 . . . . 0.0 110.263 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -79.48 13.2 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 120.835 -1.166 . . . . 0.0 111.124 170.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.4 t -134.67 171.09 14.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 60.16 136.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.04 -32.35 67.89 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.376 -0.828 . . . . 0.0 112.772 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.5 m -55.76 -32.59 63.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -102.23 -46.16 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.391 1.091 . . . . 0.0 110.49 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.15 -33.29 75.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -79.61 -32.25 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.497 -0.752 . . . . 0.0 110.898 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 41.0 p -91.67 -16.89 26.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.36 148.57 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.863 . . . . 0.0 111.967 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.93 152.81 37.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.596 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.32 51.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.33 -33.91 76.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.43 -35.34 80.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.511 1.148 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -80.76 -22.54 40.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.219 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.67 -51.79 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.4 pt -73.47 -36.02 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.71 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -20.07 65.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.51 13.11 Favored Glycine 0 CA--C 1.517 0.18 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -95.81 -25.77 15.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.369 1.585 . . . . 0.0 115.069 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -94.32 -10.27 0.15 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 121.507 3.892 . . . . 0.0 121.507 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.63 -17.67 23.1 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 113.674 -3.75 . . . . 0.0 117.077 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -102.44 4.39 38.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.702 0.683 . . . . 0.0 109.781 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.9 t -98.81 -46.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.909 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -101.23 6.49 42.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.808 0.813 . . . . 0.0 111.635 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.9 -157.7 0.1 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.952 1.301 . . . . 0.0 113.174 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.16 161.11 30.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -138.14 126.24 22.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 HG13 ' A' ' 7' ' ' VAL . 40.4 mm -110.75 103.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -166.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -98.43 71.42 2.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.042 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 5' ' ' ILE . 18.7 m -93.01 157.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.298 -170.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 20' ' ' CYS . 37.0 mtmt -62.87 142.91 58.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -82.21 161.88 22.58 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 171.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.31 143.85 54.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.868 1.318 . . . . 0.0 113.849 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.44 130.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -4.78 48.84 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.978 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.39 78.59 4.6 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.305 1.053 . . . . 0.0 112.369 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 75.6 Cg_endo -72.51 45.47 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 119.043 2.67 . . . . 0.0 119.043 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -131.01 -7.16 3.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 114.187 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.28 159.18 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.7 mt -61.18 142.55 56.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.24 153.43 22.22 Favored Glycine 0 CA--C 1.508 -0.383 0 O-C-N 121.514 -0.741 . . . . 0.0 114.9 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.93 103.13 10.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.655 1.217 . . . . 0.0 108.814 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 23.5 t -132.69 137.63 30.2 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.36 -29.13 72.08 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 115.32 -2.653 . . . . 0.0 112.304 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -80.9 -16.87 52.41 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.452 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -70.23 -52.01 26.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.84 -20.08 65.12 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.943 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -61.02 -43.75 98.43 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.668 2.031 . . . . 0.0 111.554 167.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.01 -54.61 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.03 -37.82 86.84 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.6 -39.5 88.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.3 p -70.59 -40.2 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 112.416 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -48.14 76.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.539 -177.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -74.57 -28.94 61.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.515 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -71.19 -36.39 71.93 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.59 -0.694 . . . . 0.0 111.191 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.17 -5.53 59.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 53.64 36.81 24.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 113.724 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.7 pt -84.25 153.44 62.6 Favored Pre-proline 0 C--O 1.246 0.879 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.795 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.4 137.61 25.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.068 -1.488 . . . . 0.0 114.689 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -151.77 161.58 42.43 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.3 126.41 52.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.2 t -88.62 135.08 33.68 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -137.2 129.56 29.72 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 71.4 mt -107.07 132.08 53.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -173.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.7 mm -105.48 101.32 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.789 1.236 . . . . 0.0 111.018 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -69.59 83.21 0.42 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.421 1.088 . . . . 0.0 113.486 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 51.12 48.26 23.37 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 122.921 1.343 . . . . 0.0 113.61 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 57.72 1.93 Allowed Glycine 0 CA--C 1.518 0.261 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.266 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.35 85.55 7.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.9 86.44 57.41 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-O 122.021 0.915 . . . . 0.0 112.219 -157.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.93 -176.51 3.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.073 -1.484 . . . . 0.0 108.31 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -47.55 -40.73 19.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.551 0.74 . . . . 0.0 112.602 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -55.87 -47.06 78.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -89.68 -21.75 22.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.11 -43.6 94.82 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -70.79 -38.8 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.502 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.3 mt -110.77 87.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.523 0.678 . . . . 0.0 112.381 -172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t 174.26 145.92 0.21 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.1 -25.12 77.09 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 116.876 1.837 . . . . 0.0 116.876 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -125.96 -14.09 6.17 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.07 -9.42 67.82 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-O 122.335 0.964 . . . . 0.0 111.642 -168.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -155.47 88.75 1.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.12 0.968 . . . . 0.0 110.534 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -143.37 150.35 51.25 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -67.09 98.51 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 115.913 -2.258 . . . . 0.0 113.145 162.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.6 t -91.55 137.72 21.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.455 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.58 113.47 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.77 126.32 33.92 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 t0 50.42 56.46 7.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.781 0.801 . . . . 0.0 112.821 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 65.5 24.31 11.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -124.97 144.13 50.53 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -123.71 132.38 53.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 118.817 0.735 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.07 134.03 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -170.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.52 -22.16 0.33 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.2 138.97 58.72 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -62.98 -29.16 70.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -165.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -85.9 -7.3 58.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.61 -10.6 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.2 -0.938 . . . . 0.0 110.16 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.07 -36.28 76.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.58 -39.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.37 -73.51 1.16 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 120.371 2.909 . . . . 0.0 120.371 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.57 -38.14 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.687 -0.89 . . . . 0.0 111.986 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.57 -41.84 95.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.795 0.725 . . . . 0.0 109.638 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.58 -34.33 73.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.39 -35.39 75.74 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.006 -1.059 . . . . 0.0 111.108 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.01 7.51 45.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.38 137.19 97.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.73 -29.11 82.92 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 117.134 -1.444 . . . . 0.0 115.299 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -81.09 169.26 19.94 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 109.811 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -57.42 134.33 62.9 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 116.811 -1.659 . . . . 0.0 116.021 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.6 135.45 3.0 Favored 'Trans proline' 0 C--O 1.247 0.962 0 N-CA-C 118.3 2.385 . . . . 0.0 118.3 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.3 mt -135.37 43.5 2.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.81 82.01 2.74 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.484 -1.385 . . . . 0.0 111.611 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -118.65 94.83 48.22 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.569 1.148 . . . . 0.0 113.775 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -106.15 59.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.905 0 N-CA-C 122.248 3.903 . . . . 0.0 122.248 -174.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -82.25 -126.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.691 0.928 . . . . 0.0 114.049 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -57.29 -32.23 66.43 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 120.982 -1.074 . . . . 0.0 112.677 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.16 -32.79 74.44 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.146 -0.972 . . . . 0.0 111.847 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.52 -33.19 60.71 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.612 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.1 p -71.27 -34.6 70.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.96 -45.42 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 123.024 0.202 . . . . 0.0 110.516 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.94 87.38 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.377 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -73.51 -0.4 14.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -94.14 -33.93 13.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 167.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.7 mt -82.26 -39.52 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.68 0.753 . . . . 0.0 110.416 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 19.9 t80 -51.64 -50.41 77.38 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.69 -33.75 12.56 Favored 'Trans proline' 0 C--N 1.347 0.478 1 C-N-CA 111.648 -5.101 . . . . 0.0 114.543 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -72.5 -39.77 67.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.253 0.479 . . . . 0.0 111.104 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 1.9 p90 -68.8 -30.0 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.908 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.54 -47.81 62.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -61.98 -44.12 97.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -75.28 -37.14 61.04 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.428 -174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -34.3 78.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.85 0.833 . . . . 0.0 110.579 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -76.65 0.05 21.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.124 0.97 . . . . 0.0 112.108 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -121.05 114.31 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -87.39 49.55 1.83 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.566 1.651 . . . . 0.0 110.309 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -88.51 170.47 11.18 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.62 50.31 2.67 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 CA-C-N 120.174 1.098 . . . . 0.0 114.938 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.04 100.39 4.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.897 1.279 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.9 -45.96 0.86 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 -38.09 93.67 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 166.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.0 m -69.57 -30.65 68.49 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.767 -0.843 . . . . 0.0 111.981 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.66 -28.88 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.709 -1.87 . . . . 0.0 110.04 172.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -75.7 -10.39 59.39 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.372 -1.455 . . . . 0.0 111.625 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.03 60.31 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 119.814 -1.804 . . . . 0.0 108.126 168.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.79 -34.92 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.549 -0.719 . . . . 0.0 111.164 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.2 -44.8 79.83 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -67.53 -26.44 66.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -77.47 -35.93 53.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 120.615 -1.303 . . . . 0.0 109.679 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.3 -20.55 60.08 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.728 -0.608 . . . . 0.0 109.52 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.92 -30.09 69.33 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.463 -0.773 . . . . 0.0 111.395 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.61 -42.09 87.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.02 -43.97 93.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.681 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.75 -35.94 77.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.91 -50.98 55.47 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.822 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.54 -36.03 81.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.879 -1.365 . . . . 0.0 110.489 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.22 -43.01 99.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -74.43 -27.81 60.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.24 -44.43 77.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.44 -54.21 5.39 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.74 -63.45 0.46 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-O 117.183 -1.899 . . . . 0.0 116.761 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.24 -162.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 1 C-N-CA 127.98 5.787 . . . . 0.0 118.565 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -55.9 175.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.67 163.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -54.25 -33.19 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.88 58.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.82 89.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 118.395 -1.225 . . . . 0.0 116.141 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -136.53 -52.54 0.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.729 1.764 . . . . 0.0 112.978 165.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -162.73 -177.56 5.62 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 117.635 -1.174 . . . . 0.0 109.96 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.07 118.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.881 1.218 . . . . 0.0 110.347 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.6 m -132.64 177.23 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.23 37.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.63 -18.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.972 -1.08 . . . . 0.0 111.711 173.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.22 -38.04 31.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -28.91 69.63 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 120.719 0.295 . . . . 0.0 110.649 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 93.9 p -77.68 -35.32 52.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.49 -46.81 3.92 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.05 81.41 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.11 -27.89 19.63 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.776 -4.349 . . . . 0.0 114.371 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.88 -29.89 63.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.02 -24.49 64.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.15 -50.35 61.52 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.007 -1.058 . . . . 0.0 110.334 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -55.45 -42.33 74.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.496 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.6 tp -57.35 -61.99 2.09 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.745 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -67.93 -32.85 73.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -170.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 -43.08 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.134 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.84 -42.15 34.55 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.086 -1.009 . . . . 0.0 112.494 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.68 -38.61 91.76 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.9 81.13 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.089 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.45 -48.86 11.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.49 -1.006 . . . . 0.0 112.968 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -86.72 -43.5 12.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -134.87 59.5 1.73 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.9 0.88 . . . . 0.0 108.766 -171.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -49.97 104.51 0.07 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -154.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -147.82 98.96 3.8 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.241 1.817 . . . . 0.0 106.222 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.41 172.06 17.05 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 115.652 -2.432 . . . . 0.0 109.728 167.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.41 118.08 56.15 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -82.19 167.04 16.09 Favored 'Trans proline' 0 C--N 1.352 0.728 0 N-CA-C 114.975 1.106 . . . . 0.0 114.975 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.92 4.2 5.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -69.6 -23.28 63.5 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.33 60.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -66.64 -19.86 65.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.637 -0.664 . . . . 0.0 112.565 -170.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.7 -33.51 40.98 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.22 -37.22 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.767 0.794 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.45 -47.77 84.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.447 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -65.24 -40.38 93.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -55.56 -53.46 56.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.194 0.521 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.43 -25.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.655 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -66.26 -42.36 88.61 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.745 -1.222 . . . . 0.0 111.6 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -41.57 99.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.07 -37.46 85.88 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 123.607 0.567 . . . . 0.0 111.918 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.15 -25.95 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t -122.13 39.56 3.86 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -103.85 136.5 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.93 -44.43 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -59.61 -47.24 86.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.961 0.886 . . . . 0.0 111.962 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -71.93 -43.46 65.26 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.14 -33.08 73.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -75.78 -42.3 50.57 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.027 -1.045 . . . . 0.0 113.094 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.2 p -88.4 -3.23 58.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -57.09 138.92 53.84 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.47 153.4 41.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.98 130.96 40.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.69 -36.97 82.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 -170.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.57 -21.26 62.7 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.505 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -97.29 -14.35 21.39 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.95 -52.34 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.61 -54.54 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.229 -0.294 . . . . 0.0 111.599 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.54 -2.34 35.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 112.654 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.18 -16.97 44.95 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.739 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -106.56 -48.99 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.15 0.976 . . . . 0.0 112.146 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.09 -26.28 2.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -66.81 -17.48 52.11 Favored 'Trans proline' 0 C--N 1.357 0.981 1 C-N-CA 112.316 -4.656 . . . . 0.0 115.501 173.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.37 -19.13 25.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.333 -1.479 . . . . 0.0 110.185 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.29 -47.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 110.601 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.83 6.52 23.49 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.27 143.24 30.92 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.4 138.17 54.39 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.48 131.9 47.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -125.77 95.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -166.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.0 m -98.01 116.91 31.2 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.21 165.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.37 133.4 47.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.556 -0.715 . . . . 0.0 112.127 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.14 165.11 24.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.701 0.4 . . . . 0.0 110.95 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 144.28 56.69 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.906 -0.497 . . . . 0.0 110.268 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.89 124.34 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.67 -13.4 52.78 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.97 89.08 12.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -171.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -69.27 76.26 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-O 123.395 1.331 . . . . 0.0 113.241 162.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -149.75 -38.38 0.15 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.887 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -135.51 153.05 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.08 152.13 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.126 0.965 . . . . 0.0 112.761 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.09 -174.57 17.67 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 202' ' ' VAL . 20.7 t70 -77.61 112.32 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.253 -1.473 . . . . 0.0 112.432 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 146.77 34.42 Favored Pre-proline 0 C--O 1.245 0.848 1 N-CA-C 97.633 -4.951 . . . . 0.0 97.633 159.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -59.26 -35.24 97.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 CA-C-O 122.65 1.021 . . . . 0.0 113.514 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.82 -0.65 53.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.689 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 t -57.41 -42.57 82.53 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.973 0.892 . . . . 0.0 110.844 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -92.41 0.29 57.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -63.67 -44.46 93.67 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.955 1.252 . . . . 0.0 109.109 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.726 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.97 -40.73 98.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.01 -38.82 92.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.181 0.9 . . . . 0.0 110.427 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 m -62.91 -40.28 97.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.064 -176.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.7 mt -69.76 -43.47 72.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.714 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.61 -32.11 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -164.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -78.2 -33.37 50.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.266 -1.373 . . . . 0.0 110.485 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.03 -14.92 58.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.111 -0.368 . . . . 0.0 111.08 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 55.82 33.16 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.745 1.618 . . . . 0.0 113.162 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.83 154.76 87.05 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.26 150.4 41.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 115.681 -2.413 . . . . 0.0 113.275 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -154.62 172.21 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -126.64 94.2 3.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.645 1.178 . . . . 0.0 108.648 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -75.87 139.69 41.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.447 . . . . 0.0 110.769 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.35 144.34 44.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.47 126.05 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -83.2 122.07 36.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -79.46 70.09 5.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt 53.47 50.69 16.8 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 161.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.36 8.66 65.97 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 114.081 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.99 106.55 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 151.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -137.84 86.42 18.27 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -62.32 173.17 3.55 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 118.007 -0.862 . . . . 0.0 110.837 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -53.01 -37.45 61.51 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -53.63 -53.13 56.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -73.85 -29.39 62.1 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 120.803 -1.185 . . . . 0.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.74 -35.65 81.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 119.274 0.943 . . . . 0.0 110.881 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.81 -20.49 61.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.92 -37.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.836 0.827 . . . . 0.0 111.301 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 t -119.71 120.93 30.19 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 109.872 -170.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.71 -29.6 88.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -97.76 2.11 49.17 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.45 -29.5 2.57 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.038 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.16 72.81 1.4 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.857 1.313 . . . . 0.0 113.181 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.43 155.19 52.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 162.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.81 142.19 56.75 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 114.685 -3.077 . . . . 0.0 110.148 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.67 164.0 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 113.33 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -100.73 88.54 3.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mt -88.46 104.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.48 52.55 13.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.883 0.849 . . . . 0.0 111.377 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t0 60.7 30.61 19.82 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -133.14 151.19 52.0 Favored 'General case' 0 C--N 1.323 -0.573 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 173.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -145.45 150.41 36.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 122.471 2.396 . . . . 0.0 116.741 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.75 150.32 32.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.487 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.46 -12.27 1.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 118.097 2.629 . . . . 0.0 118.097 -169.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -68.49 142.94 55.16 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.047 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -60.56 -27.39 67.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -82.95 -35.45 25.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.223 -0.923 . . . . 0.0 111.088 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -83.67 -14.7 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.293 -0.879 . . . . 0.0 112.29 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 pt -70.85 -6.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.665 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.74 -52.7 8.37 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 157.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.55 -47.06 92.18 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 118.819 2.288 . . . . 0.0 118.819 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -82.57 -27.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -60.69 -44.56 96.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.325 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -65.18 -41.56 94.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 118.414 0.552 . . . . 0.0 110.796 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -58.7 -35.99 73.51 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.839 -1.163 . . . . 0.0 112.301 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.15 17.13 23.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.903 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.07 131.7 80.77 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.05 -12.38 30.34 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 114.586 -3.143 . . . . 0.0 115.024 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -114.78 149.57 42.6 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 118.901 0.773 . . . . 0.0 109.864 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.26 121.78 9.94 Favored 'Trans proline' 0 C--O 1.24 0.59 0 N-CA-C 116.46 1.677 . . . . 0.0 116.46 -148.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.32 161.33 20.01 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.4 mt -139.96 64.95 1.44 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.424 1.107 . . . . 0.0 110.531 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.76 63.13 6.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.517 -0.74 . . . . 0.0 111.815 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 104.25 50.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.89 54.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 124.571 3.514 . . . . 0.0 120.752 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.24 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 116.724 -1.717 . . . . 0.0 115.086 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -34.36 72.49 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.011 -1.681 . . . . 0.0 114.21 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -32.12 73.66 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.729 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 -24.96 55.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.6 p -71.93 -37.19 70.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.41 -49.27 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.61 97.0 Favored Glycine 0 CA--C 1.516 0.149 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.413 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -75.9 -10.0 59.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -78.54 -38.48 40.36 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.78 -1.2 . . . . 0.0 109.901 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.23 -48.15 50.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.689 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -51.28 -53.44 49.19 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -170.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.07 -22.67 16.76 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 114.214 -3.391 . . . . 0.0 114.517 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.6 m -67.33 -38.98 85.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -86.38 -23.94 25.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.67 -33.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -63.76 -45.13 91.17 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.606 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -62.74 -38.16 89.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.5 tp -66.94 -46.32 75.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.297 0.953 . . . . 0.0 111.043 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -69.33 -21.68 63.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.488 0.661 . . . . 0.0 111.619 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.7 t -90.38 138.27 31.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -128.08 30.68 5.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.35 171.53 4.04 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -71.93 59.2 2.85 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 120.711 1.29 . . . . 0.0 114.492 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -60.29 122.19 13.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.109 1.764 . . . . 0.0 112.877 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -152.8 -42.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.235 0.541 . . . . 0.0 109.715 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.64 96.48 Favored Glycine 0 C--O 1.22 -0.745 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.8 p -73.62 -17.63 61.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.392 -1.063 . . . . 0.0 113.062 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.59 -39.24 53.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.833 1.301 . . . . 0.0 107.61 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -79.1 -14.22 59.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.663 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.08 80.23 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.671 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.27 -42.45 93.21 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.98 -43.23 95.24 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.006 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -70.7 -42.15 71.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.73 -33.52 68.79 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 120.146 -1.596 . . . . 0.0 108.983 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.27 -16.43 59.0 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 121.437 -0.789 . . . . 0.0 110.656 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -70.8 -33.52 70.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 119.992 1.269 . . . . 0.0 109.61 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 -39.45 89.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.38 -43.8 93.34 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.173 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.41 -39.07 89.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.538 0.735 . . . . 0.0 110.225 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.4 -51.67 50.4 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -61.35 -38.62 87.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.851 -0.794 . . . . 0.0 112.401 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.81 -39.47 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.537 -0.727 . . . . 0.0 110.717 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -72.66 -24.86 61.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.729 1.604 . . . . 0.0 114.48 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.71 -11.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -118.11 -43.73 2.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.12 -76.32 0.23 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.466 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -67.88 -169.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.063 3.175 . . . . 0.0 117.656 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -53.86 168.66 0.19 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.788 1.635 . . . . 0.0 113.962 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -63.2 -21.79 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -151.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.5 -11.63 53.42 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.186 -0.946 . . . . 0.0 113.338 173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.51 0.48 72.87 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -143.74 -49.54 0.3 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -162.32 176.07 10.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.64 125.79 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.9 p -130.72 -172.3 2.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.64 -31.45 25.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.46 -42.97 81.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 118.784 0.72 . . . . 0.0 110.131 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -66.86 -39.02 87.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.61 -21.53 66.58 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.4 m -91.01 -36.07 14.28 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.98 -49.32 7.43 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.6 48.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.18 -31.34 45.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 113.459 -3.894 . . . . 0.0 113.958 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -30.61 42.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.93 -34.55 76.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.032 0.833 . . . . 0.0 113.19 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -61.9 -43.6 98.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.985 1.266 . . . . 0.0 109.907 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -73.56 -28.54 61.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.146 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.7 -52.24 64.07 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.98 -33.23 75.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.025 -172.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.1 t -72.38 -61.87 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.463 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.28 66.77 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 111.293 -168.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.57 -42.94 77.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.54 -34.47 89.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.874 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -95.06 -16.03 22.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -108.69 -39.9 5.23 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -142.22 58.09 1.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -54.65 116.82 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -134.64 98.44 13.5 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 164.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.41 164.59 32.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 115.124 -2.784 . . . . 0.0 109.29 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.32 117.16 54.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 171.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.68 168.69 24.15 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 117.428 -1.248 . . . . 0.0 112.575 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -4.95 41.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.492 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -66.68 -22.12 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.123 -0.986 . . . . 0.0 110.181 168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.52 50.75 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -56.75 -29.05 62.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -79.64 -32.6 41.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.578 -1.326 . . . . 0.0 110.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.88 -37.92 70.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.87 -43.79 91.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.072 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -64.7 -38.49 91.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 112.361 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.79 -47.83 84.1 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.949 -0.47 . . . . 0.0 111.764 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.16 -27.34 26.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 O-C-N 120.999 -1.063 . . . . 0.0 111.096 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.97 -33.55 74.86 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.649 -1.282 . . . . 0.0 111.977 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.86 -31.53 71.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.67 0.668 . . . . 0.0 110.229 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.82 -5.77 51.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.384 0.611 . . . . 0.0 112.18 174.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -101.61 9.44 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.0 t -112.11 165.71 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 61.44 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.27 -27.82 69.3 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.138 -0.976 . . . . 0.0 112.341 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 m -56.06 -40.71 73.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -96.56 -50.69 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.496 0.665 . . . . 0.0 109.605 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.87 -43.97 90.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -76.06 -30.53 58.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 52.5 p -75.17 -12.4 60.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.646 -0.659 . . . . 0.0 112.532 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -58.05 132.36 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.47 0.652 . . . . 0.0 110.777 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.04 154.59 39.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.817 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.57 117.28 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.549 1.155 . . . . 0.0 111.188 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.44 -35.52 73.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.3 -37.42 87.1 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.775 -1.203 . . . . 0.0 107.853 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -75.83 -3.97 38.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.533 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 58.5 t -86.32 -46.51 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.6 -52.28 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.348 1.07 . . . . 0.0 108.17 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.21 27.66 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.138 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -112.71 -46.41 0.73 Allowed Glycine 0 N--CA 1.454 -0.12 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 167.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -53.68 7.45 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -84.61 -1.48 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 120.751 3.612 . . . . 0.0 120.751 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.39 -18.91 43.98 Favored 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 111.398 -5.268 . . . . 0.0 112.687 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.98 -2.22 39.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -104.42 -39.21 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -83.9 -19.87 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.747 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -179.565 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 tpp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.014 -0.041 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.74 150.72 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.76 140.99 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.74 142.13 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.1 mt -134.09 158.56 42.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -171.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -148.43 113.95 5.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.5 164.92 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -52.85 129.42 30.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.1 0.864 . . . . 0.0 112.168 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -79.02 168.97 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.434 0.635 . . . . 0.0 109.665 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' ' CG ' ' A' ' 201' ' ' HIS . . . -62.4 134.32 56.29 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.08 120.8 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.91 4.93 86.74 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.402 -173.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 88.81 4.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.84 36.06 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.052 1.835 . . . . 0.0 115.323 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -108.91 -19.71 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -151.87 162.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -73.88 165.29 25.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.191 0.596 . . . . 0.0 111.939 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.76 170.01 27.8 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -75.06 104.13 5.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -115.91 161.34 31.31 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 147.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -65.5 -17.72 58.02 Favored 'Trans proline' 0 C--N 1.348 0.519 0 N-CA-C 116.881 1.839 . . . . 0.0 116.881 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -117.76 7.82 12.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.4 -44.21 92.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.9 0.857 . . . . 0.0 111.985 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -80.26 -13.94 58.8 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.786 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -61.46 -43.74 98.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.956 2.162 . . . . 0.0 112.842 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -66.41 -46.67 86.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.6 mt -66.24 -39.22 89.39 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.541 -0.725 . . . . 0.0 112.174 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -43.62 95.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.93 -0.481 . . . . 0.0 110.29 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 p -69.18 -38.59 78.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.442 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -46.29 80.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.94 -27.33 36.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.692 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -66.79 -39.64 87.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.473 -1.392 . . . . 0.0 109.381 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -83.83 4.49 28.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.659 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.4 pttm 44.07 47.04 7.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.028 2.131 . . . . 0.0 115.62 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.87 149.9 36.2 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.35 158.44 36.88 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 117.601 -1.133 . . . . 0.0 114.05 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.81 162.13 41.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -144.3 140.91 29.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 t 68.96 123.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 126.227 2.204 . . . . 0.0 111.533 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -141.06 19.04 2.28 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.78 148.99 43.24 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.326 3.084 . . . . 0.0 119.326 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 45' ' ' GLY . 35.4 mm -131.03 108.58 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.443 1.897 . . . . 0.0 106.774 162.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.98 93.25 8.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.286 -1.509 . . . . 0.0 114.201 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt 47.33 48.23 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.518 1.127 . . . . 0.0 112.674 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 76.03 35.01 45.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.664 -175.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -64.13 107.4 1.27 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 152.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -145.01 79.12 12.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.472 0.653 . . . . 0.0 112.733 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.89 172.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 115.055 -2.83 . . . . 0.0 110.7 165.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.48 -30.58 60.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.236 -0.29 . . . . 0.0 111.571 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -56.16 -51.66 67.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.32 -25.56 59.63 Favored 'General case' 0 C--O 1.218 -0.581 0 O-C-N 120.646 -1.284 . . . . 0.0 111.194 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.13 -25.49 64.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 119.22 0.918 . . . . 0.0 112.081 172.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.79 -29.33 61.06 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.492 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.67 -50.64 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 112.281 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -94.72 118.24 66.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 121.175 -0.953 . . . . 0.0 108.635 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.85 -21.38 38.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 N-CA-C 116.337 1.63 . . . . 0.0 116.337 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -93.69 -14.66 26.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.881 0.848 . . . . 0.0 110.839 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.79 -0.49 61.51 Favored Glycine 0 C--O 1.224 -0.471 0 O-C-N 121.78 -0.575 . . . . 0.0 113.212 -166.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -151.84 32.72 0.55 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.43 144.14 48.44 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.83 149.24 72.47 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 116.188 -2.075 . . . . 0.0 114.058 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.32 168.07 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.14 133.2 67.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 101.813 -3.402 . . . . 0.0 101.813 158.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -117.37 121.32 40.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 163.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -131.41 123.38 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 t70 55.88 35.13 24.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.593 1.187 . . . . 0.0 111.077 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.78 23.04 12.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.457 1.903 . . . . 0.0 115.788 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -121.09 140.73 51.56 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -115.77 153.93 30.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.97 148.13 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -152.03 38.61 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -112.31 149.41 32.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.6 p -58.47 -28.47 65.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.56 -37.77 15.43 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.575 0.584 . . . . 0.0 112.575 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 m -75.98 -17.81 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.914 -1.116 . . . . 0.0 112.722 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.91 -8.0 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.231 -0.293 . . . . 0.0 111.376 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.9 t -105.39 -51.44 8.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 160.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.22 91.95 Favored Glycine 0 C--O 1.228 -0.279 0 N-CA-C 117.941 1.936 . . . . 0.0 117.941 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.6 mt -77.52 -31.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.57 -43.99 96.69 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.481 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.41 -46.99 87.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.793 0.724 . . . . 0.0 109.835 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -66.19 -17.98 65.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -106.78 -5.61 18.32 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.029 0.532 . . . . 0.0 112.295 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -70.04 138.55 87.43 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -30.63 82.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.49 157.96 74.33 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 120.201 1.364 . . . . 0.0 107.949 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.77 141.12 93.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.013 -2.191 . . . . 0.0 114.792 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.56 151.39 52.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 116.919 -1.587 . . . . 0.0 111.415 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.5 mt -130.93 49.99 2.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 63.32 6.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.498 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.5 99.79 45.55 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.14 46.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 N-CA-C 121.231 3.512 . . . . 0.0 121.231 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -78.42 -124.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.225 0 CA-C-N 121.194 1.462 . . . . 0.0 114.237 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.34 -25.35 65.76 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.752 -1.843 . . . . 0.0 113.095 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.68 -42.52 99.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.541 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.45 -34.87 41.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.384 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.5 p -65.34 -34.56 78.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.098 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.56 -43.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.041 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.58 -37.18 93.77 Favored Glycine 0 CA--C 1.52 0.355 0 O-C-N 120.684 -1.26 . . . . 0.0 115.265 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 p -72.2 -15.37 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -77.61 -35.06 53.14 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.468 1.128 . . . . 0.0 110.13 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -77.73 -42.19 28.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.933 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -49.32 -52.68 46.89 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.75 -21.75 12.43 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 114.157 -3.429 . . . . 0.0 114.858 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.9 m -68.22 -43.59 77.66 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.576 -0.702 . . . . 0.0 111.619 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -78.0 -27.7 49.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 118.383 -1.327 . . . . 0.0 113.349 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.09 -29.24 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.15 -40.54 94.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.21 -36.28 81.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.616 -0.677 . . . . 0.0 111.226 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.51 -37.4 85.89 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.296 -0.253 . . . . 0.0 111.53 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -75.83 -27.91 58.07 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.238 -0.914 . . . . 0.0 113.458 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -61.32 137.35 58.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -128.6 29.7 5.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.21 172.53 9.51 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.39 106.17 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 114.234 -3.377 . . . . 0.0 109.939 149.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -125.69 26.57 6.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.44 -36.41 76.6 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.61 -41.06 97.97 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -24.58 59.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.253 1.527 . . . . 0.0 113.176 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.08 -42.05 94.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.229 1.014 . . . . 0.0 108.675 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -76.95 -16.16 59.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.193 -0.942 . . . . 0.0 112.21 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.39 -37.3 71.57 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.51 -41.09 96.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.395 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.25 -47.26 81.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.365 0.416 . . . . 0.0 110.043 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -67.56 -39.56 84.93 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.47 -42.32 95.97 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.097 -1.002 . . . . 0.0 109.871 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.46 -20.44 57.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.137 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.43 -35.28 80.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.535 0.607 . . . . 0.0 111.736 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.06 99.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.194 0.997 . . . . 0.0 109.725 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.14 -35.72 74.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.403 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.294 0.638 . . . . 0.0 112.462 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.66 -39.81 93.85 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.869 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.7 -32.62 72.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -48.43 35.74 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.285 -0.884 . . . . 0.0 110.113 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.01 -8.65 56.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -168.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.86 -10.56 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 167.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -117.45 -45.68 2.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.38 -67.88 0.23 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 119.981 2.753 . . . . 0.0 119.981 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -68.7 -169.33 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.665 2.733 . . . . 0.0 113.92 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -56.08 173.76 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.6 mt -56.83 -40.36 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 112.159 -154.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.86 10.63 2.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.12 -22.69 37.07 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.08 -40.88 0.59 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.06 170.54 21.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.78 123.11 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -128.44 171.77 11.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.85 -32.62 32.68 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.74 -41.64 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 121.641 -0.662 . . . . 0.0 111.437 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.52 -40.86 93.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.03 -21.19 63.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.316 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.2 m -85.6 -34.16 21.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -97.85 -46.25 6.01 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.18 -38.83 72.62 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.7 -31.0 33.59 Favored 'Trans proline' 0 C--N 1.352 0.748 1 C-N-CA 111.838 -4.975 . . . . 0.0 115.465 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -72.11 -30.78 65.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.095 -1.003 . . . . 0.0 108.957 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.9 -34.5 77.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.42 -47.03 83.64 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.174 -0.954 . . . . 0.0 109.063 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.93 -33.63 75.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.643 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.85 -52.72 64.22 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.84 -36.55 79.4 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -169.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.6 m -77.05 -35.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.14 -45.57 56.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.667 0.746 . . . . 0.0 110.304 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.44 -38.52 91.3 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.929 0.492 . . . . 0.0 109.754 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.87 -34.94 89.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.987 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.24 -49.65 11.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.347 0.573 . . . . 0.0 112.487 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -76.89 -47.44 21.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -148.19 66.0 1.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -165.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -54.73 112.67 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -163.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -141.83 91.88 8.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.04 155.74 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 115.286 -2.676 . . . . 0.0 109.473 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.91 123.58 89.65 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.65 154.8 63.98 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.557 -2.495 . . . . 0.0 112.247 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -75.22 2.7 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -71.22 -29.66 65.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.61 58.21 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -27.36 69.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.311 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -64.05 1.0 Allowed 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 167.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.74 -37.24 78.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -159.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.89 -50.93 71.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -76.19 -25.1 54.84 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.171 -0.956 . . . . 0.0 113.136 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.24 -49.47 71.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.548 0.689 . . . . 0.0 109.198 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.7 mt -62.61 -44.65 99.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.45 -48.34 81.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.7 -47.94 76.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 110.283 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.18 -19.26 58.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.25 -32.97 64.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 t -116.81 29.69 7.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.52 0.676 . . . . 0.0 110.573 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -67.82 144.43 55.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.58 -37.63 70.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.645 1.111 . . . . 0.0 110.869 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -58.08 -50.02 74.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -68.05 -40.51 82.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -56.69 -36.91 70.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.562 0.696 . . . . 0.0 110.901 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -82.67 -36.18 26.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 59.5 p -104.83 3.16 30.8 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -170.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.86 141.43 49.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.512 -0.743 . . . . 0.0 111.82 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.49 163.49 27.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.52 127.24 31.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -62.77 -36.24 82.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 111.899 -173.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -61.16 -30.13 70.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.741 0.781 . . . . 0.0 110.552 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' CG ' ' HB1' ' A' ' 10' ' ' ALA . 88.2 m-70 -96.44 -5.45 39.62 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.782 -0.574 . . . . 0.0 112.02 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.94 -50.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 162.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.87 -67.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.107 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.99 62.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.57 -1.331 . . . . 0.0 111.917 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.33 -30.55 10.7 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -99.27 -28.93 13.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.91 1.855 . . . . 0.0 111.184 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -73.96 -3.1 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -67.74 -19.32 47.49 Favored 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 109.306 -6.663 . . . . 0.0 114.281 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -74.33 -23.08 58.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.348 0.976 . . . . 0.0 113.084 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.19 -31.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -100.12 27.43 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.962 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.816 1.646 . . . . 0.0 114.863 -174.735 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 119.705 -0.188 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.98 138.97 46.36 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.192 -0.942 . . . . 0.0 109.415 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 mp -124.87 140.37 52.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 103.439 -2.801 . . . . 0.0 103.439 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -132.79 162.39 31.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.35 155.42 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.7 m -115.75 118.37 32.86 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 101.703 -3.443 . . . . 0.0 101.703 164.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.64 159.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -71.92 122.25 20.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 162.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -75.06 165.37 25.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.58 130.43 46.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.152 0.977 . . . . 0.0 112.179 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.26 123.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -9.93 66.79 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.34 0.896 . . . . 0.0 115.34 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.29 87.38 13.71 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.471 1.136 . . . . 0.0 112.027 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.16 50.87 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.967 3.778 . . . . 0.0 117.01 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.11 -31.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -126.51 158.25 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.86 139.16 58.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.32 1.048 . . . . 0.0 109.522 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' CYS . . . -104.5 -157.92 23.75 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 120.188 2.835 . . . . 0.0 120.188 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.02 31.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.156 2.182 . . . . 0.0 113.803 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLY . 40.5 t -66.69 121.98 80.0 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.721 177.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.88 -26.09 52.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 N-CA-C 117.06 1.908 . . . . 0.0 117.06 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.9 2.47 9.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 61' ' ' PRO . 68.2 m -64.59 -42.96 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.207 -0.933 . . . . 0.0 111.575 -174.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.16 -15.41 61.97 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.752 -1.179 . . . . 0.0 113.258 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.253 1.388 . . . . 0.0 110.675 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -44.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.29 -29.46 65.08 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 119.274 0.943 . . . . 0.0 112.684 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 p -76.56 -34.56 58.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.043 -1.036 . . . . 0.0 110.175 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.46 -39.47 85.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.114 0.959 . . . . 0.0 113.115 -175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -78.31 -27.19 47.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -67.54 -37.82 83.27 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.763 -1.21 . . . . 0.0 110.014 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -74.95 -17.85 60.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 54.73 36.57 26.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -78.0 165.15 52.79 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -54.41 139.18 74.33 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 119.495 0.855 . . . . 0.0 112.783 162.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.0 173.37 11.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 -143.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -110.21 118.43 36.32 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 112.772 -155.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -161.51 123.27 2.9 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 162.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -138.49 150.32 46.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 160.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 93.8 mt -108.15 120.55 42.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.182 0.446 . . . . 0.0 111.812 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.54 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -84.53 81.14 8.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.998 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 mt 52.63 31.07 9.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.52 79.42 1.46 Allowed Glycine 0 C--O 1.235 0.186 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -110.36 -74.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.814 0.816 . . . . 0.0 110.269 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.27 149.32 91.59 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.994 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.8 -167.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 116.768 1.795 . . . . 0.0 116.768 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -52.87 -22.4 5.44 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.62 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.595 1.089 . . . . 0.0 111.2 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.75 -34.93 64.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.533 -0.729 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.76 -27.24 62.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.44 -33.25 73.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.441 0.639 . . . . 0.0 110.771 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.8 mm -84.96 -48.51 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.404 0.621 . . . . 0.0 111.268 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -82.6 114.33 51.09 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 122.987 0.515 . . . . 0.0 111.4 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.46 -24.41 31.08 Favored 'Trans proline' 0 C--N 1.347 0.496 0 N-CA-C 117.294 1.998 . . . . 0.0 117.294 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -92.83 -7.47 46.28 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.82 -16.54 11.25 Favored Glycine 0 C--O 1.225 -0.434 0 O-C-N 121.705 -0.622 . . . . 0.0 112.683 -167.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -140.89 24.93 2.16 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.47 163.41 59.2 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 58.4 Cg_endo -67.19 142.93 62.76 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.148 -4.768 . . . . 0.0 112.352 161.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.1 t -128.84 132.97 67.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.67 122.45 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.43 1.109 . . . . 0.0 109.625 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -95.32 128.92 42.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.45 91.49 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.4 t0 51.16 51.39 17.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.289 1.042 . . . . 0.0 110.864 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t0 63.16 8.36 3.27 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.66 144.03 34.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 157.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -128.0 124.82 38.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 120.481 1.491 . . . . 0.0 109.167 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.43 156.99 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.94 96.58 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -154.65 153.92 32.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 101.815 -3.402 . . . . 0.0 101.815 167.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.9 p -61.96 -32.57 73.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -95.6 -14.36 23.61 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -81.36 -21.12 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.937 -1.727 . . . . 0.0 108.041 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -21.31 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.143 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -89.1 -48.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.62 -64.7 1.2 Allowed Glycine 0 CA--C 1.519 0.291 0 N-CA-C 120.389 2.915 . . . . 0.0 120.389 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.81 -34.16 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.651 0.739 . . . . 0.0 109.336 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.94 -47.21 87.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.089 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.25 -34.28 77.66 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.09 0.859 . . . . 0.0 112.107 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.46 -28.06 63.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.809 0.844 . . . . 0.0 110.407 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -120.2 21.55 11.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -100.82 76.22 0.14 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.442 0.697 . . . . 0.0 111.647 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.7 5.63 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.748 2 C-N-CA 125.757 4.305 . . . . 0.0 123.119 -131.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.88 172.48 8.9 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 158.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.61 135.42 70.34 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 114.988 -2.875 . . . . 0.0 116.904 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.54 116.8 4.81 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.477 1.451 . . . . 0.0 114.033 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.78 81.7 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.544 1.164 . . . . 0.0 113.528 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -118.27 73.72 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.969 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.19 114.62 63.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -106.7 61.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.64 0 N-CA-C 117.846 2.21 . . . . 0.0 117.846 168.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.95 -132.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 120.03 1.047 . . . . 0.0 112.715 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.06 -37.53 61.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -25.69 68.26 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 120.927 -1.108 . . . . 0.0 112.515 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.55 70.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.8 p -72.53 -33.67 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.68 -49.48 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.507 0.67 . . . . 0.0 109.244 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.64 94.64 Favored Glycine 0 C--O 1.228 -0.234 0 O-C-N 122.094 -0.379 . . . . 0.0 113.915 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.1 p -71.68 -12.37 61.3 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.99 -36.56 27.75 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.98 -1.075 . . . . 0.0 110.313 169.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.97 -46.6 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.353 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -50.0 -54.24 34.93 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -171.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.35 -19.85 12.98 Favored 'Trans proline' 0 C--N 1.349 0.601 1 C-N-CA 112.305 -4.664 . . . . 0.0 114.319 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -66.88 -47.16 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -73.32 -24.47 60.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.006 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.44 -38.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.91 -48.89 76.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.88 -43.92 94.48 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.77 -18.7 62.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.0 0.2 43.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.384 -0.197 . . . . 0.0 110.607 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 t -110.19 142.18 42.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.73 33.53 4.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.65 171.56 10.5 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.84 78.78 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 CA-C-N 120.642 1.265 . . . . 0.0 114.569 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -91.26 26.02 2.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -155.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.3 -35.42 80.3 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.683 -1.886 . . . . 0.0 112.263 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.39 -32.06 68.36 Favored Glycine 0 C--O 1.223 -0.562 0 O-C-N 121.463 -0.773 . . . . 0.0 112.966 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 m -77.98 -30.35 50.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.536 1.168 . . . . 0.0 111.398 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.0 -41.79 99.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.502 1.144 . . . . 0.0 108.351 171.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -73.75 -24.29 59.86 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.172 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.45 99.43 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 120.799 -1.188 . . . . 0.0 108.819 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.0 -44.41 96.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.13 -44.15 97.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -80.84 -30.65 35.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.65 -35.59 60.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.062 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.71 -17.45 57.61 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 120.96 -1.088 . . . . 0.0 109.837 173.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -69.55 -35.66 75.64 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.294 -1.504 . . . . 0.0 110.286 167.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.15 -45.53 93.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.11 -39.54 90.38 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -40.77 98.3 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.927 -1.108 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.95 -35.87 72.65 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.643 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -72.87 -36.84 67.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.483 -1.01 . . . . 0.0 112.631 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.24 -43.25 91.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 109.825 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.32 -19.49 63.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.979 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.68 -25.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.807 0.73 . . . . 0.0 111.095 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -112.46 -35.89 5.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.87 -71.16 0.22 Allowed Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.403 -1.776 . . . . 0.0 114.714 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.44 -160.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.799 4.333 . . . . 0.0 118.486 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -56.92 166.67 0.95 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.286 1.434 . . . . 0.0 112.159 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -52.46 -33.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.53 8.08 4.74 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.97 -33.81 5.49 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.07 -40.22 2.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.747 1.273 . . . . 0.0 112.331 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.41 -178.52 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.977 0.511 . . . . 0.0 110.249 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.8 mt -67.42 121.34 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 m -153.29 171.25 18.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -25.57 -54.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.969 1 N-CA-C 122.677 4.325 . . . . 0.0 122.677 -173.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.17 -35.34 75.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.015 -1.053 . . . . 0.0 110.483 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.32 -43.43 73.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.23 -32.56 73.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.596 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.2 m -71.13 -38.65 72.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.1 tp -100.32 -45.69 5.51 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -170.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.41 -43.13 97.38 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.12 -20.79 24.62 Favored 'Trans proline' 0 C--N 1.35 0.614 1 C-N-CA 111.296 -5.336 . . . . 0.0 114.782 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -78.29 -22.35 48.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 120.931 -1.106 . . . . 0.0 110.556 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 -27.01 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 118.435 0.561 . . . . 0.0 111.092 169.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.7 -44.53 64.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.157 -0.965 . . . . 0.0 110.263 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -62.67 -30.27 71.26 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.875 -0.515 . . . . 0.0 111.211 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.92 -58.36 8.9 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.25 -31.65 72.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.273 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.86 -54.88 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.758 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.86 -41.19 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.1 tp -67.77 -37.82 82.61 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.01 -32.88 81.86 Favored Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -74.95 -48.38 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.39 -45.05 12.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -167.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -149.1 60.98 1.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -52.3 120.64 5.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -162.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -145.48 93.82 5.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 163.01 39.58 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 115.882 -2.279 . . . . 0.0 109.879 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.4 124.81 90.84 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.7 166.44 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 117.105 -1.464 . . . . 0.0 113.92 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.86 -0.14 20.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.436 1.112 . . . . 0.0 112.27 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.31 -14.37 61.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.25 51.95 1.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.9 t -62.77 -26.26 68.62 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.709 -0.62 . . . . 0.0 112.464 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.91 -35.25 62.22 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.696 -1.252 . . . . 0.0 108.066 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.2 -40.39 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 109.368 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.42 -44.66 90.51 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.969 -0.457 . . . . 0.0 111.491 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.52 -23.83 61.06 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.027 -1.046 . . . . 0.0 111.734 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.405 ' CZ ' HD11 ' A' ' 186' ' ' LEU . 17.3 t80 -68.96 -49.17 60.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.905 0.482 . . . . 0.0 110.31 173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.64 -33.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 120.906 -1.121 . . . . 0.0 111.372 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.02 -38.9 90.44 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.861 -1.149 . . . . 0.0 111.459 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.61 -42.69 86.48 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.69 -0.631 . . . . 0.0 111.835 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.405 HD11 ' CZ ' ' A' ' 182' ' ' TYR . 40.5 mt -66.18 -46.72 76.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -55.85 -42.43 75.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.9 t -106.32 71.25 0.87 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 111.037 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.58 153.41 43.74 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -57.33 -48.68 78.35 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.809 0.693 . . . . 0.0 110.699 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.0 t -65.58 -43.71 88.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.928 0.87 . . . . 0.0 112.28 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -65.25 -45.26 85.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.641 0.734 . . . . 0.0 110.626 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.98 -37.68 81.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.499 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -69.65 -36.49 76.12 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.0 -1.062 . . . . 0.0 111.984 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 64.2 p -87.93 -0.28 56.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -62.04 141.17 58.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.92 44.73 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.41 122.11 15.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.02 -48.6 73.33 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -166.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 200' ' ' GLU . 0.9 OUTLIER -64.68 -21.71 66.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -95.64 -1.59 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.58 -44.73 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 164.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.95 -55.08 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.15 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.8 5.45 9.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.509 -0.744 . . . . 0.0 112.819 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.71 -44.26 3.7 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 169.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -91.06 -38.37 12.83 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.34 -20.42 0.58 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.34 -24.58 71.53 Favored 'Trans proline' 0 C--N 1.353 0.776 1 C-N-CA 111.761 -5.026 . . . . 0.0 115.372 167.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -79.63 -36.47 37.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.175 1.807 . . . . 0.0 111.226 172.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.61 -35.54 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 121.614 -0.679 . . . . 0.0 110.345 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.12 -16.0 20.69 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-N 119.141 0.882 . . . . 0.0 113.168 -171.932 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.373 0.13 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.38 154.81 43.06 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 109.25 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp -139.0 160.71 39.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.36 139.79 43.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.84 114.36 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.8 m -109.86 130.84 55.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.08 139.82 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 123.991 0.807 . . . . 0.0 112.264 -164.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.48 128.5 36.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.087 0.403 . . . . 0.0 110.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.05 176.34 9.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.202 1.001 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . . . -61.39 148.51 41.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.858 1.313 . . . . 0.0 109.385 167.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.39 109.84 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.354 -170.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.97 23.48 66.4 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.665 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . . . -146.92 89.29 5.69 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.96 54.52 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.945 3.097 . . . . 0.0 114.245 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -141.43 -28.08 0.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 pt -141.45 168.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 118.445 0.566 . . . . 0.0 110.518 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.27 146.82 45.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.114 1.765 . . . . 0.0 112.748 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.74 -174.6 13.81 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -73.56 92.43 1.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.422 1.106 . . . . 0.0 111.355 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.77 135.72 22.42 Favored Pre-proline 0 C--O 1.246 0.883 1 N-CA-C 99.344 -4.317 . . . . 0.0 99.344 138.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -57.42 -39.62 87.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.21 0.754 . . . . 0.0 112.956 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.24 -23.29 43.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.054 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.53 -34.24 77.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.801 -1.187 . . . . 0.0 113.418 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -80.61 -12.74 59.46 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.565 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' A' ' 155' ' ' PRO . 89.0 mtt180 -69.0 -41.91 77.18 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -44.95 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mt -64.26 -39.37 93.82 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.748 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.52 -43.3 97.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.569 0.622 . . . . 0.0 111.385 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 p -70.17 -39.13 75.49 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.62 -43.91 88.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -76.24 -29.28 57.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.548 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -68.42 -34.32 75.8 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.528 -1.358 . . . . 0.0 111.401 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG3' HD21 ' A' ' 84' ' ' ASN . 33.9 mmtp -88.52 -11.46 45.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.47 51.97 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.352 1.461 . . . . 0.0 113.622 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.3 pt -98.8 155.1 37.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.05 145.16 30.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.837 -2.975 . . . . 0.0 111.314 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.54 157.95 41.81 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 121.993 -0.442 . . . . 0.0 110.756 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -110.78 110.51 21.17 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.662 0.385 . . . . 0.0 111.719 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -86.1 128.38 34.87 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.11 93.57 4.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.654 1.182 . . . . 0.0 111.437 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.67 142.91 57.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.889 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.05 94.2 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.5 85.07 5.99 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.495 -0.753 . . . . 0.0 112.039 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt 54.35 45.06 27.98 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.002 0.906 . . . . 0.0 113.164 166.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.72 94.36 1.85 Allowed Glycine 0 C--O 1.238 0.352 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.523 -168.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -124.59 -91.08 0.55 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -69.68 152.38 96.2 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.204 -170.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.97 -175.68 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.552 2.168 . . . . 0.0 115.282 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -64.19 -10.76 25.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -161.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -49.3 -41.04 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.741 0.416 . . . . 0.0 110.094 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -79.84 -28.69 40.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.2 -34.8 78.28 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.895 0.855 . . . . 0.0 110.507 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.89 -36.64 84.59 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 121.362 -0.837 . . . . 0.0 110.362 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.1 mt -75.62 -45.81 38.11 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 C-N-CA 124.038 0.935 . . . . 0.0 112.716 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.586 ' OG ' HG22 ' A' ' 60' ' ' VAL . 28.7 t -102.99 129.62 25.27 Favored Pre-proline 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 112.973 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.29 -23.16 28.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 116.655 -1.764 . . . . 0.0 116.39 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.72 -10.96 25.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.788 -1.195 . . . . 0.0 110.718 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 -5.93 67.5 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 121.561 -0.712 . . . . 0.0 113.8 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -144.89 34.43 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -167.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' OG ' ' A' ' 55' ' ' SER . 11.8 m -119.16 161.81 34.92 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.934 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.63 151.25 58.11 Favored 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 111.417 -5.255 . . . . 0.0 110.081 171.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.6 161.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.29 126.26 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.999 0.818 . . . . 0.0 109.375 160.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.05 87.64 3.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.06 111.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 47.76 56.15 7.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.132 0.895 . . . . 0.0 113.27 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 t70 71.4 -7.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.94 122.85 44.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.047 -1.033 . . . . 0.0 110.147 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -107.07 131.42 54.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.65 144.74 37.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-N 115.256 -0.883 . . . . 0.0 113.331 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.72 115.63 1.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.35 157.08 10.63 Favored 'General case' 0 N--CA 1.472 0.654 1 N-CA-C 96.959 -5.2 . . . . 0.0 96.959 160.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.9 p -57.44 -35.17 69.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.92 -41.17 60.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.059 -0.4 . . . . 0.0 111.907 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -81.64 -17.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.837 -0.539 . . . . 0.0 110.691 -171.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -23.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.63 -47.91 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.083 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.1 62.47 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.4 mt -80.47 -29.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.596 1.698 . . . . 0.0 106.629 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.28 -41.15 92.72 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.718 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.59 -39.75 80.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 112.798 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -60.47 -33.46 72.6 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.131 -0.981 . . . . 0.0 111.454 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.81 10.86 38.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.446 HD21 ' HG3' ' A' ' 33' ' ' LYS . 33.8 t-20 -69.54 130.99 90.13 Favored Pre-proline 0 C--O 1.247 0.927 0 O-C-N 121.606 -0.683 . . . . 0.0 109.195 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.41 -17.3 30.64 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.129 -1.448 . . . . 0.0 113.779 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.98 161.54 27.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -63.93 144.13 87.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 115.807 -2.329 . . . . 0.0 117.122 -169.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.23 136.52 7.85 Favored 'Trans proline' 0 C--O 1.24 0.584 0 N-CA-C 118.366 2.41 . . . . 0.0 118.366 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.26 41.36 3.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.329 1.052 . . . . 0.0 111.981 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.57 66.76 4.17 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.759 0.824 . . . . 0.0 112.016 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.11 106.08 28.52 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -100.7 75.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 125.158 3.905 . . . . 0.0 118.01 166.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -91.0 -140.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.474 1.449 . . . . 0.0 114.241 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.87 -37.12 29.65 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.05 -25.52 64.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.114 -0.991 . . . . 0.0 112.428 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.49 47.42 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.874 -0.516 . . . . 0.0 111.895 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.1 p -70.12 -32.81 71.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.71 -38.84 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.9 -39.41 93.98 Favored Glycine 0 C--O 1.227 -0.308 0 O-C-N 121.702 -0.624 . . . . 0.0 112.815 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.9 p -76.51 5.92 6.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.083 1.441 . . . . 0.0 114.45 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -104.29 -25.49 12.86 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.419 -0.801 . . . . 0.0 112.535 165.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.3 mt -85.92 -47.89 16.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.955 0.407 . . . . 0.0 111.098 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -50.37 -52.02 58.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.19 -20.97 10.94 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 114.307 -3.328 . . . . 0.0 115.861 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.1 p -79.73 -37.88 34.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -46.8 89.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.494 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.84 -26.7 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 121.39 -0.819 . . . . 0.0 112.318 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -65.45 -43.17 91.21 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.26 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.38 -23.37 63.73 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.3 tp -66.05 -38.83 89.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.774 0.715 . . . . 0.0 110.955 171.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -83.02 -31.27 27.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 t -74.0 131.24 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -114.64 30.61 7.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.298 1.047 . . . . 0.0 109.497 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.35 171.34 8.02 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.013 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.28 95.73 0.69 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 116.249 -2.034 . . . . 0.0 112.447 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -115.3 59.23 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.281 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -94.63 -45.18 7.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.64 -28.01 62.05 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.288 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 p -97.8 -5.1 35.55 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.6 -31.31 66.77 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 161.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -76.73 0.08 21.81 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.947 -1.096 . . . . 0.0 111.596 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.22 69.23 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.19 -35.42 79.6 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.473 -0.767 . . . . 0.0 109.942 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.2 -43.64 92.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.89 -28.77 64.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.18 -36.29 40.54 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.543 -1.348 . . . . 0.0 110.381 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.3 mt -74.37 -25.48 59.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.072 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.74 -34.29 72.76 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 118.55 0.613 . . . . 0.0 111.231 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.7 77.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.12 -36.2 82.53 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.751 0.705 . . . . 0.0 111.936 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.99 -42.12 89.28 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.12 0.568 . . . . 0.0 111.741 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.04 57.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.358 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -36.23 75.28 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.807 0.443 . . . . 0.0 111.521 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -54.09 18.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.678 -0.638 . . . . 0.0 109.937 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.6 -24.24 67.02 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.6 m -79.57 -11.35 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -114.61 -39.86 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.48 -68.17 0.27 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 121.267 3.267 . . . . 0.0 121.267 173.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -74.47 -171.42 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 N-CA-C 120.213 3.121 . . . . 0.0 120.213 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -49.73 154.03 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.028 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -67.2 -32.8 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.692 -124.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.15 -19.48 5.13 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.97 3.51 48.71 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-O 119.224 -0.765 . . . . 0.0 112.18 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -139.61 -62.25 0.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -163.24 178.9 7.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.89 114.05 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 124.143 0.902 . . . . 0.0 110.593 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -120.92 -169.93 1.92 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.5 29.31 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.71 -40.56 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.404 -1.435 . . . . 0.0 111.601 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.5 -39.9 94.65 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.3 -28.98 68.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -70.92 -37.22 72.9 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.084 -1.01 . . . . 0.0 111.719 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.12 -59.93 2.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.88 76.61 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 25' ' ' ARG . 89.8 Cg_endo -69.1 -24.33 32.82 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 113.842 -3.639 . . . . 0.0 115.996 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -88.02 -29.41 20.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.294 1.406 . . . . 0.0 108.902 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.85 -35.73 73.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.376 0.535 . . . . 0.0 110.54 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.46 -48.46 71.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -65.36 -40.88 94.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.43 76.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.819 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.67 -28.21 68.28 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.811 1.187 . . . . 0.0 112.888 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.1 m -81.01 -38.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 O-C-N 121.052 -1.03 . . . . 0.0 110.102 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.26 -49.5 19.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.145 0.429 . . . . 0.0 111.979 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.01 -35.41 80.61 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.06 -29.91 76.24 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 115.432 0.933 . . . . 0.0 115.432 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -89.7 -44.1 10.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.371 1.085 . . . . 0.0 113.057 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.17 -37.27 20.36 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -138.5 30.92 2.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.917 0.487 . . . . 0.0 112.277 -163.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -22.93 109.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -152.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -142.22 90.44 8.21 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.869 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.55 160.01 42.03 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 117.121 -1.453 . . . . 0.0 110.344 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.62 121.65 85.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.93 162.43 34.74 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 116.619 -1.788 . . . . 0.0 113.911 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -4.41 30.37 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.317 -0.864 . . . . 0.0 112.949 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -66.62 -22.91 66.11 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.478 0.656 . . . . 0.0 110.206 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.33 66.38 0.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 m -58.53 -36.57 74.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.361 -170.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -51.69 68.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.57 -41.58 80.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -161.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.23 -46.99 65.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.726 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.56 -45.73 89.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.092 -176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -72.6 -29.05 63.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.459 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.59 -40.96 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.857 1.208 . . . . 0.0 110.057 171.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.82 -33.75 74.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.553 -0.717 . . . . 0.0 112.721 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.9 -38.13 79.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.196 0.907 . . . . 0.0 110.869 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.5 -42.02 88.01 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.387 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -50.49 -38.79 46.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -173.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.3 t -120.79 38.55 4.01 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.727 1.251 . . . . 0.0 110.761 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -78.85 143.32 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 161.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -56.55 -45.37 81.28 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.58 1.082 . . . . 0.0 113.653 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -62.22 -44.78 95.81 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -77.07 -38.0 53.41 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.396 -0.815 . . . . 0.0 112.67 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -59.32 -36.46 75.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.045 0.926 . . . . 0.0 110.874 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.01 -40.95 44.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.9 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.7 p -98.47 -3.63 36.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -60.28 140.86 56.84 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.21 150.03 40.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.9 139.01 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -63.93 -39.27 93.79 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.75 -31.04 71.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.568 1.175 . . . . 0.0 109.698 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -96.16 10.19 38.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.526 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -100.85 -51.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.439 156.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.9 -66.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.07 -9.73 58.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.107 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.78 -31.37 29.74 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.442 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -110.6 -28.09 8.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.605 1.202 . . . . 0.0 112.975 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -74.46 -9.7 0.15 Allowed Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 121.618 3.932 . . . . 0.0 121.618 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.92 -20.36 57.94 Favored 'Trans proline' 0 C--N 1.36 1.147 1 C-N-CA 111.354 -5.297 . . . . 0.0 114.639 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -73.31 -27.97 61.82 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.346 -0.846 . . . . 0.0 113.204 172.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.2 t -72.56 -34.88 49.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.489 1.138 . . . . 0.0 108.216 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -79.26 2.48 21.12 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.381 0 C-N-CA 128.545 2.738 . . . . 0.0 115.872 -179.034 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.217 -0.657 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.28 0.7 OUTLIER -171.27 -148.49 0.05 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.372 1.442 . . . . 0.0 109.937 160.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.33 143.96 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -133.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -126.15 110.98 14.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.845 -3.391 . . . . 0.0 101.845 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.3 167.24 26.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.76 139.56 44.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.81 156.34 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.03 127.17 30.25 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 164.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.03 119.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.22 75.39 Favored Glycine 0 C--O 1.25 1.102 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.01 76.79 8.63 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.745 -0.727 . . . . 0.0 111.605 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.9 53.7 2.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.623 2.882 . . . . 0.0 116.52 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -128.51 -37.59 1.79 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.483 -0.76 . . . . 0.0 112.13 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.2 mt -95.92 142.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.38 152.39 17.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.25 176.16 48.38 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.44 31.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.551 -1.825 . . . . 0.0 115.573 -172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.7 t -96.01 145.75 30.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.632 -0.667 . . . . 0.0 112.38 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -68.33 -47.96 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 117.028 -1.514 . . . . 0.0 115.191 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -19.93 60.49 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.824 -0.547 . . . . 0.0 110.208 -172.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.4 t -55.7 -55.59 30.45 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.656 0.597 . . . . 0.0 109.708 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.56 -15.14 59.93 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 96.0 mtt180 -61.43 -52.74 63.29 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.283 1.401 . . . . 0.0 109.782 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HG12 ' A' ' 76' ' ' ILE . 16.4 m -79.2 -31.84 14.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.691 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -62.13 -44.83 95.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.932 0.787 . . . . 0.0 110.444 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.041 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -61.33 -36.33 79.84 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.396 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.2 -40.09 31.66 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.69 -0.631 . . . . 0.0 111.799 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -70.12 -31.25 68.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.32 0.509 . . . . 0.0 111.642 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.34 -34.6 77.66 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.917 -1.114 . . . . 0.0 110.761 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -82.29 -14.32 55.58 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.101 -0.999 . . . . 0.0 112.647 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 56.49 57.87 4.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.647 . . . . 0.0 112.918 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 pt -94.71 161.83 27.47 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.82 151.24 68.67 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 115.858 -2.295 . . . . 0.0 110.942 164.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -147.36 154.84 41.39 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -100.07 -92.77 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -165.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 178.37 7.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -153.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -134.13 174.75 10.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.095 0.958 . . . . 0.0 113.524 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.54 152.32 0.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -94.98 117.92 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 166.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.04 72.28 10.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.5 67.17 1.0 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 167.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.82 -2.41 84.29 Favored Glycine 0 C--O 1.228 -0.279 0 O-C-N 121.186 -0.946 . . . . 0.0 113.411 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -87.19 92.2 8.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -122.08 83.96 45.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 122.132 0.967 . . . . 0.0 113.078 -170.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.69 172.74 13.8 Favored 'Trans proline' 0 C--O 1.238 0.488 0 N-CA-C 110.33 -0.681 . . . . 0.0 110.33 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -55.69 -34.07 64.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -54.63 -53.04 59.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 118.716 0.689 . . . . 0.0 111.884 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -73.33 -29.14 62.47 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.644 -1.285 . . . . 0.0 112.671 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.45 -25.84 64.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.581 1.082 . . . . 0.0 111.855 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -74.34 -41.36 61.2 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.761 -0.587 . . . . 0.0 109.525 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -74.01 -54.64 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -100.86 136.18 19.86 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.871 0.868 . . . . 0.0 111.971 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.59 -24.6 15.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 116.256 -2.029 . . . . 0.0 116.304 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -104.97 -5.37 21.06 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.13 -5.21 51.12 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 122.798 1.221 . . . . 0.0 113.284 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -148.85 37.31 0.8 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.786 1.234 . . . . 0.0 111.629 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.85 136.21 28.47 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -58.26 149.38 73.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 114.354 0.867 . . . . 0.0 114.354 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 m -136.14 169.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.92 141.81 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 156.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -103.27 93.65 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.25 96.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.078 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.07 37.36 24.61 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.545 1.164 . . . . 0.0 112.125 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t0 67.94 41.25 2.13 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 126.156 1.782 . . . . 0.0 115.661 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -131.16 153.02 49.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 167.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.63 126.46 20.77 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.37 149.58 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.12 81.77 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -151.28 152.59 33.43 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 168.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.2 p -55.3 -29.99 59.29 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -165.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.18 -35.52 10.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.286 0.565 . . . . 0.0 112.165 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.53 -37.48 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.604 0.716 . . . . 0.0 110.528 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG12 HG11 ' A' ' 26' ' ' VAL . 11.8 tt -60.17 -29.99 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.629 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.8 t -88.45 -49.57 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.493 0.717 . . . . 0.0 111.77 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.83 -34.12 71.48 Favored Glycine 0 C--O 1.235 0.213 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.936 -168.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.26 -30.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.52 -44.25 97.41 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 121.895 -0.503 . . . . 0.0 109.851 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -62.87 -46.3 88.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.349 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.85 -37.17 85.79 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.479 -0.763 . . . . 0.0 112.33 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.59 7.32 46.67 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -81.61 129.23 66.44 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.14 -17.08 22.21 Favored 'Trans proline' 0 C--O 1.244 0.8 0 N-CA-C 116.023 1.509 . . . . 0.0 116.023 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.41 148.87 67.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -60.22 116.78 3.56 Favored 'Trans proline' 0 C--O 1.243 0.753 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.58 170.36 11.66 Favored 'Trans proline' 0 C--O 1.249 1.033 0 N-CA-C 115.114 1.159 . . . . 0.0 115.114 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 HG22 ' A' ' 147' ' ' THR . 12.5 tp -141.54 69.91 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 122.598 1.19 . . . . 0.0 110.005 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.47 65.06 6.45 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.277 -1.328 . . . . 0.0 112.46 -175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 m -120.12 100.54 47.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.21 86.18 0.06 OUTLIER 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.512 3.475 . . . . 0.0 117.989 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -88.55 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.004 1 C-N-CA 127.23 5.286 . . . . 0.0 111.739 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -45.36 -34.8 3.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.52 -30.17 71.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 120.559 -1.338 . . . . 0.0 112.366 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.35 -28.64 34.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.053 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -72.06 -32.38 67.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.125 0.875 . . . . 0.0 109.638 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.44 -40.62 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.318 -0.864 . . . . 0.0 109.684 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.02 -30.84 70.99 Favored Glycine 0 CA--C 1.521 0.425 0 O-C-N 121.793 -0.567 . . . . 0.0 114.313 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -73.12 -9.49 58.77 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -80.76 -46.62 15.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt -75.63 -42.12 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.925 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.13 -53.26 67.2 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.78 -18.99 21.55 Favored 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 112.637 -4.442 . . . . 0.0 113.636 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.0 t -66.96 -56.55 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.015 0.526 . . . . 0.0 111.804 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -72.92 -23.97 60.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.79 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -68.23 -47.25 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -63.26 -44.39 95.28 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -69.79 -34.89 74.35 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.06 -34.45 76.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.195 0.907 . . . . 0.0 110.286 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.78 -24.89 61.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.631 0.772 . . . . 0.0 111.762 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -87.77 127.54 35.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -116.71 39.13 3.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.51 -175.31 0.18 Allowed Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 127.053 2.141 . . . . 0.0 109.68 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.08 41.26 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 114.675 0.99 . . . . 0.0 114.675 146.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -71.79 105.75 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.653 -1.279 . . . . 0.0 112.595 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.98 -54.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.4 -36.33 93.06 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.654 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.3 p -77.85 -21.92 50.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.383 0.592 . . . . 0.0 112.204 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.63 -35.75 75.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.659 1.695 . . . . 0.0 107.02 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -79.77 -3.69 48.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.72 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.48 -31.33 24.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.882 -1.136 . . . . 0.0 108.081 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.55 -41.24 88.95 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.335 -0.853 . . . . 0.0 110.065 165.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.82 -36.53 72.37 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.91 -0.493 . . . . 0.0 110.925 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -64.0 -36.24 83.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -78.02 -33.71 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.3 -24.59 61.35 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.63 -0.668 . . . . 0.0 111.001 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.09 -33.06 71.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.579 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.28 80.45 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.108 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.94 -34.55 78.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.397 1.094 . . . . 0.0 111.744 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.76 -38.66 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.26 -36.49 93.28 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.803 -1.09 . . . . 0.0 114.665 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -69.15 -46.22 68.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.864 1.332 . . . . 0.0 110.643 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 178' ' ' HIS . 5.8 tt -68.41 -38.39 81.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.558 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -68.74 -20.07 64.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.798 1.181 . . . . 0.0 112.851 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -81.73 -52.26 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.91 -31.84 40.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.17 -81.95 0.3 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-O 117.881 -1.511 . . . . 0.0 114.319 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -77.47 -174.25 2.13 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.214 3.276 . . . . 0.0 114.18 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -33.12 165.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 119.463 3.134 . . . . 0.0 119.463 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.02 -41.37 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 121.232 -0.918 . . . . 0.0 111.113 -152.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.75 -0.27 2.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.94 47.92 Favored Glycine 0 N--CA 1.453 -0.17 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.15 -39.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.692 0.746 . . . . 0.0 112.559 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -160.95 176.84 10.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 114.11 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 89' ' ' LEU . 27.2 p -123.12 -168.51 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.82 -24.94 10.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.19 -55.04 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.171 0.896 . . . . 0.0 109.614 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.46 -38.22 84.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.68 -18.93 65.63 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.799 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 97.0 p -86.24 -39.58 16.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.252 0.933 . . . . 0.0 111.957 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.83 -45.45 8.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -168.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.45 91.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 25' ' ' ARG . 76.7 Cg_exo -58.67 -35.51 98.54 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 115.988 -2.208 . . . . 0.0 116.548 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -84.98 -22.78 29.0 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.754 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.97 -28.61 68.41 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.145 -0.972 . . . . 0.0 112.697 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.55 -40.02 93.18 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -67.81 -34.56 76.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.731 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 HD22 ' A' ' 164' ' ' LEU . 44.5 tp -60.25 -53.06 62.22 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.169 0.44 . . . . 0.0 109.967 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -68.5 -21.67 64.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.97 -41.19 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.965 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.62 -57.0 4.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.274 -0.891 . . . . 0.0 111.628 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.418 HD22 HD11 ' A' ' 160' ' ' LEU . 43.3 tp -64.73 -36.69 85.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.64 -33.29 76.66 Favored Glycine 0 C--O 1.237 0.322 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.372 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -100.39 -42.74 6.49 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -47.43 24.36 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.198 0.908 . . . . 0.0 113.214 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -136.43 64.17 1.56 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.95 114.61 0.95 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -163.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -144.33 93.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.34 158.96 47.7 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.724 -1.718 . . . . 0.0 111.127 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.21 124.41 88.88 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.26 151.22 60.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 117.023 -1.518 . . . . 0.0 112.139 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -77.69 -0.88 28.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -72.64 -24.13 61.01 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.4 62.86 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -58.95 -35.99 74.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.153 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.544 ' CD2' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -60.72 -55.88 27.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.88 -41.64 91.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -165.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 tp -67.33 -44.73 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.2 -45.1 89.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -25.31 43.19 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 118.944 -1.103 . . . . 0.0 112.041 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 13.9 mt -64.71 -32.69 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -62.35 -39.17 92.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.327 0.584 . . . . 0.0 110.613 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.22 -43.68 85.99 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.926 -0.484 . . . . 0.0 110.405 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.73 -31.69 71.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 118.486 0.585 . . . . 0.0 111.788 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.25 -23.84 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.814 -1.179 . . . . 0.0 112.243 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t -147.29 66.33 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -105.41 149.58 26.01 Favored 'General case' 0 CA--C 1.498 -1.034 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 161.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.54 -41.31 89.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.811 0.815 . . . . 0.0 110.4 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -63.8 -46.67 84.1 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.429 -0.794 . . . . 0.0 111.038 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.36 -34.75 74.32 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.891 -0.506 . . . . 0.0 110.203 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -73.55 -38.74 65.13 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.123 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.0 p -90.49 2.17 55.97 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -63.18 145.19 56.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.205 -0.934 . . . . 0.0 111.619 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 166.46 23.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.51 43.86 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -65.34 -50.75 64.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.332 1.063 . . . . 0.0 108.264 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.36 -29.16 68.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.285 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.85 1.93 55.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.2 t -96.53 -45.0 12.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.29 -53.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.917 -1.115 . . . . 0.0 112.15 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.14 23.31 11.8 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.46 -34.9 0.59 Allowed Glycine 0 C--O 1.226 -0.38 0 CA-C-N 114.612 -1.177 . . . . 0.0 114.272 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -97.05 -41.78 8.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.159 0.979 . . . . 0.0 112.785 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.35 -15.22 0.26 Allowed Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 119.412 3.116 . . . . 0.0 119.412 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 C--N 1.359 1.129 1 C-N-CA 109.882 -6.279 . . . . 0.0 113.833 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -136.0 158.39 44.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 160.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.36 126.39 75.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.1 t -128.99 109.09 10.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -128.17 156.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.204 -167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.05 129.95 43.24 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.35 167.65 20.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.38 140.21 58.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.851 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.23 127.33 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.14 86.35 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 117.131 1.612 . . . . 0.0 117.131 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.91 100.14 2.54 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 119.323 1.562 . . . . 0.0 113.699 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.38 0.69 6.43 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 N-CA-C 116.578 1.722 . . . . 0.0 116.578 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 -12.14 45.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.12 166.66 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.055 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -82.03 143.41 31.57 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.077 0.951 . . . . 0.0 111.483 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.26 -166.15 12.16 Favored Glycine 0 N--CA 1.46 0.282 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.17 127.15 30.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.473 1.137 . . . . 0.0 109.976 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.9 t -157.67 134.07 6.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.64 -43.09 41.27 Favored 'Trans proline' 0 C--N 1.345 0.35 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -119.93 2.87 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.03 -44.19 96.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.051 0.929 . . . . 0.0 112.016 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -72.89 -12.14 60.85 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.28 -39.13 85.98 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.773 -1.205 . . . . 0.0 109.544 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.71 -45.91 76.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -39.83 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.763 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.6 -49.35 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 p -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.51 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.22 -25.98 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -69.24 -38.56 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.216 0.916 . . . . 0.0 109.595 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -65.7 -41.77 91.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -75.77 -8.14 56.13 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 53.71 39.02 29.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.565 1.146 . . . . 0.0 113.93 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.57 157.07 39.05 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.66 137.17 22.18 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 114.987 -2.875 . . . . 0.0 113.399 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -150.98 161.26 43.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -105.68 132.95 51.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -84.27 123.83 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -118.85 145.08 45.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.94 135.49 55.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.95 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -76.88 61.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 52.48 52.48 14.06 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.703 1.201 . . . . 0.0 113.717 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 64.95 1.16 Allowed Glycine 0 C--O 1.228 -0.225 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -87.31 -77.51 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -165.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.02 162.5 22.66 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.15 174.11 2.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 118.002 -0.865 . . . . 0.0 114.0 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 5.59 -55.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 1 N-CA-C 122.441 4.238 . . . . 0.0 122.441 171.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -50.57 -38.42 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.433 1.469 . . . . 0.0 112.312 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.82 -20.1 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.92 -25.73 23.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.779 . . . . 0.0 109.242 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -74.33 -31.66 62.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.384 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 mt -63.76 -52.87 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -118.64 129.36 25.43 Favored Pre-proline 0 N--CA 1.469 0.494 0 O-C-N 121.986 -0.446 . . . . 0.0 110.957 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.49 -22.74 44.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 N-CA-C 116.609 1.734 . . . . 0.0 116.609 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.76 0.15 35.36 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.418 0.554 . . . . 0.0 111.135 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.75 69.48 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.073 -1.017 . . . . 0.0 114.292 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -158.25 -29.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.7 m -69.89 152.77 95.89 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 118.77 0.713 . . . . 0.0 111.575 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.74 154.41 59.14 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 117.302 -1.332 . . . . 0.0 113.147 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.7 161.8 23.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.511 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.67 137.61 33.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -106.75 93.61 4.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 55.0 mt -97.19 108.68 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t0 49.01 46.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 123.493 1.616 . . . . 0.0 111.419 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 73.27 4.89 4.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.648 -2.523 . . . . 0.0 117.322 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -112.5 139.31 48.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -98.28 141.29 31.36 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 -168.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.8 t -123.87 123.71 67.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.5 -37.75 1.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -165.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.61 149.87 49.37 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.05 -1.032 . . . . 0.0 110.309 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.3 p -60.08 -34.23 73.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -170.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -88.85 -13.33 39.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.25 -19.57 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 108.854 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.4 mt -66.33 -26.77 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 165.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -84.43 -40.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 120.504 -1.372 . . . . 0.0 111.462 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.45 -64.02 0.83 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 118.883 2.313 . . . . 0.0 118.883 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.78 -34.39 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.328 1.064 . . . . 0.0 111.103 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.31 -46.32 79.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.948 -0.47 . . . . 0.0 110.691 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.23 -40.76 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.507 . . . . 0.0 110.369 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.69 -35.72 81.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -95.34 -12.31 26.3 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.29 127.81 93.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.38 -12.92 37.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.67 162.06 71.9 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.553 -1.342 . . . . 0.0 108.096 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.9 137.52 82.03 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 116.386 -1.943 . . . . 0.0 114.836 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.14 150.94 29.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 116.342 -1.972 . . . . 0.0 113.062 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.5 mt -132.83 66.61 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.944 0.878 . . . . 0.0 110.395 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -108.64 84.87 2.0 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.1 m -113.78 97.89 45.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -112.93 78.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.513 2.142 . . . . 0.0 114.913 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -91.16 -131.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.657 2.905 . . . . 0.0 113.319 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -54.34 -40.47 68.07 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.178 -0.951 . . . . 0.0 112.254 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.49 -26.46 68.73 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.453 -0.779 . . . . 0.0 111.447 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.68 -28.52 45.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.9 p -81.95 -27.89 33.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.974 0.806 . . . . 0.0 109.153 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.7 -43.79 82.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.83 -30.38 76.95 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 120.829 -1.17 . . . . 0.0 114.181 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.7 p -77.5 -7.06 55.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.378 1.089 . . . . 0.0 113.139 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -93.97 -36.32 12.22 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.783 0.72 . . . . 0.0 110.974 166.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.93 -48.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.619 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -54.57 -54.49 48.26 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HA ' HG22 ' A' ' 107' ' ' VAL . 93.5 Cg_endo -72.06 -24.88 19.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 113.436 -3.91 . . . . 0.0 113.784 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 t -65.8 -45.25 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -76.36 -29.62 57.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.793 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 104' ' ' PRO . 21.9 m -75.57 -26.23 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 118.48 -1.288 . . . . 0.0 110.038 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.61 -43.63 80.0 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.78 -39.45 84.93 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.757 -0.589 . . . . 0.0 111.195 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.2 mt -62.97 -36.51 83.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -92.36 -24.48 18.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.1 t -68.64 142.46 55.09 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -127.02 40.71 3.67 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.924 1.345 . . . . 0.0 107.669 159.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -77.78 173.39 7.67 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -61.73 102.15 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 114.948 -2.901 . . . . 0.0 109.199 146.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -122.92 24.78 8.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.849 -159.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.53 -22.89 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.238 1.018 . . . . 0.0 110.69 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.14 -33.26 54.74 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 m -68.09 -28.02 66.99 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.027 -0.69 . . . . 0.0 111.535 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -65.46 -36.15 83.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.639 -1.288 . . . . 0.0 110.013 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.07 -33.39 61.67 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.8 -0.563 . . . . 0.0 110.677 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.69 88.47 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 110.558 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.25 -46.78 88.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.74 -42.95 99.63 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.721 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.81 -41.88 86.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -69.39 -35.77 76.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.707 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.51 -35.66 77.8 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.502 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.3 -29.68 70.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.691 0.678 . . . . 0.0 111.647 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.26 -51.57 65.65 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.327 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.26 -26.11 63.68 Favored 'General case' 0 C--O 1.221 -0.43 0 O-C-N 121.878 -0.514 . . . . 0.0 111.725 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.01 -39.87 93.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.683 0.393 . . . . 0.0 110.509 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.86 -54.72 26.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.52 -39.96 89.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.89 -45.36 78.27 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.76 -23.01 62.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.404 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.61 -49.39 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.674 -0.641 . . . . 0.0 111.139 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -82.64 -37.93 24.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -77.28 0.26 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-O 116.828 -2.095 . . . . 0.0 116.931 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -60.57 -131.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 1 C-N-CA 127.989 5.793 . . . . 0.0 120.728 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.43 171.68 7.06 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.937 -1.102 . . . . 0.0 111.293 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.72 -17.42 21.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.32 5.25 35.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.27 -24.77 17.46 Favored Glycine 0 C--O 1.227 -0.334 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.44 -54.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.307 1.553 . . . . 0.0 114.535 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -156.81 176.87 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.05 120.55 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.6 p -140.75 -168.57 2.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -40.44 -38.55 0.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 118.279 2.696 . . . . 0.0 118.279 173.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.88 -43.54 96.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.131 0.967 . . . . 0.0 108.705 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.91 -39.33 79.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.9 mt -61.54 -37.46 83.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.475 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.4 p -77.69 -43.55 30.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.5 tp -95.12 -46.72 6.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -167.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.8 92.92 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.55 -19.41 19.06 Favored 'Trans proline' 0 C--N 1.346 0.446 1 C-N-CA 113.006 -4.196 . . . . 0.0 113.753 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.81 -23.15 20.68 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.983 -1.073 . . . . 0.0 109.587 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.6 mt -63.28 -31.35 72.47 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 165.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.45 -51.08 71.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -63.57 -34.34 77.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.0 -56.0 27.9 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.395 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.94 -51.54 43.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.692 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.69 -42.07 64.64 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.388 -0.82 . . . . 0.0 111.564 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.54 -46.9 86.27 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.26 93.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.033 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.71 -47.18 14.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.629 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -93.76 -34.39 13.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -167.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -137.44 50.47 1.96 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.959 -0.463 . . . . 0.0 110.836 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -53.02 121.71 7.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -156.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -148.15 89.2 5.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.38 153.3 74.42 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 114.639 -3.107 . . . . 0.0 109.87 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.92 126.03 91.79 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.84 155.54 57.93 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 117.142 -1.438 . . . . 0.0 112.31 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.42 -10.03 52.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -67.73 -25.24 65.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.048 -0.408 . . . . 0.0 110.488 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.99 61.54 1.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -31.52 68.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.712 -1.586 . . . . 0.0 113.137 -171.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -43.04 99.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.102 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -38.06 33.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.18 -40.12 88.86 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.631 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.08 -45.7 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.496 -0.753 . . . . 0.0 111.932 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.94 -39.85 95.87 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.64 -32.34 57.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.68 -35.58 78.38 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.167 -0.958 . . . . 0.0 111.057 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.08 -21.05 60.84 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.943 -0.473 . . . . 0.0 111.568 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.13 -8.85 58.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.232 1.015 . . . . 0.0 110.434 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -103.53 23.73 12.18 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.23 -0.919 . . . . 0.0 110.154 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.7 p -124.84 164.43 20.04 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 49.05 150.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 121.225 3.787 . . . . 0.0 121.225 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -56.93 -34.86 68.39 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 120.555 -1.341 . . . . 0.0 114.381 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -18.95 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.09 -44.86 2.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.485 0.66 . . . . 0.0 110.856 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.53 -42.65 99.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.84 -30.91 24.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.201 1.0 . . . . 0.0 109.722 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.7 p -79.01 -12.54 60.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -40.63 119.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 113.078 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.12 138.92 50.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 165.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.43 138.58 58.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.806 0.276 . . . . 0.0 111.233 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.55 -43.78 89.43 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.56 -31.19 67.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.194 0.997 . . . . 0.0 111.141 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -102.68 0.97 33.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.2 -50.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 161.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.4 pt -69.41 -50.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 121.618 -0.676 . . . . 0.0 111.875 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.11 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.336 -0.852 . . . . 0.0 110.291 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.8 -16.17 58.58 Favored Glycine 0 CA--C 1.517 0.173 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -113.15 -54.22 2.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.58 -31.04 8.55 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--N 1.357 1.006 1 C-N-CA 111.733 -5.045 . . . . 0.0 114.475 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.46 0.073 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -124.88 156.32 38.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.403 HD11 ' HG ' ' A' ' 30' ' ' LEU . 44.8 mt -130.65 113.96 26.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.7 127.3 39.33 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.03 163.06 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 119.655 1.116 . . . . 0.0 112.926 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.49 126.42 29.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -82.92 172.69 12.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.04 142.83 58.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.45 134.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.67 -21.61 17.74 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.3 100.8 1.73 Allowed Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.0 96.39 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 116.917 -1.589 . . . . 0.0 114.383 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -159.36 -39.97 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -104.45 158.22 5.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.12 160.09 16.08 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 110.295 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 -179.44 18.37 Favored Glycine 0 CA--C 1.507 -0.436 0 CA-C-N 116.458 -0.337 . . . . 0.0 112.992 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.87 92.89 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.335 1.065 . . . . 0.0 111.165 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.67 132.86 24.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 103.345 -2.835 . . . . 0.0 103.345 165.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.76 -38.03 32.8 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 116.693 -1.738 . . . . 0.0 111.992 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.26 -21.44 36.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.746 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.303 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -74.14 -26.65 60.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.882 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.81 -39.62 89.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.58 1.536 . . . . 0.0 111.151 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.63 -44.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.836 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.28 -38.21 85.96 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.397 -0.814 . . . . 0.0 110.541 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.92 -48.24 79.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 p -72.32 -31.47 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.727 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 5' ' ' ILE . 4.0 mm? -68.4 -46.24 70.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.206 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -65.02 -33.11 75.26 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.793 -0.567 . . . . 0.0 110.579 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.06 -41.92 99.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.373 0.606 . . . . 0.0 112.343 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.82 -16.51 57.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.29 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 59.64 40.5 19.97 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.305 1.442 . . . . 0.0 112.931 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 pt -101.49 154.61 37.14 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.62 118.96 5.98 Favored 'Trans proline' 0 C--N 1.347 0.459 0 N-CA-C 117.375 2.029 . . . . 0.0 117.375 -171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -126.32 156.17 40.86 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.816 0.817 . . . . 0.0 113.072 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.24 110.43 20.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.007 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -84.2 125.51 32.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 118.754 0.706 . . . . 0.0 111.526 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -121.95 139.29 53.84 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.539 0.736 . . . . 0.0 112.194 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 2.6 mm? -102.0 120.03 39.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.733 -169.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.05 120.88 45.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -77.65 76.78 4.18 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.822 0.82 . . . . 0.0 112.215 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.1 mt 55.67 27.88 11.25 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 162.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.92 2.35 11.29 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 114.245 0.458 . . . . 0.0 114.245 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -78.21 109.41 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.754 -0.851 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -116.53 87.9 22.41 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.61 169.45 12.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 N-CA-C 109.916 -0.84 . . . . 0.0 109.916 169.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -54.86 -40.19 69.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.196 0.453 . . . . 0.0 111.303 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -62.15 -39.04 91.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.53 -22.25 35.07 Favored 'General case' 0 C--O 1.212 -0.888 0 O-C-N 120.604 -1.31 . . . . 0.0 112.777 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.9 tp -68.22 -40.16 82.15 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 120.009 -1.682 . . . . 0.0 111.216 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.05 -35.2 71.86 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.346 -0.846 . . . . 0.0 112.846 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mt -117.62 22.59 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 121.478 0.656 . . . . 0.0 111.485 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -147.45 119.86 4.72 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.047 -1.658 . . . . 0.0 108.483 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.34 -13.66 37.36 Favored 'Trans proline' 0 C--N 1.352 0.731 0 N-CA-C 118.689 2.534 . . . . 0.0 118.689 -173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -120.83 7.34 10.43 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.92 -0.488 . . . . 0.0 110.117 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.16 2.07 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-O 122.641 1.134 . . . . 0.0 113.143 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -134.07 99.31 4.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.57 146.18 16.17 Favored Pre-proline 0 C--N 1.318 -0.778 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 170.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.9 142.09 38.26 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 116.868 -1.621 . . . . 0.0 111.982 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.81 131.63 50.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.152 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.91 129.9 36.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.41 71.91 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.175 0.988 . . . . 0.0 108.658 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.2 mt -87.66 126.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 54.97 35.58 24.91 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.478 1.111 . . . . 0.0 112.984 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t0 61.62 25.07 15.05 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -115.46 150.59 36.24 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.08 135.98 53.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -172.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.65 123.17 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -174.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.33 8.76 1.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -165.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -99.41 147.67 25.01 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.025 -1.672 . . . . 0.0 109.946 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.2 p -58.72 -33.52 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -83.23 -13.22 55.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.045 1.402 . . . . 0.0 111.615 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.7 -32.23 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.842 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -66.96 -15.61 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 121.759 -0.588 . . . . 0.0 111.177 161.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.0 t -83.2 -46.24 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 120.333 -1.479 . . . . 0.0 110.418 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.74 2.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 121.164 3.225 . . . . 0.0 121.164 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.4 mt -80.95 -26.89 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.78 -1.424 . . . . 0.0 110.558 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.91 -48.3 75.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.71 -39.99 95.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.315 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.68 -34.48 77.2 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.846 -0.534 . . . . 0.0 111.64 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -97.0 -1.33 45.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -82.68 132.37 52.02 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.57 -9.92 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 115.517 -2.522 . . . . 0.0 114.833 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -74.24 158.1 85.86 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.62 124.58 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 116.138 -2.108 . . . . 0.0 115.658 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.37 144.29 28.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 120.641 0.894 . . . . 0.0 112.856 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -138.94 45.1 2.01 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.022 0.915 . . . . 0.0 109.367 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.06 90.44 2.49 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m -125.63 90.74 49.99 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.212 1.005 . . . . 0.0 110.282 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -100.63 63.56 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 1 C-N-CA 125.687 4.258 . . . . 0.0 119.351 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -87.05 -128.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 CA-C-N 119.918 1.006 . . . . 0.0 114.637 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.54 -38.52 74.87 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.921 1.691 . . . . 0.0 113.745 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -64.68 -25.13 67.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.117 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.92 -32.98 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.4 -0.813 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.8 p -75.0 -33.89 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.38 -45.44 82.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.07 83.97 Favored Glycine 0 C--O 1.229 -0.21 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.61 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.3 p -63.28 -17.0 62.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.0 -27.53 13.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.6 mt -79.36 -44.78 23.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -53.36 -48.79 91.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.35 -27.9 10.91 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 111.645 -5.103 . . . . 0.0 113.507 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -67.15 -44.62 79.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -70.85 -20.65 62.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.058 -1.057 . . . . 0.0 112.703 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.2 t -85.35 -41.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -59.27 -46.97 87.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.046 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.68 -24.21 53.18 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -27.27 61.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.268 0.94 . . . . 0.0 110.994 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.98 -3.45 58.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.348 0.659 . . . . 0.0 111.641 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.3 t -121.25 121.96 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -167.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.03 41.79 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.93 -177.54 0.33 Allowed Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.504 1.121 . . . . 0.0 108.848 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.27 61.03 0.5 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 156.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -86.29 80.01 8.87 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.153 -1.592 . . . . 0.0 107.4 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -118.78 -65.35 1.18 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.45 -44.27 96.98 Favored Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.335 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -77.7 -8.79 58.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.28 -32.62 55.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.954 -1.716 . . . . 0.0 106.432 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -79.28 -9.81 59.67 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 120.956 -1.09 . . . . 0.0 111.237 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.84 74.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 165.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.74 -42.51 90.9 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.829 -1.169 . . . . 0.0 109.956 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 tp -56.46 -44.28 80.38 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.59 -27.86 68.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -81.45 -34.21 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.111 -0.993 . . . . 0.0 110.581 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -73.15 -23.58 60.47 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.0 110.481 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -68.31 -29.75 68.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.857 -0.527 . . . . 0.0 110.308 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.66 85.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.63 -39.01 80.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.99 -41.11 91.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.57 0.748 . . . . 0.0 110.027 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.65 -41.76 56.2 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.013 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -62.21 -32.62 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.65 -55.08 11.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.086 0.946 . . . . 0.0 112.624 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -76.67 -10.4 59.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.73 -0.606 . . . . 0.0 112.423 -159.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -79.81 -8.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.67 -40.75 2.86 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.33 -66.53 0.25 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.65 -169.74 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 125.174 3.916 . . . . 0.0 115.689 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -57.82 165.45 1.74 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.086 0.955 . . . . 0.0 111.841 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 pt -65.81 -21.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -146.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.92 -13.29 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.31 -11.42 61.73 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.86 -45.21 0.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -164.17 -179.32 6.08 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.89 121.46 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.4 m -138.95 179.39 6.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -38.75 -38.76 0.44 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -69.13 -39.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 120.741 -1.224 . . . . 0.0 111.792 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.84 -39.5 72.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.26 -7.21 28.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.4 p -104.55 -45.36 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.212 -0.423 . . . . 0.0 112.017 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.48 -50.94 12.76 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.16 81.17 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.02 -18.75 52.01 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 113.605 -3.797 . . . . 0.0 117.317 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -94.74 -24.41 17.12 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.346 -1.471 . . . . 0.0 109.401 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.72 -25.93 67.52 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.396 -0.815 . . . . 0.0 111.902 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -49.0 59.02 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.186 0.903 . . . . 0.0 110.318 166.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -72.98 -21.14 60.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.59 -50.11 70.74 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 122.228 0.211 . . . . 0.0 111.177 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -72.04 -20.66 61.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.806 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.6 t -78.83 -57.35 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.48 -52.26 28.31 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.69 -42.2 91.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.663 0.744 . . . . 0.0 110.642 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.29 -32.35 82.43 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -90.88 -38.33 12.99 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.205 -1.173 . . . . 0.0 114.101 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -81.82 -46.44 14.15 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -145.4 70.49 1.26 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -165.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -53.71 117.77 3.41 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -143.53 89.06 7.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.65 161.94 40.84 Favored 'Trans proline' 0 C--O 1.235 0.34 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.19 127.23 92.42 Favored Pre-proline 0 C--O 1.245 0.852 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.47 154.89 45.49 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.695 -1.736 . . . . 0.0 112.092 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.8 -2.72 31.24 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.563 -0.711 . . . . 0.0 110.731 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -69.5 -21.49 63.67 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.69 -0.631 . . . . 0.0 111.586 166.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.51 65.21 0.71 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.4 m -57.39 -34.95 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.992 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -53.86 53.5 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.569 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.2 t -68.43 -34.86 68.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -168.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.97 -52.0 65.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.351 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.35 -41.55 96.7 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.278 -0.264 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -60.63 -52.01 66.98 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.39 -37.48 79.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 121.859 -0.526 . . . . 0.0 111.312 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.93 -41.78 99.59 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.445 0.64 . . . . 0.0 112.433 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.0 mt -71.52 -40.36 70.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.01 -20.0 63.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.124 0.488 . . . . 0.0 111.429 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.72 -27.91 69.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.419 -0.801 . . . . 0.0 112.373 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 t -136.99 69.93 1.41 Allowed 'General case' 0 C--O 1.243 0.758 0 O-C-N 121.43 -0.794 . . . . 0.0 112.771 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -125.9 138.79 53.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 162.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -59.43 -37.99 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.81 1.641 . . . . 0.0 113.188 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -37.31 78.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -85.16 -34.87 22.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.093 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -70.56 -42.34 71.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.33 -35.2 73.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.688 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.4 p -77.2 -19.29 56.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.896 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -51.96 122.77 8.96 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.248 0.619 . . . . 0.0 111.626 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.15 173.07 9.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.547 0.739 . . . . 0.0 110.308 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.71 126.96 31.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.9 -29.64 69.71 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.587 -0.695 . . . . 0.0 112.242 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.12 -35.68 79.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.145 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -85.77 -6.78 59.06 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.83 -54.3 7.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.0 mt -68.7 -61.39 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.932 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.32 -3.26 39.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.843 -0.536 . . . . 0.0 110.852 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.82 -13.3 61.11 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -99.17 -21.18 16.25 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.911 1.356 . . . . 0.0 111.803 166.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.4 -8.18 0.13 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.362 1.268 1 C-N-CA 110.851 -5.633 . . . . 0.0 112.852 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.221 -0.406 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.88 159.65 40.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.5 mt -129.98 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.57 157.49 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -167.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.21 128.85 34.01 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.175 -0.953 . . . . 0.0 108.622 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.17 158.42 16.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 140.18 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.362 170.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.57 126.85 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.11 0.2 60.4 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 78.15 4.01 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.75 1.775 . . . . 0.0 114.917 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.82 90.79 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 N-CA-C 116.925 1.856 . . . . 0.0 116.925 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -157.25 -49.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.82 157.25 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 103.323 -2.843 . . . . 0.0 103.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.46 166.91 15.14 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.486 1.114 . . . . 0.0 111.739 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.11 -173.82 16.22 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -76.66 99.05 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 122.471 1.129 . . . . 0.0 110.833 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.17 136.07 17.82 Favored Pre-proline 0 C--N 1.319 -0.74 1 N-CA-C 100.134 -4.025 . . . . 0.0 100.134 162.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.29 -36.65 34.89 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 116.22 -2.053 . . . . 0.0 112.047 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -72.57 -26.0 61.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.112 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.54 -41.71 92.75 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.432 1.111 . . . . 0.0 109.863 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.98 -33.77 63.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.518 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.57 -45.99 84.52 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.148 1.34 . . . . 0.0 111.779 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.67 -35.34 65.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.479 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.55 -46.7 25.32 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.316 -0.865 . . . . 0.0 112.941 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -39.6 94.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -64.3 -43.59 94.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 112.084 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -27.14 28.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -75.45 -31.63 60.36 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 118.486 0.584 . . . . 0.0 111.041 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.52 -37.98 89.42 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.388 -1.445 . . . . 0.0 109.515 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.65 -20.4 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 51.56 40.13 26.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 112.346 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.18 135.38 73.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.64 140.95 89.35 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 115.733 -2.378 . . . . 0.0 114.215 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -148.53 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -114.53 124.51 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 167.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -90.82 149.6 21.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -135.28 133.33 38.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.38 110.79 21.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.16 109.2 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.27 78.23 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.709 0.766 . . . . 0.0 112.957 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt 55.27 54.39 8.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.7 160.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.88 15.22 58.26 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.207 -0.906 . . . . 0.0 114.39 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -74.41 114.91 13.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.342 1.071 . . . . 0.0 108.482 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 89.04 11.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -67.45 176.3 5.04 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 115.989 -2.208 . . . . 0.0 109.164 166.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -54.95 -31.45 60.51 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.553 -0.717 . . . . 0.0 112.56 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -56.98 -51.45 69.16 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.964 0.802 . . . . 0.0 112.608 172.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.25 -24.38 61.36 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 120.285 -1.509 . . . . 0.0 111.513 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.24 -35.24 77.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.603 -0.686 . . . . 0.0 112.093 170.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -67.4 -42.74 82.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.458 -0.776 . . . . 0.0 110.134 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.12 -51.79 16.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -104.63 126.41 31.39 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -65.11 -31.91 53.75 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -90.39 -4.41 57.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 120.63 -1.294 . . . . 0.0 110.244 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.93 -34.78 2.34 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-O 121.418 0.454 . . . . 0.0 112.478 -166.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -112.03 0.87 16.13 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 118.993 2.96 . . . . 0.0 118.993 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.0 147.05 72.92 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 120.145 1.338 . . . . 0.0 108.145 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.54 151.15 58.56 Favored 'Trans proline' 0 C--N 1.345 0.394 0 O-C-N 122.721 0.853 . . . . 0.0 111.495 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.87 162.6 20.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.769 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.65 128.44 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -85.49 96.33 9.57 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.73 97.76 7.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 121.014 1.734 . . . . 0.0 106.816 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.36 46.39 25.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.108 0.563 . . . . 0.0 112.507 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 71.86 4.6 5.09 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.67 2.388 . . . . 0.0 115.842 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.21 108.4 19.89 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -94.54 134.46 37.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.148 -166.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.21 134.3 65.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.0 -28.31 2.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -75.97 131.18 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.4 p -67.54 -23.12 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -95.67 -21.32 18.27 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.748 -0.595 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.08 -34.55 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.99 -24.85 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.16 -32.68 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 120.446 -1.408 . . . . 0.0 110.166 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.9 -54.81 0.42 Allowed Glycine 0 C--O 1.226 -0.386 0 N-CA-C 119.609 2.604 . . . . 0.0 119.609 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.82 -31.02 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.211 1.505 . . . . 0.0 110.885 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.88 -34.7 76.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.846 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -73.36 -38.63 65.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.884 -0.51 . . . . 0.0 111.446 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.63 -31.91 73.22 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.411 -0.805 . . . . 0.0 113.127 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 5.4 43.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -98.31 135.45 21.25 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.28 -8.87 24.64 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 116.485 -1.877 . . . . 0.0 116.67 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.05 160.15 76.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.365 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.86 137.14 65.9 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 114.86 -2.96 . . . . 0.0 114.191 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.57 88.59 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 115.967 1.487 . . . . 0.0 115.967 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.59 63.67 7.7 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 120.483 -1.386 . . . . 0.0 112.471 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.73 86.06 2.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 m -125.76 87.74 55.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.575 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -98.61 48.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 122.185 3.879 . . . . 0.0 122.185 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -80.35 -117.93 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.677 1.278 . . . . 0.0 112.289 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -53.42 -35.43 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.11 -37.56 87.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.78 0.8 . . . . 0.0 109.925 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.88 42.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.818 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -67.95 -32.29 72.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.76 -50.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.8 96.39 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.467 -0.873 . . . . 0.0 115.083 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.0 p -73.52 -8.33 55.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -80.01 -35.42 37.37 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.02 -1.05 . . . . 0.0 110.568 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.98 -37.32 9.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.633 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.65 -54.22 38.18 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.93 -24.39 13.01 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 113.423 -3.918 . . . . 0.0 113.036 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -71.73 -39.53 70.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HD13 ' A' ' 123' ' ' LEU . 3.3 p90 -75.53 -26.15 57.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.787 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.71 -28.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 120.898 -1.126 . . . . 0.0 109.245 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.53 -42.77 99.74 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.768 -1.207 . . . . 0.0 109.444 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -65.21 -40.22 93.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.814 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.92 -39.1 90.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -76.16 -11.04 59.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -87.09 141.99 28.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -127.91 27.79 5.66 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -72.4 170.78 11.62 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.2 52.21 1.85 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-O 122.926 1.136 . . . . 0.0 114.378 167.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -83.67 38.55 0.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -140.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -67.25 -24.71 65.83 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.52 90.73 Favored Glycine 0 N--CA 1.454 -0.123 0 O-C-N 120.835 -1.165 . . . . 0.0 111.325 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 m -74.34 -30.57 62.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.862 -0.787 . . . . 0.0 110.16 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -66.45 -34.51 78.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.862 0.839 . . . . 0.0 111.02 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -76.31 -30.35 57.7 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.64 96.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.296 -0.878 . . . . 0.0 109.523 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 17.0 tp -63.73 -47.3 81.61 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.98 -43.58 98.6 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.481 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.46 -44.25 83.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.893 0.77 . . . . 0.0 112.11 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.98 -27.72 54.84 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.116 -0.99 . . . . 0.0 112.347 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.01 -22.95 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.634 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -71.7 -31.13 66.42 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.101 -0.999 . . . . 0.0 109.998 168.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.68 90.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 122.0 -0.437 . . . . 0.0 112.11 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.07 -36.81 80.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.632 0.73 . . . . 0.0 110.73 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.26 -52.63 38.87 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.514 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -56.76 -42.29 79.09 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.051 -0.676 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.54 -45.14 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.13 -27.08 62.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.146 1.339 . . . . 0.0 112.677 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.08 -33.84 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 122.808 0.443 . . . . 0.0 110.318 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.56 -35.12 8.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.76 -75.02 0.24 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-O 117.381 -1.788 . . . . 0.0 116.553 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -61.55 -159.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 126.428 4.752 . . . . 0.0 118.994 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.59 167.43 1.47 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.519 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -45.5 -32.74 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.57 -7.55 39.51 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.779 -1.2 . . . . 0.0 114.236 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.05 3.71 90.64 Favored Glycine 0 CA--C 1.511 -0.203 0 O-C-N 121.672 -0.643 . . . . 0.0 113.327 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -142.39 -61.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -158.28 176.01 13.01 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.2 mm -63.12 127.98 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.0 m -142.71 161.98 36.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -171.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.27 -22.97 45.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.61 -23.61 29.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.66 -40.96 22.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.1 mt -70.79 -12.22 61.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.217 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.9 p -96.13 -23.73 16.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.2 tp -100.41 -49.17 4.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.31 -40.7 70.18 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.59 -38.63 93.01 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 114.637 -3.109 . . . . 0.0 118.259 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -87.93 -22.05 24.57 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.366 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.62 -37.74 85.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.095 1.316 . . . . 0.0 111.579 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.6 -50.27 71.93 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.801 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -63.83 -33.37 75.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.446 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.3 tp -63.47 -52.47 61.22 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.728 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.08 -34.59 78.37 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.714 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.83 -54.05 21.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.997 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.22 -44.18 63.31 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.283 -0.885 . . . . 0.0 111.693 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.15 -37.4 75.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.64 -36.57 93.44 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -75.98 -51.64 11.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.206 -1.173 . . . . 0.0 113.028 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -80.54 -36.99 32.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -146.89 53.07 1.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -171.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -34.38 102.79 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -157.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -142.7 85.41 10.22 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 169.74 21.86 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 116.296 -2.002 . . . . 0.0 109.019 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.4 mm -73.25 124.19 90.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.47 163.6 31.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 116.06 -2.16 . . . . 0.0 113.634 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.85 -4.65 36.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.491 -0.756 . . . . 0.0 112.112 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.25 -21.2 66.5 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.09 -1.006 . . . . 0.0 110.123 165.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.53 57.04 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.7 m -57.37 -34.64 69.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.088 -0.383 . . . . 0.0 111.289 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -68.79 -40.66 79.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.88 -43.03 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.137 0.494 . . . . 0.0 110.256 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.93 -43.5 92.58 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.768 -0.583 . . . . 0.0 111.788 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -69.36 -34.33 74.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.609 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -59.07 -49.31 78.36 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.84 -36.64 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.272 -0.893 . . . . 0.0 111.809 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.28 -37.81 88.81 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.523 -1.361 . . . . 0.0 112.592 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.84 -43.98 97.35 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.0 mt -65.77 -41.9 91.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.881 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.35 -33.48 65.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.1 m -115.98 18.49 15.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -66.66 139.61 57.87 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.89 -43.68 81.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.995 0.816 . . . . 0.0 112.545 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 p -67.13 -41.23 86.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -42.75 49.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.661 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 196' ' ' ARG . 37.6 ttmt -52.83 -44.92 67.07 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.544 -0.723 . . . . 0.0 112.003 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.17 -43.11 99.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.471 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 50.8 p -96.5 -4.04 42.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 193' ' ' LYS . 55.9 mtp180 -56.14 133.61 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.31 148.48 50.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.83 134.7 56.64 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.443 0.464 . . . . 0.0 109.829 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.53 -34.3 72.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.74 -32.45 70.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.139 0.971 . . . . 0.0 111.423 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -94.78 -21.36 18.78 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.415 -0.803 . . . . 0.0 111.941 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.33 -42.41 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.7 -74.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.35 63.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.67 -25.27 33.13 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.06 -0.59 . . . . 0.0 114.143 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 -22.16 12.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.912 0.856 . . . . 0.0 113.177 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.59 -17.37 0.37 Allowed Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--N 1.36 1.132 1 C-N-CA 111.043 -5.504 . . . . 0.0 115.402 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.238 0.495 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.75 146.82 44.47 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 121.922 -0.486 . . . . 0.0 110.518 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.8 mt -111.23 98.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.8 t -101.82 108.71 20.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.7 m -132.58 162.49 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.33 142.64 56.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -97.41 167.8 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.174 0.443 . . . . 0.0 110.741 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.97 58.37 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.86 112.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.27 85.46 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 114.634 -1.166 . . . . 0.0 115.461 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.7 82.36 7.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.008 0.904 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.25 43.24 0.71 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 124.666 3.577 . . . . 0.0 115.938 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.78 -8.1 2.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.86 156.57 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.68 154.0 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.26 174.32 45.23 Favored Glycine 0 C--O 1.238 0.345 0 N-CA-C 120.787 3.075 . . . . 0.0 120.787 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.37 75.68 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.755 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.95 133.68 21.18 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.41 -40.56 56.65 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-O 123.092 1.205 . . . . 0.0 111.445 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -77.79 -17.84 57.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -60.8 -48.83 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 111.292 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.17 -12.48 60.9 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.273 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -59.18 -48.92 79.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.958 1.708 . . . . 0.0 109.029 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.74 -50.44 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.206 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.66 -41.84 91.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.053 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.95 -45.87 83.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.1 p -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.509 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 -32.49 33.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.246 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -68.66 -38.14 80.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 118.741 0.7 . . . . 0.0 112.454 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.15 -28.78 69.05 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 120.916 -1.115 . . . . 0.0 111.134 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -91.58 -12.91 32.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 53.17 33.8 16.04 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -81.61 151.97 69.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.87 143.11 44.62 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 115.419 -2.587 . . . . 0.0 112.874 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -150.97 162.5 40.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -124.53 112.35 16.75 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.1 t -80.52 133.06 35.76 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -114.68 130.7 56.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 3.8 mm? -109.69 121.04 44.33 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -172.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.67 104.18 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.37 90.09 0.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.189 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt 49.25 49.99 18.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.724 1.209 . . . . 0.0 113.784 174.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.33 43.47 38.21 Favored Glycine 0 C--O 1.229 -0.217 0 C-N-CA 119.845 -1.169 . . . . 0.0 112.966 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -75.81 84.25 2.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 161.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -115.47 95.69 43.83 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.383 0.673 . . . . 0.0 111.598 -160.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 169.98 18.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 N-CA-C 109.902 -0.845 . . . . 0.0 109.902 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -55.84 -32.65 63.78 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 0.506 . . . . 0.0 111.768 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -55.07 -52.54 62.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.46 -24.44 59.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 120.882 -1.136 . . . . 0.0 111.478 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.29 -32.17 73.42 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.239 0.543 . . . . 0.0 111.405 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -74.43 -39.23 62.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.663 0.744 . . . . 0.0 111.468 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.41 -37.01 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 t -121.54 143.0 36.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.91 -37.35 86.3 Favored 'Trans proline' 0 C--N 1.355 0.917 0 N-CA-C 116.207 1.579 . . . . 0.0 116.207 170.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -93.96 -21.13 19.39 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.109 -0.994 . . . . 0.0 111.941 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 4.63 90.37 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-O 122.189 0.883 . . . . 0.0 111.513 -167.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -160.68 75.19 0.54 Allowed 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.859 1.264 . . . . 0.0 109.808 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.5 160.52 63.99 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 135.48 32.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 113.473 -3.884 . . . . 0.0 112.382 165.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.35 141.69 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.58 126.34 54.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -92.7 91.06 7.34 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.61 85.09 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.5 t0 53.62 60.07 3.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.294 1.045 . . . . 0.0 112.041 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 67.49 3.69 3.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.751 1.62 . . . . 0.0 115.265 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -103.34 99.77 9.62 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.159 -0.963 . . . . 0.0 109.034 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -80.57 134.71 35.96 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.475 0.71 . . . . 0.0 111.776 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.12 126.15 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.736 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.76 80.91 1.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -148.54 145.33 27.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 162.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -58.37 -34.26 70.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -81.24 -18.17 46.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.57 -20.33 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.14 -9.91 12.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.45 -60.45 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 162.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.89 -36.35 90.94 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.6 mt -86.17 -27.7 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 120.869 -1.371 . . . . 0.0 107.94 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.41 -39.28 94.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.89 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.72 -37.61 87.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.974 0.806 . . . . 0.0 110.788 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.06 -28.42 68.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.771 1.272 . . . . 0.0 112.006 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -102.77 1.64 34.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.505 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -75.56 143.04 74.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.184 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 -16.78 12.87 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 115.59 1.342 . . . . 0.0 115.59 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -90.67 161.79 35.36 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 103.544 -2.762 . . . . 0.0 103.544 174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.06 142.44 97.21 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 N-CA-C 119.135 2.706 . . . . 0.0 119.135 -163.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.48 106.76 2.32 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 121.585 1.523 . . . . 0.0 115.907 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.04 40.72 2.57 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 122.068 0.937 . . . . 0.0 112.745 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 79.77 5.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.308 -1.495 . . . . 0.0 112.34 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -118.93 94.54 48.25 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.08 82.18 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 124.33 3.353 . . . . 0.0 119.974 165.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.56 -146.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.392 1.395 . . . . 0.0 111.635 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -46.25 -40.32 11.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -62.79 -27.97 69.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.11 -29.04 61.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 76.8 p -76.19 -31.4 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.485 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.06 -40.63 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.546 -1.206 . . . . 0.0 114.131 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.1 p -66.98 -11.16 55.98 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -98.13 -34.01 10.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.2 pt -75.27 -30.85 23.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.042 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.73 -56.15 10.06 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -167.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.91 -20.62 16.9 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 114.618 -3.122 . . . . 0.0 113.661 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.9 t -64.29 -43.29 95.2 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.16 0.984 . . . . 0.0 111.647 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -37.83 84.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.042 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 107' ' ' VAL . 0.5 OUTLIER -67.3 -38.58 81.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.207 176.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.2 -44.93 95.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.315 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.63 -27.69 61.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.8 -46.03 91.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.232 0.923 . . . . 0.0 112.166 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -72.5 -22.41 61.05 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.066 0.936 . . . . 0.0 112.234 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 t -86.3 143.06 28.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -127.9 32.99 4.85 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 123.44 1.59 . . . . 0.0 109.333 164.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.21 170.8 7.95 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.0 47.02 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.12 101.47 13.83 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.1 -45.01 1.14 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.257 0.623 . . . . 0.0 111.795 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.8 -21.03 79.03 Favored Glycine 0 C--O 1.236 0.248 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.5 p -93.72 -11.97 30.28 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 168.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -67.04 -34.97 78.85 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 119.528 -1.983 . . . . 0.0 105.799 162.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -79.34 3.28 18.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.332 -0.855 . . . . 0.0 113.167 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.45 -28.56 61.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.33 -37.47 85.75 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.959 -1.088 . . . . 0.0 109.925 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.5 tp -61.91 -36.14 80.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.459 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -78.52 -34.88 46.95 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -72.8 -39.26 66.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.711 -1.868 . . . . 0.0 110.266 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 110.444 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -64.06 -35.52 81.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.924 0.783 . . . . 0.0 109.372 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.43 81.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.73 -42.73 97.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.579 -0.701 . . . . 0.0 110.737 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.366 1.066 . . . . 0.0 112.455 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.91 -36.52 41.43 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.578 -0.701 . . . . 0.0 114.01 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.63 -28.13 66.63 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.65 -52.8 27.23 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.392 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.35 -19.44 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.05 -9.14 12.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -113.51 -53.4 2.7 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.69 -59.04 0.47 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -71.39 -164.77 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.959 3.106 . . . . 0.0 115.062 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -54.9 160.07 2.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.7 tp -61.53 -22.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -163.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.23 -11.46 60.91 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.295 -1.503 . . . . 0.0 114.076 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.82 -26.76 8.69 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.12 -44.27 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -161.88 -177.03 5.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.396 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.44 109.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.8 m -128.79 -174.37 3.23 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 147' ' ' THR . . . -47.14 -38.26 11.32 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.31 -46.75 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 118.868 0.758 . . . . 0.0 110.158 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.92 -39.76 75.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.462 0.649 . . . . 0.0 110.349 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.69 -24.39 66.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.686 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.5 m -82.03 -36.6 27.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 83.6 mt -97.87 -46.25 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.55 36.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.56 -33.96 43.95 Favored 'Trans proline' 0 C--N 1.353 0.8 1 C-N-CA 112.067 -4.822 . . . . 0.0 115.629 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -80.87 -28.32 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.41 -1.432 . . . . 0.0 109.358 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.8 mt -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.244 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.03 -49.92 75.75 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.053 0.842 . . . . 0.0 111.68 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -64.2 -31.77 73.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -54.03 16.53 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 121.598 -0.688 . . . . 0.0 109.713 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -30.8 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.02 -35.4 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.076 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.56 -43.54 15.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.46 -36.6 84.39 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.408 0.683 . . . . 0.0 109.624 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.72 -35.17 91.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.539 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -74.47 -51.19 15.54 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.778 -0.837 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -77.67 -47.4 19.31 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -149.42 74.94 1.26 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -168.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.69 115.97 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -161.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -131.83 97.12 19.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 148.5 46.44 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 115.644 -2.437 . . . . 0.0 113.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.32 120.75 72.65 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -71.23 167.44 26.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 N-CA-C 116.776 1.798 . . . . 0.0 116.776 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.98 -16.34 63.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.958 0.903 . . . . 0.0 111.169 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -72.64 -13.52 61.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.516 0.726 . . . . 0.0 111.963 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.53 52.06 1.0 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -25.8 68.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -54.41 43.55 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.73 -36.08 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.62 -49.25 78.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -69.23 -37.27 77.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.821 0.343 . . . . 0.0 111.772 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -62.17 -49.2 76.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.81 0.844 . . . . 0.0 110.136 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 80.4 mt -71.95 -29.55 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.268 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.47 -46.21 87.24 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.966 -1.084 . . . . 0.0 111.277 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.59 -35.28 78.68 Favored 'General case' 0 C--O 1.216 -0.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.543 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.97 -37.07 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.029 0.918 . . . . 0.0 110.417 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -67.32 -27.56 67.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.64 -0.663 . . . . 0.0 111.338 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 t -145.35 72.81 1.33 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.989 0.899 . . . . 0.0 112.712 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -127.15 139.84 52.68 Favored 'General case' 0 N--CA 1.468 0.452 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 168.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -60.57 -39.68 88.89 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.7 p -61.57 -33.45 73.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.883 0.849 . . . . 0.0 112.681 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.4 -36.12 20.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.255 0.55 . . . . 0.0 110.892 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -62.47 -38.94 91.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.47 -28.6 46.54 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.236 1.017 . . . . 0.0 112.567 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 p -95.4 -0.48 52.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -61.44 144.98 53.2 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.37 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.56 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 134.31 48.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.14 -42.39 89.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 111.747 -167.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -62.14 -22.92 66.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.72 -9.42 46.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.56 -0.712 . . . . 0.0 110.762 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.46 -43.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 168.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -60.58 -66.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.25 0.548 . . . . 0.0 109.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.99 60.64 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.932 -1.105 . . . . 0.0 111.643 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.71 -26.6 45.44 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.285 -0.959 . . . . 0.0 114.113 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -88.23 -38.89 14.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.461 1.124 . . . . 0.0 109.42 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.91 -18.05 0.43 Allowed Pre-proline 0 C--N 1.321 -0.636 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 C--N 1.355 0.87 1 C-N-CA 110.516 -5.856 . . . . 0.0 114.403 171.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.535 0.371 0 CA-C-O 120.878 0.371 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -108.24 137.84 45.54 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 30' ' ' LEU . 56.1 mt -110.27 117.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 173.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 m -110.71 129.66 55.77 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.77 159.99 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.16 130.02 41.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.94 0.496 . . . . 0.0 110.005 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -73.88 170.97 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 111.84 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 132.11 49.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.165 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.65 112.85 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.79 -28.8 6.04 Favored Glycine 0 C--O 1.242 0.652 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.417 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.24 93.39 2.7 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.278 1.031 . . . . 0.0 112.594 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.27 72.87 5.24 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 121.181 1.254 . . . . 0.0 114.873 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -142.98 13.44 1.86 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.384 -1.448 . . . . 0.0 111.77 166.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.69 152.93 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 1 N-CA-C 99.409 -4.293 . . . . 0.0 99.409 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 3.5 pp -65.37 158.43 26.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.938 1.295 . . . . 0.0 112.404 169.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.1 175.78 15.85 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -79.11 90.92 4.86 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.555 1.169 . . . . 0.0 109.958 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 124.94 29.15 Favored Pre-proline 0 C--N 1.319 -0.739 1 N-CA-C 97.161 -5.125 . . . . 0.0 97.161 161.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -66.42 -30.04 44.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 115.63 -2.446 . . . . 0.0 116.121 -168.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.73 -24.72 53.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.779 -0.575 . . . . 0.0 111.445 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.56 -40.72 97.74 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 123.121 1.439 . . . . 0.0 110.217 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -72.47 -16.01 61.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.587 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.15 -34.97 75.83 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.283 -0.885 . . . . 0.0 110.442 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.19 -41.36 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 122.554 1.169 . . . . 0.0 107.957 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.46 -44.93 85.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.816 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.17 -43.53 91.42 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.485 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -67.43 -39.2 85.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.428 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 5' ' ' ILE . 3.0 mp -71.95 -38.19 69.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.31 -26.58 62.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.111 0.414 . . . . 0.0 110.892 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -39.0 73.53 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.217 -0.927 . . . . 0.0 112.706 169.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -79.93 -10.03 59.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.509 -0.744 . . . . 0.0 112.66 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 55.44 35.51 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.749 1.219 . . . . 0.0 111.946 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 pt -89.05 154.78 49.73 Favored Pre-proline 0 C--O 1.242 0.701 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.93 153.21 58.18 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 114.215 -3.39 . . . . 0.0 112.666 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.04 157.26 41.42 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.68 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.88 118.16 33.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 171.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.9 t -91.02 120.46 32.03 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -114.2 112.45 23.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.426 1.108 . . . . 0.0 110.913 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.1 mt -96.57 109.93 22.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.407 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -83.36 116.41 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -72.33 54.07 0.3 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.658 1.983 . . . . 0.0 114.821 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt 54.4 54.46 9.38 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.856 1.663 . . . . 0.0 109.183 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.29 70.41 1.22 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.5 116.36 28.95 Favored 'General case' 0 C--N 1.32 -0.686 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 163.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -123.78 60.08 19.1 Favored Pre-proline 0 C--O 1.248 0.983 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.87 174.68 11.93 Favored 'Trans proline' 0 C--O 1.239 0.555 1 C-N-CA 113.118 -4.121 . . . . 0.0 110.41 161.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -55.0 -36.46 65.46 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.774 0.43 . . . . 0.0 110.572 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -55.8 -52.58 63.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -74.99 -27.2 60.06 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.213 -0.929 . . . . 0.0 111.817 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.03 -32.04 72.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.594 1.088 . . . . 0.0 111.624 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.91 -39.42 83.57 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.734 -0.604 . . . . 0.0 109.864 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.95 -37.23 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.85 0.86 . . . . 0.0 112.408 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -128.46 128.15 23.61 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.3 -14.3 31.21 Favored 'Trans proline' 0 C--O 1.242 0.714 0 N-CA-C 118.148 2.326 . . . . 0.0 118.148 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -102.97 -7.65 21.28 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.088 0.858 . . . . 0.0 110.767 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.8 8.23 72.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -159.86 55.64 0.37 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.382 1.073 . . . . 0.0 111.851 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.45 155.66 81.17 Favored Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 120.736 -1.228 . . . . 0.0 109.635 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.19 148.14 30.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 114.387 -3.275 . . . . 0.0 113.83 168.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.17 166.0 30.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.96 123.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 154.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -114.4 95.02 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mt -101.23 122.92 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 50.64 43.58 27.67 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.004 0.522 . . . . 0.0 111.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 68.39 12.87 8.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.13 2.641 . . . . 0.0 118.13 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -115.76 122.86 46.73 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.695 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -104.65 147.12 28.01 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -124.58 152.09 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.42 38.9 0.64 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 119.29 3.07 . . . . 0.0 119.29 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.19 153.72 31.34 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.882 1.673 . . . . 0.0 107.867 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -58.43 -32.65 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.54 -40.72 41.59 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.82 -0.55 . . . . 0.0 111.651 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -82.03 -20.31 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.2 pt -71.46 -3.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.854 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.55 -48.34 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 159.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.24 -36.31 91.57 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.0 mt -87.01 -30.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 120.227 2.013 . . . . 0.0 106.065 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.53 -49.42 74.81 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.656 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -60.5 -37.25 80.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.441 1.473 . . . . 0.0 112.255 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.5 -21.12 64.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -112.46 -6.34 14.0 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -76.79 135.55 67.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.55 -19.85 27.77 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 116.545 1.71 . . . . 0.0 116.545 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -75.7 160.89 78.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.029 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.44 129.19 33.84 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.78 130.32 3.67 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 N-CA-C 116.683 1.763 . . . . 0.0 116.683 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB3' HG23 ' A' ' 147' ' ' THR . 95.7 mt -125.92 48.5 2.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.72 1.208 . . . . 0.0 112.617 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.53 75.18 10.3 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.081 -1.637 . . . . 0.0 108.58 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -116.29 102.42 53.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.15 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -108.32 72.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.208 3.272 . . . . 0.0 118.21 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -82.36 -148.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 1 C-N-CA 125.681 4.254 . . . . 0.0 111.177 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.54 -29.95 28.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.71 -25.23 65.56 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 120.334 -1.479 . . . . 0.0 113.275 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.97 -34.04 59.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.8 p -72.29 -35.69 68.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -45.09 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.1 82.91 Favored Glycine 0 C--O 1.229 -0.162 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.793 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 p -70.18 -13.95 62.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -82.3 -40.6 21.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.481 -0.762 . . . . 0.0 109.671 170.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.36 -33.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 74.9 t80 -54.65 -51.87 74.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.98 -25.42 16.34 Favored 'Trans proline' 0 C--N 1.351 0.669 1 C-N-CA 112.615 -4.457 . . . . 0.0 114.042 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -69.0 -38.55 79.34 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE 0.262 0.4 OUTLIER -77.7 -27.23 50.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 118.511 -1.276 . . . . 0.0 113.703 178.806 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.74 -28.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.576 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -61.19 -44.77 96.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.492 -0.755 . . . . 0.0 110.944 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -65.7 -41.26 92.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.84 -38.91 83.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.993 -0.442 . . . . 0.0 111.615 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.4 27.35 1.47 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 t -121.13 122.0 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -113.75 26.5 10.3 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.34 168.2 30.0 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.06 94.28 0.73 Allowed 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 117.198 -1.402 . . . . 0.0 108.84 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.49 26.39 9.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 123.413 1.578 . . . . 0.0 110.993 -150.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.92 -28.49 69.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.957 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.24 -24.55 76.22 Favored Glycine 0 CA--C 1.519 0.326 0 O-C-N 121.165 -0.96 . . . . 0.0 114.156 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -91.35 -24.08 19.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.08 0.94 . . . . 0.0 111.098 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.21 -44.52 95.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 163.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -76.75 -12.73 60.03 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.752 -1.218 . . . . 0.0 114.252 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.56 -31.13 61.99 Favored 'General case' 0 C--O 1.217 -0.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.699 168.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.01 -42.36 99.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.77 -45.65 91.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.401 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -75.47 -36.78 60.6 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -76.82 -35.13 57.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.626 -1.296 . . . . 0.0 108.656 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.65 -19.03 58.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.346 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.58 -35.89 82.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.537 1.062 . . . . 0.0 110.412 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.3 mt -63.6 -37.96 89.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.937 -1.102 . . . . 0.0 113.564 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.14 -43.12 92.91 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.759 -0.588 . . . . 0.0 110.89 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.58 40.7 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.557 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -62.54 -38.06 88.53 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.432 -0.452 . . . . 0.0 111.61 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.7 -40.75 69.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.257 -0.902 . . . . 0.0 112.971 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.04 -16.65 64.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.977 1.262 . . . . 0.0 112.265 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.63 -53.84 37.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 O-C-N 121.437 -0.789 . . . . 0.0 109.363 165.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.45 -51.12 9.77 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.57 -72.23 0.29 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.554 -1.692 . . . . 0.0 115.48 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -69.35 176.86 5.91 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.012 2.475 . . . . 0.0 116.236 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -42.17 154.54 0.05 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.71 1.604 . . . . 0.0 114.411 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.65 -37.03 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.379 1.071 . . . . 0.0 112.672 -142.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.64 -22.22 65.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 117.465 2.395 . . . . 0.0 117.465 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.97 3.49 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 117.364 1.705 . . . . 0.0 117.364 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -129.6 -41.56 1.34 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.793 1.796 . . . . 0.0 114.015 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -159.87 -179.89 8.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.17 131.78 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.614 0.643 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 89' ' ' LEU . 80.3 m -145.88 171.89 14.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -35.64 -39.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.51 -40.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.38 -38.92 74.79 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.04 -15.54 63.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 98.3 p -96.35 -34.41 11.58 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.63 -48.99 9.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.2 92.98 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 59.3 Cg_endo -63.46 -36.2 56.14 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 112.85 -4.3 . . . . 0.0 116.762 -178.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -78.76 -30.76 45.86 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.982 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.85 -29.33 70.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 155' ' ' PRO . 42.4 m-85 -63.47 -50.62 69.0 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 123.248 1.499 . . . . 0.0 109.11 173.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -77.1 -20.18 56.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.618 -170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 tp -64.14 -51.45 63.81 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.099 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.04 -34.0 77.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.381 1.446 . . . . 0.0 112.213 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.4 -52.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.78 41.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.546 -0.722 . . . . 0.0 111.549 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 tp -66.1 -42.69 88.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.704 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.83 -35.47 92.06 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.022 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -74.24 -47.35 35.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.746 -0.855 . . . . 0.0 111.528 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -87.0 -52.28 5.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -129.96 76.12 1.7 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.265 1.426 . . . . 0.0 108.089 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -56.14 121.36 9.24 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -168.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -151.0 92.76 3.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.7 163.59 36.89 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 114.994 -2.871 . . . . 0.0 109.963 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.57 118.99 65.55 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.24 166.22 26.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.714 -1.057 . . . . 0.0 111.996 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.68 3.0 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -68.12 -21.61 64.93 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.606 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -112.28 68.42 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.8 m -55.37 -38.17 68.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -55.17 -59.42 4.8 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.27 -34.51 70.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -166.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.5 tp -62.82 -44.34 96.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.28 -0.888 . . . . 0.0 113.323 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -78.78 -30.3 45.46 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.884 -1.135 . . . . 0.0 111.173 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.45 -49.2 77.78 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.666 0.787 . . . . 0.0 110.434 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.7 mm -69.88 -32.3 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.479 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.22 -38.54 91.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.047 -1.033 . . . . 0.0 112.738 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.56 -31.81 65.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 110.954 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.01 -11.43 59.55 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.637 -0.665 . . . . 0.0 111.952 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -92.73 27.38 2.37 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 122.716 1.246 . . . . 0.0 111.597 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.3 5.24 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 176.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 60.7 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.87 -32.67 67.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.924 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 m -50.8 -30.26 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -115.17 -42.68 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.494 1.14 . . . . 0.0 111.006 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.47 -31.47 62.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -94.19 -24.61 17.43 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.3 p -90.79 -21.94 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.3 126.58 27.91 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.291 0.567 . . . . 0.0 110.332 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.35 167.02 21.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.3 49.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -69.08 -37.4 78.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -162.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.45 -40.51 91.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.263 1.03 . . . . 0.0 109.748 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -78.09 -13.55 59.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.11 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.17 -50.32 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.09 -55.08 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.044 0.926 . . . . 0.0 111.494 -172.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.75 -3.09 36.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.404 1.081 . . . . 0.0 111.18 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.33 -29.9 26.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.34 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -102.96 -39.95 6.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.606 . . . . 0.0 113.22 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -59.72 -29.67 6.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--N 1.357 0.989 1 C-N-CA 111.81 -4.994 . . . . 0.0 114.238 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--O 1.232 0.156 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.33 138.33 44.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 168.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.43 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -125.82 111.3 14.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.28 155.96 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.67 125.64 24.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.64 164.24 23.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.59 127.09 30.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.351 0.596 . . . . 0.0 110.802 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.39 94.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.994 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.12 -19.45 7.28 Favored Glycine 0 C--O 1.235 0.163 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.795 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.1 69.56 23.05 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.47 74.14 5.26 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 N-CA-C 116.664 1.756 . . . . 0.0 116.664 -169.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -146.22 10.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.212 1.006 . . . . 0.0 109.442 167.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -135.03 155.78 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.33 143.48 57.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.707 0.685 . . . . 0.0 109.952 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 167.67 12.44 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 118.702 2.241 . . . . 0.0 118.702 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -65.39 103.97 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.929 -1.636 . . . . 0.0 113.781 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.2 t -166.36 141.37 3.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -62.98 -40.65 33.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 116.706 -1.729 . . . . 0.0 112.674 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.54 -27.14 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.743 -1.571 . . . . 0.0 111.471 -171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.88 -62.42 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.653 0.74 . . . . 0.0 109.644 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -70.4 -27.49 64.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.029 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -57.33 -46.16 83.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.598 1.09 . . . . 0.0 111.693 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -76.99 -35.92 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.222 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.36 -44.46 87.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.09 -39.17 93.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.466 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -39.54 93.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.685 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -33.5 54.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.958 -172.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -77.52 -33.58 54.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -67.05 -39.24 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.694 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.42 -6.46 58.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.716 -0.615 . . . . 0.0 112.402 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.26 41.63 31.9 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 113.213 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -97.6 146.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.33 152.63 34.94 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 114.738 -3.041 . . . . 0.0 113.829 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -150.58 156.6 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.937 0.875 . . . . 0.0 112.582 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.5 t -139.57 124.65 18.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.938 1.245 . . . . 0.0 112.95 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -114.18 124.85 53.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.85 108.04 20.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -83.77 95.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -67.64 97.31 0.6 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.92 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.9 mt 31.91 48.81 0.11 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.24 47.09 3.65 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.811 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -68.91 101.79 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 160.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -137.43 75.51 45.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -165.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -66.24 171.44 10.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 116.798 -1.668 . . . . 0.0 109.885 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -56.08 -36.61 68.31 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.691 -0.631 . . . . 0.0 112.313 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.95 -42.37 79.97 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -79.96 -31.44 39.94 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.086 -1.009 . . . . 0.0 111.418 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 mt -67.1 -24.67 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.296 -0.252 . . . . 0.0 111.67 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -66.75 -37.49 84.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.163 0.506 . . . . 0.0 110.962 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -88.91 -52.08 11.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-O 121.193 0.521 . . . . 0.0 111.806 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -87.35 117.06 68.07 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 120.886 -1.134 . . . . 0.0 111.302 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.33 -23.87 65.21 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 118.505 2.463 . . . . 0.0 118.505 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.4 -10.8 18.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.883 -1.136 . . . . 0.0 112.538 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -0.39 37.9 Favored Glycine 0 C--O 1.224 -0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 113.414 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -146.25 34.82 0.98 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.87 0.843 . . . . 0.0 110.708 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.8 141.2 37.48 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.68 147.85 90.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 116.131 -2.113 . . . . 0.0 113.063 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.93 162.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 132.78 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -105.81 136.53 45.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.88 91.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.1 t0 50.55 52.96 13.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.124 0.964 . . . . 0.0 111.391 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 t70 62.15 24.27 14.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -110.91 163.94 13.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -146.76 159.64 43.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.848 2.113 . . . . 0.0 115.447 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.42 162.27 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.66 -116.13 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.6 173.37 1.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 p -58.3 -30.05 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -158.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -77.92 -26.17 48.82 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.851 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -83.3 -34.85 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.87 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.306 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.81 -45.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.875 0.761 . . . . 0.0 111.646 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.43 -33.92 51.72 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -118.39 -51.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.5 -40.36 85.2 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.998 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.02 -38.36 85.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.238 0.926 . . . . 0.0 109.367 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.21 -31.82 71.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.01 1.26 49.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.54 135.87 83.73 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 -21.68 72.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 116.607 -1.795 . . . . 0.0 116.589 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -93.37 161.02 32.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.19 144.44 90.52 Favored 'Trans proline' 0 C--N 1.354 0.847 0 N-CA-C 116.705 1.771 . . . . 0.0 116.705 -156.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -84.95 29.16 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.029 1.819 . . . . 0.0 115.317 -163.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.33 111.58 3.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.81 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.15 26.55 2.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.244 1.021 . . . . 0.0 110.461 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.67 123.68 58.92 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -170.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -114.74 62.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.605 0 N-CA-C 116.452 1.674 . . . . 0.0 116.452 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -83.38 -132.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 121.192 1.261 . . . . 0.0 113.845 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.91 -32.98 70.03 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.442 -1.411 . . . . 0.0 110.638 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -62.55 -31.81 72.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.321 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.6 20.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.166 -0.334 . . . . 0.0 110.746 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.4 p -68.3 -39.26 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.537 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.76 -46.5 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.598 -0.689 . . . . 0.0 109.431 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.28 74.55 Favored Glycine 0 CA--C 1.516 0.097 0 N-CA-C 115.549 0.98 . . . . 0.0 115.549 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -66.77 -17.93 65.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -81.91 -33.65 30.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 110.757 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.97 -43.67 81.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -50.52 -59.79 6.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.59 -16.13 15.09 Favored 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 112.195 -4.737 . . . . 0.0 114.578 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -61.98 -37.4 84.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.531 1.06 . . . . 0.0 111.182 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -84.63 -24.9 28.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.985 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.72 -42.3 80.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -55.89 -47.69 76.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.514 0.725 . . . . 0.0 109.601 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.87 -41.51 97.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.58 -40.21 92.5 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -84.94 -8.31 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 t -87.91 144.07 26.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.17 39.45 2.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 123.144 1.449 . . . . 0.0 108.192 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.67 -179.36 0.51 Allowed Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 112.559 -2.11 . . . . 0.0 108.994 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -63.42 89.24 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 115.654 -2.431 . . . . 0.0 112.404 151.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -88.85 98.16 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.23 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.02 -49.08 0.46 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.025 -0.422 . . . . 0.0 110.681 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.2 -35.67 92.38 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -82.82 -36.71 25.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.44 1.114 . . . . 0.0 108.221 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.31 -31.85 73.2 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.161 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.09 73.54 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.692 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.11 -47.47 84.48 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.05 -47.8 83.08 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.88 -37.33 73.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -69.12 -44.12 73.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.24 -22.87 62.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.079 -1.013 . . . . 0.0 111.372 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.74 -33.56 75.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.473 0.579 . . . . 0.0 110.368 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.92 -46.11 79.47 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.511 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.2 mt -67.1 -38.58 85.93 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.552 -0.717 . . . . 0.0 111.239 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.002 0.521 . . . . 0.0 110.343 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.96 -51.81 50.24 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -60.94 -38.32 85.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.47 -51.39 67.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.382 0.611 . . . . 0.0 111.828 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.68 -16.1 61.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -165.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.02 -27.75 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.51 0.724 . . . . 0.0 110.778 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -106.42 -45.11 4.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 -59.71 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 119.013 2.365 . . . . 0.0 119.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -67.97 -154.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 122.019 2.909 . . . . 0.0 115.897 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -58.91 168.98 1.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.909 0.884 . . . . 0.0 112.939 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.77 -36.36 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -163.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.27 -3.58 4.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.95 -30.62 9.87 Favored Glycine 0 CA--C 1.51 -0.279 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -124.6 -43.96 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -159.17 172.22 18.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.68 118.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.1 m -139.84 -175.9 4.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 147' ' ' THR . . . -45.26 -41.06 8.16 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 118.736 2.865 . . . . 0.0 118.736 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.11 -39.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 119.391 0.996 . . . . 0.0 110.314 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -71.13 -35.69 71.83 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.26 -24.63 67.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.983 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.4 p -97.83 -41.68 7.93 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.13 -47.46 43.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.43 97.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.79 -25.32 20.38 Favored 'Trans proline' 0 C--N 1.347 0.493 1 C-N-CA 111.202 -5.398 . . . . 0.0 114.924 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -72.89 -31.82 64.94 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 119.916 -1.74 . . . . 0.0 109.22 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.79 -29.52 68.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -63.86 -47.65 79.89 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.886 -1.134 . . . . 0.0 110.589 168.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -62.24 -31.81 72.41 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.86 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.73 -59.15 3.82 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.279 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.02 -35.15 79.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.256 0.934 . . . . 0.0 111.743 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -57.21 -41.12 77.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.163 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.48 -35.08 14.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.66 -41.44 92.5 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.275 -0.891 . . . . 0.0 112.148 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.82 69.5 Favored Glycine 0 C--O 1.228 -0.239 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -73.27 -49.01 29.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -100.99 -29.11 12.37 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.697 2.481 . . . . 0.0 117.697 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -124.51 20.14 8.73 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.228 0.467 . . . . 0.0 110.831 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -13.25 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 -153.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -115.06 92.63 31.84 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.46 155.96 62.53 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 113.819 -3.654 . . . . 0.0 108.951 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.9 mt -65.92 125.77 90.57 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.79 153.62 58.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 117.418 -1.254 . . . . 0.0 111.317 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.69 0.98 11.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.82 -27.73 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 165.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.99 67.45 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -33.06 69.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.508 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -62.73 1.5 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.16 -35.23 67.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -160.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.45 -41.81 84.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.625 -0.672 . . . . 0.0 111.886 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -67.4 -37.04 82.5 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.469 -0.769 . . . . 0.0 110.46 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.2 -41.19 97.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.941 0.896 . . . . 0.0 112.88 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.38 -31.44 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.668 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.28 -41.5 98.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.408 -1.432 . . . . 0.0 111.159 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.36 -34.92 78.3 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.539 -0.726 . . . . 0.0 111.784 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.11 -49.78 76.28 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -70.14 -15.7 63.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.6 t -75.68 -49.32 18.71 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -85.03 144.34 28.34 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.65 -24.1 67.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.179 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.7 m -51.99 -36.58 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.82 -40.64 6.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.952 0.882 . . . . 0.0 109.2 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.29 -33.93 73.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.23 -33.56 32.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -93.77 -10.33 34.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -54.99 135.79 48.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.414 1.102 . . . . 0.0 111.778 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.08 150.92 47.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.408 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.32 121.79 13.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -40.26 93.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -169.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.47 -30.52 71.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 122.684 1.231 . . . . 0.0 108.979 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.75 9.37 39.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.627 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.66 -44.01 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.1 pt -66.04 -37.66 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.216 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.93 -3.54 45.38 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.19 -32.05 13.05 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -101.52 -55.96 2.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.87 -30.59 4.54 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 -172.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--N 1.351 0.71 1 C-N-CA 111.539 -5.174 . . . . 0.0 114.381 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.235 0.313 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -132.47 169.68 16.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -133.78 142.17 42.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -124.64 133.84 53.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.374 -2.824 . . . . 0.0 103.374 162.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.48 160.05 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.803 1.183 . . . . 0.0 109.586 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.69 133.98 51.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.928 0.331 . . . . 0.0 110.715 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.06 165.36 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.018 0.437 . . . . 0.0 110.028 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.25 127.99 33.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.31 129.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.61 -19.78 51.94 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-O 118.776 -1.013 . . . . 0.0 114.675 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.06 81.92 7.31 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 118.385 1.093 . . . . 0.0 113.327 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.06 71.0 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 N-CA-C 115.849 1.442 . . . . 0.0 115.849 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -142.58 -11.08 0.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.057 164.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -131.4 168.95 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.2 1.0 . . . . 0.0 109.231 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 mt -75.26 147.68 40.06 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.35 171.61 15.39 Favored Glycine 0 C--O 1.237 0.285 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.17 97.19 8.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.915 0.864 . . . . 0.0 109.252 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 132.31 20.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 166.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -67.77 -43.37 5.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 115.331 -2.646 . . . . 0.0 115.211 -168.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -26.1 64.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.848 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -64.34 -44.5 91.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.985 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.48 -41.97 88.16 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.5 -0.75 . . . . 0.0 110.491 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 tpt85 -58.62 -41.13 85.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.54 -41.78 80.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.253 0.933 . . . . 0.0 112.459 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.59 -39.42 84.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.389 0.614 . . . . 0.0 111.179 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.45 -41.84 99.03 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.39 95.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.751 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.7 -40.72 72.72 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.219 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -70.87 -36.97 73.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.507 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -68.91 -39.54 79.63 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.057 -1.027 . . . . 0.0 110.475 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HG3' HD21 ' A' ' 84' ' ' ASN . 67.1 mmtt -79.16 -4.52 50.85 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 56.1 34.87 24.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.821 1.248 . . . . 0.0 114.152 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.18 135.74 23.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.9 148.62 25.3 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 116.023 -2.184 . . . . 0.0 114.979 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -144.91 153.81 41.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.034 0.921 . . . . 0.0 112.418 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.34 117.16 32.35 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.9 123.18 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 123.995 0.809 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -111.12 94.22 4.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.33 135.65 52.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.764 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -85.25 110.82 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -78.73 53.4 1.34 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.852 1.261 . . . . 0.0 112.661 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 mt 51.05 38.97 22.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 112.843 177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.85 72.96 0.2 Allowed Glycine 0 CA--C 1.512 -0.141 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.75 -178.45 6.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 111.648 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.79 150.13 91.65 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 124.337 1.055 . . . . 0.0 113.395 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -20.03 -137.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.258 2 C-N-CA 128.975 6.45 . . . . 0.0 125.304 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -66.61 -26.9 67.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.963 -1.71 . . . . 0.0 113.975 -161.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -61.24 -44.27 97.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 110.553 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.27 -33.92 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.156 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.29 -29.35 67.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -70.15 -30.77 68.0 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.243 -0.911 . . . . 0.0 110.703 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.36 -58.94 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.041 0.448 . . . . 0.0 111.73 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 121.31 76.15 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 120.845 -1.159 . . . . 0.0 108.56 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.07 -21.79 31.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 N-CA-C 117.098 1.922 . . . . 0.0 117.098 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.1 -9.41 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.823 -1.173 . . . . 0.0 110.221 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -31.15 2.38 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.362 -162.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -118.59 31.37 6.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.81 155.1 60.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.2 171.0 17.73 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 117.247 -1.369 . . . . 0.0 113.262 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.61 159.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 163.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.25 130.45 48.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 146.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -105.32 90.81 3.54 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 mt -100.36 113.25 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 52.68 41.9 31.5 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.787 0.803 . . . . 0.0 111.596 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.29 37.76 20.18 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -136.72 148.36 47.26 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -133.95 140.72 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 119.554 3.168 . . . . 0.0 119.554 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.33 139.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.76 1.224 . . . . 0.0 108.337 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.19 15.91 0.47 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 155.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -63.57 139.14 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.734 -1.228 . . . . 0.0 108.169 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -154.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.97 -37.98 17.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.782 0.801 . . . . 0.0 109.641 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.94 -36.41 75.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.887 0.851 . . . . 0.0 111.115 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -25.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.997 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.87 -40.37 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.87 -59.08 1.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.77 . . . . 0.0 114.572 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -66.95 -39.5 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.423 -0.799 . . . . 0.0 112.806 -169.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -61.47 -44.31 97.33 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 120.109 1.322 . . . . 0.0 108.77 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -67.75 -35.07 78.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.218 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.23 -17.7 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.169 -0.957 . . . . 0.0 113.056 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -109.04 3.24 21.86 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.738 -0.601 . . . . 0.0 111.434 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.456 HD21 ' HG3' ' A' ' 33' ' ' LYS . 31.2 t-20 -76.96 126.71 85.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.75 -8.99 22.14 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 116.62 -1.787 . . . . 0.0 114.199 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.1 162.99 17.99 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.8 138.51 85.84 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 N-CA-C 118.003 2.27 . . . . 0.0 118.003 -158.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.79 87.29 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.674 1.582 . . . . 0.0 115.709 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.31 53.4 0.96 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 123.103 1.43 . . . . 0.0 111.638 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.26 77.92 8.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.856 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.1 m -122.51 95.32 46.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 O-C-N 121.762 -0.586 . . . . 0.0 110.43 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.29 73.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 123.722 2.948 . . . . 0.0 116.458 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -84.41 -138.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 119.081 0.707 . . . . 0.0 113.221 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.95 -35.75 59.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -66.26 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.548 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.18 -32.19 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.2 p -71.94 -38.08 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.077 0.853 . . . . 0.0 109.129 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.07 -39.62 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.98 -33.05 67.68 Favored Glycine 0 C--O 1.224 -0.485 0 O-C-N 121.477 -0.764 . . . . 0.0 113.702 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.8 p -71.06 -11.81 61.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.432 1.116 . . . . 0.0 113.607 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -96.77 -26.42 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 109.516 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.25 -56.26 7.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.261 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -59.39 -55.14 49.11 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -165.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.03 -20.46 19.29 Favored 'Trans proline' 0 C--N 1.351 0.667 1 C-N-CA 113.006 -4.196 . . . . 0.0 112.716 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -69.46 -36.1 76.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.819 -0.551 . . . . 0.0 110.119 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.88 -35.97 77.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.085 -1.009 . . . . 0.0 112.018 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.0 -42.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -57.11 -49.12 76.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.304 0.642 . . . . 0.0 111.786 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -81.62 -11.16 59.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 tp -77.99 -36.95 48.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.557 0.694 . . . . 0.0 111.333 165.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -70.2 -25.45 63.42 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.304 -0.873 . . . . 0.0 111.453 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 t -88.93 149.12 23.47 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -132.05 40.58 3.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 123.105 1.431 . . . . 0.0 109.085 161.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.42 171.82 3.09 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.57 72.5 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 CA-C-O 123.158 1.233 . . . . 0.0 114.161 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -85.33 101.79 12.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.933 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.61 -52.58 0.35 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.66 -30.75 78.55 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.8 p -77.36 -24.22 50.69 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 118.452 1.126 . . . . 0.0 112.867 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -73.22 -35.91 66.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -67.42 -31.47 71.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.29 -35.85 80.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 120.506 -1.371 . . . . 0.0 111.093 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.82 -37.99 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.163 -0.335 . . . . 0.0 110.178 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.69 -41.1 89.94 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -67.88 -33.3 74.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.869 -1.144 . . . . 0.0 112.604 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -64.96 -40.65 95.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.58 -23.99 61.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.551 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.09 -26.48 66.74 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 118.626 0.648 . . . . 0.0 110.668 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.15 -46.64 70.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.35 -40.67 85.87 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 121.414 -0.803 . . . . 0.0 111.169 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.23 -39.63 87.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.33 -47.31 85.87 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-O 119.489 -0.617 . . . . 0.0 112.734 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -64.0 -41.56 97.45 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.029 0.914 . . . . 0.0 108.991 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -44.51 82.53 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.25 -0.906 . . . . 0.0 112.333 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.31 -12.62 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.0 m -96.57 -8.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.582 0.628 . . . . 0.0 112.254 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.72 -43.59 4.01 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.61 -76.19 0.24 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -69.37 -176.09 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 CA-C-N 120.909 2.354 . . . . 0.0 118.047 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -54.89 161.45 1.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.32 -30.04 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.972 -116.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.27 18.8 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.86 85.79 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -144.56 -48.6 0.26 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -172.95 175.02 3.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -166.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.3 mm -61.14 121.41 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -135.98 178.59 6.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.48 -27.37 24.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.0 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.422 0.629 . . . . 0.0 110.517 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.56 -39.8 94.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.96 -21.6 61.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.06 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.2 p -87.5 -36.56 17.57 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.674 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.18 -47.25 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.52 94.62 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.8 -29.33 12.65 Favored 'Trans proline' 0 C--N 1.352 0.73 1 C-N-CA 111.849 -4.967 . . . . 0.0 113.696 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.23 -25.87 42.56 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.135 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.07 -35.57 80.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.095 0.861 . . . . 0.0 111.494 167.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.86 -47.46 80.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -63.09 -35.09 79.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.35 -51.4 57.57 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.388 -0.82 . . . . 0.0 111.0 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -65.01 -30.88 71.89 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.751 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.17 -58.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 117.902 0.319 . . . . 0.0 110.489 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.74 67.22 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.134 -0.979 . . . . 0.0 113.127 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.03 -35.14 74.08 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.39 -37.5 94.56 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.907 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -66.07 -42.07 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.269 -0.548 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -100.74 -42.95 6.29 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 118.504 2.779 . . . . 0.0 118.504 -164.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -140.89 57.52 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -47.35 122.08 4.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -152.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -155.0 93.22 2.77 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.44 165.56 32.16 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 115.848 -2.301 . . . . 0.0 109.64 166.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.82 121.12 71.79 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.41 161.68 41.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 116.5 -1.867 . . . . 0.0 113.345 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -73.35 1.37 9.73 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.5 -21.65 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.667 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.43 78.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -40.35 82.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -54.52 39.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -66.0 -43.79 92.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.69 -47.03 85.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -75.35 -33.97 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.653 -0.654 . . . . 0.0 112.6 -174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.36 -20.67 50.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.02 -42.03 94.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -63.45 -33.5 75.7 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.496 -1.378 . . . . 0.0 111.261 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.0 -42.87 75.89 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.932 -0.48 . . . . 0.0 111.511 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.16 -18.91 22.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.38 -35.72 70.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.7 t -128.11 68.2 1.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.597 165.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -103.84 140.39 37.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.083 -3.673 . . . . 0.0 101.083 154.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.05 -45.87 68.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.8 t -61.64 -45.48 93.89 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.303 1.049 . . . . 0.0 112.518 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.73 -41.07 68.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.764 -174.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.78 -40.11 82.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.782 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -78.44 -35.3 47.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 36.4 p -88.55 -15.97 33.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -65.36 150.12 48.83 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.614 -0.678 . . . . 0.0 112.604 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.84 160.19 30.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.19 143.55 50.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -56.84 -42.95 80.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -59.71 -40.45 88.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 0.0 110.964 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.05 -12.5 60.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.58 -48.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -68.11 -51.45 48.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.323 1.059 . . . . 0.0 108.578 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.5 -5.75 44.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.18 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.77 -29.54 15.59 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 119.517 -0.602 . . . . 0.0 114.313 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -106.82 -26.07 11.42 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -64.87 -18.8 0.47 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 119.522 3.156 . . . . 0.0 119.522 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.358 1.034 1 C-N-CA 112.905 -4.263 . . . . 0.0 116.282 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.23 0.052 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -114.65 141.55 47.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.848 1.204 . . . . 0.0 112.323 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.51 96.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 t -96.16 118.62 33.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.22 163.7 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -166.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -67.88 130.88 44.34 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.634 -0.666 . . . . 0.0 112.553 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.3 166.53 22.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.479 174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.88 139.72 56.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.65 126.83 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.885 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.04 -16.17 17.57 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.21 76.45 13.4 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 50.7 Cg_endo -75.33 42.24 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 118.391 2.42 . . . . 0.0 118.391 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -112.12 -12.56 13.65 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -125.84 159.33 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.63 135.44 57.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.839 1.255 . . . . 0.0 111.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.32 -163.7 36.99 Favored Glycine 0 CA--C 1.511 -0.198 0 N-CA-C 119.307 2.483 . . . . 0.0 119.307 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -76.35 76.38 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.157 1.383 . . . . 0.0 109.774 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -141.35 82.98 13.93 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 121.221 -0.925 . . . . 0.0 113.147 -171.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.27 -22.71 75.4 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 116.079 -2.147 . . . . 0.0 115.571 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -68.85 -38.43 79.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -69.55 -40.45 76.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.69 -35.32 79.3 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 118.381 -0.818 . . . . 0.0 112.275 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -57.59 -39.81 77.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.725 1.602 . . . . 0.0 110.767 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.42 -52.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.42 0.629 . . . . 0.0 110.293 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.09 -37.78 88.7 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.81 -41.78 97.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -66.89 -32.49 73.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.308 0.575 . . . . 0.0 111.29 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.43 -46.38 48.82 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.146 -0.346 . . . . 0.0 111.112 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -72.52 -34.37 67.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -36.31 83.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.021 -1.05 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -86.22 -7.08 58.81 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 59.55 29.33 18.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.487 1.515 . . . . 0.0 114.121 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -80.84 136.18 51.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.82 153.18 53.31 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.178 -1.415 . . . . 0.0 114.214 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -156.57 171.69 19.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.37 124.9 48.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 t -83.5 145.81 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -139.66 146.43 39.69 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 102.799 -3.037 . . . . 0.0 102.799 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.6 mt -114.73 132.34 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.73 119.89 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.32 72.79 7.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.55 1.167 . . . . 0.0 109.937 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 mt 57.22 27.16 13.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.6 33.64 Favored Glycine 0 C--O 1.226 -0.351 0 O-C-N 121.871 -0.518 . . . . 0.0 113.537 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -68.33 117.41 10.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 154.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -140.1 101.16 7.01 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.3 175.68 7.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.972 -0.885 . . . . 0.0 111.133 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -56.49 -36.48 69.17 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 122.146 -0.346 . . . . 0.0 111.017 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -56.6 -40.58 75.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -71.52 -31.81 67.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.142 -0.974 . . . . 0.0 108.959 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.29 -23.62 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.34 -35.29 79.1 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.303 -0.873 . . . . 0.0 110.241 172.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.05 -53.03 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -90.59 139.05 26.42 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 121.661 -0.649 . . . . 0.0 111.004 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.12 -22.91 46.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 116.974 -1.551 . . . . 0.0 115.858 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -108.11 -6.24 16.57 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 0.0 111.992 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.54 4.35 38.22 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.373 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.65 58.44 1.12 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.968 0.907 . . . . 0.0 110.819 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.82 159.17 69.83 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 100.343 -3.947 . . . . 0.0 100.343 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -69.16 147.98 67.95 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 114.081 -3.479 . . . . 0.0 111.47 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.1 155.54 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.164 0.507 . . . . 0.0 109.966 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -123.33 109.18 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.67 84.98 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.8 95.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.153 0.981 . . . . 0.0 108.361 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.3 t0 51.94 46.85 25.89 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.434 1.111 . . . . 0.0 111.779 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t0 58.99 30.55 20.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -114.85 165.85 12.4 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 166.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -150.58 149.79 30.37 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.06 157.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -115.52 -121.65 0.3 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.66 -176.91 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -166.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -54.41 -36.44 63.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.67 -20.43 53.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.943 0.878 . . . . 0.0 110.006 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.6 t -91.87 -43.89 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -42.04 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.71 -0.619 . . . . 0.0 111.14 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.32 -13.85 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.66 0.743 . . . . 0.0 112.299 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.04 -64.04 0.71 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.42 -47.39 45.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.631 -168.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.08 -40.45 94.67 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.606 1.548 . . . . 0.0 108.702 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -63.42 -42.66 98.72 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.704 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.95 -40.19 94.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -87.12 4.96 40.15 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.933 -0.48 . . . . 0.0 111.968 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.45 135.91 93.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.987 -0.445 . . . . 0.0 111.516 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.44 -6.07 16.05 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.891 1.073 . . . . 0.0 114.891 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -112.11 162.32 21.87 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.38 130.89 39.75 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 116.381 -1.946 . . . . 0.0 116.791 -161.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.8 146.02 32.99 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 116.763 -1.691 . . . . 0.0 111.914 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.26 45.74 2.73 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.24 80.26 7.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.3 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.2 p -114.31 106.02 53.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -98.51 59.16 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.357 2.705 . . . . 0.0 118.71 163.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.18 -146.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 120.112 1.076 . . . . 0.0 113.107 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -51.43 -32.27 26.0 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -68.6 -30.57 69.33 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.417 -0.802 . . . . 0.0 111.599 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.46 47.48 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.247 -0.283 . . . . 0.0 110.642 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.5 p -74.85 -30.52 61.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.731 -0.605 . . . . 0.0 112.531 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.1 t -75.12 -40.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.08 91.25 Favored Glycine 0 C--O 1.222 -0.605 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.252 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.3 p -71.47 -11.66 60.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -81.21 -32.39 33.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.628 1.204 . . . . 0.0 110.004 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.3 -43.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.179 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.66 -56.83 19.18 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.3 -13.21 13.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 113.973 -3.551 . . . . 0.0 113.464 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 t -69.55 -49.51 53.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.992 -0.443 . . . . 0.0 109.808 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -70.72 -26.99 63.63 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.608 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.33 -44.51 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.2 -44.82 87.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.74 -25.96 59.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.0 OUTLIER -77.0 -37.33 55.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.092 0.86 . . . . 0.0 110.667 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -87.94 40.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t -152.02 144.81 24.34 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -131.16 34.41 4.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.34 168.63 7.51 Favored Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 163.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.61 44.3 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 N-CA-C 115.959 1.484 . . . . 0.0 115.959 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.71 116.69 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.765 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -150.88 -55.49 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.74 -40.6 97.54 Favored Glycine 0 C--O 1.217 -0.906 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.1 p -69.42 -27.55 65.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.86 1.33 . . . . 0.0 112.56 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -73.73 -29.35 62.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.778 1.275 . . . . 0.0 108.372 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -83.98 -24.55 30.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.715 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.46 86.27 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.755 -1.216 . . . . 0.0 108.632 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.985 -0.447 . . . . 0.0 111.455 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.59 -40.23 86.78 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -67.33 -34.46 77.38 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.975 -1.078 . . . . 0.0 113.496 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -65.58 -42.36 91.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.718 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.8 mt -65.9 -35.52 80.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.927 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -64.98 -28.96 69.87 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.607 0.363 . . . . 0.0 111.932 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 -44.74 93.33 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.821 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 -38.35 80.41 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.908 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.12 -42.92 95.79 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.653 1.115 . . . . 0.0 111.732 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -34.14 89.11 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.952 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -77.16 -43.49 33.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.655 -0.909 . . . . 0.0 110.363 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -41.35 74.08 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -70.58 -20.76 62.75 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.896 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.94 -47.03 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 167.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -73.96 -46.18 45.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.22 -73.95 0.22 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 116.784 -2.12 . . . . 0.0 117.407 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -61.46 -164.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 126.268 4.645 . . . . 0.0 118.932 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -58.3 172.98 0.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.776 0.83 . . . . 0.0 113.123 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.29 -39.26 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.302 0.641 . . . . 0.0 112.283 -160.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.08 4.88 1.87 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.17 -14.02 66.27 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -134.58 -49.42 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -166.17 179.01 5.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -171.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 120.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -129.87 -164.09 1.37 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 171.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.75 -38.55 15.73 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.84 -40.19 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 123.033 1.397 . . . . 0.0 111.303 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -73.28 -32.31 64.58 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 120.992 -1.067 . . . . 0.0 109.915 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.9 -33.18 71.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.803 -0.561 . . . . 0.0 110.361 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.0 p -80.08 -45.96 17.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -81.18 -42.87 20.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.68 -37.83 60.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.9 -22.48 23.28 Favored 'Trans proline' 0 C--N 1.35 0.628 1 C-N-CA 111.893 -4.938 . . . . 0.0 114.731 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -74.72 -31.8 61.96 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 108.796 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.65 -31.71 71.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.502 0.592 . . . . 0.0 112.217 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -62.65 -51.38 67.5 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.418 -0.801 . . . . 0.0 109.753 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -65.58 -28.64 69.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.531 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 110' ' ' LEU . 40.1 tp -60.61 -52.36 65.5 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.602 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.36 -38.34 84.65 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.902 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.63 -49.47 84.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 203' ' ' ILE . . . -78.89 -50.31 11.43 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 120.571 -1.331 . . . . 0.0 114.191 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.07 -37.56 87.94 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.274 -0.891 . . . . 0.0 110.016 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.18 79.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -86.68 -36.02 18.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.074 0.937 . . . . 0.0 110.846 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 203' ' ' ILE . 32.3 m-85 -91.68 -37.29 13.11 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -150.31 62.04 0.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -52.81 128.56 27.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.261 -159.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -138.61 97.98 9.03 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.96 151.22 82.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 114.164 -3.424 . . . . 0.0 110.791 167.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.8 mt -71.6 126.84 91.56 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.68 160.7 47.41 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 117.092 -1.472 . . . . 0.0 112.781 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -74.05 -1.57 20.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.09 -1.18 57.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.515 0.674 . . . . 0.0 109.71 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.6 mt -121.71 55.56 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.0 m -58.39 -33.43 69.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -59.87 4.06 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.39 -38.61 81.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.9 tp -63.32 -45.52 90.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.585 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -83.32 -24.34 32.17 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.008 -0.433 . . . . 0.0 110.208 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.22 -47.82 82.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.58 -48.34 87.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -61.82 -35.45 78.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.17 -45.61 66.37 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.791 -0.568 . . . . 0.0 111.171 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.3 -20.83 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.35 -22.75 54.56 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.051 0.54 . . . . 0.0 112.12 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 t -128.02 67.42 1.35 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.394 1.093 . . . . 0.0 109.635 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.12 142.37 47.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 155.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -59.94 -38.78 83.41 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.671 0.607 . . . . 0.0 111.203 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.7 p -57.5 -46.13 84.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.523 0.601 . . . . 0.0 111.521 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -49.57 55.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.866 0.365 . . . . 0.0 111.698 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.33 -47.13 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -71.94 -24.24 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 112.824 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 70.4 p -120.36 27.32 8.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.914 0.864 . . . . 0.0 111.328 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -63.19 157.4 22.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.351 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 160.97 30.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.41 109.68 5.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -60.4 -36.45 78.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.16 -36.16 76.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.977 0.894 . . . . 0.0 109.69 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -90.8 -8.0 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.879 -0.513 . . . . 0.0 111.086 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.33 -50.71 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 163.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 163' ' ' ALA 0.265 19.7 pt -69.5 -50.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.734 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.26 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.302 -0.874 . . . . 0.0 111.464 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.93 -31.95 13.84 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -95.61 -42.64 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -20.63 0.6 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 120.566 3.543 . . . . 0.0 120.566 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.353 0.769 1 C-N-CA 111.337 -5.308 . . . . 0.0 113.779 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--O 1.234 0.264 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -143.85 155.43 44.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.506 1.048 . . . . 0.0 109.487 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.98 106.07 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.33 1.062 . . . . 0.0 113.062 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.2 m -87.44 64.54 8.23 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.375 -0.828 . . . . 0.0 112.993 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 m -71.47 152.22 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.61 134.75 38.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.56 171.5 12.29 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.94 137.36 58.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.803 0.811 . . . . 0.0 112.502 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.16 118.4 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.95 82.97 Favored Glycine 0 C--O 1.246 0.864 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.54 100.01 4.43 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.81 80.11 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 CA-C-O 122.701 1.042 . . . . 0.0 113.926 169.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -148.51 -31.19 0.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.482 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.38 162.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.7 158.13 35.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.24 -178.78 15.46 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.76 105.84 10.34 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.8 m -128.68 153.03 79.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 149.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.18 -39.78 65.77 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.475 -1.884 . . . . 0.0 109.755 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -14.91 63.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.77 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.7 -58.02 3.46 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.69 -26.22 66.07 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.59 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -47.36 -45.95 25.32 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 120.996 1.725 . . . . 0.0 113.161 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.36 -34.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.05 -39.88 96.06 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.538 -1.351 . . . . 0.0 110.13 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.6 -33.55 72.85 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -74.71 -46.74 35.54 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.727 -0.608 . . . . 0.0 109.592 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -40.81 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.808 0.731 . . . . 0.0 111.054 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -69.03 -43.24 75.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.872 -1.142 . . . . 0.0 108.271 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.59 -12.18 60.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.066 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtmm 54.67 42.94 30.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.073 1.349 . . . . 0.0 111.874 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -95.09 157.95 35.66 Favored Pre-proline 0 C--O 1.242 0.682 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.795 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.5 119.74 6.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 117.05 -1.5 . . . . 0.0 113.909 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -136.45 154.59 50.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.566 0.698 . . . . 0.0 109.128 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.36 150.62 37.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 t -119.44 139.74 51.55 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 122.267 1.032 . . . . 0.0 113.234 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.06 97.71 5.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.385 1.474 . . . . 0.0 111.278 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.3 mt -70.67 127.96 34.45 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.563 0.697 . . . . 0.0 112.619 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.15 108.0 22.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -78.29 69.32 4.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.583 1.182 . . . . 0.0 110.45 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 58.4 41.58 22.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.791 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.69 85.02 1.4 Allowed Glycine 0 C--O 1.24 0.491 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -129.24 -76.75 0.55 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -155.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 71.5 mmtt -71.7 152.08 93.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 74.6 Cg_exo -58.22 -160.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 2 C-N-CA 127.266 5.31 . . . . 0.0 123.527 -170.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.27 -13.87 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -52.22 -47.17 65.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.822 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -81.6 -38.17 26.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 112.215 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.57 -27.37 67.68 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.4 -0.813 . . . . 0.0 112.027 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.75 -34.29 75.34 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.6 mt -97.41 -46.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.965 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -76.04 127.82 84.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.42 -31.75 13.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 115.672 -2.419 . . . . 0.0 116.506 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -86.9 -21.37 26.36 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.578 -1.326 . . . . 0.0 110.277 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.23 85.08 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.288 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -147.15 27.23 1.05 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.973 0.909 . . . . 0.0 111.837 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.24 143.68 27.09 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.333 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.38 159.19 53.52 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 117.353 -1.298 . . . . 0.0 113.542 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t 77.72 153.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 128.428 2.691 . . . . 0.0 109.714 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.6 33.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.769 1.628 . . . . 0.0 113.547 149.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -153.24 125.67 8.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.537 3.162 . . . . 0.0 119.537 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -147.1 134.65 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 109.506 166.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.55 39.3 24.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.031 0.933 . . . . 0.0 113.191 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.37 20.38 10.97 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.734 1.614 . . . . 0.0 114.031 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -125.33 165.79 17.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.733 1.613 . . . . 0.0 106.914 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -112.09 118.45 35.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.21 129.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 112.123 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.26 112.71 2.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.399 1.08 . . . . 0.0 111.94 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -164.11 151.46 12.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 162.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.3 p -54.56 -37.86 65.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.6 -33.09 28.08 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.015 0.912 . . . . 0.0 109.954 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -72.31 -40.7 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -73.03 -11.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -103.19 -5.46 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.627 0.649 . . . . 0.0 111.435 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.36 -66.91 0.13 Allowed Glycine 0 CA--C 1.519 0.32 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.9 -35.12 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.8 -1.412 . . . . 0.0 110.084 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.6 -38.26 86.92 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.738 -1.226 . . . . 0.0 111.726 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.77 -31.79 68.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.254 0.549 . . . . 0.0 110.528 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -65.41 -27.74 68.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.019 0.914 . . . . 0.0 111.471 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.24 6.41 40.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.867 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.44 144.04 91.23 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.05 -28.89 18.57 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 115.24 -2.706 . . . . 0.0 115.087 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.4 165.71 48.58 Favored Pre-proline 0 N--CA 1.473 0.681 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.11 142.88 76.48 Favored 'Trans proline' 0 C--N 1.354 0.868 0 N-CA-C 117.688 2.149 . . . . 0.0 117.688 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.9 90.91 0.88 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.003 1.136 . . . . 0.0 114.955 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -108.94 79.07 1.18 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.843 1.306 . . . . 0.0 111.758 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.26 73.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.841 -173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -115.63 116.15 41.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.001 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -98.35 74.67 0.07 OUTLIER 'Trans proline' 0 CA--C 1.558 1.723 1 C-N-CA 127.194 5.263 . . . . 0.0 119.032 164.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -85.13 -149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 121.304 1.336 . . . . 0.0 113.504 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.24 -38.6 12.57 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.7 m-85 -66.22 -26.1 67.22 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.44 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.31 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.756 -0.59 . . . . 0.0 111.328 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.3 p -75.1 -34.39 61.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.91 -39.25 83.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -32.52 80.72 Favored Glycine 0 C--O 1.226 -0.387 0 O-C-N 121.435 -0.791 . . . . 0.0 114.202 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -70.43 -6.64 37.23 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -104.11 -35.07 8.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.502 0.667 . . . . 0.0 110.988 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.57 -51.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.432 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 89.2 t80 -56.04 -52.1 75.33 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -69.04 -26.4 31.01 Favored 'Trans proline' 0 C--N 1.35 0.606 1 C-N-CA 112.118 -4.788 . . . . 0.0 113.178 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -65.48 -42.57 92.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 103' ' ' PHE 0.287 10.7 p90 -78.98 -18.12 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.441 -177.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -79.33 -37.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.953 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.25 -40.45 90.35 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.773 -0.579 . . . . 0.0 111.607 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -64.71 -40.21 94.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.094 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.23 -35.75 82.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.142 0.496 . . . . 0.0 112.167 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.67 -0.31 26.21 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.3 t -107.0 127.82 53.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -166.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -116.64 34.37 5.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 123.272 1.51 . . . . 0.0 109.05 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.44 168.56 13.6 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 166.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.91 63.74 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-O 123.172 1.238 . . . . 0.0 113.516 159.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -80.38 69.52 6.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -167.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.92 -40.33 20.28 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.554 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 -38.84 91.81 Favored Glycine 0 C--O 1.228 -0.241 0 O-C-N 121.837 -0.539 . . . . 0.0 112.93 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 -28.48 64.01 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.288 -0.536 . . . . 0.0 110.41 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.22 -38.8 82.27 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.41 -1.431 . . . . 0.0 109.996 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -78.95 -12.48 60.03 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.114 -0.991 . . . . 0.0 113.113 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.31 76.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.9 mt -60.34 -44.27 95.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.513 0.673 . . . . 0.0 109.325 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.87 -51.64 68.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.04 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.26 -29.26 47.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -70.51 -40.49 73.49 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 mt -68.63 -24.43 64.55 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.122 -0.986 . . . . 0.0 112.354 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -61.6 -32.97 73.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.429 0.558 . . . . 0.0 112.261 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -43.07 89.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.93 -27.74 63.99 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.844 -0.535 . . . . 0.0 111.569 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.98 -48.91 72.31 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.696 -0.627 . . . . 0.0 111.838 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.12 -36.42 91.85 Favored Glycine 0 C--O 1.235 0.2 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.592 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -35.53 80.81 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 122.369 -0.489 . . . . 0.0 111.237 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -73.26 -10.21 59.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -162.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.9 m -82.03 -12.36 12.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -112.71 -49.09 2.96 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.28 -60.65 0.35 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -79.22 -177.82 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.771 2.314 . . . . 0.0 116.728 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -40.64 151.86 0.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 pt -74.45 3.24 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -141.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.05 -8.9 57.82 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.632 1.206 . . . . 0.0 109.258 162.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.88 6.22 65.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.622 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -143.26 -49.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -165.97 -174.69 3.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.479 1.112 . . . . 0.0 108.163 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.89 123.07 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.3 m -139.36 172.24 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.29 5.07 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 95' ' ' PHE . 7.4 p -60.29 -37.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -78.45 -40.56 35.27 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.098 -1.001 . . . . 0.0 108.41 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.91 -16.26 61.02 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.831 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.8 m -77.3 -35.04 55.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.82 -38.68 6.01 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -47.96 -42.41 48.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -57.35 -37.66 96.94 Favored 'Trans proline' 0 C--N 1.354 0.864 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -99.32 -17.33 18.1 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.615 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.51 -32.69 72.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 118.506 0.594 . . . . 0.0 110.926 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.28 -52.87 63.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -68.99 -19.33 64.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.51 -47.49 72.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -36.28 80.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.276 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 -50.07 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.4 -51.67 34.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.39 -0.819 . . . . 0.0 110.34 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.82 -41.39 83.12 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.233 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.09 71.14 Favored Glycine 0 C--O 1.234 0.127 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.682 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -90.41 -40.53 12.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -96.53 -41.01 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -137.53 71.95 1.41 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.966 1.306 . . . . 0.0 108.847 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -67.84 86.32 0.23 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -154.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -121.65 99.14 45.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 110.931 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.78 168.26 23.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 118.374 -0.617 . . . . 0.0 112.676 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.54 122.02 86.01 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.6 161.88 43.94 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 116.716 -1.723 . . . . 0.0 111.319 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -69.18 -15.05 63.31 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.286 -0.884 . . . . 0.0 111.712 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.63 -25.17 68.1 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.364 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.25 61.87 0.6 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.78 1.276 . . . . 0.0 109.289 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -22.78 66.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -171.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -50.19 74.82 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -25.3 16.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.688 -168.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -61.28 -48.41 81.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.443 170.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.78 -40.45 88.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.004 0.907 . . . . 0.0 112.39 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -66.85 -49.27 66.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.053 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.4 mm -66.76 -33.89 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.52 -46.83 88.71 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.329 -0.857 . . . . 0.0 111.846 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.6 mt -66.96 -43.14 83.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.903 0.383 . . . . 0.0 111.14 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.54 -32.36 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.484 1.114 . . . . 0.0 111.849 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -62.7 -29.3 70.56 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.372 -0.83 . . . . 0.0 113.144 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -144.0 57.46 1.34 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -90.28 144.5 25.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 150.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.72 -39.65 85.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.908 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -59.02 -44.05 91.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.095 0.95 . . . . 0.0 111.297 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.24 -41.94 60.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.056 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.1 -39.83 93.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.237 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -74.32 -32.27 62.78 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.2 p -101.23 0.56 37.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 117.724 2.491 . . . . 0.0 117.724 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -58.02 150.29 21.21 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.59 167.45 20.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.742 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.77 127.19 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.99 -38.59 91.63 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 117.846 0.294 . . . . 0.0 111.081 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.29 -40.41 74.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 109.028 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -94.41 -1.78 53.07 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.5 t -77.66 -53.41 14.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 163.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.4 mt -67.74 -56.88 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.597 0.713 . . . . 0.0 110.344 -171.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . . . -76.4 -4.85 44.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.02 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.03 -23.8 36.99 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.374 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -102.27 -35.99 8.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 204' ' ' ALA . 8.8 pt-20 -63.69 -23.66 1.13 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.356 0.96 1 C-N-CA 112.852 -4.299 . . . . 0.0 114.746 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -123.53 136.5 54.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.16 125.62 57.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 175.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.4 m -129.63 105.59 8.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.19 160.77 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -169.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 130.7 45.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.07 172.03 14.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.937 0.398 . . . . 0.0 111.271 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 137.94 58.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.72 141.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.354 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.32 -38.2 3.01 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.12 81.45 6.19 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 123.107 0.563 . . . . 0.0 110.49 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.49 89.47 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 N-CA-C 117.956 2.252 . . . . 0.0 117.956 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -144.74 -33.43 0.38 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -88.98 164.29 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.34 146.17 49.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.458 1.503 . . . . 0.0 111.253 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.33 173.04 22.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 122.579 3.792 . . . . 0.0 122.579 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -81.13 78.58 7.92 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 t -128.61 135.66 27.92 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.57 -42.59 52.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 119.074 0.705 . . . . 0.0 113.703 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -12.61 60.02 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.9 t -60.47 -45.47 93.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.541 0.686 . . . . 0.0 111.247 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.96 -7.45 59.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -63.18 -43.95 96.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -42.55 67.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.734 -1.576 . . . . 0.0 111.169 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.75 -43.71 79.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.131 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.06 -40.18 87.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.255 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.2 m -62.86 -34.42 77.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.348 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -46.7 32.61 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 112.526 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.8 -24.91 61.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.735 0.303 . . . . 0.0 111.401 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.65 -31.8 71.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.28 -0.887 . . . . 0.0 111.584 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -95.81 -16.15 22.05 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 50.1 46.13 24.9 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -76.55 137.15 67.33 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 163.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.91 148.42 70.46 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 115.834 -2.311 . . . . 0.0 113.425 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -141.95 151.63 42.74 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 122.775 1.274 . . . . 0.0 113.481 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -91.97 117.61 29.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.305 -1.77 . . . . 0.0 107.494 169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 t -99.16 121.2 40.7 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -114.96 140.0 49.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.46 126.62 53.69 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -90.4 104.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -73.06 71.64 1.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.763 0.825 . . . . 0.0 113.153 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.0 mt 56.08 52.84 9.83 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.88 1.272 . . . . 0.0 113.082 169.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.21 80.19 1.01 Allowed Glycine 0 CA--C 1.51 -0.229 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.695 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -116.01 -88.86 0.58 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -148.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -74.73 159.13 83.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 119.209 -0.425 . . . . 0.0 111.729 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -60.01 -165.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.199 2.599 . . . . 0.0 118.021 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -42.21 -37.57 1.51 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -50.11 -45.99 53.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.406 0.548 . . . . 0.0 111.439 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.34 -22.37 41.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.82 -23.31 60.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.393 0.616 . . . . 0.0 110.314 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.41 -41.04 49.1 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.854 -0.529 . . . . 0.0 110.853 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.25 -40.98 86.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -116.43 128.17 26.2 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.462 1.483 . . . . 0.0 111.758 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.34 -16.51 31.19 Favored 'Trans proline' 0 C--N 1.35 0.628 0 N-CA-C 117.003 1.886 . . . . 0.0 117.003 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -100.39 -4.88 28.15 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.842 0.746 . . . . 0.0 112.147 166.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.27 -28.2 3.84 Favored Glycine 0 CA--C 1.52 0.353 0 O-C-N 122.048 -0.407 . . . . 0.0 114.081 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 33.17 2.62 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.28 148.89 35.26 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 151.13 73.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 117.222 -1.385 . . . . 0.0 113.794 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' A' ' 71' ' ' ALA . 33.8 m -133.86 169.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.336 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.8 t -124.25 138.04 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 153.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -104.68 96.37 6.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.14 129.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t0 60.26 34.18 20.92 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.78 1.276 . . . . 0.0 111.018 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.27 21.38 12.03 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.782 2.433 . . . . 0.0 114.299 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -127.56 127.88 44.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.681 0.792 . . . . 0.0 110.047 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -108.02 144.0 35.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.6 t -131.46 140.09 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -136.79 -0.43 2.34 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.06 139.73 30.23 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.08 -1.013 . . . . 0.0 111.143 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.5 p -75.03 -26.17 59.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 -152.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -80.65 -35.18 34.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -91.47 -10.48 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.777 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -76.53 2.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.468 -0.77 . . . . 0.0 110.389 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.1 -56.66 5.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 O-C-N 121.688 -0.633 . . . . 0.0 110.229 152.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.11 -42.79 99.43 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 120.111 2.804 . . . . 0.0 120.111 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.58 -37.4 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 118.937 1.368 . . . . 0.0 107.466 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -40.93 97.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.02 -42.2 98.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.745 0.702 . . . . 0.0 111.222 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -61.49 -34.09 74.9 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 111.462 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.03 16.4 19.69 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.09 116.95 52.74 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.49 -13.76 38.25 Favored 'Trans proline' 0 C--O 1.245 0.86 1 N-CA-C 123.16 4.254 . . . . 0.0 123.16 -167.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.43 155.37 74.09 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-N 121.357 1.89 . . . . 0.0 107.126 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.77 125.53 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 116.635 -1.777 . . . . 0.0 116.306 -168.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.19 152.84 18.53 Favored 'Trans proline' 0 C--O 1.243 0.768 0 N-CA-C 116.569 1.719 . . . . 0.0 116.569 -175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -130.76 56.87 1.76 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 69.96 8.85 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.458 -1.401 . . . . 0.0 114.251 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 m -122.31 98.43 44.11 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 123.499 0.72 . . . . 0.0 110.962 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.01 80.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.509 2.806 . . . . 0.0 116.188 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -82.76 -138.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.561 1.508 . . . . 0.0 113.487 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.65 -34.84 69.78 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 125.022 1.329 . . . . 0.0 111.931 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -65.17 -28.46 69.42 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.431 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.34 -19.25 30.08 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.912 -0.492 . . . . 0.0 110.94 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.7 p -71.56 -38.96 70.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.41 -41.67 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.12 -37.46 80.1 Favored Glycine 0 C--O 1.226 -0.406 0 CA-C-N 116.49 -0.323 . . . . 0.0 113.129 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.3 p -73.03 -9.89 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.24 -39.77 14.19 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.111 0.414 . . . . 0.0 111.633 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.6 -32.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -56.06 -51.96 76.51 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.48 -11.54 15.72 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 113.612 -3.792 . . . . 0.0 113.837 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -75.09 -44.05 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.233 -0.917 . . . . 0.0 110.97 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -20.86 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.199 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.37 -42.22 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.78 -44.34 90.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.29 -32.24 73.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.44 -41.99 92.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -97.91 -16.42 19.75 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -167.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -106.95 30.06 6.5 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.176 0.989 . . . . 0.0 111.254 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.55 165.59 18.32 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.458 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.68 70.95 4.91 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.387 1.391 . . . . 0.0 113.884 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.9 81.2 8.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -163.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -99.73 -37.71 8.99 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.04 -40.41 97.03 Favored Glycine 0 N--CA 1.453 -0.228 0 O-C-N 121.733 -0.604 . . . . 0.0 111.673 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.6 m -71.31 -32.58 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.027 0.414 . . . . 0.0 110.741 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.77 -41.38 97.98 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.918 -1.114 . . . . 0.0 109.713 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -76.18 -15.26 60.09 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.456 -0.777 . . . . 0.0 110.941 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.71 -41.83 71.41 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.41 -41.04 96.85 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.342 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 tp -58.19 -36.15 72.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -81.3 -38.07 27.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.62 -38.16 80.32 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.716 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.9 mt -74.04 -19.63 60.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.829 -1.169 . . . . 0.0 110.659 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -66.25 -32.28 73.6 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.95 -42.43 80.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -41.17 98.97 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.17 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.09 -38.67 83.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.526 0.603 . . . . 0.0 110.42 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -55.54 24.69 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -61.07 -40.45 93.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.877 -0.778 . . . . 0.0 110.555 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.716 -0.615 . . . . 0.0 111.45 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.3 -27.19 62.3 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.9 -49.85 65.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.68 -44.19 19.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.54 -69.29 0.24 Allowed Glycine 0 C--O 1.25 1.139 0 CA-C-O 116.797 -2.113 . . . . 0.0 116.06 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -72.43 -159.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 125.212 3.941 . . . . 0.0 114.499 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -54.33 163.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.82 -21.95 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -161.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.22 -19.32 63.04 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.791 -1.193 . . . . 0.0 113.255 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.41 -13.45 33.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.356 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -143.39 -47.44 0.3 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -162.54 179.62 7.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mm -71.36 114.43 9.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -129.91 -169.35 2.11 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.83 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.65 -49.96 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.335 1.064 . . . . 0.0 110.746 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.99 -36.93 67.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.819 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.97 -20.55 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.167 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.2 m -83.61 -48.62 10.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.19 -48.73 15.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.91 93.57 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.29 -36.07 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 1 C-N-CA 112.599 -4.467 . . . . 0.0 114.852 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -79.22 -26.94 42.46 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.526 -1.359 . . . . 0.0 110.483 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.32 -33.76 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.973 0.806 . . . . 0.0 111.333 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -66.15 -38.19 87.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.288 -1.507 . . . . 0.0 113.767 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -67.53 -35.95 80.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.1 tp -62.41 -51.89 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.636 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -65.95 -26.12 67.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -170.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.67 -50.44 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 118.499 0.591 . . . . 0.0 111.614 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.95 -43.07 75.78 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.681 -0.637 . . . . 0.0 111.139 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.86 -42.09 67.29 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.35 93.27 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 119.92 -1.134 . . . . 0.0 114.538 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.58 -49.61 14.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.349 1.075 . . . . 0.0 112.878 173.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -87.53 -37.24 17.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -136.71 62.47 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.152 -0.967 . . . . 0.0 110.509 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -53.55 110.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -161.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -146.5 94.48 4.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.36 168.14 25.5 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 114.9 -2.933 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.55 119.55 57.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.41 162.38 30.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 115.632 -2.445 . . . . 0.0 113.396 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.9 6.3 3.44 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.363 -0.836 . . . . 0.0 112.847 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -70.51 -22.83 62.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.423 0.63 . . . . 0.0 109.357 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.88 60.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.1 m -54.27 -38.0 65.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.015 -0.428 . . . . 0.0 111.779 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -71.85 -26.93 62.56 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 120.809 -1.182 . . . . 0.0 111.938 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.6 -34.09 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.413 1.006 . . . . 0.0 110.625 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.67 -44.37 93.96 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 120.831 -1.168 . . . . 0.0 109.641 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -70.0 -31.7 69.52 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.714 -0.616 . . . . 0.0 112.464 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 121.953 -0.467 . . . . 0.0 111.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -30.9 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 118.57 0.623 . . . . 0.0 111.121 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -68.41 -37.85 80.7 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.186 -0.946 . . . . 0.0 112.453 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.57 -34.2 73.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.45 -39.79 94.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.74 13.89 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.1 t -96.63 -52.7 3.83 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -94.03 157.05 16.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.185 -1.572 . . . . 0.0 112.594 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.38 -21.34 49.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -53.27 -30.89 40.92 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.719 0.771 . . . . 0.0 111.47 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -103.58 -44.32 5.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.697 0.761 . . . . 0.0 112.235 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -61.13 -29.69 69.93 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -85.8 -29.98 23.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 48.4 p -86.02 -18.01 33.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -60.79 140.31 57.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.691 0.758 . . . . 0.0 111.574 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.49 170.59 15.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.28 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.81 117.73 7.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.4 pm0 -60.82 -35.58 76.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -63.91 -40.03 95.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.573 -0.704 . . . . 0.0 109.216 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -78.88 -13.54 59.75 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.29 -50.37 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -45.89 47.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.782 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.6 -23.48 65.39 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.84 -16.53 57.99 Favored Glycine 0 C--O 1.24 0.469 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -89.01 -35.21 16.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 117.607 0.703 . . . . 0.0 111.614 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.95 -23.91 1.35 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 120.307 3.447 . . . . 0.0 120.307 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.353 0.797 1 C-N-CA 111.105 -5.463 . . . . 0.0 115.874 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.8 144.14 47.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.85 116.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.0 m -116.3 114.39 24.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.87 160.76 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.99 124.36 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 164.62 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.898 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 142.21 58.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.73 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 127.22 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.48 -25.1 29.57 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.401 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.53 99.43 2.27 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 117.742 0.771 . . . . 0.0 111.338 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.98 55.51 5.33 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 114.546 0.941 . . . . 0.0 114.546 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -120.12 1.31 10.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.591 -0.693 . . . . 0.0 112.292 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.5 tt -148.79 160.85 5.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.47 145.5 51.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.338 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.67 -176.69 44.24 Favored Glycine 0 C--O 1.237 0.307 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.39 64.92 2.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 111.549 -2.325 . . . . 0.0 108.205 170.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.9 t -132.1 101.84 14.84 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 112.38 -2.191 . . . . 0.0 107.812 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.42 -38.31 64.98 Favored 'Trans proline' 0 C--N 1.346 0.422 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -72.2 -32.56 66.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.2 m -63.29 -43.07 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.989 0.9 . . . . 0.0 111.887 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.38 -20.99 62.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.855 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -61.4 -33.52 73.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.675 -0.64 . . . . 0.0 110.212 174.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.47 -49.07 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.412 0.625 . . . . 0.0 111.131 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.45 -37.58 88.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.2 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.45 -41.79 90.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 151' ' ' LEU . 73.6 p -73.29 -40.75 64.29 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.299 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -27.33 48.85 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.522 -0.736 . . . . 0.0 111.679 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -71.03 -35.24 71.91 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 118.8 0.727 . . . . 0.0 112.439 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -68.11 -35.66 78.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 119.112 0.869 . . . . 0.0 110.203 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -71.85 -20.77 61.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 56.09 37.12 28.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.596 1.159 . . . . 0.0 109.715 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -86.72 148.67 46.63 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.22 146.73 32.23 Favored 'Trans proline' 0 C--N 1.35 0.608 1 C-N-CA 113.225 -4.05 . . . . 0.0 113.733 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.89 161.23 41.5 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.73 113.83 27.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.27 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -83.91 124.31 30.86 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 122.697 0.399 . . . . 0.0 110.97 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -116.02 124.35 50.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.42 119.91 37.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.3 mt -88.09 107.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.01 80.48 2.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.08 0.943 . . . . 0.0 110.577 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.5 mt 56.09 53.15 9.41 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.535 167.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.75 35.5 10.12 Favored Glycine 0 C--O 1.236 0.274 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.171 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.87 113.59 10.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -146.55 84.68 7.6 Favored Pre-proline 0 C--O 1.254 1.296 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -161.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.92 166.96 20.97 Favored 'Trans proline' 0 C--O 1.235 0.356 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 158.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -57.83 -33.34 68.51 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.552 0.341 . . . . 0.0 111.227 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -54.66 -45.52 73.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.361 0.6 . . . . 0.0 112.468 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -77.79 -27.27 50.16 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -65.97 -34.77 78.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.007 0.432 . . . . 0.0 111.547 171.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -67.97 -43.87 77.98 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.101 -0.999 . . . . 0.0 110.273 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -70.1 -51.89 35.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -104.2 121.14 48.58 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-N 120.611 1.55 . . . . 0.0 114.743 -167.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.52 -24.61 30.58 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 118.932 2.628 . . . . 0.0 118.932 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -101.47 -5.37 25.34 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.3 1.409 . . . . 0.0 110.68 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.5 -47.5 3.85 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.255 -164.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -119.94 64.75 0.82 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.599 1.19 . . . . 0.0 113.604 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.52 155.86 73.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 165.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.92 154.3 58.23 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 113.564 -3.824 . . . . 0.0 111.476 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.16 142.57 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.93 125.61 67.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 165.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -98.85 89.09 4.2 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.2 101.46 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.61 47.54 22.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.748 0.819 . . . . 0.0 112.944 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t0 65.04 22.18 12.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 -173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -109.85 127.73 54.88 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.068 -1.02 . . . . 0.0 108.55 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -105.24 117.34 33.77 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.841 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.0 138.7 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.617 0.644 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.24 19.54 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 118.816 2.895 . . . . 0.0 118.816 -164.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.64 148.36 29.44 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.754 -1.216 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.1 p -63.78 -25.25 68.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -165.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -82.57 -35.06 27.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.304 -0.247 . . . . 0.0 111.539 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.63 -19.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.63 -0.669 . . . . 0.0 112.392 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 pt -77.37 4.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.11 0.481 . . . . 0.0 111.175 172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.94 -51.0 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.31 -55.19 7.09 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 120.249 2.86 . . . . 0.0 120.249 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.55 -29.57 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.35 1.575 . . . . 0.0 107.198 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -58.82 -43.84 90.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.76 -40.18 76.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.882 0.849 . . . . 0.0 110.664 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -63.03 -34.96 78.69 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.37 3.66 52.76 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -70.45 128.7 90.97 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.759 -0.588 . . . . 0.0 110.84 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.46 -4.99 15.69 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 N-CA-C 115.709 1.388 . . . . 0.0 115.709 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.12 155.7 37.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -59.72 122.02 10.79 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 116.603 -1.798 . . . . 0.0 116.497 -163.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.76 151.83 25.07 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 116.802 -1.665 . . . . 0.0 115.518 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.2 mt -136.87 49.9 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.942 1.697 . . . . 0.0 109.509 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.9 77.94 4.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 m -114.37 101.57 54.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -96.59 67.13 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.754 1 C-N-CA 126.045 4.497 . . . . 0.0 118.613 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.66 -113.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 116.914 -1.591 . . . . 0.0 114.134 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -63.91 -31.28 72.41 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 119.425 -2.047 . . . . 0.0 115.173 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.45 -11.77 60.57 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.358 -1.463 . . . . 0.0 111.825 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.36 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 119.762 -1.837 . . . . 0.0 110.132 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -48.25 45.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.54 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.137 0.494 . . . . 0.0 110.374 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.33 91.22 Favored Glycine 0 C--O 1.224 -0.506 0 O-C-N 120.944 -1.098 . . . . 0.0 111.764 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.1 p -70.59 -2.69 15.05 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -99.03 -36.52 9.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.722 0.772 . . . . 0.0 110.471 171.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.89 -50.16 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.685 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.78 -53.9 59.76 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.03 -17.42 31.85 Favored 'Trans proline' 0 C--N 1.349 0.579 1 C-N-CA 112.751 -4.366 . . . . 0.0 113.702 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -68.38 -56.12 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.815 0.734 . . . . 0.0 111.04 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -76.96 -25.23 52.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.428 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.27 -38.94 82.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -72.77 -44.36 61.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -68.95 -30.87 69.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.298 0.954 . . . . 0.0 112.696 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.9 tp -67.46 -38.41 84.42 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.207 -0.933 . . . . 0.0 110.762 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.9 -25.33 61.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.219 0.533 . . . . 0.0 111.98 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -90.65 109.93 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -93.59 67.87 3.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.26 176.7 1.73 Allowed Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.41 61.06 2.68 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 CA-C-N 120.195 1.105 . . . . 0.0 113.29 161.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.26 116.71 17.21 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -153.2 -57.04 0.12 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.38 -33.01 84.92 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 170.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -74.32 -30.58 62.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.047 1.424 . . . . 0.0 114.831 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.51 -32.07 70.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.251 -1.53 . . . . 0.0 107.316 174.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -77.95 -12.64 60.0 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.979 -1.075 . . . . 0.0 112.707 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.27 -34.67 31.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.224 -1.547 . . . . 0.0 107.673 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.1 tp -64.1 -35.66 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.79 -39.91 78.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.33 173.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -68.9 -35.03 76.37 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.997 0.817 . . . . 0.0 111.959 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.07 -38.56 88.62 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.416 -1.428 . . . . 0.0 110.757 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.05 -20.35 49.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.04 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.22 -36.6 82.03 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.267 0.94 . . . . 0.0 110.571 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.45 -39.18 93.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.18 -50.42 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.025 0.53 . . . . 0.0 111.873 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.98 -34.99 64.88 Favored Glycine 0 C--O 1.234 0.141 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.573 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -57.51 -42.5 82.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 122.026 0.917 . . . . 0.0 110.577 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -35.11 65.22 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -73.21 -18.48 61.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 m -89.7 4.3 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -121.44 -45.77 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.29 -70.96 0.23 Allowed Glycine 0 CA--C 1.531 1.076 0 N-CA-C 120.941 3.136 . . . . 0.0 120.941 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.22 -164.95 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.723 1 C-N-CA 127.896 5.731 . . . . 0.0 118.822 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.09 166.8 7.21 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 169.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.8 mt -78.53 -24.63 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -128.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.7 -6.44 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.39 -17.22 37.25 Favored Glycine 0 C--O 1.23 -0.146 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.05 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -130.44 -44.8 1.11 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -166.45 178.1 6.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.25 126.23 16.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.7 p -131.63 -170.18 2.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.88 -36.04 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -35.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.946 -1.096 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.27 -42.91 96.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 29' ' ' SER . 92.0 mt -63.46 -32.91 74.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 81.5 p -72.9 -37.64 67.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -97.73 -42.88 7.4 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -166.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.45 57.4 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.12 -29.87 14.05 Favored 'Trans proline' 0 C--N 1.35 0.618 1 C-N-CA 111.781 -5.013 . . . . 0.0 115.701 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -76.59 -28.72 56.3 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 119.979 -1.701 . . . . 0.0 108.366 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.6 tp -66.44 -34.32 77.69 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.45 0.568 . . . . 0.0 111.783 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.35 -46.8 81.88 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.629 -0.67 . . . . 0.0 109.73 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -60.87 -33.58 73.31 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.16 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.92 -50.58 61.95 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.618 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -30.35 71.37 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.71 1.141 . . . . 0.0 111.607 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 94.5 t -73.06 -57.46 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.352 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -44.67 65.46 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.745 -1.222 . . . . 0.0 111.418 -166.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.41 -34.41 70.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.8 93.68 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.911 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -76.87 -46.87 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.622 -0.928 . . . . 0.0 112.37 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.96 -47.53 12.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -171.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.55 63.06 1.45 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -40.68 112.41 0.29 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -161.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -144.99 81.01 10.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.803 0.841 . . . . 0.0 111.959 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.47 154.78 40.56 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 113.303 -3.998 . . . . 0.0 110.118 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.23 129.9 91.55 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.41 163.65 31.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.711 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -76.82 6.51 6.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.257 1.503 . . . . 0.0 113.048 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.82 -15.99 42.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.372 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.2 mt -120.21 47.56 1.74 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 108.398 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.3 t -62.91 -18.82 63.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -160.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -48.66 80.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.264 1.847 . . . . 0.0 108.405 174.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.94 -33.03 50.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 118.042 -1.463 . . . . 0.0 107.883 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.2 -52.25 59.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.95 -39.53 94.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.577 0.703 . . . . 0.0 109.784 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.28 -22.78 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.752 -0.592 . . . . 0.0 111.948 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.6 mm -65.66 -34.59 71.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.456 1.025 . . . . 0.0 108.982 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.3 -33.48 75.37 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 111.159 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.06 -45.18 74.57 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.65 -30.17 70.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -67.92 -23.18 65.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.215 -0.928 . . . . 0.0 110.841 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -144.99 69.77 1.26 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.802 0.81 . . . . 0.0 111.071 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -131.99 144.54 50.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.55 -37.38 78.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -166.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.7 t -72.51 -50.48 25.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.94 1.352 . . . . 0.0 110.43 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.9 -28.98 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.698 -165.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.5 -43.39 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.302 1.041 . . . . 0.0 111.509 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.97 -37.17 78.62 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.47 -0.769 . . . . 0.0 112.17 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 32.1 p -81.72 -0.72 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -55.0 119.79 5.96 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.828 -0.545 . . . . 0.0 110.927 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.78 153.96 42.57 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.24 130.46 46.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -61.01 -36.12 78.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.065 0.46 . . . . 0.0 111.021 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -83.61 -25.51 30.78 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.857 -0.527 . . . . 0.0 109.649 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.39 -58.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -43.21 64.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 120.945 -1.097 . . . . 0.0 111.664 -168.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.79 0.09 48.84 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.605 -0.684 . . . . 0.0 111.591 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.09 -34.98 7.29 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -77.73 -41.73 36.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.676 -0.896 . . . . 0.0 112.376 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.44 -36.82 50.73 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo . . . . . 0 C--N 1.349 0.578 0 C-N-CA 114.956 -2.896 . . . . 0.0 114.545 176.283 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.685 0.279 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -121.32 142.66 49.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.56 149.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -140.46 130.27 24.47 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 34.5 m -132.7 165.7 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -58.71 118.33 5.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.54 173.12 12.91 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.24 0.543 . . . . 0.0 111.189 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.03 124.64 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.09 55.93 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 64.26 12.99 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 119.163 1.482 . . . . 0.0 112.452 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.38 108.03 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 115.617 -2.456 . . . . 0.0 115.864 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -172.71 -53.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.4 mt -99.65 144.32 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 108.573 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.67 150.51 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.184 1.394 . . . . 0.0 114.599 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -156.09 11.79 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 10.0 t70 -84.71 116.82 23.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.18 -1.188 . . . . 0.0 110.394 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -165.38 140.4 4.17 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 173.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.81 -55.29 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.827 -2.982 . . . . 0.0 112.514 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -66.26 -29.31 69.52 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.29 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -44.13 -59.0 2.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -86.17 -11.65 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.924 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.39 -48.8 79.57 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 m -68.82 -43.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.457 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.99 -41.52 90.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.551 -173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.19 -46.8 76.07 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.185 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.1 p -65.3 -42.44 93.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 119.593 1.088 . . . . 0.0 112.533 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.72 -36.17 73.08 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.056 -1.027 . . . . 0.0 111.775 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -76.81 -29.91 56.18 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.654 -0.654 . . . . 0.0 111.816 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.67 -29.64 70.23 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.643 -1.286 . . . . 0.0 111.265 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.18 -8.45 57.81 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.14 37.48 26.35 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.61 1.564 . . . . 0.0 113.63 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.47 157.58 67.38 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.353 0.524 . . . . 0.0 111.076 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.57 127.18 10.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -147.26 167.65 23.71 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.211 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.69 148.77 28.98 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t 72.44 143.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.852 2.061 . . . . 0.0 114.235 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.98 71.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 110.894 170.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.24 143.15 18.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.97 146.58 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.055 1.742 . . . . 0.0 108.399 158.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -88.75 80.24 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt 53.77 35.44 21.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.848 0.832 . . . . 0.0 113.209 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 1.37 83.72 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -82.87 78.82 9.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.343 1.571 . . . . 0.0 113.174 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -134.41 159.85 70.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.05 -176.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 114.662 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.29 -28.36 27.68 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -45.88 -40.71 10.38 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -85.96 -28.93 23.94 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 112.329 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.22 -22.55 63.86 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.847 0.832 . . . . 0.0 111.098 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -76.07 -3.67 37.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 112.097 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.16 -67.91 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 t -73.45 126.03 90.25 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -158.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.23 -24.26 27.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 N-CA-C 117.538 2.091 . . . . 0.0 117.538 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -100.76 -5.16 26.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.903 0.859 . . . . 0.0 111.089 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 -29.32 2.17 Favored Glycine 0 C--O 1.225 -0.427 0 O-C-N 121.806 -0.559 . . . . 0.0 113.813 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -130.81 45.61 2.79 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.149 0.974 . . . . 0.0 112.862 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.93 155.86 60.17 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.448 -0.783 . . . . 0.0 110.057 170.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . 72.8 Cg_endo -66.64 153.21 78.78 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 123.323 1.17 . . . . 0.0 113.706 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.21 159.34 36.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.71 124.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -92.88 80.91 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.065 0.848 . . . . 0.0 109.325 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mt -83.42 105.58 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t0 53.33 45.81 27.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.288 1.042 . . . . 0.0 109.679 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 68.7 9.87 7.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -121.84 128.15 51.33 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -94.71 144.1 25.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.09 132.55 55.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 176.77 132.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.257 1.823 . . . . 0.0 115.249 148.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -175.7 177.31 1.74 Allowed 'General case' 0 N--CA 1.48 1.034 1 N-CA-C 97.404 -5.036 . . . . 0.0 97.404 170.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.34 58.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -84.38 -24.28 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 120.695 -1.253 . . . . 0.0 110.702 -163.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.01 -24.1 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.443 HG13 HD22 ' A' ' 80' ' ' LEU . 2.2 tp -80.63 -13.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 120.791 -1.193 . . . . 0.0 109.329 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.4 t -82.72 -39.22 15.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.963 171.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.73 -55.2 0.62 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -69.08 -39.66 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.357 1.079 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 HG13 ' A' ' 76' ' ' ILE . 21.7 tp -60.66 -37.55 81.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.657 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -68.88 -45.72 70.27 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.031 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -61.96 -37.12 83.55 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -85.86 10.17 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -100.63 133.55 21.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.063 -0.398 . . . . 0.0 111.51 175.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -66.43 -24.82 49.19 Favored 'Trans proline' 0 C--O 1.24 0.614 0 N-CA-C 116.781 1.8 . . . . 0.0 116.781 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -75.41 157.45 84.62 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.45 126.64 23.16 Favored 'Trans proline' 0 C--O 1.243 0.746 0 N-CA-C 114.741 1.016 . . . . 0.0 114.741 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.9 150.43 26.88 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 117.904 -0.931 . . . . 0.0 112.318 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 tp -142.04 64.7 1.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.841 1.305 . . . . 0.0 112.495 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.21 70.75 9.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.41 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -117.56 106.27 46.7 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.599 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -95.32 74.67 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 125.913 4.408 . . . . 0.0 119.001 164.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -87.1 -113.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 CA-C-N 119.198 0.749 . . . . 0.0 112.089 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -61.8 -43.07 99.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.998 -1.064 . . . . 0.0 112.658 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.33 -11.13 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.96 -48.75 13.95 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.617 -1.302 . . . . 0.0 111.919 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.8 p -77.89 -30.84 50.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.7 t -85.25 -36.12 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.39 -33.1 83.38 Favored Glycine 0 C--O 1.228 -0.24 0 O-C-N 121.077 -1.014 . . . . 0.0 114.078 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.4 p -75.65 -3.45 34.61 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -83.53 -34.84 25.17 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.824 -1.172 . . . . 0.0 110.777 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -38.8 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.266 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 69.7 t80 -52.72 -52.88 60.16 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 C--N 1.35 0.617 1 C-N-CA 113.186 -4.076 . . . . 0.0 114.294 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -67.41 -40.1 85.55 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.091 -1.006 . . . . 0.0 111.273 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 10.0 p90 -75.03 -33.32 61.76 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.901 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.38 -29.83 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -67.34 -42.99 82.62 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.737 -0.602 . . . . 0.0 109.995 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.52 -37.56 85.28 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.379 -0.826 . . . . 0.0 112.838 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.1 tp -63.99 -36.56 84.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.59 -30.98 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.4 t -89.43 110.57 21.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -98.09 44.15 1.05 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.782 1.277 . . . . 0.0 108.435 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -72.59 174.32 4.54 Favored Pre-proline 0 C--O 1.255 1.376 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 172.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.8 60.48 2.91 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 117.845 -0.97 . . . . 0.0 113.157 159.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -77.35 92.76 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -92.45 -38.3 12.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 162.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.02 -43.62 90.52 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.733 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 m -72.28 -26.28 61.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.369 1.085 . . . . 0.0 110.623 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.32 -41.39 85.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -76.78 -12.46 59.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.475 -0.766 . . . . 0.0 112.831 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.21 61.5 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.67 -42.11 95.6 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.32 -41.85 97.69 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -65.95 -46.47 78.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.926 0.869 . . . . 0.0 113.096 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -74.16 -35.05 64.01 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.97 -20.15 56.45 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.717 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -67.68 -33.34 74.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.076 1.307 . . . . 0.0 109.384 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.23 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.0 -34.8 79.3 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -38.9 90.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.845 0.858 . . . . 0.0 108.986 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -53.51 38.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.325 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -59.94 -29.65 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.021 -0.694 . . . . 0.0 112.016 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.6 -57.82 6.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -73.96 -12.33 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -166.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.9 t -61.71 -49.0 86.08 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 121.043 -1.035 . . . . 0.0 110.429 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -100.39 -39.65 7.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.41 -45.69 1.28 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.09 -163.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.112 2.956 . . . . 0.0 114.557 170.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.27 164.35 1.82 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.351 0.66 . . . . 0.0 109.885 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 mt -71.17 -22.87 22.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 121.48 -0.762 . . . . 0.0 110.389 -165.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -53.3 -35.19 59.85 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 167.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.21 -30.86 4.64 Favored Glycine 0 CA--C 1.518 0.259 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -129.76 -43.8 1.22 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -160.71 177.95 9.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.41 101.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 119.688 1.131 . . . . 0.0 109.471 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 175.78 5.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.89 60.77 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.59 -31.14 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.38 -0.825 . . . . 0.0 112.485 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 6.3 t0 -81.21 -37.53 28.48 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.598 -1.314 . . . . 0.0 108.11 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.96 -16.9 64.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.161 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.6 m -79.97 -36.4 36.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.92 -36.39 11.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.19 76.43 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -68.81 -19.91 40.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 113.809 -3.661 . . . . 0.0 116.807 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -94.26 -22.83 18.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.078 -1.014 . . . . 0.0 111.532 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.19 -36.64 84.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.72 -43.25 94.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.371 -0.83 . . . . 0.0 112.887 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 12.3 m-70 -71.65 -29.22 64.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.301 -0.874 . . . . 0.0 112.443 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.3 -49.5 73.76 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.31 -37.58 83.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.6 m -80.07 -27.04 12.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.424 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.22 -44.11 7.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.09 -41.31 97.35 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.92 -38.68 95.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.748 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -73.98 -41.19 62.3 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.145 -1.209 . . . . 0.0 113.368 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -107.17 -46.55 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.25 61.05 0.75 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -165.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.14 104.09 0.22 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -142.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -150.02 100.73 3.22 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 123.465 0.706 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.5 160.42 41.59 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 115.647 -2.435 . . . . 0.0 110.087 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.3 130.59 90.87 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.63 158.32 39.78 Favored 'Trans proline' 0 C--N 1.346 0.409 0 N-CA-C 114.878 1.069 . . . . 0.0 114.878 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.66 2.85 49.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -68.21 -23.11 64.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 159.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.5 mt -114.65 42.23 2.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.333 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 51.9 m -53.41 -31.72 46.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.974 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -61.19 -36.04 78.79 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.292 -1.505 . . . . 0.0 113.234 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 -40.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.7 tp -60.05 -39.47 86.07 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.52 -0.737 . . . . 0.0 111.773 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -72.75 -23.8 60.88 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.616 -0.678 . . . . 0.0 112.164 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -38.85 61.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.5 mm -65.87 -39.61 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.11 -37.56 87.87 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.543 -1.348 . . . . 0.0 112.787 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.81 -44.85 88.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.7 -44.6 86.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.875 0.735 . . . . 0.0 110.798 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.85 -21.45 29.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.49 39.98 3.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.874 0.369 . . . . 0.0 111.465 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -72.18 143.09 49.02 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 100.445 -3.909 . . . . 0.0 100.445 155.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.03 -34.11 77.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 119.785 1.175 . . . . 0.0 110.213 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -61.65 -43.36 99.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.719 0.771 . . . . 0.0 111.006 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -70.87 -37.45 73.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.902 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.01 -44.45 82.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.0 -30.39 31.59 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.8 p -104.72 11.28 34.15 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -76.59 153.4 35.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.606 -0.684 . . . . 0.0 111.562 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.72 152.06 33.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.91 133.13 47.8 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.39 -34.29 76.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -160.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -56.81 -20.03 20.42 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -175.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -116.9 15.82 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 110.949 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.96 -46.74 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 101.794 -3.409 . . . . 0.0 101.794 156.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.23 -60.79 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.501 0.32 . . . . 0.0 110.76 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.07 60.42 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.118 -1.614 . . . . 0.0 114.173 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.96 -28.56 11.76 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 118.127 2.011 . . . . 0.0 118.127 -171.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -101.15 -24.33 14.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 111.581 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -71.56 -6.58 0.1 Allowed Pre-proline 0 C--O 1.242 0.679 0 N-CA-C 121.737 3.977 . . . . 0.0 121.737 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--N 1.357 1.011 1 C-N-CA 109.944 -6.237 . . . . 0.0 114.474 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -165.63 164.5 19.14 Favored 'General case' 0 C--O 1.245 0.854 1 N-CA-C 96.289 -5.449 . . . . 0.0 96.289 178.124 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -151.34 -10.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.0 122.54 7.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.369 2.35 . . . . 0.0 117.341 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.56 158.52 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.606 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.75 134.13 44.85 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.12 165.66 20.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 138.48 58.35 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.64 132.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.22 -50.97 4.33 Favored Glycine 0 CA--C 1.516 0.122 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.62 76.64 69.82 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 122.588 0.355 . . . . 0.0 111.418 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.25 114.11 2.71 Favored 'Trans proline' 0 C--O 1.234 0.278 0 CA-C-O 122.352 0.897 . . . . 0.0 111.62 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -166.96 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.69 159.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.2 tp -44.91 142.53 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.847 1.259 . . . . 0.0 112.084 160.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.96 -169.68 30.93 Favored Glycine 0 C--O 1.23 -0.111 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -72.85 98.2 2.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.447 1.117 . . . . 0.0 108.602 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -142.04 105.0 5.67 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.045 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.62 -44.44 48.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 115.346 1.248 . . . . 0.0 115.346 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -78.18 -29.78 48.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.9 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.1 m -65.77 -46.12 79.96 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.694 -0.629 . . . . 0.0 112.405 -169.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.27 -12.47 60.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.359 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.33 -44.81 95.62 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.86 -46.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.37 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.87 -39.91 87.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.2 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.8 -40.49 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.787 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.6 p -68.86 -34.25 75.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.646 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -40.35 42.93 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.07 -0.394 . . . . 0.0 110.869 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -73.08 -29.74 63.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.714 -0.616 . . . . 0.0 112.309 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.1 -33.47 75.87 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.295 -1.503 . . . . 0.0 110.587 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -87.27 0.07 55.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 53.21 32.38 13.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.439 1.896 . . . . 0.0 114.618 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.7 121.23 66.5 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.05 142.14 34.01 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 115.703 -2.398 . . . . 0.0 112.475 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -140.45 176.39 8.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.823 0.849 . . . . 0.0 109.064 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.77 155.12 28.39 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 t -154.29 138.43 16.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 119.678 1.126 . . . . 0.0 110.823 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -96.64 136.38 37.25 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.26 105.67 16.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.6 mm -79.25 95.03 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -78.55 80.83 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.239 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 52.62 51.8 15.34 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 155.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.47 34.02 6.87 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.696 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.86 -58.54 5.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -106.28 142.73 25.5 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.356 -160.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.75 -166.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.241 0.654 0 N-CA-C 116.166 1.564 . . . . 0.0 116.166 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -41.74 -31.73 0.33 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 118.833 2.901 . . . . 0.0 118.833 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -51.81 -42.03 62.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.472 1.033 . . . . 0.0 113.184 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -24.56 22.43 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.971 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.56 -26.01 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.608 0.718 . . . . 0.0 110.783 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.32 -30.3 70.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.75 -44.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.805 -170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -88.33 118.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 121.641 -0.662 . . . . 0.0 110.815 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -34.36 97.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 116.377 1.645 . . . . 0.0 116.377 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.2 4.15 39.09 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.282 -0.886 . . . . 0.0 110.611 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.23 -15.51 8.8 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -142.69 24.2 1.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.31 156.13 47.57 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 156.2 51.45 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 117.198 -1.401 . . . . 0.0 113.358 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -145.48 123.18 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.784 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 4' ' ' GLU . 43.7 t -88.82 119.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 173.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.99 130.44 34.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 161.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.94 103.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t0 61.69 39.12 14.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.457 1.123 . . . . 0.0 112.813 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 t0 58.87 36.58 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.777 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.23 144.94 50.59 Favored 'General case' 0 C--N 1.323 -0.568 1 N-CA-C 98.684 -4.561 . . . . 0.0 98.684 164.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -128.84 156.31 43.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.02 123.97 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.32 81.53 0.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.79 148.58 26.49 Favored 'General case' 0 N--CA 1.471 0.581 1 N-CA-C 98.649 -4.574 . . . . 0.0 98.649 162.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -60.26 -28.85 68.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -166.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.2 -28.96 17.5 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.629 -0.67 . . . . 0.0 112.446 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.49 -22.99 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.156 -0.965 . . . . 0.0 110.483 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.93 -0.88 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.752 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.34 -60.16 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.376 165.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -50.0 36.4 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.37 -26.55 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.5 tp -63.5 -39.44 94.45 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.432 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.9 -34.41 77.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.363 1.438 . . . . 0.0 111.033 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.82 -36.95 85.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.969 0.89 . . . . 0.0 111.36 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -91.09 -3.86 56.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -70.31 133.17 87.49 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.8 -15.65 26.64 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 115.254 -2.698 . . . . 0.0 114.864 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -87.89 170.64 11.15 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.48 139.08 86.57 Favored 'Trans proline' 0 C--N 1.353 0.768 0 N-CA-C 117.128 1.934 . . . . 0.0 117.128 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.63 110.47 2.41 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 114.014 0.736 . . . . 0.0 114.014 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.8 mt -118.58 56.88 0.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.73 88.0 2.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -116.42 123.75 30.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 166.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -94.49 67.07 0.32 Allowed 'Trans proline' 0 CA--C 1.556 1.593 0 N-CA-C 119.253 2.751 . . . . 0.0 119.253 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.35 -167.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.764 -1.024 . . . . 0.0 111.028 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 14.71 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 1 N-CA-C 122.286 4.18 . . . . 0.0 122.286 167.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.33 -22.16 62.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.639 -0.663 . . . . 0.0 111.697 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.49 75.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.377 0.535 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -44.98 89.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.235 0.54 . . . . 0.0 109.755 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.56 -41.03 85.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.831 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.31 90.42 Favored Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.602 -0.686 . . . . 0.0 112.245 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -70.63 -8.79 54.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -101.55 -33.89 9.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 111.133 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.13 -42.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 122.891 0.477 . . . . 0.0 110.27 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -54.56 55.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.48 -30.36 79.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 114.961 -2.892 . . . . 0.0 114.52 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -61.59 -54.3 44.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.922 0.328 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -70.98 -27.72 63.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 117.916 -1.513 . . . . 0.0 113.906 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 m -74.03 -36.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.962 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -62.47 -51.32 67.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.93 -42.19 85.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.761 1.619 . . . . 0.0 112.302 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -71.52 -30.77 66.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.439 0.638 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -81.57 138.16 35.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.172 0.987 . . . . 0.0 113.641 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -124.84 30.75 5.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.29 173.42 7.02 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.44 51.76 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 CA-C-N 121.492 1.569 . . . . 0.0 116.126 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -75.45 106.41 6.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.39 -51.49 1.01 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 -40.14 94.85 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -18.02 59.48 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 120.607 -1.525 . . . . 0.0 114.237 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.76 -33.05 71.89 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.74 3.79 15.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.056 -1.028 . . . . 0.0 113.222 173.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.77 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 119.836 -1.79 . . . . 0.0 107.417 165.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.06 -37.88 81.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.496 -0.753 . . . . 0.0 109.705 171.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.28 -43.54 83.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -69.82 -34.65 73.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.72 -37.06 79.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.374 -1.454 . . . . 0.0 110.696 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.16 -20.88 59.13 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.267 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -71.27 -32.68 68.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.722 -1.237 . . . . 0.0 110.579 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.37 93.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.8 -41.38 97.91 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.557 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.9 -37.66 80.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.161 0.985 . . . . 0.0 110.838 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.29 -51.7 47.06 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.94 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -64.97 -32.73 74.59 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.604 -0.939 . . . . 0.0 111.062 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.3 -46.98 78.23 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.253 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.13 -24.59 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.885 1.221 . . . . 0.0 112.677 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -76.02 -49.25 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 122.128 -0.357 . . . . 0.0 111.501 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -83.7 -26.11 30.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.78 -93.6 1.12 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -71.57 -177.73 2.63 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 118.496 2.46 . . . . 0.0 118.496 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -36.65 148.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.081 2.153 . . . . 0.0 114.001 170.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 pt -77.37 23.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -149.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.44 -20.37 60.05 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.302 -1.499 . . . . 0.0 109.405 149.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.39 67.86 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -145.57 -54.93 0.29 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -163.21 -173.71 3.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.9 mt -77.1 114.94 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -138.93 -170.23 2.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -39.66 -45.36 1.66 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 119.62 3.193 . . . . 0.0 119.62 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.55 -39.27 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.239 . . . . 0.0 110.365 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.81 -44.64 66.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.336 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.43 -19.03 65.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.445 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -81.24 -44.65 17.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 27.6 tp -87.91 -45.79 9.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.2 -37.59 55.05 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.26 -36.9 26.35 Favored 'Trans proline' 0 C--N 1.354 0.842 1 C-N-CA 111.519 -5.187 . . . . 0.0 113.47 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -77.77 -24.26 49.01 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.63 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.74 -34.84 76.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.597 1.09 . . . . 0.0 112.434 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -66.17 -44.67 83.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.258 -0.901 . . . . 0.0 110.521 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -66.42 -31.62 72.5 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.0 -54.04 47.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -71.11 -34.32 70.97 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.96 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.11 -36.37 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.02 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.55 12.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.532 1.06 . . . . 0.0 110.232 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.34 -35.84 81.38 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.17 92.89 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.629 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -85.57 -24.94 27.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.363 -1.081 . . . . 0.0 113.439 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -101.55 -40.48 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -139.43 47.75 1.87 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 109.987 -172.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -34.31 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 -149.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -146.36 107.23 4.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.61 169.07 15.64 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 118.378 0.456 . . . . 0.0 111.935 162.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 93.8 mt -67.3 124.51 89.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -73.02 164.65 34.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.52 -8.35 57.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.505 0.669 . . . . 0.0 110.493 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.29 -24.12 67.11 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.669 166.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -118.5 44.47 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.8 t -63.12 -18.33 63.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -165.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.41 -33.93 65.23 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.915 -1.741 . . . . 0.0 109.371 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.88 -46.49 79.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.3 -41.79 98.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.286 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -65.06 -48.27 74.38 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 120.862 -1.149 . . . . 0.0 111.436 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -31.77 70.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.24 -175.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.01 -31.13 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 119.575 1.079 . . . . 0.0 111.716 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -71.09 -34.66 71.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.104 -1.622 . . . . 0.0 111.16 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.71 -41.39 92.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.33 -38.74 91.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -54.57 -41.08 69.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.579 0.627 . . . . 0.0 111.201 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 t -91.25 -0.11 57.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -64.99 144.2 57.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -58.4 -43.25 88.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.322 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.6 t -60.36 -46.87 88.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -42.78 79.93 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.531 -0.73 . . . . 0.0 111.803 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.64 -42.05 82.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.919 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -77.12 -31.69 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.6 p -99.92 -9.05 23.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -64.88 142.74 58.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.123 0.874 . . . . 0.0 112.409 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.75 161.44 30.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.79 133.97 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.72 -35.29 79.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -52.5 -39.56 61.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.621 0.768 . . . . 0.0 112.661 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.72 -14.84 29.31 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.712 -0.618 . . . . 0.0 111.893 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 43.3 t -74.5 -37.59 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.4 mt -66.32 -37.74 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.295 -0.878 . . . . 0.0 108.703 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.45 -5.97 12.98 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.477 -0.764 . . . . 0.0 112.622 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.91 73.49 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.777 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -93.09 -23.24 18.69 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 118.619 1.209 . . . . 0.0 109.927 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.37 128.88 94.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.719 0.408 . . . . 0.0 111.424 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 CA--C 1.533 0.446 0 CA-C-N 119.674 0.919 . . . . 0.0 112.446 -65.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -87.67 -4.82 58.91 Favored 'General case' 0 C--N 1.322 -0.595 1 N-CA-C 124.968 5.173 . . . . 0.0 124.968 -146.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.502 HG23 HG13 ' A' ' 7' ' ' VAL . 10.1 mm -87.93 126.89 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 122.647 2.476 . . . . 0.0 112.38 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.401 ' HB2' HG22 ' A' ' 62' ' ' VAL . 72.4 m -129.64 121.11 26.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 152.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.502 HG13 HG23 ' A' ' 5' ' ' ILE . 11.7 m -137.2 156.14 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.685 1.129 . . . . 0.0 113.812 -174.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.96 133.29 55.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.3 165.48 13.41 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 144.4 57.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.69 131.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -44.84 3.41 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 118.851 -0.971 . . . . 0.0 114.925 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.32 85.04 52.03 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -72.85 62.24 3.87 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 121.397 1.398 . . . . 0.0 115.291 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -141.57 -10.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.047 1.339 . . . . 0.0 111.002 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.3 tt -135.42 156.23 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.83 156.6 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.01 0.924 . . . . 0.0 112.39 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.81 156.06 17.94 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.42 95.12 5.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.792 0.806 . . . . 0.0 112.685 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 75.0 m -100.16 150.23 36.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 139.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.16 -34.69 98.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.034 -1.511 . . . . 0.0 114.053 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.24 -31.04 70.83 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.96 -51.91 67.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -30.04 63.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.297 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -59.8 -40.1 87.21 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.01 -1.056 . . . . 0.0 111.494 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.46 -50.6 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -60.87 -39.13 88.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 tp -58.07 -45.18 87.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.798 0.726 . . . . 0.0 110.988 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.0 p -66.13 -36.7 83.84 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.16 -0.963 . . . . 0.0 111.5 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.08 -41.68 70.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.907 -0.496 . . . . 0.0 111.465 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -32.13 58.78 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.927 -0.483 . . . . 0.0 112.251 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.7 -37.22 81.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.173 -0.954 . . . . 0.0 111.6 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -91.92 1.97 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.507 0.67 . . . . 0.0 111.349 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 57.62 26.3 12.72 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.136 1.774 . . . . 0.0 114.71 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.56 141.71 48.97 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -68.01 164.81 30.43 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 116.377 -1.948 . . . . 0.0 110.78 175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -154.28 151.31 28.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -79.91 148.48 31.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -128.38 125.75 39.28 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.107 0.88 . . . . 0.0 110.591 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -111.9 112.22 23.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -80.84 134.23 35.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.64 116.93 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -79.32 79.18 5.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 112.658 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt 57.3 39.43 28.5 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.26 69.63 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.24 -0.981 . . . . 0.0 114.215 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.85 118.17 14.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 149.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.26 122.72 7.58 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.616 0.246 . . . . 0.0 111.619 -172.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.1 176.32 10.09 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.378 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -55.66 -37.27 68.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.863 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -53.62 -45.72 70.21 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -80.11 -22.73 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.676 -1.265 . . . . 0.0 112.488 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.241 -0.912 . . . . 0.0 111.049 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.05 -11.56 60.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.439 -0.788 . . . . 0.0 112.13 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.94 -61.06 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.654 0.74 . . . . 0.0 112.358 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -86.86 129.97 50.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 -166.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.02 -28.65 41.39 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 116.082 -2.146 . . . . 0.0 114.03 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -89.28 -10.49 46.67 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.042 -1.036 . . . . 0.0 111.077 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.01 -7.2 36.97 Favored Glycine 0 C--O 1.22 -0.726 0 O-C-N 121.709 -0.619 . . . . 0.0 113.003 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -144.85 16.27 1.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.47 143.13 28.76 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -59.18 156.48 34.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 N-CA-C 114.676 0.991 . . . . 0.0 114.676 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 6' ' ' CYS . 24.4 m -134.98 169.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.5 m -106.76 142.7 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 160.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -126.67 53.48 1.67 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 123.033 1.397 . . . . 0.0 111.112 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -68.35 126.8 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 57.17 30.77 18.89 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.193 0.997 . . . . 0.0 111.864 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.13 18.13 11.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.082 1.753 . . . . 0.0 113.482 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -106.25 112.2 25.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.19 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -74.9 140.29 43.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.45 130.02 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.16 41.52 1.51 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -157.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.78 144.63 39.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.557 -1.34 . . . . 0.0 108.331 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -58.83 -32.35 69.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -75.97 -31.75 59.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.241 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.75 -11.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.635 -1.291 . . . . 0.0 110.342 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.12 -26.51 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 t -73.79 -44.01 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.388 -1.445 . . . . 0.0 110.447 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.54 -64.77 0.83 Allowed Glycine 0 CA--C 1.519 0.341 0 N-CA-C 119.986 2.754 . . . . 0.0 119.986 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.53 -38.06 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.969 0.884 . . . . 0.0 111.748 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.14 -45.76 83.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.888 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.87 -28.05 60.5 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.641 -1.224 . . . . 0.0 113.316 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -63.14 -40.99 99.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.56 -7.91 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -68.15 119.11 65.16 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 160.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.15 0.65 9.51 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 116.064 1.524 . . . . 0.0 116.064 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.92 162.55 67.63 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.66 132.48 49.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 115.956 1.483 . . . . 0.0 115.956 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.16 140.28 19.7 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 116.878 -1.615 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.7 mt -137.25 43.23 2.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.308 0.575 . . . . 0.0 111.501 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 80.14 4.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.968 0.89 . . . . 0.0 110.437 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.8 m -116.59 93.54 40.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -90.73 81.18 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.08 3.187 . . . . 0.0 117.543 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -87.97 -137.37 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.528 0.867 . . . . 0.0 112.704 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.45 -30.95 68.87 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.941 -1.1 . . . . 0.0 112.874 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -63.26 -29.75 71.02 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.553 -0.717 . . . . 0.0 110.597 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.91 -28.73 25.72 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.095 -0.378 . . . . 0.0 111.995 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.2 p -73.53 -33.08 64.57 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.69 -49.17 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.65 62.24 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -60.39 -26.5 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -81.44 -42.62 20.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.049 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.98 -41.06 79.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.022 -166.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.48 -56.29 33.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.08 -20.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 113.827 -3.648 . . . . 0.0 113.856 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -64.76 -49.88 69.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.583 1.083 . . . . 0.0 109.943 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -72.14 -31.19 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.68 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.81 -40.01 80.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.32 -40.53 81.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.425 -1.422 . . . . 0.0 111.959 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.91 -26.71 67.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.206 0.912 . . . . 0.0 111.944 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.83 -50.67 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -70.1 -24.88 63.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.5 t -75.84 141.35 42.47 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.707 -0.62 . . . . 0.0 110.795 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -130.0 32.66 4.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.58 167.99 2.12 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 162.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -65.89 92.11 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 116.953 -1.565 . . . . 0.0 112.222 165.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.42 106.84 18.77 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.561 -169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -148.0 -48.87 0.16 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.788 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.44 -33.29 86.09 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.4 p -76.77 -20.31 56.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.594 -0.945 . . . . 0.0 113.381 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -75.3 -31.08 60.56 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.38 -28.38 59.48 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 172.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.27 95.19 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.906 -1.121 . . . . 0.0 110.09 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.53 -38.98 93.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.739 -0.601 . . . . 0.0 110.815 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -43.68 94.04 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.525 173.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -67.4 -36.97 82.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.406 1.003 . . . . 0.0 112.977 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.67 -45.7 81.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.89 -20.32 61.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 120.823 -1.173 . . . . 0.0 110.597 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.56 -28.77 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.753 -1.217 . . . . 0.0 111.557 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 -42.31 89.83 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.1 -38.39 85.59 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.01 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.96 -38.65 89.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.3 0.64 . . . . 0.0 109.808 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.59 -54.87 23.39 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.151 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -62.27 -28.18 69.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.822 -0.81 . . . . 0.0 112.577 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.27 -54.66 13.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.823 -0.548 . . . . 0.0 110.103 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.85 -22.29 65.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.21 -9.76 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.119 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -119.65 -44.53 2.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.53 -46.38 1.18 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 119.639 2.616 . . . . 0.0 119.639 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -68.79 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.695 3.248 . . . . 0.0 116.744 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -58.0 175.1 0.22 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.326 1.05 . . . . 0.0 112.444 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.63 -32.26 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.431 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.57 -3.81 5.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.28 -5.29 60.2 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -137.24 -53.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.692 1.246 . . . . 0.0 113.171 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.49 177.6 5.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 100.984 -3.71 . . . . 0.0 100.984 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.92 126.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.18 1.354 . . . . 0.0 109.181 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 m -143.29 174.39 10.76 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -41.59 -40.26 1.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.66 -32.01 56.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 120.495 1.498 . . . . 0.0 110.942 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.92 -39.23 79.76 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.27 -34.85 78.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.2 p -74.07 -37.24 64.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.74 -46.94 3.7 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -167.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.59 92.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.31 -13.73 18.65 Favored 'Trans proline' 0 C--N 1.349 0.591 1 C-N-CA 111.987 -4.876 . . . . 0.0 113.327 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -91.87 -26.67 18.37 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.909 -0.494 . . . . 0.0 110.477 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.7 -34.18 76.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.947 -0.47 . . . . 0.0 110.635 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.58 -50.14 63.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.468 1.128 . . . . 0.0 108.988 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -73.52 -14.89 61.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.718 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.3 tp -65.76 -54.27 29.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.216 0.916 . . . . 0.0 109.674 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.98 -26.85 63.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.437 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.9 -58.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 121.67 -0.644 . . . . 0.0 110.233 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.75 54.48 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.015 -1.053 . . . . 0.0 111.581 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.4 -37.92 83.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.51 95.66 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.993 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -72.31 -34.18 67.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.011 1.405 . . . . 0.0 113.418 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.03 -33.95 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 118.818 2.896 . . . . 0.0 118.818 -172.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.02 61.97 1.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -53.86 114.54 1.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -158.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -133.61 97.35 15.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 160.25 40.86 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.034 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 84.2 mt -73.11 122.4 87.56 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.59 165.36 25.08 Favored 'Trans proline' 0 C--N 1.346 0.438 0 N-CA-C 114.526 0.933 . . . . 0.0 114.526 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.22 -5.71 45.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.801 -0.562 . . . . 0.0 112.007 175.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.11 -21.87 64.92 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.985 -0.447 . . . . 0.0 110.801 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.65 58.68 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.48 72.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.451 -167.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -78.02 -35.62 49.61 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.989 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.8 -39.2 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.57 -42.38 91.84 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.592 -0.693 . . . . 0.0 111.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.99 -36.02 81.25 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 120.997 -1.065 . . . . 0.0 110.083 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -64.75 -43.32 93.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.0 -25.72 30.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 O-C-N 120.404 -1.435 . . . . 0.0 110.514 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.93 -25.94 66.61 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.065 -1.647 . . . . 0.0 112.091 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -71.67 -30.51 65.79 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.696 0.68 . . . . 0.0 109.176 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.26 -28.45 42.39 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.824 0.345 . . . . 0.0 110.263 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -79.48 13.2 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 120.835 -1.166 . . . . 0.0 111.124 170.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.4 t -134.67 171.09 14.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 60.16 136.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.04 -32.35 67.89 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.376 -0.828 . . . . 0.0 112.772 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.5 m -55.76 -32.59 63.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -102.23 -46.16 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.391 1.091 . . . . 0.0 110.49 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.15 -33.29 75.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -79.61 -32.25 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.497 -0.752 . . . . 0.0 110.898 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 41.0 p -91.67 -16.89 26.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.36 148.57 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.863 . . . . 0.0 111.967 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.93 152.81 37.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.596 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.32 51.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.33 -33.91 76.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.43 -35.34 80.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.511 1.148 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -80.76 -22.54 40.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.219 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.67 -51.79 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.4 pt -73.47 -36.02 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.71 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -20.07 65.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.51 13.11 Favored Glycine 0 CA--C 1.517 0.18 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -95.81 -25.77 15.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.369 1.585 . . . . 0.0 115.069 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -94.32 -10.27 0.15 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 121.507 3.892 . . . . 0.0 121.507 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo . . . . . 0 C--N 1.356 0.938 0 C-N-CA 113.674 -3.75 . . . . 0.0 117.077 -172.56 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.233 0.187 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -138.14 126.24 22.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 HG13 ' A' ' 7' ' ' VAL . 40.4 mm -110.75 103.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -166.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -98.43 71.42 2.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.042 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 5' ' ' ILE . 18.7 m -93.01 157.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.298 -170.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 20' ' ' CYS . 37.0 mtmt -62.87 142.91 58.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -82.21 161.88 22.58 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 171.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.31 143.85 54.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.868 1.318 . . . . 0.0 113.849 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.44 130.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -4.78 48.84 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.978 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.39 78.59 4.6 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.305 1.053 . . . . 0.0 112.369 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 75.6 Cg_endo -72.51 45.47 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 119.043 2.67 . . . . 0.0 119.043 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -131.01 -7.16 3.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 114.187 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.28 159.18 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.7 mt -61.18 142.55 56.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.24 153.43 22.22 Favored Glycine 0 CA--C 1.508 -0.383 0 O-C-N 121.514 -0.741 . . . . 0.0 114.9 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.93 103.13 10.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.655 1.217 . . . . 0.0 108.814 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 23.5 t -132.69 137.63 30.2 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.36 -29.13 72.08 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 115.32 -2.653 . . . . 0.0 112.304 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -80.9 -16.87 52.41 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.452 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -70.23 -52.01 26.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.84 -20.08 65.12 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.943 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -61.02 -43.75 98.43 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.668 2.031 . . . . 0.0 111.554 167.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.01 -54.61 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.03 -37.82 86.84 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.6 -39.5 88.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.3 p -70.59 -40.2 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 112.416 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -48.14 76.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.539 -177.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -74.57 -28.94 61.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.515 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -71.19 -36.39 71.93 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.59 -0.694 . . . . 0.0 111.191 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.17 -5.53 59.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 53.64 36.81 24.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 113.724 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.7 pt -84.25 153.44 62.6 Favored Pre-proline 0 C--O 1.246 0.879 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.795 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.4 137.61 25.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.068 -1.488 . . . . 0.0 114.689 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -151.77 161.58 42.43 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.3 126.41 52.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.2 t -88.62 135.08 33.68 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -137.2 129.56 29.72 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 71.4 mt -107.07 132.08 53.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -173.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.7 mm -105.48 101.32 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.789 1.236 . . . . 0.0 111.018 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -69.59 83.21 0.42 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.421 1.088 . . . . 0.0 113.486 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 51.12 48.26 23.37 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 122.921 1.343 . . . . 0.0 113.61 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 57.72 1.93 Allowed Glycine 0 CA--C 1.518 0.261 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.266 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.35 85.55 7.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.9 86.44 57.41 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-O 122.021 0.915 . . . . 0.0 112.219 -157.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.93 -176.51 3.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.073 -1.484 . . . . 0.0 108.31 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -47.55 -40.73 19.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.551 0.74 . . . . 0.0 112.602 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -55.87 -47.06 78.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -89.68 -21.75 22.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.11 -43.6 94.82 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -70.79 -38.8 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.502 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.3 mt -110.77 87.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.523 0.678 . . . . 0.0 112.381 -172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t 174.26 145.92 0.21 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.1 -25.12 77.09 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 116.876 1.837 . . . . 0.0 116.876 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -125.96 -14.09 6.17 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.07 -9.42 67.82 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-O 122.335 0.964 . . . . 0.0 111.642 -168.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -155.47 88.75 1.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.12 0.968 . . . . 0.0 110.534 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -143.37 150.35 51.25 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -67.09 98.51 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 115.913 -2.258 . . . . 0.0 113.145 162.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.6 t -91.55 137.72 21.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.455 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.58 113.47 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.77 126.32 33.92 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 t0 50.42 56.46 7.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.781 0.801 . . . . 0.0 112.821 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 65.5 24.31 11.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -124.97 144.13 50.53 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -123.71 132.38 53.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 118.817 0.735 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.07 134.03 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.52 -22.16 0.33 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.2 138.97 58.72 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -62.98 -29.16 70.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -165.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -85.9 -7.3 58.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.61 -10.6 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.2 -0.938 . . . . 0.0 110.16 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.07 -36.28 76.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.58 -39.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.37 -73.51 1.16 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 120.371 2.909 . . . . 0.0 120.371 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.57 -38.14 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.687 -0.89 . . . . 0.0 111.986 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.57 -41.84 95.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.795 0.725 . . . . 0.0 109.638 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.58 -34.33 73.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.39 -35.39 75.74 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.006 -1.059 . . . . 0.0 111.108 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.01 7.51 45.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.38 137.19 97.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.73 -29.11 82.92 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 117.134 -1.444 . . . . 0.0 115.299 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -81.09 169.26 19.94 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 109.811 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -57.42 134.33 62.9 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 116.811 -1.659 . . . . 0.0 116.021 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.6 135.45 3.0 Favored 'Trans proline' 0 C--O 1.247 0.962 0 N-CA-C 118.3 2.385 . . . . 0.0 118.3 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.3 mt -135.37 43.5 2.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.81 82.01 2.74 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.484 -1.385 . . . . 0.0 111.611 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -118.65 94.83 48.22 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.569 1.148 . . . . 0.0 113.775 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -106.15 59.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.905 0 N-CA-C 122.248 3.903 . . . . 0.0 122.248 -174.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -82.25 -126.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.691 0.928 . . . . 0.0 114.049 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -57.29 -32.23 66.43 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 120.982 -1.074 . . . . 0.0 112.677 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.16 -32.79 74.44 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.146 -0.972 . . . . 0.0 111.847 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.52 -33.19 60.71 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.612 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.1 p -71.27 -34.6 70.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.96 -45.42 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 123.024 0.202 . . . . 0.0 110.516 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.94 87.38 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.377 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -73.51 -0.4 14.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -94.14 -33.93 13.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 167.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.7 mt -82.26 -39.52 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.68 0.753 . . . . 0.0 110.416 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 19.9 t80 -51.64 -50.41 77.38 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.69 -33.75 12.56 Favored 'Trans proline' 0 C--N 1.347 0.478 1 C-N-CA 111.648 -5.101 . . . . 0.0 114.543 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -72.5 -39.77 67.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.253 0.479 . . . . 0.0 111.104 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 1.9 p90 -68.8 -30.0 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.908 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.54 -47.81 62.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -61.98 -44.12 97.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -75.28 -37.14 61.04 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.428 -174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -34.3 78.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.85 0.833 . . . . 0.0 110.579 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -76.65 0.05 21.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.124 0.97 . . . . 0.0 112.108 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -121.05 114.31 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -87.39 49.55 1.83 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.566 1.651 . . . . 0.0 110.309 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -88.51 170.47 11.18 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.62 50.31 2.67 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 CA-C-N 120.174 1.098 . . . . 0.0 114.938 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.04 100.39 4.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.897 1.279 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.9 -45.96 0.86 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 -38.09 93.67 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 166.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.0 m -69.57 -30.65 68.49 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.767 -0.843 . . . . 0.0 111.981 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.66 -28.88 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.709 -1.87 . . . . 0.0 110.04 172.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -75.7 -10.39 59.39 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.372 -1.455 . . . . 0.0 111.625 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.03 60.31 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 119.814 -1.804 . . . . 0.0 108.126 168.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.79 -34.92 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.549 -0.719 . . . . 0.0 111.164 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.2 -44.8 79.83 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -67.53 -26.44 66.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -77.47 -35.93 53.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 120.615 -1.303 . . . . 0.0 109.679 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.3 -20.55 60.08 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.728 -0.608 . . . . 0.0 109.52 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.92 -30.09 69.33 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.463 -0.773 . . . . 0.0 111.395 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.61 -42.09 87.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.02 -43.97 93.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.681 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.75 -35.94 77.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.91 -50.98 55.47 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.822 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.54 -36.03 81.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.879 -1.365 . . . . 0.0 110.489 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.22 -43.01 99.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -74.43 -27.81 60.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.24 -44.43 77.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.44 -54.21 5.39 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.74 -63.45 0.46 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-O 117.183 -1.899 . . . . 0.0 116.761 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.24 -162.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 1 C-N-CA 127.98 5.787 . . . . 0.0 118.565 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -55.9 175.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.67 163.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -54.25 -33.19 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.88 58.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.82 89.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 118.395 -1.225 . . . . 0.0 116.141 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -136.53 -52.54 0.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.729 1.764 . . . . 0.0 112.978 165.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -162.73 -177.56 5.62 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 117.635 -1.174 . . . . 0.0 109.96 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.07 118.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.881 1.218 . . . . 0.0 110.347 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.6 m -132.64 177.23 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.23 37.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.63 -18.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.972 -1.08 . . . . 0.0 111.711 173.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.22 -38.04 31.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -28.91 69.63 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 120.719 0.295 . . . . 0.0 110.649 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 93.9 p -77.68 -35.32 52.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.49 -46.81 3.92 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.05 81.41 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.11 -27.89 19.63 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.776 -4.349 . . . . 0.0 114.371 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.88 -29.89 63.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.02 -24.49 64.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.15 -50.35 61.52 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.007 -1.058 . . . . 0.0 110.334 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -55.45 -42.33 74.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.496 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.6 tp -57.35 -61.99 2.09 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.745 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -67.93 -32.85 73.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -170.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 -43.08 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.134 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.84 -42.15 34.55 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.086 -1.009 . . . . 0.0 112.494 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.68 -38.61 91.76 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.9 81.13 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.089 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.45 -48.86 11.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.49 -1.006 . . . . 0.0 112.968 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -86.72 -43.5 12.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -134.87 59.5 1.73 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.9 0.88 . . . . 0.0 108.766 -171.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -49.97 104.51 0.07 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -154.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -147.82 98.96 3.8 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.241 1.817 . . . . 0.0 106.222 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.41 172.06 17.05 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 115.652 -2.432 . . . . 0.0 109.728 167.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.41 118.08 56.15 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -82.19 167.04 16.09 Favored 'Trans proline' 0 C--N 1.352 0.728 0 N-CA-C 114.975 1.106 . . . . 0.0 114.975 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.92 4.2 5.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -69.6 -23.28 63.5 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.33 60.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -66.64 -19.86 65.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.637 -0.664 . . . . 0.0 112.565 -170.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.7 -33.51 40.98 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.22 -37.22 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.767 0.794 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.45 -47.77 84.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.447 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -65.24 -40.38 93.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -55.56 -53.46 56.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.194 0.521 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.43 -25.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.655 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -66.26 -42.36 88.61 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.745 -1.222 . . . . 0.0 111.6 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -41.57 99.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.07 -37.46 85.88 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 123.607 0.567 . . . . 0.0 111.918 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.15 -25.95 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t -122.13 39.56 3.86 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -103.85 136.5 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.93 -44.43 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -59.61 -47.24 86.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.961 0.886 . . . . 0.0 111.962 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -71.93 -43.46 65.26 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.14 -33.08 73.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -75.78 -42.3 50.57 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.027 -1.045 . . . . 0.0 113.094 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.2 p -88.4 -3.23 58.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -57.09 138.92 53.84 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.47 153.4 41.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.98 130.96 40.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.69 -36.97 82.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 -170.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.57 -21.26 62.7 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.505 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -97.29 -14.35 21.39 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.95 -52.34 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.61 -54.54 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.229 -0.294 . . . . 0.0 111.599 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.54 -2.34 35.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 112.654 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.18 -16.97 44.95 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.739 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -106.56 -48.99 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.15 0.976 . . . . 0.0 112.146 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.09 -26.28 2.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 C--N 1.357 0.981 1 C-N-CA 112.316 -4.656 . . . . 0.0 115.501 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.48 131.9 47.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -125.77 95.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -166.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.0 m -98.01 116.91 31.2 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.21 165.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.37 133.4 47.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.556 -0.715 . . . . 0.0 112.127 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.14 165.11 24.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.701 0.4 . . . . 0.0 110.95 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 144.28 56.69 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.906 -0.497 . . . . 0.0 110.268 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.89 124.34 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.67 -13.4 52.78 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.97 89.08 12.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -171.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -69.27 76.26 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-O 123.395 1.331 . . . . 0.0 113.241 162.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -149.75 -38.38 0.15 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.887 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -135.51 153.05 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.08 152.13 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.126 0.965 . . . . 0.0 112.761 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.09 -174.57 17.67 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 202' ' ' VAL . 20.7 t70 -77.61 112.32 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.253 -1.473 . . . . 0.0 112.432 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 146.77 34.42 Favored Pre-proline 0 C--O 1.245 0.848 1 N-CA-C 97.633 -4.951 . . . . 0.0 97.633 159.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -59.26 -35.24 97.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 CA-C-O 122.65 1.021 . . . . 0.0 113.514 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.82 -0.65 53.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.689 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 t -57.41 -42.57 82.53 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.973 0.892 . . . . 0.0 110.844 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -92.41 0.29 57.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -63.67 -44.46 93.67 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.955 1.252 . . . . 0.0 109.109 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.726 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.97 -40.73 98.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.01 -38.82 92.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.181 0.9 . . . . 0.0 110.427 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 m -62.91 -40.28 97.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.064 -176.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.7 mt -69.76 -43.47 72.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.714 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.61 -32.11 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -164.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -78.2 -33.37 50.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.266 -1.373 . . . . 0.0 110.485 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.03 -14.92 58.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.111 -0.368 . . . . 0.0 111.08 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 55.82 33.16 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.745 1.618 . . . . 0.0 113.162 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.83 154.76 87.05 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.26 150.4 41.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 115.681 -2.413 . . . . 0.0 113.275 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -154.62 172.21 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -126.64 94.2 3.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.645 1.178 . . . . 0.0 108.648 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -75.87 139.69 41.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.447 . . . . 0.0 110.769 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.35 144.34 44.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.47 126.05 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -83.2 122.07 36.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -79.46 70.09 5.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt 53.47 50.69 16.8 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 161.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.36 8.66 65.97 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 114.081 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.99 106.55 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 151.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -137.84 86.42 18.27 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -62.32 173.17 3.55 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 118.007 -0.862 . . . . 0.0 110.837 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -53.01 -37.45 61.51 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -53.63 -53.13 56.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -73.85 -29.39 62.1 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 120.803 -1.185 . . . . 0.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.74 -35.65 81.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 119.274 0.943 . . . . 0.0 110.881 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.81 -20.49 61.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.92 -37.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.836 0.827 . . . . 0.0 111.301 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 t -119.71 120.93 30.19 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 109.872 -170.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.71 -29.6 88.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -97.76 2.11 49.17 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.45 -29.5 2.57 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.038 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.16 72.81 1.4 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.857 1.313 . . . . 0.0 113.181 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.43 155.19 52.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 162.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.81 142.19 56.75 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 114.685 -3.077 . . . . 0.0 110.148 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.67 164.0 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 113.33 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -100.73 88.54 3.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mt -88.46 104.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.48 52.55 13.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.883 0.849 . . . . 0.0 111.377 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t0 60.7 30.61 19.82 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -133.14 151.19 52.0 Favored 'General case' 0 C--N 1.323 -0.573 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 173.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -145.45 150.41 36.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 122.471 2.396 . . . . 0.0 116.741 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.75 150.32 32.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.487 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.46 -12.27 1.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 118.097 2.629 . . . . 0.0 118.097 -169.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -68.49 142.94 55.16 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.047 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -60.56 -27.39 67.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -82.95 -35.45 25.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.223 -0.923 . . . . 0.0 111.088 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -83.67 -14.7 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.293 -0.879 . . . . 0.0 112.29 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 pt -70.85 -6.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.665 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.74 -52.7 8.37 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 157.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.55 -47.06 92.18 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 118.819 2.288 . . . . 0.0 118.819 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -82.57 -27.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -60.69 -44.56 96.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.325 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -65.18 -41.56 94.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 118.414 0.552 . . . . 0.0 110.796 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -58.7 -35.99 73.51 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.839 -1.163 . . . . 0.0 112.301 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.15 17.13 23.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.903 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.07 131.7 80.77 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.05 -12.38 30.34 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 114.586 -3.143 . . . . 0.0 115.024 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -114.78 149.57 42.6 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 118.901 0.773 . . . . 0.0 109.864 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.26 121.78 9.94 Favored 'Trans proline' 0 C--O 1.24 0.59 0 N-CA-C 116.46 1.677 . . . . 0.0 116.46 -148.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.32 161.33 20.01 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.4 mt -139.96 64.95 1.44 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.424 1.107 . . . . 0.0 110.531 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.76 63.13 6.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.517 -0.74 . . . . 0.0 111.815 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 104.25 50.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.89 54.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 124.571 3.514 . . . . 0.0 120.752 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.24 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 116.724 -1.717 . . . . 0.0 115.086 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -34.36 72.49 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.011 -1.681 . . . . 0.0 114.21 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -32.12 73.66 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.729 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 -24.96 55.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.6 p -71.93 -37.19 70.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.41 -49.27 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.61 97.0 Favored Glycine 0 CA--C 1.516 0.149 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.413 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -75.9 -10.0 59.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -78.54 -38.48 40.36 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.78 -1.2 . . . . 0.0 109.901 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.23 -48.15 50.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.689 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -51.28 -53.44 49.19 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -170.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.07 -22.67 16.76 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 114.214 -3.391 . . . . 0.0 114.517 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.6 m -67.33 -38.98 85.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -86.38 -23.94 25.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.67 -33.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -63.76 -45.13 91.17 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.606 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -62.74 -38.16 89.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.5 tp -66.94 -46.32 75.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.297 0.953 . . . . 0.0 111.043 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -69.33 -21.68 63.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.488 0.661 . . . . 0.0 111.619 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.7 t -90.38 138.27 31.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -128.08 30.68 5.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.35 171.53 4.04 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -71.93 59.2 2.85 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 120.711 1.29 . . . . 0.0 114.492 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -60.29 122.19 13.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.109 1.764 . . . . 0.0 112.877 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -152.8 -42.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.235 0.541 . . . . 0.0 109.715 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.64 96.48 Favored Glycine 0 C--O 1.22 -0.745 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.8 p -73.62 -17.63 61.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.392 -1.063 . . . . 0.0 113.062 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.59 -39.24 53.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.833 1.301 . . . . 0.0 107.61 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -79.1 -14.22 59.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.663 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.08 80.23 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.671 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.27 -42.45 93.21 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.98 -43.23 95.24 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.006 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -70.7 -42.15 71.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.73 -33.52 68.79 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 120.146 -1.596 . . . . 0.0 108.983 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.27 -16.43 59.0 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 121.437 -0.789 . . . . 0.0 110.656 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -70.8 -33.52 70.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 119.992 1.269 . . . . 0.0 109.61 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 -39.45 89.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.38 -43.8 93.34 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.173 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.41 -39.07 89.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.538 0.735 . . . . 0.0 110.225 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.4 -51.67 50.4 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -61.35 -38.62 87.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.851 -0.794 . . . . 0.0 112.401 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.81 -39.47 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.537 -0.727 . . . . 0.0 110.717 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -72.66 -24.86 61.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.729 1.604 . . . . 0.0 114.48 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.71 -11.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -118.11 -43.73 2.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.12 -76.32 0.23 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.466 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -67.88 -169.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.063 3.175 . . . . 0.0 117.656 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -53.86 168.66 0.19 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.788 1.635 . . . . 0.0 113.962 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -63.2 -21.79 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -151.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.5 -11.63 53.42 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.186 -0.946 . . . . 0.0 113.338 173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.51 0.48 72.87 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -143.74 -49.54 0.3 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -162.32 176.07 10.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.64 125.79 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.9 p -130.72 -172.3 2.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.64 -31.45 25.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.46 -42.97 81.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 118.784 0.72 . . . . 0.0 110.131 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -66.86 -39.02 87.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.61 -21.53 66.58 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.4 m -91.01 -36.07 14.28 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.98 -49.32 7.43 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.6 48.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.18 -31.34 45.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 113.459 -3.894 . . . . 0.0 113.958 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -30.61 42.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.93 -34.55 76.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.032 0.833 . . . . 0.0 113.19 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -61.9 -43.6 98.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.985 1.266 . . . . 0.0 109.907 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -73.56 -28.54 61.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.146 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.7 -52.24 64.07 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.98 -33.23 75.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.025 -172.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.1 t -72.38 -61.87 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.463 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.28 66.77 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 111.293 -168.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.57 -42.94 77.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.54 -34.47 89.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.874 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -95.06 -16.03 22.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -108.69 -39.9 5.23 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -142.22 58.09 1.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -54.65 116.82 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -134.64 98.44 13.5 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 164.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.41 164.59 32.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 115.124 -2.784 . . . . 0.0 109.29 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.32 117.16 54.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 171.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.68 168.69 24.15 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 117.428 -1.248 . . . . 0.0 112.575 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -4.95 41.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.492 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -66.68 -22.12 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.123 -0.986 . . . . 0.0 110.181 168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.52 50.75 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -56.75 -29.05 62.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.64 -32.6 41.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.578 -1.326 . . . . 0.0 110.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.88 -37.92 70.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.87 -43.79 91.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.072 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -64.7 -38.49 91.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 112.361 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.79 -47.83 84.1 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.949 -0.47 . . . . 0.0 111.764 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.16 -27.34 26.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 O-C-N 120.999 -1.063 . . . . 0.0 111.096 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.97 -33.55 74.86 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.649 -1.282 . . . . 0.0 111.977 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.86 -31.53 71.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.67 0.668 . . . . 0.0 110.229 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.82 -5.77 51.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.384 0.611 . . . . 0.0 112.18 174.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -101.61 9.44 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.0 t -112.11 165.71 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 61.44 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.27 -27.82 69.3 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.138 -0.976 . . . . 0.0 112.341 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 m -56.06 -40.71 73.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -96.56 -50.69 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.496 0.665 . . . . 0.0 109.605 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.87 -43.97 90.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -76.06 -30.53 58.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 52.5 p -75.17 -12.4 60.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.646 -0.659 . . . . 0.0 112.532 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -58.05 132.36 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.47 0.652 . . . . 0.0 110.777 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.04 154.59 39.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.817 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.57 117.28 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.549 1.155 . . . . 0.0 111.188 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.44 -35.52 73.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.3 -37.42 87.1 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.775 -1.203 . . . . 0.0 107.853 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -75.83 -3.97 38.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.533 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 58.5 t -86.32 -46.51 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.6 -52.28 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.348 1.07 . . . . 0.0 108.17 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.21 27.66 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.138 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -112.71 -46.41 0.73 Allowed Glycine 0 N--CA 1.454 -0.12 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 167.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -53.68 7.45 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -84.61 -1.48 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 120.751 3.612 . . . . 0.0 120.751 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--N 1.358 1.053 1 C-N-CA 111.398 -5.268 . . . . 0.0 112.687 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.237 0.437 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.74 142.13 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.1 mt -134.09 158.56 42.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -171.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -148.43 113.95 5.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.5 164.92 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -52.85 129.42 30.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.1 0.864 . . . . 0.0 112.168 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -79.02 168.97 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.434 0.635 . . . . 0.0 109.665 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' ' CG ' ' A' ' 201' ' ' HIS . . . -62.4 134.32 56.29 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.08 120.8 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.91 4.93 86.74 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.402 -173.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 88.81 4.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.84 36.06 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.052 1.835 . . . . 0.0 115.323 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -108.91 -19.71 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -151.87 162.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -73.88 165.29 25.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.191 0.596 . . . . 0.0 111.939 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.76 170.01 27.8 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -75.06 104.13 5.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -115.91 161.34 31.31 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 147.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -65.5 -17.72 58.02 Favored 'Trans proline' 0 C--N 1.348 0.519 0 N-CA-C 116.881 1.839 . . . . 0.0 116.881 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -117.76 7.82 12.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.4 -44.21 92.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.9 0.857 . . . . 0.0 111.985 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -80.26 -13.94 58.8 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.786 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -61.46 -43.74 98.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.956 2.162 . . . . 0.0 112.842 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -66.41 -46.67 86.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.6 mt -66.24 -39.22 89.39 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.541 -0.725 . . . . 0.0 112.174 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -43.62 95.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.93 -0.481 . . . . 0.0 110.29 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 p -69.18 -38.59 78.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.442 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -46.29 80.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.94 -27.33 36.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.692 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -66.79 -39.64 87.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.473 -1.392 . . . . 0.0 109.381 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -83.83 4.49 28.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.659 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.4 pttm 44.07 47.04 7.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.028 2.131 . . . . 0.0 115.62 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.87 149.9 36.2 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.35 158.44 36.88 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 117.601 -1.133 . . . . 0.0 114.05 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.81 162.13 41.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -144.3 140.91 29.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 t 68.96 123.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 126.227 2.204 . . . . 0.0 111.533 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -141.06 19.04 2.28 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.78 148.99 43.24 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.326 3.084 . . . . 0.0 119.326 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 45' ' ' GLY . 35.4 mm -131.03 108.58 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.443 1.897 . . . . 0.0 106.774 162.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.98 93.25 8.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.286 -1.509 . . . . 0.0 114.201 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt 47.33 48.23 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.518 1.127 . . . . 0.0 112.674 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 76.03 35.01 45.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.664 -175.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -64.13 107.4 1.27 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 152.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -145.01 79.12 12.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.472 0.653 . . . . 0.0 112.733 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.89 172.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 115.055 -2.83 . . . . 0.0 110.7 165.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.48 -30.58 60.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.236 -0.29 . . . . 0.0 111.571 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -56.16 -51.66 67.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.32 -25.56 59.63 Favored 'General case' 0 C--O 1.218 -0.581 0 O-C-N 120.646 -1.284 . . . . 0.0 111.194 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.13 -25.49 64.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 119.22 0.918 . . . . 0.0 112.081 172.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.79 -29.33 61.06 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.492 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.67 -50.64 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 112.281 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -94.72 118.24 66.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 121.175 -0.953 . . . . 0.0 108.635 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.85 -21.38 38.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 N-CA-C 116.337 1.63 . . . . 0.0 116.337 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -93.69 -14.66 26.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.881 0.848 . . . . 0.0 110.839 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.79 -0.49 61.51 Favored Glycine 0 C--O 1.224 -0.471 0 O-C-N 121.78 -0.575 . . . . 0.0 113.212 -166.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -151.84 32.72 0.55 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.43 144.14 48.44 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.83 149.24 72.47 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 116.188 -2.075 . . . . 0.0 114.058 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.32 168.07 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.14 133.2 67.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 101.813 -3.402 . . . . 0.0 101.813 158.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -117.37 121.32 40.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 163.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -131.41 123.38 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 t70 55.88 35.13 24.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.593 1.187 . . . . 0.0 111.077 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.78 23.04 12.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.457 1.903 . . . . 0.0 115.788 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -121.09 140.73 51.56 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -115.77 153.93 30.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.97 148.13 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -152.03 38.61 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -112.31 149.41 32.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.6 p -58.47 -28.47 65.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.56 -37.77 15.43 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.575 0.584 . . . . 0.0 112.575 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 m -75.98 -17.81 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.914 -1.116 . . . . 0.0 112.722 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.91 -8.0 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.231 -0.293 . . . . 0.0 111.376 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.9 t -105.39 -51.44 8.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 160.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.22 91.95 Favored Glycine 0 C--O 1.228 -0.279 0 N-CA-C 117.941 1.936 . . . . 0.0 117.941 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.6 mt -77.52 -31.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.57 -43.99 96.69 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.481 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.41 -46.99 87.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.793 0.724 . . . . 0.0 109.835 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -66.19 -17.98 65.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -106.78 -5.61 18.32 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.029 0.532 . . . . 0.0 112.295 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -70.04 138.55 87.43 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -30.63 82.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.49 157.96 74.33 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 120.201 1.364 . . . . 0.0 107.949 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.77 141.12 93.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.013 -2.191 . . . . 0.0 114.792 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.56 151.39 52.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 116.919 -1.587 . . . . 0.0 111.415 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.5 mt -130.93 49.99 2.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 63.32 6.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.498 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.5 99.79 45.55 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.14 46.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 N-CA-C 121.231 3.512 . . . . 0.0 121.231 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -78.42 -124.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.225 0 CA-C-N 121.194 1.462 . . . . 0.0 114.237 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.34 -25.35 65.76 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.752 -1.843 . . . . 0.0 113.095 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.68 -42.52 99.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.541 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.45 -34.87 41.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.384 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.5 p -65.34 -34.56 78.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.098 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.56 -43.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.041 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.58 -37.18 93.77 Favored Glycine 0 CA--C 1.52 0.355 0 O-C-N 120.684 -1.26 . . . . 0.0 115.265 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 p -72.2 -15.37 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -77.61 -35.06 53.14 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.468 1.128 . . . . 0.0 110.13 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -77.73 -42.19 28.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.933 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -49.32 -52.68 46.89 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.75 -21.75 12.43 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 114.157 -3.429 . . . . 0.0 114.858 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.9 m -68.22 -43.59 77.66 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.576 -0.702 . . . . 0.0 111.619 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -78.0 -27.7 49.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 118.383 -1.327 . . . . 0.0 113.349 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.09 -29.24 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.15 -40.54 94.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.21 -36.28 81.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.616 -0.677 . . . . 0.0 111.226 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.51 -37.4 85.89 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.296 -0.253 . . . . 0.0 111.53 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -75.83 -27.91 58.07 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.238 -0.914 . . . . 0.0 113.458 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -61.32 137.35 58.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -128.6 29.7 5.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.21 172.53 9.51 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.39 106.17 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 114.234 -3.377 . . . . 0.0 109.939 149.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -125.69 26.57 6.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.44 -36.41 76.6 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.61 -41.06 97.97 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -24.58 59.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.253 1.527 . . . . 0.0 113.176 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.08 -42.05 94.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.229 1.014 . . . . 0.0 108.675 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -76.95 -16.16 59.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.193 -0.942 . . . . 0.0 112.21 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.39 -37.3 71.57 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.51 -41.09 96.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.395 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.25 -47.26 81.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.365 0.416 . . . . 0.0 110.043 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -67.56 -39.56 84.93 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.47 -42.32 95.97 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.097 -1.002 . . . . 0.0 109.871 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.46 -20.44 57.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.137 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.43 -35.28 80.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.535 0.607 . . . . 0.0 111.736 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.06 99.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.194 0.997 . . . . 0.0 109.725 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.14 -35.72 74.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.403 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.294 0.638 . . . . 0.0 112.462 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.66 -39.81 93.85 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.869 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.7 -32.62 72.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -48.43 35.74 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.285 -0.884 . . . . 0.0 110.113 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.01 -8.65 56.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -168.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.86 -10.56 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 167.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -117.45 -45.68 2.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.38 -67.88 0.23 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 119.981 2.753 . . . . 0.0 119.981 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -68.7 -169.33 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.665 2.733 . . . . 0.0 113.92 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -56.08 173.76 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.6 mt -56.83 -40.36 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 112.159 -154.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.86 10.63 2.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.12 -22.69 37.07 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.08 -40.88 0.59 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.06 170.54 21.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.78 123.11 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -128.44 171.77 11.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.85 -32.62 32.68 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.74 -41.64 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 121.641 -0.662 . . . . 0.0 111.437 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.52 -40.86 93.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.03 -21.19 63.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.316 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.2 m -85.6 -34.16 21.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -97.85 -46.25 6.01 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.18 -38.83 72.62 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.7 -31.0 33.59 Favored 'Trans proline' 0 C--N 1.352 0.748 1 C-N-CA 111.838 -4.975 . . . . 0.0 115.465 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -72.11 -30.78 65.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.095 -1.003 . . . . 0.0 108.957 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.9 -34.5 77.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.42 -47.03 83.64 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.174 -0.954 . . . . 0.0 109.063 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.93 -33.63 75.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.643 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.85 -52.72 64.22 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.84 -36.55 79.4 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -169.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.6 m -77.05 -35.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.14 -45.57 56.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.667 0.746 . . . . 0.0 110.304 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.44 -38.52 91.3 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.929 0.492 . . . . 0.0 109.754 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.87 -34.94 89.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.987 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.24 -49.65 11.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.347 0.573 . . . . 0.0 112.487 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -76.89 -47.44 21.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -148.19 66.0 1.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -165.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -54.73 112.67 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -163.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -141.83 91.88 8.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.04 155.74 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 115.286 -2.676 . . . . 0.0 109.473 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.91 123.58 89.65 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.65 154.8 63.98 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.557 -2.495 . . . . 0.0 112.247 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -75.22 2.7 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -71.22 -29.66 65.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.61 58.21 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -27.36 69.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.311 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -64.05 1.0 Allowed 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 167.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.74 -37.24 78.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -159.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.89 -50.93 71.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -76.19 -25.1 54.84 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.171 -0.956 . . . . 0.0 113.136 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.24 -49.47 71.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.548 0.689 . . . . 0.0 109.198 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.7 mt -62.61 -44.65 99.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.45 -48.34 81.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.7 -47.94 76.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 110.283 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.18 -19.26 58.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.25 -32.97 64.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 t -116.81 29.69 7.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.52 0.676 . . . . 0.0 110.573 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -67.82 144.43 55.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.58 -37.63 70.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.645 1.111 . . . . 0.0 110.869 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -58.08 -50.02 74.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -68.05 -40.51 82.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -56.69 -36.91 70.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.562 0.696 . . . . 0.0 110.901 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -82.67 -36.18 26.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 59.5 p -104.83 3.16 30.8 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -170.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.86 141.43 49.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.512 -0.743 . . . . 0.0 111.82 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.49 163.49 27.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.52 127.24 31.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -62.77 -36.24 82.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 111.899 -173.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -61.16 -30.13 70.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.741 0.781 . . . . 0.0 110.552 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.441 ' CG ' ' HB1' ' A' ' 10' ' ' ALA . 88.2 m-70 -96.44 -5.45 39.62 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.782 -0.574 . . . . 0.0 112.02 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.94 -50.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 162.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.87 -67.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.107 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.99 62.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.57 -1.331 . . . . 0.0 111.917 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.33 -30.55 10.7 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -99.27 -28.93 13.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.91 1.855 . . . . 0.0 111.184 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -73.96 -3.1 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo . . . . . 0 C--N 1.36 1.137 1 C-N-CA 109.306 -6.663 . . . . 0.0 114.281 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 103.439 -2.801 . . . . 0.0 103.439 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -132.79 162.39 31.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.35 155.42 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.7 m -115.75 118.37 32.86 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 101.703 -3.443 . . . . 0.0 101.703 164.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.64 159.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -71.92 122.25 20.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 162.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -75.06 165.37 25.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.58 130.43 46.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.152 0.977 . . . . 0.0 112.179 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.26 123.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -9.93 66.79 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.34 0.896 . . . . 0.0 115.34 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.29 87.38 13.71 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.471 1.136 . . . . 0.0 112.027 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.16 50.87 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.967 3.778 . . . . 0.0 117.01 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.11 -31.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -126.51 158.25 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.86 139.16 58.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.32 1.048 . . . . 0.0 109.522 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' CYS . . . -104.5 -157.92 23.75 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 120.188 2.835 . . . . 0.0 120.188 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.02 31.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.156 2.182 . . . . 0.0 113.803 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLY . 40.5 t -66.69 121.98 80.0 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.721 177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.88 -26.09 52.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 N-CA-C 117.06 1.908 . . . . 0.0 117.06 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.9 2.47 9.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 61' ' ' PRO . 68.2 m -64.59 -42.96 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.207 -0.933 . . . . 0.0 111.575 -174.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.16 -15.41 61.97 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.752 -1.179 . . . . 0.0 113.258 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.253 1.388 . . . . 0.0 110.675 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -44.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.29 -29.46 65.08 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 119.274 0.943 . . . . 0.0 112.684 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 p -76.56 -34.56 58.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.043 -1.036 . . . . 0.0 110.175 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.46 -39.47 85.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.114 0.959 . . . . 0.0 113.115 -175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -78.31 -27.19 47.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -67.54 -37.82 83.27 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.763 -1.21 . . . . 0.0 110.014 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -74.95 -17.85 60.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 54.73 36.57 26.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -78.0 165.15 52.79 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -54.41 139.18 74.33 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 119.495 0.855 . . . . 0.0 112.783 162.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.0 173.37 11.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 -143.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -110.21 118.43 36.32 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 112.772 -155.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -161.51 123.27 2.9 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 162.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -138.49 150.32 46.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 160.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 93.8 mt -108.15 120.55 42.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.182 0.446 . . . . 0.0 111.812 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.54 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -84.53 81.14 8.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.998 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 mt 52.63 31.07 9.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.52 79.42 1.46 Allowed Glycine 0 C--O 1.235 0.186 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -110.36 -74.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.814 0.816 . . . . 0.0 110.269 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.27 149.32 91.59 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.994 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.8 -167.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 116.768 1.795 . . . . 0.0 116.768 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -52.87 -22.4 5.44 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.62 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.595 1.089 . . . . 0.0 111.2 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.75 -34.93 64.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.533 -0.729 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.76 -27.24 62.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.44 -33.25 73.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.441 0.639 . . . . 0.0 110.771 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.8 mm -84.96 -48.51 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.404 0.621 . . . . 0.0 111.268 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -82.6 114.33 51.09 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 122.987 0.515 . . . . 0.0 111.4 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.46 -24.41 31.08 Favored 'Trans proline' 0 C--N 1.347 0.496 0 N-CA-C 117.294 1.998 . . . . 0.0 117.294 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -92.83 -7.47 46.28 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.82 -16.54 11.25 Favored Glycine 0 C--O 1.225 -0.434 0 O-C-N 121.705 -0.622 . . . . 0.0 112.683 -167.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -140.89 24.93 2.16 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.47 163.41 59.2 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 58.4 Cg_endo -67.19 142.93 62.76 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.148 -4.768 . . . . 0.0 112.352 161.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.1 t -128.84 132.97 67.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.67 122.45 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.43 1.109 . . . . 0.0 109.625 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -95.32 128.92 42.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.45 91.49 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.4 t0 51.16 51.39 17.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.289 1.042 . . . . 0.0 110.864 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t0 63.16 8.36 3.27 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.66 144.03 34.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 157.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -128.0 124.82 38.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 120.481 1.491 . . . . 0.0 109.167 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.43 156.99 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.94 96.58 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -154.65 153.92 32.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 101.815 -3.402 . . . . 0.0 101.815 167.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.9 p -61.96 -32.57 73.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -95.6 -14.36 23.61 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -81.36 -21.12 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.937 -1.727 . . . . 0.0 108.041 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -21.31 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.143 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -89.1 -48.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.62 -64.7 1.2 Allowed Glycine 0 CA--C 1.519 0.291 0 N-CA-C 120.389 2.915 . . . . 0.0 120.389 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.81 -34.16 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.651 0.739 . . . . 0.0 109.336 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.94 -47.21 87.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.089 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.25 -34.28 77.66 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.09 0.859 . . . . 0.0 112.107 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.46 -28.06 63.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.809 0.844 . . . . 0.0 110.407 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -120.2 21.55 11.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -100.82 76.22 0.14 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.442 0.697 . . . . 0.0 111.647 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.7 5.63 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.748 2 C-N-CA 125.757 4.305 . . . . 0.0 123.119 -131.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.88 172.48 8.9 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 158.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.61 135.42 70.34 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 114.988 -2.875 . . . . 0.0 116.904 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.54 116.8 4.81 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.477 1.451 . . . . 0.0 114.033 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.78 81.7 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.544 1.164 . . . . 0.0 113.528 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -118.27 73.72 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.969 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.19 114.62 63.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -106.7 61.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.64 0 N-CA-C 117.846 2.21 . . . . 0.0 117.846 168.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.95 -132.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 120.03 1.047 . . . . 0.0 112.715 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.06 -37.53 61.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -25.69 68.26 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 120.927 -1.108 . . . . 0.0 112.515 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.55 70.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.8 p -72.53 -33.67 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.68 -49.48 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.507 0.67 . . . . 0.0 109.244 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.64 94.64 Favored Glycine 0 C--O 1.228 -0.234 0 O-C-N 122.094 -0.379 . . . . 0.0 113.915 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.1 p -71.68 -12.37 61.3 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.99 -36.56 27.75 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.98 -1.075 . . . . 0.0 110.313 169.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.97 -46.6 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.353 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -50.0 -54.24 34.93 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -171.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.35 -19.85 12.98 Favored 'Trans proline' 0 C--N 1.349 0.601 1 C-N-CA 112.305 -4.664 . . . . 0.0 114.319 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -66.88 -47.16 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -73.32 -24.47 60.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.006 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.44 -38.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.91 -48.89 76.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.88 -43.92 94.48 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.77 -18.7 62.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.0 0.2 43.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.384 -0.197 . . . . 0.0 110.607 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 t -110.19 142.18 42.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.73 33.53 4.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.65 171.56 10.5 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.84 78.78 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 CA-C-N 120.642 1.265 . . . . 0.0 114.569 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -91.26 26.02 2.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -155.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.3 -35.42 80.3 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.683 -1.886 . . . . 0.0 112.263 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.39 -32.06 68.36 Favored Glycine 0 C--O 1.223 -0.562 0 O-C-N 121.463 -0.773 . . . . 0.0 112.966 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 m -77.98 -30.35 50.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.536 1.168 . . . . 0.0 111.398 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.0 -41.79 99.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.502 1.144 . . . . 0.0 108.351 171.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -73.75 -24.29 59.86 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.172 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.45 99.43 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 120.799 -1.188 . . . . 0.0 108.819 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.0 -44.41 96.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.13 -44.15 97.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -80.84 -30.65 35.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.65 -35.59 60.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.062 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.71 -17.45 57.61 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 120.96 -1.088 . . . . 0.0 109.837 173.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -69.55 -35.66 75.64 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.294 -1.504 . . . . 0.0 110.286 167.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.15 -45.53 93.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.11 -39.54 90.38 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -40.77 98.3 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.927 -1.108 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.95 -35.87 72.65 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.643 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -72.87 -36.84 67.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.483 -1.01 . . . . 0.0 112.631 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.24 -43.25 91.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 109.825 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.32 -19.49 63.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.979 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.68 -25.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.807 0.73 . . . . 0.0 111.095 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -112.46 -35.89 5.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.87 -71.16 0.22 Allowed Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.403 -1.776 . . . . 0.0 114.714 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.44 -160.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.799 4.333 . . . . 0.0 118.486 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -56.92 166.67 0.95 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.286 1.434 . . . . 0.0 112.159 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -52.46 -33.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.53 8.08 4.74 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.97 -33.81 5.49 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.07 -40.22 2.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.747 1.273 . . . . 0.0 112.331 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.41 -178.52 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.977 0.511 . . . . 0.0 110.249 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.8 mt -67.42 121.34 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 m -153.29 171.25 18.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -25.57 -54.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.969 1 N-CA-C 122.677 4.325 . . . . 0.0 122.677 -173.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.17 -35.34 75.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.015 -1.053 . . . . 0.0 110.483 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.32 -43.43 73.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.23 -32.56 73.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.596 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.2 m -71.13 -38.65 72.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.1 tp -100.32 -45.69 5.51 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -170.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.41 -43.13 97.38 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.12 -20.79 24.62 Favored 'Trans proline' 0 C--N 1.35 0.614 1 C-N-CA 111.296 -5.336 . . . . 0.0 114.782 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -78.29 -22.35 48.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 120.931 -1.106 . . . . 0.0 110.556 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 -27.01 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 118.435 0.561 . . . . 0.0 111.092 169.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.7 -44.53 64.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.157 -0.965 . . . . 0.0 110.263 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -62.67 -30.27 71.26 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.875 -0.515 . . . . 0.0 111.211 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.92 -58.36 8.9 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.25 -31.65 72.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.273 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.86 -54.88 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.758 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.86 -41.19 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.1 tp -67.77 -37.82 82.61 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.01 -32.88 81.86 Favored Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -74.95 -48.38 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.39 -45.05 12.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -167.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -149.1 60.98 1.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -52.3 120.64 5.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -162.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -145.48 93.82 5.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 163.01 39.58 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 115.882 -2.279 . . . . 0.0 109.879 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.4 124.81 90.84 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.7 166.44 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 117.105 -1.464 . . . . 0.0 113.92 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.86 -0.14 20.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.436 1.112 . . . . 0.0 112.27 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.31 -14.37 61.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.25 51.95 1.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.9 t -62.77 -26.26 68.62 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.709 -0.62 . . . . 0.0 112.464 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.91 -35.25 62.22 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.696 -1.252 . . . . 0.0 108.066 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.2 -40.39 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 109.368 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.42 -44.66 90.51 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.969 -0.457 . . . . 0.0 111.491 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.52 -23.83 61.06 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.027 -1.046 . . . . 0.0 111.734 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.405 ' CZ ' HD11 ' A' ' 186' ' ' LEU . 17.3 t80 -68.96 -49.17 60.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.905 0.482 . . . . 0.0 110.31 173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.64 -33.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 120.906 -1.121 . . . . 0.0 111.372 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.02 -38.9 90.44 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.861 -1.149 . . . . 0.0 111.459 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.61 -42.69 86.48 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.69 -0.631 . . . . 0.0 111.835 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.405 HD11 ' CZ ' ' A' ' 182' ' ' TYR . 40.5 mt -66.18 -46.72 76.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -55.85 -42.43 75.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.9 t -106.32 71.25 0.87 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 111.037 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.58 153.41 43.74 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -57.33 -48.68 78.35 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.809 0.693 . . . . 0.0 110.699 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.0 t -65.58 -43.71 88.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.928 0.87 . . . . 0.0 112.28 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -65.25 -45.26 85.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.641 0.734 . . . . 0.0 110.626 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.98 -37.68 81.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.499 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -69.65 -36.49 76.12 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.0 -1.062 . . . . 0.0 111.984 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 64.2 p -87.93 -0.28 56.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -62.04 141.17 58.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.92 44.73 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.41 122.11 15.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.02 -48.6 73.33 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -166.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 200' ' ' GLU . 0.9 OUTLIER -64.68 -21.71 66.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -95.64 -1.59 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.58 -44.73 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 164.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.95 -55.08 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.15 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.8 5.45 9.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.509 -0.744 . . . . 0.0 112.819 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.71 -44.26 3.7 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 169.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -91.06 -38.37 12.83 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.34 -20.42 0.58 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.353 0.776 1 C-N-CA 111.761 -5.026 . . . . 0.0 115.372 167.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.517 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.36 139.79 43.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.84 114.36 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.8 m -109.86 130.84 55.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.08 139.82 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 123.991 0.807 . . . . 0.0 112.264 -164.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.48 128.5 36.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.087 0.403 . . . . 0.0 110.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.05 176.34 9.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.202 1.001 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . . . -61.39 148.51 41.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.858 1.313 . . . . 0.0 109.385 167.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.39 109.84 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.354 -170.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.97 23.48 66.4 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.665 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . . . -146.92 89.29 5.69 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.96 54.52 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.945 3.097 . . . . 0.0 114.245 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -141.43 -28.08 0.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 pt -141.45 168.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 118.445 0.566 . . . . 0.0 110.518 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.27 146.82 45.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.114 1.765 . . . . 0.0 112.748 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.74 -174.6 13.81 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -73.56 92.43 1.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.422 1.106 . . . . 0.0 111.355 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.77 135.72 22.42 Favored Pre-proline 0 C--O 1.246 0.883 1 N-CA-C 99.344 -4.317 . . . . 0.0 99.344 138.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -57.42 -39.62 87.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.21 0.754 . . . . 0.0 112.956 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.24 -23.29 43.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.054 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.53 -34.24 77.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.801 -1.187 . . . . 0.0 113.418 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -80.61 -12.74 59.46 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.565 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' A' ' 155' ' ' PRO . 89.0 mtt180 -69.0 -41.91 77.18 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -44.95 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mt -64.26 -39.37 93.82 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.748 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.52 -43.3 97.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.569 0.622 . . . . 0.0 111.385 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 p -70.17 -39.13 75.49 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.62 -43.91 88.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -76.24 -29.28 57.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.548 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -68.42 -34.32 75.8 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.528 -1.358 . . . . 0.0 111.401 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG3' HD21 ' A' ' 84' ' ' ASN . 33.9 mmtp -88.52 -11.46 45.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.47 51.97 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.352 1.461 . . . . 0.0 113.622 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.3 pt -98.8 155.1 37.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.05 145.16 30.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.837 -2.975 . . . . 0.0 111.314 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.54 157.95 41.81 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 121.993 -0.442 . . . . 0.0 110.756 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -110.78 110.51 21.17 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.662 0.385 . . . . 0.0 111.719 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -86.1 128.38 34.87 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.11 93.57 4.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.654 1.182 . . . . 0.0 111.437 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.67 142.91 57.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.889 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.05 94.2 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.5 85.07 5.99 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.495 -0.753 . . . . 0.0 112.039 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt 54.35 45.06 27.98 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.002 0.906 . . . . 0.0 113.164 166.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.72 94.36 1.85 Allowed Glycine 0 C--O 1.238 0.352 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.523 -168.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -124.59 -91.08 0.55 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -69.68 152.38 96.2 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.204 -170.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.97 -175.68 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.552 2.168 . . . . 0.0 115.282 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -64.19 -10.76 25.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -161.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -49.3 -41.04 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.741 0.416 . . . . 0.0 110.094 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -79.84 -28.69 40.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.2 -34.8 78.28 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.895 0.855 . . . . 0.0 110.507 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.89 -36.64 84.59 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 121.362 -0.837 . . . . 0.0 110.362 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.1 mt -75.62 -45.81 38.11 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 C-N-CA 124.038 0.935 . . . . 0.0 112.716 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.586 ' OG ' HG22 ' A' ' 60' ' ' VAL . 28.7 t -102.99 129.62 25.27 Favored Pre-proline 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 112.973 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.29 -23.16 28.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 116.655 -1.764 . . . . 0.0 116.39 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.72 -10.96 25.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.788 -1.195 . . . . 0.0 110.718 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 -5.93 67.5 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 121.561 -0.712 . . . . 0.0 113.8 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -144.89 34.43 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -167.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' OG ' ' A' ' 55' ' ' SER . 11.8 m -119.16 161.81 34.92 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.934 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.63 151.25 58.11 Favored 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 111.417 -5.255 . . . . 0.0 110.081 171.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.6 161.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.29 126.26 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.999 0.818 . . . . 0.0 109.375 160.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.05 87.64 3.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.06 111.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 47.76 56.15 7.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.132 0.895 . . . . 0.0 113.27 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 t70 71.4 -7.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.94 122.85 44.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.047 -1.033 . . . . 0.0 110.147 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -107.07 131.42 54.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.65 144.74 37.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-N 115.256 -0.883 . . . . 0.0 113.331 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.72 115.63 1.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.35 157.08 10.63 Favored 'General case' 0 N--CA 1.472 0.654 1 N-CA-C 96.959 -5.2 . . . . 0.0 96.959 160.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.9 p -57.44 -35.17 69.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.92 -41.17 60.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.059 -0.4 . . . . 0.0 111.907 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -81.64 -17.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.837 -0.539 . . . . 0.0 110.691 -171.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -23.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.63 -47.91 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.083 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.1 62.47 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.4 mt -80.47 -29.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.596 1.698 . . . . 0.0 106.629 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.28 -41.15 92.72 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.718 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.59 -39.75 80.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 112.798 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -60.47 -33.46 72.6 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.131 -0.981 . . . . 0.0 111.454 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.81 10.86 38.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.446 HD21 ' HG3' ' A' ' 33' ' ' LYS . 33.8 t-20 -69.54 130.99 90.13 Favored Pre-proline 0 C--O 1.247 0.927 0 O-C-N 121.606 -0.683 . . . . 0.0 109.195 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.41 -17.3 30.64 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.129 -1.448 . . . . 0.0 113.779 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.98 161.54 27.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -63.93 144.13 87.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 115.807 -2.329 . . . . 0.0 117.122 -169.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.23 136.52 7.85 Favored 'Trans proline' 0 C--O 1.24 0.584 0 N-CA-C 118.366 2.41 . . . . 0.0 118.366 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.26 41.36 3.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.329 1.052 . . . . 0.0 111.981 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.57 66.76 4.17 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.759 0.824 . . . . 0.0 112.016 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.11 106.08 28.52 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -100.7 75.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 125.158 3.905 . . . . 0.0 118.01 166.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -91.0 -140.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.474 1.449 . . . . 0.0 114.241 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.87 -37.12 29.65 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.05 -25.52 64.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.114 -0.991 . . . . 0.0 112.428 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.49 47.42 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.874 -0.516 . . . . 0.0 111.895 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.1 p -70.12 -32.81 71.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.71 -38.84 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.9 -39.41 93.98 Favored Glycine 0 C--O 1.227 -0.308 0 O-C-N 121.702 -0.624 . . . . 0.0 112.815 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.9 p -76.51 5.92 6.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.083 1.441 . . . . 0.0 114.45 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -104.29 -25.49 12.86 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.419 -0.801 . . . . 0.0 112.535 165.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.3 mt -85.92 -47.89 16.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.955 0.407 . . . . 0.0 111.098 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -50.37 -52.02 58.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.19 -20.97 10.94 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 114.307 -3.328 . . . . 0.0 115.861 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.1 p -79.73 -37.88 34.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -46.8 89.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.494 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.84 -26.7 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 121.39 -0.819 . . . . 0.0 112.318 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -65.45 -43.17 91.21 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.26 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.38 -23.37 63.73 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.3 tp -66.05 -38.83 89.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.774 0.715 . . . . 0.0 110.955 171.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -83.02 -31.27 27.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 t -74.0 131.24 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -114.64 30.61 7.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.298 1.047 . . . . 0.0 109.497 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.35 171.34 8.02 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.013 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.28 95.73 0.69 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 116.249 -2.034 . . . . 0.0 112.447 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -115.3 59.23 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.281 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -94.63 -45.18 7.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.64 -28.01 62.05 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.288 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 p -97.8 -5.1 35.55 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.6 -31.31 66.77 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 161.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -76.73 0.08 21.81 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.947 -1.096 . . . . 0.0 111.596 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.22 69.23 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.19 -35.42 79.6 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.473 -0.767 . . . . 0.0 109.942 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.2 -43.64 92.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.89 -28.77 64.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.18 -36.29 40.54 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.543 -1.348 . . . . 0.0 110.381 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.3 mt -74.37 -25.48 59.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.072 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.74 -34.29 72.76 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 118.55 0.613 . . . . 0.0 111.231 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.7 77.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.12 -36.2 82.53 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.751 0.705 . . . . 0.0 111.936 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.99 -42.12 89.28 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.12 0.568 . . . . 0.0 111.741 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.04 57.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.358 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -36.23 75.28 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.807 0.443 . . . . 0.0 111.521 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -54.09 18.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.678 -0.638 . . . . 0.0 109.937 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.6 -24.24 67.02 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.6 m -79.57 -11.35 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.61 -39.86 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.48 -68.17 0.27 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 121.267 3.267 . . . . 0.0 121.267 173.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -74.47 -171.42 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 N-CA-C 120.213 3.121 . . . . 0.0 120.213 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -49.73 154.03 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.028 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -67.2 -32.8 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.692 -124.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.15 -19.48 5.13 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.97 3.51 48.71 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-O 119.224 -0.765 . . . . 0.0 112.18 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -139.61 -62.25 0.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -163.24 178.9 7.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.89 114.05 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 124.143 0.902 . . . . 0.0 110.593 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -120.92 -169.93 1.92 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.5 29.31 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.71 -40.56 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.404 -1.435 . . . . 0.0 111.601 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.5 -39.9 94.65 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.3 -28.98 68.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -70.92 -37.22 72.9 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.084 -1.01 . . . . 0.0 111.719 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.12 -59.93 2.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.88 76.61 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 25' ' ' ARG . 89.8 Cg_endo -69.1 -24.33 32.82 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 113.842 -3.639 . . . . 0.0 115.996 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -88.02 -29.41 20.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.294 1.406 . . . . 0.0 108.902 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.85 -35.73 73.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.376 0.535 . . . . 0.0 110.54 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.46 -48.46 71.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -65.36 -40.88 94.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.43 76.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.819 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.67 -28.21 68.28 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.811 1.187 . . . . 0.0 112.888 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.1 m -81.01 -38.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 O-C-N 121.052 -1.03 . . . . 0.0 110.102 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.26 -49.5 19.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.145 0.429 . . . . 0.0 111.979 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.01 -35.41 80.61 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.06 -29.91 76.24 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 115.432 0.933 . . . . 0.0 115.432 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -89.7 -44.1 10.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.371 1.085 . . . . 0.0 113.057 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.17 -37.27 20.36 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -138.5 30.92 2.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.917 0.487 . . . . 0.0 112.277 -163.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -22.93 109.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -152.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -142.22 90.44 8.21 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.869 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.55 160.01 42.03 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 117.121 -1.453 . . . . 0.0 110.344 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.62 121.65 85.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.93 162.43 34.74 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 116.619 -1.788 . . . . 0.0 113.911 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -4.41 30.37 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.317 -0.864 . . . . 0.0 112.949 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -66.62 -22.91 66.11 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.478 0.656 . . . . 0.0 110.206 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.33 66.38 0.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 m -58.53 -36.57 74.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.361 -170.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -51.69 68.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.57 -41.58 80.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -161.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.23 -46.99 65.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.726 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.56 -45.73 89.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.092 -176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -72.6 -29.05 63.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.459 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.59 -40.96 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.857 1.208 . . . . 0.0 110.057 171.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.82 -33.75 74.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.553 -0.717 . . . . 0.0 112.721 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.9 -38.13 79.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.196 0.907 . . . . 0.0 110.869 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.5 -42.02 88.01 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.387 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -50.49 -38.79 46.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -173.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.3 t -120.79 38.55 4.01 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.727 1.251 . . . . 0.0 110.761 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -78.85 143.32 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 161.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -56.55 -45.37 81.28 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.58 1.082 . . . . 0.0 113.653 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -62.22 -44.78 95.81 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -77.07 -38.0 53.41 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.396 -0.815 . . . . 0.0 112.67 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -59.32 -36.46 75.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.045 0.926 . . . . 0.0 110.874 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.01 -40.95 44.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.9 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.7 p -98.47 -3.63 36.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -60.28 140.86 56.84 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.21 150.03 40.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.9 139.01 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -63.93 -39.27 93.79 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.75 -31.04 71.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.568 1.175 . . . . 0.0 109.698 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -96.16 10.19 38.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.526 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -100.85 -51.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.439 156.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.9 -66.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.07 -9.73 58.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.107 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.78 -31.37 29.74 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.442 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -110.6 -28.09 8.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.605 1.202 . . . . 0.0 112.975 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -74.46 -9.7 0.15 Allowed Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 121.618 3.932 . . . . 0.0 121.618 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.36 1.147 1 C-N-CA 111.354 -5.297 . . . . 0.0 114.639 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 tpp . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 140.77 37.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.04 1.291 . . . . 0.0 108.289 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.41 142.02 45.56 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.28 0.7 OUTLIER -171.27 -148.49 0.05 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.372 1.442 . . . . 0.0 109.937 160.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.33 143.96 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -133.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.9 m -126.15 110.98 14.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 101.845 -3.391 . . . . 0.0 101.845 171.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.3 167.24 26.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.76 139.56 44.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 170.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.81 156.34 19.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.03 127.17 30.25 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 164.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.03 119.54 13.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.22 75.39 Favored Glycine 0 C--O 1.25 1.102 0 N-CA-C 114.59 0.596 . . . . 0.0 114.59 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.01 76.79 8.63 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.745 -0.727 . . . . 0.0 111.605 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.9 53.7 2.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.623 2.882 . . . . 0.0 116.52 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -128.51 -37.59 1.79 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 121.483 -0.76 . . . . 0.0 112.13 173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 82.2 mt -95.92 142.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.38 152.39 17.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.25 176.16 48.38 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 -170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -81.44 31.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.551 -1.825 . . . . 0.0 115.573 -172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 17.7 t -96.01 145.75 30.11 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.632 -0.667 . . . . 0.0 112.38 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -68.33 -47.96 1.38 Allowed 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 117.028 -1.514 . . . . 0.0 115.191 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -19.93 60.49 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 121.824 -0.547 . . . . 0.0 110.208 -172.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.4 t -55.7 -55.59 30.45 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.656 0.597 . . . . 0.0 109.708 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.56 -15.14 59.93 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 96.0 mtt180 -61.43 -52.74 63.29 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.283 1.401 . . . . 0.0 109.782 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HG12 ' A' ' 76' ' ' ILE . 16.4 m -79.2 -31.84 14.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.691 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -62.13 -44.83 95.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.932 0.787 . . . . 0.0 110.444 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.3 tp -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.041 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -61.33 -36.33 79.84 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.396 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.2 -40.09 31.66 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.69 -0.631 . . . . 0.0 111.799 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -70.12 -31.25 68.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.32 0.509 . . . . 0.0 111.642 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.34 -34.6 77.66 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.917 -1.114 . . . . 0.0 110.761 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -82.29 -14.32 55.58 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.101 -0.999 . . . . 0.0 112.647 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 56.49 57.87 4.58 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.647 . . . . 0.0 112.918 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 pt -94.71 161.83 27.47 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.291 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.82 151.24 68.67 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 115.858 -2.295 . . . . 0.0 110.942 164.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -147.36 154.84 41.39 Favored 'General case' 0 C--O 1.248 1.025 0 N-CA-C 120.104 3.372 . . . . 0.0 120.104 -169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -100.07 -92.77 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -165.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 178.37 7.73 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -153.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -134.13 174.75 10.15 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.095 0.958 . . . . 0.0 113.524 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -43.54 152.32 0.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -94.98 117.92 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 166.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.04 72.28 10.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp 51.5 67.17 1.0 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 167.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.82 -2.41 84.29 Favored Glycine 0 C--O 1.228 -0.279 0 O-C-N 121.186 -0.946 . . . . 0.0 113.411 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -87.19 92.2 8.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -122.08 83.96 45.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 122.132 0.967 . . . . 0.0 113.078 -170.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -71.69 172.74 13.8 Favored 'Trans proline' 0 C--O 1.238 0.488 0 N-CA-C 110.33 -0.681 . . . . 0.0 110.33 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -55.69 -34.07 64.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.5 t90 -54.63 -53.04 59.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 118.716 0.689 . . . . 0.0 111.884 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -73.33 -29.14 62.47 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.644 -1.285 . . . . 0.0 112.671 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.45 -25.84 64.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.581 1.082 . . . . 0.0 111.855 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -74.34 -41.36 61.2 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.761 -0.587 . . . . 0.0 109.525 171.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.4 mt -74.01 -54.64 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -100.86 136.18 19.86 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.871 0.868 . . . . 0.0 111.971 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.59 -24.6 15.84 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 116.256 -2.029 . . . . 0.0 116.304 -169.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -104.97 -5.37 21.06 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.13 -5.21 51.12 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 122.798 1.221 . . . . 0.0 113.284 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -148.85 37.31 0.8 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.786 1.234 . . . . 0.0 111.629 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.85 136.21 28.47 Favored Pre-proline 0 N--CA 1.476 0.861 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -58.26 149.38 73.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 114.354 0.867 . . . . 0.0 114.354 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 m -136.14 169.76 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.92 141.81 18.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 156.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -103.27 93.65 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.25 96.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.078 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.9 t0 53.07 37.36 24.61 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.545 1.164 . . . . 0.0 112.125 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.9 t0 67.94 41.25 2.13 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 126.156 1.782 . . . . 0.0 115.661 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -131.16 153.02 49.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 102.183 -3.266 . . . . 0.0 102.183 167.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.63 126.46 20.77 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.37 149.58 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.12 81.77 1.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -151.28 152.59 33.43 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 168.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.2 p -55.3 -29.99 59.29 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -165.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -97.18 -35.52 10.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.286 0.565 . . . . 0.0 112.165 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.53 -37.48 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.604 0.716 . . . . 0.0 110.528 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG12 HG11 ' A' ' 26' ' ' VAL . 11.8 tt -60.17 -29.99 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.629 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.8 t -88.45 -49.57 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.493 0.717 . . . . 0.0 111.77 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.83 -34.12 71.48 Favored Glycine 0 C--O 1.235 0.213 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.936 -168.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.26 -30.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.52 -44.25 97.41 Favored 'General case' 0 C--O 1.222 -0.35 0 O-C-N 121.895 -0.503 . . . . 0.0 109.851 174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -62.87 -46.3 88.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.349 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.85 -37.17 85.79 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 121.479 -0.763 . . . . 0.0 112.33 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.59 7.32 46.67 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -81.61 129.23 66.44 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.14 -17.08 22.21 Favored 'Trans proline' 0 C--O 1.244 0.8 0 N-CA-C 116.023 1.509 . . . . 0.0 116.023 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.41 148.87 67.58 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -60.22 116.78 3.56 Favored 'Trans proline' 0 C--O 1.243 0.753 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.58 170.36 11.66 Favored 'Trans proline' 0 C--O 1.249 1.033 0 N-CA-C 115.114 1.159 . . . . 0.0 115.114 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 HG22 ' A' ' 147' ' ' THR . 12.5 tp -141.54 69.91 1.34 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 122.598 1.19 . . . . 0.0 110.005 173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.47 65.06 6.45 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.277 -1.328 . . . . 0.0 112.46 -175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 m -120.12 100.54 47.97 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -98.21 86.18 0.06 OUTLIER 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.512 3.475 . . . . 0.0 117.989 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -88.55 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.004 1 C-N-CA 127.23 5.286 . . . . 0.0 111.739 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -45.36 -34.8 3.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -62.52 -30.17 71.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 120.559 -1.338 . . . . 0.0 112.366 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.35 -28.64 34.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.053 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -72.06 -32.38 67.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.125 0.875 . . . . 0.0 109.638 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.44 -40.62 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 121.318 -0.864 . . . . 0.0 109.684 168.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.02 -30.84 70.99 Favored Glycine 0 CA--C 1.521 0.425 0 O-C-N 121.793 -0.567 . . . . 0.0 114.313 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 p -73.12 -9.49 58.77 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -80.76 -46.62 15.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 168.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt -75.63 -42.12 41.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.126 -1.397 . . . . 0.0 111.925 -167.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.13 -53.26 67.2 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.78 -18.99 21.55 Favored 'Trans proline' 0 C--N 1.351 0.704 1 C-N-CA 112.637 -4.442 . . . . 0.0 113.636 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.0 t -66.96 -56.55 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.015 0.526 . . . . 0.0 111.804 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -72.92 -23.97 60.76 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 118.432 -1.307 . . . . 0.0 111.79 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -68.23 -47.25 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -63.26 -44.39 95.28 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -69.79 -34.89 74.35 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.06 -34.45 76.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 119.195 0.907 . . . . 0.0 110.286 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.78 -24.89 61.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.631 0.772 . . . . 0.0 111.762 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.3 t -87.77 127.54 35.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -116.71 39.13 3.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -65.51 -175.31 0.18 Allowed Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 127.053 2.141 . . . . 0.0 109.68 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.08 41.26 0.33 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 114.675 0.99 . . . . 0.0 114.675 146.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -71.79 105.75 3.88 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.653 -1.279 . . . . 0.0 112.595 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.98 -54.12 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.4 -36.33 93.06 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.654 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.3 p -77.85 -21.92 50.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.383 0.592 . . . . 0.0 112.204 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.63 -35.75 75.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.659 1.695 . . . . 0.0 107.02 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -79.77 -3.69 48.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.72 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.48 -31.33 24.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.882 -1.136 . . . . 0.0 108.081 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 20.3 tp -66.55 -41.24 88.95 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.335 -0.853 . . . . 0.0 110.065 165.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.82 -36.53 72.37 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 121.91 -0.493 . . . . 0.0 110.925 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -64.0 -36.24 83.32 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -78.02 -33.71 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.3 -24.59 61.35 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 121.63 -0.668 . . . . 0.0 111.001 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.09 -33.06 71.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.579 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.08 -44.28 80.45 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.108 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.94 -34.55 78.22 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.397 1.094 . . . . 0.0 111.744 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.76 -38.66 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.26 -36.49 93.28 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 114.803 -1.09 . . . . 0.0 114.665 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -69.15 -46.22 68.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 118.864 1.332 . . . . 0.0 110.643 -176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 178' ' ' HIS . 5.8 tt -68.41 -38.39 81.22 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.558 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -68.74 -20.07 64.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.798 1.181 . . . . 0.0 112.851 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.3 t -81.73 -52.26 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 168.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.91 -31.84 40.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.557 2.429 . . . . 0.0 117.557 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.17 -81.95 0.3 Allowed Glycine 0 CA--C 1.521 0.448 0 CA-C-O 117.881 -1.511 . . . . 0.0 114.319 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -77.47 -174.25 2.13 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.214 3.276 . . . . 0.0 114.18 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -33.12 165.49 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 119.463 3.134 . . . . 0.0 119.463 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.02 -41.37 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 121.232 -0.918 . . . . 0.0 111.113 -152.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.75 -0.27 2.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.86 -17.94 47.92 Favored Glycine 0 N--CA 1.453 -0.17 0 N-CA-C 116.184 1.234 . . . . 0.0 116.184 166.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -138.15 -39.19 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.692 0.746 . . . . 0.0 112.559 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -160.95 176.84 10.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.19 114.11 3.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.409 HG22 HD23 ' A' ' 89' ' ' LEU . 27.2 p -123.12 -168.51 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.82 -24.94 10.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.19 -55.04 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.171 0.896 . . . . 0.0 109.614 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.46 -38.22 84.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.68 -18.93 65.63 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.799 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 97.0 p -86.24 -39.58 16.43 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.252 0.933 . . . . 0.0 111.957 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.83 -45.45 8.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -168.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.45 91.05 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 25' ' ' ARG . 76.7 Cg_exo -58.67 -35.51 98.54 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 115.988 -2.208 . . . . 0.0 116.548 177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -84.98 -22.78 29.0 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.754 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 39.4 mt -66.97 -28.61 68.41 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.145 -0.972 . . . . 0.0 112.697 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.55 -40.02 93.18 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.752 -1.217 . . . . 0.0 110.27 169.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -67.81 -34.56 76.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.731 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.418 HD11 HD22 ' A' ' 164' ' ' LEU . 44.5 tp -60.25 -53.06 62.22 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.169 0.44 . . . . 0.0 109.967 174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -68.5 -21.67 64.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.97 -41.19 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.965 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.62 -57.0 4.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.274 -0.891 . . . . 0.0 111.628 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.418 HD22 HD11 ' A' ' 160' ' ' LEU . 43.3 tp -64.73 -36.69 85.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.64 -33.29 76.66 Favored Glycine 0 C--O 1.237 0.322 0 CA-C-O 119.637 -0.535 . . . . 0.0 114.372 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -100.39 -42.74 6.49 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -47.43 24.36 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.198 0.908 . . . . 0.0 113.214 -175.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -136.43 64.17 1.56 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -47.95 114.61 0.95 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -163.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -144.33 93.14 5.95 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.34 158.96 47.7 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 116.724 -1.718 . . . . 0.0 111.127 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.6 mm -67.21 124.41 88.88 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.26 151.22 60.23 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 117.023 -1.518 . . . . 0.0 112.139 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -77.69 -0.88 28.44 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -72.64 -24.13 61.01 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 170.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.4 62.86 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.2 m -58.95 -35.99 74.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.153 -168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.544 ' CD2' HD13 ' A' ' 134' ' ' LEU . 1.0 OUTLIER -60.72 -55.88 27.91 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.88 -41.64 91.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -165.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 tp -67.33 -44.73 78.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.2 -45.1 89.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.05 -25.31 43.19 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 118.944 -1.103 . . . . 0.0 112.041 -177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 13.9 mt -64.71 -32.69 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.2 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -62.35 -39.17 92.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.327 0.584 . . . . 0.0 110.613 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -66.22 -43.68 85.99 Favored 'General case' 0 C--O 1.218 -0.602 0 O-C-N 121.926 -0.484 . . . . 0.0 110.405 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.73 -31.69 71.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 118.486 0.585 . . . . 0.0 111.788 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.25 -23.84 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.814 -1.179 . . . . 0.0 112.243 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t -147.29 66.33 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mtp85 -105.41 149.58 26.01 Favored 'General case' 0 CA--C 1.498 -1.034 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 161.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.54 -41.31 89.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.811 0.815 . . . . 0.0 110.4 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -63.8 -46.67 84.1 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -73.88 -40.82 62.93 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.429 -0.794 . . . . 0.0 111.038 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.36 -34.75 74.32 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.891 -0.506 . . . . 0.0 110.203 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -73.55 -38.74 65.13 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.123 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.0 p -90.49 2.17 55.97 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -63.18 145.19 56.03 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.205 -0.934 . . . . 0.0 111.619 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 166.46 23.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.51 43.86 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -65.34 -50.75 64.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.332 1.063 . . . . 0.0 108.264 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.36 -29.16 68.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.285 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.85 1.93 55.4 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.2 t -96.53 -45.0 12.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 160.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.7 mt -66.29 -53.1 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.917 -1.115 . . . . 0.0 112.15 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -102.14 23.31 11.8 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.46 -34.9 0.59 Allowed Glycine 0 C--O 1.226 -0.38 0 CA-C-N 114.612 -1.177 . . . . 0.0 114.272 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -97.05 -41.78 8.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.159 0.979 . . . . 0.0 112.785 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -73.35 -15.22 0.26 Allowed Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 119.412 3.116 . . . . 0.0 119.412 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -69.9 -23.24 30.36 Favored 'Trans proline' 0 C--N 1.359 1.129 1 C-N-CA 109.882 -6.279 . . . . 0.0 113.833 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -63.13 -38.6 91.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.385 0.993 . . . . 0.0 110.656 170.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.64 -32.22 48.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 123.634 0.774 . . . . 0.0 109.42 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.5 -54.25 6.09 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 CA-C-O 115.528 -2.177 . . . . 0.0 112.513 -176.451 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtp . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.63 -151.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.233 1.013 . . . . 0.0 110.015 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.32 164.68 15.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -136.0 158.39 44.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 160.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.36 126.39 75.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.1 t -128.99 109.09 10.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m -128.17 156.11 40.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.204 -167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.05 129.95 43.24 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.35 167.65 20.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.38 140.21 58.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.851 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.23 127.33 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.22 -4.14 86.35 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 117.131 1.612 . . . . 0.0 117.131 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.91 100.14 2.54 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 119.323 1.562 . . . . 0.0 113.699 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.38 0.69 6.43 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 N-CA-C 116.578 1.722 . . . . 0.0 116.578 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.95 -12.14 45.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.12 166.66 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.22 0.533 . . . . 0.0 112.055 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.1 tp -82.03 143.41 31.57 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.077 0.951 . . . . 0.0 111.483 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.26 -166.15 12.16 Favored Glycine 0 N--CA 1.46 0.282 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.17 127.15 30.14 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.473 1.137 . . . . 0.0 109.976 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.9 t -157.67 134.07 6.31 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.64 -43.09 41.27 Favored 'Trans proline' 0 C--N 1.345 0.35 0 N-CA-C 117.756 2.175 . . . . 0.0 117.756 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -119.93 2.87 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.03 -44.19 96.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.051 0.929 . . . . 0.0 112.016 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -72.89 -12.14 60.85 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.603 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.28 -39.13 85.98 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 120.773 -1.205 . . . . 0.0 109.544 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.71 -45.91 76.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 -39.83 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.763 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -59.6 -49.35 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 p -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.51 -171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.22 -25.98 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -69.24 -38.56 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.216 0.916 . . . . 0.0 109.595 169.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -65.7 -41.77 91.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.263 -0.898 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -75.77 -8.14 56.13 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 53.71 39.02 29.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.565 1.146 . . . . 0.0 113.93 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.57 157.07 39.05 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.66 137.17 22.18 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 114.987 -2.875 . . . . 0.0 113.399 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -150.98 161.26 43.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -105.68 132.95 51.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -84.27 123.83 30.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -118.85 145.08 45.97 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.94 135.49 55.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.95 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -76.88 61.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 52.48 52.48 14.06 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.703 1.201 . . . . 0.0 113.717 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 64.95 1.16 Allowed Glycine 0 C--O 1.228 -0.225 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -87.31 -77.51 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 -165.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -97.02 162.5 22.66 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -170.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.15 174.11 2.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 118.002 -0.865 . . . . 0.0 114.0 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 5.59 -55.53 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.866 1 N-CA-C 122.441 4.238 . . . . 0.0 122.441 171.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -50.57 -38.42 45.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 120.433 1.469 . . . . 0.0 112.312 174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.82 -20.1 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.92 -25.73 23.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.779 . . . . 0.0 109.242 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -74.33 -31.66 62.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.384 170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.4 mt -63.76 -52.87 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -118.64 129.36 25.43 Favored Pre-proline 0 N--CA 1.469 0.494 0 O-C-N 121.986 -0.446 . . . . 0.0 110.957 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.49 -22.74 44.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 N-CA-C 116.609 1.734 . . . . 0.0 116.609 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.76 0.15 35.36 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.418 0.554 . . . . 0.0 111.135 171.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.75 69.48 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.073 -1.017 . . . . 0.0 114.292 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -158.25 -29.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.7 m -69.89 152.77 95.89 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 118.77 0.713 . . . . 0.0 111.575 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.74 154.41 59.14 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 117.302 -1.332 . . . . 0.0 113.147 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.7 161.8 23.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.511 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -104.67 137.61 33.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -106.75 93.61 4.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 55.0 mt -97.19 108.68 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t0 49.01 46.69 22.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 123.493 1.616 . . . . 0.0 111.419 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 73.27 4.89 4.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.648 -2.523 . . . . 0.0 117.322 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -112.5 139.31 48.19 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -98.28 141.29 31.36 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 118.554 2.798 . . . . 0.0 118.554 -168.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.8 t -123.87 123.71 67.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.5 -37.75 1.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 118.981 2.956 . . . . 0.0 118.981 -165.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.61 149.87 49.37 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.05 -1.032 . . . . 0.0 110.309 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.3 p -60.08 -34.23 73.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -170.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -88.85 -13.33 39.51 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.25 -19.57 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 108.854 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.4 mt -66.33 -26.77 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 165.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.9 t -84.43 -40.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 O-C-N 120.504 -1.372 . . . . 0.0 111.462 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.45 -64.02 0.83 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 118.883 2.313 . . . . 0.0 118.883 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.78 -34.39 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.328 1.064 . . . . 0.0 111.103 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tt -56.31 -46.32 79.89 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.948 -0.47 . . . . 0.0 110.691 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.23 -40.76 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.507 . . . . 0.0 110.369 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.69 -35.72 81.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -95.34 -12.31 26.3 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -68.29 127.81 93.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 175.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.38 -12.92 37.67 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.67 162.06 71.9 Favored Pre-proline 0 N--CA 1.47 0.542 0 O-C-N 120.553 -1.342 . . . . 0.0 108.096 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.9 137.52 82.03 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 116.386 -1.943 . . . . 0.0 114.836 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -77.14 150.94 29.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 116.342 -1.972 . . . . 0.0 113.062 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.5 mt -132.83 66.61 1.56 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.944 0.878 . . . . 0.0 110.395 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -108.64 84.87 2.0 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.1 m -113.78 97.89 45.78 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -112.93 78.34 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.513 2.142 . . . . 0.0 114.913 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -91.16 -131.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.657 2.905 . . . . 0.0 113.319 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -54.34 -40.47 68.07 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.178 -0.951 . . . . 0.0 112.254 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -63.49 -26.46 68.73 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.453 -0.779 . . . . 0.0 111.447 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.68 -28.52 45.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.9 p -81.95 -27.89 33.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.974 0.806 . . . . 0.0 109.153 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.7 -43.79 82.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.83 -30.38 76.95 Favored Glycine 0 CA--C 1.517 0.212 0 O-C-N 120.829 -1.17 . . . . 0.0 114.181 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.7 p -77.5 -7.06 55.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.378 1.089 . . . . 0.0 113.139 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -93.97 -36.32 12.22 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.783 0.72 . . . . 0.0 110.974 166.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 90.5 mt -65.93 -48.87 80.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.619 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -54.57 -54.49 48.26 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HA ' HG22 ' A' ' 107' ' ' VAL . 93.5 Cg_endo -72.06 -24.88 19.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 113.436 -3.91 . . . . 0.0 113.784 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 t -65.8 -45.25 83.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -76.36 -29.62 57.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 117.772 -1.571 . . . . 0.0 113.793 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 104' ' ' PRO . 21.9 m -75.57 -26.23 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 118.48 -1.288 . . . . 0.0 110.038 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.61 -43.63 80.0 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -59.78 -39.45 84.93 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.757 -0.589 . . . . 0.0 111.195 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.2 mt -62.97 -36.51 83.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -92.36 -24.48 18.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 43.1 t -68.64 142.46 55.09 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -127.02 40.71 3.67 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.924 1.345 . . . . 0.0 107.669 159.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -77.78 173.39 7.67 Favored Pre-proline 0 C--O 1.245 0.826 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -61.73 102.15 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 114.948 -2.901 . . . . 0.0 109.199 146.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -122.92 24.78 8.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.849 -159.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -87.53 -22.89 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.238 1.018 . . . . 0.0 110.69 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.14 -33.26 54.74 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 m -68.09 -28.02 66.99 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 122.027 -0.69 . . . . 0.0 111.535 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -65.46 -36.15 83.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.639 -1.288 . . . . 0.0 110.013 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -75.07 -33.39 61.67 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.8 -0.563 . . . . 0.0 110.677 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.69 88.47 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.982 -1.074 . . . . 0.0 110.558 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.9 tp -61.25 -46.78 88.95 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.74 -42.95 99.63 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.721 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.81 -41.88 86.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -69.39 -35.77 76.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 118.959 -1.096 . . . . 0.0 108.707 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.51 -35.66 77.8 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.502 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.3 -29.68 70.95 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.691 0.678 . . . . 0.0 111.647 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.26 -51.57 65.65 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.791 -0.764 . . . . 0.0 109.327 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.26 -26.11 63.68 Favored 'General case' 0 C--O 1.221 -0.43 0 O-C-N 121.878 -0.514 . . . . 0.0 111.725 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.01 -39.87 93.71 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.683 0.393 . . . . 0.0 110.509 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.86 -54.72 26.46 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.52 -39.96 89.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.5 tt -66.89 -45.36 78.27 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -70.76 -23.01 62.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.951 1.25 . . . . 0.0 112.404 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.61 -49.39 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.674 -0.641 . . . . 0.0 111.139 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -82.64 -37.93 24.21 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -77.28 0.26 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-O 116.828 -2.095 . . . . 0.0 116.931 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -60.57 -131.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 1 C-N-CA 127.989 5.793 . . . . 0.0 120.728 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -68.43 171.68 7.06 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.937 -1.102 . . . . 0.0 111.293 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.72 -17.42 21.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.32 5.25 35.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.27 -24.77 17.46 Favored Glycine 0 C--O 1.227 -0.334 0 N-CA-C 115.896 1.118 . . . . 0.0 115.896 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.44 -54.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.307 1.553 . . . . 0.0 114.535 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -156.81 176.87 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.05 120.55 11.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 74.6 p -140.75 -168.57 2.61 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -40.44 -38.55 0.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 118.279 2.696 . . . . 0.0 118.279 173.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.88 -43.54 96.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.131 0.967 . . . . 0.0 108.705 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.91 -39.33 79.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 43.9 mt -61.54 -37.46 83.84 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.964 0.411 . . . . 0.0 111.475 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 88.4 p -77.69 -43.55 30.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.5 tp -95.12 -46.72 6.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -167.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.14 -41.8 92.92 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.55 -19.41 19.06 Favored 'Trans proline' 0 C--N 1.346 0.446 1 C-N-CA 113.006 -4.196 . . . . 0.0 113.753 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -90.81 -23.15 20.68 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.983 -1.073 . . . . 0.0 109.587 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.6 mt -63.28 -31.35 72.47 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.78 165.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.45 -51.08 71.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -63.57 -34.34 77.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.1 tp -59.0 -56.0 27.9 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.395 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.94 -51.54 43.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.692 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.69 -42.07 64.64 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.388 -0.82 . . . . 0.0 111.564 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.54 -46.9 86.27 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.26 93.2 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.033 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.71 -47.18 14.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.206 -0.998 . . . . 0.0 113.629 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -93.76 -34.39 13.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -167.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -137.44 50.47 1.96 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.959 -0.463 . . . . 0.0 110.836 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -53.02 121.71 7.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -156.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -148.15 89.2 5.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -68.38 153.3 74.42 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 114.639 -3.107 . . . . 0.0 109.87 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.92 126.03 91.79 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.84 155.54 57.93 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 117.142 -1.438 . . . . 0.0 112.31 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.42 -10.03 52.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -67.73 -25.24 65.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.048 -0.408 . . . . 0.0 110.488 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.99 61.54 1.11 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -31.52 68.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.712 -1.586 . . . . 0.0 113.137 -171.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -43.04 99.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.102 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -38.06 33.05 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.0 tp -60.18 -40.12 88.86 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.631 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.08 -45.7 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.496 -0.753 . . . . 0.0 111.932 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.94 -39.85 95.87 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.64 -32.34 57.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.68 -35.58 78.38 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.167 -0.958 . . . . 0.0 111.057 172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.08 -21.05 60.84 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.943 -0.473 . . . . 0.0 111.568 176.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 50.8 mt -78.13 -8.85 58.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.232 1.015 . . . . 0.0 110.434 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -103.53 23.73 12.18 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 121.23 -0.919 . . . . 0.0 110.154 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.7 p -124.84 164.43 20.04 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 49.05 150.72 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 121.225 3.787 . . . . 0.0 121.225 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -56.93 -34.86 68.39 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 120.555 -1.341 . . . . 0.0 114.381 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -18.95 23.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.09 -44.86 2.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.485 0.66 . . . . 0.0 110.856 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -61.53 -42.65 99.14 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -84.84 -30.91 24.12 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.201 1.0 . . . . 0.0 109.722 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 71.7 p -79.01 -12.54 60.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.707 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -40.63 119.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 113.078 172.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.12 138.92 50.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 165.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.43 138.58 58.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.806 0.276 . . . . 0.0 111.233 -173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.55 -43.78 89.43 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.56 -31.19 67.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.194 0.997 . . . . 0.0 111.141 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -102.68 0.97 33.93 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.2 -50.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 161.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 6.4 pt -69.41 -50.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 121.618 -0.676 . . . . 0.0 111.875 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -86.5 -2.11 58.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.336 -0.852 . . . . 0.0 110.291 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.8 -16.17 58.58 Favored Glycine 0 CA--C 1.517 0.173 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -113.15 -54.22 2.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.58 -31.04 8.55 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.39 -29.34 45.79 Favored 'Trans proline' 0 C--N 1.357 1.006 1 C-N-CA 111.733 -5.045 . . . . 0.0 114.475 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.69 -14.9 58.43 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.571 -0.706 . . . . 0.0 111.455 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.0 t -81.11 -42.03 19.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -64.39 -38.92 92.72 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.941 -0.474 . . . . 0.0 111.578 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 124.162 0.985 . . . . 0.0 109.863 -179.859 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 tpp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.17 155.9 36.44 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.71 173.24 16.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 111.075 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -124.88 156.32 38.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.403 HD11 ' HG ' ' A' ' 30' ' ' LEU . 44.8 mt -130.65 113.96 26.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 175.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.7 127.3 39.33 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.03 163.06 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 119.655 1.116 . . . . 0.0 112.926 -176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -71.49 126.42 29.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 173.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -82.92 172.69 12.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.04 142.83 58.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.45 134.95 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.67 -21.61 17.74 Favored Glycine 0 C--O 1.246 0.888 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.3 100.8 1.73 Allowed Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.0 96.39 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 116.917 -1.589 . . . . 0.0 114.383 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -159.36 -39.97 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -104.45 158.22 5.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.12 160.09 16.08 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.057 0.456 . . . . 0.0 110.295 172.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 -179.44 18.37 Favored Glycine 0 CA--C 1.507 -0.436 0 CA-C-N 116.458 -0.337 . . . . 0.0 112.992 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.87 92.89 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.335 1.065 . . . . 0.0 111.165 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.67 132.86 24.44 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 103.345 -2.835 . . . . 0.0 103.345 165.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -64.76 -38.03 32.8 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 116.693 -1.738 . . . . 0.0 111.992 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.26 -21.44 36.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.746 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.4 p -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.303 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -74.14 -26.65 60.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.882 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.81 -39.62 89.65 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.58 1.536 . . . . 0.0 111.151 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.63 -44.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.836 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.28 -38.21 85.96 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.397 -0.814 . . . . 0.0 110.541 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.92 -48.24 79.8 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.6 p -72.32 -31.47 65.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.727 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.403 ' HG ' HD11 ' A' ' 5' ' ' ILE . 4.0 mm? -68.4 -46.24 70.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.206 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -65.02 -33.11 75.26 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.793 -0.567 . . . . 0.0 110.579 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -63.06 -41.92 99.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.373 0.606 . . . . 0.0 112.343 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -78.82 -16.51 57.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.29 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 59.64 40.5 19.97 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.305 1.442 . . . . 0.0 112.931 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 pt -101.49 154.61 37.14 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.62 118.96 5.98 Favored 'Trans proline' 0 C--N 1.347 0.459 0 N-CA-C 117.375 2.029 . . . . 0.0 117.375 -171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -126.32 156.17 40.86 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 121.816 0.817 . . . . 0.0 113.072 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.24 110.43 20.91 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.007 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -84.2 125.51 32.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 118.754 0.706 . . . . 0.0 111.526 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -121.95 139.29 53.84 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.539 0.736 . . . . 0.0 112.194 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 2.6 mm? -102.0 120.03 39.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.733 -169.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.05 120.88 45.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -77.65 76.78 4.18 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.822 0.82 . . . . 0.0 112.215 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.1 mt 55.67 27.88 11.25 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 162.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.92 2.35 11.29 Favored Glycine 0 CA--C 1.516 0.128 0 N-CA-C 114.245 0.458 . . . . 0.0 114.245 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -78.21 109.41 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.754 -0.851 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -116.53 87.9 22.41 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.61 169.45 12.82 Favored 'Trans proline' 0 C--N 1.347 0.47 0 N-CA-C 109.916 -0.84 . . . . 0.0 109.916 169.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -54.86 -40.19 69.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.196 0.453 . . . . 0.0 111.303 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -62.15 -39.04 91.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.53 -22.25 35.07 Favored 'General case' 0 C--O 1.212 -0.888 0 O-C-N 120.604 -1.31 . . . . 0.0 112.777 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.9 tp -68.22 -40.16 82.15 Favored 'General case' 0 C--O 1.243 0.722 0 O-C-N 120.009 -1.682 . . . . 0.0 111.216 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.05 -35.2 71.86 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.346 -0.846 . . . . 0.0 112.846 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.5 mt -117.62 22.59 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 121.478 0.656 . . . . 0.0 111.485 -170.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -147.45 119.86 4.72 Favored Pre-proline 0 N--CA 1.474 0.767 0 O-C-N 120.047 -1.658 . . . . 0.0 108.483 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.34 -13.66 37.36 Favored 'Trans proline' 0 C--N 1.352 0.731 0 N-CA-C 118.689 2.534 . . . . 0.0 118.689 -173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -120.83 7.34 10.43 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.92 -0.488 . . . . 0.0 110.117 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.16 2.07 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-O 122.641 1.134 . . . . 0.0 113.143 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -134.07 99.31 4.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.57 146.18 16.17 Favored Pre-proline 0 C--N 1.318 -0.778 1 N-CA-C 98.199 -4.741 . . . . 0.0 98.199 170.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.9 142.09 38.26 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 116.868 -1.621 . . . . 0.0 111.982 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.81 131.63 50.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.152 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.91 129.9 36.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 163.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.41 71.91 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.175 0.988 . . . . 0.0 108.658 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.2 mt -87.66 126.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 54.97 35.58 24.91 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.478 1.111 . . . . 0.0 112.984 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.9 t0 61.62 25.07 15.05 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -115.46 150.59 36.24 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.08 135.98 53.23 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.315 2.339 . . . . 0.0 117.315 -172.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.65 123.17 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -174.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.33 8.76 1.06 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -165.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -99.41 147.67 25.01 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.025 -1.672 . . . . 0.0 109.946 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.2 p -58.72 -33.52 70.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -83.23 -13.22 55.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 123.045 1.402 . . . . 0.0 111.615 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.6 t -101.7 -32.23 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.842 -167.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.3 pt -66.96 -15.61 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 121.759 -0.588 . . . . 0.0 111.177 161.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.0 t -83.2 -46.24 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 120.333 -1.479 . . . . 0.0 110.418 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.3 -46.74 2.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 121.164 3.225 . . . . 0.0 121.164 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.4 mt -80.95 -26.89 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 120.78 -1.424 . . . . 0.0 110.558 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.91 -48.3 75.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -63.71 -39.99 95.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.315 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.68 -34.48 77.2 Favored 'General case' 0 C--O 1.242 0.66 0 O-C-N 121.846 -0.534 . . . . 0.0 111.64 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -97.0 -1.33 45.73 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -82.68 132.37 52.02 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.57 -9.92 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 115.517 -2.522 . . . . 0.0 114.833 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -74.24 158.1 85.86 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.62 124.58 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 116.138 -2.108 . . . . 0.0 115.658 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.37 144.29 28.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 120.641 0.894 . . . . 0.0 112.856 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -138.94 45.1 2.01 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 122.022 0.915 . . . . 0.0 109.367 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.06 90.44 2.49 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m -125.63 90.74 49.99 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.212 1.005 . . . . 0.0 110.282 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -100.63 63.56 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 1 C-N-CA 125.687 4.258 . . . . 0.0 119.351 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -87.05 -128.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 0 CA-C-N 119.918 1.006 . . . . 0.0 114.637 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -57.54 -38.52 74.87 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.921 1.691 . . . . 0.0 113.745 -174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -64.68 -25.13 67.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.117 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.92 -32.98 67.91 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.4 -0.813 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.8 p -75.0 -33.89 61.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.38 -45.44 82.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.07 83.97 Favored Glycine 0 C--O 1.229 -0.21 0 CA-C-O 119.207 -0.774 . . . . 0.0 113.61 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.3 p -63.28 -17.0 62.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -99.0 -27.53 13.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.486 0.66 . . . . 0.0 112.436 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.6 mt -79.36 -44.78 23.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -53.36 -48.79 91.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.35 -27.9 10.91 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 111.645 -5.103 . . . . 0.0 113.507 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.3 m -67.15 -44.62 79.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -70.85 -20.65 62.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.058 -1.057 . . . . 0.0 112.703 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.2 t -85.35 -41.78 15.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -59.27 -46.97 87.1 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.046 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -76.68 -24.21 53.18 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.48 -27.27 61.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.268 0.94 . . . . 0.0 110.994 174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.98 -3.45 58.77 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.348 0.659 . . . . 0.0 111.641 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.3 t -121.25 121.96 38.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -167.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -105.03 41.79 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.93 -177.54 0.33 Allowed Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.504 1.121 . . . . 0.0 108.848 169.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.27 61.03 0.5 Allowed 'Trans proline' 0 CA--C 1.552 1.406 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 156.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -86.29 80.01 8.87 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.153 -1.592 . . . . 0.0 107.4 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -118.78 -65.35 1.18 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.45 -44.27 96.98 Favored Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.335 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.8 p -77.7 -8.79 58.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -77.28 -32.62 55.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.954 -1.716 . . . . 0.0 106.432 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -79.28 -9.81 59.67 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 120.956 -1.09 . . . . 0.0 111.237 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.26 -32.84 74.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 165.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.74 -42.51 90.9 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.829 -1.169 . . . . 0.0 109.956 174.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.9 tp -56.46 -44.28 80.38 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.59 -27.86 68.05 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -81.45 -34.21 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.111 -0.993 . . . . 0.0 110.581 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -73.15 -23.58 60.47 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 122.211 -0.306 . . . . 0.0 110.481 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -68.31 -29.75 68.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.857 -0.527 . . . . 0.0 110.308 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.72 -42.66 85.97 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.63 -39.01 80.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.99 -41.11 91.37 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.57 0.748 . . . . 0.0 110.027 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.65 -41.76 56.2 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.013 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -62.21 -32.62 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.65 -55.08 11.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.086 0.946 . . . . 0.0 112.624 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -76.67 -10.4 59.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.73 -0.606 . . . . 0.0 112.423 -159.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.2 m -79.81 -8.65 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.67 -40.75 2.86 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.33 -66.53 0.25 Allowed Glycine 0 CA--C 1.53 1.014 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -69.65 -169.74 0.34 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 125.174 3.916 . . . . 0.0 115.689 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -57.82 165.45 1.74 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.086 0.955 . . . . 0.0 111.841 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 pt -65.81 -21.08 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -146.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.92 -13.29 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.31 -11.42 61.73 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -134.86 -45.21 0.73 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -164.17 -179.32 6.08 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.2 mm -64.89 121.46 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.4 m -138.95 179.39 6.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -38.75 -38.76 0.44 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -69.13 -39.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 120.741 -1.224 . . . . 0.0 111.792 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.84 -39.5 72.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.26 -7.21 28.66 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.4 p -104.55 -45.36 4.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.212 -0.423 . . . . 0.0 112.017 172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.48 -50.94 12.76 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.16 81.17 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.02 -18.75 52.01 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 113.605 -3.797 . . . . 0.0 117.317 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -94.74 -24.41 17.12 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.346 -1.471 . . . . 0.0 109.401 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.72 -25.93 67.52 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 121.396 -0.815 . . . . 0.0 111.902 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -50.75 -49.0 59.02 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.186 0.903 . . . . 0.0 110.318 166.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -72.98 -21.14 60.9 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.59 -50.11 70.74 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 122.228 0.211 . . . . 0.0 111.177 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -72.04 -20.66 61.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.806 -173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 65.6 t -78.83 -57.35 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.48 -52.26 28.31 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.194 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 tp -65.69 -42.2 91.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.663 0.744 . . . . 0.0 110.642 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.29 -32.35 82.43 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -90.88 -38.33 12.99 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.205 -1.173 . . . . 0.0 114.101 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -81.82 -46.44 14.15 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -145.4 70.49 1.26 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -165.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -53.71 117.77 3.41 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -166.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -143.53 89.06 7.64 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.65 161.94 40.84 Favored 'Trans proline' 0 C--O 1.235 0.34 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.2 mm -70.19 127.23 92.42 Favored Pre-proline 0 C--O 1.245 0.852 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 -177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.47 154.89 45.49 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 116.695 -1.736 . . . . 0.0 112.092 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.8 -2.72 31.24 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.563 -0.711 . . . . 0.0 110.731 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -69.5 -21.49 63.67 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.69 -0.631 . . . . 0.0 111.586 166.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.51 65.21 0.71 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.4 m -57.39 -34.95 69.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.992 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.43 -53.86 53.5 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.569 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 52.2 t -68.43 -34.86 68.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -168.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.97 -52.0 65.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.351 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.35 -41.55 96.7 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 122.278 -0.264 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -60.63 -52.01 66.98 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.39 -37.48 79.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 121.859 -0.526 . . . . 0.0 111.312 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.93 -41.78 99.59 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.445 0.64 . . . . 0.0 112.433 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 47.0 mt -71.52 -40.36 70.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.01 -20.0 63.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.124 0.488 . . . . 0.0 111.429 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.72 -27.91 69.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.419 -0.801 . . . . 0.0 112.373 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 t -136.99 69.93 1.41 Allowed 'General case' 0 C--O 1.243 0.758 0 O-C-N 121.43 -0.794 . . . . 0.0 112.771 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -125.9 138.79 53.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 162.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -59.43 -37.99 79.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 120.81 1.641 . . . . 0.0 113.188 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -37.31 78.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -85.16 -34.87 22.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.093 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -70.56 -42.34 71.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -173.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.33 -35.2 73.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.931 -0.708 . . . . 0.0 111.688 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.4 p -77.2 -19.29 56.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.896 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -51.96 122.77 8.96 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.248 0.619 . . . . 0.0 111.626 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.15 173.07 9.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.547 0.739 . . . . 0.0 110.308 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.71 126.96 31.66 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.9 -29.64 69.71 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.587 -0.695 . . . . 0.0 112.242 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -62.12 -35.68 79.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.145 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -85.77 -6.78 59.06 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 72.8 t -92.83 -54.3 7.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.0 mt -68.7 -61.39 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.932 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.32 -3.26 39.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.843 -0.536 . . . . 0.0 110.852 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.82 -13.3 61.11 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -99.17 -21.18 16.25 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.911 1.356 . . . . 0.0 111.803 166.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.4 -8.18 0.13 Allowed Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.34 -17.43 30.77 Favored 'Trans proline' 0 C--N 1.362 1.268 1 C-N-CA 110.851 -5.633 . . . . 0.0 112.852 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -85.33 1.98 46.12 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.978 0.511 . . . . 0.0 111.699 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.18 -44.41 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.419 0.688 . . . . 0.0 111.793 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -71.43 -25.24 62.24 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.689 -0.632 . . . . 0.0 110.275 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.788 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.34 159.6 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.98 172.81 13.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.745 -171.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.88 159.65 40.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.5 mt -129.98 143.57 40.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 166.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.57 157.49 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -167.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.21 128.85 34.01 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.175 -0.953 . . . . 0.0 108.622 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.17 158.42 16.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.09 140.18 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.362 170.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.57 126.85 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.11 0.2 60.4 Favored Glycine 0 CA--C 1.518 0.279 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 78.15 4.01 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.75 1.775 . . . . 0.0 114.917 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.82 90.79 0.82 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 N-CA-C 116.925 1.856 . . . . 0.0 116.925 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -157.25 -49.27 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.82 157.25 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 103.323 -2.843 . . . . 0.0 103.323 168.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.46 166.91 15.14 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.486 1.114 . . . . 0.0 111.739 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.11 -173.82 16.22 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 118.737 2.255 . . . . 0.0 118.737 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -76.66 99.05 4.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 122.471 1.129 . . . . 0.0 110.833 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.17 136.07 17.82 Favored Pre-proline 0 C--N 1.319 -0.74 1 N-CA-C 100.134 -4.025 . . . . 0.0 100.134 162.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.29 -36.65 34.89 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 116.22 -2.053 . . . . 0.0 112.047 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -72.57 -26.0 61.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.112 -172.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.1 t -65.54 -41.71 92.75 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.432 1.111 . . . . 0.0 109.863 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -73.98 -33.77 63.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.518 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.57 -45.99 84.52 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.148 1.34 . . . . 0.0 111.779 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.67 -35.34 65.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.479 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.6 mt -76.55 -46.7 25.32 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.316 -0.865 . . . . 0.0 112.941 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -39.6 94.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 p -64.3 -43.59 94.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 112.084 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -27.14 28.45 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -75.45 -31.63 60.36 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 118.486 0.584 . . . . 0.0 111.041 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.52 -37.98 89.42 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.388 -1.445 . . . . 0.0 109.515 173.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.65 -20.4 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 51.56 40.13 26.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 0.0 112.346 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.18 135.38 73.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.64 140.95 89.35 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 115.733 -2.378 . . . . 0.0 114.215 -176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -148.53 157.64 43.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -114.53 124.51 52.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 167.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 t -90.82 149.6 21.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -135.28 133.33 38.8 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.38 110.79 21.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.16 109.2 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.27 78.23 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.709 0.766 . . . . 0.0 112.957 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt 55.27 54.39 8.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.7 160.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 89.88 15.22 58.26 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.207 -0.906 . . . . 0.0 114.39 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -74.41 114.91 13.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.342 1.071 . . . . 0.0 108.482 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.23 89.04 11.1 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -67.45 176.3 5.04 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 115.989 -2.208 . . . . 0.0 109.164 166.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -54.95 -31.45 60.51 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.553 -0.717 . . . . 0.0 112.56 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -56.98 -51.45 69.16 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.964 0.802 . . . . 0.0 112.608 172.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -72.25 -24.38 61.36 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 120.285 -1.509 . . . . 0.0 111.513 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.24 -35.24 77.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.603 -0.686 . . . . 0.0 112.093 170.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -67.4 -42.74 82.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.458 -0.776 . . . . 0.0 110.134 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mm -79.12 -51.79 16.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.5 t -104.63 126.41 31.39 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -167.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -65.11 -31.91 53.75 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 -176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -90.39 -4.41 57.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 120.63 -1.294 . . . . 0.0 110.244 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.93 -34.78 2.34 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-O 121.418 0.454 . . . . 0.0 112.478 -166.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -112.03 0.87 16.13 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 118.993 2.96 . . . . 0.0 118.993 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.0 147.05 72.92 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 120.145 1.338 . . . . 0.0 108.145 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.54 151.15 58.56 Favored 'Trans proline' 0 C--N 1.345 0.394 0 O-C-N 122.721 0.853 . . . . 0.0 111.495 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.87 162.6 20.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.769 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.65 128.44 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -85.49 96.33 9.57 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.73 97.76 7.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 121.014 1.734 . . . . 0.0 106.816 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.36 46.39 25.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.108 0.563 . . . . 0.0 112.507 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 71.86 4.6 5.09 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.67 2.388 . . . . 0.0 115.842 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -106.21 108.4 19.89 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -94.54 134.46 37.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.148 -166.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.21 134.3 65.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.0 -28.31 2.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -171.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -75.97 131.18 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.4 p -67.54 -23.12 65.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -95.67 -21.32 18.27 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.748 -0.595 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.08 -34.55 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.99 -24.85 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.16 -32.68 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 O-C-N 120.446 -1.408 . . . . 0.0 110.166 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.9 -54.81 0.42 Allowed Glycine 0 C--O 1.226 -0.386 0 N-CA-C 119.609 2.604 . . . . 0.0 119.609 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.82 -31.02 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.211 1.505 . . . . 0.0 110.885 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.88 -34.7 76.49 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.327 -0.858 . . . . 0.0 109.846 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -73.36 -38.63 65.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.884 -0.51 . . . . 0.0 111.446 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.63 -31.91 73.22 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.411 -0.805 . . . . 0.0 113.127 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 5.4 43.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -98.31 135.45 21.25 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.28 -8.87 24.64 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 116.485 -1.877 . . . . 0.0 116.67 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.05 160.15 76.07 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.365 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -61.86 137.14 65.9 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 114.86 -2.96 . . . . 0.0 114.191 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.57 88.59 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 N-CA-C 115.967 1.487 . . . . 0.0 115.967 -175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.3 mt -87.59 63.67 7.7 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 120.483 -1.386 . . . . 0.0 112.471 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.73 86.06 2.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.1 m -125.76 87.74 55.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.152 -0.451 . . . . 0.0 111.575 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -98.61 48.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 122.185 3.879 . . . . 0.0 122.185 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -80.35 -117.93 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.677 1.278 . . . . 0.0 112.289 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -53.42 -35.43 60.41 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.11 -37.56 87.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.78 0.8 . . . . 0.0 109.925 -174.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.28 -34.88 42.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.818 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -67.95 -32.29 72.62 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.42 -0.8 . . . . 0.0 110.826 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.76 -50.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.8 96.39 Favored Glycine 0 CA--C 1.516 0.144 0 C-N-CA 120.467 -0.873 . . . . 0.0 115.083 -174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.0 p -73.52 -8.33 55.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -80.01 -35.42 37.37 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.02 -1.05 . . . . 0.0 110.568 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.98 -37.32 9.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.633 -174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.65 -54.22 38.18 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.93 -24.39 13.01 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 113.423 -3.918 . . . . 0.0 113.036 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 m -71.73 -39.53 70.03 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HD13 ' A' ' 123' ' ' LEU . 3.3 p90 -75.53 -26.15 57.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.787 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.71 -28.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 120.898 -1.126 . . . . 0.0 109.245 172.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.53 -42.77 99.74 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.768 -1.207 . . . . 0.0 109.444 171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -65.21 -40.22 93.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.814 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.92 -39.1 90.88 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -76.16 -11.04 59.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.593 0.961 . . . . 0.0 113.593 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -87.09 141.99 28.26 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -127.91 27.79 5.66 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -72.4 170.78 11.62 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.2 52.21 1.85 Allowed 'Trans proline' 0 CA--C 1.546 1.078 0 CA-C-O 122.926 1.136 . . . . 0.0 114.378 167.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -83.67 38.55 0.64 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -140.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -67.25 -24.71 65.83 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.59 -39.52 90.73 Favored Glycine 0 N--CA 1.454 -0.123 0 O-C-N 120.835 -1.165 . . . . 0.0 111.325 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 m -74.34 -30.57 62.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.862 -0.787 . . . . 0.0 110.16 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -66.45 -34.51 78.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.862 0.839 . . . . 0.0 111.02 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -76.31 -30.35 57.7 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.64 96.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.296 -0.878 . . . . 0.0 109.523 171.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 106' ' ' PHE . 17.0 tp -63.73 -47.3 81.61 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.98 -43.58 98.6 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.481 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.46 -44.25 83.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.893 0.77 . . . . 0.0 112.11 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -76.98 -27.72 54.84 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.116 -0.99 . . . . 0.0 112.347 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.3 tp -79.01 -22.95 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.634 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -71.7 -31.13 66.42 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.101 -0.999 . . . . 0.0 109.998 168.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.68 90.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.0 tp -64.99 -39.13 93.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 122.0 -0.437 . . . . 0.0 112.11 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.07 -36.81 80.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.632 0.73 . . . . 0.0 110.73 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.26 -52.63 38.87 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.514 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -56.76 -42.29 79.09 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.051 -0.676 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.54 -45.14 80.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.13 -27.08 62.39 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.146 1.339 . . . . 0.0 112.677 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.08 -33.84 60.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 122.808 0.443 . . . . 0.0 110.318 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.56 -35.12 8.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.76 -75.02 0.24 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-O 117.381 -1.788 . . . . 0.0 116.553 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -61.55 -159.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 1 C-N-CA 126.428 4.752 . . . . 0.0 118.994 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.59 167.43 1.47 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.519 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -45.5 -32.74 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 -169.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.57 -7.55 39.51 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 120.779 -1.2 . . . . 0.0 114.236 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.05 3.71 90.64 Favored Glycine 0 CA--C 1.511 -0.203 0 O-C-N 121.672 -0.643 . . . . 0.0 113.327 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -142.39 -61.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -158.28 176.01 13.01 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.2 mm -63.12 127.98 24.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 88.0 m -142.71 161.98 36.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -171.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.27 -22.97 45.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.61 -23.61 29.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.66 -40.96 22.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 51.1 mt -70.79 -12.22 61.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.217 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 78.9 p -96.13 -23.73 16.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.2 tp -100.41 -49.17 4.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.31 -40.7 70.18 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -57.59 -38.63 93.01 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 114.637 -3.109 . . . . 0.0 118.259 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -87.93 -22.05 24.57 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.366 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.62 -37.74 85.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.095 1.316 . . . . 0.0 111.579 172.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.6 -50.27 71.93 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.801 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -63.83 -33.37 75.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.446 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.3 tp -63.47 -52.47 61.22 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.728 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.08 -34.59 78.37 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 118.823 -1.151 . . . . 0.0 111.714 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.83 -54.05 21.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.997 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.22 -44.18 63.31 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.283 -0.885 . . . . 0.0 111.693 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.15 -37.4 75.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.64 -36.57 93.44 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -75.98 -51.64 11.95 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.206 -1.173 . . . . 0.0 113.028 175.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -80.54 -36.99 32.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -146.89 53.07 1.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -171.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -34.38 102.79 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -157.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -142.7 85.41 10.22 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.25 169.74 21.86 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 116.296 -2.002 . . . . 0.0 109.019 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.4 mm -73.25 124.19 90.3 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.47 163.6 31.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 116.06 -2.16 . . . . 0.0 113.634 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.85 -4.65 36.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.491 -0.756 . . . . 0.0 112.112 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.25 -21.2 66.5 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.09 -1.006 . . . . 0.0 110.123 165.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.8 mt -116.53 57.04 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.7 m -57.37 -34.64 69.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.088 -0.383 . . . . 0.0 111.289 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -68.79 -40.66 79.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.88 -43.03 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.137 0.494 . . . . 0.0 110.256 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.93 -43.5 92.58 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 121.768 -0.583 . . . . 0.0 111.788 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -69.36 -34.33 74.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.609 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -59.07 -49.31 78.36 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 172.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 95.6 mt -64.84 -36.64 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.272 -0.893 . . . . 0.0 111.809 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.28 -37.81 88.81 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.523 -1.361 . . . . 0.0 112.592 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.84 -43.98 97.35 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 49.0 mt -65.77 -41.9 91.47 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.881 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.35 -33.48 65.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.1 m -115.98 18.49 15.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -66.66 139.61 57.87 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.89 -43.68 81.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.995 0.816 . . . . 0.0 112.545 -174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 p -67.13 -41.23 86.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -42.75 49.99 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.661 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 196' ' ' ARG . 37.6 ttmt -52.83 -44.92 67.07 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.544 -0.723 . . . . 0.0 112.003 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.17 -43.11 99.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.471 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 50.8 p -96.5 -4.04 42.18 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 193' ' ' LYS . 55.9 mtp180 -56.14 133.61 52.3 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.31 148.48 50.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.83 134.7 56.64 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.443 0.464 . . . . 0.0 109.829 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.53 -34.3 72.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.74 -32.45 70.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.139 0.971 . . . . 0.0 111.423 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -94.78 -21.36 18.78 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.415 -0.803 . . . . 0.0 111.941 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.33 -42.41 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.7 -74.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.01 -16.35 63.16 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.67 -25.27 33.13 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.06 -0.59 . . . . 0.0 114.143 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 -22.16 12.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.912 0.856 . . . . 0.0 113.177 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.59 -17.37 0.37 Allowed Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 119.204 3.039 . . . . 0.0 119.204 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.81 -21.18 44.86 Favored 'Trans proline' 0 C--N 1.36 1.132 1 C-N-CA 111.043 -5.504 . . . . 0.0 115.402 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -77.95 -24.06 48.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.55 -32.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -82.59 9.65 8.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.949 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.806 0 C-N-CA 126.569 1.948 . . . . 0.0 114.375 -178.349 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mmm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.34 -170.8 0.11 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.288 1.435 . . . . 0.0 113.472 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.04 161.96 37.45 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.75 146.82 44.47 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 121.922 -0.486 . . . . 0.0 110.518 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.8 mt -111.23 98.84 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.8 t -101.82 108.71 20.28 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.7 m -132.58 162.49 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -167.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -61.33 142.64 56.75 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -97.41 167.8 10.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.174 0.443 . . . . 0.0 110.741 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.97 58.37 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.6 t -65.86 112.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.27 85.46 Favored Glycine 0 C--O 1.239 0.436 0 CA-C-N 114.634 -1.166 . . . . 0.0 115.461 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.7 82.36 7.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 118.008 0.904 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.25 43.24 0.71 Allowed 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 124.666 3.577 . . . . 0.0 115.938 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.78 -8.1 2.14 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.3 mt -128.86 156.57 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.68 154.0 26.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.26 174.32 45.23 Favored Glycine 0 C--O 1.238 0.345 0 N-CA-C 120.787 3.075 . . . . 0.0 120.787 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -87.37 75.68 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.755 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.95 133.68 21.18 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.41 -40.56 56.65 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-O 123.092 1.205 . . . . 0.0 111.445 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -77.79 -17.84 57.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.622 -170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.8 t -60.8 -48.83 80.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.487 0.66 . . . . 0.0 111.292 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -73.17 -12.48 60.9 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 117.541 -1.219 . . . . 0.0 114.273 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 74.7 mtt-85 -59.18 -48.92 79.83 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.958 1.708 . . . . 0.0 109.029 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.74 -50.44 70.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.206 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.7 mt -59.66 -41.84 91.48 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.053 -174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.95 -45.87 83.93 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.1 p -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.509 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 -32.49 33.07 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 119.674 -0.81 . . . . 0.0 112.246 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -68.66 -38.14 80.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 118.741 0.7 . . . . 0.0 112.454 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.15 -28.78 69.05 Favored 'General case' 0 C--O 1.248 0.975 0 O-C-N 120.916 -1.115 . . . . 0.0 111.134 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -91.58 -12.91 32.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 53.17 33.8 16.04 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.2 pt -81.61 151.97 69.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.87 143.11 44.62 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 115.419 -2.587 . . . . 0.0 112.874 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -150.97 162.5 40.71 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -124.53 112.35 16.75 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.1 t -80.52 133.06 35.76 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -114.68 130.7 56.85 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 3.8 mm? -109.69 121.04 44.33 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -172.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.67 104.18 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -69.37 90.09 0.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.189 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt 49.25 49.99 18.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.724 1.209 . . . . 0.0 113.784 174.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.33 43.47 38.21 Favored Glycine 0 C--O 1.229 -0.217 0 C-N-CA 119.845 -1.169 . . . . 0.0 112.966 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -75.81 84.25 2.77 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 161.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -115.47 95.69 43.83 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.383 0.673 . . . . 0.0 111.598 -160.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 169.98 18.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 N-CA-C 109.902 -0.845 . . . . 0.0 109.902 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -55.84 -32.65 63.78 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 0.506 . . . . 0.0 111.768 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -55.07 -52.54 62.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.46 -24.44 59.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 120.882 -1.136 . . . . 0.0 111.478 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.29 -32.17 73.42 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.239 0.543 . . . . 0.0 111.405 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -74.43 -39.23 62.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.663 0.744 . . . . 0.0 111.468 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -74.41 -37.01 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 t -121.54 143.0 36.86 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.91 -37.35 86.3 Favored 'Trans proline' 0 C--N 1.355 0.917 0 N-CA-C 116.207 1.579 . . . . 0.0 116.207 170.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -93.96 -21.13 19.39 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.109 -0.994 . . . . 0.0 111.941 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 4.63 90.37 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-O 122.189 0.883 . . . . 0.0 111.513 -167.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -160.68 75.19 0.54 Allowed 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.859 1.264 . . . . 0.0 109.808 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.5 160.52 63.99 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 135.48 32.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 113.473 -3.884 . . . . 0.0 112.382 165.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.35 141.69 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.58 126.34 54.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -92.7 91.06 7.34 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.61 85.09 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.5 t0 53.62 60.07 3.92 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.294 1.045 . . . . 0.0 112.041 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 67.49 3.69 3.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.751 1.62 . . . . 0.0 115.265 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -103.34 99.77 9.62 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.159 -0.963 . . . . 0.0 109.034 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -80.57 134.71 35.96 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.475 0.71 . . . . 0.0 111.776 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -127.12 126.15 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 117.875 -1.06 . . . . 0.0 109.736 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.76 80.91 1.28 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -148.54 145.33 27.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 162.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.5 p -58.37 -34.26 70.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -81.24 -18.17 46.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.266 0.939 . . . . 0.0 111.537 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.57 -20.33 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -169.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.14 -9.91 12.69 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.45 -60.45 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 162.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.89 -36.35 90.94 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.6 mt -86.17 -27.7 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 120.869 -1.371 . . . . 0.0 107.94 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.41 -39.28 94.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.89 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.72 -37.61 87.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.974 0.806 . . . . 0.0 110.788 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -67.06 -28.42 68.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.771 1.272 . . . . 0.0 112.006 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -102.77 1.64 34.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.505 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -75.56 143.04 74.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.184 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 -16.78 12.87 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 N-CA-C 115.59 1.342 . . . . 0.0 115.59 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -90.67 161.79 35.36 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 103.544 -2.762 . . . . 0.0 103.544 174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.06 142.44 97.21 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 N-CA-C 119.135 2.706 . . . . 0.0 119.135 -163.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.48 106.76 2.32 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 121.585 1.523 . . . . 0.0 115.907 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.04 40.72 2.57 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 122.068 0.937 . . . . 0.0 112.745 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.76 79.77 5.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.308 -1.495 . . . . 0.0 112.34 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -118.93 94.54 48.25 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.08 82.18 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.907 0 C-N-CA 124.33 3.353 . . . . 0.0 119.974 165.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -87.56 -146.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 121.392 1.395 . . . . 0.0 111.635 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -46.25 -40.32 11.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -62.79 -27.97 69.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.11 -29.04 61.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 110.033 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 76.8 p -76.19 -31.4 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.485 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.06 -40.63 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 114.546 -1.206 . . . . 0.0 114.131 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.1 p -66.98 -11.16 55.98 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -98.13 -34.01 10.92 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.2 pt -75.27 -30.85 23.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.042 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.73 -56.15 10.06 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -167.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.91 -20.62 16.9 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 114.618 -3.122 . . . . 0.0 113.661 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.9 t -64.29 -43.29 95.2 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.16 0.984 . . . . 0.0 111.647 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -37.83 84.24 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.042 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 107' ' ' VAL . 0.5 OUTLIER -67.3 -38.58 81.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.207 176.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.2 -44.93 95.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.315 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -73.63 -27.69 61.4 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.8 -46.03 91.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.232 0.923 . . . . 0.0 112.166 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -72.5 -22.41 61.05 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.066 0.936 . . . . 0.0 112.234 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 t -86.3 143.06 28.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -127.9 32.99 4.85 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 123.44 1.59 . . . . 0.0 109.333 164.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.21 170.8 7.95 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -69.0 47.02 0.42 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 160.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.12 101.47 13.83 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.1 -45.01 1.14 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.257 0.623 . . . . 0.0 111.795 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.8 -21.03 79.03 Favored Glycine 0 C--O 1.236 0.248 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.5 p -93.72 -11.97 30.28 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 168.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -67.04 -34.97 78.85 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 119.528 -1.983 . . . . 0.0 105.799 162.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -79.34 3.28 18.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.332 -0.855 . . . . 0.0 113.167 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.45 -28.56 61.09 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.33 -37.47 85.75 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.959 -1.088 . . . . 0.0 109.925 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.5 tp -61.91 -36.14 80.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.459 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -78.52 -34.88 46.95 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -72.8 -39.26 66.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 119.711 -1.868 . . . . 0.0 110.266 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 110.444 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -64.06 -35.52 81.02 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.924 0.783 . . . . 0.0 109.372 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.43 81.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -60.73 -42.73 97.89 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.579 -0.701 . . . . 0.0 110.737 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.366 1.066 . . . . 0.0 112.455 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.91 -36.52 41.43 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.578 -0.701 . . . . 0.0 114.01 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -68.63 -28.13 66.63 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -68.65 -52.8 27.23 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.392 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -68.35 -19.44 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.05 -9.14 12.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -113.51 -53.4 2.7 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.69 -59.04 0.47 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -71.39 -164.77 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.959 3.106 . . . . 0.0 115.062 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -54.9 160.07 2.09 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.7 tp -61.53 -22.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -163.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.23 -11.46 60.91 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.295 -1.503 . . . . 0.0 114.076 171.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.82 -26.76 8.69 Favored Glycine 0 C--O 1.235 0.173 0 N-CA-C 116.214 1.245 . . . . 0.0 116.214 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -134.12 -44.27 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -161.88 -177.03 5.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.396 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.44 109.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.8 m -128.79 -174.37 3.23 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 147' ' ' THR . . . -47.14 -38.26 11.32 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.31 -46.75 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 118.868 0.758 . . . . 0.0 110.158 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.92 -39.76 75.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.462 0.649 . . . . 0.0 110.349 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.69 -24.39 66.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.686 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.5 m -82.03 -36.6 27.58 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 83.6 mt -97.87 -46.25 6.0 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.55 36.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.56 -33.96 43.95 Favored 'Trans proline' 0 C--N 1.353 0.8 1 C-N-CA 112.067 -4.822 . . . . 0.0 115.629 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -80.87 -28.32 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.41 -1.432 . . . . 0.0 109.358 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 55.8 mt -60.07 -39.68 86.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.244 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -60.03 -49.92 75.75 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.053 0.842 . . . . 0.0 111.68 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -64.2 -31.77 73.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.025 0.44 . . . . 0.0 111.213 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -54.03 16.53 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 121.598 -0.688 . . . . 0.0 109.713 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -30.8 71.3 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.02 -35.4 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.076 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.56 -43.54 15.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.46 -36.6 84.39 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.408 0.683 . . . . 0.0 109.624 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.72 -35.17 91.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.539 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -74.47 -51.19 15.54 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.778 -0.837 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -77.67 -47.4 19.31 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -149.42 74.94 1.26 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -168.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.69 115.97 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -161.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -131.83 97.12 19.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.79 148.5 46.44 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 115.644 -2.437 . . . . 0.0 113.137 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 48.3 mm -66.32 120.75 72.65 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -71.23 167.44 26.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 N-CA-C 116.776 1.798 . . . . 0.0 116.776 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.98 -16.34 63.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.958 0.903 . . . . 0.0 111.169 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -72.64 -13.52 61.39 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.516 0.726 . . . . 0.0 111.963 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.53 52.06 1.0 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -25.8 68.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -54.41 43.55 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.73 -36.08 76.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -169.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.62 -49.25 78.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -69.23 -37.27 77.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.821 0.343 . . . . 0.0 111.772 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -62.17 -49.2 76.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.81 0.844 . . . . 0.0 110.136 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 80.4 mt -71.95 -29.55 33.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.268 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.47 -46.21 87.24 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.966 -1.084 . . . . 0.0 111.277 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.59 -35.28 78.68 Favored 'General case' 0 C--O 1.216 -0.668 0 O-C-N 121.154 -0.966 . . . . 0.0 110.543 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.97 -37.07 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.029 0.918 . . . . 0.0 110.417 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -67.32 -27.56 67.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.64 -0.663 . . . . 0.0 111.338 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 t -145.35 72.81 1.33 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.989 0.899 . . . . 0.0 112.712 175.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -127.15 139.84 52.68 Favored 'General case' 0 N--CA 1.468 0.452 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 168.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -60.57 -39.68 88.89 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.7 p -61.57 -33.45 73.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.883 0.849 . . . . 0.0 112.681 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.4 -36.12 20.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.255 0.55 . . . . 0.0 110.892 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -62.47 -38.94 91.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -78.47 -28.6 46.54 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.236 1.017 . . . . 0.0 112.567 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 68.3 p -95.4 -0.48 52.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -61.44 144.98 53.2 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.37 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -76.87 154.56 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.43 134.31 48.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.14 -42.39 89.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 111.747 -167.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -62.14 -22.92 66.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -90.72 -9.42 46.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.56 -0.712 . . . . 0.0 110.762 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.46 -43.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 168.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -60.58 -66.81 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.25 0.548 . . . . 0.0 109.715 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.99 60.64 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.932 -1.105 . . . . 0.0 111.643 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.71 -26.6 45.44 Favored Glycine 0 C--O 1.235 0.184 0 C-N-CA 120.285 -0.959 . . . . 0.0 114.113 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -88.23 -38.89 14.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.461 1.124 . . . . 0.0 109.42 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.91 -18.05 0.43 Allowed Pre-proline 0 C--N 1.321 -0.636 1 N-CA-C 121.825 4.009 . . . . 0.0 121.825 -173.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.355 0.87 1 C-N-CA 110.516 -5.856 . . . . 0.0 114.403 171.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -73.28 -31.37 64.03 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.2 t -84.05 -46.87 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.595 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -79.07 -30.17 43.79 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -171.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.619 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -168.501 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.1 163.51 27.5 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 170.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 pp -155.81 170.0 23.09 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.55 0.614 . . . . 0.0 111.621 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -108.24 137.84 45.54 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 30' ' ' LEU . 56.1 mt -110.27 117.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 173.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 m -110.71 129.66 55.77 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.77 159.99 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.16 130.02 41.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.94 0.496 . . . . 0.0 110.005 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -73.88 170.97 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.629 0.728 . . . . 0.0 111.84 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.9 132.11 49.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.165 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.65 112.85 12.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.075 -1.084 . . . . 0.0 108.075 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.79 -28.8 6.04 Favored Glycine 0 C--O 1.242 0.652 0 CA-C-O 118.917 -0.935 . . . . 0.0 111.417 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.24 93.39 2.7 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.278 1.031 . . . . 0.0 112.594 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.27 72.87 5.24 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 121.181 1.254 . . . . 0.0 114.873 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -142.98 13.44 1.86 Allowed 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.384 -1.448 . . . . 0.0 111.77 166.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 77.0 mt -144.69 152.93 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 1 N-CA-C 99.409 -4.293 . . . . 0.0 99.409 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 3.5 pp -65.37 158.43 26.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.938 1.295 . . . . 0.0 112.404 169.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.1 175.78 15.85 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 117.51 1.764 . . . . 0.0 117.51 -174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -79.11 90.92 4.86 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.555 1.169 . . . . 0.0 109.958 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 124.94 29.15 Favored Pre-proline 0 C--N 1.319 -0.739 1 N-CA-C 97.161 -5.125 . . . . 0.0 97.161 161.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -66.42 -30.04 44.69 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 115.63 -2.446 . . . . 0.0 116.121 -168.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.73 -24.72 53.02 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.779 -0.575 . . . . 0.0 111.445 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -62.56 -40.72 97.74 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 123.121 1.439 . . . . 0.0 110.217 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -72.47 -16.01 61.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 113.839 -1.528 . . . . 0.0 113.587 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.15 -34.97 75.83 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.283 -0.885 . . . . 0.0 110.442 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -72.19 -41.36 66.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 122.554 1.169 . . . . 0.0 107.957 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.8 mt -65.46 -44.93 85.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.816 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.17 -43.53 91.42 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.485 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -67.43 -39.2 85.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.428 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 5' ' ' ILE . 3.0 mp -71.95 -38.19 69.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -72.31 -26.58 62.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 118.111 0.414 . . . . 0.0 110.892 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -39.0 73.53 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 121.217 -0.927 . . . . 0.0 112.706 169.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -79.93 -10.03 59.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.509 -0.744 . . . . 0.0 112.66 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 55.44 35.51 25.21 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.749 1.219 . . . . 0.0 111.946 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 pt -89.05 154.78 49.73 Favored Pre-proline 0 C--O 1.242 0.701 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.93 153.21 58.18 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 114.215 -3.39 . . . . 0.0 112.666 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -152.04 157.26 41.42 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.68 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -97.88 118.16 33.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 171.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.9 t -91.02 120.46 32.03 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -114.2 112.45 23.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.426 1.108 . . . . 0.0 110.913 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.1 mt -96.57 109.93 22.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.407 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.9 mt -83.36 116.41 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -72.33 54.07 0.3 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.658 1.983 . . . . 0.0 114.821 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt 54.4 54.46 9.38 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.856 1.663 . . . . 0.0 109.183 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.29 70.41 1.22 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.5 116.36 28.95 Favored 'General case' 0 C--N 1.32 -0.686 1 N-CA-C 99.318 -4.327 . . . . 0.0 99.318 163.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -123.78 60.08 19.1 Favored Pre-proline 0 C--O 1.248 0.983 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.87 174.68 11.93 Favored 'Trans proline' 0 C--O 1.239 0.555 1 C-N-CA 113.118 -4.121 . . . . 0.0 110.41 161.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -55.0 -36.46 65.46 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.774 0.43 . . . . 0.0 110.572 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -55.8 -52.58 63.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -74.99 -27.2 60.06 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.213 -0.929 . . . . 0.0 111.817 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -68.03 -32.04 72.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.594 1.088 . . . . 0.0 111.624 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.91 -39.42 83.57 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.734 -0.604 . . . . 0.0 109.864 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.95 -37.23 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.85 0.86 . . . . 0.0 112.408 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.9 t -128.46 128.15 23.61 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.3 -14.3 31.21 Favored 'Trans proline' 0 C--O 1.242 0.714 0 N-CA-C 118.148 2.326 . . . . 0.0 118.148 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -102.97 -7.65 21.28 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.088 0.858 . . . . 0.0 110.767 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.8 8.23 72.17 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -167.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -159.86 55.64 0.37 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.382 1.073 . . . . 0.0 111.851 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.45 155.66 81.17 Favored Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 120.736 -1.228 . . . . 0.0 109.635 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -76.19 148.14 30.46 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 114.387 -3.275 . . . . 0.0 113.83 168.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.17 166.0 30.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.96 123.54 71.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 154.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -114.4 95.02 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mt -101.23 122.92 53.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 50.64 43.58 27.67 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.004 0.522 . . . . 0.0 111.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 68.39 12.87 8.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.13 2.641 . . . . 0.0 118.13 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -115.76 122.86 46.73 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.695 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 64.9 p-90 -104.65 147.12 28.01 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 m -124.58 152.09 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -151.42 38.9 0.64 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 119.29 3.07 . . . . 0.0 119.29 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.19 153.72 31.34 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.882 1.673 . . . . 0.0 107.867 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.0 p -58.43 -32.65 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.54 -40.72 41.59 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.82 -0.55 . . . . 0.0 111.651 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 m -82.03 -20.31 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.2 pt -71.46 -3.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.292 -0.88 . . . . 0.0 111.854 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.55 -48.34 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 159.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.24 -36.31 91.57 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.0 mt -87.01 -30.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 120.227 2.013 . . . . 0.0 106.065 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.53 -49.42 74.81 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.656 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -60.5 -37.25 80.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.441 1.473 . . . . 0.0 112.255 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.5 -21.12 64.61 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -112.46 -6.34 14.0 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -76.79 135.55 67.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 103.619 -2.734 . . . . 0.0 103.619 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.55 -19.85 27.77 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 N-CA-C 116.545 1.71 . . . . 0.0 116.545 -175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -75.7 160.89 78.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.029 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.44 129.19 33.84 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 N-CA-C 116.343 1.632 . . . . 0.0 116.343 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.78 130.32 3.67 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 N-CA-C 116.683 1.763 . . . . 0.0 116.683 -173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB3' HG23 ' A' ' 147' ' ' THR . 95.7 mt -125.92 48.5 2.08 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.72 1.208 . . . . 0.0 112.617 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -84.53 75.18 10.3 Favored 'General case' 0 C--O 1.246 0.875 0 O-C-N 120.081 -1.637 . . . . 0.0 108.58 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.3 m -116.29 102.42 53.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.15 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -108.32 72.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.208 3.272 . . . . 0.0 118.21 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -82.36 -148.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 1 C-N-CA 125.681 4.254 . . . . 0.0 111.177 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.54 -29.95 28.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -67.71 -25.23 65.56 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 120.334 -1.479 . . . . 0.0 113.275 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.97 -34.04 59.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.8 p -72.29 -35.69 68.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -45.09 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.1 82.91 Favored Glycine 0 C--O 1.229 -0.162 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.793 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.3 p -70.18 -13.95 62.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -82.3 -40.6 21.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.481 -0.762 . . . . 0.0 109.671 170.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.36 -33.43 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 74.9 t80 -54.65 -51.87 74.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.98 -25.42 16.34 Favored 'Trans proline' 0 C--N 1.351 0.669 1 C-N-CA 112.615 -4.457 . . . . 0.0 114.042 173.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -69.0 -38.55 79.34 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 103' ' ' PHE 0.262 0.4 OUTLIER -77.7 -27.23 50.63 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 118.511 -1.276 . . . . 0.0 113.703 178.806 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -79.74 -28.1 12.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 118.897 -1.121 . . . . 0.0 108.576 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -61.19 -44.77 96.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.492 -0.755 . . . . 0.0 110.944 172.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -65.7 -41.26 92.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.312 0.577 . . . . 0.0 110.957 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.84 -38.91 83.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.993 -0.442 . . . . 0.0 111.615 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.4 27.35 1.47 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.1 t -121.13 122.0 39.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -113.75 26.5 10.3 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -77.34 168.2 30.0 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.06 94.28 0.73 Allowed 'Trans proline' 0 C--O 1.242 0.71 0 C-N-CA 117.198 -1.402 . . . . 0.0 108.84 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.49 26.39 9.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 123.413 1.578 . . . . 0.0 110.993 -150.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.92 -28.49 69.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.957 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.24 -24.55 76.22 Favored Glycine 0 CA--C 1.519 0.326 0 O-C-N 121.165 -0.96 . . . . 0.0 114.156 172.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -91.35 -24.08 19.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.08 0.94 . . . . 0.0 111.098 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.21 -44.52 95.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 163.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -76.75 -12.73 60.03 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.752 -1.218 . . . . 0.0 114.252 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.56 -31.13 61.99 Favored 'General case' 0 C--O 1.217 -0.621 0 O-C-N 121.272 -0.892 . . . . 0.0 108.699 168.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.01 -42.36 99.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.77 -45.65 91.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.401 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -75.47 -36.78 60.6 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -76.82 -35.13 57.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 120.626 -1.296 . . . . 0.0 108.656 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.65 -19.03 58.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 118.402 -0.809 . . . . 0.0 110.346 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.58 -35.89 82.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.537 1.062 . . . . 0.0 110.412 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.99 81.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.3 mt -63.6 -37.96 89.29 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 120.937 -1.102 . . . . 0.0 113.564 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.14 -43.12 92.91 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.759 -0.588 . . . . 0.0 110.89 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.94 -49.58 40.7 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.557 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -62.54 -38.06 88.53 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.432 -0.452 . . . . 0.0 111.61 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.7 -40.75 69.3 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.257 -0.902 . . . . 0.0 112.971 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -68.04 -16.65 64.12 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.977 1.262 . . . . 0.0 112.265 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.4 t -64.63 -53.84 37.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 O-C-N 121.437 -0.789 . . . . 0.0 109.363 165.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -79.45 -51.12 9.77 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 118.036 2.606 . . . . 0.0 118.036 -173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.57 -72.23 0.29 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 117.554 -1.692 . . . . 0.0 115.48 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -69.35 176.86 5.91 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.012 2.475 . . . . 0.0 116.236 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -42.17 154.54 0.05 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.71 1.604 . . . . 0.0 114.411 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.65 -37.03 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.379 1.071 . . . . 0.0 112.672 -142.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.64 -22.22 65.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 117.465 2.395 . . . . 0.0 117.465 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.97 3.49 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 117.364 1.705 . . . . 0.0 117.364 173.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -129.6 -41.56 1.34 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 119.793 1.796 . . . . 0.0 114.015 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -159.87 -179.89 8.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.5 mt -59.17 131.78 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.614 0.643 . . . . 0.0 109.697 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 89' ' ' LEU . 80.3 m -145.88 171.89 14.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -35.64 -39.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.51 -40.22 83.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.38 -38.92 74.79 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.04 -15.54 63.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 98.3 p -96.35 -34.41 11.58 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 172.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.63 -48.99 9.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.2 92.98 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 59.3 Cg_endo -63.46 -36.2 56.14 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 112.85 -4.3 . . . . 0.0 116.762 -178.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -78.76 -30.76 45.86 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 118.775 -1.17 . . . . 0.0 108.982 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.85 -29.33 70.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 155' ' ' PRO . 42.4 m-85 -63.47 -50.62 69.0 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 123.248 1.499 . . . . 0.0 109.11 173.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -77.1 -20.18 56.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.618 -170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 44.7 tp -64.14 -51.45 63.81 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.099 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -65.04 -34.0 77.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 120.381 1.446 . . . . 0.0 112.213 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.4 -52.2 54.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.715 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.78 41.83 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.546 -0.722 . . . . 0.0 111.549 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.7 tp -66.1 -42.69 88.91 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.704 -172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.83 -35.47 92.06 Favored Glycine 0 C--O 1.238 0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.022 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -74.24 -47.35 35.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.746 -0.855 . . . . 0.0 111.528 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -87.0 -52.28 5.54 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -129.96 76.12 1.7 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.265 1.426 . . . . 0.0 108.089 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -56.14 121.36 9.24 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -168.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -151.0 92.76 3.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.7 163.59 36.89 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 114.994 -2.871 . . . . 0.0 109.963 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.57 118.99 65.55 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.24 166.22 26.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.714 -1.057 . . . . 0.0 111.996 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -73.68 3.0 6.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -68.12 -21.61 64.93 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.606 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -112.28 68.42 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.8 m -55.37 -38.17 68.49 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -55.17 -59.42 4.8 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.27 -34.51 70.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -166.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.5 tp -62.82 -44.34 96.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.28 -0.888 . . . . 0.0 113.323 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -78.78 -30.3 45.46 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.884 -1.135 . . . . 0.0 111.173 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -61.45 -49.2 77.78 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.666 0.787 . . . . 0.0 110.434 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.7 mm -69.88 -32.3 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.479 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.22 -38.54 91.57 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.047 -1.033 . . . . 0.0 112.738 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.4 mt -72.56 -31.81 65.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.286 0.565 . . . . 0.0 110.954 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.01 -11.43 59.55 Favored 'General case' 0 C--O 1.213 -0.862 0 O-C-N 121.637 -0.665 . . . . 0.0 111.952 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -92.73 27.38 2.37 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 122.716 1.246 . . . . 0.0 111.597 163.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.74 179.3 5.24 Favored 'General case' 0 C--N 1.319 -0.723 1 N-CA-C 100.186 -4.005 . . . . 0.0 100.186 176.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 60.7 135.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.87 -32.67 67.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.924 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 m -50.8 -30.26 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -115.17 -42.68 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.494 1.14 . . . . 0.0 111.006 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.47 -31.47 62.0 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -94.19 -24.61 17.43 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 40.3 p -90.79 -21.94 21.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.3 126.58 27.91 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 121.291 0.567 . . . . 0.0 110.332 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.35 167.02 21.35 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.3 49.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -69.08 -37.4 78.43 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -162.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.45 -40.51 91.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.263 1.03 . . . . 0.0 109.748 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -78.09 -13.55 59.83 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.11 -175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.17 -50.32 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 168.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -69.09 -55.08 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 122.044 0.926 . . . . 0.0 111.494 -172.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.75 -3.09 36.35 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.404 1.081 . . . . 0.0 111.18 -175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -85.33 -29.9 26.41 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.34 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -102.96 -39.95 6.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.606 . . . . 0.0 113.22 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -59.72 -29.67 6.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.12 -18.71 30.54 Favored 'Trans proline' 0 C--N 1.357 0.989 1 C-N-CA 111.81 -4.994 . . . . 0.0 114.238 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -81.35 -16.87 51.04 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.0 -38.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.453 173.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -82.05 -44.13 17.0 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.84 0 CA-C-O 113.261 -3.257 . . . . 0.0 113.949 -171.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mmm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 119.132 -0.461 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.13 159.93 39.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 165.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.23 -179.42 3.67 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.33 138.33 44.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 168.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.43 130.53 66.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -125.82 111.3 14.7 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.28 155.96 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -60.67 125.64 24.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.64 164.24 23.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.59 127.09 30.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.351 0.596 . . . . 0.0 110.802 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 t -75.39 94.02 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.994 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.12 -19.45 7.28 Favored Glycine 0 C--O 1.235 0.163 0 CA-C-N 116.404 -0.362 . . . . 0.0 113.795 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.1 69.56 23.05 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -77.47 74.14 5.26 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 N-CA-C 116.664 1.756 . . . . 0.0 116.664 -169.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -146.22 10.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 122.212 1.006 . . . . 0.0 109.442 167.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.9 mt -135.03 155.78 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 101.323 -3.584 . . . . 0.0 101.323 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.33 143.48 57.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.707 0.685 . . . . 0.0 109.952 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.55 167.67 12.44 Favored Glycine 0 CA--C 1.51 -0.224 0 N-CA-C 118.702 2.241 . . . . 0.0 118.702 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -65.39 103.97 0.9 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.929 -1.636 . . . . 0.0 113.781 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.2 t -166.36 141.37 3.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -62.98 -40.65 33.19 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 116.706 -1.729 . . . . 0.0 112.674 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.54 -27.14 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.743 -1.571 . . . . 0.0 111.471 -171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.88 -62.42 1.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.653 0.74 . . . . 0.0 109.644 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -70.4 -27.49 64.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.029 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -57.33 -46.16 83.54 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.598 1.09 . . . . 0.0 111.693 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -76.99 -35.92 24.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.222 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.36 -44.46 87.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.09 -39.17 93.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.466 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -39.54 93.01 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.685 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -33.5 54.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.958 -172.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -77.52 -33.58 54.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -67.05 -39.24 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.694 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -81.42 -6.46 58.96 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.716 -0.615 . . . . 0.0 112.402 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 54.26 41.63 31.9 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 113.213 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.4 pt -97.6 146.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.33 152.63 34.94 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 114.738 -3.041 . . . . 0.0 113.829 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -150.58 156.6 41.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.937 0.875 . . . . 0.0 112.582 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.5 t -139.57 124.65 18.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.938 1.245 . . . . 0.0 112.95 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -114.18 124.85 53.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.85 108.04 20.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 mm -83.77 95.66 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -67.64 97.31 0.6 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.92 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.9 mt 31.91 48.81 0.11 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.24 47.09 3.65 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.811 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -68.91 101.79 1.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 160.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -137.43 75.51 45.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -165.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -66.24 171.44 10.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 116.798 -1.668 . . . . 0.0 109.885 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -56.08 -36.61 68.31 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.691 -0.631 . . . . 0.0 112.313 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -56.95 -42.37 79.97 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 172.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -79.96 -31.44 39.94 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.086 -1.009 . . . . 0.0 111.418 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.9 mt -67.1 -24.67 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.296 -0.252 . . . . 0.0 111.67 175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -66.75 -37.49 84.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.163 0.506 . . . . 0.0 110.962 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -88.91 -52.08 11.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 CA-C-O 121.193 0.521 . . . . 0.0 111.806 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -87.35 117.06 68.07 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 120.886 -1.134 . . . . 0.0 111.302 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -58.33 -23.87 65.21 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 118.505 2.463 . . . . 0.0 118.505 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -103.4 -10.8 18.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.883 -1.136 . . . . 0.0 112.538 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -0.39 37.9 Favored Glycine 0 C--O 1.224 -0.478 0 O-C-N 121.071 -1.018 . . . . 0.0 113.414 -164.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -146.25 34.82 0.98 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.87 0.843 . . . . 0.0 110.708 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.8 141.2 37.48 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.68 147.85 90.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 116.131 -2.113 . . . . 0.0 113.063 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.7 m -140.93 162.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.93 132.78 53.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -105.81 136.53 45.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.88 91.25 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.1 t0 50.55 52.96 13.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.124 0.964 . . . . 0.0 111.391 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.4 t70 62.15 24.27 14.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -110.91 163.94 13.3 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -146.76 159.64 43.24 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.848 2.113 . . . . 0.0 115.447 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.42 162.27 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.66 -116.13 0.29 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.6 173.37 1.7 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 p -58.3 -30.05 66.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 -158.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -77.92 -26.17 48.82 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.851 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -83.3 -34.85 11.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -39.87 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.306 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.81 -45.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.875 0.761 . . . . 0.0 111.646 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.43 -33.92 51.72 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 115.984 1.154 . . . . 0.0 115.984 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -118.39 -51.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -172.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.5 -40.36 85.2 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.998 -172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -61.02 -38.36 85.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 119.238 0.926 . . . . 0.0 109.367 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -68.21 -31.82 71.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -97.01 1.26 49.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -71.54 135.87 83.73 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -63.19 -21.68 72.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 116.607 -1.795 . . . . 0.0 116.589 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -93.37 161.02 32.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.19 144.44 90.52 Favored 'Trans proline' 0 C--N 1.354 0.847 0 N-CA-C 116.705 1.771 . . . . 0.0 116.705 -156.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -84.95 29.16 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.029 1.819 . . . . 0.0 115.317 -163.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.3 mt -66.33 111.58 3.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.81 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.15 26.55 2.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.244 1.021 . . . . 0.0 110.461 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.67 123.68 58.92 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -170.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -114.74 62.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.605 0 N-CA-C 116.452 1.674 . . . . 0.0 116.452 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -83.38 -132.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 121.192 1.261 . . . . 0.0 113.845 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.91 -32.98 70.03 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.442 -1.411 . . . . 0.0 110.638 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -62.55 -31.81 72.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.321 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.6 20.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.166 -0.334 . . . . 0.0 110.746 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.4 p -68.3 -39.26 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.537 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.2 t -73.76 -46.5 47.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.598 -0.689 . . . . 0.0 109.431 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.28 74.55 Favored Glycine 0 CA--C 1.516 0.097 0 N-CA-C 115.549 0.98 . . . . 0.0 115.549 -174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -66.77 -17.93 65.12 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -81.91 -33.65 30.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.275 0.943 . . . . 0.0 110.757 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.97 -43.67 81.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -50.52 -59.79 6.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.59 -16.13 15.09 Favored 'Trans proline' 0 C--N 1.351 0.674 1 C-N-CA 112.195 -4.737 . . . . 0.0 114.578 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m -61.98 -37.4 84.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.531 1.06 . . . . 0.0 111.182 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -84.63 -24.9 28.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.985 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.72 -42.3 80.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -55.89 -47.69 76.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.514 0.725 . . . . 0.0 109.601 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.87 -41.51 97.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.58 -40.21 92.5 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -84.94 -8.31 58.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 t -87.91 144.07 26.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.17 39.45 2.92 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 123.144 1.449 . . . . 0.0 108.192 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.67 -179.36 0.51 Allowed Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 112.559 -2.11 . . . . 0.0 108.994 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -63.42 89.24 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 115.654 -2.431 . . . . 0.0 112.404 151.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -88.85 98.16 11.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.23 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -140.02 -49.08 0.46 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.025 -0.422 . . . . 0.0 110.681 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.2 -35.67 92.38 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.3 p -75.82 -18.35 59.51 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -82.82 -36.71 25.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.44 1.114 . . . . 0.0 108.221 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -65.31 -31.85 73.2 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.161 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.09 73.54 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.692 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.11 -47.47 84.48 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.05 -47.8 83.08 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.514 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.88 -37.33 73.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -69.12 -44.12 73.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.24 -22.87 62.85 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.079 -1.013 . . . . 0.0 111.372 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.74 -33.56 75.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.473 0.579 . . . . 0.0 110.368 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.92 -46.11 79.47 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.511 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 22.2 mt -67.1 -38.58 85.93 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.552 -0.717 . . . . 0.0 111.239 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.002 0.521 . . . . 0.0 110.343 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.96 -51.81 50.24 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -60.94 -38.32 85.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.47 -51.39 67.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.382 0.611 . . . . 0.0 111.828 -177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -73.68 -16.1 61.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -165.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.02 -27.75 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 123.51 0.724 . . . . 0.0 110.778 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -106.42 -45.11 4.35 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.54 -59.71 0.35 Allowed Glycine 0 CA--C 1.529 0.962 0 N-CA-C 119.013 2.365 . . . . 0.0 119.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -67.97 -154.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 122.019 2.909 . . . . 0.0 115.897 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -58.91 168.98 1.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.909 0.884 . . . . 0.0 112.939 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.77 -36.36 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -163.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.27 -3.58 4.2 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 116.727 2.121 . . . . 0.0 116.727 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 103.95 -30.62 9.87 Favored Glycine 0 CA--C 1.51 -0.279 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 168.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -124.6 -43.96 2.0 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -159.17 172.22 18.48 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -172.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.68 118.18 2.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 148' ' ' ALA . 3.1 m -139.84 -175.9 4.38 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 147' ' ' THR . . . -45.26 -41.06 8.16 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 118.736 2.865 . . . . 0.0 118.736 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.11 -39.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 119.391 0.996 . . . . 0.0 110.314 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -71.13 -35.69 71.83 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.26 -24.63 67.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.983 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.4 p -97.83 -41.68 7.93 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 75.9 mt -73.13 -47.46 43.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.43 97.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.79 -25.32 20.38 Favored 'Trans proline' 0 C--N 1.347 0.493 1 C-N-CA 111.202 -5.398 . . . . 0.0 114.924 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -72.89 -31.82 64.94 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 119.916 -1.74 . . . . 0.0 109.22 176.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.79 -29.52 68.72 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -63.86 -47.65 79.89 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.886 -1.134 . . . . 0.0 110.589 168.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -62.24 -31.81 72.41 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.86 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.73 -59.15 3.82 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.279 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.02 -35.15 79.77 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.256 0.934 . . . . 0.0 111.743 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -57.21 -41.12 77.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.163 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.48 -35.08 14.54 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.66 -41.44 92.5 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.275 -0.891 . . . . 0.0 112.148 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.82 69.5 Favored Glycine 0 C--O 1.228 -0.239 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -73.27 -49.01 29.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -100.99 -29.11 12.37 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.697 2.481 . . . . 0.0 117.697 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -124.51 20.14 8.73 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.228 0.467 . . . . 0.0 110.831 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -13.25 91.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 119.141 3.015 . . . . 0.0 119.141 -153.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -115.06 92.63 31.84 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.46 155.96 62.53 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 113.819 -3.654 . . . . 0.0 108.951 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.9 mt -65.92 125.77 90.57 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.79 153.62 58.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 117.418 -1.254 . . . . 0.0 111.317 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.69 0.98 11.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.82 -27.73 68.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 165.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.99 67.45 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -33.06 69.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.508 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -62.73 1.5 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 17.6 t -69.16 -35.23 67.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -160.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.45 -41.81 84.1 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.625 -0.672 . . . . 0.0 111.886 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -67.4 -37.04 82.5 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.469 -0.769 . . . . 0.0 110.46 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -64.2 -41.19 97.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 123.941 0.896 . . . . 0.0 112.88 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.38 -31.44 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.668 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.28 -41.5 98.53 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.408 -1.432 . . . . 0.0 111.159 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.36 -34.92 78.3 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.539 -0.726 . . . . 0.0 111.784 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.11 -49.78 76.28 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -70.14 -15.7 63.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.6 t -75.68 -49.32 18.71 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -85.03 144.34 28.34 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.65 -24.1 67.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.179 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.7 m -51.99 -36.58 50.27 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.82 -40.64 6.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.952 0.882 . . . . 0.0 109.2 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.29 -33.93 73.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -81.23 -33.56 32.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 69.2 p -93.77 -10.33 34.57 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -54.99 135.79 48.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 122.414 1.102 . . . . 0.0 111.778 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.08 150.92 47.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.408 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.32 121.79 13.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -40.26 93.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -169.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.47 -30.52 71.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 122.684 1.231 . . . . 0.0 108.979 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.75 9.37 39.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.627 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 90.0 t -93.66 -44.01 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.1 pt -66.04 -37.66 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.216 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -78.93 -3.54 45.38 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.19 -32.05 13.05 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -101.52 -55.96 2.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.87 -30.59 4.54 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 -172.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.38 -27.88 47.05 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 111.539 -5.174 . . . . 0.0 114.381 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -69.29 -34.2 74.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.622 0.646 . . . . 0.0 110.661 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.87 -39.08 74.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -68.01 -44.3 76.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.448 1.099 . . . . 0.0 110.707 179.468 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.2 -161.99 0.06 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.723 1.209 . . . . 0.0 113.933 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.75 169.19 23.36 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -132.47 169.68 16.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 mm -133.78 142.17 42.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -124.64 133.84 53.1 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.374 -2.824 . . . . 0.0 103.374 162.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.48 160.05 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.803 1.183 . . . . 0.0 109.586 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.69 133.98 51.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.928 0.331 . . . . 0.0 110.715 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.06 165.36 25.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.018 0.437 . . . . 0.0 110.028 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.25 127.99 33.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.31 129.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.61 -19.78 51.94 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-O 118.776 -1.013 . . . . 0.0 114.675 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.06 81.92 7.31 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 118.385 1.093 . . . . 0.0 113.327 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.06 71.0 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 N-CA-C 115.849 1.442 . . . . 0.0 115.849 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -142.58 -11.08 0.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.057 164.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -131.4 168.95 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.2 1.0 . . . . 0.0 109.231 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 mt -75.26 147.68 40.06 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.35 171.61 15.39 Favored Glycine 0 C--O 1.237 0.285 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.17 97.19 8.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.915 0.864 . . . . 0.0 109.252 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.38 132.31 20.91 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 166.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -67.77 -43.37 5.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 115.331 -2.646 . . . . 0.0 115.211 -168.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -26.1 64.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.848 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.8 m -64.34 -44.5 91.29 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.985 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -66.48 -41.97 88.16 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.5 -0.75 . . . . 0.0 110.491 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 tpt85 -58.62 -41.13 85.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.54 -41.78 80.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.253 0.933 . . . . 0.0 112.459 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.59 -39.42 84.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.389 0.614 . . . . 0.0 111.179 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.45 -41.84 99.03 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.39 95.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.751 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.7 -40.72 72.72 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.219 -174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -70.87 -36.97 73.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.507 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -68.91 -39.54 79.63 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.057 -1.027 . . . . 0.0 110.475 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HG3' HD21 ' A' ' 84' ' ' ASN . 67.1 mmtt -79.16 -4.52 50.85 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 56.1 34.87 24.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.821 1.248 . . . . 0.0 114.152 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.4 pt -95.18 135.74 23.18 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.9 148.62 25.3 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 116.023 -2.184 . . . . 0.0 114.979 -168.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -144.91 153.81 41.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.034 0.921 . . . . 0.0 112.418 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -111.34 117.16 32.35 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.2 t -89.9 123.18 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 123.995 0.809 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -111.12 94.22 4.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.33 135.65 52.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.764 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.2 mm -85.25 110.82 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 173.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -78.73 53.4 1.34 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.852 1.261 . . . . 0.0 112.661 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.7 mt 51.05 38.97 22.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 112.843 177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.85 72.96 0.2 Allowed Glycine 0 CA--C 1.512 -0.141 0 N-CA-C 106.468 -2.653 . . . . 0.0 106.468 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.75 -178.45 6.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 111.648 -172.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.79 150.13 91.65 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 124.337 1.055 . . . . 0.0 113.395 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -20.03 -137.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.258 2 C-N-CA 128.975 6.45 . . . . 0.0 125.304 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -66.61 -26.9 67.3 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.963 -1.71 . . . . 0.0 113.975 -161.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 t90 -61.24 -44.27 97.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 110.553 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -77.27 -33.92 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.156 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.29 -29.35 67.2 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -70.15 -30.77 68.0 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.243 -0.911 . . . . 0.0 110.703 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.36 -58.94 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.041 0.448 . . . . 0.0 111.73 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.7 t -83.72 121.31 76.15 Favored Pre-proline 0 C--N 1.322 -0.615 0 O-C-N 120.845 -1.159 . . . . 0.0 108.56 -172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.07 -21.79 31.53 Favored 'Trans proline' 0 C--N 1.346 0.412 0 N-CA-C 117.098 1.922 . . . . 0.0 117.098 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -94.1 -9.41 36.66 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.823 -1.173 . . . . 0.0 110.221 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -31.15 2.38 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.362 -162.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -118.59 31.37 6.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.81 155.1 60.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.2 171.0 17.73 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 117.247 -1.369 . . . . 0.0 113.262 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.61 159.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 163.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.25 130.45 48.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 103.028 -2.953 . . . . 0.0 103.028 146.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -105.32 90.81 3.54 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 mt -100.36 113.25 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 52.68 41.9 31.5 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.787 0.803 . . . . 0.0 111.596 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.5 t0 60.29 37.76 20.18 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -136.72 148.36 47.26 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -133.95 140.72 46.94 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 119.554 3.168 . . . . 0.0 119.554 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.33 139.28 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.76 1.224 . . . . 0.0 108.337 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.19 15.91 0.47 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 155.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -63.57 139.14 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.734 -1.228 . . . . 0.0 108.169 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -154.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.97 -37.98 17.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.782 0.801 . . . . 0.0 109.641 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.0 t -67.94 -36.41 75.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.887 0.851 . . . . 0.0 111.115 -172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -25.35 37.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.997 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.87 -40.37 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.87 -59.08 1.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.77 . . . . 0.0 114.572 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -66.95 -39.5 83.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 118.423 -0.799 . . . . 0.0 112.806 -169.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 tp -61.47 -44.31 97.33 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 120.109 1.322 . . . . 0.0 108.77 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -67.75 -35.07 78.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.218 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.23 -17.7 63.8 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.169 -0.957 . . . . 0.0 113.056 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -109.04 3.24 21.86 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.738 -0.601 . . . . 0.0 111.434 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.456 HD21 ' HG3' ' A' ' 33' ' ' LYS . 31.2 t-20 -76.96 126.71 85.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.75 -8.99 22.14 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 116.62 -1.787 . . . . 0.0 114.199 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -106.1 162.99 17.99 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -56.8 138.51 85.84 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 N-CA-C 118.003 2.27 . . . . 0.0 118.003 -158.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.79 87.29 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.674 1.582 . . . . 0.0 115.709 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.31 53.4 0.96 Allowed 'General case' 0 C--O 1.24 0.599 0 CA-C-O 123.103 1.43 . . . . 0.0 111.638 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.26 77.92 8.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.856 174.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.1 m -122.51 95.32 46.93 Favored Pre-proline 0 C--N 1.32 -0.714 0 O-C-N 121.762 -0.586 . . . . 0.0 110.43 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.29 73.41 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 123.722 2.948 . . . . 0.0 116.458 169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -84.41 -138.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 119.081 0.707 . . . . 0.0 113.221 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.95 -35.75 59.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -66.26 -26.75 67.5 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.256 -0.902 . . . . 0.0 110.548 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.18 -32.19 24.73 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.2 p -71.94 -38.08 69.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.077 0.853 . . . . 0.0 109.129 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.07 -39.62 84.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.98 -33.05 67.68 Favored Glycine 0 C--O 1.224 -0.485 0 O-C-N 121.477 -0.764 . . . . 0.0 113.702 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.8 p -71.06 -11.81 61.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.432 1.116 . . . . 0.0 113.607 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -96.77 -26.42 15.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.668 0.747 . . . . 0.0 109.516 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 75.7 mt -79.25 -56.26 7.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.261 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -59.39 -55.14 49.11 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -165.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.03 -20.46 19.29 Favored 'Trans proline' 0 C--N 1.351 0.667 1 C-N-CA 113.006 -4.196 . . . . 0.0 112.716 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.0 m -69.46 -36.1 76.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.819 -0.551 . . . . 0.0 110.119 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.88 -35.97 77.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 121.085 -1.009 . . . . 0.0 112.018 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.8 t -67.0 -42.26 88.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -57.11 -49.12 76.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.304 0.642 . . . . 0.0 111.786 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -81.62 -11.16 59.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.3 tp -77.99 -36.95 48.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.557 0.694 . . . . 0.0 111.333 165.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -70.2 -25.45 63.42 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.304 -0.873 . . . . 0.0 111.453 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 t -88.93 149.12 23.47 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -132.05 40.58 3.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 123.105 1.431 . . . . 0.0 109.085 161.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.42 171.82 3.09 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 167.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.57 72.5 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 CA-C-O 123.158 1.233 . . . . 0.0 114.161 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -85.33 101.79 12.85 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.933 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.61 -52.58 0.35 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.66 -30.75 78.55 Favored Glycine 0 C--O 1.226 -0.364 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.8 p -77.36 -24.22 50.69 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 118.452 1.126 . . . . 0.0 112.867 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -73.22 -35.91 66.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -67.42 -31.47 71.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.488 -0.757 . . . . 0.0 110.875 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.29 -35.85 80.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 120.506 -1.371 . . . . 0.0 111.093 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.82 -37.99 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.163 -0.335 . . . . 0.0 110.178 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.69 -41.1 89.94 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 172.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -67.88 -33.3 74.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.869 -1.144 . . . . 0.0 112.604 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -64.96 -40.65 95.31 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.58 -23.99 61.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.551 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.09 -26.48 66.74 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 118.626 0.648 . . . . 0.0 110.668 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.15 -46.64 70.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 tp -67.35 -40.67 85.87 Favored 'General case' 0 C--O 1.22 -0.452 0 O-C-N 121.414 -0.803 . . . . 0.0 111.169 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -60.23 -39.63 87.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.33 -47.31 85.87 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-O 119.489 -0.617 . . . . 0.0 112.734 177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -64.0 -41.56 97.45 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.029 0.914 . . . . 0.0 108.991 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -44.51 82.53 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.25 -0.906 . . . . 0.0 112.333 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -72.31 -12.62 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.0 m -96.57 -8.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 118.582 0.628 . . . . 0.0 112.254 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -109.72 -43.59 4.01 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.61 -76.19 0.24 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -69.37 -176.09 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 CA-C-N 120.909 2.354 . . . . 0.0 118.047 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -54.89 161.45 1.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.32 -30.04 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.972 -116.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.27 18.8 0.11 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.26 6.86 85.79 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -144.56 -48.6 0.26 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -172.95 175.02 3.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 -166.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.3 mm -61.14 121.41 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 m -135.98 178.59 6.93 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.48 -27.37 24.88 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 44.0 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.422 0.629 . . . . 0.0 110.517 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.56 -39.8 94.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.96 -21.6 61.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.06 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.2 p -87.5 -36.56 17.57 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.674 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -91.18 -47.25 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.8 -42.52 94.62 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.8 -29.33 12.65 Favored 'Trans proline' 0 C--N 1.352 0.73 1 C-N-CA 111.849 -4.967 . . . . 0.0 113.696 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.23 -25.87 42.56 Favored 'General case' 0 C--O 1.216 -0.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.135 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.07 -35.57 80.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 119.095 0.861 . . . . 0.0 111.494 167.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -63.86 -47.46 80.61 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -63.09 -35.09 79.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.35 -51.4 57.57 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.388 -0.82 . . . . 0.0 111.0 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -65.01 -30.88 71.89 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.751 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.17 -58.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 117.902 0.319 . . . . 0.0 110.489 172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.05 -43.74 67.22 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.134 -0.979 . . . . 0.0 113.127 -171.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.03 -35.14 74.08 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.39 -37.5 94.56 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.907 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -66.07 -42.07 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.269 -0.548 . . . . 0.0 111.471 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -100.74 -42.95 6.29 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 118.504 2.779 . . . . 0.0 118.504 -164.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -140.89 57.52 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -47.35 122.08 4.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -152.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -155.0 93.22 2.77 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.44 165.56 32.16 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 115.848 -2.301 . . . . 0.0 109.64 166.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.82 121.12 71.79 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.41 161.68 41.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 116.5 -1.867 . . . . 0.0 113.345 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -73.35 1.37 9.73 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.5 -21.65 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.667 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.43 78.7 1.15 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.52 -40.35 82.65 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -54.52 39.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 44.3 t -66.0 -43.79 92.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.69 -47.03 85.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -75.35 -33.97 61.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.653 -0.654 . . . . 0.0 112.6 -174.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -78.36 -20.67 50.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.02 -42.03 94.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -63.45 -33.5 75.7 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.496 -1.378 . . . . 0.0 111.261 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.0 -42.87 75.89 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.932 -0.48 . . . . 0.0 111.511 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.16 -18.91 22.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.38 -35.72 70.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.7 t -128.11 68.2 1.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.597 165.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -103.84 140.39 37.72 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.083 -3.673 . . . . 0.0 101.083 154.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -53.05 -45.87 68.26 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 40.8 t -61.64 -45.48 93.89 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.303 1.049 . . . . 0.0 112.518 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.73 -41.07 68.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.764 -174.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.78 -40.11 82.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.782 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -78.44 -35.3 47.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 36.4 p -88.55 -15.97 33.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -65.36 150.12 48.83 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.614 -0.678 . . . . 0.0 112.604 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.84 160.19 30.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.19 143.55 50.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -56.84 -42.95 80.59 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -59.71 -40.45 88.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 0.0 110.964 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -79.05 -12.5 60.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.7 t -72.58 -48.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -68.11 -51.45 48.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.323 1.059 . . . . 0.0 108.578 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.5 -5.75 44.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.18 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.77 -29.54 15.59 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 119.517 -0.602 . . . . 0.0 114.313 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -106.82 -26.07 11.42 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -64.87 -18.8 0.47 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 119.522 3.156 . . . . 0.0 119.522 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 -14.48 44.45 Favored 'Trans proline' 0 C--N 1.358 1.034 1 C-N-CA 112.905 -4.263 . . . . 0.0 116.282 168.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -98.64 7.39 46.17 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.337 0.589 . . . . 0.0 111.3 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 98.9 t -111.36 -40.38 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -76.83 -10.84 59.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.617 1.339 . . . . 0.0 114.617 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 178.535 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 145.73 49.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 172.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -147.21 167.96 22.89 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -114.65 141.55 47.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.848 1.204 . . . . 0.0 112.323 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mm -119.51 96.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.1 t -96.16 118.62 33.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.22 163.7 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -166.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -67.88 130.88 44.34 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.634 -0.666 . . . . 0.0 112.553 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.3 166.53 22.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.479 174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.88 139.72 56.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.65 126.83 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.885 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.04 -16.17 17.57 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.994 1.158 . . . . 0.0 115.994 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.21 76.45 13.4 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 50.7 Cg_endo -75.33 42.24 0.86 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 N-CA-C 118.391 2.42 . . . . 0.0 118.391 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -112.12 -12.56 13.65 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -125.84 159.33 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.63 135.44 57.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.839 1.255 . . . . 0.0 111.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.32 -163.7 36.99 Favored Glycine 0 CA--C 1.511 -0.198 0 N-CA-C 119.307 2.483 . . . . 0.0 119.307 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -76.35 76.38 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.157 1.383 . . . . 0.0 109.774 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -141.35 82.98 13.93 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 121.221 -0.925 . . . . 0.0 113.147 -171.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.27 -22.71 75.4 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 116.079 -2.147 . . . . 0.0 115.571 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -68.85 -38.43 79.78 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -69.55 -40.45 76.81 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -62.69 -35.32 79.3 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 118.381 -0.818 . . . . 0.0 112.275 175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -57.59 -39.81 77.64 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.725 1.602 . . . . 0.0 110.767 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.42 -52.86 42.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.42 0.629 . . . . 0.0 110.293 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.09 -37.78 88.7 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.7 mt -63.81 -41.78 97.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.1 p -66.89 -32.49 73.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.308 0.575 . . . . 0.0 111.29 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.43 -46.38 48.82 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.146 -0.346 . . . . 0.0 111.112 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -72.52 -34.37 67.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -36.31 83.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.021 -1.05 . . . . 0.0 110.18 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -86.22 -7.08 58.81 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.3 mttp 59.55 29.33 18.89 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.487 1.515 . . . . 0.0 114.121 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -80.84 136.18 51.34 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.82 153.18 53.31 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.178 -1.415 . . . . 0.0 114.214 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -156.57 171.69 19.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.101 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -118.37 124.9 48.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.8 t -83.5 145.81 28.72 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -139.66 146.43 39.69 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 102.799 -3.037 . . . . 0.0 102.799 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.6 mt -114.73 132.34 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.73 119.89 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.32 72.79 7.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.55 1.167 . . . . 0.0 109.937 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.0 mt 57.22 27.16 13.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.15 11.6 33.64 Favored Glycine 0 C--O 1.226 -0.351 0 O-C-N 121.871 -0.518 . . . . 0.0 113.537 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -68.33 117.41 10.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 154.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -140.1 101.16 7.01 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.3 175.68 7.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.972 -0.885 . . . . 0.0 111.133 173.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -56.49 -36.48 69.17 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 122.146 -0.346 . . . . 0.0 111.017 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -56.6 -40.58 75.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -71.52 -31.81 67.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.142 -0.974 . . . . 0.0 108.959 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -77.29 -23.62 51.09 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -67.34 -35.29 79.1 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.303 -0.873 . . . . 0.0 110.241 172.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -99.05 -53.03 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -90.59 139.05 26.42 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 121.661 -0.649 . . . . 0.0 111.004 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.12 -22.91 46.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 116.974 -1.551 . . . . 0.0 115.858 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -108.11 -6.24 16.57 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.434 0.635 . . . . 0.0 111.992 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.54 4.35 38.22 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.373 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.65 58.44 1.12 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.968 0.907 . . . . 0.0 110.819 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.9 m -137.82 159.17 69.83 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 100.343 -3.947 . . . . 0.0 100.343 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -69.16 147.98 67.95 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 114.081 -3.479 . . . . 0.0 111.47 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.1 155.54 38.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.164 0.507 . . . . 0.0 109.966 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.2 t -123.33 109.18 22.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -91.67 84.98 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.6 mt -81.8 95.68 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.153 0.981 . . . . 0.0 108.361 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.3 t0 51.94 46.85 25.89 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.434 1.111 . . . . 0.0 111.779 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 t0 58.99 30.55 20.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -114.85 165.85 12.4 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 166.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 12.9 p90 -150.58 149.79 30.37 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.06 157.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -115.52 -121.65 0.3 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.66 -176.91 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -166.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 p -54.41 -36.44 63.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.67 -20.43 53.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.943 0.878 . . . . 0.0 110.006 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.6 t -91.87 -43.89 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -42.04 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.71 -0.619 . . . . 0.0 111.14 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.32 -13.85 17.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.66 0.743 . . . . 0.0 112.299 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.04 -64.04 0.71 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -73.42 -47.39 45.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.631 -168.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.08 -40.45 94.67 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.606 1.548 . . . . 0.0 108.702 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -63.42 -42.66 98.72 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.704 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -64.95 -40.19 94.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -87.12 4.96 40.15 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.933 -0.48 . . . . 0.0 111.968 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.45 135.91 93.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 121.987 -0.445 . . . . 0.0 111.516 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.44 -6.07 16.05 Favored 'Trans proline' 0 C--N 1.348 0.54 0 N-CA-C 114.891 1.073 . . . . 0.0 114.891 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -112.11 162.32 21.87 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.38 130.89 39.75 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 116.381 -1.946 . . . . 0.0 116.791 -161.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.8 146.02 32.99 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 116.763 -1.691 . . . . 0.0 111.914 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.26 45.74 2.73 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -81.24 80.26 7.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.3 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 37.2 p -114.31 106.02 53.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -98.51 59.16 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.738 0 C-N-CA 123.357 2.705 . . . . 0.0 118.71 163.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -81.18 -146.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 120.112 1.076 . . . . 0.0 113.107 -177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -51.43 -32.27 26.0 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -68.6 -30.57 69.33 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.417 -0.802 . . . . 0.0 111.599 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.17 -36.46 47.48 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.247 -0.283 . . . . 0.0 110.642 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 42.5 p -74.85 -30.52 61.37 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.731 -0.605 . . . . 0.0 112.531 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.1 t -75.12 -40.66 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 171.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -37.08 91.25 Favored Glycine 0 C--O 1.222 -0.605 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.252 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.3 p -71.47 -11.66 60.99 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -81.21 -32.39 33.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.628 1.204 . . . . 0.0 110.004 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.9 mt -80.3 -43.06 21.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.179 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.66 -56.83 19.18 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.3 -13.21 13.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 113.973 -3.551 . . . . 0.0 113.464 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.5 t -69.55 -49.51 53.64 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.992 -0.443 . . . . 0.0 109.808 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -70.72 -26.99 63.63 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 118.03 -1.468 . . . . 0.0 111.608 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.33 -44.51 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -65.2 -44.82 87.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.74 -25.96 59.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.0 OUTLIER -77.0 -37.33 55.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.092 0.86 . . . . 0.0 110.667 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -87.94 40.14 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t -152.02 144.81 24.34 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -131.16 34.41 4.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.34 168.63 7.51 Favored Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 163.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.61 44.3 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 N-CA-C 115.959 1.484 . . . . 0.0 115.959 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.71 116.69 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.765 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -150.88 -55.49 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.74 -40.6 97.54 Favored Glycine 0 C--O 1.217 -0.906 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.1 p -69.42 -27.55 65.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.86 1.33 . . . . 0.0 112.56 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -73.73 -29.35 62.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.778 1.275 . . . . 0.0 108.372 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -83.98 -24.55 30.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.715 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.46 86.27 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.755 -1.216 . . . . 0.0 108.632 169.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.34 -39.54 93.43 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.985 -0.447 . . . . 0.0 111.455 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.59 -40.23 86.78 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -67.33 -34.46 77.38 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 120.975 -1.078 . . . . 0.0 113.496 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -65.58 -42.36 91.8 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.718 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.8 mt -65.9 -35.52 80.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.927 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -64.98 -28.96 69.87 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.607 0.363 . . . . 0.0 111.932 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.54 -44.74 93.33 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.379 -0.929 . . . . 0.0 108.821 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.64 -38.35 80.41 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.908 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.12 -42.92 95.79 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.653 1.115 . . . . 0.0 111.732 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.49 -34.14 89.11 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.952 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -77.16 -43.49 33.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.655 -0.909 . . . . 0.0 110.363 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -41.35 74.08 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -70.58 -20.76 62.75 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.896 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.94 -47.03 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 167.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -73.96 -46.18 45.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.22 -73.95 0.22 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 116.784 -2.12 . . . . 0.0 117.407 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -61.46 -164.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.688 1 C-N-CA 126.268 4.645 . . . . 0.0 118.932 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -58.3 172.98 0.4 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.776 0.83 . . . . 0.0 113.123 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.29 -39.26 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.302 0.641 . . . . 0.0 112.283 -160.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.08 4.88 1.87 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.17 -14.02 66.27 Favored Glycine 0 C--O 1.229 -0.191 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -134.58 -49.42 0.77 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -166.17 179.01 5.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 -171.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 120.08 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -129.87 -164.09 1.37 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 171.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.75 -38.55 15.73 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.84 -40.19 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 123.033 1.397 . . . . 0.0 111.303 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -73.28 -32.31 64.58 Favored 'General case' 0 C--N 1.321 -0.67 0 O-C-N 120.992 -1.067 . . . . 0.0 109.915 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 98.9 mt -69.9 -33.18 71.84 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.803 -0.561 . . . . 0.0 110.361 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 82.0 p -80.08 -45.96 17.35 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.8 mt -81.18 -42.87 20.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.68 -37.83 60.6 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 117.192 2.293 . . . . 0.0 117.192 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.9 -22.48 23.28 Favored 'Trans proline' 0 C--N 1.35 0.628 1 C-N-CA 111.893 -4.938 . . . . 0.0 114.731 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -74.72 -31.8 61.96 Favored 'General case' 0 C--O 1.216 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 108.796 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.65 -31.71 71.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.502 0.592 . . . . 0.0 112.217 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -62.65 -51.38 67.5 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.418 -0.801 . . . . 0.0 109.753 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -65.58 -28.64 69.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.531 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 110' ' ' LEU . 40.1 tp -60.61 -52.36 65.5 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.602 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -67.36 -38.34 84.65 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.902 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.63 -49.47 84.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 203' ' ' ILE . . . -78.89 -50.31 11.43 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 120.571 -1.331 . . . . 0.0 114.191 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.07 -37.56 87.94 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 121.274 -0.891 . . . . 0.0 110.016 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.18 79.91 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -86.68 -36.02 18.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.074 0.937 . . . . 0.0 110.846 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 203' ' ' ILE . 32.3 m-85 -91.68 -37.29 13.11 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 120.671 3.582 . . . . 0.0 120.671 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -150.31 62.04 0.96 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -52.81 128.56 27.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.515 -1.675 . . . . 0.0 113.261 -159.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -138.61 97.98 9.03 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.96 151.22 82.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 114.164 -3.424 . . . . 0.0 110.791 167.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 52.8 mt -71.6 126.84 91.56 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.68 160.7 47.41 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 117.092 -1.472 . . . . 0.0 112.781 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -74.05 -1.57 20.63 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.09 -1.18 57.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.515 0.674 . . . . 0.0 109.71 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 84.6 mt -121.71 55.56 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.996 -1.854 . . . . 0.0 105.996 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.0 m -58.39 -33.43 69.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -59.87 4.06 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.39 -38.61 81.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.9 tp -63.32 -45.52 90.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.585 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -83.32 -24.34 32.17 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.008 -0.433 . . . . 0.0 110.208 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -62.22 -47.82 82.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.58 -48.34 87.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -61.82 -35.45 78.27 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 75.1 mt -70.17 -45.61 66.37 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.791 -0.568 . . . . 0.0 111.171 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.3 -20.83 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.35 -22.75 54.56 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.051 0.54 . . . . 0.0 112.12 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 t -128.02 67.42 1.35 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.394 1.093 . . . . 0.0 109.635 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.0 mmt-85 -118.12 142.37 47.49 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 155.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -59.94 -38.78 83.41 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.671 0.607 . . . . 0.0 111.203 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.7 p -57.5 -46.13 84.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.523 0.601 . . . . 0.0 111.521 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -49.57 55.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.866 0.365 . . . . 0.0 111.698 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.33 -47.13 52.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -71.94 -24.24 61.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 112.824 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 70.4 p -120.36 27.32 8.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.914 0.864 . . . . 0.0 111.328 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -63.19 157.4 22.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.351 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.47 160.97 30.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.41 109.68 5.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -60.4 -36.45 78.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.16 -36.16 76.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.977 0.894 . . . . 0.0 109.69 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -90.8 -8.0 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 121.879 -0.513 . . . . 0.0 111.086 -173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.33 -50.71 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 163.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 163' ' ' ALA 0.265 19.7 pt -69.5 -50.21 52.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.734 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.26 53.1 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.302 -0.874 . . . . 0.0 111.464 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -87.93 -31.95 13.84 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -95.61 -42.64 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -20.63 0.6 Allowed Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 120.566 3.543 . . . . 0.0 120.566 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.54 -21.97 59.22 Favored 'Trans proline' 0 C--N 1.353 0.769 1 C-N-CA 111.337 -5.308 . . . . 0.0 113.779 173.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -79.14 -33.08 44.47 Favored 'General case' 0 C--O 1.224 -0.272 0 O-C-N 122.041 -0.412 . . . . 0.0 111.285 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.2 t -70.46 -39.54 76.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -75.32 -13.8 60.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.754 176.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.28 167.26 17.96 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.931 0.892 . . . . 0.0 109.376 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -148.55 165.65 30.6 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -143.85 155.43 44.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.506 1.048 . . . . 0.0 109.487 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.98 106.07 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.33 1.062 . . . . 0.0 113.062 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.2 m -87.44 64.54 8.23 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.375 -0.828 . . . . 0.0 112.993 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 m -71.47 152.22 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.61 134.75 38.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.56 171.5 12.29 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.94 137.36 58.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.803 0.811 . . . . 0.0 112.502 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.16 118.4 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.38 -6.95 82.97 Favored Glycine 0 C--O 1.246 0.864 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.54 100.01 4.43 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.81 80.11 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 CA-C-O 122.701 1.042 . . . . 0.0 113.926 169.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -148.51 -31.19 0.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.482 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.38 162.88 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 -170.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.7 158.13 35.96 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -126.24 -178.78 15.46 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.76 105.84 10.34 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 63.8 m -128.68 153.03 79.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 149.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.18 -39.78 65.77 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.475 -1.884 . . . . 0.0 109.755 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.14 -14.91 63.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.77 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.7 -58.02 3.46 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.69 -26.22 66.07 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.59 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -47.36 -45.95 25.32 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 120.996 1.725 . . . . 0.0 113.161 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.36 -34.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.05 -39.88 96.06 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.538 -1.351 . . . . 0.0 110.13 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.6 -33.55 72.85 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.286 0.846 . . . . 0.0 113.286 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -74.71 -46.74 35.54 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.727 -0.608 . . . . 0.0 109.592 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -40.81 76.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -71.77 -25.78 62.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.808 0.731 . . . . 0.0 111.054 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -69.03 -43.24 75.12 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.872 -1.142 . . . . 0.0 108.271 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.59 -12.18 60.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.066 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.4 mtmm 54.67 42.94 30.88 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.073 1.349 . . . . 0.0 111.874 173.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -95.09 157.95 35.66 Favored Pre-proline 0 C--O 1.242 0.682 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.795 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.5 119.74 6.3 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 117.05 -1.5 . . . . 0.0 113.909 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -136.45 154.59 50.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.566 0.698 . . . . 0.0 109.128 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -116.36 150.62 37.41 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 t -119.44 139.74 51.55 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 122.267 1.032 . . . . 0.0 113.234 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -123.06 97.71 5.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.385 1.474 . . . . 0.0 111.278 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.3 mt -70.67 127.96 34.45 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.563 0.697 . . . . 0.0 112.619 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.8 mt -101.15 108.0 22.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -78.29 69.32 4.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.583 1.182 . . . . 0.0 110.45 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 58.4 41.58 22.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.791 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.69 85.02 1.4 Allowed Glycine 0 C--O 1.24 0.491 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -129.24 -76.75 0.55 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -155.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 71.5 mmtt -71.7 152.08 93.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 74.6 Cg_exo -58.22 -160.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 2 C-N-CA 127.266 5.31 . . . . 0.0 123.527 -170.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -57.27 -13.87 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -52.22 -47.17 65.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.822 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -81.6 -38.17 26.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 112.215 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.57 -27.37 67.68 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.4 -0.813 . . . . 0.0 112.027 -171.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.75 -34.29 75.34 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.6 mt -97.41 -46.6 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.965 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.6 t -76.04 127.82 84.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.42 -31.75 13.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 115.672 -2.419 . . . . 0.0 116.506 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -86.9 -21.37 26.36 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.578 -1.326 . . . . 0.0 110.277 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.23 85.08 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.288 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -147.15 27.23 1.05 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.973 0.909 . . . . 0.0 111.837 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.24 143.68 27.09 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.333 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -67.38 159.19 53.52 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 117.353 -1.298 . . . . 0.0 113.542 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t 77.72 153.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 128.428 2.691 . . . . 0.0 109.714 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -163.6 33.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 125.769 1.628 . . . . 0.0 113.547 149.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -153.24 125.67 8.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.537 3.162 . . . . 0.0 119.537 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pt -147.1 134.65 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.539 1.136 . . . . 0.0 109.506 166.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.55 39.3 24.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.031 0.933 . . . . 0.0 113.191 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.37 20.38 10.97 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.734 1.614 . . . . 0.0 114.031 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -125.33 165.79 17.72 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.733 1.613 . . . . 0.0 106.914 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -112.09 118.45 35.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 -167.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.5 t -141.21 129.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.403 0.681 . . . . 0.0 112.123 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.26 112.71 2.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.399 1.08 . . . . 0.0 111.94 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -164.11 151.46 12.07 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 102.732 -3.062 . . . . 0.0 102.732 162.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.3 p -54.56 -37.86 65.95 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.6 -33.09 28.08 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.015 0.912 . . . . 0.0 109.954 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.3 t -72.31 -40.7 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.1 pt -73.03 -11.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -103.19 -5.46 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.627 0.649 . . . . 0.0 111.435 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.36 -66.91 0.13 Allowed Glycine 0 CA--C 1.519 0.32 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.9 -35.12 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.8 -1.412 . . . . 0.0 110.084 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.6 -38.26 86.92 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.738 -1.226 . . . . 0.0 111.726 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.77 -31.79 68.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.254 0.549 . . . . 0.0 110.528 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -65.41 -27.74 68.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.019 0.914 . . . . 0.0 111.471 176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.24 6.41 40.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.867 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.44 144.04 91.23 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.05 -28.89 18.57 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 115.24 -2.706 . . . . 0.0 115.087 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.4 165.71 48.58 Favored Pre-proline 0 N--CA 1.473 0.681 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.11 142.88 76.48 Favored 'Trans proline' 0 C--N 1.354 0.868 0 N-CA-C 117.688 2.149 . . . . 0.0 117.688 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.9 90.91 0.88 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.003 1.136 . . . . 0.0 114.955 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.8 mt -108.94 79.07 1.18 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.843 1.306 . . . . 0.0 111.758 -174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.26 73.46 0.85 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.841 -173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -115.63 116.15 41.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.001 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -98.35 74.67 0.07 OUTLIER 'Trans proline' 0 CA--C 1.558 1.723 1 C-N-CA 127.194 5.263 . . . . 0.0 119.032 164.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -85.13 -149.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 121.304 1.336 . . . . 0.0 113.504 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -47.24 -38.6 12.57 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' HB2' HG21 ' A' ' 149' ' ' VAL . 4.7 m-85 -66.22 -26.1 67.22 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.863 -1.148 . . . . 0.0 112.44 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.31 65.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.756 -0.59 . . . . 0.0 111.328 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 99.3 p -75.1 -34.39 61.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.2 t -66.91 -39.25 83.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.11 -32.52 80.72 Favored Glycine 0 C--O 1.226 -0.387 0 O-C-N 121.435 -0.791 . . . . 0.0 114.202 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -70.43 -6.64 37.23 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -104.11 -35.07 8.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.502 0.667 . . . . 0.0 110.988 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.57 -51.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.432 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 89.2 t80 -56.04 -52.1 75.33 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -69.04 -26.4 31.01 Favored 'Trans proline' 0 C--N 1.35 0.606 1 C-N-CA 112.118 -4.788 . . . . 0.0 113.178 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -65.48 -42.57 92.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 103' ' ' PHE 0.287 10.7 p90 -78.98 -18.12 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.321 -1.352 . . . . 0.0 114.441 -177.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -79.33 -37.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.953 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -60.25 -40.45 90.35 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.773 -0.579 . . . . 0.0 111.607 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -64.71 -40.21 94.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.094 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.23 -35.75 82.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.142 0.496 . . . . 0.0 112.167 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.67 -0.31 26.21 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.3 t -107.0 127.82 53.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -166.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -116.64 34.37 5.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 123.272 1.51 . . . . 0.0 109.05 168.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.44 168.56 13.6 Favored Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 166.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.91 63.74 3.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-O 123.172 1.238 . . . . 0.0 113.516 159.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -80.38 69.52 6.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -167.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.92 -40.33 20.28 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.252 -0.905 . . . . 0.0 110.554 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 -38.84 91.81 Favored Glycine 0 C--O 1.228 -0.241 0 O-C-N 121.837 -0.539 . . . . 0.0 112.93 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 -28.48 64.01 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.288 -0.536 . . . . 0.0 110.41 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -68.22 -38.8 82.27 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.41 -1.431 . . . . 0.0 109.996 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -78.95 -12.48 60.03 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.114 -0.991 . . . . 0.0 113.113 175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.31 76.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.9 mt -60.34 -44.27 95.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.513 0.673 . . . . 0.0 109.325 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.87 -51.64 68.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.04 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.26 -29.26 47.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -70.51 -40.49 73.49 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 mt -68.63 -24.43 64.55 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.122 -0.986 . . . . 0.0 112.354 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -61.6 -32.97 73.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.429 0.558 . . . . 0.0 112.261 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.8 -43.07 89.8 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.2 tp -70.93 -27.74 63.99 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.844 -0.535 . . . . 0.0 111.569 176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.98 -48.91 72.31 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.696 -0.627 . . . . 0.0 111.838 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.12 -36.42 91.85 Favored Glycine 0 C--O 1.235 0.2 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.592 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.62 -35.53 80.81 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 122.369 -0.489 . . . . 0.0 111.237 176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -68.55 -53.69 21.38 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.465 -0.772 . . . . 0.0 110.634 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -73.26 -10.21 59.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -162.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.9 m -82.03 -12.36 12.37 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -112.71 -49.09 2.96 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.28 -60.65 0.35 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -79.22 -177.82 4.17 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.771 2.314 . . . . 0.0 116.728 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -40.64 151.86 0.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 pt -74.45 3.24 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -141.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.05 -8.9 57.82 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.632 1.206 . . . . 0.0 109.258 162.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.88 6.22 65.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.622 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -143.26 -49.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -165.97 -174.69 3.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.479 1.112 . . . . 0.0 108.163 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.89 123.07 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.3 m -139.36 172.24 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.25 -40.29 5.07 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 116.18 1.918 . . . . 0.0 116.18 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 95' ' ' PHE . 7.4 p -60.29 -37.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -78.45 -40.56 35.27 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.098 -1.001 . . . . 0.0 108.41 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.91 -16.26 61.02 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.831 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 66.8 m -77.3 -35.04 55.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.82 -38.68 6.01 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -47.96 -42.41 48.04 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -57.35 -37.66 96.94 Favored 'Trans proline' 0 C--N 1.354 0.864 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -99.32 -17.33 18.1 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.615 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 41.5 mt -68.51 -32.69 72.84 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 118.506 0.594 . . . . 0.0 110.926 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.28 -52.87 63.76 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.107 0.956 . . . . 0.0 109.021 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -68.99 -19.33 64.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.51 -47.49 72.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.51 -36.28 80.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.276 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 -50.07 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.4 -51.67 34.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.39 -0.819 . . . . 0.0 110.34 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.82 -41.39 83.12 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.233 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.7 -33.09 71.14 Favored Glycine 0 C--O 1.234 0.127 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.682 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -90.41 -40.53 12.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -96.53 -41.01 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -137.53 71.95 1.41 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.966 1.306 . . . . 0.0 108.847 -172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -67.84 86.32 0.23 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -154.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -121.65 99.14 45.2 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.173 0.989 . . . . 0.0 110.931 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.78 168.26 23.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 118.374 -0.617 . . . . 0.0 112.676 173.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.54 122.02 86.01 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.6 161.88 43.94 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 116.716 -1.723 . . . . 0.0 111.319 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -69.18 -15.05 63.31 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.286 -0.884 . . . . 0.0 111.712 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.63 -25.17 68.1 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.364 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.25 61.87 0.6 Allowed 'General case' 0 C--O 1.239 0.505 0 CA-C-O 122.78 1.276 . . . . 0.0 109.289 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -22.78 66.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -171.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -50.19 74.82 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 121.071 -1.018 . . . . 0.0 109.731 174.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -25.3 16.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 C-N-CA 118.22 -1.392 . . . . 0.0 108.688 -168.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -61.28 -48.41 81.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.443 170.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.78 -40.45 88.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.004 0.907 . . . . 0.0 112.39 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -66.85 -49.27 66.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.053 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 34.4 mm -66.76 -33.89 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -60.52 -46.83 88.71 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.329 -0.857 . . . . 0.0 111.846 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 38.6 mt -66.96 -43.14 83.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.903 0.383 . . . . 0.0 111.14 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.54 -32.36 71.42 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.484 1.114 . . . . 0.0 111.849 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -62.7 -29.3 70.56 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.372 -0.83 . . . . 0.0 113.144 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.2 t -144.0 57.46 1.34 Allowed 'General case' 0 C--O 1.242 0.683 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -90.28 144.5 25.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 150.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -59.72 -39.65 85.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.908 -173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -59.02 -44.05 91.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.095 0.95 . . . . 0.0 111.297 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.24 -41.94 60.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.056 -172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.1 -39.83 93.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.237 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -74.32 -32.27 62.78 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.2 p -101.23 0.56 37.68 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 117.724 2.491 . . . . 0.0 117.724 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -58.02 150.29 21.21 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.59 167.45 20.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.742 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.77 127.19 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.99 -38.59 91.63 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 117.846 0.294 . . . . 0.0 111.081 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -56.29 -40.41 74.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 109.028 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -94.41 -1.78 53.07 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.5 t -77.66 -53.41 14.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 163.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 15.4 mt -67.74 -56.88 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.597 0.713 . . . . 0.0 110.344 -171.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 207' ' ' GLU . . . -76.4 -4.85 44.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.02 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.03 -23.8 36.99 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.374 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -102.27 -35.99 8.65 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 204' ' ' ALA . 8.8 pt-20 -63.69 -23.66 1.13 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 119.235 3.05 . . . . 0.0 119.235 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.36 -18.76 22.87 Favored 'Trans proline' 0 C--N 1.356 0.96 1 C-N-CA 112.852 -4.299 . . . . 0.0 114.746 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.23 -9.44 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.877 -1.139 . . . . 0.0 110.765 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.08 -45.92 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -83.07 -23.23 33.22 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.392 0 CA-C-O 116.59 -1.671 . . . . 0.0 108.69 -172.024 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.036 0.446 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.6 160.78 41.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 pp -154.1 168.59 25.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.645 0.657 . . . . 0.0 111.702 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -123.53 136.5 54.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mt -103.16 125.62 57.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 175.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.4 m -129.63 105.59 8.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.19 160.77 33.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -169.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -63.77 130.7 45.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.07 172.03 14.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.937 0.398 . . . . 0.0 111.271 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 137.94 58.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.3 t -70.72 141.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.121 -1.399 . . . . 0.0 107.354 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.32 -38.2 3.01 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.12 81.45 6.19 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 123.107 0.563 . . . . 0.0 110.49 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.49 89.47 0.83 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 N-CA-C 117.956 2.252 . . . . 0.0 117.956 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -144.74 -33.43 0.38 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mt -88.98 164.29 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.34 146.17 49.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.458 1.503 . . . . 0.0 111.253 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.33 173.04 22.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 122.579 3.792 . . . . 0.0 122.579 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -81.13 78.58 7.92 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 t -128.61 135.66 27.92 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -58.57 -42.59 52.91 Favored 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 119.074 0.705 . . . . 0.0 113.703 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.38 -12.61 60.02 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -173.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.9 t -60.47 -45.47 93.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.541 0.686 . . . . 0.0 111.247 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.96 -7.45 59.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -63.18 -43.95 96.78 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -42.55 67.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 113.734 -1.576 . . . . 0.0 111.169 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.8 mt -67.75 -43.71 79.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.131 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.06 -40.18 87.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.255 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.2 m -62.86 -34.42 77.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.348 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.14 -46.7 32.61 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.761 -0.587 . . . . 0.0 112.526 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.8 -24.91 61.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.735 0.303 . . . . 0.0 111.401 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.65 -31.8 71.2 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.28 -0.887 . . . . 0.0 111.584 172.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -95.81 -16.15 22.05 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 50.1 46.13 24.9 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -76.55 137.15 67.33 Favored Pre-proline 0 C--O 1.248 1.001 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 163.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.91 148.42 70.46 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 115.834 -2.311 . . . . 0.0 113.425 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -141.95 151.63 42.74 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-O 122.775 1.274 . . . . 0.0 113.481 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -91.97 117.61 29.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.305 -1.77 . . . . 0.0 107.494 169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 t -99.16 121.2 40.7 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -114.96 140.0 49.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.46 126.62 53.69 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -90.4 104.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 174.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -73.06 71.64 1.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.763 0.825 . . . . 0.0 113.153 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.0 mt 56.08 52.84 9.83 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.88 1.272 . . . . 0.0 113.082 169.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.21 80.19 1.01 Allowed Glycine 0 CA--C 1.51 -0.229 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.695 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -116.01 -88.86 0.58 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -148.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -74.73 159.13 83.87 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 119.209 -0.425 . . . . 0.0 111.729 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -60.01 -165.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.199 2.599 . . . . 0.0 118.021 174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -42.21 -37.57 1.51 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -50.11 -45.99 53.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.406 0.548 . . . . 0.0 111.439 175.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.34 -22.37 41.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.82 -23.31 60.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.393 0.616 . . . . 0.0 110.314 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -76.41 -41.04 49.1 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.854 -0.529 . . . . 0.0 110.853 170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.25 -40.98 86.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -116.43 128.17 26.2 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-N 120.462 1.483 . . . . 0.0 111.758 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.34 -16.51 31.19 Favored 'Trans proline' 0 C--N 1.35 0.628 0 N-CA-C 117.003 1.886 . . . . 0.0 117.003 -173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -100.39 -4.88 28.15 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.842 0.746 . . . . 0.0 112.147 166.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.27 -28.2 3.84 Favored Glycine 0 CA--C 1.52 0.353 0 O-C-N 122.048 -0.407 . . . . 0.0 114.081 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 33.17 2.62 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.28 148.89 35.26 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 151.13 73.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 117.222 -1.385 . . . . 0.0 113.794 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' A' ' 71' ' ' ALA . 33.8 m -133.86 169.84 20.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 114.209 -1.36 . . . . 0.0 107.336 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.8 t -124.25 138.04 55.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 153.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -104.68 96.37 6.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.14 129.99 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.9 t0 60.26 34.18 20.92 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.78 1.276 . . . . 0.0 111.018 172.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.27 21.38 12.03 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 127.782 2.433 . . . . 0.0 114.299 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -127.56 127.88 44.65 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.681 0.792 . . . . 0.0 110.047 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -108.02 144.0 35.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.6 t -131.46 140.09 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 -175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -136.79 -0.43 2.34 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -93.06 139.73 30.23 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.08 -1.013 . . . . 0.0 111.143 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.5 p -75.03 -26.17 59.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 118.197 2.665 . . . . 0.0 118.197 -152.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -80.65 -35.18 34.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -91.47 -10.48 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.777 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 tp -76.53 2.73 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.468 -0.77 . . . . 0.0 110.389 166.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.3 t -100.1 -56.66 5.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 O-C-N 121.688 -0.633 . . . . 0.0 110.229 152.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.11 -42.79 99.43 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 120.111 2.804 . . . . 0.0 120.111 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.58 -37.4 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 118.937 1.368 . . . . 0.0 107.466 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -40.93 97.44 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.02 -42.2 98.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.745 0.702 . . . . 0.0 111.222 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -61.49 -34.09 74.9 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 111.462 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -97.03 16.4 19.69 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -110.09 116.95 52.74 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.49 -13.76 38.25 Favored 'Trans proline' 0 C--O 1.245 0.86 1 N-CA-C 123.16 4.254 . . . . 0.0 123.16 -167.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.43 155.37 74.09 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-N 121.357 1.89 . . . . 0.0 107.126 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.77 125.53 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 116.635 -1.777 . . . . 0.0 116.306 -168.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.19 152.84 18.53 Favored 'Trans proline' 0 C--O 1.243 0.768 0 N-CA-C 116.569 1.719 . . . . 0.0 116.569 -175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -130.76 56.87 1.76 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 69.96 8.85 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.458 -1.401 . . . . 0.0 114.251 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.1 m -122.31 98.43 44.11 Favored Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 123.499 0.72 . . . . 0.0 110.962 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -99.01 80.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.509 2.806 . . . . 0.0 116.188 169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -82.76 -138.76 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.561 1.508 . . . . 0.0 113.487 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.65 -34.84 69.78 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 125.022 1.329 . . . . 0.0 111.931 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -65.17 -28.46 69.42 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.431 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.34 -19.25 30.08 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.912 -0.492 . . . . 0.0 110.94 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 85.7 p -71.56 -38.96 70.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.41 -41.67 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.12 -37.46 80.1 Favored Glycine 0 C--O 1.226 -0.406 0 CA-C-N 116.49 -0.323 . . . . 0.0 113.129 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.3 p -73.03 -9.89 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -88.24 -39.77 14.19 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.111 0.414 . . . . 0.0 111.633 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.6 -32.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -56.06 -51.96 76.51 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -78.48 -11.54 15.72 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 113.612 -3.792 . . . . 0.0 113.837 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.9 t -75.09 -44.05 49.62 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.233 -0.917 . . . . 0.0 110.97 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.01 -20.86 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.199 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.37 -42.22 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 172.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.78 -44.34 90.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.91 0.386 . . . . 0.0 110.057 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.29 -32.24 73.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.1 mt -65.44 -41.99 92.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.493 ' HA ' HG12 ' A' ' 210' ' ' VAL . 60.2 pttt -97.91 -16.42 19.75 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -167.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -106.95 30.06 6.5 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.176 0.989 . . . . 0.0 111.254 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.55 165.59 18.32 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 114.116 -1.402 . . . . 0.0 107.458 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.68 70.95 4.91 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.387 1.391 . . . . 0.0 113.884 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -86.9 81.2 8.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -163.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -99.73 -37.71 8.99 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.04 -40.41 97.03 Favored Glycine 0 N--CA 1.453 -0.228 0 O-C-N 121.733 -0.604 . . . . 0.0 111.673 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 58.6 m -71.31 -32.58 68.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.027 0.414 . . . . 0.0 110.741 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.77 -41.38 97.98 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.918 -1.114 . . . . 0.0 109.713 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -76.18 -15.26 60.09 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.456 -0.777 . . . . 0.0 110.941 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.71 -41.83 71.41 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.41 -41.04 96.85 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.342 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 56.5 tp -58.19 -36.15 72.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -81.3 -38.07 27.38 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -68.62 -38.16 80.32 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.716 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.9 mt -74.04 -19.63 60.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.829 -1.169 . . . . 0.0 110.659 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -66.25 -32.28 73.6 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.008 -1.058 . . . . 0.0 110.245 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.95 -42.43 80.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -41.17 98.97 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.17 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.09 -38.67 83.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.526 0.603 . . . . 0.0 110.42 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -55.54 24.69 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.414 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -61.07 -40.45 93.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.877 -0.778 . . . . 0.0 110.555 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.716 -0.615 . . . . 0.0 111.45 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.3 -27.19 62.3 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.9 -49.85 65.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.68 -44.19 19.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.54 -69.29 0.24 Allowed Glycine 0 C--O 1.25 1.139 0 CA-C-O 116.797 -2.113 . . . . 0.0 116.06 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -72.43 -159.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 125.212 3.941 . . . . 0.0 114.499 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -54.33 163.39 0.86 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.3 tp -64.82 -21.95 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -161.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.22 -19.32 63.04 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.791 -1.193 . . . . 0.0 113.255 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 109.41 -13.45 33.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 123.812 0.72 . . . . 0.0 114.356 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -143.39 -47.44 0.3 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -162.54 179.62 7.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 38.5 mm -71.36 114.43 9.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -129.91 -169.35 2.11 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.83 -32.65 6.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.65 -49.96 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.335 1.064 . . . . 0.0 110.746 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.99 -36.93 67.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.819 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.5 mt -66.97 -20.55 65.91 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.297 -0.161 . . . . 0.0 111.167 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.2 m -83.61 -48.62 10.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.19 -48.73 15.23 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.91 93.57 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -173.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.29 -36.07 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 1 C-N-CA 112.599 -4.467 . . . . 0.0 114.852 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -79.22 -26.94 42.46 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.526 -1.359 . . . . 0.0 110.483 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.9 mt -59.32 -33.76 71.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 118.973 0.806 . . . . 0.0 111.333 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -66.15 -38.19 87.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.288 -1.507 . . . . 0.0 113.767 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -67.53 -35.95 80.06 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.1 tp -62.41 -51.89 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.636 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -65.95 -26.12 67.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -170.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.67 -50.44 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 118.499 0.591 . . . . 0.0 111.614 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.95 -43.07 75.78 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.681 -0.637 . . . . 0.0 111.139 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.86 -42.09 67.29 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.35 93.27 Favored Glycine 0 C--O 1.236 0.248 0 C-N-CA 119.92 -1.134 . . . . 0.0 114.538 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -77.58 -49.61 14.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 118.349 1.075 . . . . 0.0 112.878 173.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -87.53 -37.24 17.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 -172.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -136.71 62.47 1.6 Allowed 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.152 -0.967 . . . . 0.0 110.509 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -53.55 110.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -161.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -146.5 94.48 4.78 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.36 168.14 25.5 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 114.9 -2.933 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 76.2 mt -64.55 119.55 57.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.41 162.38 30.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 115.632 -2.445 . . . . 0.0 113.396 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.9 6.3 3.44 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.363 -0.836 . . . . 0.0 112.847 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -70.51 -22.83 62.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.423 0.63 . . . . 0.0 109.357 166.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.88 60.53 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.1 m -54.27 -38.0 65.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.015 -0.428 . . . . 0.0 111.779 -175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -71.85 -26.93 62.56 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 120.809 -1.182 . . . . 0.0 111.938 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.6 -34.09 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.413 1.006 . . . . 0.0 110.625 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.67 -44.37 93.96 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 120.831 -1.168 . . . . 0.0 109.641 175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -70.0 -31.7 69.52 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.714 -0.616 . . . . 0.0 112.464 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.25 -45.98 89.73 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 121.953 -0.467 . . . . 0.0 111.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -30.9 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 118.57 0.623 . . . . 0.0 111.121 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -68.41 -37.85 80.7 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.186 -0.946 . . . . 0.0 112.453 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.57 -34.2 73.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.45 -39.79 94.49 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.74 13.89 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.1 t -96.63 -52.7 3.83 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 118.195 2.665 . . . . 0.0 118.195 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -94.03 157.05 16.28 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.185 -1.572 . . . . 0.0 112.594 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -58.38 -21.34 49.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.2 m -53.27 -30.89 40.92 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.719 0.771 . . . . 0.0 111.47 172.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -103.58 -44.32 5.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.697 0.761 . . . . 0.0 112.235 174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -61.13 -29.69 69.93 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -85.8 -29.98 23.37 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 48.4 p -86.02 -18.01 33.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -60.79 140.31 57.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.691 0.758 . . . . 0.0 111.574 177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.49 170.59 15.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.28 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.81 117.73 7.96 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.4 pm0 -60.82 -35.58 76.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -171.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -63.91 -40.03 95.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.573 -0.704 . . . . 0.0 109.216 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -78.88 -13.54 59.75 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.29 -50.37 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -45.89 47.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.782 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.6 -23.48 65.39 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.884 -0.51 . . . . 0.0 111.977 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -88.84 -16.53 57.99 Favored Glycine 0 C--O 1.24 0.469 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -89.01 -35.21 16.51 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 117.607 0.703 . . . . 0.0 111.614 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.95 -23.91 1.35 Allowed Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 120.307 3.447 . . . . 0.0 120.307 -174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.73 -21.73 64.66 Favored 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 111.105 -5.463 . . . . 0.0 115.874 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.85 -9.44 59.6 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 120.787 -1.196 . . . . 0.0 112.917 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -98.07 -27.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -83.8 -32.64 25.24 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.38 -172.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.2 mtp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.16 146.58 47.31 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.502 0.592 . . . . 0.0 110.636 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.02 167.77 20.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -119.8 144.14 47.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.85 116.67 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.0 m -116.3 114.39 24.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.87 160.76 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -69.99 124.36 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 164.62 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.898 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 142.21 58.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.73 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.62 127.22 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.48 -25.1 29.57 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.401 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.53 99.43 2.27 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 117.742 0.771 . . . . 0.0 111.338 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.98 55.51 5.33 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 N-CA-C 114.546 0.941 . . . . 0.0 114.546 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -120.12 1.31 10.84 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.591 -0.693 . . . . 0.0 112.292 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.5 tt -148.79 160.85 5.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.7 mt -61.47 145.5 51.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.338 177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.67 -176.69 44.24 Favored Glycine 0 C--O 1.237 0.307 0 N-CA-C 119.859 2.704 . . . . 0.0 119.859 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.39 64.92 2.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 111.549 -2.325 . . . . 0.0 108.205 170.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.9 t -132.1 101.84 14.84 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 112.38 -2.191 . . . . 0.0 107.812 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.42 -38.31 64.98 Favored 'Trans proline' 0 C--N 1.346 0.422 0 N-CA-C 114.729 1.011 . . . . 0.0 114.729 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -72.2 -32.56 66.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.2 m -63.29 -43.07 98.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.989 0.9 . . . . 0.0 111.887 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.38 -20.99 62.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.855 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -61.4 -33.52 73.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.675 -0.64 . . . . 0.0 110.212 174.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.47 -49.07 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.412 0.625 . . . . 0.0 111.131 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.45 -37.58 88.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.2 -175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.45 -41.79 90.49 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 151' ' ' LEU . 73.6 p -73.29 -40.75 64.29 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.299 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.02 -27.33 48.85 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.522 -0.736 . . . . 0.0 111.679 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -71.03 -35.24 71.91 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 118.8 0.727 . . . . 0.0 112.439 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -68.11 -35.66 78.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 119.112 0.869 . . . . 0.0 110.203 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -71.85 -20.77 61.77 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 56.09 37.12 28.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.596 1.159 . . . . 0.0 109.715 -175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tt -86.72 148.67 46.63 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.22 146.73 32.23 Favored 'Trans proline' 0 C--N 1.35 0.608 1 C-N-CA 113.225 -4.05 . . . . 0.0 113.733 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -154.89 161.23 41.5 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -107.73 113.83 27.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.27 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -83.91 124.31 30.86 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 122.697 0.399 . . . . 0.0 110.97 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -116.02 124.35 50.26 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -98.42 119.91 37.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.3 mt -88.09 107.22 17.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.01 80.48 2.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.08 0.943 . . . . 0.0 110.577 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.5 mt 56.09 53.15 9.41 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.535 167.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.75 35.5 10.12 Favored Glycine 0 C--O 1.236 0.274 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.171 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.87 113.59 10.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -146.55 84.68 7.6 Favored Pre-proline 0 C--O 1.254 1.296 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -161.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -66.92 166.96 20.97 Favored 'Trans proline' 0 C--O 1.235 0.356 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 158.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -57.83 -33.34 68.51 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.552 0.341 . . . . 0.0 111.227 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 57.1 t-105 -54.66 -45.52 73.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.361 0.6 . . . . 0.0 112.468 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -77.79 -27.27 50.16 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 121.118 -0.989 . . . . 0.0 111.571 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -65.97 -34.77 78.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.007 0.432 . . . . 0.0 111.547 171.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -67.97 -43.87 77.98 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.101 -0.999 . . . . 0.0 110.273 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -70.1 -51.89 35.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -104.2 121.14 48.58 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-N 120.611 1.55 . . . . 0.0 114.743 -167.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.52 -24.61 30.58 Favored 'Trans proline' 0 C--N 1.35 0.625 0 N-CA-C 118.932 2.628 . . . . 0.0 118.932 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -101.47 -5.37 25.34 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.3 1.409 . . . . 0.0 110.68 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.5 -47.5 3.85 Favored Glycine 0 C--O 1.227 -0.34 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.255 -164.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -119.94 64.75 0.82 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.599 1.19 . . . . 0.0 113.604 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.52 155.86 73.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 165.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.92 154.3 58.23 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 C-N-CA 113.564 -3.824 . . . . 0.0 111.476 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.16 142.57 41.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.93 125.61 67.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 165.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -98.85 89.09 4.2 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.7 mt -90.2 101.46 12.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t0 49.61 47.54 22.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.748 0.819 . . . . 0.0 112.944 -176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t0 65.04 22.18 12.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 -173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -109.85 127.73 54.88 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.068 -1.02 . . . . 0.0 108.55 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -105.24 117.34 33.77 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.841 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.0 138.7 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.617 0.644 . . . . 0.0 110.677 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.24 19.54 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 118.816 2.895 . . . . 0.0 118.816 -164.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -107.64 148.36 29.44 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.754 -1.216 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.1 p -63.78 -25.25 68.1 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -165.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -82.57 -35.06 27.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.304 -0.247 . . . . 0.0 111.539 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.63 -19.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 121.63 -0.669 . . . . 0.0 112.392 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.1 pt -77.37 4.28 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.11 0.481 . . . . 0.0 111.175 172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.94 -51.0 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.31 -55.19 7.09 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 120.249 2.86 . . . . 0.0 120.249 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.55 -29.57 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 119.35 1.575 . . . . 0.0 107.198 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -58.82 -43.84 90.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -69.76 -40.18 76.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.882 0.849 . . . . 0.0 110.664 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -63.03 -34.96 78.69 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -96.37 3.66 52.76 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -70.45 128.7 90.97 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.759 -0.588 . . . . 0.0 110.84 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -76.46 -4.99 15.69 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 N-CA-C 115.709 1.388 . . . . 0.0 115.709 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -105.12 155.7 37.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -59.72 122.02 10.79 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 116.603 -1.798 . . . . 0.0 116.497 -163.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.76 151.83 25.07 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 116.802 -1.665 . . . . 0.0 115.518 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.2 mt -136.87 49.9 2.03 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.942 1.697 . . . . 0.0 109.509 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.9 77.94 4.4 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.1 m -114.37 101.57 54.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -96.59 67.13 0.14 Allowed 'Trans proline' 0 CA--C 1.559 1.754 1 C-N-CA 126.045 4.497 . . . . 0.0 118.613 170.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.66 -113.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 116.914 -1.591 . . . . 0.0 114.134 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -63.91 -31.28 72.41 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 119.425 -2.047 . . . . 0.0 115.173 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.45 -11.77 60.57 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.358 -1.463 . . . . 0.0 111.825 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -42.08 60.36 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 119.762 -1.837 . . . . 0.0 110.132 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -48.25 45.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.54 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.137 0.494 . . . . 0.0 110.374 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.33 91.22 Favored Glycine 0 C--O 1.224 -0.506 0 O-C-N 120.944 -1.098 . . . . 0.0 111.764 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.1 p -70.59 -2.69 15.05 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -99.03 -36.52 9.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.722 0.772 . . . . 0.0 110.471 171.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 72.9 mt -71.89 -50.16 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.685 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -56.78 -53.9 59.76 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.03 -17.42 31.85 Favored 'Trans proline' 0 C--N 1.349 0.579 1 C-N-CA 112.751 -4.366 . . . . 0.0 113.702 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.6 m -68.38 -56.12 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.815 0.734 . . . . 0.0 111.04 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -76.96 -25.23 52.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.428 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.27 -38.94 82.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -72.77 -44.36 61.69 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -68.95 -30.87 69.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 119.298 0.954 . . . . 0.0 112.696 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.9 tp -67.46 -38.41 84.42 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.207 -0.933 . . . . 0.0 110.762 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.9 -25.33 61.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.219 0.533 . . . . 0.0 111.98 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -90.65 109.93 21.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -93.59 67.87 3.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 171.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.26 176.7 1.73 Allowed Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.41 61.06 2.68 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 CA-C-N 120.195 1.105 . . . . 0.0 113.29 161.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.26 116.71 17.21 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -153.2 -57.04 0.12 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.38 -33.01 84.92 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 170.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -74.32 -30.58 62.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.047 1.424 . . . . 0.0 114.831 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.51 -32.07 70.69 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 120.251 -1.53 . . . . 0.0 107.316 174.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -77.95 -12.64 60.0 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.979 -1.075 . . . . 0.0 112.707 172.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.27 -34.67 31.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.224 -1.547 . . . . 0.0 107.673 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.1 tp -64.1 -35.66 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.2 tp -57.79 -39.91 78.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.33 173.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -68.9 -35.03 76.37 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.997 0.817 . . . . 0.0 111.959 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -66.07 -38.56 88.62 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.416 -1.428 . . . . 0.0 110.757 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.05 -20.35 49.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.04 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.22 -36.6 82.03 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.267 0.94 . . . . 0.0 110.571 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.47 -48.68 80.71 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.45 -39.18 93.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.18 -50.42 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.025 0.53 . . . . 0.0 111.873 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.98 -34.99 64.88 Favored Glycine 0 C--O 1.234 0.141 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.573 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -57.51 -42.5 82.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 122.026 0.917 . . . . 0.0 110.577 177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -35.11 65.22 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -73.21 -18.48 61.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 m -89.7 4.3 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -121.44 -45.77 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.586 2.069 . . . . 0.0 116.586 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.29 -70.96 0.23 Allowed Glycine 0 CA--C 1.531 1.076 0 N-CA-C 120.941 3.136 . . . . 0.0 120.941 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.22 -164.95 0.21 Allowed 'Trans proline' 0 C--N 1.352 0.723 1 C-N-CA 127.896 5.731 . . . . 0.0 118.822 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.09 166.8 7.21 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 169.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.8 mt -78.53 -24.63 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.56 0.695 . . . . 0.0 110.606 -128.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.7 -6.44 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.39 -17.22 37.25 Favored Glycine 0 C--O 1.23 -0.146 0 CA-C-O 119.389 -0.673 . . . . 0.0 113.05 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -130.44 -44.8 1.11 Allowed 'General case' 0 C--O 1.246 0.882 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -166.45 178.1 6.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.9 mm -59.25 126.23 16.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 167.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 35.7 p -131.63 -170.18 2.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -44.88 -36.04 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -35.55 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.946 -1.096 . . . . 0.0 111.83 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.27 -42.91 96.22 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 29' ' ' SER . 92.0 mt -63.46 -32.91 74.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 81.5 p -72.9 -37.64 67.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -97.73 -42.88 7.4 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -166.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.08 -37.45 57.4 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -176.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.12 -29.87 14.05 Favored 'Trans proline' 0 C--N 1.35 0.618 1 C-N-CA 111.781 -5.013 . . . . 0.0 115.701 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -76.59 -28.72 56.3 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 119.979 -1.701 . . . . 0.0 108.366 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.6 tp -66.44 -34.32 77.69 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.45 0.568 . . . . 0.0 111.783 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.35 -46.8 81.88 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.629 -0.67 . . . . 0.0 109.73 171.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -60.87 -33.58 73.31 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.16 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.92 -50.58 61.95 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.618 174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 -30.35 71.37 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.71 1.141 . . . . 0.0 111.607 -174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 94.5 t -73.06 -57.46 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.291 0.567 . . . . 0.0 111.352 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -44.67 65.46 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.745 -1.222 . . . . 0.0 111.418 -166.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.41 -34.41 70.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.8 93.68 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.911 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -76.87 -46.87 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.622 -0.928 . . . . 0.0 112.37 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -81.96 -47.53 12.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -171.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -128.55 63.06 1.45 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -40.68 112.41 0.29 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -161.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -144.99 81.01 10.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.803 0.841 . . . . 0.0 111.959 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.47 154.78 40.56 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 113.303 -3.998 . . . . 0.0 110.118 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 27.8 mt -69.23 129.9 91.55 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.41 163.65 31.93 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.711 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -76.82 6.51 6.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.257 1.503 . . . . 0.0 113.048 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.82 -15.99 42.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.372 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 52.2 mt -120.21 47.56 1.74 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.581 1.152 . . . . 0.0 108.398 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.3 t -62.91 -18.82 63.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -160.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -48.66 80.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.264 1.847 . . . . 0.0 108.405 174.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.94 -33.03 50.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 118.042 -1.463 . . . . 0.0 107.883 -167.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.2 -52.25 59.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.95 -39.53 94.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.577 0.703 . . . . 0.0 109.784 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.28 -22.78 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.752 -0.592 . . . . 0.0 111.948 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 1.6 mm -65.66 -34.59 71.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.456 1.025 . . . . 0.0 108.982 171.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -67.3 -33.48 75.37 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.148 -0.97 . . . . 0.0 111.159 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.06 -45.18 74.57 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.2 mt -66.65 -30.17 70.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -67.92 -23.18 65.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.215 -0.928 . . . . 0.0 110.841 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.0 t -144.99 69.77 1.26 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.802 0.81 . . . . 0.0 111.071 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -131.99 144.54 50.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.55 -37.38 78.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -166.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.7 t -72.51 -50.48 25.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.94 1.352 . . . . 0.0 110.43 170.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.9 -28.98 64.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.698 -165.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.5 -43.39 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.302 1.041 . . . . 0.0 111.509 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.97 -37.17 78.62 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.47 -0.769 . . . . 0.0 112.17 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 32.1 p -81.72 -0.72 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -55.0 119.79 5.96 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 121.828 -0.545 . . . . 0.0 110.927 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.78 153.96 42.57 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.24 130.46 46.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -61.01 -36.12 78.66 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.065 0.46 . . . . 0.0 111.021 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -83.61 -25.51 30.78 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.857 -0.527 . . . . 0.0 109.649 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.39 -58.6 6.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 170.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -43.21 64.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 120.945 -1.097 . . . . 0.0 111.664 -168.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -83.79 0.09 48.84 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.605 -0.684 . . . . 0.0 111.591 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.09 -34.98 7.29 Favored Glycine 0 C--O 1.24 0.519 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -77.73 -41.73 36.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.676 -0.896 . . . . 0.0 112.376 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.44 -36.82 50.73 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 -176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.53 -19.83 65.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 114.956 -2.896 . . . . 0.0 114.545 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -84.94 -29.84 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.151 -0.968 . . . . 0.0 111.69 171.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.52 -49.26 72.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 118.333 0.515 . . . . 0.0 110.402 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.23 -32.44 24.49 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -167.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.646 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.526 -164.702 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.609 0.242 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 171.16 0.07 Allowed 'General case' 0 C--O 1.25 1.092 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.35 166.52 24.53 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.329 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -121.32 142.66 49.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.56 149.94 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -140.46 130.27 24.47 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 34.5 m -132.7 165.7 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -58.71 118.33 5.57 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.54 173.12 12.91 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.24 0.543 . . . . 0.0 111.189 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.03 124.64 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.83 -6.09 55.93 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 64.26 12.99 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-N 119.163 1.482 . . . . 0.0 112.452 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.38 108.03 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 115.617 -2.456 . . . . 0.0 115.864 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -172.71 -53.06 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.4 mt -99.65 144.32 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.725 1.21 . . . . 0.0 108.573 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.67 150.51 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.184 1.394 . . . . 0.0 114.599 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -156.09 11.79 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 10.0 t70 -84.71 116.82 23.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.18 -1.188 . . . . 0.0 110.394 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -165.38 140.4 4.17 Favored Pre-proline 0 C--O 1.243 0.755 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 173.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.81 -55.29 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.827 -2.982 . . . . 0.0 112.514 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -66.26 -29.31 69.52 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.29 -169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 t -44.13 -59.0 2.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -86.17 -11.65 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.924 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.39 -48.8 79.57 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 m -68.82 -43.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.457 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.99 -41.52 90.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.551 -173.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 tp -66.19 -46.8 76.07 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.185 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.1 p -65.3 -42.44 93.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 119.593 1.088 . . . . 0.0 112.533 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.72 -36.17 73.08 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.056 -1.027 . . . . 0.0 111.775 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -76.81 -29.91 56.18 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 121.654 -0.654 . . . . 0.0 111.816 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.67 -29.64 70.23 Favored 'General case' 0 C--O 1.243 0.713 0 O-C-N 120.643 -1.286 . . . . 0.0 111.265 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -86.18 -8.45 57.81 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.14 37.48 26.35 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.61 1.564 . . . . 0.0 113.63 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 pp -82.47 157.58 67.38 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 118.353 0.524 . . . . 0.0 111.076 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.57 127.18 10.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 N-CA-C 116.122 1.547 . . . . 0.0 116.122 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -147.26 167.65 23.71 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.211 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -150.69 148.77 28.98 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 t 72.44 143.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.852 2.061 . . . . 0.0 114.235 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -162.98 71.49 0.28 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.635 1.174 . . . . 0.0 110.894 170.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.24 143.15 18.84 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.97 146.58 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.055 1.742 . . . . 0.0 108.399 158.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -88.75 80.24 7.26 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.0 mt 53.77 35.44 21.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.848 0.832 . . . . 0.0 113.209 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.43 1.37 83.72 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 118.488 2.155 . . . . 0.0 118.488 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -82.87 78.82 9.41 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.343 1.571 . . . . 0.0 113.174 -177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -134.41 159.85 70.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -62.05 -176.17 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 114.662 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.29 -28.36 27.68 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -45.88 -40.71 10.38 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -85.96 -28.93 23.94 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 112.329 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.22 -22.55 63.86 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.847 0.832 . . . . 0.0 111.098 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -76.07 -3.67 37.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.105 1.362 . . . . 0.0 112.097 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.8 mt -117.16 -67.91 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 t -73.45 126.03 90.25 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -158.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.23 -24.26 27.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 N-CA-C 117.538 2.091 . . . . 0.0 117.538 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -100.76 -5.16 26.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.903 0.859 . . . . 0.0 111.089 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.13 -29.32 2.17 Favored Glycine 0 C--O 1.225 -0.427 0 O-C-N 121.806 -0.559 . . . . 0.0 113.813 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -130.81 45.61 2.79 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.149 0.974 . . . . 0.0 112.862 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.93 155.86 60.17 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.448 -0.783 . . . . 0.0 110.057 170.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 7' ' ' VAL . 72.8 Cg_endo -66.64 153.21 78.78 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 123.323 1.17 . . . . 0.0 113.706 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.21 159.34 36.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.71 124.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 166.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -92.88 80.91 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.065 0.848 . . . . 0.0 109.325 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mt -83.42 105.58 13.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 t0 53.33 45.81 27.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.288 1.042 . . . . 0.0 109.679 177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 68.7 9.87 7.58 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -121.84 128.15 51.33 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.6 p90 -94.71 144.1 25.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.2 t -134.09 132.55 55.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 103.904 -2.628 . . . . 0.0 103.904 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 176.77 132.82 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 126.257 1.823 . . . . 0.0 115.249 148.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -175.7 177.31 1.74 Allowed 'General case' 0 N--CA 1.48 1.034 1 N-CA-C 97.404 -5.036 . . . . 0.0 97.404 170.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -53.34 58.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 118.427 2.751 . . . . 0.0 118.427 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -84.38 -24.28 29.73 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 120.695 -1.253 . . . . 0.0 110.702 -163.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.8 m -74.01 -24.1 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 171.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.443 HG13 HD22 ' A' ' 80' ' ' LEU . 2.2 tp -80.63 -13.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 120.791 -1.193 . . . . 0.0 109.329 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.4 t -82.72 -39.22 15.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.963 171.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.73 -55.2 0.62 Allowed Glycine 0 N--CA 1.463 0.437 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -69.08 -39.66 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.357 1.079 . . . . 0.0 110.274 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD22 HG13 ' A' ' 76' ' ' ILE . 21.7 tp -60.66 -37.55 81.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.657 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -68.88 -45.72 70.27 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.031 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -61.96 -37.12 83.55 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -85.86 10.17 14.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -100.63 133.55 21.17 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.063 -0.398 . . . . 0.0 111.51 175.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -66.43 -24.82 49.19 Favored 'Trans proline' 0 C--O 1.24 0.614 0 N-CA-C 116.781 1.8 . . . . 0.0 116.781 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -75.41 157.45 84.62 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.45 126.64 23.16 Favored 'Trans proline' 0 C--O 1.243 0.746 0 N-CA-C 114.741 1.016 . . . . 0.0 114.741 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.9 150.43 26.88 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 117.904 -0.931 . . . . 0.0 112.318 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 tp -142.04 64.7 1.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.841 1.305 . . . . 0.0 112.495 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.21 70.75 9.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.41 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -117.56 106.27 46.7 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.599 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -95.32 74.67 0.16 Allowed 'Trans proline' 0 CA--C 1.559 1.756 1 C-N-CA 125.913 4.408 . . . . 0.0 119.001 164.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -87.1 -113.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.675 0 CA-C-N 119.198 0.749 . . . . 0.0 112.089 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -61.8 -43.07 99.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.998 -1.064 . . . . 0.0 112.658 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.33 -11.13 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -174.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.96 -48.75 13.95 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.617 -1.302 . . . . 0.0 111.919 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.8 p -77.89 -30.84 50.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.338 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.7 t -85.25 -36.12 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.39 -33.1 83.38 Favored Glycine 0 C--O 1.228 -0.24 0 O-C-N 121.077 -1.014 . . . . 0.0 114.078 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.4 p -75.65 -3.45 34.61 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -83.53 -34.84 25.17 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.824 -1.172 . . . . 0.0 110.777 169.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -38.8 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.266 -175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 69.7 t80 -52.72 -52.88 60.16 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.82 -22.47 17.58 Favored 'Trans proline' 0 C--N 1.35 0.617 1 C-N-CA 113.186 -4.076 . . . . 0.0 114.294 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.2 m -67.41 -40.1 85.55 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.091 -1.006 . . . . 0.0 111.273 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 10.0 p90 -75.03 -33.32 61.76 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.901 -177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.38 -29.83 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -67.34 -42.99 82.62 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.737 -0.602 . . . . 0.0 109.995 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.52 -37.56 85.28 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.379 -0.826 . . . . 0.0 112.838 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.1 tp -63.99 -36.56 84.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -89.59 -30.98 17.79 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.4 t -89.43 110.57 21.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -98.09 44.15 1.05 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.782 1.277 . . . . 0.0 108.435 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -72.59 174.32 4.54 Favored Pre-proline 0 C--O 1.255 1.376 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 172.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.8 60.48 2.91 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 117.845 -0.97 . . . . 0.0 113.157 159.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -77.35 92.76 3.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -92.45 -38.3 12.06 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 162.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.02 -43.62 90.52 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.733 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.1 m -72.28 -26.28 61.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.369 1.085 . . . . 0.0 110.623 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -67.32 -41.39 85.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -76.78 -12.46 59.98 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.475 -0.766 . . . . 0.0 112.831 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.21 61.5 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.67 -42.11 95.6 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.32 -41.85 97.69 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -65.95 -46.47 78.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.926 0.869 . . . . 0.0 113.096 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -74.16 -35.05 64.01 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.928 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.97 -20.15 56.45 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.717 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -67.68 -33.34 74.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.076 1.307 . . . . 0.0 109.384 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.23 85.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.0 -34.8 79.3 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -38.9 90.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.845 0.858 . . . . 0.0 108.986 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.55 -53.51 38.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.325 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -59.94 -29.65 68.55 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.021 -0.694 . . . . 0.0 112.016 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.6 -57.82 6.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -73.96 -12.33 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -166.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.9 t -61.71 -49.0 86.08 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 121.043 -1.035 . . . . 0.0 110.429 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -100.39 -39.65 7.87 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 109.41 -45.69 1.28 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.09 -163.28 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.112 2.956 . . . . 0.0 114.557 170.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.27 164.35 1.82 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.351 0.66 . . . . 0.0 109.885 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 mt -71.17 -22.87 22.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 O-C-N 121.48 -0.762 . . . . 0.0 110.389 -165.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 150' ' ' ASP . . . -53.3 -35.19 59.85 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 167.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.21 -30.86 4.64 Favored Glycine 0 CA--C 1.518 0.259 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -129.76 -43.8 1.22 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -160.71 177.95 9.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.41 101.1 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 119.688 1.131 . . . . 0.0 109.471 167.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.9 p -99.33 175.78 5.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.89 60.77 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.211 1.559 . . . . 0.0 115.211 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.59 -31.14 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.38 -0.825 . . . . 0.0 112.485 176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 6.3 t0 -81.21 -37.53 28.48 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.598 -1.314 . . . . 0.0 108.11 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.96 -16.9 64.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.0 -1.454 . . . . 0.0 110.161 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 74.6 m -79.97 -36.4 36.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.92 -36.39 11.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.19 76.43 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -68.81 -19.91 40.29 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 113.809 -3.661 . . . . 0.0 116.807 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -94.26 -22.83 18.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.078 -1.014 . . . . 0.0 111.532 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.19 -36.64 84.81 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -59.72 -43.25 94.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 121.371 -0.83 . . . . 0.0 112.887 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 19' ' ' ASP . 12.3 m-70 -71.65 -29.22 64.39 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.301 -0.874 . . . . 0.0 112.443 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.3 -49.5 73.76 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.31 -37.58 83.74 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.6 m -80.07 -27.04 12.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.424 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.22 -44.11 7.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -64.09 -41.31 97.35 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.92 -38.68 95.8 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.333 -1.413 . . . . 0.0 113.748 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -73.98 -41.19 62.3 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.145 -1.209 . . . . 0.0 113.368 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -107.17 -46.55 3.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.25 61.05 0.75 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -165.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -59.14 104.09 0.22 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -142.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -150.02 100.73 3.22 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 123.465 0.706 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.5 160.42 41.59 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 115.647 -2.435 . . . . 0.0 110.087 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.3 130.59 90.87 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.63 158.32 39.78 Favored 'Trans proline' 0 C--N 1.346 0.409 0 N-CA-C 114.878 1.069 . . . . 0.0 114.878 -173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.66 2.85 49.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -68.21 -23.11 64.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 159.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.5 mt -114.65 42.23 2.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.333 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 51.9 m -53.41 -31.72 46.4 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.974 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -61.19 -36.04 78.79 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.292 -1.505 . . . . 0.0 113.234 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.3 -40.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 53.7 tp -60.05 -39.47 86.07 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.52 -0.737 . . . . 0.0 111.773 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -72.75 -23.8 60.88 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.616 -0.678 . . . . 0.0 112.164 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.02 -38.85 61.43 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.5 mm -65.87 -39.61 85.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 172.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.11 -37.56 87.87 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.543 -1.348 . . . . 0.0 112.787 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.81 -44.85 88.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.7 -44.6 86.01 Favored 'General case' 0 C--O 1.22 -0.49 0 O-C-N 123.875 0.735 . . . . 0.0 110.798 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.85 -21.45 29.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -173.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.49 39.98 3.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.874 0.369 . . . . 0.0 111.465 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -72.18 143.09 49.02 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 100.445 -3.909 . . . . 0.0 100.445 155.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.03 -34.11 77.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 119.785 1.175 . . . . 0.0 110.213 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.4 p -61.65 -43.36 99.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.719 0.771 . . . . 0.0 111.006 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -70.87 -37.45 73.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.902 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.01 -44.45 82.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.133 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.0 -30.39 31.59 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 117.715 2.487 . . . . 0.0 117.715 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.8 p -104.72 11.28 34.15 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -76.59 153.4 35.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.606 -0.684 . . . . 0.0 111.562 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.72 152.06 33.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.91 133.13 47.8 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.39 -34.29 76.96 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -160.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -56.81 -20.03 20.42 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -175.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -116.9 15.82 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 110.949 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.96 -46.74 18.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 101.794 -3.409 . . . . 0.0 101.794 156.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 3.3 mp -62.23 -60.79 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.501 0.32 . . . . 0.0 110.76 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.25 -24.07 60.42 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.118 -1.614 . . . . 0.0 114.173 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.96 -28.56 11.76 Favored Glycine 0 C--O 1.228 -0.246 0 N-CA-C 118.127 2.011 . . . . 0.0 118.127 -171.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 41.5 t90 -101.15 -24.33 14.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 111.581 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -71.56 -6.58 0.1 Allowed Pre-proline 0 C--O 1.242 0.679 0 N-CA-C 121.737 3.977 . . . . 0.0 121.737 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.35 -20.68 42.15 Favored 'Trans proline' 0 C--N 1.357 1.011 1 C-N-CA 109.944 -6.237 . . . . 0.0 114.474 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -79.62 -12.71 59.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.145 -0.972 . . . . 0.0 111.45 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 89.3 t -82.69 -43.86 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.88 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -114.27 -19.72 11.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-O 115.491 -2.195 . . . . 0.0 108.938 179.613 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 ttp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.4 171.69 14.45 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 167.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.4 139.75 53.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -173.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -165.63 164.5 19.14 Favored 'General case' 0 C--O 1.245 0.854 1 N-CA-C 96.289 -5.449 . . . . 0.0 96.289 178.124 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.9 tt -151.34 -10.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.0 t -151.0 122.54 7.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.369 2.35 . . . . 0.0 117.341 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.56 158.52 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.106 0.479 . . . . 0.0 111.606 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -72.75 134.13 44.85 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.12 165.66 20.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.84 138.48 58.35 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.64 132.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.22 -50.97 4.33 Favored Glycine 0 CA--C 1.516 0.122 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.62 76.64 69.82 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 122.588 0.355 . . . . 0.0 111.418 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.25 114.11 2.71 Favored 'Trans proline' 0 C--O 1.234 0.278 0 CA-C-O 122.352 0.897 . . . . 0.0 111.62 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -166.96 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.4 mt -107.69 159.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.2 tp -44.91 142.53 1.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.847 1.259 . . . . 0.0 112.084 160.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.96 -169.68 30.93 Favored Glycine 0 C--O 1.23 -0.111 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -72.85 98.2 2.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.447 1.117 . . . . 0.0 108.602 173.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -142.04 105.0 5.67 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.045 -174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.62 -44.44 48.08 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 115.346 1.248 . . . . 0.0 115.346 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-30 -78.18 -29.78 48.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.9 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.1 m -65.77 -46.12 79.96 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 121.694 -0.629 . . . . 0.0 112.405 -169.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.27 -12.47 60.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 117.772 -1.571 . . . . 0.0 110.359 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -62.33 -44.81 95.62 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.86 -46.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.37 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.87 -39.91 87.66 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.2 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.8 -40.49 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.787 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 80.6 p -68.86 -34.25 75.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.646 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.53 -40.35 42.93 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.07 -0.394 . . . . 0.0 110.869 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -73.08 -29.74 63.16 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.714 -0.616 . . . . 0.0 112.309 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -66.1 -33.47 75.87 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.295 -1.503 . . . . 0.0 110.587 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -87.27 0.07 55.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.844 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 53.21 32.38 13.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.439 1.896 . . . . 0.0 114.618 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.7 121.23 66.5 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.05 142.14 34.01 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 115.703 -2.398 . . . . 0.0 112.475 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -140.45 176.39 8.82 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.823 0.849 . . . . 0.0 109.064 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.77 155.12 28.39 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 t -154.29 138.43 16.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 119.678 1.126 . . . . 0.0 110.823 169.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -96.64 136.38 37.25 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.26 105.67 16.11 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 29.6 mm -79.25 95.03 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -78.55 80.83 4.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.239 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt 52.62 51.8 15.34 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 155.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.47 34.02 6.87 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.696 -170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.86 -58.54 5.35 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -106.28 142.73 25.5 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.356 -160.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -62.75 -166.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.241 0.654 0 N-CA-C 116.166 1.564 . . . . 0.0 116.166 170.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -41.74 -31.73 0.33 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 118.833 2.901 . . . . 0.0 118.833 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -51.81 -42.03 62.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.472 1.033 . . . . 0.0 113.184 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -24.56 22.43 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.971 177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.56 -26.01 63.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.608 0.718 . . . . 0.0 110.783 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -66.32 -30.3 70.68 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.75 -44.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.805 -170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -88.33 118.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 121.641 -0.662 . . . . 0.0 110.815 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 -34.36 97.59 Favored 'Trans proline' 0 C--N 1.348 0.522 0 N-CA-C 116.377 1.645 . . . . 0.0 116.377 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.2 4.15 39.09 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.282 -0.886 . . . . 0.0 110.611 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.23 -15.51 8.8 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 116.202 1.241 . . . . 0.0 116.202 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -142.69 24.2 1.89 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.31 156.13 47.57 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 156.2 51.45 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 117.198 -1.401 . . . . 0.0 113.358 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -145.48 123.18 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.784 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 4' ' ' GLU . 43.7 t -88.82 119.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 173.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.99 130.44 34.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 161.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.8 mm -115.94 103.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 169.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t0 61.69 39.12 14.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.457 1.123 . . . . 0.0 112.813 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.6 t0 58.87 36.58 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.884 -1.507 . . . . 0.0 113.777 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.23 144.94 50.59 Favored 'General case' 0 C--N 1.323 -0.568 1 N-CA-C 98.684 -4.561 . . . . 0.0 98.684 164.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -128.84 156.31 43.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.02 123.97 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.32 81.53 0.98 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -153.79 148.58 26.49 Favored 'General case' 0 N--CA 1.471 0.581 1 N-CA-C 98.649 -4.574 . . . . 0.0 98.649 162.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -60.26 -28.85 68.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -166.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -91.2 -28.96 17.5 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.629 -0.67 . . . . 0.0 112.446 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -82.49 -22.99 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.156 -0.965 . . . . 0.0 110.483 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.93 -0.88 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 122.123 0.963 . . . . 0.0 108.752 174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -107.34 -60.16 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.376 165.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -50.0 36.4 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.8 mt -75.37 -26.55 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.5 tp -63.5 -39.44 94.45 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.432 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.9 -34.41 77.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.363 1.438 . . . . 0.0 111.033 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.82 -36.95 85.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.969 0.89 . . . . 0.0 111.36 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -91.09 -3.86 56.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -70.31 133.17 87.49 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.8 -15.65 26.64 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 115.254 -2.698 . . . . 0.0 114.864 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -87.89 170.64 11.15 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.48 139.08 86.57 Favored 'Trans proline' 0 C--N 1.353 0.768 0 N-CA-C 117.128 1.934 . . . . 0.0 117.128 -169.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.63 110.47 2.41 Favored 'Trans proline' 0 C--N 1.35 0.616 0 N-CA-C 114.014 0.736 . . . . 0.0 114.014 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.8 mt -118.58 56.88 0.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.73 88.0 2.72 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -116.42 123.75 30.3 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 166.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -94.49 67.07 0.32 Allowed 'Trans proline' 0 CA--C 1.556 1.593 0 N-CA-C 119.253 2.751 . . . . 0.0 119.253 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -83.35 -167.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.764 -1.024 . . . . 0.0 111.028 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 14.71 -73.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 1 N-CA-C 122.286 4.18 . . . . 0.0 122.286 167.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.33 -22.16 62.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.639 -0.663 . . . . 0.0 111.697 -172.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.49 75.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.377 0.535 . . . . 0.0 110.211 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -44.98 89.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.235 0.54 . . . . 0.0 109.755 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.56 -41.03 85.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.831 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.31 90.42 Favored Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.602 -0.686 . . . . 0.0 112.245 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -70.63 -8.79 54.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -101.55 -33.89 9.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.098 0.475 . . . . 0.0 111.133 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 67.5 mt -67.13 -42.35 88.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 122.891 0.477 . . . . 0.0 110.27 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -54.56 55.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.48 -30.36 79.85 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 114.961 -2.892 . . . . 0.0 114.52 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -61.59 -54.3 44.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.922 0.328 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -70.98 -27.72 63.92 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 117.916 -1.513 . . . . 0.0 113.906 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 m -74.03 -36.06 43.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 118.098 -1.441 . . . . 0.0 107.962 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -62.47 -51.32 67.95 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -74.06 -29.62 61.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.93 -42.19 85.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.761 1.619 . . . . 0.0 112.302 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -71.52 -30.77 66.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.439 0.638 . . . . 0.0 111.222 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -81.57 138.16 35.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.172 0.987 . . . . 0.0 113.641 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -124.84 30.75 5.83 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -75.29 173.42 7.02 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -75.44 51.76 3.03 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 CA-C-N 121.492 1.569 . . . . 0.0 116.126 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -75.45 106.41 6.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 120.86 -1.15 . . . . 0.0 109.8 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.39 -51.49 1.01 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 170.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.15 -40.14 94.85 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 162.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -18.02 59.48 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 120.607 -1.525 . . . . 0.0 114.237 174.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.76 -33.05 71.89 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -78.74 3.79 15.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.056 -1.028 . . . . 0.0 113.222 173.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.77 62.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 119.836 -1.79 . . . . 0.0 107.417 165.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.06 -37.88 81.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.496 -0.753 . . . . 0.0 109.705 171.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tp -57.28 -43.54 83.19 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -69.82 -34.65 73.97 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.72 -37.06 79.19 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 120.374 -1.454 . . . . 0.0 110.696 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.16 -20.88 59.13 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.267 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -71.27 -32.68 68.98 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.722 -1.237 . . . . 0.0 110.579 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.37 93.54 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.8 -41.38 97.91 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.557 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.9 -37.66 80.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.161 0.985 . . . . 0.0 110.838 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.29 -51.7 47.06 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.94 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -64.97 -32.73 74.59 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.604 -0.939 . . . . 0.0 111.062 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.3 -46.98 78.23 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.253 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.13 -24.59 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 119.885 1.221 . . . . 0.0 112.677 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -76.02 -49.25 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 122.128 -0.357 . . . . 0.0 111.501 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -83.7 -26.11 30.07 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.78 -93.6 1.12 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -71.57 -177.73 2.63 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 118.496 2.46 . . . . 0.0 118.496 -175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -36.65 148.59 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 127.081 2.153 . . . . 0.0 114.001 170.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.8 pt -77.37 23.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -149.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.44 -20.37 60.05 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.302 -1.499 . . . . 0.0 109.405 149.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.39 67.86 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -145.57 -54.93 0.29 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -163.21 -173.71 3.51 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.675 -2.342 . . . . 0.0 104.675 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.9 mt -77.1 114.94 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.7 p -138.93 -170.23 2.81 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -39.66 -45.36 1.66 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 119.62 3.193 . . . . 0.0 119.62 -174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.0 t -67.55 -39.27 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.239 . . . . 0.0 110.365 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.81 -44.64 66.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.336 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.43 -19.03 65.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.445 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.9 m -81.24 -44.65 17.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 27.6 tp -87.91 -45.79 9.95 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.2 -37.59 55.05 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.26 -36.9 26.35 Favored 'Trans proline' 0 C--N 1.354 0.842 1 C-N-CA 111.519 -5.187 . . . . 0.0 113.47 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -77.77 -24.26 49.01 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.63 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.1 mt -61.74 -34.84 76.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.597 1.09 . . . . 0.0 112.434 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -66.17 -44.67 83.4 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.258 -0.901 . . . . 0.0 110.521 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -66.42 -31.62 72.5 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.0 -54.04 47.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -71.11 -34.32 70.97 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.96 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.5 m -72.11 -36.37 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.02 177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.55 12.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.532 1.06 . . . . 0.0 110.232 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -66.34 -35.84 81.38 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.22 -36.17 92.89 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.629 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -85.57 -24.94 27.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.363 -1.081 . . . . 0.0 113.439 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -101.55 -40.48 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -139.43 47.75 1.87 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 109.987 -172.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -34.31 104.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 118.964 2.95 . . . . 0.0 118.964 -149.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -146.36 107.23 4.14 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.61 169.07 15.64 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 118.378 0.456 . . . . 0.0 111.935 162.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 93.8 mt -67.3 124.51 89.19 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -73.02 164.65 34.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.52 -8.35 57.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.505 0.669 . . . . 0.0 110.493 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -62.29 -24.12 67.11 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.669 166.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.6 mt -118.5 44.47 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.8 t -63.12 -18.33 63.3 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -165.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -73.41 -33.93 65.23 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.915 -1.741 . . . . 0.0 109.371 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.88 -46.49 79.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.3 -41.79 98.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.286 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -65.06 -48.27 74.38 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 120.862 -1.149 . . . . 0.0 111.436 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -31.77 70.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.24 -175.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.01 -31.13 44.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 119.575 1.079 . . . . 0.0 111.716 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -71.09 -34.66 71.35 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.104 -1.622 . . . . 0.0 111.16 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 72.8 mt -65.71 -41.39 92.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.33 -38.74 91.07 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -54.57 -41.08 69.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.579 0.627 . . . . 0.0 111.201 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 t -91.25 -0.11 57.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -64.99 144.2 57.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -58.4 -43.25 88.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.29 0.567 . . . . 0.0 110.322 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 44.6 t -60.36 -46.87 88.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -42.78 79.93 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.531 -0.73 . . . . 0.0 111.803 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.64 -42.05 82.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.919 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -77.12 -31.69 55.96 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 67.6 p -99.92 -9.05 23.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ptt-85 -64.88 142.74 58.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 119.123 0.874 . . . . 0.0 112.409 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.75 161.44 30.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.79 133.97 44.73 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -62.72 -35.29 79.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -52.5 -39.56 61.39 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.621 0.768 . . . . 0.0 112.661 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -91.72 -14.84 29.31 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.712 -0.618 . . . . 0.0 111.893 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 43.3 t -74.5 -37.59 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.4 mt -66.32 -37.74 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 121.295 -0.878 . . . . 0.0 108.703 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.45 -5.97 12.98 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.477 -0.764 . . . . 0.0 112.622 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.91 73.49 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.777 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -93.09 -23.24 18.69 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 118.619 1.209 . . . . 0.0 109.927 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.37 128.88 94.18 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 122.719 0.408 . . . . 0.0 111.424 175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.14 4.27 0.76 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 CA-C-N 119.674 0.919 . . . . 0.0 112.446 -65.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -54.63 -29.74 52.97 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . 0.285 27.8 m 47.59 12.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.947 2.499 . . . . 0.0 117.109 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 43.3 t30 49.21 -0.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.994 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.744 -174.329 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 tpp . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.04 4.12 1.93 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 118.568 2.803 . . . . 0.0 118.568 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.8 mp -131.95 -21.24 2.43 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -87.67 -4.82 58.91 Favored 'General case' 0 C--N 1.322 -0.595 1 N-CA-C 124.968 5.173 . . . . 0.0 124.968 -146.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.502 HG23 HG13 ' A' ' 7' ' ' VAL . 10.1 mm -87.93 126.89 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 122.647 2.476 . . . . 0.0 112.38 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.401 ' HB2' HG22 ' A' ' 62' ' ' VAL . 72.4 m -129.64 121.11 26.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 152.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.502 HG13 HG23 ' A' ' 5' ' ' ILE . 11.7 m -137.2 156.14 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.685 1.129 . . . . 0.0 113.812 -174.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -60.96 133.29 55.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 170.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.3 165.48 13.41 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.99 144.4 57.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.69 131.41 28.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -44.84 3.41 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-O 118.851 -0.971 . . . . 0.0 114.925 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.32 85.04 52.03 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -72.85 62.24 3.87 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 121.397 1.398 . . . . 0.0 115.291 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -141.57 -10.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.047 1.339 . . . . 0.0 111.002 174.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.3 tt -135.42 156.23 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.83 156.6 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.01 0.924 . . . . 0.0 112.39 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.81 156.06 17.94 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -78.42 95.12 5.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.792 0.806 . . . . 0.0 112.685 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 75.0 m -100.16 150.23 36.72 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 139.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -59.16 -34.69 98.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 117.034 -1.511 . . . . 0.0 114.053 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.24 -31.04 70.83 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -60.96 -51.91 67.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -30.04 63.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.297 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -59.8 -40.1 87.21 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.01 -1.056 . . . . 0.0 111.494 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.46 -50.6 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -60.87 -39.13 88.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.5 tp -58.07 -45.18 87.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.798 0.726 . . . . 0.0 110.988 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 97.0 p -66.13 -36.7 83.84 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.16 -0.963 . . . . 0.0 111.5 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -71.08 -41.68 70.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.907 -0.496 . . . . 0.0 111.465 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -32.13 58.78 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.927 -0.483 . . . . 0.0 112.251 177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.7 -37.22 81.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.173 -0.954 . . . . 0.0 111.6 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -91.92 1.97 56.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.507 0.67 . . . . 0.0 111.349 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 57.62 26.3 12.72 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.136 1.774 . . . . 0.0 114.71 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 pt -81.56 141.71 48.97 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -68.01 164.81 30.43 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 116.377 -1.948 . . . . 0.0 110.78 175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -154.28 151.31 28.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -79.91 148.48 31.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 103.101 -2.925 . . . . 0.0 103.101 163.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -128.38 125.75 39.28 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.107 0.88 . . . . 0.0 110.591 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -111.9 112.22 23.73 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -80.84 134.23 35.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.64 116.93 54.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -79.32 79.18 5.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.513 0.673 . . . . 0.0 112.658 -176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.0 mt 57.3 39.43 28.5 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.26 69.63 Favored Glycine 0 C--N 1.321 -0.262 0 C-N-CA 120.24 -0.981 . . . . 0.0 114.215 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -71.85 118.17 14.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 149.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.26 122.72 7.58 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.616 0.246 . . . . 0.0 111.619 -172.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.1 176.32 10.09 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.378 171.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -55.66 -37.27 68.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.863 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -53.62 -45.72 70.21 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -80.11 -22.73 41.82 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.676 -1.265 . . . . 0.0 112.488 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.49 -34.83 78.79 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.241 -0.912 . . . . 0.0 111.049 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.05 -11.56 60.97 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.439 -0.788 . . . . 0.0 112.13 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -106.94 -61.06 2.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.654 0.74 . . . . 0.0 112.358 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -86.86 129.97 50.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 -166.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.02 -28.65 41.39 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 116.082 -2.146 . . . . 0.0 114.03 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -89.28 -10.49 46.67 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.042 -1.036 . . . . 0.0 111.077 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.01 -7.2 36.97 Favored Glycine 0 C--O 1.22 -0.726 0 O-C-N 121.709 -0.619 . . . . 0.0 113.003 -169.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -144.85 16.27 1.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.47 143.13 28.76 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -59.18 156.48 34.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 N-CA-C 114.676 0.991 . . . . 0.0 114.676 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 6' ' ' CYS . 24.4 m -134.98 169.67 20.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 175.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.5 m -106.76 142.7 18.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 160.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -126.67 53.48 1.67 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 123.033 1.397 . . . . 0.0 111.112 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.1 mt -68.35 126.8 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 57.17 30.77 18.89 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.193 0.997 . . . . 0.0 111.864 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.6 t70 64.13 18.13 11.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.082 1.753 . . . . 0.0 113.482 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -106.25 112.2 25.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.572 -0.705 . . . . 0.0 109.19 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -74.9 140.29 43.7 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.45 130.02 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.16 41.52 1.51 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -157.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -138.78 144.63 39.47 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.557 -1.34 . . . . 0.0 108.331 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -58.83 -32.35 69.31 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -75.97 -31.75 59.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.936 0.398 . . . . 0.0 111.241 -177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.75 -11.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.635 -1.291 . . . . 0.0 110.342 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.12 -26.51 32.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 165.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.8 t -73.79 -44.01 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 120.388 -1.445 . . . . 0.0 110.447 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -99.54 -64.77 0.83 Allowed Glycine 0 CA--C 1.519 0.341 0 N-CA-C 119.986 2.754 . . . . 0.0 119.986 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.53 -38.06 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.969 0.884 . . . . 0.0 111.748 -176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.14 -45.76 83.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.888 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -74.87 -28.05 60.5 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.641 -1.224 . . . . 0.0 113.316 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -63.14 -40.99 99.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.56 -7.91 30.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -68.15 119.11 65.16 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 160.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.15 0.65 9.51 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 116.064 1.524 . . . . 0.0 116.064 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.92 162.55 67.63 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.66 132.48 49.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 N-CA-C 115.956 1.483 . . . . 0.0 115.956 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.16 140.28 19.7 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 116.878 -1.615 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.7 mt -137.25 43.23 2.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.308 0.575 . . . . 0.0 111.501 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.07 80.14 4.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.968 0.89 . . . . 0.0 110.437 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.8 m -116.59 93.54 40.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -90.73 81.18 0.46 Allowed 'Trans proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.08 3.187 . . . . 0.0 117.543 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -87.97 -137.37 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 CA-C-N 119.528 0.867 . . . . 0.0 112.704 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.45 -30.95 68.87 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.941 -1.1 . . . . 0.0 112.874 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -63.26 -29.75 71.02 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.553 -0.717 . . . . 0.0 110.597 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.91 -28.73 25.72 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.095 -0.378 . . . . 0.0 111.995 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.2 p -73.53 -33.08 64.57 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.69 -49.17 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.65 62.24 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -60.39 -26.5 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -81.44 -42.62 20.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.049 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.98 -41.06 79.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.022 -166.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -56.48 -56.29 33.64 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.08 -20.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 113.827 -3.648 . . . . 0.0 113.856 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 62.5 m -64.76 -49.88 69.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.583 1.083 . . . . 0.0 109.943 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -72.14 -31.19 65.75 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.68 -175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.7 t -68.81 -40.01 80.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -68.32 -40.53 81.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.425 -1.422 . . . . 0.0 111.959 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.91 -26.71 67.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.206 0.912 . . . . 0.0 111.944 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.83 -50.67 55.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -70.1 -24.88 63.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.5 t -75.84 141.35 42.47 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.707 -0.62 . . . . 0.0 110.795 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -130.0 32.66 4.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.58 167.99 2.12 Favored Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 162.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -65.89 92.11 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 116.953 -1.565 . . . . 0.0 112.222 165.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -93.42 106.84 18.77 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.561 -169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -148.0 -48.87 0.16 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.788 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.44 -33.29 86.09 Favored Glycine 0 C--O 1.226 -0.365 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.4 p -76.77 -20.31 56.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.594 -0.945 . . . . 0.0 113.381 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -75.3 -31.08 60.56 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.38 -28.38 59.48 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.611 -0.68 . . . . 0.0 110.36 172.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.27 95.19 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.906 -1.121 . . . . 0.0 110.09 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.7 tp -63.53 -38.98 93.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.739 -0.601 . . . . 0.0 110.815 174.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -43.68 94.04 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.525 173.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -67.4 -36.97 82.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.406 1.003 . . . . 0.0 112.977 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.67 -45.7 81.9 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.294 -0.879 . . . . 0.0 109.382 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.89 -20.32 61.8 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 120.823 -1.173 . . . . 0.0 110.597 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.56 -28.77 68.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 120.753 -1.217 . . . . 0.0 111.557 173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 -42.31 89.83 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.1 -38.39 85.59 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.01 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.96 -38.65 89.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.3 0.64 . . . . 0.0 109.808 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.59 -54.87 23.39 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.151 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -62.27 -28.18 69.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.822 -0.81 . . . . 0.0 112.577 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.27 -54.66 13.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.823 -0.548 . . . . 0.0 110.103 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.85 -22.29 65.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.21 -9.76 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.119 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -119.65 -44.53 2.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 107.53 -46.38 1.18 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 119.639 2.616 . . . . 0.0 119.639 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -68.79 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.695 3.248 . . . . 0.0 116.744 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -58.0 175.1 0.22 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.326 1.05 . . . . 0.0 112.444 169.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.63 -32.26 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.445 -0.784 . . . . 0.0 110.431 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.57 -3.81 5.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 116.643 2.09 . . . . 0.0 116.643 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.28 -5.29 60.2 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 116.715 1.446 . . . . 0.0 116.715 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -137.24 -53.56 0.68 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.692 1.246 . . . . 0.0 113.171 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -167.49 177.6 5.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 100.984 -3.71 . . . . 0.0 100.984 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.92 126.17 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.18 1.354 . . . . 0.0 109.181 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 m -143.29 174.39 10.76 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -41.59 -40.26 1.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 120.334 3.457 . . . . 0.0 120.334 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.66 -32.01 56.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 120.495 1.498 . . . . 0.0 110.942 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -68.92 -39.23 79.76 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.27 -34.85 78.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 77.2 p -74.07 -37.24 64.28 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -107.74 -46.94 3.7 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -167.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.75 -41.59 92.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.31 -13.73 18.65 Favored 'Trans proline' 0 C--N 1.349 0.591 1 C-N-CA 111.987 -4.876 . . . . 0.0 113.327 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -91.87 -26.67 18.37 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.909 -0.494 . . . . 0.0 110.477 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.7 -34.18 76.61 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.947 -0.47 . . . . 0.0 110.635 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.58 -50.14 63.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.468 1.128 . . . . 0.0 108.988 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -73.52 -14.89 61.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.718 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.3 tp -65.76 -54.27 29.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.216 0.916 . . . . 0.0 109.674 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -70.98 -26.85 63.33 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.437 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 54.7 t -63.9 -58.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 121.67 -0.644 . . . . 0.0 110.233 171.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.35 -47.75 54.48 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.015 -1.053 . . . . 0.0 111.581 -169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 18.9 tp -67.4 -37.92 83.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.81 -38.51 95.66 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.993 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -72.31 -34.18 67.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.011 1.405 . . . . 0.0 113.418 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -105.03 -33.95 8.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 118.818 2.896 . . . . 0.0 118.818 -172.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.02 61.97 1.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -53.86 114.54 1.61 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -158.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -133.61 97.35 15.89 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 167.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 160.25 40.86 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 115.969 -2.221 . . . . 0.0 109.034 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 84.2 mt -73.11 122.4 87.56 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.59 165.36 25.08 Favored 'Trans proline' 0 C--N 1.346 0.438 0 N-CA-C 114.526 0.933 . . . . 0.0 114.526 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.22 -5.71 45.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.801 -0.562 . . . . 0.0 112.007 175.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -68.11 -21.87 64.92 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.985 -0.447 . . . . 0.0 110.801 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.3 mt -110.65 58.68 0.61 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -34.48 72.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.451 -167.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -78.02 -35.62 49.61 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.989 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.8 -39.2 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.57 -42.38 91.84 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.592 -0.693 . . . . 0.0 111.154 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.99 -36.02 81.25 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 120.997 -1.065 . . . . 0.0 110.083 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -64.75 -43.32 93.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.0 -25.72 30.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 O-C-N 120.404 -1.435 . . . . 0.0 110.514 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -66.93 -25.94 66.61 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.065 -1.647 . . . . 0.0 112.091 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.6 mt -71.67 -30.51 65.79 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.696 0.68 . . . . 0.0 109.176 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.26 -28.45 42.39 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.824 0.345 . . . . 0.0 110.263 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -79.48 13.2 2.08 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 120.835 -1.166 . . . . 0.0 111.124 170.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.4 t -134.67 171.09 14.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.1 mtp-105 60.16 136.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.04 -32.35 67.89 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.376 -0.828 . . . . 0.0 112.772 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.5 m -55.76 -32.59 63.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -102.23 -46.16 4.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.391 1.091 . . . . 0.0 110.49 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.15 -33.29 75.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -79.61 -32.25 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.497 -0.752 . . . . 0.0 110.898 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 41.0 p -91.67 -16.89 26.32 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -62.36 148.57 44.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.863 . . . . 0.0 111.967 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.93 152.81 37.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.596 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.32 51.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.33 -33.91 76.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -160.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.43 -35.34 80.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.511 1.148 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -80.76 -22.54 40.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.219 -176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.5 t -63.67 -51.79 65.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.4 pt -73.47 -36.02 47.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.71 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -20.07 65.99 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -94.65 -26.51 13.11 Favored Glycine 0 CA--C 1.517 0.18 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -95.81 -25.77 15.91 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.369 1.585 . . . . 0.0 115.069 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -94.32 -10.27 0.15 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 121.507 3.892 . . . . 0.0 121.507 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.63 -17.67 23.1 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 113.674 -3.75 . . . . 0.0 117.077 -172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -102.44 4.39 38.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.702 0.683 . . . . 0.0 109.781 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.9 t -98.81 -46.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.909 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -101.23 6.49 42.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.808 0.813 . . . . 0.0 111.635 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.9 -157.7 0.1 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.952 1.301 . . . . 0.0 113.174 -177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.16 161.11 30.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -138.14 126.24 22.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.567 HG22 HG13 ' A' ' 7' ' ' VAL . 40.4 mm -110.75 103.62 15.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -166.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.6 m -98.43 71.42 2.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.042 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.567 HG13 HG22 ' A' ' 5' ' ' ILE . 18.7 m -93.01 157.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.298 -170.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 20' ' ' CYS . 37.0 mtmt -62.87 142.91 58.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -82.21 161.88 22.58 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 171.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.31 143.85 54.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 122.868 1.318 . . . . 0.0 113.849 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.44 130.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -4.78 48.84 Favored Glycine 0 C--O 1.241 0.553 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.978 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.39 78.59 4.6 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.305 1.053 . . . . 0.0 112.369 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 75.6 Cg_endo -72.51 45.47 0.85 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 119.043 2.67 . . . . 0.0 119.043 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -131.01 -7.16 3.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.883 1.273 . . . . 0.0 114.187 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.28 159.18 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.7 mt -61.18 142.55 56.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.24 153.43 22.22 Favored Glycine 0 CA--C 1.508 -0.383 0 O-C-N 121.514 -0.741 . . . . 0.0 114.9 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.93 103.13 10.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.655 1.217 . . . . 0.0 108.814 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 23.5 t -132.69 137.63 30.2 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.36 -29.13 72.08 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 115.32 -2.653 . . . . 0.0 112.304 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -80.9 -16.87 52.41 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.452 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.8 t -70.23 -52.01 26.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.84 -20.08 65.12 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.943 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -61.02 -43.75 98.43 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.668 2.031 . . . . 0.0 111.554 167.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.01 -54.61 21.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.03 -37.82 86.84 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -167.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.6 -39.5 88.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.3 p -70.59 -40.2 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 112.416 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -48.14 76.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.539 -177.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -74.57 -28.94 61.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.515 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -71.19 -36.39 71.93 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.59 -0.694 . . . . 0.0 111.191 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -85.17 -5.53 59.33 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 53.64 36.81 24.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 113.724 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 26.7 pt -84.25 153.44 62.6 Favored Pre-proline 0 C--O 1.246 0.879 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.795 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.4 137.61 25.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.068 -1.488 . . . . 0.0 114.689 -179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -151.77 161.58 42.43 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.3 126.41 52.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.2 t -88.62 135.08 33.68 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -137.2 129.56 29.72 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 71.4 mt -107.07 132.08 53.38 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -173.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.7 mm -105.48 101.32 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.789 1.236 . . . . 0.0 111.018 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -69.59 83.21 0.42 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.421 1.088 . . . . 0.0 113.486 176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt 51.12 48.26 23.37 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 122.921 1.343 . . . . 0.0 113.61 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.52 57.72 1.93 Allowed Glycine 0 CA--C 1.518 0.261 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.266 -173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -84.35 85.55 7.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.9 86.44 57.41 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-O 122.021 0.915 . . . . 0.0 112.219 -157.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.93 -176.51 3.22 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.073 -1.484 . . . . 0.0 108.31 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -47.55 -40.73 19.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.551 0.74 . . . . 0.0 112.602 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -55.87 -47.06 78.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -89.68 -21.75 22.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.217 -0.927 . . . . 0.0 110.939 -174.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.11 -43.6 94.82 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 171.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -70.79 -38.8 73.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.502 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.3 mt -110.77 87.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.523 0.678 . . . . 0.0 112.381 -172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.4 t 174.26 145.92 0.21 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -62.1 -25.12 77.09 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 116.876 1.837 . . . . 0.0 116.876 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -125.96 -14.09 6.17 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.07 -9.42 67.82 Favored Glycine 0 N--CA 1.463 0.463 0 CA-C-O 122.335 0.964 . . . . 0.0 111.642 -168.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -155.47 88.75 1.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.12 0.968 . . . . 0.0 110.534 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -143.37 150.35 51.25 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 101.107 -3.664 . . . . 0.0 101.107 -178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -67.09 98.51 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 115.913 -2.258 . . . . 0.0 113.145 162.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.6 t -91.55 137.72 21.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.455 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.58 113.47 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -85.77 126.32 33.92 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -127.11 88.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 t0 50.42 56.46 7.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.781 0.801 . . . . 0.0 112.821 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 65.5 24.31 11.85 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -124.97 144.13 50.53 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 102.039 -3.319 . . . . 0.0 102.039 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -123.71 132.38 53.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 118.817 0.735 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.07 134.03 61.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -170.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.52 -22.16 0.33 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.2 138.97 58.72 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -62.98 -29.16 70.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -165.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -85.9 -7.3 58.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.61 -10.6 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.2 -0.938 . . . . 0.0 110.16 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -64.07 -36.28 76.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 159.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.7 t -74.58 -39.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.092 -1.005 . . . . 0.0 111.324 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.37 -73.51 1.16 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 120.371 2.909 . . . . 0.0 120.371 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.57 -38.14 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 121.687 -0.89 . . . . 0.0 111.986 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 tp -60.57 -41.84 95.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.795 0.725 . . . . 0.0 109.638 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.58 -34.33 73.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.39 -35.39 75.74 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.006 -1.059 . . . . 0.0 111.108 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.01 7.51 45.86 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.38 137.19 97.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -61.73 -29.11 82.92 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 117.134 -1.444 . . . . 0.0 115.299 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -81.09 169.26 19.94 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 109.811 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -57.42 134.33 62.9 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 116.811 -1.659 . . . . 0.0 116.021 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.6 135.45 3.0 Favored 'Trans proline' 0 C--O 1.247 0.962 0 N-CA-C 118.3 2.385 . . . . 0.0 118.3 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.3 mt -135.37 43.5 2.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.81 82.01 2.74 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.484 -1.385 . . . . 0.0 111.611 171.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -118.65 94.83 48.22 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.569 1.148 . . . . 0.0 113.775 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -106.15 59.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.905 0 N-CA-C 122.248 3.903 . . . . 0.0 122.248 -174.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -82.25 -126.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 120.691 0.928 . . . . 0.0 114.049 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -57.29 -32.23 66.43 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 120.982 -1.074 . . . . 0.0 112.677 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -66.16 -32.79 74.44 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 121.146 -0.972 . . . . 0.0 111.847 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.52 -33.19 60.71 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.612 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.1 p -71.27 -34.6 70.83 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.96 -45.42 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 123.024 0.202 . . . . 0.0 110.516 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.5 -35.94 87.38 Favored Glycine 0 CA--C 1.516 0.138 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.377 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.8 p -73.51 -0.4 14.95 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -94.14 -33.93 13.14 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 167.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.7 mt -82.26 -39.52 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.68 0.753 . . . . 0.0 110.416 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HA ' ' CE2' ' A' ' 106' ' ' PHE . 19.9 t80 -51.64 -50.41 77.38 Favored Pre-proline 0 C--O 1.239 0.539 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.69 -33.75 12.56 Favored 'Trans proline' 0 C--N 1.347 0.478 1 C-N-CA 111.648 -5.101 . . . . 0.0 114.543 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.4 p -72.5 -39.77 67.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.253 0.479 . . . . 0.0 111.104 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 103' ' ' PHE . 1.9 p90 -68.8 -30.0 68.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 117.996 -1.482 . . . . 0.0 113.908 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.54 -47.81 62.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -61.98 -44.12 97.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -75.28 -37.14 61.04 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.775 -0.77 . . . . 0.0 112.428 -174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.91 -34.3 78.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.85 0.833 . . . . 0.0 110.579 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -76.65 0.05 21.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.124 0.97 . . . . 0.0 112.108 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -121.05 114.31 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -87.39 49.55 1.83 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 123.566 1.651 . . . . 0.0 110.309 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -88.51 170.47 11.18 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 173.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.62 50.31 2.67 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 CA-C-N 120.174 1.098 . . . . 0.0 114.938 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -75.04 100.39 4.18 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.897 1.279 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.9 -45.96 0.86 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 166.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 -38.09 93.67 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 166.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 50.0 m -69.57 -30.65 68.49 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.767 -0.843 . . . . 0.0 111.981 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.66 -28.88 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.709 -1.87 . . . . 0.0 110.04 172.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -75.7 -10.39 59.39 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.372 -1.455 . . . . 0.0 111.625 170.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.03 60.31 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 119.814 -1.804 . . . . 0.0 108.126 168.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.5 tp -67.79 -34.92 77.71 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.549 -0.719 . . . . 0.0 111.164 170.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.0 tp -56.2 -44.8 79.83 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -67.53 -26.44 66.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -77.47 -35.93 53.28 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 120.615 -1.303 . . . . 0.0 109.679 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -74.3 -20.55 60.08 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.728 -0.608 . . . . 0.0 109.52 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -67.92 -30.09 69.33 Favored 'General case' 0 CA--C 1.511 -0.541 0 O-C-N 121.463 -0.773 . . . . 0.0 111.395 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.61 -42.09 87.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.02 -43.97 93.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.681 176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.75 -35.94 77.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.05 0.54 . . . . 0.0 110.515 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.91 -50.98 55.47 Favored Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.822 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.54 -36.03 81.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.879 -1.365 . . . . 0.0 110.489 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.22 -43.01 99.32 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -74.43 -27.81 60.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.24 -44.43 77.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.44 -54.21 5.39 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.74 -63.45 0.46 Allowed Glycine 0 CA--C 1.528 0.905 0 CA-C-O 117.183 -1.899 . . . . 0.0 116.761 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.24 -162.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 1 C-N-CA 127.98 5.787 . . . . 0.0 118.565 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -55.9 175.14 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.67 163.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -54.25 -33.19 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -172.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.8 -9.88 58.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.25 3.82 89.79 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 118.395 -1.225 . . . . 0.0 116.141 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -136.53 -52.54 0.71 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.729 1.764 . . . . 0.0 112.978 165.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -162.73 -177.56 5.62 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 117.635 -1.174 . . . . 0.0 109.96 -175.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.07 118.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.881 1.218 . . . . 0.0 110.347 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 33.6 m -132.64 177.23 7.78 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.02 -20.23 37.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.63 -18.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.972 -1.08 . . . . 0.0 111.711 173.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.22 -38.04 31.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -28.91 69.63 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 120.719 0.295 . . . . 0.0 110.649 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 93.9 p -77.68 -35.32 52.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.49 -46.81 3.92 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.05 81.41 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.11 -27.89 19.63 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.776 -4.349 . . . . 0.0 114.371 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -72.88 -29.89 63.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.02 -24.49 64.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 174.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.15 -50.35 61.52 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.007 -1.058 . . . . 0.0 110.334 170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -55.45 -42.33 74.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.496 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.6 tp -57.35 -61.99 2.09 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.745 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -67.93 -32.85 73.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -170.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 -43.08 83.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.134 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.84 -42.15 34.55 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.086 -1.009 . . . . 0.0 112.494 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.1 tp -63.68 -38.61 91.76 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.9 81.13 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.089 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.45 -48.86 11.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.49 -1.006 . . . . 0.0 112.968 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -86.72 -43.5 12.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -134.87 59.5 1.73 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.9 0.88 . . . . 0.0 108.766 -171.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -49.97 104.51 0.07 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -154.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -147.82 98.96 3.8 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.241 1.817 . . . . 0.0 106.222 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.41 172.06 17.05 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 115.652 -2.432 . . . . 0.0 109.728 167.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 89.9 mt -68.41 118.08 56.15 Favored Pre-proline 0 C--O 1.242 0.71 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -82.19 167.04 16.09 Favored 'Trans proline' 0 C--N 1.352 0.728 0 N-CA-C 114.975 1.106 . . . . 0.0 114.975 -172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.92 4.2 5.69 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -69.6 -23.28 63.5 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.33 60.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -66.64 -19.86 65.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.637 -0.664 . . . . 0.0 112.565 -170.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.7 -33.51 40.98 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.22 -37.22 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.767 0.794 . . . . 0.0 109.445 175.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.45 -47.77 84.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.447 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -65.24 -40.38 93.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -55.56 -53.46 56.12 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.194 0.521 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.4 tp -74.43 -25.23 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.655 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -66.26 -42.36 88.61 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.745 -1.222 . . . . 0.0 111.6 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.02 -41.57 99.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.07 -37.46 85.88 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 123.607 0.567 . . . . 0.0 111.918 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.15 -25.95 62.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.4 t -122.13 39.56 3.86 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.864 173.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -103.85 136.5 43.4 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.93 -44.43 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.3 t -59.61 -47.24 86.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.961 0.886 . . . . 0.0 111.962 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -71.93 -43.46 65.26 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -62.14 -33.08 73.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -75.78 -42.3 50.57 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.027 -1.045 . . . . 0.0 113.094 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.2 p -88.4 -3.23 58.87 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -57.09 138.92 53.84 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.47 153.4 41.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -73.98 130.96 40.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.69 -36.97 82.43 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 -170.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.57 -21.26 62.7 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.505 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -97.29 -14.35 21.39 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.95 -52.34 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 162.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 56.3 mt -69.61 -54.54 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 122.229 -0.294 . . . . 0.0 111.599 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.54 -2.34 35.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.362 -0.836 . . . . 0.0 112.654 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.18 -16.97 44.95 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.739 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -106.56 -48.99 3.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.15 0.976 . . . . 0.0 112.146 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.09 -26.28 2.58 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -66.81 -17.48 52.11 Favored 'Trans proline' 0 C--N 1.357 0.981 1 C-N-CA 112.316 -4.656 . . . . 0.0 115.501 173.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.37 -19.13 25.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.333 -1.479 . . . . 0.0 110.185 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -82.29 -47.36 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 110.601 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -109.83 6.52 23.49 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 -175.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.201 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.27 143.24 30.92 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.4 138.17 54.39 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -101.48 131.9 47.38 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.5 mm -125.77 95.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -166.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.0 m -98.01 116.91 31.2 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -128.21 165.33 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.37 133.4 47.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.556 -0.715 . . . . 0.0 112.127 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.14 165.11 24.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.701 0.4 . . . . 0.0 110.95 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 144.28 56.69 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.906 -0.497 . . . . 0.0 110.268 170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.3 t -61.89 124.34 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.67 -13.4 52.78 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.97 89.08 12.96 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -171.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -69.27 76.26 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-O 123.395 1.331 . . . . 0.0 113.241 162.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -149.75 -38.38 0.15 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.887 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -135.51 153.05 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.08 152.13 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.126 0.965 . . . . 0.0 112.761 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.09 -174.57 17.67 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 118.016 1.967 . . . . 0.0 118.016 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 202' ' ' VAL . 20.7 t70 -77.61 112.32 14.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.253 -1.473 . . . . 0.0 112.432 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.32 146.77 34.42 Favored Pre-proline 0 C--O 1.245 0.848 1 N-CA-C 97.633 -4.951 . . . . 0.0 97.633 159.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -59.26 -35.24 97.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 CA-C-O 122.65 1.021 . . . . 0.0 113.514 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.82 -0.65 53.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.689 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 t -57.41 -42.57 82.53 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.973 0.892 . . . . 0.0 110.844 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -92.41 0.29 57.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -63.67 -44.46 93.67 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.955 1.252 . . . . 0.0 109.109 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.53 76.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.726 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.97 -40.73 98.59 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.01 -38.82 92.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.181 0.9 . . . . 0.0 110.427 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 m -62.91 -40.28 97.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.064 -176.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.7 mt -69.76 -43.47 72.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.714 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -74.61 -32.11 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -164.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -78.2 -33.37 50.07 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.266 -1.373 . . . . 0.0 110.485 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -80.03 -14.92 58.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.111 -0.368 . . . . 0.0 111.08 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 55.82 33.16 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.745 1.618 . . . . 0.0 113.162 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.4 pt -74.83 154.76 87.05 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.26 150.4 41.98 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 115.681 -2.413 . . . . 0.0 113.275 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -154.62 172.21 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -126.64 94.2 3.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.645 1.178 . . . . 0.0 108.648 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.1 t -75.87 139.69 41.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.038 0.447 . . . . 0.0 110.769 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.35 144.34 44.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.47 126.05 51.77 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -83.2 122.07 36.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -79.46 70.09 5.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt 53.47 50.69 16.8 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 161.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.36 8.66 65.97 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 114.081 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.99 106.55 3.71 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 151.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -137.84 86.42 18.27 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -172.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -62.32 173.17 3.55 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 118.007 -0.862 . . . . 0.0 110.837 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -53.01 -37.45 61.51 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -53.63 -53.13 56.3 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -73.85 -29.39 62.1 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 120.803 -1.185 . . . . 0.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.74 -35.65 81.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 119.274 0.943 . . . . 0.0 110.881 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.81 -20.49 61.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.3 mt -99.92 -37.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.836 0.827 . . . . 0.0 111.301 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.0 t -119.71 120.93 30.19 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.37 0.668 . . . . 0.0 109.872 -170.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.71 -29.6 88.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -97.76 2.11 49.17 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.45 -29.5 2.57 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.038 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.16 72.81 1.4 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 122.857 1.313 . . . . 0.0 113.181 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.43 155.19 52.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 162.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.81 142.19 56.75 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 114.685 -3.077 . . . . 0.0 110.148 172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.67 164.0 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.35 113.33 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -100.73 88.54 3.62 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mt -88.46 104.24 14.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.48 52.55 13.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.883 0.849 . . . . 0.0 111.377 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 t0 60.7 30.61 19.82 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -133.14 151.19 52.0 Favored 'General case' 0 C--N 1.323 -0.573 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 173.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -145.45 150.41 36.45 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 122.471 2.396 . . . . 0.0 116.741 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.75 150.32 32.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.487 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.46 -12.27 1.18 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 118.097 2.629 . . . . 0.0 118.097 -169.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -68.49 142.94 55.16 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.047 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -60.56 -27.39 67.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -82.95 -35.45 25.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.223 -0.923 . . . . 0.0 111.088 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -83.67 -14.7 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.293 -0.879 . . . . 0.0 112.29 -168.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 pt -70.85 -6.86 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.665 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.74 -52.7 8.37 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 157.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.55 -47.06 92.18 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 118.819 2.288 . . . . 0.0 118.819 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.9 mt -82.57 -27.05 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -60.69 -44.56 96.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.325 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -65.18 -41.56 94.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 118.414 0.552 . . . . 0.0 110.796 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -58.7 -35.99 73.51 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.839 -1.163 . . . . 0.0 112.301 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -107.15 17.13 23.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.903 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -74.07 131.7 80.77 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.05 -12.38 30.34 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 114.586 -3.143 . . . . 0.0 115.024 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -114.78 149.57 42.6 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 118.901 0.773 . . . . 0.0 109.864 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -62.26 121.78 9.94 Favored 'Trans proline' 0 C--O 1.24 0.59 0 N-CA-C 116.46 1.677 . . . . 0.0 116.46 -148.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -81.32 161.33 20.01 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.4 mt -139.96 64.95 1.44 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.424 1.107 . . . . 0.0 110.531 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.76 63.13 6.72 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.517 -0.74 . . . . 0.0 111.815 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.48 104.25 50.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.89 54.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 124.571 3.514 . . . . 0.0 120.752 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.24 -112.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 116.724 -1.717 . . . . 0.0 115.086 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.49 -34.36 72.49 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.011 -1.681 . . . . 0.0 114.21 -173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -32.12 73.66 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.729 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 -24.96 55.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.6 p -71.93 -37.19 70.08 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.41 -49.27 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.61 97.0 Favored Glycine 0 CA--C 1.516 0.149 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.413 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -75.9 -10.0 59.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -78.54 -38.48 40.36 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.78 -1.2 . . . . 0.0 109.901 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 52.0 mt -72.23 -48.15 50.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.689 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -51.28 -53.44 49.19 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -170.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.07 -22.67 16.76 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 114.214 -3.391 . . . . 0.0 114.517 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.6 m -67.33 -38.98 85.75 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -86.38 -23.94 25.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.67 -33.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -63.76 -45.13 91.17 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.606 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -62.74 -38.16 89.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.5 tp -66.94 -46.32 75.11 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.297 0.953 . . . . 0.0 111.043 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -69.33 -21.68 63.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.488 0.661 . . . . 0.0 111.619 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.7 t -90.38 138.27 31.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -128.08 30.68 5.2 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.35 171.53 4.04 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -71.93 59.2 2.85 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 CA-C-N 120.711 1.29 . . . . 0.0 114.492 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -60.29 122.19 13.89 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.109 1.764 . . . . 0.0 112.877 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -152.8 -42.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.235 0.541 . . . . 0.0 109.715 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.06 -39.64 96.48 Favored Glycine 0 C--O 1.22 -0.745 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.8 p -73.62 -17.63 61.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.392 -1.063 . . . . 0.0 113.062 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.59 -39.24 53.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.833 1.301 . . . . 0.0 107.61 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -79.1 -14.22 59.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.663 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.08 80.23 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.671 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.27 -42.45 93.21 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.98 -43.23 95.24 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.006 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -70.7 -42.15 71.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.73 -33.52 68.79 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 120.146 -1.596 . . . . 0.0 108.983 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.27 -16.43 59.0 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 121.437 -0.789 . . . . 0.0 110.656 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -70.8 -33.52 70.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 119.992 1.269 . . . . 0.0 109.61 172.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.32 -39.45 89.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.38 -43.8 93.34 Favored 'General case' 0 C--O 1.215 -0.748 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.173 174.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.41 -39.07 89.4 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.538 0.735 . . . . 0.0 110.225 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.4 -51.67 50.4 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -61.35 -38.62 87.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.851 -0.794 . . . . 0.0 112.401 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.81 -39.47 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.537 -0.727 . . . . 0.0 110.717 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -72.66 -24.86 61.09 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.729 1.604 . . . . 0.0 114.48 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -79.71 -11.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -118.11 -43.73 2.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.12 -76.32 0.23 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.466 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -67.88 -169.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.063 3.175 . . . . 0.0 117.656 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -53.86 168.66 0.19 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.788 1.635 . . . . 0.0 113.962 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.2 tt -63.2 -21.79 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -151.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.5 -11.63 53.42 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.186 -0.946 . . . . 0.0 113.338 173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.51 0.48 72.87 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -143.74 -49.54 0.3 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -162.32 176.07 10.94 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.7 mm -66.64 125.79 24.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.9 p -130.72 -172.3 2.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.64 -31.45 25.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.46 -42.97 81.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 118.784 0.72 . . . . 0.0 110.131 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -66.86 -39.02 87.44 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.61 -21.53 66.58 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.4 m -91.01 -36.07 14.28 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.0 tp -86.98 -49.32 7.43 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.22 -36.6 48.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.18 -31.34 45.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 113.459 -3.894 . . . . 0.0 113.958 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.36 -30.61 42.71 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.93 -34.55 76.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.032 0.833 . . . . 0.0 113.19 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -61.9 -43.6 98.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.985 1.266 . . . . 0.0 109.907 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -73.56 -28.54 61.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.146 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.7 -52.24 64.07 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.98 -33.23 75.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.025 -172.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.1 t -72.38 -61.87 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.463 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.28 66.77 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 120.512 -1.368 . . . . 0.0 111.293 -168.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.57 -42.94 77.58 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.54 -34.47 89.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.874 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -95.06 -16.03 22.99 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -108.69 -39.9 5.23 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -142.22 58.09 1.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -54.65 116.82 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -160.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -134.64 98.44 13.5 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 164.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.41 164.59 32.33 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 115.124 -2.784 . . . . 0.0 109.29 174.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 72.6 mt -71.32 117.16 54.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 171.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.68 168.69 24.15 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 117.428 -1.248 . . . . 0.0 112.575 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -4.95 41.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.679 0.752 . . . . 0.0 110.492 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -66.68 -22.12 66.09 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.123 -0.986 . . . . 0.0 110.181 168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.52 50.75 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -56.75 -29.05 62.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -79.64 -32.6 41.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.578 -1.326 . . . . 0.0 110.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 61.9 t -70.88 -37.92 70.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.87 -43.79 91.78 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.072 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -64.7 -38.49 91.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 112.361 174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -59.79 -47.83 84.1 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.949 -0.47 . . . . 0.0 111.764 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.16 -27.34 26.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 O-C-N 120.999 -1.063 . . . . 0.0 111.096 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -67.97 -33.55 74.86 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.649 -1.282 . . . . 0.0 111.977 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.86 -31.53 71.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 118.67 0.668 . . . . 0.0 110.229 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.82 -5.77 51.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.384 0.611 . . . . 0.0 112.18 174.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -101.61 9.44 41.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.997 -1.065 . . . . 0.0 109.927 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.0 t -112.11 165.71 11.89 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 61.44 141.97 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -64.27 -27.82 69.3 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.138 -0.976 . . . . 0.0 112.341 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 m -56.06 -40.71 73.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -96.56 -50.69 4.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.496 0.665 . . . . 0.0 109.605 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.87 -43.97 90.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -76.06 -30.53 58.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 52.5 p -75.17 -12.4 60.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.646 -0.659 . . . . 0.0 112.532 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -58.05 132.36 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.47 0.652 . . . . 0.0 110.777 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.04 154.59 39.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.817 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.57 117.28 4.01 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.549 1.155 . . . . 0.0 111.188 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.44 -35.52 73.41 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -158.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.3 -37.42 87.1 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.775 -1.203 . . . . 0.0 107.853 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -75.83 -3.97 38.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.88 -1.055 . . . . 0.0 113.533 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 19' ' ' ASP . 58.5 t -86.32 -46.51 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -65.6 -52.28 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.348 1.07 . . . . 0.0 108.17 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -91.21 27.66 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.138 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -112.71 -46.41 0.73 Allowed Glycine 0 N--CA 1.454 -0.12 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 167.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -53.68 7.45 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -84.61 -1.48 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 120.751 3.612 . . . . 0.0 120.751 -171.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.39 -18.91 43.98 Favored 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 111.398 -5.268 . . . . 0.0 112.687 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.98 -2.22 39.12 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -104.42 -39.21 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -83.9 -19.87 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.747 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -179.565 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 tpp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.014 -0.041 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.74 150.72 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -129.76 140.99 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.74 142.13 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.1 mt -134.09 158.56 42.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -171.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -148.43 113.95 5.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.5 164.92 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -52.85 129.42 30.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.1 0.864 . . . . 0.0 112.168 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . . . -79.02 168.97 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.434 0.635 . . . . 0.0 109.665 176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' ' CG ' ' A' ' 201' ' ' HIS . . . -62.4 134.32 56.29 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.08 120.8 21.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.91 4.93 86.74 Favored Glycine 0 C--O 1.238 0.362 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.402 -173.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.19 88.81 4.04 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.84 36.06 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.052 1.835 . . . . 0.0 115.323 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -108.91 -19.71 13.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 tt -151.87 162.73 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -73.88 165.29 25.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.191 0.596 . . . . 0.0 111.939 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.76 170.01 27.8 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -75.06 104.13 5.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -167.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -115.91 161.34 31.31 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 147.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -65.5 -17.72 58.02 Favored 'Trans proline' 0 C--N 1.348 0.519 0 N-CA-C 116.881 1.839 . . . . 0.0 116.881 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -117.76 7.82 12.57 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.7 p -59.4 -44.21 92.84 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.9 0.857 . . . . 0.0 111.985 -174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -80.26 -13.94 58.8 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.786 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -61.46 -43.74 98.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.956 2.162 . . . . 0.0 112.842 -172.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -66.41 -46.67 86.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.6 mt -66.24 -39.22 89.39 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.541 -0.725 . . . . 0.0 112.174 -175.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -43.62 95.13 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.93 -0.481 . . . . 0.0 110.29 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 p -69.18 -38.59 78.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.442 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.37 -46.29 80.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 174.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.94 -27.33 36.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.692 -169.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -66.79 -39.64 87.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.473 -1.392 . . . . 0.0 109.381 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -83.83 4.49 28.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.659 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.4 pttm 44.07 47.04 7.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.028 2.131 . . . . 0.0 115.62 171.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 pt -97.87 149.9 36.2 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -76.35 158.44 36.88 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 117.601 -1.133 . . . . 0.0 114.05 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.81 162.13 41.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -144.3 140.91 29.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 t 68.96 123.73 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 126.227 2.204 . . . . 0.0 111.533 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -141.06 19.04 2.28 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 118.729 2.863 . . . . 0.0 118.729 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.1 mt -120.78 148.99 43.24 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 119.326 3.084 . . . . 0.0 119.326 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 45' ' ' GLY . 35.4 mm -131.03 108.58 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.443 1.897 . . . . 0.0 106.774 162.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.98 93.25 8.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.286 -1.509 . . . . 0.0 114.201 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt 47.33 48.23 16.41 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.518 1.127 . . . . 0.0 112.674 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 76.03 35.01 45.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.664 -175.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -64.13 107.4 1.27 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 152.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -145.01 79.12 12.09 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 121.472 0.653 . . . . 0.0 112.733 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.89 172.9 3.41 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 115.055 -2.83 . . . . 0.0 110.7 165.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.48 -30.58 60.86 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.236 -0.29 . . . . 0.0 111.571 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -56.16 -51.66 67.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -74.32 -25.56 59.63 Favored 'General case' 0 C--O 1.218 -0.581 0 O-C-N 120.646 -1.284 . . . . 0.0 111.194 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.5 mt -69.13 -25.49 64.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 119.22 0.918 . . . . 0.0 112.081 172.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.79 -29.33 61.06 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.532 -0.73 . . . . 0.0 110.492 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.67 -50.64 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 112.281 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -94.72 118.24 66.83 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 121.175 -0.953 . . . . 0.0 108.635 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.85 -21.38 38.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 N-CA-C 116.337 1.63 . . . . 0.0 116.337 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -93.69 -14.66 26.1 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.881 0.848 . . . . 0.0 110.839 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.79 -0.49 61.51 Favored Glycine 0 C--O 1.224 -0.471 0 O-C-N 121.78 -0.575 . . . . 0.0 113.212 -166.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -151.84 32.72 0.55 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.6 p -126.43 144.14 48.44 Favored Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.83 149.24 72.47 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 116.188 -2.075 . . . . 0.0 114.058 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.32 168.07 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.14 133.2 67.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 101.813 -3.402 . . . . 0.0 101.813 158.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -117.37 121.32 40.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 163.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.8 tt -131.41 123.38 52.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -172.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 t70 55.88 35.13 24.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.593 1.187 . . . . 0.0 111.077 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 64.78 23.04 12.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.457 1.903 . . . . 0.0 115.788 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -121.09 140.73 51.56 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -115.77 153.93 30.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.97 148.13 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -152.03 38.61 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -112.31 149.41 32.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.6 p -58.47 -28.47 65.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -168.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -88.56 -37.77 15.43 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.575 0.584 . . . . 0.0 112.575 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.1 m -75.98 -17.81 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.914 -1.116 . . . . 0.0 112.722 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.9 pt -69.91 -8.0 9.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.231 -0.293 . . . . 0.0 111.376 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.9 t -105.39 -51.44 8.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 160.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.22 91.95 Favored Glycine 0 C--O 1.228 -0.279 0 N-CA-C 117.941 1.936 . . . . 0.0 117.941 -172.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.6 mt -77.52 -31.97 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.57 -43.99 96.69 Favored 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.481 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.41 -46.99 87.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.793 0.724 . . . . 0.0 109.835 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -66.19 -17.98 65.07 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -106.78 -5.61 18.32 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.029 0.532 . . . . 0.0 112.295 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -70.04 138.55 87.43 Favored Pre-proline 0 C--N 1.323 -0.579 0 O-C-N 121.644 -0.66 . . . . 0.0 109.769 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -30.63 82.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.49 157.96 74.33 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 120.201 1.364 . . . . 0.0 107.949 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.77 141.12 93.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.013 -2.191 . . . . 0.0 114.792 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.56 151.39 52.73 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 116.919 -1.587 . . . . 0.0 111.415 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.5 mt -130.93 49.99 2.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -82.03 63.32 6.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.498 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.5 99.79 45.55 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -98.14 46.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 N-CA-C 121.231 3.512 . . . . 0.0 121.231 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -78.42 -124.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.225 0 CA-C-N 121.194 1.462 . . . . 0.0 114.237 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.34 -25.35 65.76 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.752 -1.843 . . . . 0.0 113.095 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -62.68 -42.52 99.67 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.541 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.45 -34.87 41.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.384 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 78.5 p -65.34 -34.56 78.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.098 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.56 -43.36 21.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.041 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.58 -37.18 93.77 Favored Glycine 0 CA--C 1.52 0.355 0 O-C-N 120.684 -1.26 . . . . 0.0 115.265 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 p -72.2 -15.37 61.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -77.61 -35.06 53.14 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.468 1.128 . . . . 0.0 110.13 171.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -77.73 -42.19 28.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.933 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -49.32 -52.68 46.89 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -76.75 -21.75 12.43 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 114.157 -3.429 . . . . 0.0 114.858 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.9 m -68.22 -43.59 77.66 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.576 -0.702 . . . . 0.0 111.619 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -78.0 -27.7 49.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 118.383 -1.327 . . . . 0.0 113.349 -175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.09 -29.24 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.15 -40.54 94.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 172.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.21 -36.28 81.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.616 -0.677 . . . . 0.0 111.226 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.51 -37.4 85.89 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.296 -0.253 . . . . 0.0 111.53 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -75.83 -27.91 58.07 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.238 -0.914 . . . . 0.0 113.458 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.8 t -61.32 137.35 58.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -128.6 29.7 5.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 166.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.21 172.53 9.51 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.39 106.17 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 114.234 -3.377 . . . . 0.0 109.939 149.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -125.69 26.57 6.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.44 -36.41 76.6 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.61 -41.06 97.97 Favored Glycine 0 C--O 1.225 -0.469 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -24.58 59.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 119.253 1.527 . . . . 0.0 113.176 177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.08 -42.05 94.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.229 1.014 . . . . 0.0 108.675 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -76.95 -16.16 59.44 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.193 -0.942 . . . . 0.0 112.21 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.39 -37.3 71.57 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.51 -41.09 96.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.395 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.3 tp -57.25 -47.26 81.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.365 0.416 . . . . 0.0 110.043 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -67.56 -39.56 84.93 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.47 -42.32 95.97 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 121.097 -1.002 . . . . 0.0 109.871 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.46 -20.44 57.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.137 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.43 -35.28 80.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.535 0.607 . . . . 0.0 111.736 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.06 99.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.194 0.997 . . . . 0.0 109.725 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.7 tp -70.14 -35.72 74.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.403 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.294 0.638 . . . . 0.0 112.462 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.66 -39.81 93.85 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 119.941 -1.123 . . . . 0.0 111.869 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.7 -32.62 72.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -48.43 35.74 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.285 -0.884 . . . . 0.0 110.113 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -74.01 -8.65 56.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -168.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.7 m -83.86 -10.56 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 167.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -117.45 -45.68 2.71 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.38 -67.88 0.23 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 119.981 2.753 . . . . 0.0 119.981 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -68.7 -169.33 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 CA-C-N 121.665 2.733 . . . . 0.0 113.92 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -56.08 173.76 0.15 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.6 mt -56.83 -40.36 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 112.159 -154.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.86 10.63 2.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.12 -22.69 37.07 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 167.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.08 -40.88 0.59 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -175.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.06 170.54 21.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -171.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.78 123.11 15.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -128.44 171.77 11.75 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.85 -32.62 32.68 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.74 -41.64 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 121.641 -0.662 . . . . 0.0 111.437 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.52 -40.86 93.48 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 46.8 mt -70.03 -21.19 63.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.316 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.2 m -85.6 -34.16 21.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 35.3 tp -97.85 -46.25 6.01 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.18 -38.83 72.62 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.7 -31.0 33.59 Favored 'Trans proline' 0 C--N 1.352 0.748 1 C-N-CA 111.838 -4.975 . . . . 0.0 115.465 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -72.11 -30.78 65.41 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.095 -1.003 . . . . 0.0 108.957 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.9 -34.5 77.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.42 -47.03 83.64 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.174 -0.954 . . . . 0.0 109.063 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.93 -33.63 75.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.643 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.85 -52.72 64.22 Favored 'General case' 0 C--O 1.208 -1.117 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.84 -36.55 79.4 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -169.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.6 m -77.05 -35.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.975 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.14 -45.57 56.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.667 0.746 . . . . 0.0 110.304 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.44 -38.52 91.3 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.929 0.492 . . . . 0.0 109.754 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.87 -34.94 89.28 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.987 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -80.24 -49.65 11.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.347 0.573 . . . . 0.0 112.487 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -76.89 -47.44 21.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -148.19 66.0 1.09 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -165.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -54.73 112.67 1.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -163.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 47.2 t90 -141.83 91.88 8.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.04 155.74 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 115.286 -2.676 . . . . 0.0 109.473 176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.91 123.58 89.65 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.65 154.8 63.98 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.557 -2.495 . . . . 0.0 112.247 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -75.22 2.7 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -71.22 -29.66 65.4 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.61 58.21 1.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -27.36 69.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.311 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -64.05 1.0 Allowed 'General case' 0 C--O 1.209 -1.046 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 167.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.74 -37.24 78.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -159.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.89 -50.93 71.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 174.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -76.19 -25.1 54.84 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.171 -0.956 . . . . 0.0 113.136 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.24 -49.47 71.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.548 0.689 . . . . 0.0 109.198 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.7 mt -62.61 -44.65 99.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.45 -48.34 81.05 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.7 -47.94 76.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 110.283 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 93.2 mt -76.18 -19.26 58.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.25 -32.97 64.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 t -116.81 29.69 7.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.52 0.676 . . . . 0.0 110.573 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -67.82 144.43 55.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.58 -37.63 70.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.645 1.111 . . . . 0.0 110.869 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -58.08 -50.02 74.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -68.05 -40.51 82.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -56.69 -36.91 70.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.562 0.696 . . . . 0.0 110.901 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -82.67 -36.18 26.17 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 59.5 p -104.83 3.16 30.8 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -170.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -57.86 141.43 49.21 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.512 -0.743 . . . . 0.0 111.82 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.49 163.49 27.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.52 127.24 31.93 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 171.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.2 mp0 -62.77 -36.24 82.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 111.899 -173.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -61.16 -30.13 70.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.741 0.781 . . . . 0.0 110.552 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.441 ' CG ' ' HB1' ' A' ' 10' ' ' ALA . 88.2 m-70 -96.44 -5.45 39.62 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 121.782 -0.574 . . . . 0.0 112.02 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.94 -50.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 162.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -64.87 -67.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.342 0.591 . . . . 0.0 110.107 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.99 62.98 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 120.57 -1.331 . . . . 0.0 111.917 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -91.33 -30.55 10.7 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -99.27 -28.93 13.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.91 1.855 . . . . 0.0 111.184 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -73.96 -3.1 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 119.926 3.306 . . . . 0.0 119.926 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -67.74 -19.32 47.49 Favored 'Trans proline' 0 C--N 1.36 1.137 1 C-N-CA 109.306 -6.663 . . . . 0.0 114.281 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -74.33 -23.08 58.99 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.348 0.976 . . . . 0.0 113.084 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.19 -31.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -100.12 27.43 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.962 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.816 1.646 . . . . 0.0 114.863 -174.735 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 119.705 -0.188 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.98 138.97 46.36 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.192 -0.942 . . . . 0.0 109.415 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 mp -124.87 140.37 52.98 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 103.439 -2.801 . . . . 0.0 103.439 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -132.79 162.39 31.62 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.35 155.42 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 101.41 -3.552 . . . . 0.0 101.41 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.7 m -115.75 118.37 32.86 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 101.703 -3.443 . . . . 0.0 101.703 164.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.64 159.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -71.92 122.25 20.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 162.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -75.06 165.37 25.35 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.58 130.43 46.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.152 0.977 . . . . 0.0 112.179 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.26 123.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.75 -9.93 66.79 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.34 0.896 . . . . 0.0 115.34 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.29 87.38 13.71 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 118.471 1.136 . . . . 0.0 112.027 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.16 50.87 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.967 3.778 . . . . 0.0 117.01 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.11 -31.6 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 -170.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -126.51 158.25 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.86 139.16 58.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.32 1.048 . . . . 0.0 109.522 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' CYS . . . -104.5 -157.92 23.75 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 120.188 2.835 . . . . 0.0 120.188 -172.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.02 31.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.156 2.182 . . . . 0.0 113.803 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLY . 40.5 t -66.69 121.98 80.0 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.721 177.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.88 -26.09 52.15 Favored 'Trans proline' 0 C--N 1.345 0.348 0 N-CA-C 117.06 1.908 . . . . 0.0 117.06 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -122.9 2.47 9.39 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 61' ' ' PRO . 68.2 m -64.59 -42.96 95.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.207 -0.933 . . . . 0.0 111.575 -174.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -72.16 -15.41 61.97 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.752 -1.179 . . . . 0.0 113.258 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.27 -38.83 92.45 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.253 1.388 . . . . 0.0 110.675 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.23 -44.88 20.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.29 -29.46 65.08 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 119.274 0.943 . . . . 0.0 112.684 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.4 p -76.56 -34.56 58.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.043 -1.036 . . . . 0.0 110.175 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.46 -39.47 85.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.114 0.959 . . . . 0.0 113.115 -175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -78.31 -27.19 47.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.104 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -67.54 -37.82 83.27 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.763 -1.21 . . . . 0.0 110.014 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -74.95 -17.85 60.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 54.73 36.57 26.59 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -78.0 165.15 52.79 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -54.41 139.18 74.33 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 119.495 0.855 . . . . 0.0 112.783 162.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.0 173.37 11.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 -143.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -110.21 118.43 36.32 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 112.772 -155.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -161.51 123.27 2.9 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 162.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -138.49 150.32 46.3 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 160.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 93.8 mt -108.15 120.55 42.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.182 0.446 . . . . 0.0 111.812 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.5 mt -81.54 92.81 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -84.53 81.14 8.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.998 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 mt 52.63 31.07 9.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.52 79.42 1.46 Allowed Glycine 0 C--O 1.235 0.186 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -110.36 -74.95 0.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.814 0.816 . . . . 0.0 110.269 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.27 149.32 91.59 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.994 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.8 -167.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 116.768 1.795 . . . . 0.0 116.768 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -52.87 -22.4 5.44 Favored 'General case' 0 C--O 1.217 -0.612 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -45.62 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 119.595 1.089 . . . . 0.0 111.2 174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.75 -34.93 64.94 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.533 -0.729 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.76 -27.24 62.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -68.44 -33.25 73.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.441 0.639 . . . . 0.0 110.771 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.8 mm -84.96 -48.51 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.404 0.621 . . . . 0.0 111.268 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -82.6 114.33 51.09 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 122.987 0.515 . . . . 0.0 111.4 -174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.46 -24.41 31.08 Favored 'Trans proline' 0 C--N 1.347 0.496 0 N-CA-C 117.294 1.998 . . . . 0.0 117.294 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -92.83 -7.47 46.28 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 172.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.82 -16.54 11.25 Favored Glycine 0 C--O 1.225 -0.434 0 O-C-N 121.705 -0.622 . . . . 0.0 112.683 -167.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -140.89 24.93 2.16 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 m -79.47 163.41 59.2 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 172.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 58.4 Cg_endo -67.19 142.93 62.76 Favored 'Trans proline' 0 C--N 1.35 0.611 1 C-N-CA 112.148 -4.768 . . . . 0.0 112.352 161.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.1 t -128.84 132.97 67.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.3 m -110.67 122.45 65.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.43 1.109 . . . . 0.0 109.625 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -95.32 128.92 42.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 75.7 mt -130.45 91.49 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.4 t0 51.16 51.39 17.08 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.289 1.042 . . . . 0.0 110.864 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 t0 63.16 8.36 3.27 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.66 144.03 34.1 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 157.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -128.0 124.82 38.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 120.481 1.491 . . . . 0.0 109.167 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.43 156.99 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.94 96.58 1.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -154.65 153.92 32.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 101.815 -3.402 . . . . 0.0 101.815 167.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.9 p -61.96 -32.57 73.03 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -95.6 -14.36 23.61 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -81.36 -21.12 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.937 -1.727 . . . . 0.0 108.041 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -21.31 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.143 171.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.7 t -89.1 -48.49 14.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.62 -64.7 1.2 Allowed Glycine 0 CA--C 1.519 0.291 0 N-CA-C 120.389 2.915 . . . . 0.0 120.389 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.81 -34.16 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.651 0.739 . . . . 0.0 109.336 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.94 -47.21 87.48 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.089 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -66.25 -34.28 77.66 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.09 0.859 . . . . 0.0 112.107 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.46 -28.06 63.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.809 0.844 . . . . 0.0 110.407 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -120.2 21.55 11.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -100.82 76.22 0.14 Allowed Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.442 0.697 . . . . 0.0 111.647 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.7 5.63 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.748 2 C-N-CA 125.757 4.305 . . . . 0.0 123.119 -131.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -74.88 172.48 8.9 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 158.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.61 135.42 70.34 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 114.988 -2.875 . . . . 0.0 116.904 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.54 116.8 4.81 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.477 1.451 . . . . 0.0 114.033 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.78 81.7 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.544 1.164 . . . . 0.0 113.528 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -118.27 73.72 0.92 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.189 -1.369 . . . . 0.0 112.969 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.19 114.62 63.28 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -106.7 61.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.64 0 N-CA-C 117.846 2.21 . . . . 0.0 117.846 168.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.95 -132.18 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.913 0 CA-C-N 120.03 1.047 . . . . 0.0 112.715 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.06 -37.53 61.69 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -25.69 68.26 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 120.927 -1.108 . . . . 0.0 112.515 -177.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.55 70.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.408 -0.807 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.8 p -72.53 -33.67 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.68 -49.48 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.507 0.67 . . . . 0.0 109.244 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.66 -37.64 94.64 Favored Glycine 0 C--O 1.228 -0.234 0 O-C-N 122.094 -0.379 . . . . 0.0 113.915 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.1 p -71.68 -12.37 61.3 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.99 -36.56 27.75 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.98 -1.075 . . . . 0.0 110.313 169.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.97 -46.6 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.353 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -50.0 -54.24 34.93 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 -171.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.35 -19.85 12.98 Favored 'Trans proline' 0 C--N 1.349 0.601 1 C-N-CA 112.305 -4.664 . . . . 0.0 114.319 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -66.88 -47.16 72.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -171.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -73.32 -24.47 60.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 118.633 -1.227 . . . . 0.0 112.006 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.44 -38.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.91 -48.89 76.98 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -59.88 -43.92 94.48 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.77 -18.7 62.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.0 0.2 43.37 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.384 -0.197 . . . . 0.0 110.607 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.9 t -110.19 142.18 42.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -127.73 33.53 4.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.65 171.56 10.5 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 173.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.84 78.78 2.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 CA-C-N 120.642 1.265 . . . . 0.0 114.569 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -91.26 26.02 2.35 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -155.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.3 -35.42 80.3 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 119.683 -1.886 . . . . 0.0 112.263 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.39 -32.06 68.36 Favored Glycine 0 C--O 1.223 -0.562 0 O-C-N 121.463 -0.773 . . . . 0.0 112.966 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 m -77.98 -30.35 50.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.536 1.168 . . . . 0.0 111.398 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.0 -41.79 99.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.502 1.144 . . . . 0.0 108.351 171.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -73.75 -24.29 59.86 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.172 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.45 99.43 Favored 'General case' 0 C--O 1.221 -0.427 0 O-C-N 120.799 -1.188 . . . . 0.0 108.819 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.0 -44.41 96.11 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.13 -44.15 97.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -80.84 -30.65 35.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.65 -35.59 60.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.151 -0.968 . . . . 0.0 109.062 175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.71 -17.45 57.61 Favored 'General case' 0 C--O 1.216 -0.68 0 O-C-N 120.96 -1.088 . . . . 0.0 109.837 173.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -69.55 -35.66 75.64 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.294 -1.504 . . . . 0.0 110.286 167.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.15 -45.53 93.04 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.11 -39.54 90.38 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -40.77 98.3 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.927 -1.108 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.95 -35.87 72.65 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.643 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -72.87 -36.84 67.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.483 -1.01 . . . . 0.0 112.631 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.2 mt -65.24 -43.25 91.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 109.825 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.32 -19.49 63.07 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.979 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.68 -25.95 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.807 0.73 . . . . 0.0 111.095 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -112.46 -35.89 5.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.87 -71.16 0.22 Allowed Glycine 0 CA--C 1.524 0.609 0 CA-C-O 117.403 -1.776 . . . . 0.0 114.714 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.44 -160.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.799 4.333 . . . . 0.0 118.486 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -56.92 166.67 0.95 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.286 1.434 . . . . 0.0 112.159 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.0 tt -52.46 -33.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.53 8.08 4.74 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.97 -33.81 5.49 Favored Glycine 0 C--O 1.225 -0.438 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 167.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.07 -40.22 2.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.747 1.273 . . . . 0.0 112.331 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -159.41 -178.52 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.977 0.511 . . . . 0.0 110.249 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.8 mt -67.42 121.34 16.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 m -153.29 171.25 18.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 -174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 90' ' ' ALA . . . -25.57 -54.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.969 1 N-CA-C 122.677 4.325 . . . . 0.0 122.677 -173.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 48.4 t -65.17 -35.34 75.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.015 -1.053 . . . . 0.0 110.483 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.32 -43.43 73.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 71.9 mt -62.23 -32.56 73.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.596 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.2 m -71.13 -38.65 72.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.1 tp -100.32 -45.69 5.51 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -170.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.41 -43.13 97.38 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.12 -20.79 24.62 Favored 'Trans proline' 0 C--N 1.35 0.614 1 C-N-CA 111.296 -5.336 . . . . 0.0 114.782 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -78.29 -22.35 48.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 120.931 -1.106 . . . . 0.0 110.556 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 -27.01 63.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 118.435 0.561 . . . . 0.0 111.092 169.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -71.7 -44.53 64.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.157 -0.965 . . . . 0.0 110.263 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -62.67 -30.27 71.26 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.875 -0.515 . . . . 0.0 111.211 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.92 -58.36 8.9 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.25 -31.65 72.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.651 -0.82 . . . . 0.0 112.273 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.4 t -64.86 -54.88 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.758 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.86 -41.19 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 48.1 tp -67.77 -37.82 82.61 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.01 -32.88 81.86 Favored Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -74.95 -48.38 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -85.39 -45.05 12.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -167.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -149.1 60.98 1.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -170.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -52.3 120.64 5.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 -162.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -145.48 93.82 5.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 163.01 39.58 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 115.882 -2.279 . . . . 0.0 109.879 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 83.0 mt -73.4 124.81 90.84 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.7 166.44 29.33 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 117.105 -1.464 . . . . 0.0 113.92 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.86 -0.14 20.21 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.436 1.112 . . . . 0.0 112.27 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.31 -14.37 61.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.25 51.95 1.17 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.9 t -62.77 -26.26 68.62 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.709 -0.62 . . . . 0.0 112.464 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -74.91 -35.25 62.22 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 120.696 -1.252 . . . . 0.0 108.066 -177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.6 t -72.2 -40.39 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.605 0.717 . . . . 0.0 109.368 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.42 -44.66 90.51 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.969 -0.457 . . . . 0.0 111.491 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.52 -23.83 61.06 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.027 -1.046 . . . . 0.0 111.734 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.405 ' CZ ' HD11 ' A' ' 186' ' ' LEU . 17.3 t80 -68.96 -49.17 60.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.905 0.482 . . . . 0.0 110.31 173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.64 -33.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 O-C-N 120.906 -1.121 . . . . 0.0 111.372 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.02 -38.9 90.44 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.861 -1.149 . . . . 0.0 111.459 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.61 -42.69 86.48 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.69 -0.631 . . . . 0.0 111.835 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.405 HD11 ' CZ ' ' A' ' 182' ' ' TYR . 40.5 mt -66.18 -46.72 76.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -55.85 -42.43 75.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 14.9 t -106.32 71.25 0.87 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 111.037 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.58 153.41 43.74 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -57.33 -48.68 78.35 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 123.809 0.693 . . . . 0.0 110.699 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.0 t -65.58 -43.71 88.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.928 0.87 . . . . 0.0 112.28 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -65.25 -45.26 85.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.641 0.734 . . . . 0.0 110.626 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.98 -37.68 81.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.499 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -69.65 -36.49 76.12 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.0 -1.062 . . . . 0.0 111.984 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 64.2 p -87.93 -0.28 56.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -62.04 141.17 58.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.34 152.92 44.73 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.41 122.11 15.94 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.02 -48.6 73.33 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -166.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 200' ' ' GLU . 0.9 OUTLIER -64.68 -21.71 66.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.692 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -95.64 -1.59 49.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.58 -44.73 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 164.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.95 -55.08 24.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.15 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.8 5.45 9.49 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.509 -0.744 . . . . 0.0 112.819 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -93.71 -44.26 3.7 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 169.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -91.06 -38.37 12.83 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.34 -20.42 0.58 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.34 -24.58 71.53 Favored 'Trans proline' 0 C--N 1.353 0.776 1 C-N-CA 111.761 -5.026 . . . . 0.0 115.372 167.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -79.63 -36.47 37.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 121.175 1.807 . . . . 0.0 111.226 172.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.61 -35.54 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 121.614 -0.679 . . . . 0.0 110.345 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -97.12 -16.0 20.69 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-N 119.141 0.882 . . . . 0.0 113.168 -171.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.373 0.13 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.38 154.81 43.06 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.615 0.766 . . . . 0.0 109.25 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 pp -139.0 160.71 39.13 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.36 139.79 43.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.84 114.36 37.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.8 m -109.86 130.84 55.48 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.08 139.82 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 123.991 0.807 . . . . 0.0 112.264 -164.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.48 128.5 36.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.087 0.403 . . . . 0.0 110.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.05 176.34 9.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.202 1.001 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 13' ' ' ALA . . . -61.39 148.51 41.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.858 1.313 . . . . 0.0 109.385 167.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.39 109.84 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.354 -170.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.97 23.48 66.4 Favored Glycine 0 C--O 1.241 0.562 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.665 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . . . -146.92 89.29 5.69 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.96 54.52 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.945 3.097 . . . . 0.0 114.245 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -141.43 -28.08 0.67 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 pt -141.45 168.69 15.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 118.445 0.566 . . . . 0.0 110.518 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -73.27 146.82 45.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.114 1.765 . . . . 0.0 112.748 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.74 -174.6 13.81 Favored Glycine 0 N--CA 1.462 0.432 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -73.56 92.43 1.92 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.422 1.106 . . . . 0.0 111.355 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.77 135.72 22.42 Favored Pre-proline 0 C--O 1.246 0.883 1 N-CA-C 99.344 -4.317 . . . . 0.0 99.344 138.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -57.42 -39.62 87.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.21 0.754 . . . . 0.0 112.956 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.24 -23.29 43.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.054 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.53 -34.24 77.76 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 120.801 -1.187 . . . . 0.0 113.418 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -80.61 -12.74 59.46 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.565 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' A' ' 155' ' ' PRO . 89.0 mtt180 -69.0 -41.91 77.18 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -44.95 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.859 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mt -64.26 -39.37 93.82 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.748 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.52 -43.3 97.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.569 0.622 . . . . 0.0 111.385 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 p -70.17 -39.13 75.49 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -65.62 -43.91 88.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -76.24 -29.28 57.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.548 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -68.42 -34.32 75.8 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.528 -1.358 . . . . 0.0 111.401 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HG3' HD21 ' A' ' 84' ' ' ASN . 33.9 mmtp -88.52 -11.46 45.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 52.47 51.97 15.1 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.352 1.461 . . . . 0.0 113.622 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.3 pt -98.8 155.1 37.03 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.05 145.16 30.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.837 -2.975 . . . . 0.0 111.314 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -152.54 157.95 41.81 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 121.993 -0.442 . . . . 0.0 110.756 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -110.78 110.51 21.17 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.662 0.385 . . . . 0.0 111.719 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.3 t -86.1 128.38 34.87 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -122.11 93.57 4.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.654 1.182 . . . . 0.0 111.437 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.67 142.91 57.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.889 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.05 94.2 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -80.5 85.07 5.99 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.495 -0.753 . . . . 0.0 112.039 177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.4 mt 54.35 45.06 27.98 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 122.002 0.906 . . . . 0.0 113.164 166.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.72 94.36 1.85 Allowed Glycine 0 C--O 1.238 0.352 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.523 -168.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -124.59 -91.08 0.55 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -69.68 152.38 96.2 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.204 -170.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.97 -175.68 0.13 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.552 2.168 . . . . 0.0 115.282 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -64.19 -10.76 25.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -161.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 64.2 t-105 -49.3 -41.04 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.741 0.416 . . . . 0.0 110.094 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -79.84 -28.69 40.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.2 -34.8 78.28 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.895 0.855 . . . . 0.0 110.507 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.89 -36.64 84.59 Favored 'General case' 0 C--O 1.249 1.054 0 O-C-N 121.362 -0.837 . . . . 0.0 110.362 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 90.1 mt -75.62 -45.81 38.11 Favored 'Isoleucine or valine' 0 C--O 1.248 1.013 0 C-N-CA 124.038 0.935 . . . . 0.0 112.716 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.586 ' OG ' HG22 ' A' ' 60' ' ' VAL . 28.7 t -102.99 129.62 25.27 Favored Pre-proline 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 112.973 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.29 -23.16 28.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 116.655 -1.764 . . . . 0.0 116.39 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.72 -10.96 25.77 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.788 -1.195 . . . . 0.0 110.718 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.67 -5.93 67.5 Favored Glycine 0 CA--C 1.524 0.607 0 O-C-N 121.561 -0.712 . . . . 0.0 113.8 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -144.89 34.43 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -167.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' OG ' ' A' ' 55' ' ' SER . 11.8 m -119.16 161.81 34.92 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.934 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.63 151.25 58.11 Favored 'Trans proline' 0 C--N 1.35 0.621 1 C-N-CA 111.417 -5.255 . . . . 0.0 110.081 171.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.6 161.51 36.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 m -122.29 126.26 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 118.999 0.818 . . . . 0.0 109.375 160.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.05 87.64 3.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.06 111.07 23.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 47.76 56.15 7.54 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.132 0.895 . . . . 0.0 113.27 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 t70 71.4 -7.32 1.2 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.94 122.85 44.2 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.047 -1.033 . . . . 0.0 110.147 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -107.07 131.42 54.12 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.65 144.74 37.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-N 115.256 -0.883 . . . . 0.0 113.331 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.72 115.63 1.65 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.35 157.08 10.63 Favored 'General case' 0 N--CA 1.472 0.654 1 N-CA-C 96.959 -5.2 . . . . 0.0 96.959 160.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.9 p -57.44 -35.17 69.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.92 -41.17 60.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.059 -0.4 . . . . 0.0 111.907 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 m -81.64 -17.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 121.837 -0.539 . . . . 0.0 110.691 -171.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -23.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -100.63 -47.91 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 110.083 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.4 -38.1 62.47 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.4 mt -80.47 -29.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.596 1.698 . . . . 0.0 106.629 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.28 -41.15 92.72 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.718 173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -68.59 -39.75 80.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 112.798 173.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -60.47 -33.46 72.6 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.131 -0.981 . . . . 0.0 111.454 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.81 10.86 38.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.446 HD21 ' HG3' ' A' ' 33' ' ' LYS . 33.8 t-20 -69.54 130.99 90.13 Favored Pre-proline 0 C--O 1.247 0.927 0 O-C-N 121.606 -0.683 . . . . 0.0 109.195 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.41 -17.3 30.64 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 117.129 -1.448 . . . . 0.0 113.779 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -94.98 161.54 27.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -63.93 144.13 87.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 115.807 -2.329 . . . . 0.0 117.122 -169.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.23 136.52 7.85 Favored 'Trans proline' 0 C--O 1.24 0.584 0 N-CA-C 118.366 2.41 . . . . 0.0 118.366 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.6 mt -120.26 41.36 3.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.329 1.052 . . . . 0.0 111.981 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.57 66.76 4.17 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.759 0.824 . . . . 0.0 112.016 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.3 m -125.11 106.08 28.52 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 118.802 -0.618 . . . . 0.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -100.7 75.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 125.158 3.905 . . . . 0.0 118.01 166.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -91.0 -140.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.474 1.449 . . . . 0.0 114.241 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -49.87 -37.12 29.65 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -172.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -69.05 -25.52 64.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.114 -0.991 . . . . 0.0 112.428 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.28 -27.49 47.42 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.874 -0.516 . . . . 0.0 111.895 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 88.1 p -70.12 -32.81 71.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.71 -38.84 45.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.9 -39.41 93.98 Favored Glycine 0 C--O 1.227 -0.308 0 O-C-N 121.702 -0.624 . . . . 0.0 112.815 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.9 p -76.51 5.92 6.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.083 1.441 . . . . 0.0 114.45 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -104.29 -25.49 12.86 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.419 -0.801 . . . . 0.0 112.535 165.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.3 mt -85.92 -47.89 16.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.955 0.407 . . . . 0.0 111.098 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -50.37 -52.02 58.55 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.19 -20.97 10.94 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 114.307 -3.328 . . . . 0.0 115.861 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.1 p -79.73 -37.88 34.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.306 -0.871 . . . . 0.0 110.724 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -46.8 89.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.831 0.824 . . . . 0.0 109.494 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.84 -26.7 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 121.39 -0.819 . . . . 0.0 112.318 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -65.45 -43.17 91.21 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 120.87 -1.144 . . . . 0.0 109.26 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.38 -23.37 63.73 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.3 tp -66.05 -38.83 89.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.774 0.715 . . . . 0.0 110.955 171.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -83.02 -31.27 27.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 t -74.0 131.24 41.19 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -114.64 30.61 7.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.298 1.047 . . . . 0.0 109.497 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -70.35 171.34 8.02 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.013 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.28 95.73 0.69 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 116.249 -2.034 . . . . 0.0 112.447 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -115.3 59.23 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.281 -171.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -94.63 -45.18 7.49 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.64 -28.01 62.05 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.288 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 p -97.8 -5.1 35.55 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -71.6 -31.31 66.77 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 161.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -76.73 0.08 21.81 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.947 -1.096 . . . . 0.0 111.596 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.22 69.23 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 166.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.19 -35.42 79.6 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 121.473 -0.767 . . . . 0.0 109.942 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.2 -43.64 92.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.89 -28.77 64.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -79.18 -36.29 40.54 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 120.543 -1.348 . . . . 0.0 110.381 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.3 mt -74.37 -25.48 59.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.072 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.74 -34.29 72.76 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 118.55 0.613 . . . . 0.0 111.231 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.89 -48.7 77.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.12 -36.2 82.53 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.751 0.705 . . . . 0.0 111.936 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.99 -42.12 89.28 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.12 0.568 . . . . 0.0 111.741 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.04 57.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.358 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -36.23 75.28 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.807 0.443 . . . . 0.0 111.521 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -54.09 18.7 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.678 -0.638 . . . . 0.0 109.937 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.6 -24.24 67.02 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -169.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.6 m -79.57 -11.35 12.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -114.61 -39.86 3.69 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 115.48 -68.17 0.27 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 121.267 3.267 . . . . 0.0 121.267 173.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -74.47 -171.42 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 N-CA-C 120.213 3.121 . . . . 0.0 120.213 -174.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -49.73 154.03 1.11 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.028 165.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -67.2 -32.8 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.692 -124.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.15 -19.48 5.13 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.97 3.51 48.71 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-O 119.224 -0.765 . . . . 0.0 112.18 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -139.61 -62.25 0.53 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -163.24 178.9 7.81 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.89 114.05 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 O-C-N 124.143 0.902 . . . . 0.0 110.593 173.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -120.92 -169.93 1.92 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.38 -30.5 29.31 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.71 -40.56 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 120.404 -1.435 . . . . 0.0 111.601 176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.5 -39.9 94.65 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 85.4 mt -67.3 -28.98 68.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 p -70.92 -37.22 72.9 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.084 -1.01 . . . . 0.0 111.719 174.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 23.4 mt -91.12 -59.93 2.03 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.06 -40.88 76.61 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 25' ' ' ARG . 89.8 Cg_endo -69.1 -24.33 32.82 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 113.842 -3.639 . . . . 0.0 115.996 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -88.02 -29.41 20.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.294 1.406 . . . . 0.0 108.902 175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.85 -35.73 73.42 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.376 0.535 . . . . 0.0 110.54 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.46 -48.46 71.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 170.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -65.36 -40.88 94.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.43 76.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.819 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.67 -28.21 68.28 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.811 1.187 . . . . 0.0 112.888 -174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.1 m -81.01 -38.05 16.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 O-C-N 121.052 -1.03 . . . . 0.0 110.102 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.26 -49.5 19.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.145 0.429 . . . . 0.0 111.979 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.01 -35.41 80.61 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.06 -29.91 76.24 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 115.432 0.933 . . . . 0.0 115.432 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -89.7 -44.1 10.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.371 1.085 . . . . 0.0 113.057 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.17 -37.27 20.36 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -138.5 30.92 2.34 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.917 0.487 . . . . 0.0 112.277 -163.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -22.93 109.81 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 119.282 3.067 . . . . 0.0 119.282 -152.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -142.22 90.44 8.21 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.869 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.55 160.01 42.03 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 117.121 -1.453 . . . . 0.0 110.344 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.62 121.65 85.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.93 162.43 34.74 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 116.619 -1.788 . . . . 0.0 113.911 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -4.41 30.37 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.317 -0.864 . . . . 0.0 112.949 177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -66.62 -22.91 66.11 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.478 0.656 . . . . 0.0 110.206 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.33 66.38 0.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.8 m -58.53 -36.57 74.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.361 -170.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -51.69 68.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 45.5 t -69.57 -41.58 80.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -161.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.0 tp -69.23 -46.99 65.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.726 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.56 -45.73 89.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.092 -176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -72.6 -29.05 63.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.459 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.59 -40.96 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.857 1.208 . . . . 0.0 110.057 171.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.82 -33.75 74.37 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.553 -0.717 . . . . 0.0 112.721 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.9 -38.13 79.4 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.196 0.907 . . . . 0.0 110.869 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.5 -42.02 88.01 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.387 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -50.49 -38.79 46.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -173.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.3 t -120.79 38.55 4.01 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.727 1.251 . . . . 0.0 110.761 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -78.85 143.32 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 161.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -56.55 -45.37 81.28 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.58 1.082 . . . . 0.0 113.653 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 37.8 p -62.22 -44.78 95.81 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -77.07 -38.0 53.41 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.396 -0.815 . . . . 0.0 112.67 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -59.32 -36.46 75.69 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.045 0.926 . . . . 0.0 110.874 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -77.01 -40.95 44.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.9 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.7 p -98.47 -3.63 36.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 117.04 2.237 . . . . 0.0 117.04 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -60.28 140.86 56.84 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.21 150.03 40.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.9 139.01 58.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -63.93 -39.27 93.79 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -61.75 -31.04 71.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 122.568 1.175 . . . . 0.0 109.698 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -96.16 10.19 38.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.526 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.2 t -100.85 -51.69 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.439 156.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.9 -66.4 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.07 -9.73 58.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.107 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.78 -31.37 29.74 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.442 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -110.6 -28.09 8.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.605 1.202 . . . . 0.0 112.975 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -74.46 -9.7 0.15 Allowed Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 121.618 3.932 . . . . 0.0 121.618 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.92 -20.36 57.94 Favored 'Trans proline' 0 C--N 1.36 1.147 1 C-N-CA 111.354 -5.297 . . . . 0.0 114.639 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -73.31 -27.97 61.82 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.346 -0.846 . . . . 0.0 113.204 172.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.2 t -72.56 -34.88 49.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.489 1.138 . . . . 0.0 108.216 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -79.26 2.48 21.12 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.381 0 C-N-CA 128.545 2.738 . . . . 0.0 115.872 -179.034 . . . . . . . . 0 0 . 1 stop_ save_